Citrus Sinensis ID: 007200
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | 2.2.26 [Sep-21-2011] | |||||||
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | yes | no | 0.985 | 0.982 | 0.855 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.960 | 0.937 | 0.808 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.990 | 0.971 | 0.787 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.960 | 0.95 | 0.795 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.959 | 0.978 | 0.711 | 0.0 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.990 | 0.990 | 0.557 | 1e-176 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.977 | 0.986 | 0.548 | 1e-171 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.941 | 0.904 | 0.532 | 1e-170 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.939 | 0.907 | 0.527 | 1e-169 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.988 | 0.958 | 0.508 | 1e-162 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/607 (85%), Positives = 555/607 (91%), Gaps = 3/607 (0%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQG 549
QRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ
Sbjct: 489 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 548
Query: 550 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQP 606
SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T HP + WI+ DSTS I+
Sbjct: 549 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIEN 608
Query: 607 DELSGPR 613
+ SGPR
Sbjct: 609 EYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/601 (80%), Positives = 528/601 (87%), Gaps = 12/601 (1%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQ 84
+SN EGDAL++L+ NL DPNNVLQSWD TLVNPCTWFHVTCN+ENSV RVDLGNA+LSGQ
Sbjct: 28 SSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQ 87
Query: 85 LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR 144
LV QLGQL NLQYLELYSNNI+G VP +LGNLTNLVSLDLYLN+ GPIP +LGKL KLR
Sbjct: 88 LVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLR 147
Query: 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNP 203
FLRLNNNSL G IP SLTN+ +LQVLDLSNN+L+G +P NGSFSLFTPISFANN L P
Sbjct: 148 FLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGP 207
Query: 204 PPS-----------PPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRK 252
S PPP + P G SATGAIAGGVAAGAALLFAAPA+A A+WR+
Sbjct: 208 VTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRR 267
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGRL DG
Sbjct: 268 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG 327
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSV
Sbjct: 328 TLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 387
Query: 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
ASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAV
Sbjct: 388 ASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 447
Query: 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492
VGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRA
Sbjct: 448 VGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRA 507
Query: 493 FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPM 552
FDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++ NY E EVEQLIQVALLCTQ SPM
Sbjct: 508 FDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPM 567
Query: 553 ERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGP 612
ERPKMSEVVRMLEGDGLAE+W+EWQK E+ RQ+ + HP + WI+DST ++ ELSGP
Sbjct: 568 ERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGP 627
Query: 613 R 613
R
Sbjct: 628 R 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 924 bits (2388), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/620 (78%), Positives = 532/620 (85%), Gaps = 13/620 (2%)
Query: 7 VVWAFLVSILFFDLLLRVAS-NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
VV+ L IL + L +AS N EGDAL+ L+ L DPNNVLQSWD TLVNPCTWFHVTC
Sbjct: 6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N+ENSV RVDLGNA LSG LV +LG L NLQYLELYSNNI+G +P LGNLTNLVSLDLY
Sbjct: 66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
LN+ +GPIP +LGKLSKLRFLRLNNNSL G IP SLTN+ +LQVLDLSNN+L+G +P NG
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185
Query: 186 SFSLFTPISFANN-QLNNPPPSPPPPLQPTPP-----------GASSGNSATGAIAGGVA 233
SFSLFTPISFANN L P S P P P SG TGAIAGGVA
Sbjct: 186 SFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVA 245
Query: 234 AGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR 293
AGAALLFAAPAIA A+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+
Sbjct: 246 AGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNK 305
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
NILGRGGFGKVYKGRL DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGF
Sbjct: 306 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 365
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
CMTPTERLLVYP+M NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKI
Sbjct: 366 CMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKI 425
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK
Sbjct: 426 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 485
Query: 474 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE 533
TDVFGYG+MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++ NY E
Sbjct: 486 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEE 545
Query: 534 EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPN 593
E+EQ+IQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ R++ + +P+PN
Sbjct: 546 RELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPN 605
Query: 594 NTWIVDSTSHIQPDELSGPR 613
+ WI+DST ++ ELSGPR
Sbjct: 606 SDWILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 919 bits (2375), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/597 (79%), Positives = 520/597 (87%), Gaps = 8/597 (1%)
Query: 23 RVASNAEGDALNALKTNLA--DP-NNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA 79
RVA NAEGDAL LK +L+ DP NNVLQSWDATLV PCTWFHVTCN EN VTRVDLGNA
Sbjct: 26 RVAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNA 85
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
LSG+LV +LGQL NLQYLELYSNNI+G++PEELG+L LVSLDLY N+++GPIP++LGK
Sbjct: 86 KLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGK 145
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199
L KLRFLRLNNNSL GEIP +LT+V LQVLD+SNN+L+GDIP NGSFSLFTPISFANN
Sbjct: 146 LGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNS 204
Query: 200 LNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHF 259
L + P PP PTP SG T AIAGGVAAGAALLFA PAIA A+W +RKP+DHF
Sbjct: 205 LTDLPEPPPTSTSPTP-PPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHF 263
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR 319
FDVPAEEDPEVHLGQLKRF+LREL VATDNFSN+N+LGRGGFGKVYKGRL DG+LVAVKR
Sbjct: 264 FDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKR 323
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
LKEERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER
Sbjct: 324 LKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 383
Query: 380 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439
+ P L+W RK IALG+ARGLAYLHDHCD KIIHRDVKAANILLDEEFEAVVGDFGLA
Sbjct: 384 PEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLA 443
Query: 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499
KLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLA
Sbjct: 444 KLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLA 503
Query: 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 559
NDDD+MLLDWVK +LKEKKLE LVD+++EG Y+E EVEQLIQ+ALLCTQ S MERPKMSE
Sbjct: 504 NDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSE 563
Query: 560 VVRMLEGDGLAERWEEWQKEEMFRQDFNHT--PHPNNTWIVD-STSHIQPDELSGPR 613
VVRMLEGDGLAERWEEWQKEEM DFN+ PH W++ S S I+ D SGPR
Sbjct: 564 VVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/610 (71%), Positives = 495/610 (81%), Gaps = 22/610 (3%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLAD---PNNVLQSWDATLVNPCTWFHVTCN 66
F+ ILF D + RV + DAL AL+++L+ NN+LQSW+AT V PC+WFHVTCN
Sbjct: 8 GFIWLILFLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCN 67
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
+ENSVTR+DLG+ANLSG+LV QL QL NLQYLEL++NNI+G++PEELG+L LVSLDL+
Sbjct: 68 TENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFA 127
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
NN++GPIP++LGKL KLRFLRL NNSL GEIPRSLT + L VLD+SNN+L+GDIP NGS
Sbjct: 128 NNISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGS 186
Query: 187 FSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIA 246
FS FT +SFANN+L + S + + AI GVAAGAALLFA
Sbjct: 187 FSQFTSMSFANNKLR----------PRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWL 236
Query: 247 LAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYK 306
+RK + HF DVPAEEDPEV+LGQ KRFSLREL VAT+ FS RN+LG+G FG +YK
Sbjct: 237 -----RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYK 291
Query: 307 GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366
GRL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+
Sbjct: 292 GRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 351
Query: 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426
M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIH DVKAANILLD
Sbjct: 352 MANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLD 411
Query: 427 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
EEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL
Sbjct: 412 EEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 471
Query: 487 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 546
ITGQ+AFDLARLANDDD+MLLDWVK +LKEKKLE LVD+++EG Y+E EVEQLIQ+ALLC
Sbjct: 472 ITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLC 531
Query: 547 TQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT--PHPNNTWIVD-STSH 603
TQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DFN+ PH W++ S S
Sbjct: 532 TQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSL 591
Query: 604 IQPDELSGPR 613
I+ D SGPR
Sbjct: 592 IENDYPSGPR 601
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1594), Expect = e-176, Method: Compositional matrix adjust.
Identities = 344/617 (55%), Positives = 420/617 (68%), Gaps = 10/617 (1%)
Query: 1 MGKLERVVWAFLVSILFFDLLLR-VASNAEGDALNALKTNLADPNNVLQSWDATLVNPCT 59
M L+++ AF ++LFF L V+ +A+GDAL AL+ +L N L W+ VNPCT
Sbjct: 3 MFSLQKMAMAF--TLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCT 60
Query: 60 WFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL 119
W V C+ +N VT + L + N SG L S++G L NL+ L L N I+G++PE+ GNLT+L
Sbjct: 61 WSQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSL 120
Query: 120 VSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
SLDL N L G IP+T+G L KL+FL L+ N L G IP SLT + +L L L +N L+G
Sbjct: 121 TSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSG 180
Query: 180 DIPTNGSFSLFT--PISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAA 237
IP SLF +F +N LN P P + S TG IAG VA
Sbjct: 181 QIPQ----SLFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTV 236
Query: 238 LLFAAPAIALAYWR-KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL 296
+LF R K D F DV E D + GQLKRF+ RELQ+ATDNFS +N+L
Sbjct: 237 VLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVL 296
Query: 297 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356
G+GGFGKVYKG L D + VAVKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T
Sbjct: 297 GQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 356
Query: 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416
TERLLVYPFM N S+A LRE P L+W RK+IALGAARG YLH+HC+PKIIHR
Sbjct: 357 QTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHR 416
Query: 417 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 476
DVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDV
Sbjct: 417 DVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDV 476
Query: 477 FGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEV 536
FGYG+MLLEL+TGQRA D +RL +DDV+LLD VK L +EK+L +VD +++G YI+EEV
Sbjct: 477 FGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEV 536
Query: 537 EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTW 596
E +IQVALLCTQGSP +RP MSEVVRMLEG+GLAERWEEWQ E+ R+ W
Sbjct: 537 EMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDW 596
Query: 597 IVDSTSHIQPDELSGPR 613
DS + ELSG R
Sbjct: 597 GEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 603 bits (1555), Expect = e-171, Method: Compositional matrix adjust.
Identities = 333/607 (54%), Positives = 413/607 (68%), Gaps = 8/607 (1%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
+ +++F L V+ +A+GDAL AL+++L L W+ V+PCTW V C+ +
Sbjct: 5 IITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDDKKH 64
Query: 71 VTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
VT V L N S G L S +G LT L+ L L N I G +PE +GNL++L SLDL N+L
Sbjct: 65 VTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLEDNHL 124
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
IP+TLG L L+FL L+ N+L G IP SLT ++ L + L +N L+G+IP SL
Sbjct: 125 TDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQ----SL 180
Query: 190 FT--PISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIAL 247
F +F N L+ P P + + P S + TG IAG V+ A +L
Sbjct: 181 FKIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFF 240
Query: 248 AYWR-KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYK 306
+ K D F DV E D + GQL+RF+ RELQ+ATD FS +N+LG+GGFGKVYK
Sbjct: 241 CKDKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYK 300
Query: 307 GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366
G L+DG+ VAVKRL + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPF
Sbjct: 301 GLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPF 360
Query: 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426
M N SVA CLRE P L+W RKQIALGAARGL YLH+HC+PKIIHRDVKAAN+LLD
Sbjct: 361 MQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 420
Query: 427 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
E+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPE +STGKSSEKTDVFGYG+MLLEL
Sbjct: 421 EDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLEL 480
Query: 487 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 546
+TGQRA D +RL +DDV+LLD VK L +EK+LE +VD ++ +YI+EEVE +IQVALLC
Sbjct: 481 VTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLC 540
Query: 547 TQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQP 606
TQ +P ERP MSEVVRMLEG+GLAERWEEWQ E+ RQ+ W DS ++
Sbjct: 541 TQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDA 600
Query: 607 DELSGPR 613
ELSG R
Sbjct: 601 IELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1541), Expect = e-170, Method: Compositional matrix adjust.
Identities = 325/610 (53%), Positives = 418/610 (68%), Gaps = 33/610 (5%)
Query: 27 NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLV 86
N E AL +K +L DP+ VL +WD V+PC+W VTC+SEN V + + NLSG L
Sbjct: 39 NFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTLS 98
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
+ LTNL+ + L +NNI GK+P E+G LT L +LDL N +G IP ++G L L++L
Sbjct: 99 PSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYL 158
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
RLNNNSL G P SL+N+ L LDLS N L+G +P + S N L P +
Sbjct: 159 RLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAA----KTFSIVGNPLICPTGT 214
Query: 207 PP----PPLQP---------TPPGASSGNSATGAIAGGVAAG-AALLFAAPAIALAYWRK 252
P L P P A + AIA G + G +L+F A + L +WR+
Sbjct: 215 EPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFL-WWRQ 273
Query: 253 RKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG L D
Sbjct: 274 RHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGD 333
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M NGS
Sbjct: 334 STVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGS 393
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
VAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+ EA
Sbjct: 394 VAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEA 449
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
VVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+TGQR
Sbjct: 450 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQR 509
Query: 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQG 549
AF+ + AN VM LDWVK + +EKKLE LVD ++ + +Y E E++++++VALLCTQ
Sbjct: 510 AFEFGKAANQKGVM-LDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQY 568
Query: 550 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH------TPHPNNTWIVDSTSH 603
P RPKMSEVVRMLEGDGLAE+WE Q+ + + N + + DS+
Sbjct: 569 LPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLL 628
Query: 604 IQPDELSGPR 613
+Q ELSGPR
Sbjct: 629 VQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 320/607 (52%), Positives = 412/607 (67%), Gaps = 31/607 (5%)
Query: 27 NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLV 86
N E AL +K++L DP+ VL +WD T V+PC+W +TC S+ V R++ + NLSG L
Sbjct: 40 NFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITC-SDGFVIRLEAPSQNLSGTLS 98
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
S +G LTNLQ + L +N I+G +P E+G L L +LDL NN G IP TL L++L
Sbjct: 99 SSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYL 158
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
R+NNNSL G IP SL N+ L LDLS N L+G +P SL + N P +
Sbjct: 159 RVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTGT 214
Query: 207 P-------PPPLQPTPPGASSGNSATG------AIAGGVAAGAALLFAAPAIALAYWRKR 253
P P+ T + + +S G A+ GV+ L L +WR+R
Sbjct: 215 EKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRR 274
Query: 254 KPED-HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
+ FFD+ + E+ LG L+RF+ +ELQ AT NFS++N++G+GGFG VYKG L DG
Sbjct: 275 HNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDG 334
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
S++AVKRLK+ GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ERLLVYP+M NGSV
Sbjct: 335 SIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSV 394
Query: 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
AS R +++P L+W RK+IALGA RGL YLH+ CDPKIIHRDVKAANILLD+ FEAV
Sbjct: 395 AS----RLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAV 450
Query: 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492
VGDFGLAKL+D++++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA
Sbjct: 451 VGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRA 510
Query: 493 FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPM 552
+ + AN +LDWVK L +EKKLEQ+VD D++ NY EVE+++QVALLCTQ P+
Sbjct: 511 LEFGKAANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPI 569
Query: 553 ERPKMSEVVRMLEGDGLAERWE-EWQKEEMFRQ-----DFNHTPHPNNTWIVDSTSHIQP 606
RPKMSEVVRMLEGDGL E+WE Q+ E R +F+ + ++ DS+ +Q
Sbjct: 570 HRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSD-LTDDSSVLVQA 628
Query: 607 DELSGPR 613
ELSGPR
Sbjct: 629 MELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1472), Expect = e-162, Method: Compositional matrix adjust.
Identities = 325/639 (50%), Positives = 428/639 (66%), Gaps = 33/639 (5%)
Query: 1 MGKLERVVW--AFLVSILFFDL----LLRVASNAEGDALNALKTNLADPNNVLQSWDATL 54
M + VVW FLV + FFD+ L N E AL A+K L DP VL++WD
Sbjct: 1 MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60
Query: 55 VNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG 114
V+PC+W V+C ++ V+ +DL + +LSG L ++G LT LQ + L +N I+G +PE +G
Sbjct: 61 VDPCSWRMVSC-TDGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L L SLDL N+ G IP +LG+L L +LRLNNNSL+G P SL+ + L ++D+S
Sbjct: 120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179
Query: 175 NKLTGDIP--TNGSFSLF-TPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG---AI 228
N L+G +P + +F + + ++N P P P SG G A+
Sbjct: 180 NNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVAL 239
Query: 229 AGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATD 288
A + AA + +WR R+ + FFDV + DPEV LG LKR++ +EL+ AT+
Sbjct: 240 AFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATN 299
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+F+++NILGRGG+G VYKG L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLL
Sbjct: 300 HFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLL 359
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
RLRGFC + ER+LVYP+M NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+
Sbjct: 360 RLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQ 419
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG
Sbjct: 420 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 479
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
+SSEKTDVFG+G++LLELITGQ+A D R A+ VM LDWVK L +E KL+QL+D D+
Sbjct: 480 QSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM-LDWVKKLHQEGKLKQLIDKDLN 538
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH 588
+ E+E+++QVALLCTQ +P RPKMSEV++MLEGDGLAERWE Q H
Sbjct: 539 DKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTG-----EH 593
Query: 589 TPHP--------------NNTWIVDSTSHIQPDELSGPR 613
P P + +I +S+ ++ ELSGPR
Sbjct: 594 QPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | ||||||
| 333952414 | 620 | somatic embryogenesis receptor-like kina | 0.991 | 0.980 | 0.868 | 0.0 | |
| 359485981 | 610 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.982 | 0.986 | 0.860 | 0.0 | |
| 356558616 | 620 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.995 | 0.983 | 0.858 | 0.0 | |
| 356558614 | 616 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.995 | 0.990 | 0.858 | 0.0 | |
| 327422167 | 620 | somatic embryogenesis receptor-like kina | 0.990 | 0.979 | 0.864 | 0.0 | |
| 14573459 | 615 | somatic embryogenesis receptor-like kina | 0.985 | 0.982 | 0.855 | 0.0 | |
| 18418211 | 615 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.985 | 0.982 | 0.855 | 0.0 | |
| 255558673 | 611 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.990 | 0.993 | 0.891 | 0.0 | |
| 297798596 | 612 | bri1-associated receptor kinase [Arabido | 0.983 | 0.985 | 0.856 | 0.0 | |
| 397880702 | 632 | leucine-rich repeat receptor-like kinase | 0.990 | 0.960 | 0.823 | 0.0 |
| >gi|333952414|gb|AEG25668.1| somatic embryogenesis receptor-like kinase 3 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1014 bits (2623), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/615 (86%), Positives = 562/615 (91%), Gaps = 7/615 (1%)
Query: 5 ERVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVT 64
+R++ L I FDL RVA NAEGDALNALKTN+ DPNNVLQSWD TLVNPCTWFHVT
Sbjct: 7 QRLISFCLWLIFVFDLAFRVAGNAEGDALNALKTNMVDPNNVLQSWDPTLVNPCTWFHVT 66
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
CNSENSVTRVDLGNANL+GQLV QLG L NLQYLELYSNNISG +P+ELGNLT LVSLDL
Sbjct: 67 CNSENSVTRVDLGNANLTGQLVPQLGSLPNLQYLELYSNNISGTIPDELGNLTELVSLDL 126
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
YLN L G IPTTLG+L KLRFLRLNNNSL G IPRSLT +++LQVLDLSNN L GD+P N
Sbjct: 127 YLNKLTGDIPTTLGQLKKLRFLRLNNNSLAGTIPRSLTTIDTLQVLDLSNNGLVGDVPVN 186
Query: 185 GSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPA 244
GSFSLFTPISFANN+LNNPPP+PPPP+ PTPP A SG S+TGAIAGGVAAGAALLFAAPA
Sbjct: 187 GSFSLFTPISFANNKLNNPPPAPPPPIPPTPP-AQSGISSTGAIAGGVAAGAALLFAAPA 245
Query: 245 IALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKV 304
I LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN+NILGRGGFGKV
Sbjct: 246 IVLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKNILGRGGFGKV 305
Query: 305 YKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364
YKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY
Sbjct: 306 YKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 365
Query: 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
PFMVNGSVASCLRER +SQP L+W++RK+IALGAARGLAYLHDHCDPKIIHRDVKAANIL
Sbjct: 366 PFMVNGSVASCLRERSESQPALDWAIRKRIALGAARGLAYLHDHCDPKIIHRDVKAANIL 425
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 484
LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL
Sbjct: 426 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 485
Query: 485 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVAL 544
ELITGQRAFDLARLANDDDVMLLDWVKGLLKE+KLE LVDSD+ GNYI+EEVEQLIQVAL
Sbjct: 486 ELITGQRAFDLARLANDDDVMLLDWVKGLLKERKLETLVDSDLNGNYIDEEVEQLIQVAL 545
Query: 545 LCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPH-----PNNTWIV- 598
LCTQG+PMERPKMSEVVRMLEGDGLAERWEEWQKEEM RQ+FN H PN WI+
Sbjct: 546 LCTQGTPMERPKMSEVVRMLEGDGLAERWEEWQKEEMVRQEFNQAHHYSHHQPNANWIIA 605
Query: 599 DSTSHIQPDELSGPR 613
DSTSHI PDELSGPR
Sbjct: 606 DSTSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485981|ref|XP_002262698.2| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like [Vitis vinifera] gi|296081547|emb|CBI20070.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1010 bits (2611), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/604 (86%), Positives = 565/604 (93%), Gaps = 2/604 (0%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F+ I+ F LRV+ N+EGDALNALK+NLADPNNVLQSWDATLVNPCTWFHVTCNS+N
Sbjct: 9 VFVSLIIVFSAFLRVSGNSEGDALNALKSNLADPNNVLQSWDATLVNPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK+PEELGNLTNLVSLDLY+N L
Sbjct: 69 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKIPEELGNLTNLVSLDLYMNKL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIPTTL KL+KLRFLRLNNN+L G IPRSLT V +LQVLDLSNN+LTGDIP +GSFSL
Sbjct: 129 SGPIPTTLAKLAKLRFLRLNNNTLTGTIPRSLTTVMTLQVLDLSNNQLTGDIPVDGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISF NN+LN P SPPPP+ PT ASSGNSATGAIAGGVAAGAALLFAAPAI LA+
Sbjct: 189 FTPISFNNNRLNPLPVSPPPPISPTLT-ASSGNSATGAIAGGVAAGAALLFAAPAIVLAW 247
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR+RKP++HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGRGGFGKVYKGRL
Sbjct: 248 WRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGRGGFGKVYKGRL 307
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN
Sbjct: 308 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 367
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER Q PLNW +RKQIALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 368 GSVASCLRERADGQSPLNWPIRKQIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 427
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 428 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 487
Query: 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQG 549
QRAFDLARLANDDDVMLLDWVKGLLK+KKLE LVD+D++G+YIE EVE+LI+VALLCT G
Sbjct: 488 QRAFDLARLANDDDVMLLDWVKGLLKDKKLETLVDADLQGDYIEVEVEELIRVALLCTDG 547
Query: 550 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDEL 609
+ +RPKMSEVVRMLEGDGLAERWE+W+K+++ RQ++NH PHP++ WI DST+ ++PDEL
Sbjct: 548 AAAQRPKMSEVVRMLEGDGLAERWEQWEKDDIIRQEYNHIPHPDSNWI-DSTAGLRPDEL 606
Query: 610 SGPR 613
SGPR
Sbjct: 607 SGPR 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558616|ref|XP_003547600.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2608), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/616 (85%), Positives = 566/616 (91%), Gaps = 6/616 (0%)
Query: 4 LERVVWAFLVSILFF-----DLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPC 58
+ERV +F+ S F+ DL+L+ + N EGDALNALK+NL DPNNVLQSWDATLVNPC
Sbjct: 5 MERVTSSFMGSFFFWAILVLDLVLKASGNQEGDALNALKSNLQDPNNVLQSWDATLVNPC 64
Query: 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCNS+NSVTRVDLGNA+LSGQLVSQLGQLTNLQYLELYSN I+GK+P+ELGNLTN
Sbjct: 65 TWFHVTCNSDNSVTRVDLGNADLSGQLVSQLGQLTNLQYLELYSNKITGKIPDELGNLTN 124
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLYLN LNGPIPTTLGKL+KLRFLRLNNNSL G IP SLTNV+SLQVLDLSNN L
Sbjct: 125 LVSLDLYLNTLNGPIPTTLGKLAKLRFLRLNNNSLTGGIPISLTNVSSLQVLDLSNNHLK 184
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAAL 238
G+IP NGSFSLFTPIS+ NN P P P+ PTPP ASSGNS TGAIAGGVAAGAAL
Sbjct: 185 GEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPTPPPASSGNSNTGAIAGGVAAGAAL 244
Query: 239 LFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
LFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGR
Sbjct: 245 LFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGR 304
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 305 GGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 364
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER +SQPPL W RK+IALG+ARGLAYLHDHCDPKIIHRDV
Sbjct: 365 ERLLVYPYMANGSVASCLRERQESQPPLGWPERKRIALGSARGLAYLHDHCDPKIIHRDV 424
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 425 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 484
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 538
YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK++KLE LVD+D++G+Y +EEVEQ
Sbjct: 485 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKDRKLETLVDADLQGSYNDEEVEQ 544
Query: 539 LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT-PHPNNTWI 597
LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+WE+WQK+E FRQDFN+ HPN WI
Sbjct: 545 LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWEQWQKDETFRQDFNNNIHHPNANWI 604
Query: 598 VDSTSHIQPDELSGPR 613
VDSTSHIQ DELSGPR
Sbjct: 605 VDSTSHIQADELSGPR 620
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558614|ref|XP_003547599.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2607), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/616 (85%), Positives = 566/616 (91%), Gaps = 6/616 (0%)
Query: 4 LERVVWAFLVSILFF-----DLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPC 58
+ERV +F+ S F+ DL+L+ + N EGDALNALK+NL DPNNVLQSWDATLVNPC
Sbjct: 1 MERVTSSFMGSFFFWAILVLDLVLKASGNQEGDALNALKSNLQDPNNVLQSWDATLVNPC 60
Query: 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCNS+NSVTRVDLGNA+LSGQLVSQLGQLTNLQYLELYSN I+GK+P+ELGNLTN
Sbjct: 61 TWFHVTCNSDNSVTRVDLGNADLSGQLVSQLGQLTNLQYLELYSNKITGKIPDELGNLTN 120
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLYLN LNGPIPTTLGKL+KLRFLRLNNNSL G IP SLTNV+SLQVLDLSNN L
Sbjct: 121 LVSLDLYLNTLNGPIPTTLGKLAKLRFLRLNNNSLTGGIPISLTNVSSLQVLDLSNNHLK 180
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAAL 238
G+IP NGSFSLFTPIS+ NN P P P+ PTPP ASSGNS TGAIAGGVAAGAAL
Sbjct: 181 GEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPTPPPASSGNSNTGAIAGGVAAGAAL 240
Query: 239 LFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
LFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGR
Sbjct: 241 LFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGR 300
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 301 GGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 360
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER +SQPPL W RK+IALG+ARGLAYLHDHCDPKIIHRDV
Sbjct: 361 ERLLVYPYMANGSVASCLRERQESQPPLGWPERKRIALGSARGLAYLHDHCDPKIIHRDV 420
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 421 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 480
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 538
YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK++KLE LVD+D++G+Y +EEVEQ
Sbjct: 481 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKDRKLETLVDADLQGSYNDEEVEQ 540
Query: 539 LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT-PHPNNTWI 597
LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+WE+WQK+E FRQDFN+ HPN WI
Sbjct: 541 LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWEQWQKDETFRQDFNNNIHHPNANWI 600
Query: 598 VDSTSHIQPDELSGPR 613
VDSTSHIQ DELSGPR
Sbjct: 601 VDSTSHIQADELSGPR 616
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|327422167|gb|AEA76434.1| somatic embryogenesis receptor-like kinase 2 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/614 (86%), Positives = 559/614 (91%), Gaps = 7/614 (1%)
Query: 6 RVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
R++ L I DL RVA NAEGDALNALKTN+ADPNNVLQSWD TLVNPCTWFHVTC
Sbjct: 8 RLISFCLWLIFVLDLAFRVAGNAEGDALNALKTNMADPNNVLQSWDPTLVNPCTWFHVTC 67
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
NSENSVTRVDLGNANL+GQLV QLG L NLQYLELYSNNISG +P+ELGNLT LVSLDLY
Sbjct: 68 NSENSVTRVDLGNANLTGQLVPQLGSLPNLQYLELYSNNISGMIPDELGNLTELVSLDLY 127
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
LN L G IPTTLG+L KLRFLRLNNNSL+G IP SLT +++LQVLDLSNN L GD+P NG
Sbjct: 128 LNKLTGDIPTTLGQLKKLRFLRLNNNSLVGTIPLSLTTIDTLQVLDLSNNGLIGDVPVNG 187
Query: 186 SFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAI 245
SFSLFTPISFANN+LNNPPP+PPPP+ PTPP A SG S+TGAIAGGVAAGAALLFAAPAI
Sbjct: 188 SFSLFTPISFANNKLNNPPPAPPPPIPPTPP-AQSGISSTGAIAGGVAAGAALLFAAPAI 246
Query: 246 ALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY 305
LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN+NILGRGGFGKVY
Sbjct: 247 VLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKNILGRGGFGKVY 306
Query: 306 KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365
KGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP
Sbjct: 307 KGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 366
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
FMVNGSVASCLRER + QP L+W++RK+IALGAARGLAYLHDHCDPKIIHRDVKAANILL
Sbjct: 367 FMVNGSVASCLRERSEFQPALDWAIRKRIALGAARGLAYLHDHCDPKIIHRDVKAANILL 426
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 485
DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV GYGVMLLE
Sbjct: 427 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVSGYGVMLLE 486
Query: 486 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL 545
LITGQRAFDLARLANDDDVMLLDWVKGLLKE+KLE LVDSD+ GNYI+EEVEQLIQVALL
Sbjct: 487 LITGQRAFDLARLANDDDVMLLDWVKGLLKERKLETLVDSDLNGNYIDEEVEQLIQVALL 546
Query: 546 CTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPH-----PNNTWIV-D 599
CTQG+PMERPKMSEVVRMLEGDGLAERWEEWQKEEM RQ+FN H PN WI+ D
Sbjct: 547 CTQGTPMERPKMSEVVRMLEGDGLAERWEEWQKEEMVRQEFNQAHHYNHHQPNANWIIAD 606
Query: 600 STSHIQPDELSGPR 613
STSHI PDELSGPR
Sbjct: 607 STSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14573459|gb|AAK68074.1|AF384970_1 somatic embryogenesis receptor-like kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/607 (85%), Positives = 555/607 (91%), Gaps = 3/607 (0%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFGLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQG 549
QRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ
Sbjct: 489 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 548
Query: 550 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQP 606
SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T HP + WI+ DSTS I+
Sbjct: 549 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIEN 608
Query: 607 DELSGPR 613
+ SGPR
Sbjct: 609 EYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18418211|ref|NP_567920.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|29427920|sp|Q94F62.2|BAK1_ARATH RecName: Full=BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1; Short=AtBAK1; Short=BRI1-associated receptor kinase 1; AltName: Full=Protein ELONGATED; AltName: Full=Somatic embryogenesis receptor kinase 3; Short=AtSERK3; AltName: Full=Somatic embryogenesis receptor-like kinase 3; Flags: Precursor gi|224589645|gb|ACN59355.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332660823|gb|AEE86223.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/607 (85%), Positives = 555/607 (91%), Gaps = 3/607 (0%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQG 549
QRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ
Sbjct: 489 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 548
Query: 550 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQP 606
SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T HP + WI+ DSTS I+
Sbjct: 549 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIEN 608
Query: 607 DELSGPR 613
+ SGPR
Sbjct: 609 EYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558673|ref|XP_002520361.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540459|gb|EEF42027.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/609 (89%), Positives = 572/609 (93%), Gaps = 2/609 (0%)
Query: 7 VVW--AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVT 64
V+W AF +L F + RVA NAEGDALNALKT+LADPNNVLQSWD TLVNPCTWFHVT
Sbjct: 3 VIWRLAFFCFVLLFHFVYRVAGNAEGDALNALKTSLADPNNVLQSWDPTLVNPCTWFHVT 62
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
CNSENSVTRVDLGNANLSG+LVSQLGQL +LQYLELYSNNISGK+PEELGNLTNLVSLDL
Sbjct: 63 CNSENSVTRVDLGNANLSGELVSQLGQLPSLQYLELYSNNISGKIPEELGNLTNLVSLDL 122
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
YLN LNGPIP TL +L +LRFLRLNNN+L G IP SLT + SLQVLDLSNNKLTGDIP N
Sbjct: 123 YLNKLNGPIPVTLSRLQRLRFLRLNNNTLSGTIPMSLTTIGSLQVLDLSNNKLTGDIPVN 182
Query: 185 GSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPA 244
GSFSLFTPISF+NN LNNPPPSPPPPL P PG S+GNSATGAIAGGVAAGAALLFAAPA
Sbjct: 183 GSFSLFTPISFSNNSLNNPPPSPPPPLTPPSPGPSNGNSATGAIAGGVAAGAALLFAAPA 242
Query: 245 IALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKV 304
IALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKV
Sbjct: 243 IALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 302
Query: 305 YKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364
YKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY
Sbjct: 303 YKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 362
Query: 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
PFMVNGSVASCLRER +SQ PLNW +RK+IALG+ARGLAYLHDHCDPKIIHRDVKAANIL
Sbjct: 363 PFMVNGSVASCLRERPESQTPLNWPIRKRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 422
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 484
LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL
Sbjct: 423 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 482
Query: 485 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVAL 544
ELITGQRAFDLARLANDDDVMLLDWVKGLLK+KKLE LVD+D++GNYI++EVEQLIQVAL
Sbjct: 483 ELITGQRAFDLARLANDDDVMLLDWVKGLLKDKKLETLVDADLQGNYIDDEVEQLIQVAL 542
Query: 545 LCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHI 604
LCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ+FNHT HP+ WIVDSTSHI
Sbjct: 543 LCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQEFNHTYHPSTNWIVDSTSHI 602
Query: 605 QPDELSGPR 613
PDELSGPR
Sbjct: 603 PPDELSGPR 611
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798596|ref|XP_002867182.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] gi|297313018|gb|EFH43441.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/608 (85%), Positives = 556/608 (91%), Gaps = 5/608 (0%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+NS
Sbjct: 5 FFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDNS 64
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
VTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL+
Sbjct: 65 VTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLS 124
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLF
Sbjct: 125 GPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNGLTGDIPVNGSFSLF 184
Query: 191 TP--ISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALA 248
TP ISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA
Sbjct: 185 TPGLISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALA 244
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSNRNILGRGGFGKVYKGR
Sbjct: 245 WWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNRNILGRGGFGKVYKGR 304
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 305 LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 364
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 365 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 424
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT
Sbjct: 425 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 484
Query: 489 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQ 548
GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GNYI+EEVEQLIQVALLCTQ
Sbjct: 485 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYIDEEVEQLIQVALLCTQ 544
Query: 549 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQ 605
SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T HP + WI+ DSTS I+
Sbjct: 545 SSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIE 604
Query: 606 PDELSGPR 613
+ SGPR
Sbjct: 605 NEYPSGPR 612
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397880702|gb|AFO67895.1| leucine-rich repeat receptor-like kinase (mitochondrion) [Brassica rapa subsp. campestris] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/630 (82%), Positives = 558/630 (88%), Gaps = 23/630 (3%)
Query: 3 KLERVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFH 62
K+ R W LV FDL+LR + NAEGDAL+ALK +L+DPN VLQSWDATLV PCTWFH
Sbjct: 7 KIARFFWLVLV----FDLVLRTSGNAEGDALSALKNSLSDPNKVLQSWDATLVTPCTWFH 62
Query: 63 VTCNSENSVTRV----------------DLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
VTCNSENSVTRV DLGNANLSGQLV+QLGQL NLQYLELYSNNI+
Sbjct: 63 VTCNSENSVTRVMVLLFASVTKSLSLLSDLGNANLSGQLVTQLGQLPNLQYLELYSNNIT 122
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
G +PE+LGNLT LVSLDLYLNNL+GPIP++LG+L KLRFLRLNNNSL GEIPRSLT V S
Sbjct: 123 GPIPEQLGNLTELVSLDLYLNNLSGPIPSSLGRLQKLRFLRLNNNSLSGEIPRSLTAVLS 182
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 226
LQVLDLSN +LTGDIP NGSFSLFTPISFAN L P SPPPP+ PTPP + N TG
Sbjct: 183 LQVLDLSNTRLTGDIPVNGSFSLFTPISFANTNLTPLPASPPPPISPTPPSPAGSNRITG 242
Query: 227 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 286
AIAGGVAAGAALLFA PAIALA WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA
Sbjct: 243 AIAGGVAAGAALLFAVPAIALALWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 302
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRN
Sbjct: 303 SDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 362
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
LLRLRGFCMTPTERLLVYP+M NGSVASCLR+R +SQPPL+W R++IALG+ARGLAYLH
Sbjct: 363 LLRLRGFCMTPTERLLVYPYMANGSVASCLRDRPESQPPLDWPKRQRIALGSARGLAYLH 422
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
DHCDPKIIHRDVKAANILLDE+FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS
Sbjct: 423 DHCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 482
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D
Sbjct: 483 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 542
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 586
++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF
Sbjct: 543 LQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 602
Query: 587 NHTPH--PNNTWIV-DSTSHIQPDELSGPR 613
++ + PN W++ DSTSHI+ D SGPR
Sbjct: 603 SYQNYNQPNTAWLIGDSTSHIENDYPSGPR 632
|
Source: Brassica rapa subsp. campestris Species: Brassica rapa Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | ||||||
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.595 | 0.581 | 0.830 | 1.3e-233 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.595 | 0.584 | 0.830 | 3.2e-232 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.993 | 0.982 | 0.703 | 4.4e-226 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.957 | 0.976 | 0.661 | 4.7e-206 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.580 | 0.580 | 0.650 | 1.5e-153 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.593 | 0.575 | 0.596 | 5.9e-148 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.587 | 0.564 | 0.598 | 1.8e-146 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.915 | 0.865 | 0.474 | 5.7e-130 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.965 | 0.933 | 0.450 | 2.5e-129 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.553 | 0.552 | 0.571 | 3.8e-127 |
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1595 (566.5 bits), Expect = 1.3e-233, Sum P(2) = 1.3e-233
Identities = 303/365 (83%), Positives = 328/365 (89%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR+RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 489 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 548
GQRAFDLARLANDDDVMLLDWV VD D++ NY E EVEQLIQVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 549 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 608
SPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ RQ+ + HP + WI+DST ++ E
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAME 623
Query: 609 LSGPR 613
LSGPR
Sbjct: 624 LSGPR 628
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 3.2e-232, Sum P(2) = 3.2e-232
Identities = 303/365 (83%), Positives = 330/365 (90%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+NILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 489 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 548
GQRAFDLARLANDDDVMLLDWV VD D++ NY E E+EQ+IQVALLCTQ
Sbjct: 501 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQ 560
Query: 549 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 608
GSPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ R++ + +P+PN+ WI+DST ++ E
Sbjct: 561 GSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVE 620
Query: 609 LSGPR 613
LSGPR
Sbjct: 621 LSGPR 625
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2182 (773.2 bits), Expect = 4.4e-226, P = 4.4e-226
Identities = 435/618 (70%), Positives = 480/618 (77%)
Query: 3 KLE-RVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLA--DP-NNVLQSWDATLVNPC 58
K+E R + FL +L F+ LRVA NAEGDAL LK +L+ DP NNVLQSWDATLV PC
Sbjct: 5 KMEQRSLLCFLYLLLLFNFTLRVAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPC 64
Query: 59 TWFHVTCNSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCN EN VTRVDLGNA NLQYLELYSNNI+G++PEELG+L
Sbjct: 65 TWFHVTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVE 124
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLY N+++GPIP++LGKL KLRFLRLNNNSL GEIP +LT+V LQVLD+SNN+L+
Sbjct: 125 LVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLS 183
Query: 179 GDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXX 238
GDIP NGSFSLFTPISFA SG
Sbjct: 184 GDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPP-PPSGGQMTAAIAGGVAAGAAL 242
Query: 239 XXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
+W +RKP+DHFFDVPAEEDPEVHLGQLKRF+LREL VATDNFSN+N+LGR
Sbjct: 243 LFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGR 302
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 303 GGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 362
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIHRDV
Sbjct: 363 ERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDV 422
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 423 KAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 482
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQ 538
YGVMLLELITGQ+AFDLARLANDDD+MLLDWV VD+++EG Y+E EVEQ
Sbjct: 483 YGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQ 542
Query: 539 LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT--PHPNNTW 596
LIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DFN+ PH W
Sbjct: 543 LIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDW 602
Query: 597 IVD-STSHIQPDELSGPR 613
++ S S I+ D SGPR
Sbjct: 603 LIPYSNSLIENDYPSGPR 620
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1993 (706.6 bits), Expect = 4.7e-206, P = 4.7e-206
Identities = 403/609 (66%), Positives = 460/609 (75%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLAD---PNNVLQSWDATLVNPCTWFHVTCNS 67
F+ ILF D + RV + DAL AL+++L+ NN+LQSW+AT V PC+WFHVTCN+
Sbjct: 9 FIWLILFLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNT 68
Query: 68 ENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
ENSVTR+DLG+AN NLQYLEL++NNI+G++PEELG+L LVSLDL+ N
Sbjct: 69 ENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFAN 128
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N++GPIP++LGKL KLRFLRL NNSL GEIPRSLT + L VLD+SNN+L+GDIP NGSF
Sbjct: 129 NISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSF 187
Query: 188 SLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXX 247
S FT +SFA + SG S
Sbjct: 188 SQFTSMSFANNKLRPRPASPSP--------SPSGTSAAIVVGVAAGAALLFALA------ 233
Query: 248 XYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+W +RK + HF DVPAEEDPEV+LGQ KRFSLREL VAT+ FS RN+LG+G FG +YKG
Sbjct: 234 -WWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292
Query: 308 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367
RL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352
Query: 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIH DVKAANILLDE
Sbjct: 353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412
Query: 428 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
EFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI
Sbjct: 413 EFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 472
Query: 488 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCT 547
TGQ+AFDLARLANDDD+MLLDWV VD+++EG Y+E EVEQLIQ+ALLCT
Sbjct: 473 TGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCT 532
Query: 548 QGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT--PHPNNTWIVD-STSHI 604
Q S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DFN+ PH W++ S S I
Sbjct: 533 QSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLI 592
Query: 605 QPDELSGPR 613
+ D SGPR
Sbjct: 593 ENDYPSGPR 601
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 1.5e-153, Sum P(2) = 1.5e-153
Identities = 233/358 (65%), Positives = 273/358 (76%)
Query: 257 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVA 316
D F DV E D + GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D + VA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 317 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
VKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S+A L
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 377 RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
RE P L+W RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 497 RLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 556
RL +DDV+LLD V VD +++G YI+EEVE +IQVALLCTQGSP +RP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 556
Query: 557 MSEVVRMLEGDGLAERWEEWQKEEMFRQ-DFNHTPHPNNTWIVDSTSHIQPDELSGPR 613
MSEVVRMLEG+GLAERWEEWQ E+ R+ +F + W DS + ELSG R
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFD-WGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 5.9e-148, Sum P(2) = 5.9e-148
Identities = 223/374 (59%), Positives = 283/374 (75%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR R+ + FFDV + DPEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGH 319
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M
Sbjct: 320 LNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMP 379
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 380 NGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDED 439
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELIT
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 489 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 548
GQ+A D R A+ VML DWV +D D+ + E+E+++QVALLCTQ
Sbjct: 500 GQKALDFGRSAHQKGVML-DWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 549 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQD-------FNHTPHPN--NTWIVD 599
+P RPKMSEV++MLEGDGLAERWE Q Q + +P + +I +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQE 618
Query: 600 STSHIQPDELSGPR 613
S+ ++ ELSGPR
Sbjct: 619 SSLVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 1.8e-146, Sum P(2) = 1.8e-146
Identities = 224/374 (59%), Positives = 285/374 (76%)
Query: 249 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+WR+R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG
Sbjct: 270 WWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKG 329
Query: 308 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367
L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M
Sbjct: 330 ILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYM 389
Query: 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
NGSVAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+
Sbjct: 390 SNGSVAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445
Query: 428 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+
Sbjct: 446 YCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELV 505
Query: 488 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDM--EGNYIEEEVEQLIQVALL 545
TGQRAF+ + AN VML DWV VD ++ + +Y E E++++++VALL
Sbjct: 506 TGQRAFEFGKAANQKGVML-DWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALL 564
Query: 546 CTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ---DFNHTPHPNNTW--IVDS 600
CTQ P RPKMSEVVRMLEGDGLAE+WE Q+ + + N ++ + + D
Sbjct: 565 CTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDD 624
Query: 601 TSH-IQPDELSGPR 613
+S +Q ELSGPR
Sbjct: 625 SSLLVQAMELSGPR 638
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 272/573 (47%), Positives = 363/573 (63%)
Query: 7 VVWAFLVSILFFDLLLRVAS-NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
++++FL + F L L N E +AL +++ NL DP+ L +WD V+PC+W +TC
Sbjct: 15 LLYSFLF-LCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITC 73
Query: 66 NSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+ +N V + + + TNL+ + L +NNISGK+P ELG L L +LDL
Sbjct: 74 SPDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLS 133
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-- 183
N +G IP ++ +LS L++LRLNNNSL G P SL+ + L LDLS N L+G +P
Sbjct: 134 NNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFP 193
Query: 184 NGSFSLF-TPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXX 242
+F++ P+ +SSG
Sbjct: 194 ARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILV 253
Query: 243 XXXXXXYW-RKRKPEDHFFDVPAEEDPEVH-LGQLKRFSLRELQVATDNFSNRNILGRGG 300
W RK++ ++ +++ + LG L+ F+ REL V TD FS++NILG GG
Sbjct: 254 LALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGG 313
Query: 301 FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360
FG VY+G+L DG++VAVKRLK+ G+ QF+ E+EMIS+AVH+NLLRL G+C T ER
Sbjct: 314 FGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGER 373
Query: 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 420
LLVYP+M NGSVAS L+ S+P L+W++RK+IA+GAARGL YLH+ CDPKIIHRDVKA
Sbjct: 374 LLVYPYMPNGSVASKLK----SKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 429
Query: 421 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 480
ANILLDE FEAVVGDFGLAKL+++ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 430 ANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 489
Query: 481 VMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLI 540
++LLELITG RA + + + ML +WV +D ++ NY + EV +++
Sbjct: 490 ILLLELITGLRALEFGKTVSQKGAML-EWVRKLHEEMKVEELLDRELGTNYDKIEVGEML 548
Query: 541 QVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 573
QVALLCTQ P RPKMSEVV MLEGDGLAERW
Sbjct: 549 QVALLCTQYLPAHRPKMSEVVLMLEGDGLAERW 581
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1269 (451.8 bits), Expect = 2.5e-129, P = 2.5e-129
Identities = 276/612 (45%), Positives = 374/612 (61%)
Query: 8 VWAFLVSILFFDL--LLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
+++ L+ + FF L N E +AL +K L DP+ V ++WD V+PC+W ++C
Sbjct: 11 IFSVLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISC 70
Query: 66 NSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+S+N V + + + TNL+ + L +NNISGK+P E+ +L L +LDL
Sbjct: 71 SSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLS 130
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-- 183
N +G IP ++ +LS L++LRLNNNSL G P SL+ + L LDLS N L G +P
Sbjct: 131 NNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFP 190
Query: 184 NGSFSLF-TPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXX 242
+F++ P+ +SSG
Sbjct: 191 ARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVI 250
Query: 243 XXXXXXYWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGF 301
++RK++ + +E+ + LG L+ F+ REL VATD FS+++ILG GGF
Sbjct: 251 LSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGF 310
Query: 302 GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361
G VY+G+ DG++VAVKRLK+ G QF+TE+EMIS+AVHRNLLRL G+C + +ERL
Sbjct: 311 GNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERL 370
Query: 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421
LVYP+M NGSVAS L+ ++P L+W+ RK+IA+GAARGL YLH+ CDPKIIHRDVKAA
Sbjct: 371 LVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAA 426
Query: 422 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
NILLDE FEAVVGDFGLAKL++++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G+
Sbjct: 427 NILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 486
Query: 482 MLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQ 541
+LLELITG RA + + + ML +WV VD ++ Y EV +++Q
Sbjct: 487 LLLELITGMRALEFGKSVSQKGAML-EWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQ 545
Query: 542 VALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTW--IVD 599
VALLCTQ P RPKMSEVV+MLEGDGLAERW D +H H N ++ I
Sbjct: 546 VALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAA-------SHDHSHFYHANMSYRTITS 598
Query: 600 STSHIQPDELSG 611
+ + Q L G
Sbjct: 599 TDGNNQTKHLFG 610
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 3.8e-127, Sum P(2) = 3.8e-127
Identities = 200/350 (57%), Positives = 254/350 (72%)
Query: 265 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER 324
++D E +G LKRFS RE+Q AT NFS +NILG+GGFG VYKG L +G++VAVKRLK+
Sbjct: 275 QQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDP- 333
Query: 325 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384
GE+QFQTEVEMI +AVHRNLLRL GFCMTP ER+LVYP+M NGSVA LR+ +P
Sbjct: 334 IYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKP 393
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
L+W+ R IALGAARGL YLH+ C+PKIIHRDVKAANILLDE FEA+VGDFGLAKL+D
Sbjct: 394 SLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQ 453
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
+D+HVTTAVRGTIGHIAPEYLSTG+SSEKTDVFG+GV++LELITG + D
Sbjct: 454 RDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGN-GQVRKG 512
Query: 505 MLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
M+L WV VD D++G + + +E+++++ALLCTQ P RP+MS+V+++L
Sbjct: 513 MILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVL 572
Query: 565 EGDGLAERWEEWQKEEMFRQDFNHTP-HPNNTWIVDSTSHIQPDELSGPR 613
EG L E+ E + N++ H ++I+++ ELSGPR
Sbjct: 573 EG--LVEQCEGGYEARAPSVSRNYSNGHEEQSFIIEAI------ELSGPR 614
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q94AG2 | SERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7870 | 0.9902 | 0.9712 | no | no |
| Q8LPS5 | SERK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7114 | 0.9592 | 0.9783 | no | no |
| Q9XIC7 | SERK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8086 | 0.9608 | 0.9378 | no | no |
| Q9SKG5 | SERK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7956 | 0.9608 | 0.95 | no | no |
| Q94F62 | BAK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8550 | 0.9853 | 0.9821 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.1 | 0.994 |
| 3rd Layer | 2.7.10 | 0.998 |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 613 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 9e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 7e-50
Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG+L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C +V +M G + S LR+ +P L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 470 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
+ K+DV+ +GV+L E+ T G++ + ++N++ +L+++K +L Q
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEE---VLEYLK---NGYRLPQ------- 224
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+L + L C P +RP SE+V +L
Sbjct: 225 ---PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-49
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C ++V +M G + LR+ L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK- 122
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 470 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
+ K+DV+ +GV+L E+ T G+ + ++N + +L+++K K +L +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYP--GMSNAE---VLEYLK---KGYRLPK------- 225
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+L ++ L C P +RP SE+V +L
Sbjct: 226 ---PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
LV + GS+ L+E + L+ +I L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 415 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 472
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 473 KTDVFGYGVMLLEL 486
K+D++ GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-47
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG+L VAVK LKE+ ++ F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-----PLNWSVRKQIALGAARGLAY 404
L G C LV +M G + LR+ P L+ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 461
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
PE L G + K+DV+ +GV+L E+ T G + L+N++ +L++++ K +L
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE---VLEYLR---KGYRLP 227
Query: 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ Y +E+ +L+ C Q P +RP SE+V LE
Sbjct: 228 K-------PEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 85/284 (29%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 296 LGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FG+VYKG L VAVK LKE ++ +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
G C +V +M G + LR+ G+ L Q+AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 467
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
GK + K+DV+ +GV+L E+ T G++ + G+ E+ LE L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-----------------PGMSNEEVLELL---- 217
Query: 527 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+G + +E+ +L+ L C P +RP SE+V L
Sbjct: 218 EDGYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
LG G FG VYK + G +VAVK LK+ + + Q + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
LV + G + L G PL+ K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 471
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 472 EKTDVFGYGVMLLELITGQ 490
K DV+ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-46
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG G FGKVY R G LVA+K +K+++ + + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
RL + LV + G + L++RG+ +QI L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLHSK 116
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
+ D++ GV+L EL+TG+ F +D + L +K +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELF--------KKIGKPKPPFPPP 219
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
I E + LI+ LL P +R E ++
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 3e-44
Identities = 136/518 (26%), Positives = 238/518 (45%), Gaps = 72/518 (13%)
Query: 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP 132
+DL SG + +LG L+ L L+L N +SG++P+EL + LVSLDL N L+G
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
IP + ++ L L L+ N L GEIP++L NV SL +++S+N L G +P+ G+F
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598
Query: 193 ISFANNQL--NNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYW 250
+ A N S PP + S T + GA L+ A A +
Sbjct: 599 SAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL------GAFLVLALVAFGFVFI 652
Query: 251 RKRKP-------------EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILG 297
R R E FFD K ++ ++ + N++
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKV----------SKSITINDILSSL---KEENVIS 699
Query: 298 RGGFGKVYKGR-LTDGSLVAVKRLKE-------ERTQGGELQFQTEVEMISMAVHRNLLR 349
RG G YKG+ + +G VK + + E G+LQ H N+++
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------------HPNIVK 747
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C + L++ ++ +++ LR L+W R++IA+G A+ L +LH C
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
P ++ ++ I++D + E + L L+ ++ ++APE T
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKD 854
Query: 470 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529
+EK+D++G+G++L+EL+TG+ D + +++W + + L+ +D + G
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRG 911
Query: 530 NYI--EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ + E+ +++ +AL CT P RP ++V++ LE
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLR 351
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 352 GFCMTPTER-LLVY-PFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
G + L ++ ++ GS++S L++ G+ P+ +RK QI GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYL 465
+ I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+ D++ G ++E+ TG+ + + L N +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F +G+GGFG+VYK R G VA+K +K E + E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAYL 405
+ G + E +V F GS+ L+ Q L QIA +GL YL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLT---ESQIAYVCKELLKGLEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEY 464
H + IIHRD+KAANILL + E + DFGL+ L D K + GT +APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEV 168
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQ 490
++ K D++ G+ +EL G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPP------LNWSVRKQIALGAARGLAYLHD 407
+ +V + G ++ ++++ + P L+W V Q+ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLHS 121
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 468 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K + K+D++ G +L EL T + F+ + L +L
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---------------------GENLLELALKI 215
Query: 527 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
++G Y E+ L+ +LL Q P ERP ++++++
Sbjct: 216 LKGQYPPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG +G VA+K L+EE + + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 406
L G C++ L+ M G + +R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ K+DV+ YGV + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 346
N+ +++GRG FG VYKG L G VA+K++ E+ + L+ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G T ++ + NGS+ +++ G L Q+ +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRA-FDLA------RLANDDD 503
+S +D++ G ++EL+TG +DL R+ DD
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L G +++ +M NGS+ LRE G+ + G A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPE 463
+HRD+ A NIL++ V DFGL++ ++ + TT +R T APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 521
++ K + +DV+ +G+++ E+++ G+R + D++ + DV+ K + +L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPP 229
Query: 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+D L Q+ L C Q ERP S++V L+
Sbjct: 230 PMDCPS----------ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 30/293 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ LG G FGKV R G VAVK L + F+ E+E++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 343 VHRNLLRLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
H N+++ +G C P R L+ ++ +GS+ L+ + +N + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICK 120
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IG 458
G+ YL + IHRD+ A NIL++ E + DFGLAK++ + G I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD------LARLANDDDVMLLDWVKG 512
APE L T K S +DV+ +GV L EL T L + M++ +
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
LLKE E+L +EV L++ LC + P +RP ++++ +++
Sbjct: 238 LLKEG--ERLPRPP----SCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-28
Identities = 63/198 (31%), Positives = 108/198 (54%), Gaps = 5/198 (2%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
+ + F L + E + L + K+++ DP L +W+++ + C W +TCN+ +
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSR 70
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNL 129
V +DL N+SG++ S + +L +Q + L +N +SG +P+++ + +L L+L NN
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
G IP G + L L L+NN L GEIP + + +SL+VLDL N L G IP + + +
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 189 LFTPISFANNQLNNPPPS 206
++ A+NQL P
Sbjct: 189 SLEFLTLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 6e-28
Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVE-MISMAVHR 345
++ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L F LV ++ GS+ L ++ + PL+ S I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 406 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 459
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 460 IAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516
+APE L S +S +D++ G+ L EL+TG F+ + ++ L + L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233
Query: 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561
L S I + L++ L P R S +
Sbjct: 234 SLASPLSPS--NPELISKAASDLLKKLL---AKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 91/284 (32%), Positives = 132/284 (46%), Gaps = 39/284 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG--AARGLAYL 405
L G C+ P+E L+V P+M +G + + +R N +V+ I G A+G+ YL
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAP 462
K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
E L T K + K+DV+ +GV+L EL+T G + DV D LL+ ++L Q
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVDSFDITVYLLQGRRLLQ 223
Query: 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E + L +V L C P RP SE+V +E
Sbjct: 224 ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G+G FG V G G VAVK LK++ F E +++ H NL++L G +
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V +M GS+ LR RG++ + + + AL G+ YL + +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 475
RD+ A N+L+ E+ A V DFGLAK V+ T APE L K S K+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSD 181
Query: 476 VFGYGVMLLELITGQRA 492
V+ +G++L E+ + R
Sbjct: 182 VWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
F+ LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGA--ARGLAYLH 406
L C ++ M GS+ + LR GQ P V I + A G+AYL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP-----VASLIDMACQVAEGMAYLE 121
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
G S K+DV+ +G++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-26
Identities = 58/137 (42%), Positives = 83/137 (60%), Gaps = 1/137 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S+ +DL NL+G + S LG L NLQYL LY N +SG +P + +L L+SLDL N+L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
+G IP + +L L L L +N+ G+IP +LT++ LQVL L +NK +G+IP N G +
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 189 LFTPISFANNQLNNPPP 205
T + + N L P
Sbjct: 357 NLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGG---ELQ------FQTEVEMISMAVH 344
++G+G +G+VY +T G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N+++ GF T + ++ GS+ SCLR G+ + L +Q+ GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 463
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 464 YLSTGKS--SEKTDVFGYGVMLLELITGQR 491
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 296 LGRGGFGKVYKG---RLTDGSL---VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+G FG VY+G + G VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARGLA 403
L G T L+V M G + S LR R P Q+A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 458
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518
+APE L G + K+DV+ +GV+L E+ T LA +GL
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQP----------YQGLSN--- 227
Query: 519 LEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E+++ ++G ++ E ++L+++ +C Q +P RP E+V L+
Sbjct: 228 -EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G+G FG VYKG L + VAVK + + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKI 413
+V + GS+ + LR++ V+K Q++L AA G+ YL
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLT-----VKKLLQMSLDAAAGMEYLESKN---C 114
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 470 SSEKTDVFGYGVMLLELITG 489
+ ++DV+ YG++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 51/107 (47%), Positives = 74/107 (69%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
L + L GQ+ +LGQ+ +L+++ L NN+SG++P E+G LT+L LDL NNL GPIP+
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+LG L L++L L N L G IP S+ ++ L LDLS+N L+G+IP
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 51/107 (47%), Positives = 72/107 (67%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
LG NLSG++ ++G LT+L +L+L NN++G +P LGNL NL L LY N L+GPIP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
++ L KL L L++NSL GEIP + + +L++L L +N TG IP
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ +LG+G G VYK R G + A+K++ + + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G E +V +M GS+A L++ G + V IA +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLH 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE +
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
S D++ G+ LLE G+ F L ++ + D
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFEL-----------MQAICDGP 219
Query: 527 ---MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 559
+ E I C Q P +RP +E
Sbjct: 220 PPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FG VY+G L DG AVK + + Q Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 351 RGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G + L ++ +V GS+A L++ G P+ +QI LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 468
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 469 KSSEKTDVFGYGVMLLELITGQ 490
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-23
Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 29/273 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+LG+G FG+V+KG L D + VAVK KE+ Q +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 355 MTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
T+R +Y M G S LR++ + L + AL AA G+AYL
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK--- 112
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
IHRD+ A N L+ E + DFG+++ D + + I APE L+ G+ S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 472 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531
++DV+ YG++L E F L G+ ++ EQ V+ +
Sbjct: 173 SESDVWSYGILLWE------TFSLGVCP----------YPGMTNQQAREQ-VEKGYRMSC 215
Query: 532 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
++ + + +V C P RPK SE+ + L
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 296 LGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ G D LVAVK LKE + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG----------QSQPPLNWSVRKQIALGAA 399
G C ++V+ +M +G + LR G L S QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGT- 456
G+ YL +HRD+ N L+ + +GDFG++ +D + T V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYRVGGHT 184
Query: 457 ---IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 8e-23
Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G C ++ FM G++ LRE + + +N V +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK--- 123
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 470
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 471 SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529
S K+DV+ +GV+L E+ T G + L+ V LL++ ME
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEK-------GYRMER 226
Query: 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E ++ ++ C Q +P +RP +E+ + E
Sbjct: 227 P--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 296 LGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG G FG V +G + VAVK LK ++ F E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL----NWSVRKQIALGAARGLAYLHD 407
G +T ++V GS+ LR+ + +++V QIA G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIA----NGMRYLES 115
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEYL 465
+ IHRD+ A NILL + + +GDFGL + L +D +V APE L
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
T S +DV+ +GV L E+ T G+ + GL + L+++
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPW-----------------AGLSGSQILKKI-- 213
Query: 525 SDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVVRML 564
D EG +E + + V L C +P +RP + + L
Sbjct: 214 -DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 63/163 (38%), Positives = 89/163 (54%), Gaps = 3/163 (1%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DLG L G++ + L LT+L++L L SN + G++P ELG + +L + L NNL+G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPI 193
P +G L+ L L L N+L G IP SL N+ +LQ L L NKL+G IP FSL I
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLI 287
Query: 194 S--FANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAA 234
S ++N L+ P LQ N+ TG I + +
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
|
Length = 968 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKR--LKEERTQGGELQF---QTEVEMISMAVHRNLL 348
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ G C+ + F+ GS++S L G P+ KQI G+AYLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 463
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQ 490
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRN 346
+F N +G+G FG V+K R D + A+K++ + E + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLN-WSVRKQIALGAARGLAY 404
++R + + +V + NG + L+ +RG+ P W QI LG LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT +++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+EK+DV+ GV+L E TG+ FD AN+ ++L ++G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPP-------- 220
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ Y +QL Q+ C +RP +++R
Sbjct: 221 --VSQMY----SQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 74/292 (25%), Positives = 143/292 (48%), Gaps = 37/292 (12%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRL-TDG---SLVAVKRLKEERTQGGELQFQTEVEMI 339
++ + + + ++G G FG+V++G L G VA+K LK T+ F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL--G 397
H N++RL G +++ +M NG++ LR+ +S + + + G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRG 115
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRG 455
A G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ +
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGL 513
I APE ++ K + +DV+ +G+++ E+++ G+R + D++ + +VM K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVM-----KAI 223
Query: 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+L +D + Q+ L C Q RP+ ++V +L+
Sbjct: 224 NDGFRLPAPMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G +G VYK G +VA+K + + + E+ ++ +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 410
T+ +V + GSV+ ++ ++ L ++IA +GL YLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT---LT---EEEIAAILYQTLKGLEYLHSN-- 118
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---HIAPEYLS 466
K IHRD+KA NILL+EE +A + DFG++ + T A R T IG +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 467 TGKSSEKTDVFGYGVMLLELITG 489
+ K D++ G+ +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 86/291 (29%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 349
LG+G FG V R L D G +VAVK+L+ + L+ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 350 LRGFCMTPTER--LLVYPFMVNGSVASCL---RERGQSQPPLNWSVRKQIALGAARGLAY 404
+G C + R LV ++ GS+ L RER + L ++ QI +G+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA--SQIC----KGMEY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP 462
L + +HRD+ NIL++ E +GDFGL K++ D + V I AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT------GQRAFDLARLAND-DDVMLLDWVKGLLK 515
E L+ K S +DV+ +GV+L EL T A + + ND M++ + LLK
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 516 EK-KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+L E I +E C P +RP SE+ +E
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKE----------CWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+G FGKV R D G L A+K LK+++ + TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 353 FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHD 407
+ E+L LV + G + S L + G+ + + +I L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLA----LEYLHS 111
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFD 494
+ D + GV+L E++TG+ F
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 59/302 (19%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRER------------------GQSQPPLNWSVR 391
L G C L++ +M G + LR R G + PL+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 448
IA A G+AYL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG--QRAFDLARLANDDDVML 506
A+ I + PE + + + ++DV+ YGV+L E+ + Q + +A
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--------- 238
Query: 507 LDWVKGLLKEKKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
E+++ +GN + + +L + LC P +RP + + R+
Sbjct: 239 -------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285
Query: 564 LE 565
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 293 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 350
N +G G FGKVY L G L+AVK ++ + + + E++++ + H NL++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 351 RGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
G R VY FM G++ L L+ V + L GLAYLH
Sbjct: 65 YG---VEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHS 117
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEY 464
H I+HRD+K ANI LD +GDFG A + T + V+ G ++APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 465 LSTGKSSEK---TDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
++ GK D++ G ++LE+ TG+R + + L N+ +M
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
I+G G FG V +G T G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ +V M G++ + LR RG++ + + Q +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL--QFSLDVAEGMEYLESK---KLV 122
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 475 DVFGYGVMLLELITGQRA 492
DV+ YGV+L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 296 LGRGGFGKVYKG--RLTDGSL--VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G C +LV G + L++R + S K++A A G+AYL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 469
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 470 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
S K+DV+ YGV L E + G + + + + + +L+ ++L +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAMLE------SGERLPR------- 219
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567
EE +++ + L C + P +RP SE+ D
Sbjct: 220 ---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 351
+G G +G+VYK R G LVA+K+++ E +G + E++++ H N++RL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 352 GFCMTPTERL-----LVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAY 404
T + +V+ +M + + L ++ + KQ+ GL Y
Sbjct: 65 EIV---TSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-CYMKQLL----EGLQY 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 465 L--STGKSSEKTDVFGYGVMLLELITGQRAF 493
L +T + + D++ G +L EL G+ F
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG+V++G + + VAVK LK + F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V M GS+ L+ L + +A A G+AYL IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 475
RD+ A N+L+ E V DFGLA+++ + I APE + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 476 VFGYGVMLLELIT 488
V+ +G++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 295 ILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LGRG FG+V+ + +LV VK L++ + + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 349 RLRGFCMTPTERLLVYPFMVNGS-----VASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
RL G C ++ + G A+ ++ PPL+ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
+ S K+DV+ +GV++ E+ T Q L++++ V L+ KLE V
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE-------VLNRLQAGKLELPV 240
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+L ++ C +P +RP SE+V L
Sbjct: 241 PEGCP--------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 410
+T ++ +M NGS+ L+ + +N K I + A A G+A++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN----KLIDMAAQIAEGMAFIERK-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 471 SEKTDVFGYGVMLLELITGQR 491
+ K+DV+ +G++L E++T R
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + VAVK LK G + F E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 410
C +V +M GS+ L+ + L + + + A A G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLESR-- 122
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLST 467
IHRD+ A NIL+ E + DFGLA+L+ +D TA G I APE +
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEAANY 178
Query: 468 GKSSEKTDVFGYGVMLLELIT 488
G+ + K+DV+ +G++L E++T
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-21
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 32 ALNALKTNLADPNNVLQSWDATLVNPCT-----WFHVTCNSENSVTR-----VDLGNANL 81
AL LK++L P W+ +PC W C +++ + + L N L
Sbjct: 376 ALQTLKSSLGLPLRF--GWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGL 430
Query: 82 SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141
G + + + +L +LQ + L N+I G +P LG++T+L LDL N+ NG IP +LG+L+
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201
LR L LN NSL G +P +L G + + FT +
Sbjct: 491 SLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT---------D 524
Query: 202 NPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRK 254
N P L+ P S G A IA GV+ L I W KR+
Sbjct: 525 NAGLCGIPGLRACGPHLSVG--AKIGIAFGVSVAFLFL----VICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA----RGLAYLHDHCDP 411
+V +M NG + + LRER + + L + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-------LGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
IHRD+ A N L+ E+ V DFGLA+ + + + + PE + S
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 472 EKTDVFGYGVMLLELITG 489
K+DV+ +GV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 295 ILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
++G G FG+V +GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 407
G +++ FM NG++ S LR+ GQ ++V + + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYLSE 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPE 463
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 521
++ K + +DV+ YG+++ E+++ G+R + D++ + DV+ + ++ +L
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVI-----NAIEQDYRLPP 232
Query: 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+D L Q+ L C Q RPK ++V L+
Sbjct: 233 PMDCPT----------ALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 43/284 (15%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
++G G FG+V GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 407
G ++V +M NGS+ + LR+ GQ ++V + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------FTVIQLVGMLRGIASGMKYLSD 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYL 465
+HRD+ A NIL++ V DFGL++++ D + + T + I APE +
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ K + +DV+ YG+++ E+++ G+R + ++N D + ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQDVIKAIE---------------- 223
Query: 525 SDMEGNYIEEEVE---QLIQVALLCTQGSPMERPKMSEVVRMLE 565
EG + ++ L Q+ L C Q ERPK ++V +L+
Sbjct: 224 ---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 40/280 (14%)
Query: 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
N LG G FG+VY+G TD VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLA 403
+++L G C+ + ++ M G + S LR+ R + P ++++ I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTIG 458
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLP 176
Query: 459 --HIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
+APE L GK + ++DV+ +GV++ E++T GQ+ + L N + +L V
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQE---VLQHVT---A 228
Query: 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 555
+L++ E +++ Q+ C P ERP
Sbjct: 229 GGRLQK----------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKG----RLTDGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V D+ + LG G FG+VY+G R D VAVK L E ++ E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER--GQSQP-PLNWSVRKQI 394
++S H+N++RL G R ++ M G + S LRE +P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTT 451
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRK 177
Query: 452 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
R I + PE G + KTDV+ +GV+L E+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 295 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR 351
+LG+G FG+ +Y+ R D SLV K + R E + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
M L+ + G++ + + + + +A ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 472 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531
K+D++ G +L EL+T +R FD N LV ++GNY
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVVKIVQGNY 218
Query: 532 IEEEVEQ----LIQVALLCTQGSPMERPKMSEVVRML 564
V LI + Q P +RP EV+
Sbjct: 219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLR-ERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ LV+ FM +G ++ LR +RG+ SQ L + L G+AYL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---V 121
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRD+ A N L+ E V DFG+ + + +T + + +PE S K S K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 474 TDVFGYGVMLLELIT 488
+DV+ +GV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLL 348
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
R+ G + L +M GSV+ L + G +V RGL+YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 409 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 464
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQ 490
L + DV+ G +++E+ T +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 295 ILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNL 347
LG G FG+V K + S VAVK LK++ T+ +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP-------LNWSVRKQI------ 394
+ L G C +V + +G++ LR R +PP + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR---RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 395 --ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 451
A ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+GGFG+V ++ G + A K+L ++R + GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 410
T + LV M G + + G+ P ++ QI G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
D F G L E+I G+ F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 80/292 (27%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 296 LGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR------ERGQSQPPLNWSVRKQIALGAARGLA 403
L G L+V M +G + S LR E +PP Q+A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIA 461
YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G + +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
PE L G + +D++ +GV+L E+ + LA +GL E+ L+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP-------YQGLSNEQVLKF 233
Query: 522 LVDSDMEGNYI------EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567
+ M+G Y+ E V L++ +C Q +P RP E+V +L+ D
Sbjct: 234 V----MDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 54/135 (40%), Positives = 80/135 (59%), Gaps = 2/135 (1%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DL N LSG++ + +G ++L+ L+L N + GK+P L NLT+L L L N L G I
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTP 192
P LG++ L+++ L N+L GEIP + + SL LDL N LTG IP++ G+
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 193 ISFANNQLNNP-PPS 206
+ N+L+ P PPS
Sbjct: 265 LFLYQNKLSGPIPPS 279
|
Length = 968 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLK--------EERTQGGELQFQTEVEMISMAVHR 345
++G G FG VY G + G L+AVK+++ ++R + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++ G + + ++ GSVA+ L G + L + +QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTIGHI 460
H+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++ +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE + + K D++ G +++E++TG+ F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 49/137 (35%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
SG++ LG+ NL L+L +NN++G++PE L + NL L L+ N+L G IP +LG
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--------------G 185
LR +RL +NS GE+P T + + LD+SNN L G I +
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 186 SFSLFTPISFANNQLNN 202
F P SF + +L N
Sbjct: 463 KFFGGLPDSFGSKRLEN 479
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F ++G+G FGKV + D + A+K + +++ + RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-------------CVEKGSVRNV 47
Query: 348 LRLRGFCMTPTERLLV----YPFMVNGSVASC----------------LRERGQSQPPLN 387
L ER ++ +PF+VN + LR + +
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS 98
Query: 388 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
K L YLH IIHRD+K NILLDE+ + DF +A
Sbjct: 99 EEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPD 153
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+TT+ GT G++APE L S D + GV E + G+R +
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 295 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 349
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 350 LRGFCMTPTER------LLVYPFMVNGSVAS-CLRERGQSQP---PLNWSVRKQIALGAA 399
L G C + +++ PFM +G + S L R P PL ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK--FMVDIA 123
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRG 455
G+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + +
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
+ IA E L+ + K+DV+ +GV + E+ T GQ
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 296 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKVYKG LT + VA+K LKE + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 350 LRGFCMTPTERLLVYPFMVNG------------SVASCLRERGQSQPPLNWSVRKQIALG 397
L G C +++ ++ +G S + L+ S IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
+ + PE + GK + ++D++ +GV+L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LKE ++ FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---------ERGQSQP--PLNWSVRKQIALGA 398
G C L+V+ +M +G + LR G+ L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 457
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ PE + K + ++D++ +GV+L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 294 NILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+G+G FG V K R +DG ++ K + T+ + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 352 GFCMTPTERLLVYPFM---VNGSVAS----CLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ + + L Y M G +A C +ER + W + Q+ L L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYE 120
Query: 405 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLH 406
L G C++PT + LV M +G + + E SQ LNW V+ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
K + ++DV+ YGV + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL D + VAVK +E + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V + G + LR G P L Q+ AA G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGK 469
HRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 470 SSEKTDVFGYGVMLLE 485
S ++DV+ +G++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
++ +M GS+ L+ E G+ P QIA G+AY+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIERK-- 122
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
IHRD++AAN+L+ E + DFGLA++++ + + I APE ++ G
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 471 SEKTDVFGYGVMLLELIT 488
+ K+DV+ +G++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 289 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
+ ++GRG FG V+ R D LV +K++ E+ T+ L Q E +++ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARGL 402
++ + ++V + G++A +++R S L++ V+ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
++H I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498
PE ++K+D++ G +L EL + +RAF+ A L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 47/109 (43%), Positives = 67/109 (61%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DL + +LSG++ + QL NL+ L L+SNN +GK+P L +L L L L+ N +G I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
P LGK + L L L+ N+L GEIP L + +L L L +N L G+IP
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAV 343
N+ +LG+G FG+VY D G +AVK++ + T+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 344 HRNLLRLRGFCMTPTERLLVY-PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
H +++ G C+ E L ++ +M GSV L+ G L +V ++ G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHI 460
YLH + I+HRD+K ANIL D +GDFG +K + + T +V GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT 488
+PE +S K DV+ G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG + DG VA+K L+E + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 406
L G C+T T +L V M G + +RE R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV--QIA----KGMSYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ + ++DV+ YGV + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 78/299 (26%), Positives = 140/299 (46%), Gaps = 54/299 (18%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 348
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRKQIALGA 398
L G C L + +G++ LR+ ++ P S ++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 399 --ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 457 IGHI-----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 510
+G + A E L+ + +DV+ YGV+L E+++ G + A +
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233
Query: 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 565
+ L + +LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 234 EKLPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D+ LG G G V K G ++AVK ++ E + + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ G + + +M GS+ L+E Q + + +IA+ +GL YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 464
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ S K+D++ G+ L+EL TG+ + ND + + L+ +V+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYP---PENDPPDGIFE---------LLQYIVN 218
Query: 525 SDM----EGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 559
G + + LC P ERP E
Sbjct: 219 EPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
F +LG G FG VYKG + +G VA+K L+E + + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARG 401
++ RL G C+T T +L + M G + +RE SQ LNW V QIA +G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIA----KG 121
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 459
+ YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+A E + + ++DV+ YGV + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 22/222 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVK-RLKEERTQGGELQFQTEVE-MISMAV--HRNLLR 349
+LG G FG V+KG + +G + + +K + + G FQ + M++M H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLH 406
L G C + +L V GS+ +R+ S P LNW V QIA +G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV--QIA----KGMYYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEY 464
+H ++HR++ A NILL + + DFG+A L+ Y D + + + I +A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALES 182
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 505
+ G+ + ++DV+ YGV + E+++ G + R D++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-18
Identities = 45/103 (43%), Positives = 61/103 (59%)
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
N +G++ L L LQ L+L+SN SG++P+ LG NL LDL NNL G IP L
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L L L +NSL GEIP+SL SL+ + L +N +G++P
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 73/236 (30%), Positives = 102/236 (43%), Gaps = 44/236 (18%)
Query: 259 FFDVPAEEDPEVHLGQLKRFS-LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVA 316
F +DPE K F+ LRE+ G G FG VY R +VA
Sbjct: 8 FSK----DDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNEVVA 44
Query: 317 VKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
+K++ Q E ++Q EV + H N + +G + LV + + GS +
Sbjct: 45 IKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSAS 102
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
L + PL I GA +GLAYLH H IHRD+KA NILL E +
Sbjct: 103 DILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKL 156
Query: 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 486
DFG A L+ ++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 157 ADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 293 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
++G G VY L + VA+KR+ E+ Q + + EV+ +S H N+++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+ E LV P++ GS+ ++ + L+ ++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST 467
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 468 GKS-SEKTDVFGYGVMLLELITG 489
K D++ +G+ +EL TG
Sbjct: 181 VHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 355 MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ L +V +M GS+ LR RG+S L + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 474 TDVFGYGVMLLELITGQR 491
+DV+ +G++L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV Y + G +VAVK LK E Q ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLAYL 405
+G C + L+ ++ GS+ L P + Q+ L A + G+AYL
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIA 461
H IHRD+ A N+LLD + +GDFGLAK + + H VR + A
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVFWYA 178
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT 488
E L K S +DV+ +GV L EL+T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRN 346
F+ +G+G FG+VYK +VA+K L+E + ++Q E++ +S
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRSPY 60
Query: 347 LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
+ + G +L ++ + GS L+ L+ + I GL YL
Sbjct: 61 ITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIA 461
H+ IHRD+KAANILL EE + + DFG L M ++T V GT +A
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMA 166
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITG 489
PE + EK D++ G+ +EL G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMI-SM 341
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 342 AVHRNLLRLRG--FCMTPT----ERLLVYPFMVNGSV---ASCLRERGQSQPPLNWSVRK 392
+ H N+ G P + LV GSV LR++G+ +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK------EE 113
Query: 393 QIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
IA RGLAYLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQ 490
T + GT +APE ++ + + + DV+ G+ +EL G+
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 77/297 (25%), Positives = 137/297 (46%), Gaps = 45/297 (15%)
Query: 284 QVATDNFSNRNILGRGGFGKVY----KGRLTDG--SLVAVKRLKEERTQGGELQFQTEVE 337
+VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--------RGQSQPPLNWS 389
++ +++RL G L++ M G + S LR Q+ P L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 122 I--QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 175
Query: 450 TTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+G + ++PE L G + +DV+ +GV+L E+ T LA
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP----- 221
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVV 561
+G+ E+ L + MEG +++ + L ++ +C Q +P RP E++
Sbjct: 222 --YQGMSNEQVLRFV----MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 42/288 (14%)
Query: 296 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV G R + V VK L+ T +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-----ERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
C+ LLV F G + + LR +Q V +++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY- 464
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 465 ------LSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKE 516
L ++K++++ GV + EL T + + DL+ D+ V+ K +++E
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVL-----KQVVRE 225
Query: 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+ + +L ++ Y + E V C P RP EV +L
Sbjct: 226 QDI-KLPKPQLDLKYSDRWYE----VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRL 350
I+G G F V + A+K L + + + + E E+++ + H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 351 RGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ E L V + NG + +R+ G L+ + A L YLH
Sbjct: 68 Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSK- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKDTHVT 450
IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 295 ILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV K + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--------------------PLNW 388
+L G C LL+ + GS+ S LRE + P L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
A +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 449 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V + R + +A E L + ++DV+ +GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
E + +V +M GS+ L+ G+ L +A A G+AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 475 DVFGYGVMLLELITGQR 491
DV+ +G++L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-17
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V +M NG + + LRE G+ P S ++ G+AYL + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLSTGKSSE 472
RD+ A N L+D++ V DFGL++ + D T++V G+ + PE L K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSV-GSKFPVRWSPPEVLLYSKFSS 180
Query: 473 KTDVFGYGVMLLELIT-GQRAFDL 495
K+DV+ +GV++ E+ + G+ ++
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G VYK R G +VA+K++K ++G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ LV+ FM + + +++R Q L S+ K +GLA+ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 468
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 469 KS-SEKTDVFGYGVMLLELITGQRAF 493
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 296 LGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 352 GFCMTPTER------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLA 403
G C+ E +++ PFM +G + S L P + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 462
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
E L+ + K+DV+ +GV + E+ T GQ + ++ + D+++ + +L+Q
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLR---QGNRLKQ 235
Query: 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
D ++ L + C +P +RP + LE
Sbjct: 236 PPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHR 345
FS+ +G G FG VY R + + +VA+K++ Q E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N ++ RG + LV + + GS + L + PL + GA +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 464
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 465 --LSTGKSSEKTDVFGYGVMLLEL 486
+ G+ K DV+ G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 352 GFCMT-----PTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 405
CMT P + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHM 113
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 466 STGKSSEKT-DVFGYGVMLLELITGQRAF 493
G + + + D F G ML +L+ G F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
E + +V FM GS+ L+E L V +A A G+AY+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERM---NYI 124
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD++AANIL+ + + DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 475 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEE 534
DV+ +G++L EL+T R G++ + LEQ V+ +
Sbjct: 185 DVWSFGILLTELVTKGRVP----------------YPGMVNREVLEQ-VERGYRMPCPQG 227
Query: 535 EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E L ++ LC + P ERP + LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK R + G LVA+K +K E E Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69
Query: 355 MTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 410
+ + +V + GS+ + RG PL+ QIA +GLAYLH+
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRG----PLS---ELQIAYVCRETLKGLAYLHET-- 120
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL- 465
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAA 174
Query: 466 --STGKSSEKTDVFGYGVMLLELITGQ 490
G K D++ G+ +EL Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 30/254 (11%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRL 350
++GRG +G VY+G+ + G +VA+K + + Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
G + ++ + GSV + ++ ++ ++ +R+ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV-- 120
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 471 SE-KTDVFGYGVMLLELITGQ---------RAFDL------ARLANDDDVMLL-DWVKGL 513
+ K D++ G+ + E+ TG RA L RL ++ LL ++V
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 514 LKEKKLEQLVDSDM 527
L E+ E+L ++
Sbjct: 239 LDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 352 GFCM-----TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 405
CM TP + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHM 113
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 466 STGKSSEKT-DVFGYGVMLLELITGQRAF 493
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ + VAVK +K G + F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHC 409
+T ++ FM GS+ L+ + G QP + K I A A G+A++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIAEGMAFIEQR- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 470 SSEKTDVFGYGVMLLELITGQR 491
+ K+DV+ +G++L+E++T R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 289 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
+F LG+G +G VYK RL+D A+K + +Q E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ + + + +V + G ++ + +R + + + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ KI+HRD+K+ANILL +GD G++K++ K T + GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
S K+D++ G +L E+ T F+ AR D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 296 LGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALG 397
G C ++V+ +M +G + LR G Q++ L S IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 295 ILGRGGFGKV----YKGRLTDGSLVAVKRLKE----ERTQGGELQFQTEV-EMISMAVHR 345
+LGRG FGKV YK G L A+K LK+ R + L + + E + H
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-ALGAARGLAY 404
L+ L T V + G + + S+P R A GL Y
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQY 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPE 463
LH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT +APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L+ + D +G GV++ E++ G+ F
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG+V+ G + VAVK LK T E F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPE-SFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
E + +V +M GS+ L++ R P L +A A G+AY+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIERM--- 121
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
IHRD+++ANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 472 EKTDVFGYGVMLLELITGQR 491
K+DV+ +G++L EL+T R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 296 LGRGGFGKVYKGRLTDG--SLVAVKRL----------KEERTQGGELQFQTEVEMISMAV 343
LG G FG VYK R + +L+A+K + K ER + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 344 -HRNLLRLRGFCMTPTERLLVYPFMVNGS----VASCLRERGQSQPPLN-WSVRKQIALG 397
H N++R +RL + ++ G+ + L+E+ Q W++ Q+ L
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V GTI
Sbjct: 126 ----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTI 177
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517
+ PE + EK DV+ +G +L ++ T Q F ML L K
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------ML------SLATK 224
Query: 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+E + + EG Y E+V +I C RP + +V M+
Sbjct: 225 IVEAVYEPLPEGMY-SEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + N +G G G+VYK G VA+K+++ + Q EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA---RGL 402
N++ + E +V +M GS+ + Q+ +N QIA +GL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEP---QIAYVCREVLQGL 129
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH +IHRD+K+ NILL ++ + DFG A + + + + V GT +AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E + K D++ G+M +E+ G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRN 346
F N +G G +G VY+ R T G +VA+K+++ + + G + E+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 347 LLRLRGFCMTPTERLLVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ L+ + L F+V +AS L P + S K + L RGL
Sbjct: 68 IVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGL 121
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 463 EYL-STGKSSEKTDVFGYGVMLLELITGQ 490
E L + D++ G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LK+ + F E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG-------QSQPP--LNWSVRKQIALGAAR 400
G C+ ++V+ +M +G + LR G + P L S IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH 459
G+ YL +HRD+ N L+ E +GDFG+++ + D + V I
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ PE + K + ++DV+ GV+L E+ T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 353
LG G FGKVYK + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 354 CMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+ ++ F G++ S + ERG ++P + + V +Q+ L +LH H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML----EALNFLHSH--- 122
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
K+IHRD+KA NILL + + + DFG+ AK T GT +APE ++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180
Query: 471 SE-----KTDVFGYGVMLLEL 486
+ K D++ G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 284 QVATDNFSNRNILGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTE 335
+V D LG G FG+V K + + VAVK LK + T+ +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 336 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----------GQSQP 384
+EM+ M H+N++ L G C ++ + G++ LR R P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 385 PLNWSVRKQI--ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
S + + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ D + TT R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGF 353
+G G G V+K + G VA+K++ R +GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ +LV +M ++ LR+ + PL + K +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 472
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 473 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+G C L+ F+ +GS+ L +++ +N + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 466
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
K +DV+ +GV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---------------LNWSVR 391
++ L G C ++ + G++ LR R +PP L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRAR---RPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VT 450
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
T R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 296 LGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+ +G +G+V+ K + T G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
++ LV ++ G +AS L G L+ V + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN--- 112
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEY 464
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITG 489
+ S+ D + G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRN 346
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 394
++ L G C ++ + G++ LR R P + + K
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 453
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 339
E + D R +LG+G +G VY R L+ +A+K + E ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALH 59
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIA 395
S HRN+++ G + + GS+++ LR + ++ + + KQI
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-KQI- 117
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAV 453
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T
Sbjct: 118 ---LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETF 169
Query: 454 RGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
GT+ ++APE + G D++ G ++E+ TG+ F
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQF-QTEVEMISMAVHRNLLRLR 351
+LG+G FGKV L L AVK LK++ Q +++ TE ++++A L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
C +RL VNG L Q + + A GL +LH+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
II+RD+K N+LLD E + DFG+ K + T T+ GT +IAPE LS
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPY 173
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503
D + GV+L E++ GQ F+ +D+D
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQI 394
++ L G C ++ + G++ LR R + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 453
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +GV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 7e-15
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT----EVEMISMAVH 344
+ LG G +G VYK R G +VA+K+++ + + G + E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N+++L T + LV+ + + + L +R PL+ ++ K I RGLAY
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAY 113
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 465 L------STGKSSEKTDVFGYGVMLLELITGQ 490
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 296 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG FGK+YKG L LVA+K LK+ +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-------------RERGQSQPPLNWSVRKQIALG 397
G +++ ++ G + L E G + L+ IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + GK S +D++ +GV+L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 31/272 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V FM NG + + LR+R G+ + S+ + + G+ YL + I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC----EGMEYLERN---SFI 122
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 473
HRD+ A N L+ V DFG+ + + D + +++ + + PE + K S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 474 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532
+DV+ +GV++ E+ T G+ F + +N + V+ + + +L + + +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPF--EKKSN------YEVVEMISRGFRLYR---PKLASMTV 230
Query: 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
E V C P RP +E++R +
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 290 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F+ +G+G FG+VYKG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
R G + T+ ++ ++ GS L+ PL + I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 469 KSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 273 GQLKRFSLRELQVATDN---FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG 328
G LK + EL D F++ +G G FG VY R + +VA+K++ Q
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 329 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP 385
E ++Q EV+ + H N + +G + LV + + GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
L I GA +GLAYLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 446 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 486
++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 30/188 (15%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHR 345
+G G +G VYK R L G VA+K+++ ++ G E+ ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 346 NLLRLRGFCMTP-TER----LLVYPFMVNGSVASCLR---ERGQSQPPLNWSVRKQIALG 397
N++RL C P T+R LV+ V+ +A+ L + G + + +Q+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKD-LMRQLL-- 117
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V T+
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTL 170
Query: 458 GHIAPEYL 465
+ APE L
Sbjct: 171 WYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV RL G L AVK LK++ Q +++ TE ++S+A + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG---------- 401
C +RL VNG L + ++K AR
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG-------------DLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IA
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
PE L D + GV+L E++ G F+ N+DD+
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 27/204 (13%)
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANIL 424
FM GS+ ++ G P+ + +IA+ GL YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 425 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ G+
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 483 LLELITGQRAFDLARLAND--DDVM-LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQL 539
++EL G+ F + + +D DD M +LD ++ +++E +L SD E++
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRLPSSDF-----PEDLRDF 245
Query: 540 IQVALLCTQGSPMERPKMSEVVRM 563
+ LL P ERP ++ M
Sbjct: 246 VDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 296 LGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLR 351
+G G FG VY +VAVK++ Q E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G + LV + + GS + L + PL I GA +GLAYLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 468
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 469 KSSEKTDVFGYGVMLLEL 486
+ K DV+ G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 352
++G G +G+VYKGR + G L A+K + + T+ E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 353 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ + + LV F GSV ++ + +W I RGLA+LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH 138
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 467 TGKSSEKT-----DVFGYGVMLLELITG 489
++ + T D++ G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 23/283 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + LG G G V K RL + ++ + +LQ Q E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59
Query: 346 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
+++ G + + + + GS+ S ++ + + V +IA +GL+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAP 462
YLH KIIHRD+K +NILL + + + DFG++ +L++ T GT ++AP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAP 172
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
E + S +DV+ G+ LLE+ + F + ++ + ++ E L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPE-L 228
Query: 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
D G EE + I+ C + P RP MLE
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPW---DMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 356 TPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ ++ F G+V + + E RG ++P + R+ + L YLH KI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM---KI 131
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--ST 467
IHRD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 468 GKSSE---KTDVFGYGVMLLEL 486
K + K D++ G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 290 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ G + T+ ++ ++ GS L E G PL+ + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG----PLDETQIATILREILKGLDYLHSE 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 467
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 468 GKSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 343
+ + ++G G +G V K R G +VA+K+ KE E +T EV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N++ L+ LV+ + V ++ L PP +VR I + +A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPD--AVRSYI-WQLLQAIA 114
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
Y H H IIHRD+K NIL+ E + DFG A+ + + T T + APE
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 464 YL----STGKSSEKTDVFGYGVMLLELITGQRAF 493
L + GK DV+ G ++ EL+ G+ F
Sbjct: 172 LLVGDTNYGKP---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL----KEERTQGGELQFQTEVEMISMAV 343
N+ +LGRG FG+VY D G +AVK++ + T + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 344 HRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H +++ G P E+ L +M GS+ L+ G + +QI +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGH 459
++YLH + I+HRD+K ANIL D +GDFG +K + +V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
++PE +S K DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + VYKGR LTD +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + L + G S +N K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 473 KTDVFGYGVMLLELITGQRAF 493
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 49/161 (30%), Positives = 81/161 (50%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
N++T +DL NL+G++ L NL L L+SN++ G++P+ LG +L + L N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ +G +P+ KL + FL ++NN+L G I ++ SLQ+L L+ NK G +P +
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAI 228
+ + NQ + P L S N +G I
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
|
Length = 968 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 290 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ G + T+ ++ ++ GS LR + + ++ K+I +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-TMLKEIL----KGLDYLHSE 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 469 KSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+L+ E V+ +M G++ +++R P + SV + I +GLA++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH 118
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 466
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 289 NFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISM-A 342
NF +LG G +GKV+ G G L A+K LK+ Q + T E + A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 343 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
V R L+ L T T+ L+ ++ G + + L +R VR IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVL 116
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 461 APEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
APE + G + D + GV+ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 295 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 349
+LG+G FG V + +L DGS VAVK LK + ++ +F E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 350 LRGFCM--TPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 401
L G + RL ++ PFM +G + + L + P ++ + + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHI 460
+ YL IHRD+ A N +L+E V DFGL+K + D + A + + +
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
A E L+ + +DV+ +GV + E++T GQ +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 11/221 (4%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
NF LG G + VYKGR T G +VA+K + + +G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+RL T + +LV+ +M + + + G + L+ + K +G+A+ H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+ +++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 468 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 6e-14
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 352
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 353 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ + LV F GSV ++ + W I RGL++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 128
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 467 TGKSSE-----KTDVFGYGVMLLELITG 489
++ + K+D++ G+ +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLK---EERTQGGELQ-FQTEVEMISMAVHRNLLR 349
+LG+G FG+VY D G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 350 LRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
G P ER L M GS+ L+ G + +QI G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 465
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 466 STGKSSEKTDVFGYGVMLLELIT 488
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 340
+N S LG G FGKV + +D + VAVK LK +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN--WSVRKQIALGA 398
+ H N++ L G C L++ + G + + LR + +S L S Q+A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA--- 151
Query: 399 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT 456
+G+A+L +C IHRD+ A N+LL + DFGLA+ +M+ + V R
Sbjct: 152 -KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + ++DV+ YG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+GGFG+V ++ G + A K+L ++R + GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 410
+ T LV M G + + G+ + + QI G LH H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI------LHLH-S 113
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
S D F G + E++ G+ F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 48/144 (33%), Positives = 82/144 (56%), Gaps = 4/144 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
++++ +DL + + L S L L NL+ L+L N++S +P+ L NL+NL +LDL
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
N ++ +P + LS L L L+NNS++ E+ SL+N+ +L L+LSNNKL +
Sbjct: 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI 251
Query: 185 GSFSLFTPISFANNQLNNPPPSPP 208
G+ S + +NNQ+++
Sbjct: 252 GNLSNLETLDLSNNQISSISSLGS 275
|
Length = 394 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVH 344
LG G + VYK R G +VA+K++K + E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGA 398
N++ L + LV+ FM + ++++ S+ K L
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMT 111
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
RGL YLH + I+HRD+K N+L+ + + DFGLA+ + +T V T
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
+ APE L + D++ G + EL+ + F L D D+
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF----LPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVH-RNLLRLRG 352
LG+GGFG+V ++ G L A K+L ++R + + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQP----PLNWSVRKQIALGAARGLAYLHDH 408
T T+ LV M G + + + P P QI G L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+II+RD+K N+LLD + + D GLA +L D + T GT G +APE L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAF 493
+ D F GV L E+I + F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 72/299 (24%), Positives = 132/299 (44%), Gaps = 43/299 (14%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQFQTEVE 337
+ ++ D + ++L G FG+++ G L D V VK +K+ ++ E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLNWSVRKQ--- 393
++ H+N+L + C+ E V YP+M G++ L++ + ++ Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 394 -IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK---D 446
+A+ A G++YLH +IH+D+ A N ++DEE + + D L++ MDY D
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 505
+ +A E L + S +DV+ +GV+L EL+T GQ + ++
Sbjct: 178 NE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--------VEID 224
Query: 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+ L +L Q ++ ++L V C P ERP S++V+ L
Sbjct: 225 PFEMAAYLKDGYRLAQPINCP----------DELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDY 444
+ KQI GL YLH +IIHRDVK NI +++ + +GD G A+
Sbjct: 162 IEKQIL----EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
+ GT+ APE L+ K + K D++ G++L E++
Sbjct: 215 -------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 289 NFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+ +G G FGK+Y K + +D +K + + E + + EV +++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARG 401
N++ +V + G + + R+RG L+W V QI+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG---- 113
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L ++HD KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+PE + KTD++ G +L EL T + F+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
NF +LG+G FGKV R L A+K LK++ + T VE +A+
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 346 N---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
L +L C +RL V ++ G + +++ G+ + P +I++G
Sbjct: 59 KPPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG---- 113
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +LH II+RD+K N++LD E + DFG+ K D T GT +IA
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIA 169
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE ++ + D + YGV+L E++ GQ FD
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F +LG+GGFG+V ++ G + A K+L+++R + GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLA 403
++ L T LV M G + + G++ + AA GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGLE 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
LH +I++RD+K NILLD+ + D GLA + + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
+ + + D + G +L E+I GQ F K +K +++E+LV
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--------------KKKIKREEVERLV 217
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMER 554
+++ Y E+ + + P ER
Sbjct: 218 -KEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/278 (21%), Positives = 120/278 (43%), Gaps = 22/278 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 345
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++ + E +V G ++ ++ + + + + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525
+ K+D++ G +L E+ Q F D + L KK+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC------KKIEQCDYP 226
Query: 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
+ ++ EE+ QL+ +C P +RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + ++A ++ + +++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
++ F G+V + + E + PL + + L YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 416 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 472 E-----KTDVFGYGVMLLEL 486
+ K DV+ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 338
L L TD + +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 339 ISMAVHRNLLRLRGFC-----MTPTERLLVYPFMVNGSVASCLR---ERGQSQPPLNWSV 390
S+ H N+++ G + + LV GSV ++ GQ L+ ++
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LDEAM 129
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450
I GA GL +LH++ +IIHRDVK NILL E + DFG++ +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 451 TAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITG 489
T+V GT +APE ++ + + + DV+ G+ +EL G
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + V+KGR LT+ +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + + + G N K RGLAY H K+
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN---VKIFLYQILRGLAYCHRR---KV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 473 KTDVFGYGVMLLELITGQRAF 493
+ D++G G + E+ +G+ F
Sbjct: 185 QIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 8e-13
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK----EERTQGGELQFQTEVEMISMAV 343
N+ +LG+G FG+VY D G +A K+++ T + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 344 HRNLLRLRGFCMTPTERLLV--YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H +++ G E+ L +M GSV L+ G L SV ++ G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGH 459
++YLH + I+HRD+K ANIL D +GDFG +K + T +V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
++PE +S K DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + V+KGR LT +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + L G N K RGL+Y H KI
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHN---VKIFMFQLLRGLSYCHKR---KI 124
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 473 KTDVFGYGVMLLELITGQRAF 493
D++G G +L E+ TG+ F
Sbjct: 184 PIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR- 351
++G+G +G+V R TDG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 352 ----GFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPP---LNWSVRKQIALGAARGLA 403
+ +V F G + L+E +G+ P + W V QIA+ L
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV--QIAMA----LQ 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
S + K+DV+ G + E+ T + AF+ A D + ++ ++G KL
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMNSLVYRIIEG-----KLPP-- 221
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
M +Y E E LI +L + P +RP + ++R
Sbjct: 222 ---MPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 296 LGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
C T LLV F G + LR R + + +++A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 469
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 470 S-------SEKTDVFGYGVMLLEL 486
+++++V+ GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 63/250 (25%), Positives = 119/250 (47%), Gaps = 41/250 (16%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
GQ L +L+ + +G G G+VYK R G ++AVK+++ RT E
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEEN 57
Query: 332 FQT--EVEMISMAVHR--NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPL 386
+ +++++ + H +++ G+ +T ++ + M ++CL + + Q P+
Sbjct: 58 KRILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPI 111
Query: 387 NWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDY 444
+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+D
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAFD------ 494
K +A G ++APE + + K DV+ G+ L+EL TGQ +
Sbjct: 169 K-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 495 --LARLANDD 502
L ++ ++
Sbjct: 226 EVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 46/294 (15%)
Query: 294 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 349
+++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 397
L G C L + +G++ LR+ ++ P S ++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 456
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
+ +A E L+ + +DV+ YGV+L E+++ G + A + + L +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 226
Query: 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 565
+LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 227 GYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMISMAVH 344
D F +G G +G+VYK R D G LVA+K RL E+ +G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65
Query: 345 RNLLRLRGFCMTPTERL----------LVYPFM---VNGSVASCLRERGQSQPPLNWSVR 391
RN++ L+ + L LV+ +M + G + S L + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH---IKSFM 122
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
KQ+ GL Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 123 KQL----LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 452 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 71/295 (24%), Positives = 136/295 (46%), Gaps = 46/295 (15%)
Query: 294 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 349
+++G G FG+V + + L A+K LKE ++ F E+E++ + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 397
L G C + + G++ LR+ ++ P + ++ Q A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 456
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
+ +A E L+ + K+DV+ +GV+L E+++ G + A + + L +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 233
Query: 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLEG 566
++E+ + D +EV +L++ C + P ERP +++ RMLE
Sbjct: 234 GYRMEKPRNCD-------DEVYELMR---QCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRV 53
Query: 348 LRLRG---------FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
L L G C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ----LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTP 165
Query: 458 GHIAPE---YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+IAPE Y GKS D + +GV+L E++ GQ FD
Sbjct: 166 DYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 295 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRL 350
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
T + V ++ G + L RER +P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVASAIGYLHSL- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 468
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 3/143 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
C+S N + ++ L + +L G++ LG +L+ + L N+ SG++P E L + LD+
Sbjct: 377 CSSGN-LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
NNL G I + + L+ L L N G +P S + L+ LDLS N+ +G +P
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRK 494
Query: 185 -GSFSLFTPISFANNQLNNPPPS 206
GS S + + N+L+ P
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
E ++ FM GS L + V +QI G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL----SGIAYLHRR---H 188
Query: 413 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 469 KSSEK-----TDVFGYGVMLLELITGQRAFDLAR 497
+ D++ GV +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHR 345
+F+ +LG+G FGKV R L A+K LK++ Q +++ E +++++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 346 NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
L C +RL V ++ G + +++ G+ + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH II+RD+K N++LD E + DFG+ K + D T GT +IAPE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++ + D + +GV+L E++ GQ F+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 293 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+ ILG G G VYK L ++AVK + + T + Q +E+E++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK---------- 55
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ----IALGAARGLAYLHD 407
C +P F V ++ C + + + IA+ +GL YL
Sbjct: 56 --CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISG 167
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ +DV+ G+ +EL G+ + N +M L + L+ +VD D
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPL---------QLLQCIVDEDP 217
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561
+ + E+ + C + P ERP ++
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 296 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
LG G FG+V+ K + + LVAVK L+ + + F EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER-------GQSQPPLNWSVR 391
+S N+ RL G C ++ +M NG + L++ + L++S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH 448
+A A G+ YL +HRD+ N L+ + + + DFG+++ + DY
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187
Query: 449 VTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+G I +A E + GK + K+DV+ +GV L E++T
Sbjct: 188 ----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRL-- 350
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74
Query: 351 ------RGFCMTPTERLLVYPFMV--------NGSVASCLRERGQSQPPLNWSVRKQIAL 396
+V P+M N SV L S K L
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------------LTESQIKCYML 122
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
G+ YLH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 295 ILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNL 347
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 348 LRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA--RGLA 403
L FC T+ L V ++ G + ++ G+ + + A GL
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+LH II+RD+K N+LLD++ + DFG+ K + +T GT +IAPE
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPE 166
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L K +E D + +GV+L E++ GQ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F +LG+GGFG+V ++ G + A KRL+++R + GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV M G + + G P ++ AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D ++RD+K NILLD+ + D GLA + + GT+G++APE L+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + D +G G ++ E+I GQ F
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVH 344
T+ + + +G G FG V R G VA+K++ K T + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L ++P E + ++ + L R PL + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 465 LST-GKSSEKTDVFGYGVMLLELITGQRAF 493
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ LG G + VYKG+ +G LVA+K ++ + +G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV+ + V+ + + + P N K RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPEN---VKLFLFQLLRGLSYIH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 465
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG----ELQFQTEVEMISMA 342
D + +G G +GKVYK R G LVA+K+ + E + G L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 343 VHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
++ ++RL + E LV+ ++ + PL K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 449
+G+A+ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 450 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 344
D+F LG G FG+V R G A+K L + + E ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAAR 400
L+ L G + LV ++ G + S LR+ G+ P + + Q+ L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVA--RFYAAQVVLA--- 113
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L YLH D I++RD+K N+LLD + + DFG AK + + T + GT ++
Sbjct: 114 -LEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYL 165
Query: 461 APEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
APE + + GK+ D + G+++ E++ G F DD+ + +
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAY 404
+++L T + LV+ F+ L++ + P + + K +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIGH 459
H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR----- 167
Query: 460 IAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAF 493
APE L K S D++ G + E++T + F
Sbjct: 168 -APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG 352
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 353 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--GLAYLHDH 408
+C T+ L V F+ G + ++++G+ + + + A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHSK 115
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGL 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD--------WVKGLLKEKK-- 518
K + D + +GV+L E++ GQ F DD+ L + + + + KE K
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH-----GDDEDELFESIRVDTPHYPRWITKESKDI 226
Query: 519 LEQLVDSD 526
LE+L + D
Sbjct: 227 LEKLFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 30/281 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV 343
NF +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 399
H N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L ++H +I+HRD+K AN+ + +GD GL + K T + V GT +
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519
++PE + + K+D++ G +L E+ Q F D + L KK+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC------KKI 220
Query: 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
E+ + ++ EE+ L+ C P +RP +S V
Sbjct: 221 EKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAV---HRNLLR 349
+G G +GKV+K R G VA+KR++ + +G L EV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 350 LRGFCM---TPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
L C T E L F V+ + + L + +P + K + RGL +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE L
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVL 181
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 509
+ D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
D + N + G +G VY+ R G +VA+K+LK E+ +G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 346 NLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++ ++ + + +V ++ + + S + + P S K + L G+A
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVA 120
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 458
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 459 HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 296 LGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 353 FCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARGLAYLHDH 408
+V + G + + +RG L+W V QI L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICLA----LKHVHDR 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500
+ K+D++ G +L E+ T + AF+ + N
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 295 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRL 350
+LG+G FGKV L TD + A+K LK++ Q ++ TE ++++A L
Sbjct: 2 VLGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
C +RL VNG L + Q + + A L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGD---LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+I+RD+K NILLD E + DFG+ K TT GT +IAPE L +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEY 173
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
D + GV++ E++ GQ F+ N+DD+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 295 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 350
++GRG + KV RL T+ + A+K +K+E E QTE + A + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN---WSVRKQIALGAARGLAYLHD 407
C RL VNG +R + P + +S +AL YLH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519
D + GV++ E++ G+ FD+ +++ D D++ ++ EK++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F + +LG+GGFG+V ++ G + A K+L+++R + GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL-GAARGLAYL 405
++ L T LV M G + + G N +Q A+ AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG------NPGFDEQRAIFYAAELCCGL 115
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 462
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 290 FSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHR 345
F + +LG+GGFG+V + R T G + A K+L+++R + GE E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GL 402
++ L T LV M G + + G ++ AA GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 47/135 (34%), Positives = 75/135 (55%), Gaps = 5/135 (3%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+DL +LS L L L+NL L+L N IS +P E+ L+ L LDL N++
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII- 222
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
+ ++L L L L L+NN L ++P S+ N+++L+ LDLSNN+++ I + GS +
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLR 280
Query: 192 PISFANNQLNNPPPS 206
+ + N L+N P
Sbjct: 281 ELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 48/225 (21%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EVEMI 339
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 340 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
H N++ L + P +V M + L + +S PL +
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQY 107
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH----- 448
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 108 FLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 449 ---VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITG 489
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 165 EYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 314 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
LVAVK L+ + T+ F E++++S + N++RL G C++ ++ +M NG +
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 374 SCLRER--------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
L +R + P ++ + +A+ A G+ YL +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ + DFG+++ + Y + R I +A E + GK + +DV+ +GV L
Sbjct: 163 GNHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 484 LELIT 488
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
+G G FG VY+G VAVK K + +F E ++ H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 351 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
G ++ + P G + S L+ S L+ + + + LAYL
Sbjct: 73 IGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLESK 126
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 469 KSSEKTDVFGYGVMLLE-LITGQRAFDLARLANDDDVMLLD 508
+ + +DV+ +GV + E L+ G + F + N+D + ++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 312 GSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
G VA+K L+ + + +F+ E + + H N++ L P L V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---D 426
G LRE + L ++ L LA H+ I+HRD+K NI++
Sbjct: 63 GRT---LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 427 EEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGYG 480
A V DFG+ L+ +D V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 481 VMLLELITGQRAFDLARLA-------NDDDVMLLDWVKGL 513
++ LE +TGQR A +A + DV L W+ G
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 343
NF +LG G +GKV+ R G L A+K LK+ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 344 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGA 398
R L+ L T T+ L+ ++ G + + L RER + Q QI G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSGE 113
Query: 399 -ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L +LH II+RD+K NILLD V+ DFGL+K + + GTI
Sbjct: 114 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 458 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
++AP+ + G + D + GV++ EL+TG F
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + VYKGR LT LVA+K ++ E +G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCD 410
T LV+ ++ + + + G N VR Q+ RGLAY H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN--VRLFLFQLL----RGLAYCHQR-- 122
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYL 465
+++HRD+K N+L+ E E + DFGLA+ Y + VT R P+ L
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVL 175
Query: 466 --STGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
ST S+ D++G G + E+ TG+ F + D
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 39/93 (41%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 460
LAYLH IIHRDVK NI LDE AV+GDFG A KL + DT GT+
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L+ KTD++ G++L E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKE----ERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG GGFG+V ++ + A+K +K+ E Q + +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ--QEHIFSEKEILEECNHPFIVKL 58
Query: 351 -RGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
R F ++ +Y + + G + + LR+RG + + YLH
Sbjct: 59 YRTF----KDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLH 110
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 465
+ II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII 164
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
D + G++L EL+TG+ F +D+D M
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 59/165 (35%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIG 458
LA H H +IHRD+K+ANILL +GDFG +K+ Y T V GT
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPY 210
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518
++APE S+K D+F GV+L EL+T +R FD N ++VM K L +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMH----KTL--AGR 261
Query: 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
+ L S I E+ Q I ALL P RP S+++ M
Sbjct: 262 YDPLPPS------ISPEM-QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 296 LGRGGFGKVYKG--RLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG G FG V KG ++ + VA+K LK E + + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 410
C E L++ M +G + + + ++ V Q+++G + YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGK-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTG 468
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 469 KSSEKTDVFGYGVMLLELIT-GQRAF 493
K S ++DV+ YG+ + E + GQ+ +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 290 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRN 346
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L LV+ F+ + + L + + L+ S ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 461
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 462 PEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 493
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+G G +G VYK R L G L AVK +K E G + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
++ + + + GS+ G PL+ + +GLAYLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTGK 469
+HRD+K ANILL + + + DFG+A + T A R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 470 S---SEKTDVFGYGVMLLELITGQRA-FDL 495
+ ++ D++ G+ +EL Q FDL
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 343
NF +LG G +GKV+ R G L A+K L++ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 344 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
R L+ L T + L+ ++ G + + L +R N+S +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEI 114
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
LA H H I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++
Sbjct: 115 ILALEHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 461 APEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDL 495
APE + G + D + G+++ EL+TG F L
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV---HRNLLRL 350
+G G +G VYK R G VA+K ++ + + G L EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 408
C T +V V LR PP L K + RGL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQS 182
Query: 469 KSSEKTDVFGYGVMLLEL 486
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FGKV + DG AVK L+++ + + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQI-ALGAARGLAYLHD 407
L T + V ++ G + L RER +P R + A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHS 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 466
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 61/287 (21%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
ILG G FG++ +G L S VA+ L+ + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G ++V +M NG++ S LR+ GQ L + G A G+ YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM- 126
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLST 467
+H+ + A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
S +DV+ +G+++ E+++ G+R + W D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPY---------------W----------------D 211
Query: 527 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEV 560
M G + + VE L Q+ L C Q ERP+ S++
Sbjct: 212 MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
N +G G G V + G VAVK++ + Q EL F EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNI 78
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAY 404
+ + + E +V F+ G++ + ++ QIA L + L++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSF 130
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH +IHRD+K+ +ILL + + DFG + K+ ++ GT +APE
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEV 186
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+S + D++ G+M++E++ G+ +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-11
Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 26 SNAEGDALNALKTNL-ADPNNVLQSWDATLVNPCTWFHVTCN 66
N + DAL A K++L DP+ L SW+ + +PC+W VTC+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE--MISMA-VHRNLLRL 350
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 351 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+C T+ L V ++ G + ++ + P +I G L +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK 115
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I++RD+K NILLD + + DFG+ K D T GT +IAPE L
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
K + D + +GV+L E++ GQ F
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G +G V+K R + G +VA+K+ E+ ++ + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ LV+ + + + L E ++ + + K+I + + + H H
Sbjct: 68 VFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---N 120
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L G +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQY 178
Query: 473 KT--DVFGYGVMLLELITGQ 490
DV+ G + EL+TGQ
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ + + E +V F+ G++ + + +N + L + L+ LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+IHRD+K+ +ILL + + DFG + K+ ++ GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELIS 189
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
+ D++ G+M++E++ G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 12/229 (5%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRL 350
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
T + V F+ G L Q Q L + + + L +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGD----LMFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519
D + GV++ E++ G+ FD+ ++++ D D++ ++ EK++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 53/223 (23%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV------------------- 336
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 337 -EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQ 393
M+S H++L+ G C+ E ++V ++ GS+ + L++ + ++W V KQ
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQ 108
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453
+A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 109 LAW----ALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITV 158
Query: 454 RGT------IGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITG 489
I + PE + ++ S D + +G L E+ +G
Sbjct: 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
G VAVK++ + Q EL F EV ++ H N++ + + E +V F+ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
+ + + +N + L R L+YLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
+ DFG + K+ ++ GT +APE +S + D++ G+M++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL-KEERTQGGELQFQTEV 336
+ +L++ ++F ++GRG FG+V R V A+K L K E + + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 337 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWS-- 389
I MA H N +++L ++ L V +M G + + + P W+
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARF 146
Query: 390 --VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 446
+AL A + + IHRDVK N+LLD+ + DFG MD +
Sbjct: 147 YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANG 196
Query: 447 -THVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNL 347
+G G +G VYK R G +VA+K+++ E G E+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--PLNWSVRKQIALGAARGLAYL 405
+RL + + LV+ F + L++ S P L+ + K +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 458
H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR---- 166
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
APE L + S D++ G + E++ + F
Sbjct: 167 --APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQFQTEVEMI----SMAVHRNLLR 349
+G+G FG+VY+ R D + A+K L K+E E+ I + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L+ T ++ LV +M G + L++ G+ ++ L L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA----LEHLHKY- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I++RD+K NILLD + DFGL+K + D T GT ++APE L K
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 470 SSEK-TDVFGYGVMLLELITGQRAF 493
K D + GV++ E+ G F
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 12/228 (5%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR 351
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
C T RL + VNG L Q Q L + A L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 472 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519
D + GV++ E++ G+ FD+ + ++ D+ D++ ++ EK +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI--ITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 286 ATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
A ++ N LG G + VYKG +G LVA+K + + +G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L T V+ +M ++ G P ++VR RGLAY
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP---YNVR-LFMFQLLRGLAY 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 465 L--STGKSSEKTDVFGYGVMLLELITGQRAF 493
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 293 RNILGRGGFGKVY--------------------KGRLTDGSLVAVKRLKEERTQGGELQF 332
+ LG G FG+V+ KGR LVAVK L+ + + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------- 379
EV+++S N++RL G C+ ++ +M NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 380 GQSQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437
+ P +++S +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 438 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495
+++ + Y + R I +A E + GK + +DV+ +GV L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 496 ARLANDD 502
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 296 LGRGGFGKVYKGRLTDGSLVA---VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRE----RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
C+ LLV+ + G + S L + R SQ L +++A A G+ ++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHKH 118
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAP 462
+H D+ N L + VGD+G+ YK+ ++ T +R +
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 463 EY---LSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR--LANDDDVMLLDWVKGLLKEK 517
E+ L T + ++ ++V+ GV L EL F+ A ++ D +L+ V +K++
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVLNHV---IKDQ 225
Query: 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
++ +L +E Y E E L Q L SP +R EV R+L
Sbjct: 226 QV-KLFKPQLELPYSERWYEVL-QFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 298 RGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G FG VY K R T G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMM 51
Query: 356 TPTE-----RL-----------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
E +L LV ++ G AS ++ G P +W+ KQ
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWA--KQYIAEVV 107
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT +
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDY 159
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE + + +D + G ++ E + G F
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 295 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FGKV R DG AVK L+++ R + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L + TE+L VNG RER +P + + A L YLH
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-----IASALGYLHS 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 466
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRN 346
+F LG G FG+V + G A+K L K E + ++Q + + I M +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 347 LL--RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ + F + F+V G + + LR+ G+ + ++ L Y
Sbjct: 79 FIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEY 133
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH D II+RD+K N+LLD + V DFG AK K T + GT ++APE
Sbjct: 134 LHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEV 186
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + + D + GV+L E I G F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 295 ILGRGGFGKVY---KGRLTD-GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLR 349
+LG+G FGKV+ K D G L A+K LK+ + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L T + L+ F+ G + + L +E ++ + + + ++AL L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELALA----LDHLHSL 117
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLS 466
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 171
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
++ D + +GV++ E++TG F
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 69/234 (29%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 355 MTPTERLLVYPFMVN--------GSVASCLR--------------ERGQSQPPLNWSVRK 392
M R + P+ V G V C+ ++G + P +
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE---DILG 106
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG--------LAKLMDY 444
+IA+ + L YLH +IHRDVK +N+L++ + + DFG +AK +D
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSE----KTDVFGYGVMLLELITGQRAFD 494
G ++APE ++ + + K+DV+ G+ ++EL TG+ +D
Sbjct: 164 ---------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G G V R G VAVK + + Q EL F EV ++ H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E ++ F+ G++ + SQ LN + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ +ILL + + DFG + KD ++ GT +APE +S +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 475 DVFGYGVMLLELITGQ 490
D++ G+M++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQ-TEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K LK+E E+ TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 352 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ +RL NG RER S+ + + ++ L YLH C
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS-C 114
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
D +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 295 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLR 349
++G+GG G+VY D VA+K+++E+ ++ L+ F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 350 LRGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA------- 399
+ C ++ VY P++ ++ S L+ Q + S+ K++A +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKE-----SLSKELAEKTSVGAFLSI 118
Query: 400 -----RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----------- 443
+ Y+H ++HRD+K NILL E V+ D+G A
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 444 ------YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
Y + + GT ++APE L +SE TD++ GV+L +++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 293 RNILGRGGFGKVYKGRLTDGS----LVAVKRLKEE---RTQGGELQFQTEVEMISMAVHR 345
+LG+GG+GKV++ R G+ + A+K LK+ R Q + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
++ L T + L+ ++ G + L G +I+L L +L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H II+RD+K NILLD + + DFGL K ++ T VT GTI ++APE L
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
+ D + G ++ +++TG F
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EVE 337
D + N + +G G +G+V T G VA+K+L FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELR 66
Query: 338 MISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
++ H N++ L TP L LV M + + ++ L+
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDH 119
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 449
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 450 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 57/278 (20%), Positives = 118/278 (42%), Gaps = 22/278 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 345
NF +GRG F +VY+ L D VA+K+++ E E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++ + E +V G ++ ++ + + + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525
+ K+D++ G +L E+ Q F D + L +K+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC------QKIEQCDYP 226
Query: 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
+ + E++ +L+ +C P +RP + V ++
Sbjct: 227 PLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 64/288 (22%), Positives = 126/288 (43%), Gaps = 58/288 (20%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG- 352
+GRG FG V K G+++AVKR++ + + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 353 --------FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
CM ++ Y + V + S + E + +IA+ +
Sbjct: 72 LFREGDCWICMELMDISLDKF--YKY-VYEVLKSVIPEE----------ILGKIAVATVK 118
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 459
L YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 460 IAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAF----------------DLARLAN 500
+APE + ++DV+ G+ L E+ TG+ + D L+N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 501 DDDVM----LLDWV-KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVA 543
++ ++++ L+K++ +E +I++ E+ + VA
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 296 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
LG G FG+V+ K D S LVAVK L+E+ + F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPP------LNWSVR 391
+S N++RL C+T ++ +M NG + L R Q +++S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+A A G+ YL +HRD+ N L+ + + + DFG+++ + Y +
Sbjct: 133 IFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYRI 188
Query: 452 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R I ++ E + GK + +DV+ +GV L E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 295 ILGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL 347
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 348 LRLRG--------------FCM---------------------TPTERLLVYPF------ 366
+ L G FC +P +R
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 367 --MVNGSVASCLRER------GQSQPPLN----WSVRKQI------ALGAARGLAYLHDH 408
+ AS L R G + PP W + + ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 466
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 467 TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525
+ ++DV+ +GV+L E+ + G + G+ ++ Q +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQINEEFCQRLKD 292
Query: 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAER 572
E ++ ++ L C QG P ERP S +V +L GD L E
Sbjct: 293 GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 342
++ D+F + LG G G V+K L+ ++L E Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ G + E + M GS+ L++ G+ + + ++++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGL 116
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 461
YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE L S ++D++ G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 297 GRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 351
GRG +G+VYK + DG A+K+ K ++ Q + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 352 GFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ ++ L++ + + R + + S+ K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 410 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKLMD------YKDTHVTTAVRGTIGH 459
++HRD+K ANIL+ + VV GD GLA+L + V TI +
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TIWY 181
Query: 460 IAPEYLSTGKSSEKT-DVFGYGVMLLELIT 488
APE L + K D++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLK---------EERTQGGE--LQFQT--EVEMI 339
LG G +GKV K T G +VA+K++K ++R G + F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
+ H N++ L + LV M AS L++ + L S K I L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDTHVTTAV 453
GL LH +HRD+ ANI ++ + + DFGLA+ D T
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 454 RG-------TIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 493
R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 337
+R+LQ+ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 338 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 391
I MA + ++ FC ++ L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAE 150
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 450
+AL A + +IHRDVK N+LLD+ + DFG MD
Sbjct: 151 VVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 451 TAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G +G VYK R +T+ +A+K+++ E+ +G E+ ++ H N++RL+
Sbjct: 10 IGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 410
+ LV+ ++ L++ S P + R K RG+AY H H
Sbjct: 69 VVHSEKRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 470 S-SEKTDVFGYGVMLLELITGQRAF 493
S D++ G + E++ + F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRG 352
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+P + LV F+ G + L+ G+ + S + L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR----FDLSRARFYTAELLCALENLHKF---N 113
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 473 KTDVFGYGVMLLELITG 489
D + GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+G+G FG+V+K R +VA+K+ L E +G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 352 GFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
C T LV+ F + +A L S K++ GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLY 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDG---------SLVAVKRLKEERTQGGELQFQTEVEM 338
D+ +G G FG+V+ R ++ V RLK+E+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRV 54
Query: 339 ISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+ H ++RL F +R L + ++ G + S LR G+ + S A
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYAS 108
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 455
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T ++APE + + ++ D + G+++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
T V ++ G + L RER S+ + + ++ L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
D +G GV++ E++ G+ F N D L + + L+++ K + + +D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELI--LMEDIKFPRTLSAD 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 342
++ D+F + LG G G V K + L+ ++L E Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ G + E + M GS+ L+E + + + ++++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 116
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 461
AYL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE L S ++D++ G+ L+EL G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRL---TDG---SLVAVKRLKEERTQGGELQFQTE 335
E+ ++T F LG FGKVYKG L G VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS------------- 382
M S H N++ L G +++ + + + L R
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 383 ---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439
+P + QIA G+ +L H ++H+D+ N+L+ ++ + D GL
Sbjct: 119 STLEPADFVHIVTQIA----AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 440 KLM---DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ + DY + + I ++PE + GK S +D++ YGV+L E+ +
Sbjct: 172 REVYAADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL--VAVKRLKEERT--QGGELQFQTEV 336
R+ ++ ++F+ LG G FG+V + VA+KR ++ + Q +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
++++ H + L G + LV F++ G + LR + + QI L
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
YL I++RD+K N+LLD++ + DFG AK++D + T + GT
Sbjct: 143 I----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGT 191
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+IAPE L + D + G+ + E++ G F
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 15/150 (10%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G V+K + + +VA+KR++ ++ +G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 354 CMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
+ + LV+ + + SC G P + S Q+ +GLA+ H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
++HRD+K N+L+++ E + DFGLA+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 46/201 (22%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 296 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G+G G V+ D G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLD 83
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ E +V ++ GS+ + E + + R+ + + L +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRD+K+ N+LL + + DFG + + + +T V GT +APE ++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 473 KTDVFGYGVMLLELITGQRAF 493
K D++ G+M +E++ G+ +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK R + G L A+K +K E + + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ + + F GS+ G PL+ S ++ +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST--- 467
HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 468 GKSSEKTDVFGYGVMLLELITGQRA-FDL 495
G ++ D++ G+ +EL Q FDL
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 298 RGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC 354
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ LV +++ G V S L G + K I+ A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLHRH---GII 126
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKL 441
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 475 DVFGYGVMLLELITGQRAF 493
D++ G+M +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G VYKGR G +VA+K+++ E +G E+ ++ H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 354 CMTPTERLLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
M + L++ F M L + L S QI G + + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCHSR--- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKS 470
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
S D++ G + E+ T + F
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 295 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
++G G FG+ + + +D A+K ++ ++ + E +++ H N++ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPP---LNWSVRKQIALGAARGLAYLHDH 408
+V + G + ++ +RG+ P L W V Q+ LG H H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ------HIH 117
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
+ K+D++ G +L EL T + F
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 455
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 456 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELI 487
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
++G+G FGKV R + AVK L+++ + E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 352 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
F ++L +NG RER +P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHSL- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
APE L+ D++ G++L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTT 451
+I++ RGL YL + KI+HRDVK +NIL++ E + DFG++ +L+D +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 156
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 67/296 (22%), Positives = 100/296 (33%), Gaps = 44/296 (14%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+ K + T +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDP 411
L +V P M GS L+ L I L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------APEYL 465
IHR VKA++ILL + + V+ + M + +PE L
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 466 STGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL---LKEKKL 519
+EK+D++ G+ EL G F D+ MLL+ V+G L +K
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDM-----PATQMLLEKVRGTVPCLLDKST 235
Query: 520 EQLVDSDMEGNYIEEEV----------------EQLIQVALLCTQGSPMERPKMSE 559
L + M + E E Q LC Q P RP S+
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 296 LGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
+GRG VY R T G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T + ++ PFM GS S L+ G S+ ++ I GA RGL YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE-----ALIGNILFGALRGLNYLHQN 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTI 457
IHR++KA++IL+ + +V GL+ L Y +T+V +
Sbjct: 121 ---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---L 172
Query: 458 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL 513
++PE L + K+D++ G+ EL TG+ F D+ R MLL +KG
Sbjct: 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGP 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA+K++ ++ EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 475 DVFGYGVMLLELITGQ 490
D++ G+M +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 318 KRLKEERTQGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPF 366
+RL +R + G +Q + E+ + H N+L++ + ++ Y F
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426
M + + ++R PL R I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD--WKDR-----PLLKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 427 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 487 IT 488
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 296 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLR 351
LG G FG V KG VAVK LK + + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIALGAARG 401
G C + L++ L E G PLN ++K ++ + G
Sbjct: 63 GICEAESWMLVME-----------LAELG----PLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 459
+ YL + +HRD+ A N+LL + A + DFGL+K + + + G +
Sbjct: 108 MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
APE ++ K S K+DV+ +GV++ E + GQ+ +
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 80/344 (23%), Positives = 129/344 (37%), Gaps = 90/344 (26%)
Query: 296 LGRGGFGKVYK------GRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL- 347
LGRG FGKV + + VAVK LKE T TE++ +I + H N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 348 ----------------------------LRLRGFCMTPT------ERLLVYPFMVNGSVA 373
LR + C +P +R + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 374 SC-----------LRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCD 410
S + ++ S + PL + ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA-VRGTIGHIAPEYLSTG 468
K IHRD+ A NILL E + DFGLA+ + YKD +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 469 KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ ++DV+ +GV+L E+ + G + G+ +++ + +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQIDEEFCRRLKEGT 293
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 571
E ++ + L C +P +RP SE+V +L GD L E
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA++++ ++ EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 475 DVFGYGVMLLELITGQRAF 493
D++ G+M +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERT------QGGE--LQFQTEVEMISMAVHRN 346
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L++L G C+ E ++V ++ G + L + L+W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN-VSLHWKL--DVAKQLASALHYLE 118
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 463
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 464 YLSTGKSS--EKTDVFGYGVMLLEL 486
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 5/85 (5%)
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG 468
K++HRD+K+ANI L +GDFG +K Y D+ V ++ GT ++APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
+ S+K D++ GV+L EL+T R F
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 45/257 (17%)
Query: 296 LGRGGFGKV-YKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRLR 351
+G G +G V G+ VA+K+L R EL + E+ ++ H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 352 GFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
TP L LV PFM + ++ S+ + + V + + +GL Y
Sbjct: 81 D-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKY 133
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAP 462
+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R AP
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR------AP 184
Query: 463 EY-LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-----E 516
E L+ ++ D++ G ++ E++TG+ F +D LD + ++K
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK----GHDH----LDQLMEIMKVTGTPS 236
Query: 517 KKLEQLVDSDMEGNYIE 533
K+ Q + S+ NY++
Sbjct: 237 KEFVQKLQSEDAKNYVK 253
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 356 TPTER--LLVYPFMVNG--SVASCLRERGQSQPPLNW--SVRKQIALGAARGLAYLHDHC 409
+ ++R L++ + + + R ++ P+ S+ K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 410 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 463
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 464 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 288 DNFSNRNILGRGGFG--KVYKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 343
+F ++++GRG FG +V + + T G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 344 HRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARG 401
+ +L+ + + L LV + G + S L R Q + ++ L
Sbjct: 60 SPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---- 114
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
+H +HRD+K N+L+D + DFG A + + GT +IA
Sbjct: 115 ---IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 462 PEYLSTGKSSEKT------DVFGYGVMLLELITGQRAF 493
PE L+T K D + GV+ E+I G+ F
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 348
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 349 RLRGFCM-TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLA 403
RL T RL LV+ M + ++ ++ R + P V+ Q+ + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK--RVKSYMYQLL----KSLD 114
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
++H + I HRD+K NIL+ ++ + DFG + + K + T T + APE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE 168
Query: 464 -YLSTGKSSEKTDVFGYGVMLLELIT 488
L+ G K D++ G + E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 5/137 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+++ +DL +S L ++ L+ L+ L+L +N+I ++ L NL NL L+L N
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L +P ++G LS L L L+NN SL ++ +L+ LDLS N L+ +P
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 189 LFTPISFANNQLNNPPP 205
L +
Sbjct: 301 LLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 295 ILGRGGFGKV--YKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRL 350
+LG+G FGKV K + T G A+K LK+E + TE ++ + H L L
Sbjct: 2 LLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ T V + G + L RER S+ + + ++ L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALDYLH--S 113
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+D + +G+G +GKV+K +GS AVK L E++ + + + +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHP 75
Query: 346 NLLRLRGF-----CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
N+++ G + LV GSV ++ + + + I A
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
GL +LH + K IHRDVK NILL E + DFG++ + T+V GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 461 APEYLSTGKS-----SEKTDVFGYGVMLLELITG 489
APE ++ + + DV+ G+ +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG+G +G VYK + +KE R + E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ +M GS+ L G + + V ++I +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 469
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 470 SSE------KTDVFGYGVMLLELITG 489
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
M + N ++L T +L+ ++ +G L + + + L+ + K+I
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVE 120
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L LH H IIH D+K N+L D + + + D+GL K++ + GT+ +
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDY 172
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+PE + D + GV+ EL+TG+ F D+D L
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGEL------QFQTEVEMISMAVHRNLL 348
LG+G FG VY + D VA +RLK + GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL------NWSVRKQIALGAARGL 402
+ + ++ + + L E + L W + Q+ L G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI--QLLL----GV 119
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
Y+H +I+HRD+KA NI L +GDFG+++L+ + T GT +++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E L K+D++ G +L E+ AF
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 296 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQT---------EVEMISMAV 343
+G G FG V+ +TD G VA+K++ FQ E++M+
Sbjct: 8 IGYGAFGVVWS--VTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFK 57
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N+L P ++V + S L + S PL+ K RGL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH I+HRD+K N+L++ + DFGLA++ + ++ T T + APE
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 464 YLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
L + + D++ G + EL+ + F
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 456
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516
+ +APE + + ++DV+ +GV+L E+ F L A+ + +D
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLG--ASPYPGVKID-------- 288
Query: 517 KKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
E+ EG + + ++ Q L C G P +RP SE+V L
Sbjct: 289 ---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 82/259 (31%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMA 342
D+F ++GRG FG+V+ R G + A+K L++ R Q + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 343 VHRNLLRLRGFC-MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI------ 394
+++L + E L LV +M G + +N +RK +
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETA 103
Query: 395 ---------ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
AL + L + IHRD+K NIL+D + + DFGL K
Sbjct: 104 RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMN 152
Query: 446 DTHVTTAVR------------------------------GTIGHIAPEYLSTGKS-SEKT 474
GT +IAPE L G +
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLEC 211
Query: 475 DVFGYGVMLLELITGQRAF 493
D + GV+L E++ G F
Sbjct: 212 DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLDE 427
S + + S P L+ + + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWP-LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 428 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YG++L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 487 IT 488
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 460 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 460 IAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAF 493
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 459 --HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ +P LS ++ D++ G + E++TG+ F
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 337
+R+L++ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 338 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 391
I MA + ++ F +R L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE 150
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 449
+AL A + + IHRDVK N+LLD+ + DFG M+ K+ V
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRC 200
Query: 450 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 356 TPTER--LLVYPFMVNG--SVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDHC 409
+ +R L++ + + + R ++ P L + K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 410 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 463
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 464 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 455
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 456 TIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK--EERTQGGELQFQTEVEMISMAVH 344
+ F ++G G +G V K R + +VA+K+ K EE + E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L+ + LV+ + V ++ L E PP VR I + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEK--VRSYI-YQLIKAIHW 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 463
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K L++E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
T V + G + L RER ++ + + ++ L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS-----ALEYLHSR-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 460 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQ-FQTEVEMISMAVH 344
++F ++GRG FG+V +L + V ++ K E + E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAARG 401
+ + L LV + V G + + L + P + IA+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 460
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 461 APEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L GK + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 456
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 457 IGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 7e-06
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL+ L+L +N ++ L NL LDL NNL P L LR L L+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV---------EMISMAVHR 345
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 346 NLLRLRG-FCMTPTER-----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
N++ L F + LV P+M + S+ + + V + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 457
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 458 GHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 399 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 456
A+G+++L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
+ +APE + + ++DV+ YG++L E+ + G + G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-----------------PGMPV 322
Query: 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ K +++ E ++ + C P++RP ++V+++E
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-05
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +DL N L+ L NL+ L+L NN++ PE L +L SLDL NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAV--- 343
D+F ++GRG FG+V AV ++K ER ++ + EM+ A
Sbjct: 1 DDFEIIKVIGRGAFGEV-----------AVVKMKHTERIYA--MKILNKWEMLKRAETAC 47
Query: 344 ---HRNLLRLRGFCMTPTER----------LLVYPFMVNGSVASCLRERGQSQPPLNWSV 390
RN+L + G C T LV + V G + + L + P
Sbjct: 48 FREERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP------ 100
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450
A + +H +HRD+K N+LLD + DFG M+ T +
Sbjct: 101 EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 451 TAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 493
+ GT +I+PE L GK + D + GV + E++ G+ F
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 330 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW- 388
L F ++S H +L + G C+ +E ++V F+ +G + CLR + + + P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 389 -SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
+V +Q+ A L+YL D ++H +V A NILL + + G + + D
Sbjct: 120 ITVAQQL----ASALSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDP 168
Query: 448 HVTTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 486
V+ I IAPE + G S S D + +G LLE+
Sbjct: 169 GVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 51/271 (18%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 304 VYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421
++ LRE + L++ + +A+ +GL L+ + ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 422 NILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSSEKTD 475
+ L+ E ++ + GL K++ +K+ V V + I EY K D
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------IKDD 204
Query: 476 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 535
++ GV+L E+ TG+ F+ N L K++ L+ + + +
Sbjct: 205 IYSLGVVLWEIFTGKIPFE-----N-------------LTTKEIYDLIINKNNSLKLPLD 246
Query: 536 VEQLIQ-VALLCTQGSPMERPKMSEVVRMLE 565
I+ + CT ++RP + E++ L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 456
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 457 IGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 493
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 33/230 (14%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLRG 352
+G+GG+G+V+ + D G +VA+KR+K+ TE ++++ L++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-----ALGAARGLAYLHD 407
L ++ G + L G R + A+ A L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFEAVDALHELGY--- 122
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYL 465
IHRD+K N L+D + DFGL+K + VT A V G+ ++APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVL 170
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 513
D + G ML E + G F + ++ L W + L
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVH 344
D+F ++GRG FG+V ++ + G + A+K L K E + E F+ E +++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 345 RNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAAR 400
R + L + L LV + V G + + L + P + +A+ +
Sbjct: 61 RWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L Y +HRD+K N+LLD+ + DFG + T + GT +I
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 461 APEYL-----STGKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L G+ + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 352
LG+G G+V+ RL G L A+K L K+E + ++ + TE E+++ H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLAY 404
T T LV + G + L Q QP K ++ AR L Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL----QRQP------GKCLSEEVARFYAAEVLLALEY 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---------- 454
LH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 119 LHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 455 ------------------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
GT +IAPE +S D + G++L E++ G F
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEE----RTQGGELQFQTEVEMISMA 342
++F ++ G +G VY R + A+K++ ++ R Q Q E ++++ A
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ--IQQVFVERDILTFA 58
Query: 343 VHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
N + FC T+R L V ++ G A+ L+ G L + +
Sbjct: 59 --ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVL 112
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH 448
L YLH++ I+HRD+K N+L+ + DFGL+K LM KDT
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 449 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ V GT +IAPE + + D + G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 455
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 456 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 30/100 (30%), Positives = 40/100 (40%), Gaps = 18/100 (18%)
Query: 94 NLQYLELYSNNISGKVPEELGNL----TNLVSLDLYLNNLNGPIPTTLGK----LSKLRF 145
L+ L L N + G E L +L L+L N + L + L
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197
Query: 146 LRLNNNSL-------MGEIPRSLTNVNSLQVLDLSNNKLT 178
L LNNN L + E SL SL+VL+L +N LT
Sbjct: 198 LDLNNNGLTDEGASALAETLASLK---SLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 17/147 (11%)
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL--RLRGFCMT 356
G +VY D V LK ++ + EV ++ + + L ++ +
Sbjct: 9 GLTNRVYLLGTKDEDYV----LKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416
L+ ++ G++ ++ ++ IA A LA LH + H
Sbjct: 65 DGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 417 DVKAANILLDEEFEAVVGDFGLAKLMD 443
D+ NIL+D+ + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 6e-04
Identities = 17/37 (45%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
TNL+ L+L +N I+ +P L NL NL +LDL N +
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLS 466
H + IIHRD+K N+L++ + +GDFG A T + GT+ APE L+
Sbjct: 277 HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA 335
Query: 467 TGKSSEKTDVFGYGVMLLE 485
+ D++ G+++ E
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 45/236 (19%)
Query: 296 LGRGGFGKVY--KGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+G G FG+V+ K + T ++ + LKE Q EV ++ H+N++R
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS----QLVIEVNVMRELKHKNIVR 76
Query: 350 -LRGFCMTPTERL-LVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
+ F ++L ++ F G ++ C + G+ + + +Q+ LA
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL----HALA 132
Query: 404 YLHDHCD----PKIIHRDVKAANILLDEEFE-----------------AVVGDFGLAKLM 442
Y H+ D +++HRD+K NI L A +GDFGL+K +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 443 DYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLA 496
+ + + GT + +PE L T +K+D++ G ++ EL +G+ F A
Sbjct: 193 GIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 456
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 457 --IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + +DV+ YG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 294 NILGRGGFGKVYKGRLTDGS-LVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
NI+G G FG VY+ D S VA+K+ L++ + + EL + H N++ L+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN------HINIIFLK 125
Query: 352 GFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ T + L V + +V ++ ++ L + K + R LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHI--- 460
+H I HRD+K N+L+D + + DFG AK + A + ++ +I
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSR 234
Query: 461 ---APEYLSTGKSSEKT--DVFGYGVMLLELITGQRAF 493
APE L G ++ T D++ G ++ E+I G F
Sbjct: 235 FYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 17/128 (13%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL----TNLQYLELYSNNISG----KVPEELGNLTNLVS 121
++ ++ LG L G L + +L+ L L +N I + E L NL
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197
Query: 122 LDLYLNNLN----GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN-----SLQVLDL 172
LDL N L + TL L L L L +N+L +L + SL L L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 173 SNNKLTGD 180
S N +T D
Sbjct: 258 SCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 453
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 296 LGRGGFGKVYKGRLTDGS------------LVAVKRLKEERTQGGELQFQTEVEMISMAV 343
LGRG ++Y G L + + ++ + + L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAAR 400
H++++ L G C+ E ++V F+ G + L +S P + V KQ+ A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL----AS 116
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT--- 456
L+YL D ++H +V NILL E + G+ G KL D +T R
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVE 170
Query: 457 -IGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 486
I IAPE + K+ S D + +G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.004
Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L L+NN + ++P L+N+ +L+ LDLS NK+T
Sbjct: 2 NLETLDLSNNQI-TDLP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.3 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.03 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.88 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.81 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.77 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.74 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.69 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.69 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.63 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.48 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.45 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.34 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.32 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-58 Score=539.45 Aligned_cols=469 Identities=28% Similarity=0.490 Sum_probs=314.0
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|+|++|++++..|..+.++++|+.|+|++|.+++.+|..+.++++|++|+|++|.+++.+|..|.++++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 46666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIA 229 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 229 (613)
+|++++.+|..+.++++|+.|++++|++.+.+|..+.+..+....+.+|+..|+.+.+... .+............++
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~---~~c~~~~~~~~~~~~~ 632 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL---PPCKRVRKTPSWWFYI 632 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC---CCCccccccceeeeeh
Confidence 6666666666666666666666666666666665555555555666666655553211100 0000000111111111
Q ss_pred cccchhhHHHhhhhhhHHHHhhccCCCCCcccCCCCCCc-cc-cc--CcccccCHHHHHHHhhCCCCCCccccCcCcEEE
Q 007200 230 GGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDP-EV-HL--GQLKRFSLRELQVATDNFSNRNILGRGGFGKVY 305 (613)
Q Consensus 230 ~~v~~~~~~l~~~~~~~~~~~r~rk~~~~~~~~~~~~~~-~~-~~--~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~ 305 (613)
+. +.++.++++++++.+.++|+|+... ......+... +. .. .....++..+ ....|...+.||+|+||.||
T Consensus 633 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy 707 (968)
T PLN00113 633 TC-TLGAFLVLALVAFGFVFIRGRNNLE-LKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASY 707 (968)
T ss_pred hH-HHHHHHHHHHHHHHHHHHHhhhccc-ccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEE
Confidence 11 1222222222222333333332111 0111110000 00 00 0011122232 33467788899999999999
Q ss_pred EEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCC
Q 007200 306 KGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384 (613)
Q Consensus 306 ~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 384 (613)
+|+.. +|..||||.+...... ...|++.+++++||||++++|++.++...++||||+++|+|.++++.
T Consensus 708 ~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------ 776 (968)
T PLN00113 708 KGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776 (968)
T ss_pred EEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------
Confidence 99974 7899999998643321 23468889999999999999999999999999999999999999963
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccc
Q 007200 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464 (613)
Q Consensus 385 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 464 (613)
++|..+..++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........ ....+++.|+|||+
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPET 849 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCccc
Confidence 7899999999999999999997666699999999999999999888875 6655432211 12257899999999
Q ss_pred cccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC--CCcHHHHHHHHHH
Q 007200 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQV 542 (613)
Q Consensus 465 ~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 542 (613)
+.+..++.++|||||||++|||+||+.||+... .......+|.+............++.... ....+....+.++
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 999999999999999999999999999996332 22345667776655555555555655433 2345566788999
Q ss_pred HHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 543 ALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 543 i~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+.+||+.||++||||+|+++.|+..
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=435.30 Aligned_cols=289 Identities=53% Similarity=0.901 Sum_probs=254.7
Q ss_pred cccccCHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 274 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
..+.|++.++..++++|+..+.||+|+||.||+|...+|+.||||++....... ..+|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999988999999887665443 5569999999999999999999999
Q ss_pred EEcCC-ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 354 CMTPT-ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 354 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
|.+.+ +.+||||||++|+|.++++..... +++|..|.+|+.++|+||+|||+.+++.|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999876543 689999999999999999999999988999999999999999999999
Q ss_pred EeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|+|||+|+..+...........||.+|+|||++..+..+.|+|||||||++.|++||+.+.+... ......+.+|...
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence 99999997654311111111169999999999999999999999999999999999999887544 2334459999999
Q ss_pred HhhcccccccccCccC-CCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 513 LLKEKKLEQLVDSDME-GNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.+....+.+++|+.+. ..+.. +....+..++..|++.+|++||+|.||++.|+.+
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999999987 55553 6888999999999999999999999999999653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=375.62 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=213.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC-ceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 366 (613)
+.+..+.||+|..|+||+++++ +++.+|+|.+..........++.+|+++++..+||+||.++|.|..+. +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445678999999999999987 788999999977766666778999999999999999999999999988 59999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|.+|+|.+.+...+. +++...-+|+.++++||.|||+ . +||||||||+|||++..|+|||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999987643 8999999999999999999996 6 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
...+.+||..|||||.+.+..|+.++||||||+.++|+++|+.||-... .......+.+.....+...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~ppP------ 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPPP------ 300 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCCC------
Confidence 4566789999999999999999999999999999999999999996441 2223333333333221111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.++. ..+..++..++..|+++||.+|||+.|+++.
T Consensus 301 ~lP~---~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPE---GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCc---ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 1356789999999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=392.97 Aligned_cols=258 Identities=32% Similarity=0.513 Sum_probs=209.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCC-ceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 364 (613)
.+.+...+.||+|+||+||+|.+.....||||++...... .....|.+|+.++.+++|||||+++|+|.++. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3444455669999999999999984444999999764322 22568999999999999999999999999987 799999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceeecCCC-cEEEeccccceec
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~ 442 (613)
|||++|+|.++++.. ....+++..+..++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++..
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999874 234599999999999999999999999 7 99999999999999997 9999999999876
Q ss_pred CCCCCceeeccccccccccccccc--cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.... ..+.+.....
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~v~~----- 260 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASAVVV----- 260 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-----
Confidence 5432 2233367999999999999 5689999999999999999999999996322 1111112211
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+...+..+...+..++..||+.||+.||++.+++..|+.+
T Consensus 261 ----~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 261 ----GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ----cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111222233567899999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=387.26 Aligned_cols=258 Identities=30% Similarity=0.456 Sum_probs=215.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..+.+...+.||+|.||.||.|.+.....||+|.++.... ...+|.+|+.+|++++|+|||+++|+|..+...+|||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 33344455678999999999999998777999999986532 3567899999999999999999999999988999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||+.|+|.++|+... +..+.....+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+....
T Consensus 281 E~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999998733 33489999999999999999999999 999999999999999999999999999996554
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.....+....-+..|.|||.+..+.++.|||||||||+||||+| |+.||... ...+.+...
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~l---------- 417 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELL---------- 417 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHH----------
Confidence 44444444445679999999999999999999999999999999 88887422 233333333
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+...+...+..++..+.++|..||+.+|++|||++.+...|+++
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 33333334556778899999999999999999999999988764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=369.88 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=206.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc------cHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++++..... .....++|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 456788899999999999999865 79999999998654322 23346799999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEecc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDF 436 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df 436 (613)
.||||||++||+|.+.+-..+. +.+...+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999977654 77788899999999999999999 99999999999999876 77999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCC---CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
|+|++.+ ........+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.... .+..+.+.+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~eQI~-- 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKEQIL-- 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHHHHh--
Confidence 9999876 4455677899999999999987653 458899999999999999999996221 1221222221
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+..... .........++..++|.+||..||++|||+.|+++
T Consensus 396 -~G~y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 -KGRYAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cCcccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111100 01123455678899999999999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=362.50 Aligned_cols=199 Identities=27% Similarity=0.472 Sum_probs=181.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.+|...+.||+|+||+||+|+++ ++..||||.+.+.. .....+.+..|+.+|+.++|||||.+++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888889999999999999987 68999999997765 44445668899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC------CcEEEeccccc
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 439 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~DfGla 439 (613)
||.||+|.++++.++. +++.+++.++.|||.||++||++ +||||||||.|||++.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998763 99999999999999999999999 99999999999999865 46899999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
+.+.. .......+|++-|||||++...+|+.|+|+||.|+++|+|++|+.||+.
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98863 3345567899999999999999999999999999999999999999973
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=378.36 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=211.4
Q ss_pred hCCCCCCccccCcCcEEEEEEe-CCCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.+|...+.||+|||+.+|++++ .+|+.||+|++.+... ......+.+||++.+.+.|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 6899999999986543 334567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|+|..++|.++++.+. ++++.+++.++.||+.||.|||++ +|+|||||..|++++++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998544 499999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.+ ......+|||.|+|||++....++..+||||+||+||-|+.|++||+.... +..+..-+..+..
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------------kety~~Ik~~~Y~- 236 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------------KETYNKIKLNEYS- 236 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------------HHHHHHHHhcCcc-
Confidence 43 345567899999999999999999999999999999999999999973321 1111111111111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+........++|.++|++||.+|||+++|+.
T Consensus 237 ------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233456788999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.98 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=209.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeE-EEEcCCc-eEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRG-FCMTPTE-RLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 363 (613)
.+|.+.++||+|.||+||++... +|..+|.|.+.-.... ....+...|+.+|++++|||||++++ .+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 44666789999999999999855 8999999999744333 33456889999999999999999998 4555555 8999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||.+|+|..+++.....+..+++.++++++.|+++||.++|++.+. -|+||||||.||+++.+|.||++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999988777777799999999999999999999995332 2889999999999999999999999999988
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
..... ...+.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||... ++.+.-+. +.....
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~K-I~qgd~--- 245 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKK-IEQGDY--- 245 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHH-HHcCCC---
Confidence 75443 345577999999999999999999999999999999999999999632 12222111 111111
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
+.++ ....+..+.+|+..|+.+||+.||+...+++.+.
T Consensus 246 --~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 --PPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111 1456788999999999999999998555554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.37 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=205.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+...++|+|+||+||+++.+ +|+.||||++...... .-.+-..+|+++|++++|+|+|.+++.|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999987 6999999999765442 234457899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||+.. +.+-++... ..++...+++++.|+++|+.|+|++ +++||||||+|||++.+|.+||||||.|+.+..
T Consensus 82 ~~dhT-vL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHT-VLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchH-HHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 99774 444444332 2388999999999999999999999 999999999999999999999999999998864
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc--------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 516 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 516 (613)
.+...+..+.|..|+|||.+.+ .+|.+.+||||+||++.||++|.+.|-. ..+.++.-.+...+.+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG-----~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG-----RSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC-----cchHHHHHHHHHHHcccCHHHHHH
Confidence 4455667778999999999988 6799999999999999999999999842 2232222222222211
Q ss_pred ----ccccccccCccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 ----KKLEQLVDSDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ----~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....-+.-+.... ...+....-++++++.|++.||++|++-+|++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111 111223456889999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=381.36 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=218.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
+...+....+.||+|+||+||+|+.. +...||||.++.........+|++|++++..++|||||+++|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34445556688999999999999854 245799999998887777889999999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
..+||+|||..|||.++|+.+.. ...+++..+.+.|+.|||.||+||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999975321 134589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCceee-ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007200 429 FEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVML 506 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~ 506 (613)
..|||+|||+++.....+.+... ...-+++|||||.+..+++|.+||||||||+|||+++ |+-||....
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--------- 710 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--------- 710 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---------
Confidence 99999999999977655443322 2234679999999999999999999999999999998 888885222
Q ss_pred HHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+.|..+++.+.+ -..++.++.++++||..||+.+|++||+++||-..|+.
T Consensus 711 n~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 711 NQEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hHHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 1223334443333 22345677899999999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=344.33 Aligned_cols=270 Identities=25% Similarity=0.331 Sum_probs=216.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|++.++||+|+||+||.++.+ +++.||+|++++..... .......|..++..++||+||+++-.|++....|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3467999999999999999999966 68899999998765433 35568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|+||+.||.|..+|++.+. |++..++.++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999987654 99999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
- ..+..+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.... ...+.....+.+...
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k~~~-- 244 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGKLPL-- 244 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCcCCC--
Confidence 3 23344566889999999999999999999999999999999999999996433 233443433333000
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCc--chhhHHHhhhhh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL--AERWEEWQKEEM 581 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~--~~~~~~~~~~~~ 581 (613)
.+.-......+++...+..||++|.....=...++...+ .-+|+.-.....
T Consensus 245 --------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 245 --------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred --------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 011123467888889999999999632222222333322 345766665553
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=342.29 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=213.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.+.|++.+.||.|..++||+|+.. .++.||||++.-+........+.+|+..++.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467999999999999999999965 7899999999988877677789999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||.+|++.+.++.....+ +++..+..|++++++||.|||.+ |.+|||||+.|||++.+|.|||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998765544 99999999999999999999999 9999999999999999999999999988766443
Q ss_pred CCce--e-ecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 446 DTHV--T-TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 446 ~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.... . ....||++|||||++.. ..|+.|+|||||||+..||.+|..||..... .+.+-..+......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTLQNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHhcCCCCC
Confidence 3221 1 45679999999999654 3589999999999999999999999962210 11111111111110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. -.....+........+.+++..|+..||++|||++++++
T Consensus 252 ~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 111122223344568999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.74 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=209.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 362 (613)
.+.|+..++||+|.||.||+|++. +|+.||+|+++-+.. +....-..+||.+|++++||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356777889999999999999965 799999999987653 33455678999999999999999999999876 68999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|+|||+. ||.-++...+. .|++.+++.++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 77777765433 499999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh---hccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---KEKK 518 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 518 (613)
........+..+.|..|+|||.+.+. .|+.++|+||.||||.||++|++.|.. ..+......+..+. .+..
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-----~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-----RTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-----ccHHHHHHHHHHHhCCCChhc
Confidence 87776666777789999999999886 599999999999999999999999963 22222222222221 1111
Q ss_pred cc-------ccccCccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LE-------QLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~-------~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+. ..+.+...... ........++|+..+|..||++|.||.++++.
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 11111111000 01123456788999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=351.73 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=213.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCC-ceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 362 (613)
..++|...++||.|.||.||+|+.. +|..||||+++.......+..-.+|+..|++++ ||||+++.+.+.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578888999999999999999965 799999999987765555666789999999999 999999999999887 9999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|||||+ .+|.++++.+. ..|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+..
T Consensus 88 VfE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999995 59999998763 4699999999999999999999999 9999999999999998889999999999977
Q ss_pred CCCCCceeeccccccccccccccc-cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... ..+..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|-. ..+.+..-.+...+.......
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG-----~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG-----ASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC-----CcHHHHHHHHHHHhCCCcccc
Confidence 5433 345667899999999875 56689999999999999999999999942 223333333444333222211
Q ss_pred ccc------------CccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVD------------SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~------------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... +...+ ...+....+..+++..|+++||++||||+|+++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 11111 1112356788999999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=346.39 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=204.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC--ceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 364 (613)
.++...+.||+|+||+||++... +|+..|||.+....... ...+.+|+.+|++++|||||+++|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45667889999999999999976 48999999987663332 456889999999999999999999855444 589999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEeccccceecC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 443 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~ 443 (613)
||+++|+|.+++...+. ++++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999988764 399999999999999999999999 9999999999999999 7999999999998766
Q ss_pred C--CCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 444 Y--KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 444 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
. ..........||+.|||||++..+. ..+++||||+||++.||+||+.||... .....++.........
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~- 241 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL- 241 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC-
Confidence 3 2222334567999999999998643 346999999999999999999999621 1112222222211111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
+ ..+........+++..|+..||++||||+++++..
T Consensus 242 ----P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 ----P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 22333456788999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=351.90 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=210.3
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 361 (613)
..++|..++.||+|+|++|++|+.. +++.||||++.+..... ....+..|-++|.+| .||.|++++--|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467888999999999999999966 78999999997654322 234577888899999 7999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+|+||+++|+|.++|+..+. |++...+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998764 99999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc----------e--eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007200 442 MDYKDTH----------V--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 442 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 509 (613)
++..... . ...++||..|.+||++..+..++.+|+|+|||++|.|+.|++||.... +....+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFqk 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQK 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHHH
Confidence 8643221 1 145789999999999999999999999999999999999999996332 1111111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
+. + ++-. +++...+...+|+.+.|..||.+|+|+.+|.+..
T Consensus 299 I~---------~-l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 IQ---------A-LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH---------H-hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 1 1112 2233346788999999999999999998888754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=355.78 Aligned_cols=267 Identities=27% Similarity=0.453 Sum_probs=214.4
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEc
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
.+..++++..+.+.+.+.||+|.||+||+|.+.. .||||+++... .+...+.|+.|+.++++-+|.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4457888888888999999999999999999862 49999997654 33456679999999999999999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+.. .+|+.+|+|.+|+.++|.... .|+......|+.||++|+.|||.+ +|||||||..||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 877 999999999999999997653 499999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCC-CCceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 437 GLAKLMDYK-DTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 437 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|++.....- .........|...|||||++.. .+|++.+|||||||++|||+||..||. .. ..+..+ |
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~---~~dqIi--f--- 603 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQ---NRDQII--F--- 603 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CC---ChhheE--E---
Confidence 999754321 1112223347889999999964 468999999999999999999999996 11 111110 0
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
++..+.+. ++ .......+.+++.+|+..||..++++||.+.+|+..|+..
T Consensus 604 mVGrG~l~----pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 604 MVGRGYLM----PD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred EecccccC----cc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 11111000 00 1112345567899999999999999999999999988753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=317.38 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=211.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|...+.+|+|.||.||+|++. +|+.||||+++.....+ -.....+|++.|+.++|+||+.++++|.......+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788899999999999999965 79999999998654333 34568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||+. +|...+++... .++..+++.++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9965 88888877543 589999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
....... +-|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|. .+.+..+...+-..+......+..+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-----G~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-----GDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-----CCchHHHHHHHHHHcCCCCcccCcc
Confidence 5444433 579999999999875 58999999999999999999887774 3444445555544443322222111
Q ss_pred CccC--------------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 525 SDME--------------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 525 ~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
-... ...-..+.....+++..|+..||.+|+|+.|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1000 00112334567999999999999999999999883
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.63 Aligned_cols=263 Identities=28% Similarity=0.459 Sum_probs=205.7
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
++..++|.+.+.||+|+||.||+|.+. +++.||||+++..........+..|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 355678999999999999999999741 35689999997654444456788999999999 89999999998876
Q ss_pred C-CceEEEEecccCCcchhhhhccCCC-----------------------------------------------------
Q 007200 357 P-TERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 382 (613)
Q Consensus 357 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 382 (613)
. ...+++|||+++|+|.++++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 5 4578999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc-eeeccccc
Q 007200 383 -----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456 (613)
Q Consensus 383 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt 456 (613)
..++++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23488899999999999999999999 9999999999999999999999999999865332221 12233466
Q ss_pred cccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHH
Q 007200 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 535 (613)
Q Consensus 457 ~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (613)
..|+|||.+.+..++.++|||||||++|||++ |..||..... .. ... ......... ..+...
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~-~~~~~~~~~---------~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFC-QRLKDGTRM---------RAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHH-HHHhcCCCC---------CCCCCC
Confidence 78999999999999999999999999999997 9999963221 10 111 111111100 011223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 536 VEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 536 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 4578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.02 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=216.2
Q ss_pred CCCCCCccccCcCcEEEEEEeC-C---CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-D---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
...+.++||.|.||.||+|+++ . ...||||.++....+....+|+.|..+|.+++||||+++.|........++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3446688999999999999976 2 34699999999988888899999999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||++|+|+.+|+.+... |.+.++..++++||.|+.||-+. ++|||||.++|||++.+..+|++|||+++.+..
T Consensus 710 EyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999987643 99999999999999999999999 999999999999999999999999999998854
Q ss_pred CCCceeeccc--cccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHVTTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
......+... -+.+|.|||.+.-+++|.+||||||||+|||.++ |..||-.. ...+.+....
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------SNQdVIkaIe------- 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SNQDVIKAIE------- 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------chHHHHHHHH-------
Confidence 4433333222 2569999999999999999999999999999665 99998411 1122232222
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+-..+.+++..|.+||..||++|-.+||.+.||+..|...
T Consensus 849 ---~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 ---QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ---hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 2223334556778999999999999999999999999999865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=348.43 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=208.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
..|..-.+||+|+.|.||.|... +++.||||++...... ..+-+..|+.+|+..+|+|||++++.|...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35777789999999999999855 7889999999765433 445678999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|+||+|.+.+.... +++.++..|...+++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999987654 89999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. .+...+||++|||||++....|++|+||||||++++||+-|++||-... ....-| .+...+ .
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAly--LIa~ng--------~ 486 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALY--LIATNG--------T 486 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHH--HHhhcC--------C
Confidence 4 4555679999999999999999999999999999999999999994211 111111 111111 1
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..-.........+.+++.+||..||++||+|.|+|+.
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1112234455789999999999999999999999983
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=342.96 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=212.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
..|+..+.||+|.||.||+|.+. +++.||+|++.-+.......+.++|+.++..++++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999976 68899999999888777788999999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|.||++.+.++.... +++..+..|++++..|+.|||++ +.+|||||+.|||+..+|.+|++|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999976542 57888889999999999999999 99999999999999999999999999998776443
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. +..++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.... +.+..-++-..
T Consensus 166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h------------------PmrvlflIpk~ 226 (467)
T KOG0201|consen 166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH------------------PMRVLFLIPKS 226 (467)
T ss_pred hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC------------------cceEEEeccCC
Confidence 33 367789999999999998899999999999999999999999995211 11111112222
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+..........+.+++..|++.||+.||+|.++++.
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222223556779999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=345.98 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=213.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.... .....+.+|+++++.++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999976 6889999999765433 345678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.| +|..++...+. ++++.+..++.+++.||.|||+. +|.|||+||.|||+++++.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 99999987654 89999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.......+.||+-|||||...+++|+..+|.||+||++||+++|++||...+ +.+.++.+..+..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v------- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPV------- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCC-------
Confidence 3445566789999999999999999999999999999999999999996332 3333433332221
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+.+....+..++...+.+||.+|.|-.+++..
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1123556788999999999999999999998763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=376.38 Aligned_cols=260 Identities=30% Similarity=0.465 Sum_probs=215.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.+..+..+.||+|+||.||.|... .|. .||||.++.........+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455666788999999999999865 343 49999999888887888999999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
++++|||++|+|..++++... ....++..+...++.|||+|+.||+++ ++|||||..+|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987521 134589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecc-ccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007200 438 LAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 438 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
+|+.+...+....... .-...|||||.+..+.++.|+|||||||++||++| |..||...+ ..+.+.....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--------n~~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--------NFEVLLDVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--------hHHHHHHHHh
Confidence 9996544443333322 23569999999999999999999999999999999 888884211 1222222333
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.+++ ..+..+++.++++|..||+.+|++||++..|++.+..+
T Consensus 920 ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 920 GGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 3322 22445678899999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.03 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=205.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc----ccHHHHHHHHHHHhhcc-cCccceeeEEEEcCC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 358 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 358 (613)
...++|...+.||+|.||+|+.|... +|+.||+|++...... .....+.+|+.+++.++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999866 7899999977654111 23446778999999999 999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 437 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 437 (613)
..++||||+.||+|.+++...+ ++.+..+..++.|++.|++|+|++ ||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998844 388899999999999999999999 99999999999999999 999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCC-CC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .......+.
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~- 236 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIR- 236 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-
Confidence 998774 2333455677999999999999877 74 88999999999999999999997311 111111111
Q ss_pred cccccccccCccCCCCcHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 EKKLEQLVDSDMEGNYIEEE-VEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... ++... ...+..++.+|+..||.+|+|+.+++.
T Consensus 237 --------~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 --------KGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --------cCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11110 11111 567899999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.38 Aligned_cols=239 Identities=27% Similarity=0.464 Sum_probs=202.0
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
++-||+|+.|.||.|++. ++.||||+++.-. ..+|+-|++++|+||+.+.|+|.....+++|||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 466999999999999997 7899999885432 3678889999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+.|+... ++.-.....+..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||-++..... .....
T Consensus 200 ~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 200 YEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 99998654 477888899999999999999999 9999999999999999999999999999876543 33456
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
++||..|||||++.+.+.+.|+|||||||+||||+||..||..-.. . ..+.-+-...+.-..+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------s-----------AIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------S-----------AIIWGVGSNSLHLPVP 333 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------h-----------eeEEeccCCcccccCc
Confidence 7899999999999999999999999999999999999999952110 0 0011111122223345
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+++.+.-|++.||+-.|..||++.+++..|+-
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 6777889999999999999999999999999963
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.18 Aligned_cols=266 Identities=24% Similarity=0.394 Sum_probs=205.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC-----------------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 349 (613)
.++|...+.||+|+||.||+|.+.+ +..||+|.+...........+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 33699999876554445567899999999999999999
Q ss_pred eeEEEEcCCceEEEEecccCCcchhhhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007200 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414 (613)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 414 (613)
+++++.+.+..+++|||+.+|+|.+++..... ....+++..+..++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998865321 113478899999999999999999999 999
Q ss_pred ecCCCCCceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh--CCC
Q 007200 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQR 491 (613)
Q Consensus 415 H~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt--g~~ 491 (613)
||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 1222345788999999988899999999999999999987 556
Q ss_pred CcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 492 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
||.... .......+............. ..+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 241 p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT-----DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC-----HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 664221 111222222222111110000 0112234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=350.40 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=206.2
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEe------CCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
.+..++|+..+.||+|+||.||+|.+ .++..||||+++..........+.+|+.++..+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456788899999999999999973 235689999997654444456788999999999 89999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCC-------------------------------------------------------
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 381 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 381 (613)
....++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999865321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 382 ----------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 382 ----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012478999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 446 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 446 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......++ ......
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~~----~~~~~~--- 336 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKMI----KEGYRM--- 336 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHHH----HhCccC---
Confidence 2211 122335668999999999999999999999999999998 888885221 111111111 111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+......+.+++.+||+.||++|||+.||++.|+.
T Consensus 337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011123578899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.90 Aligned_cols=264 Identities=30% Similarity=0.435 Sum_probs=212.7
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeCC--C--CE-EEEEEecc--ccCcccHHHHHHHHHHHhhcccCccceee
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD--G--SL-VAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 351 (613)
....|+...++-...++||+|+||.||+|++.. + .. ||||..+. ........+|..|.+++.+++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566666777777999999999999999662 2 23 89999885 34455667899999999999999999999
Q ss_pred EEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 007200 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (613)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 431 (613)
|++......++|||+|.||+|.++|+.... .++..++..++.++|+||+|||++ +++||||.++|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 999999999999999999999999988654 389999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCceee-ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007200 432 VVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 509 (613)
||+|||+++.... ..... ...-+.+|+|||.+..+.+++++|||||||++||+++ |..||.... .. .
T Consensus 302 KISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--------~~-~ 370 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--------NY-E 370 (474)
T ss_pred EeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--------HH-H
Confidence 9999999975431 11111 1124679999999999999999999999999999999 888885322 11 1
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+...+ .....+...+...+..+..++.+||..+|++||||.++.+.|+..
T Consensus 371 v~~kI--------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 371 VKAKI--------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred HHHHH--------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 11111 011112222334567788899999999999999999999999865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.24 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=204.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467888999999999999999754 3568999999876544445678899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987643 2489999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... . .+.+... ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-----~---~~~~~~~-~~~~--- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-----G---QDVIKAV-EDGF--- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-----H---HHHHHHH-HCCC---
Confidence 3222111122335678999999999999999999999999999775 999995321 1 1111111 1110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001122344678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.49 Aligned_cols=265 Identities=25% Similarity=0.408 Sum_probs=207.3
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 354 (613)
.+....++|.+.+.||+|+||.||+|+.. ++..||+|+++..........+.+|+.+++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34455678999999999999999999742 24579999997665444456788999999999 899999999999
Q ss_pred EcCCceEEEEecccCCcchhhhhccCC-----------------------------------------------------
Q 007200 355 MTPTERLLVYPFMVNGSVASCLRERGQ----------------------------------------------------- 381 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 381 (613)
......++||||+.+|+|.++++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999998864211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 382 -------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 382 -------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
...++++..+.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 113478899999999999999999999 9999999999999999999999999999865432221
Q ss_pred -eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..... ....... ...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~----~~~~~~~-----~~~ 335 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFY----KMVKRGY-----QMS 335 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHH----HHHHccc-----Ccc
Confidence 1122335668999999998999999999999999999997 9999953211 00111 1111110 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. +......+.+++.+||+.||++|||+.+|++.|++
T Consensus 336 ~----~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 336 R----PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 01123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.17 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=204.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc-HHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 363 (613)
++|+.++.|++|.||.||+|+++ +++.||+|+++.+..... .....+||.+|.+.+|||||.+.++.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677889999999999999987 788999999986543322 33568999999999999999999988754 678999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||+. +|.++++... .+|...+++.++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 8999888755 3599999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---cccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKL 519 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 519 (613)
.. ....+..+.|..|+|||.+.+.+ |+++.|+||+|||+.||+++++.|.. ..+....+.+...+. +..+
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-----~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-----KSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-----CchHHHHHHHHHHhCCCccccC
Confidence 54 33345566899999999998764 89999999999999999999999952 223333333333221 1111
Q ss_pred cccccCc------c--------CCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSD------M--------EGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~------~--------~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+.... . ...+... ..+.-++++...+..||.+|.||+|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1110000 0 0011000 2355678888999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=332.28 Aligned_cols=245 Identities=16% Similarity=0.266 Sum_probs=196.8
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCccc--HHHHHHHHHHHhhcccCccceeeEEEEc----CCceEEEEecc
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPFM 367 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 367 (613)
..||+|++|.||+|.+ +|+.||||.++....... ...+.+|+.++.+++||||++++|++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 589999999976533221 3567899999999999999999999876 34678999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+|+|.+++.... .+++.....++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997643 3889999999999999999999732 78899999999999999999999999997654321
Q ss_pred ceeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 448 HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~------- 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKNN------- 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCC-------
Confidence 12347899999999976 678999999999999999999999996321 1111111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 011112345678999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=325.64 Aligned_cols=265 Identities=28% Similarity=0.378 Sum_probs=199.8
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHh--hcccCccceeeEEEEcCC----ceEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTPT----ERLL 362 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~l 362 (613)
.....++||+|+||.||+|.+. ++.||||++... ....|+.|-++.+ .+.|+||++++++-.... +.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999999999986 699999999654 3456778877776 557999999999866544 8899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------CDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
|++|.+.|+|.+||..+- ++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999998764 89999999999999999999974 3568999999999999999999999999
Q ss_pred ccceecCCCC-CceeeccccccccccccccccCCC------CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH--
Q 007200 437 GLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL-- 507 (613)
Q Consensus 437 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~-- 507 (613)
|+|..+.+.. .......+||.+|||||++.+... -.+.||||+|.+||||+++..-++. ....+....+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 9998886432 223445779999999999976532 2468999999999999998766542 11122222222
Q ss_pred -------HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 508 -------DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 508 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+.++..+-.++....+...-. ....+..+.+.+..||..||+-|.|+.=+.+.+...
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 222222211111111100000 013456788999999999999999999998887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.01 Aligned_cols=238 Identities=24% Similarity=0.347 Sum_probs=199.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- ...+....|..+|+.+.||+++++.+.+.+....+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356788899999999999999977 6889999999765422 2344577899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||++||.|.++++..+. |++..++.++.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999998664 99999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. +...+||+.|+|||.+....+.+++|-|||||++|||+.|.+||..... .+.. .+++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY---------~KI~ 254 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIY---------EKIL 254 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHH---------HHHH
Confidence 32 5678899999999999999999999999999999999999999963321 1111 1122
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMER 554 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 554 (613)
...+ .++.-....+.+++...++.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2211 1233334567888888888898888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=331.43 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=201.1
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
....++|+.+..||+|+||.||+|+-+ +|..+|+|++++.... .....+..|-.+|...++|.||+++-.|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456688999999999999999999966 7999999999876432 3455688899999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
||||||++||++..+|...+. +++..++.++.+++-|++.+|+. |++||||||+|+|+|..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999987653 99999999999999999999999 99999999999999999999999999985
Q ss_pred ecCCC----------------------C-Cc----e-------------------eeccccccccccccccccCCCCCcc
Q 007200 441 LMDYK----------------------D-TH----V-------------------TTAVRGTIGHIAPEYLSTGKSSEKT 474 (613)
Q Consensus 441 ~~~~~----------------------~-~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 474 (613)
-+... + .. . ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 33110 0 00 0 0124599999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 007200 475 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER 554 (613)
Q Consensus 475 DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 554 (613)
|.||+|||+|||+.|.+||..... ...-..+..|-.....+. ......+..++|.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999963321 111122233322111111 11222567888888888 99999
Q ss_pred CC
Q 007200 555 PK 556 (613)
Q Consensus 555 Pt 556 (613)
.-
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 86
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=338.03 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=213.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCc-eEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 363 (613)
.++|...+++|+|+||.++..+++ ++..|++|.+.-..... ......+|+.+++++.|||||.+.+.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999999877 67899999997655332 34467899999999999999999999999888 8999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|+||+||++.+.+.... +.-|+++.+..++.|++.|+.|||++ +|+|||||+.||++++++.|||+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998765 23499999999999999999999998 99999999999999999999999999999987
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+. ...+....+. .
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~-----~- 222 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRG-----L- 222 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhc-----c-
Confidence 6553 33456699999999999999999999999999999999999999974432 1111111111 1
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....+......+..++..|+..+|+.||++.+++..
T Consensus 223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112334556789999999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=305.25 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=215.0
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEE-eCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 357 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 357 (613)
.+..++|.+.+.+|+|||+-||.++ ..++..||+|++.... ....+...+|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3456789999999999999999998 4478899999998776 34566788999999999999999999886533
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
.+.|++++|...|+|.+.++.....+..+++.+++.|+.++++||++||+. .+.+.||||||.|||+.+++.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 458999999999999999988777777799999999999999999999998 2359999999999999999999999999
Q ss_pred cceecCCCC--------Cceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchH
Q 007200 438 LAKLMDYKD--------THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506 (613)
Q Consensus 438 la~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~ 506 (613)
.++..+-.- -+.......|..|+|||.+.- ...+.++|||||||++|+|+.|..||+....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------- 246 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------- 246 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence 987543211 111233458999999999853 3468999999999999999999999973321
Q ss_pred HHHHHHHhhccc-ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 507 LDWVKGLLKEKK-LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 507 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+.+. .-++.............++.+.+++.+|++.||.+||++.+++..+++
T Consensus 247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111 122333333333333467899999999999999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.51 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=207.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.-|++++.||.|+.|.|..|++. +|+.+|||++.+.. .......+.+|+-+|+.+.||||+++++.+.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34777899999999999999965 89999999997653 2233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|-|.+++...+. +.+.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 99999999999987764 89999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.+..-...+|++.|.|||++.+.+| +.++||||+|||||.|+||+.||+.. ++...+... ..+..
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV-~~G~f---- 229 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKV-QRGVF---- 229 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHH-HcCcc----
Confidence 3344556779999999999999987 57899999999999999999999621 111211111 11111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+.....+..+|+.+|+..||+.|.|++||++.
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122334578899999999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.03 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=199.9
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
|...+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999975 7899999998654322 2234578899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988765332 2489999999999999999999999 99999999999999999999999999998654221
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~--------- 220 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKED--------- 220 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhcc---------
Confidence 223345899999999999999999999999999999999999999632210 0111111111110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
...+.......+.+++.+||+.||++||+ ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112223457889999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=325.26 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=202.5
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-------------ccHHHHHHHHHHHhhcccCccce
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~ 349 (613)
....+.|++.+.||+|.||.|-+|+.. +++.||||++.+.... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999976 7999999999743211 11347889999999999999999
Q ss_pred eeEEEEcC--CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 007200 350 LRGFCMTP--TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (613)
Q Consensus 350 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 427 (613)
++++..++ +..|||+|||..|.+...=. ..+.+++.++++++.+++.||+|||.+ ||+||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99998764 67899999999987654322 222389999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCC----CceeeccccccccccccccccCC----CCCcccchhHHHHHHHHHhCCCCccccccc
Q 007200 428 EFEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (613)
Q Consensus 428 ~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwS~G~il~elltg~~p~~~~~~~ 499 (613)
+|++||+|||.+....... ........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 9999999999997663221 11122356999999999987743 3678899999999999999999995221
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
. .+. ..+++...+.....++..+.+.+++..+|.+||++|.+..+|....
T Consensus 324 ---~---~~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ---E---LEL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---H---HHH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 111 1223333333333345567899999999999999999999997754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=303.53 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=209.4
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.+.++|++.+.||+|.||.||.|+.+ ++..||+|++.+.... ....++.+|+++.+.++||||++++++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34578999999999999999999965 6889999998765322 23457899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+++||..+|++...++..... .+++.....++.|+|.||.|+|.+ +|+||||||+|+|++..+.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999854433 388999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
-+ ...+...+||..|.+||...+..++..+|+|++|++.||++.|.+||.... ...... .
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYk------------r 233 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYK------------R 233 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHH------------H
Confidence 43 344566789999999999999999999999999999999999999996222 101111 1
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+...+. .++........++|..|+..+|.+|.+..|+++.
T Consensus 234 I~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 234 IRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111111 1123334578899999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=326.38 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=207.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|++.++||+|+||.||+|...++..||+|.+..... ....+..|+.+++.++|+||+++++++.+....+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34567889999999999999999988888999998865332 3457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.++++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999875432 2488899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+.+..++.++|||||||++|+|+| |+.||... ........+. ....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~~---~~~~----- 222 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-----SNSDVMSALQ---RGYR----- 222 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-----CHHHHHHHHH---cCCC-----
Confidence 32222223335678999999988889999999999999999998 99999521 1111111111 1100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. ........+.+++.+|++.+|++||+++++++.|++
T Consensus 223 -~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 -MP----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 111233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.86 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=176.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|+..+.||+|+||.||++++. +|..+|+|.+...........+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999977 6889999998765444445678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3889999999999999999999852 5999999999999999999999999998755322
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12334589999999999998999999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.07 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=200.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|...+.||+|+||+||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 68899999997654444445678999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+ +|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 89888865432 378999999999999999999999 99999999999999999999999999997654322
Q ss_pred Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh----------
Q 007200 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 515 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 515 (613)
. ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||..... ......+.....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHHhhcc
Confidence 2 1233457899999999865 4689999999999999999999999953221 111111111110
Q ss_pred --cccccccccCccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --EKKLEQLVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+...... .........+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001111111100000 0112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.39 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=203.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
++|+..+.||+|+||.||++.++++..+|+|.+..... ....+..|+.+++.++||||+++++++..+...+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45788899999999999999988888999998764322 3457889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999875432 388999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+......... ..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~~---~~~- 223 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFRL---YRP- 223 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCC---CCC-
Confidence 22222335668999999988889999999999999999999 899995221 11222222111111 011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 ------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11235689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.35 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=207.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC-C-----CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
++|++.+.||+|+||.||+|.... + ..||+|.++..........+.+|+..+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 568888999999999999998642 2 5799999876554444567899999999999999999999999989999
Q ss_pred EEEecccCCcchhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 362 LVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
++|||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998754211 13488999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999976533221 12223346788999999988899999999999999999998 9999863221 1
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+. ...+..... ...+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 234 ~~-~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EV-IEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-HHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111111111 11223445789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.88 Aligned_cols=264 Identities=23% Similarity=0.405 Sum_probs=222.1
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeCC---CC--EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD---GS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
+.+++++..+.....++||.|.||.||+|++.+ |+ .||||..+.+-..+..+.|.+|..+++.++||||++++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 344555566666677899999999999998643 33 4899999887777778899999999999999999999999
Q ss_pred EEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 007200 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 433 (613)
|.+ ...|+|||.++-|.|.++++.... .++......++.||..||+|||+. .+|||||..+|||+.....||+
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 976 568999999999999999987654 389999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
+|||+++.+............-++.|||||.+.-++++.+||||-|||++||+++ |..||..-
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv---------------- 596 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV---------------- 596 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------
Confidence 9999999887766555444445779999999999999999999999999999876 99999522
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+...+.-.++...+-..++.|+..+..++.+||+.||.+||++.|+...|.++
T Consensus 597 --kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 597 --KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred --cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 12222223333334445667788899999999999999999999999999765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.20 Aligned_cols=266 Identities=18% Similarity=0.257 Sum_probs=201.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|++. +++.||+|+++.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 688999999875432 2234567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99988776554322 2389999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH---------HHHHHHhhc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL---------DWVKGLLKE 516 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~ 516 (613)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ..... .+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhcc
Confidence 3333334568999999999998889999999999999999999999996321100 00000 001100011
Q ss_pred ccccccccCccCC------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEG------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........+.... .........+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 001123456899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=331.72 Aligned_cols=267 Identities=22% Similarity=0.373 Sum_probs=220.3
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+...+...+.++||+|.||.|.++....+.+||||.++.........+|.+|+++|.+++||||++++|.|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556677789999999999999999878999999999888777778999999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
+|||++|+|..++..+.... ........|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998764322 45566778999999999999999 99999999999999999999999999999665
Q ss_pred CCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh--CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 444 YKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 444 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
..+.. .....+-+.+|||||.+..++++.+||||+||+++||+++ ...||... .+...++-..++.+.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-----t~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-----TDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-----hHHHHHHhhhhhcCCCCcc
Confidence 44433 2333445789999999999999999999999999999765 77788522 1222333334444444333
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.++.. +.-++..+.++|..||..|.++||+++++...|++
T Consensus 764 ~~l~~------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 764 VVLSR------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred eeccC------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 33322 33456789999999999999999999999998875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=328.46 Aligned_cols=249 Identities=29% Similarity=0.522 Sum_probs=195.0
Q ss_pred CCccccCcCcEEEEEEeC-----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 293 RNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 256799999976555545678999999999999999999999999888899999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.++++... ...+++..+..|+.||++||+|||++ +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999998862 23489999999999999999999999 999999999999999999999999999987632221
Q ss_pred -ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 448 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 448 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.||... ...+............
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~~~----- 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQRLP----- 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEETT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccce-----
Confidence 22233346779999999999999999999999999999999 77887421 1222222222222111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
.+......+.+++..||+.||++|||+.++++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112346788999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.06 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=207.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|+..+.||+|++|.||+|...+++.||+|.++.... ....+.+|+.++++++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567888999999999999999987788899999875432 3456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997643 23489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
...........+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...... .......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~---~~~~~~~----- 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEVLQ---QVDQGYR----- 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH---HHHcCCC-----
Confidence 22211122223457999999998899999999999999999999 999985211 111111 1111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.50 Aligned_cols=243 Identities=23% Similarity=0.280 Sum_probs=196.3
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|+.++..++||||+++++++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999976 789999999975432 223346778999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 450 (613)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999987543 489999999999999999999999 99999999999999999999999999987532221 222
Q ss_pred eccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC
Q 007200 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530 (613)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (613)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......... .. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~-~~------~~---- 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILM-EE------IR---- 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHc-CC------CC----
Confidence 34569999999999999999999999999999999999999995221 1111111111 10 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 531 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 531 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
.+......+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1122345788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=327.44 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=198.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 6889999999765444344567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 67777776543 2388899999999999999999999 9999999999999999999999999999754332
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc---cccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KLEQ 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 521 (613)
.. ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.... ........+....... ....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK----DIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhCCCChhhccc
Confidence 21 22334588999999998654 57889999999999999999999996321 0001111111110000 0000
Q ss_pred -----cccCc-cC---CCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 -----LVDSD-ME---GNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 -----~~~~~-~~---~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...+. .. ..... .....+.+++..|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01245789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.30 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=206.9
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 356 (613)
....++|.+.+.||+|+||.||+|++. .+..||||+++..........+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678889999999999999999853 134699999976554444567899999999996 9999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCC-------------------------------------------------------
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 381 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 381 (613)
....++|||||++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865311
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 007200 382 -------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (613)
Q Consensus 382 -------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 424 (613)
....+++..+..++.|+++||+|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012478889999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCC
Q 007200 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 502 (613)
Q Consensus 425 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~ 502 (613)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 999999999999999865432221 1223346788999999999899999999999999999997 9999852210
Q ss_pred cchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+ ........... ...........+.+++.+||+.||++|||+.+|.+.|+.
T Consensus 346 ~----~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 D----STFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred h----HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0 00111111110 001112334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.64 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=203.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||.||+|++. +++.||+|+++..... .....+..|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999977 5889999999754322 23446788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 388999999999999999999999 999999999999999999999999999975533
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~---~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWK---ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcc---cccc
Confidence 22345589999999999999999999999999999999999999963221 11111111100 0011
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..............+.+++.+|+..+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 110000011234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=325.79 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=207.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..........+.+|+++++.+.|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 4789999997665544556899999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 361 LLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
+++|||+++++|.++++..+. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976432 234588999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007200 431 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 508 (613)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... . .+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----N---EE 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HH
Confidence 99999999976532221 11223335778999999999999999999999999999998 999985221 1 11
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.+.... ..... .........+.+++.+||+.||++||++.||++.|+
T Consensus 233 ~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 VIECIT-QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 11111 011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.21 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=199.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||.||+|++. +++.||+|.+..... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 688999999875421 123456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... .......... ...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~-~~~----- 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILA-GRL----- 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhc-CCc-----
Confidence 22 23468999999999999999999999999999999999999995221 1111111111 110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 563 (613)
.. +......+.+++.+||+.||++||+ ++++++.
T Consensus 233 -~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KF----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1112346789999999999999997 5666543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=317.47 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=209.9
Q ss_pred hCCCCCCccccCcCcEEEEEEe-CCCCEEEEEEeccccCccc--HHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.+|++.+.||+|.||+|-+|.. ..|+.||||.+++....+. ...+.+||++|+.++||||+.++++|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5688889999999999999985 5899999999987765433 346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||..+|.|++|+.+++. +++.+++.+++||+.|+.|+|.+ ++||||||.+|||+|.++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999988764 99999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
....-..++|++-|.+||++.+.+| .+.+|-||+||+||.|+.|.-||+... ....++++-+. +..
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~G----aYr 271 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRG----AYR 271 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhcc----ccc
Confidence 3334566889999999999999988 689999999999999999999997332 22222222221 122
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
.+.. +....-+|++|+..+|++|.|+.+|....
T Consensus 272 EP~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 EPET--------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCCC--------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2222 23567789999999999999999998754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.06 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=204.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
+..++|+..+.||+|+||.||+|.+. .+..||+|.+...........+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 256799999865443334556889999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
..++||||+.+++|.++++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753221 23468889999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 510 (613)
|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999987654322211 112235778999999998899999999999999999999 788885221 11111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
..... ..... .+......+.+++.+|++.||++|||+.|+++.|+
T Consensus 232 ~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVME-GGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHc-CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111 11100 11123357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=330.97 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=200.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999976 689999999865322 123446888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.++++..+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999976542
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~-~----- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGK-L----- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-c-----
Confidence 2 123458999999999999889999999999999999999999996321 111111111111 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 563 (613)
. .+......+.+++.+|++.||.+||+ +.++++.
T Consensus 216 -~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -E----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -C----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 11112356889999999999999995 7777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=316.98 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----ceEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 362 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 362 (613)
.|...+++|.|+||.||+|... +++.||||+.-.+..- -.+|+.+|++++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3566789999999999999976 5789999998655432 237899999999999999999886432 2358
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEecccccee
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 441 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~ 441 (613)
|||||+. +|.+.++........++...++-++.||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 89999886544445588899999999999999999998 99999999999999977 8999999999998
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
+...+.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.. +........+..++......
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-----~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-----DSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-----CCHHHHHHHHHHHhCCCCHH
Confidence 8655544 334578999999999876 589999999999999999999999953 23333333333333222211
Q ss_pred cc--cc--------CccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QL--VD--------SDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~--~~--------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
++ +. +..... .......+..+++.+++..+|.+|.++.|+++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11 11 111111 122334678999999999999999999999873
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=322.92 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=204.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..+|...+.||+|+||.||+|.+. .++.||+|.+.... .....+.+|++++..++|+||+++++++..+...+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 355778889999999999999976 58899999986542 234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999875432 3489999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+......... .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~------~ 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGY------R 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCC------C
Confidence 2222222224568999999998899999999999999999998 999985221 111111111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 ~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 M----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1 1112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.11 Aligned_cols=263 Identities=29% Similarity=0.439 Sum_probs=204.9
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
++..++|++.+.||+|+||.||+|... +++.||+|+++..........+..|+.++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 345678999999999999999999642 35789999997655444445678899999999 79999999998865
Q ss_pred C-CceEEEEecccCCcchhhhhccCCC-----------------------------------------------------
Q 007200 357 P-TERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 382 (613)
Q Consensus 357 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 382 (613)
. ...+++|||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5678999999999999988542210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce-eecccccc
Q 007200 383 ----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTI 457 (613)
Q Consensus 383 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~ 457 (613)
..++++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||+++.+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12589999999999999999999999 99999999999999999999999999998764332221 22234567
Q ss_pred ccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHH
Q 007200 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEV 536 (613)
Q Consensus 458 ~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (613)
.|+|||.+.+..++.++|||||||++|||++ |+.||..... . +............ ..+....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~----~~~~~~~~~~~~~---------~~~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----D----EEFCRRLKEGTRM---------RAPEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----c----HHHHHHHhccCCC---------CCCccCC
Confidence 8999999999999999999999999999998 9999953211 0 0111111111110 0111233
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 537 EQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 537 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+.+++.+||+.+|++||++.|+++.|++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.45 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=196.0
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||.||+|... +++.||+|.+.... .......+..|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 68899999987542 222345678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99997643 389999999999999999999999 99999999999999999999999999997543222 22334
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.......... ..+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~-----------~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPL-----------RFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCC-----------CCC
Confidence 569999999999999999999999999999999999999995221 1122222211110 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
......+.+++.+||+.||++||++..+.+.|+..
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 22335688999999999999998755555554443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=320.25 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=202.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
++|...+.||+|+||+||.|...++..+|+|.+..... ....+.+|+.++.+++||||+++++++.+....+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45778889999999999999987777799998875432 3456889999999999999999999999888899999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+|+|.+++..... .+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999876432 489999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .............
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----N---SETVEKVSQGLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----H---HHHHHHHhcCCCC-------
Confidence 22222335678999999988889999999999999999998 999985221 1 1111111111110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.........+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112467899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=320.73 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=206.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|+..+.||+|+||+||+|.+.. ...||||.++..........+..|+.++..++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999998752 457999998766555455678899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+|||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~---~~~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQDVIKAV---EDGYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH---HcCCCC-
Confidence 522221 1222335678999999998889999999999999999998 999984211 11111111 111000
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.20 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=195.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|+||.||+|++. +|+.||||++...........+.+|+++++.++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44566788999999999999976 68999999997654444456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+|+|.... ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 256778889999999999999999 99999999999999999999999999998654322
Q ss_pred Cceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
. ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..... ..+...+........
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQP--- 293 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccCC---
Confidence 1 1233468999999998743 2345689999999999999999999962211 111111111110000
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112234578999999999999999999999983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=311.03 Aligned_cols=267 Identities=25% Similarity=0.318 Sum_probs=205.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCc-cceeeEEEEcCC-----
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT----- 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 358 (613)
...|...++||+|.||+||+|+.+ +|+.||+|+++.... ++......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999966 789999999987654 334455789999999999999 999999998877
Q ss_pred -ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
..++|+||++. +|..++.........++...++.++.||++||+|||++ +|+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999954 89999987654323477789999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh-
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 515 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 515 (613)
+|+....... .....++|..|+|||++.+. .|+...||||+|||+.||+++++.|.... +..+...+...+.
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-----e~~ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-----EIDQLFRIFRLLGT 239 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHHcCC
Confidence 9996653222 24455689999999999887 68999999999999999999999995322 2222222222221
Q ss_pred --cccccccc---cCcc--C-----CCCcHHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 --EKKLEQLV---DSDM--E-----GNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 --~~~~~~~~---~~~~--~-----~~~~~~~---~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
++.+..+. +-.. . ....... .....+++.+|++.+|.+|.|++.+++.
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111111 1110 0 0001111 1367899999999999999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.84 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=175.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...........+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999977 6888999988765444445678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+|+|.+++.... .+++..+..++.+++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997643 3789999999999999999999742 6999999999999999999999999998754322
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234589999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.81 Aligned_cols=262 Identities=29% Similarity=0.434 Sum_probs=222.1
Q ss_pred HHHHHHhhCCCCCCccccCcCcEEEEEEeCC-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 281 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
++|+....+.....+||-|.||.||.|.|+. .-.||||.++.+..+ ..+|..|..+|+.+.|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5677777778888999999999999999984 557999999877654 5679999999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.|+|+|||..|+|.+|+++..... ++.-..+.++.||+.|++||..+ ++|||||..+|+|+.++..||++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999876543 67778899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
+.+............-.+.|.|||.+....++.|+|||+|||+|||+.| |..||-... + ..+.+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------l-SqVY~------ 477 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------L-SQVYG------ 477 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------H-HHHHH------
Confidence 9887655444444445678999999999999999999999999999988 888874221 1 12222
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+++...+.+.++.|+.+++++|+.||+++|.+||+++|+-+.+|..
T Consensus 478 ---LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 478 ---LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ---HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 2333344445667888999999999999999999999999988753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=317.55 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=197.7
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
+.||+|+||.||+|.+. +++.+|+|.+...........+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999976 68899999887554444556789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee-e
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 451 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~ 451 (613)
.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99987543 2488999999999999999999999 999999999999999999999999999875432111111 1
Q ss_pred ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC
Q 007200 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530 (613)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (613)
...++..|+|||.+.++.++.++||||||+++|||++ |..||..... .. ........ ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~---------~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQG---------VRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcC---------CCCC
Confidence 1123457999999998899999999999999999998 8888852210 01 11111110 0011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 531 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 531 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.+......+.+++.+|++.+|++|||+.++++.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12223467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.90 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=210.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCC-CEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEE-EEc-----
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGF-CMT----- 356 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 356 (613)
+...++++.+.|.+|||+.||.|.+..+ ..||+|++... .+.......+|+++|++|. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3445677889999999999999998755 99999999776 4556677899999999997 9999999993 221
Q ss_pred -CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 357 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 357 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
.-+.+|.||||.||.|-++|..+...+ |++.++++|+.|+++|+++||.. +++|+|||||.+|||++.++..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 246789999999999999998766544 99999999999999999999986 66799999999999999999999999
Q ss_pred cccceecCCCC-Ccee-------ecccccccccccccc---ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc
Q 007200 436 FGLAKLMDYKD-THVT-------TAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504 (613)
Q Consensus 436 fGla~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~ 504 (613)
||.|...-... .... ....-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 99986432221 1110 112368999999987 46788999999999999999999999997331
Q ss_pred hHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 505 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+++........+.+...+.+||+.||++||++||++-+|+..+-.+
T Consensus 263 --------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred --------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1233444333333457788999999999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.89 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=201.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc-----CC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PT 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 358 (613)
....|...+.||+|+||.|+.+.+. +|+.||||++..... ....++-.+|+++++.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999976 799999999974432 3335567899999999999999999999865 35
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..|+|+|+| +.+|...++... .++...+..++.||++||.|+|+. +|+||||||+|++++.++.+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 679999999 568888887643 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC-Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 439 AKLMDYKD-THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 439 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+..+... ....+..+.|..|.|||.+.. ..|+.+.||||.|||+.||++|++.|.... .......+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-----~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-----YVHQLQLILELLGT 246 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-----hHHHHHHHHHhcCC
Confidence 99875431 122345668999999998754 579999999999999999999999995322 22222222211111
Q ss_pred c---c--------ccccccCc--c-CCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 517 K---K--------LEQLVDSD--M-EGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 517 ~---~--------~~~~~~~~--~-~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. . ....+..- . ...+ -+......++++.+|+..||.+|+|++|.++.
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 1 11111100 0 0000 01223467899999999999999999999984
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=318.88 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=204.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..++|.+.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3467888999999999999999988888899999875433 3456889999999999999999999875 456899999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.++++.... ..+++..+..++.+++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||... .. .+..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-----~~---~~~~~~~~~~~~------ 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----NN---REVLEQVERGYR------ 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-----CH---HHHHHHHHcCCC------
Confidence 3222222335678999999988889999999999999999999 89998521 11 111111111100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.92 Aligned_cols=261 Identities=20% Similarity=0.313 Sum_probs=208.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||.||+|+.. +++.||||.+.... .......+..|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999976 78999999876432 2233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433334588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... .....+........ .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~------~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQCD------Y 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcCC------C
Confidence 222 1223458889999999988889999999999999999999999985221 11112211111100 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+ ..........+.+++.+||+.+|++||++.++++.+++.
T Consensus 226 ~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 111223446789999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=329.61 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.+|+..+.||+|+||.||+|++. ++. .||+|.++..........+..|+.+++.++||||++++|++..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999864 333 48999987654444456788999999999999999999998764 5789
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
++||+.+|+|.++++.... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999976432 388999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee-eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
........ ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+... ..+. .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~-~~~~~~~~~- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEI-SSILEKGER- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHH-HHHHhCCCC-
Confidence 54332211 12224668999999999999999999999999999998 999995221 1111 111111100
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
......+...+.+++.+||..+|++||++.+++..+...
T Consensus 230 --------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000112235688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.02 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=202.6
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 359 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 359 (613)
....++|...++||+|.||+|+++..+ +++.+|||++++... .+..+....|-.++.... ||.+++++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455678999999999999999999987 688999999987653 334556777888877665 9999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+.||++..+.+.. .|++..+..++..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999955544432 399999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+..- ..+..+..++||+.|||||++.+..|+.++|.|||||+||||+.|..||...+ ++ .+ .
T Consensus 516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----Ee-e~------------F 577 (694)
T KOG0694|consen 516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----EE-EV------------F 577 (694)
T ss_pred cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----HH-HH------------H
Confidence 8543 23346778999999999999999999999999999999999999999995221 11 11 1
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
..++..+ ..++.....+.+.|++..+..+|++|.-+
T Consensus 578 dsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111 12344456788999999999999999865
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.18 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=208.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
...+|+..+.||+|+||.||+|...++..+|+|.+...... ....+..|+.+++.++|+||+++++++.+....+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34678889999999999999999888899999998755432 34568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.++++.... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... . .+..........
T Consensus 158 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~---~~~~~~~~~~~~------ 222 (261)
T cd05148 158 VY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----N---HEVYDQITAGYR------ 222 (261)
T ss_pred cc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----H---HHHHHHHHhCCc------
Confidence 21 1223336778999999988889999999999999999998 899995321 1 111111111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+||+.||++|||++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11112334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=318.10 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=201.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45778899999999999999988777899999864332 2456888999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999875432 489999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||+... .. +......... .
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~---~~~~~~~~~~------~-- 219 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-----NS---EVVESVSAGY------R-- 219 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-----HH---HHHHHHHcCC------c--
Confidence 11112224457999999998899999999999999999999 899986321 11 1111111110 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
...+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011112346799999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=336.19 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=202.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
...++|+..+.||+|+||.||+++.. +++.||+|++.... .......+..|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44578999999999999999999976 68899999986532 1222345778999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998653 278889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccC----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
.............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~ 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHK 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC
Confidence 643332223345699999999998653 37889999999999999999999996322 111111111111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
.. ............+.+++..|++.+|++ |||+.++++.
T Consensus 264 ~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Cc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 000001123467889999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.35 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=203.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.++|++.+.||+|+||.||+|.+.++..||+|.++.... ....+.+|++++..++|+||+++++++. ....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 467899999999999999999987777899999875332 3457889999999999999999999874 4568999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+|+|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 22478999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
........++..|+|||...+..++.++||||||+++|||+| |+.||.... . .+........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~--------- 219 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERG--------- 219 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcC---------
Confidence 222223346778999999988899999999999999999999 888885221 0 0111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.......+....+.+++.+|++.+|++||+++++++.|++
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0011123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.63 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=193.5
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|... +++.||+|+++..... .....+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6889999999764322 2234577888888766 799999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99998886543 389999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...............++..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence 23456899999999999999999999999999999999999999643222222222223332222221110
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
.+......+.+++.+||+.||++||++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112233568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.67 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=197.3
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||++.+. +++.||+|+++..... .....+..|..++..+ +||||+++++++.++...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999976 6889999999764322 2234578899999888 699999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++...+ ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99998886543 389999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||+.............++........... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C--
Confidence 23456899999999999999999999999999999999999999743322222222223333322222111 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPK------MSEVVR 562 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 562 (613)
+......+.+++.+|++.||++||+ +.++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122356889999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.54 Aligned_cols=261 Identities=20% Similarity=0.235 Sum_probs=197.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..+|++.+.||+|+||.||++.+. +++.||+|.... ..+.+|+++++.++||||+++++++..+...++++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 467999999999999999999976 688999996532 246789999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
++. ++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 985 68888876543 388999999999999999999999 9999999999999999999999999999754332
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccC-C-CcchHHHHHHHHhhc---c---
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-D-DDVMLLDWVKGLLKE---K--- 517 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~-~-~~~~~~~~~~~~~~~---~--- 517 (613)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........+...... .
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 2223334569999999999999999999999999999999999998874221100 0 000011111000000 0
Q ss_pred ----ccccc---------ccCccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 ----KLEQL---------VDSDME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ----~~~~~---------~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+... ..+... ..........+.+++.+||+.||++|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 000000 0001123457889999999999999999999987
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=325.74 Aligned_cols=264 Identities=29% Similarity=0.439 Sum_probs=208.3
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 355 (613)
+.+..++|+..+.||+|+||.||++.... ...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34556778899999999999999998642 3579999987655444455688999999999 7999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
.+...+++|||+++|+|.++++... .....+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999986532 2234589999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 501 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~ 501 (613)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence 99999999999999998654322111 122235678999999988899999999999999999997 989885211
Q ss_pred CcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+.. ....... ....+......+.+++.+|+..||++|||+.++++.|+++
T Consensus 240 ----~~~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ----VEELF-KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHH-HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111 1111111 0011122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.47 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=195.2
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.||+|+||.||++... +|+.||+|.++.... ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999975 689999999976432 223345778999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 450 (613)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998886543 389999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC
Q 007200 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530 (613)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (613)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~-------~~---- 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-------IR---- 213 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-------CC----
Confidence 335689999999999999999999999999999999999999953211 11111111100 00
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 531 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 531 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
.+......+.+++..||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1112345688999999999999998 78887763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.65 Aligned_cols=267 Identities=27% Similarity=0.384 Sum_probs=201.5
Q ss_pred CCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEE
Q 007200 290 FSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 362 (613)
|...+.||+|+||+||++.. .++..||+|.++..........+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 257789999997654444456788999999999999999999988653 45789
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+|||+.+++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998653 289999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... ......++..|+|||.+.+..++.++||||||+++|||+||+.||......... ......+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhh
Confidence 432211 112223566799999998888999999999999999999999998532210000 000000000000111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+..+.......+......+.+++..||+.+|++|||++++++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111223446799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.11 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=205.9
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|.+.++||+|+||.||+|...+++.||+|.+..... ....+..|+.+++.++|+||+++++++ .....+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence 34577889999999999999999988899999999875433 345788999999999999999999986 456789999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999865432 3489999999999999999999999 999999999999999999999999999976653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||.... . ...+.........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~~~~~~~---- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----N---PEVIQNLERGYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----h---HHHHHHHHcCCCC----
Confidence 32222223346678999999988889999999999999999999 999995221 1 1111111111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .......+.+++.+|++.+|++|||++++++.|+.
T Consensus 223 --~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --PR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 11223579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=334.04 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=201.5
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
++....++|+..+.||+|+||.||+++.. +++.+|+|.+.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999976 68899999986432 1223345788999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998653 278899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
+...............||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.... .........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 9876533322233456999999999987543 7889999999999999999999996322 111111111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
..... ............+.+++..|+..++.. ||++.|+++.
T Consensus 261 ~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11110 000011122456778888888755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.91 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=199.6
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcch
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (613)
+.||+|+||.||+|...++..+|+|.++..........+..|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876654444557889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeecc
Q 007200 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453 (613)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 453 (613)
+++..... .+++..+..++.+++.||.|+|+. +++||||||+||+++.++.+|++|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99865432 378999999999999999999999 999999999999999999999999999875433222111222
Q ss_pred ccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 454 ~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
.++..|+|||.+.+..++.++||||||+++|++++ |..||.... . ............. ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~---~~~~~~~~~~~~~----------~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----N---QQAREQVEKGYRM----------SCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----H---HHHHHHHHcCCCC----------CCC
Confidence 34667999999988889999999999999999998 999995221 1 1111111111110 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
......+.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=329.47 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=202.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||++... +|+.||+|+++.... ......+..|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999976 688999999976432 223456888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccc------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..........||+.|+|||.+. ...++.++|||||||++|||++|+.||.... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 4333333456899999999986 4567899999999999999999999996321 1111222221111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....+ .......+.+++..|+. +|++|||+.++++.
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111100 11223568889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=328.85 Aligned_cols=243 Identities=25% Similarity=0.296 Sum_probs=196.0
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.||+|+||.||++... +|+.||+|++..... ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999976 689999999975432 223456788999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 450 (613)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998886543 389999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC
Q 007200 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530 (613)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (613)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~-------~~~---- 213 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------DIK---- 213 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccC-------Ccc----
Confidence 33569999999999998899999999999999999999999995321 11111111110 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 531 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 531 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
.+......+.+++.+||+.||++|| ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1112335688999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.88 Aligned_cols=248 Identities=23% Similarity=0.275 Sum_probs=200.3
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC--CCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
..++|...+.||+|+||.||+|.+.. +..||+|.+..... ......+..|+.++..++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998653 36899999865432 223456788999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999997643 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........ ...
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~---~~~~~i~~-~~~-- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PL---LIYQKILE-GII-- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HH---HHHHHHhc-CCC--
Confidence 5432 223468999999999999889999999999999999999999996321 11 11111111 100
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
..+......+.+++.+|++.||++|+ +++++++.
T Consensus 246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01112234678999999999999995 78888764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.97 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=194.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC--CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhc---ccCccceeeEEEEc-----
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT----- 356 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 356 (613)
++|++.+.||+|+||+||+|++. +++.||+|.++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999987543322 234556677776655 69999999999852
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
....++||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356799999996 689888875432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh-
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 515 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 515 (613)
|+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||.... .......+.....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~-----~~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCC
Confidence 999865432 22334558999999999988899999999999999999999999996322 1111111111110
Q ss_pred --ccccc-------ccccCccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --EKKLE-------QLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --~~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... ......... .........+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000 001122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.28 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=203.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||+|... +|+.||+|+++.... ......+..|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 689999999975432 123456888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999997652 389999999999999999999999 999999999999999999999999999976543
Q ss_pred CC----------------------------CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007200 445 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (613)
Q Consensus 445 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~ 496 (613)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223345899999999999999999999999999999999999999632
Q ss_pred cccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 007200 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRM 563 (613)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 563 (613)
. ............ .....+. .......+.+++..|+. ||.+||+ ++++++.
T Consensus 234 ~--------~~~~~~~i~~~~--~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 T--------LQETYNKIINWK--ESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred C--------HHHHHHHHhccC--CcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2 111111111100 0000000 01134678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.14 Aligned_cols=252 Identities=26% Similarity=0.320 Sum_probs=197.5
Q ss_pred CCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC---cccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCce
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 360 (613)
+|++.+.||+|+||+||+++.. +++.||+|++..... ......+..|+.++..++ |+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 578999999865321 122345778999999995 99999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987543 388999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..............||+.|+|||.+.+.. ++.++|||||||++|||+||+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhc----
Confidence 65433333334456999999999997654 7889999999999999999999996322111 11111111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
.++.. +......+.+++.+|++.||++|| +++++++
T Consensus 226 ---~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 112235678999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.15 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=208.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCC-----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc-CC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 358 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 358 (613)
+..++|...+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.+++.++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346788999999999999999999765 678999998765555456678899999999999999999998876 57
Q ss_pred ceEEEEecccCCcchhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEe
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQS----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 434 (613)
..+++++|+.+++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764322 14589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007200 435 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 435 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ......++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLK- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHH-
Confidence 999998654332221 122335678999999988889999999999999999999 999995221 111122111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..... .........+.+++.+||..||++|||+.++++.|++.
T Consensus 234 --~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 --DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred --cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111 01112335789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=335.69 Aligned_cols=264 Identities=21% Similarity=0.340 Sum_probs=207.3
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 355 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 355 (613)
+.+..++|.+.+.||+|+||.||+|++. .+..||+|+++..........+..|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455667888899999999999999853 345799999986544444457889999999997 999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCC------------------------------------------------------
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 381 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 381 (613)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999865321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007200 382 ----------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (613)
Q Consensus 382 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 421 (613)
..+.+++..+..++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 123478888999999999999999998 9999999999
Q ss_pred ceeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007200 422 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 499 (613)
Q Consensus 422 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~ 499 (613)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986532221 11222346788999999998889999999999999999998 8899852210
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+.......... ....+......+.+++.+||..+|++||++++|++.|++
T Consensus 348 -------~~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 -------NEQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -------hHHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011111111110 001111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.93 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=210.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 78999999886432 2223557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.........+++..+..++.++++||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876444445689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+....... ...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~----- 225 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEK-CDY----- 225 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhc-CCC-----
Confidence 3222 223458889999999988889999999999999999999999995221 111121111111 100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+.. ........+.+++.+||..+|++|||+.+|++.|++.
T Consensus 226 ~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 PPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 000 1113446788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.54 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=203.8
Q ss_pred hCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|++.+.||+|+||+||+|.. .++..+|+|.+...........+.+|+++++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5677889999999999999984 24678999999765444444678899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 363 VYPFMVNGSVASCLRERGQ-------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+|||+.+++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853221 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 999999999986543221 12223335678999999988889999999999999999998 998985211 11111
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......... ..+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 237 ----~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ----EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111 0111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.29 Aligned_cols=262 Identities=20% Similarity=0.354 Sum_probs=195.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC-----CceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 361 (613)
+|++.+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999976 689999999875322 22344688999999999999999999988643 2479
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+. ++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68888886543 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh--
Q 007200 442 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 515 (613)
Q Consensus 442 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 515 (613)
...... .......|++.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 432211 12233568999999999866 5789999999999999999999999953211 111111111000
Q ss_pred ---------cccccccc---cCccCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 ---------EKKLEQLV---DSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 ---------~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........ ........ .......+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 00123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.29 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=195.7
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||+||++.+. +|+.||+|.+....... ....+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 68899999986543221 234577899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
..++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988765433344689999999999999999999999 999999999999999999999999999976543322 2233
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... ... ...+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~---------~~~--~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRIL---------NDS--VTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhc---------ccC--CCCc
Confidence 46899999999999999999999999999999999999999632210 00011111110 110 0112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
......+.+++..|++.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 23446788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.68 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=203.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999998753 567899988765544445678999999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEE
Q 007200 360 RLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 433 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl 433 (613)
.+++|||+.+++|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999876432 122489999999999999999999999 999999999999998754 5999
Q ss_pred eccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHH
Q 007200 434 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+|||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.... .. ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-----~~---~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-----NQ---EVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HH---HHHH
Confidence 9999998663222111 111223568999999999999999999999999999997 999996321 11 1111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
....... ...+......+.+++.+|++.+|++|||+.+|++.|+
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111 0111223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=326.88 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=203.7
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEc
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
..++....++|++.+.||+|+||.||++... +++.+|+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456667789999999999999999999977 68899999986432 12223457789999999999999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+...++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998653 278889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 999876543332334456999999999987543 78899999999999999999999963221 111111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRML 564 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 564 (613)
........... ........+.+++..|+..++.+ ||++.++++..
T Consensus 259 i~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111110 11123456788899999844433 77888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.60 Aligned_cols=257 Identities=29% Similarity=0.429 Sum_probs=203.0
Q ss_pred CCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+|.+.+.||+|+||.||+|... ....+++|.+..........++..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 2356899988765544445678899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 363 VYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
++||+.+++|.+++..... ...++++..+..++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998864211 123588999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999997654322211 122335678999999988889999999999999999998 999985221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+.. ...... ....+......+.+++.+|++.+|++||++.++++.|++
T Consensus 235 --~~~~~~----~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 235 --PERLFN----LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred --HHHHHH----HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 111111 111110 011112233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.72 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=195.0
Q ss_pred CccccCcCcEEEEEEeC----CCCEEEEEEeccccC---cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 294 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.||+|+||.||+++.. +++.||+|+++.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 578999999875421 22234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++...+ .+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987643 378889999999999999999999 99999999999999999999999999987543222
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....... . .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~-~------~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGK-L------N 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-C------C
Confidence 22233568999999999998889999999999999999999999996322 111122221111 0 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
.+......+.+++.+|++.||++|| ++.++++.
T Consensus 219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1112235688999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.24 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=195.6
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+..|++++..++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999876 688999999975432 2234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987643 388999999999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeeccccccccccccccccCCCCCcccchhH
Q 007200 446 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479 (613)
Q Consensus 446 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~ 479 (613)
.. .......||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHH--ccCCCCCCCCCH
Q 007200 480 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL--CTQGSPMERPKM 557 (613)
Q Consensus 480 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~ 557 (613)
||++|||++|+.||..... ............. . ..+ ........+.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~---~--~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--------TETQLKVINWENT---L--HIP--PQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--------HHHHHHHHccccc---c--CCC--CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999963221 0111111110000 0 000 001122456667766 666777779999
Q ss_pred HHHHHH
Q 007200 558 SEVVRM 563 (613)
Q Consensus 558 ~evl~~ 563 (613)
.++++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.77 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=205.8
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
++..++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+..++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 356788999999999999999999753 24579999887554433445688899999999999999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 431 (613)
...+++|||+.+|+|.++++.... .....++..+..++.|++.||+|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 123467888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007200 432 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 509 (613)
+|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 999999987654322111 112235678999999998899999999999999999998 788885221 1111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........... ........+.+++.+|++.||++|||+.++++.|++
T Consensus 231 ~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 231 LKFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111111100 111223579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.19 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=206.5
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
....++|...+.||+|+||.||++... .+..||+|.++..........+..|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999742 24579999987654444456789999999999 79999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
.+..+++|||+.+|+|.++++.... ..+++..+..++.|++.||+|||++ +|+|+||||+||+++.++.++++||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007200 437 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 437 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... ...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~----~~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFY----KLI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHH----HHH
Confidence 999865433221 1222345778999999999999999999999999999998 9999852211 00111 111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.... ...........+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 258 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 258 KEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1110 000111123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.45 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=206.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.+.|++.+.||+|.|+.||++... +|+.+|+|++.... .....+.+.+|+.+-..++||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456778889999999999999865 79999999886432 3335677899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGla~~ 441 (613)
|+|.|++|..-+-.+. .+++..+-.++.||+++|.|+|.+ +|||||+||+|+++.. ..-+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987665442 378899999999999999999999 9999999999999954 34689999999998
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
+. ++.......|||.|||||++...+|+..+|||+.||+||-++.|++||.. +....+.+.+. . +
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-----~~~~rlye~I~---~-g---- 227 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRLYEQIK---A-G---- 227 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-----ccHHHHHHHHh---c-c----
Confidence 76 55566778899999999999999999999999999999999999999952 12212222211 1 1
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+-..+........++..+++++|+..||.+|.|+.|.+..
T Consensus 228 --~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 228 --AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111222333445678889999999999999999998763
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.23 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=206.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
..++|.+.+.||+|+||.||+|.... +..||+|.+...........+.+|+.++..++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45678889999999999999998642 368999998755444445578899999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 007200 360 RLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 433 (613)
.+++|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998754321 23478899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHH
Q 007200 434 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 434 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++||++| |+.||.... ......++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~- 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFV- 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHH-
Confidence 999999765433221 1223346788999999988889999999999999999998 999985211 11111111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...... ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 ---IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111100 011122467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.15 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=202.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.++|.+.+.||+|++|.||+|.+..+..+|+|.+..... ....+.+|+.+++.+.|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 356888899999999999999988777899998765332 3456889999999999999999999875 4568999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.++++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999976432 3488999999999999999999999 99999999999999999999999999998664332
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
........++..|+|||...+..++.++||||||+++|||+| |+.||.... ......+ ......
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~---~~~~~~------- 221 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLEQ---VERGYR------- 221 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH---HHcCCC-------
Confidence 222222346678999999988889999999999999999999 899985211 1111111 111100
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+||+.||++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.14 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=198.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|+..+.||+|+||+||+|.+. +++ .+++|.+...........+..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56778899999999999999974 344 4778877544333334567788888999999999999998754 55789
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
++||+++|+|.+++..... .+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... ......++..|+|||.+.++.++.++|||||||++||+++ |+.||.... .....+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~----~~~~~~~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPD----LLEKGERL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH----HHHCCCcC
Confidence 433221 1223446778999999998899999999999999999998 999985221 111111 11111100
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+ ..+...+.+++.+||..||++|||+.|+++.|..
T Consensus 231 --~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 --AQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred --CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 001 1123467889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.95 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.+|.+.+.||+|+||+||+|...+ +..||+|+++..........+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677889999999999998642 46799999976544433456889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 362 LVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123488899999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999876543221 11223345778999999988889999999999999999998 888885221 11
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
++...... .... ..+..+...+.+++..||+.+|++||++.+|++.|+.
T Consensus 234 ~~~~~i~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRN-RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222111 1111 1122344668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.85 Aligned_cols=239 Identities=28% Similarity=0.391 Sum_probs=191.3
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|+.. +++.||+|++.... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999976 68899999987543 222344567788888766 699999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999887643 389999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ............. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~----~------ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEV----V------ 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCC----C------
Confidence 334568999999999999899999999999999999999999996322 1111222211110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSE 559 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 559 (613)
.+......+.+++.+|++.||++||++.+
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11122356889999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.12 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=198.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 689999999975421 223345788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeeccccccccccccccccCCCCCcccchhHHHHHHHHH
Q 007200 445 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487 (613)
Q Consensus 445 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ell 487 (613)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999999999999999999999999
Q ss_pred hCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 007200 488 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK---MSEVVRM 563 (613)
Q Consensus 488 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 563 (613)
+|+.||.... ................. + . .......+.+++..|+. +|.+|++ +.|+++.
T Consensus 234 ~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~--~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDN--------PQETYRKIINWKETLQF--P---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCC--------HHHHHHHHHcCCCccCC--C---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999996321 11111111111000000 0 0 01123467788888886 9999998 7777663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.17 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=205.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 358 (613)
..++|.+.+.||+|+||+||+|+.. +|+.||||++..... ......+.+|+..+..++|+|++++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999865 789999999865432 333456888999999999999999988765432
Q ss_pred ---ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 359 ---ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 359 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
..++||||+.+|+|.++++.......++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 35799999999999999976554455699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCC-CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 436 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 436 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHKTL 258 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHh
Confidence 99998654322 122334569999999999999999999999999999999999999996321 112222221
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... .. ..+......+.+++..||+.||++||++.++++.
T Consensus 259 ~~~-~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR-YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC-CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 00 0112234578899999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.80 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=195.5
Q ss_pred ccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 295 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.||+|+||.||+|.+. .+..||+|.+...........+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355799999876544444567899999999999999999999875 457899999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee-
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 450 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 450 (613)
|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999875332 489999999999999999999999 999999999999999999999999999976543322211
Q ss_pred -eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 451 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 451 -~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||.... . .+..........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~~~~~~---------- 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----G---PEVMSFIEQGKR---------- 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----H---HHHHHHHHCCCC----------
Confidence 11223578999999988889999999999999999996 999995221 1 111111111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+.....++.+++..||..+|++||++.+|.+.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111122346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=321.58 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=193.7
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.+++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999976 578999999876432 22334567788888765 799999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99998887543 388999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~----~------ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDV----L------ 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC----C------
Confidence 234568999999999999899999999999999999999999996322 1111112111110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERP-------KMSEVVRM 563 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 563 (613)
.+......+.+++..|++.||++|| ++.++++.
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111235688999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.50 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=190.2
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhh-cccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|... +++.||+|.++.... ......+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999976 588999999975432 2223345566666664 4799999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999887643 389999999999999999999999 99999999999999999999999999997643322 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . .+......... +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~---~~~~~~i~~~~-------~~--- 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----E---DELFDSILNDR-------PH--- 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHcCC-------CC---
Confidence 334568999999999999999999999999999999999999996321 1 11111111110 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVR 562 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 562 (613)
.+......+.+++..||+.||++||++. ++++
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1112235678999999999999999875 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.96 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=207.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 355 (613)
+..++|.+.+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45677888999999999999999742 24579999987654444456788999999999 7999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
.....+++|||+.+|+|.+++..... ....+++..+..++.||++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999976422 123478899999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 501 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~ 501 (613)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999998765332221 222335678999999988889999999999999999998 788884221
Q ss_pred CcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+........... .........+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 245 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 ----VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ----HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11222221111110 11122346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.39 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=207.4
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|.+.+.||+|+||.||+|..+++..+|||.+..... ....+..|+.+++.++|+||+++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999988788899999875432 3457889999999999999999999999889999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 3489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ...... .......
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~---~~~~~~~----- 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NREVLE---QVERGYR----- 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH---HHHcCCC-----
Confidence 22221222234568999999998889999999999999999998 999985211 111111 1111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. .........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -M----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 0111124578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.11 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=201.0
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
+|+..+.||+|+||+||++... +++.||+|.+...... .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999975 6889999998654322 123457789999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865432 3489999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
. ......|+..|+|||.+.+..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~-------- 220 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKED-------- 220 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhc--------
Confidence 2 1223458999999999998889999999999999999999999996321 111111111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
...........+.+++..||+.||++|| +++++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111223446788999999999999999 78787664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.11 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=202.6
Q ss_pred CCCCCCccccCcCcEEEEEEeC-C-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.|...+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3888899999999999999865 3 6778888764432 22344678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++|+|.++++.......++++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998875433444689999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 447 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+........ .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~-~----- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKY-D----- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-C-----
Confidence 1 12334569999999999999999999999999999999999999995321 1111222111110 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+......+.+++..||+.||++||++.+++.
T Consensus 290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011123356899999999999999999999975
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=321.38 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=192.4
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHH---hhcccCccceeeEEEEcCCceEEE
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
|.+.+.||+|+||.||+|.+. +|+.||||+++.... ......+..|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999976 689999999975431 12233466665554 567799999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++|+|..+++.. .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999998887542 389999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~----- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDEV----- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----
Confidence 222 22334568999999999999899999999999999999999999996321 1111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. .+......+.+++.+||+.||++|| ++.++++
T Consensus 219 --~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 1112235678999999999999999 4555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.72 Aligned_cols=200 Identities=22% Similarity=0.342 Sum_probs=173.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||+||++... +++.||+|++..... ......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999876 688999999975432 222346788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCC
Q 007200 445 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (613)
Q Consensus 445 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~ 490 (613)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCcc
Q 007200 491 RAFD 494 (613)
Q Consensus 491 ~p~~ 494 (613)
.||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.17 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=206.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC-----------------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 349 (613)
.++|++.+.||+|+||.||+|.... +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999998642 24589999886655555667889999999999999999
Q ss_pred eeEEEEcCCceEEEEecccCCcchhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
+++++..+...+++|||+.+++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876441 122589999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh--CCCCccccccc
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 499 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt--g~~p~~~~~~~ 499 (613)
|++++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999976543221 12223446778999999988889999999999999999998 677774221
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.......+............. ......+..+.+++.+|++.||++|||+.||++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111112221111111111100 011123367999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.65 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=204.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||+||++... ++..+|+|.+.... ......+..|++++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467888999999999999999852 34568999886543 22345688999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 007200 361 LLVYPFMVNGSVASCLRERGQ---------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 431 (613)
+++|||+.+++|.+++...+. ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 223489999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007200 432 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 509 (613)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999999765432211 1122335678999999998889999999999999999998 8999853221 111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..... ...... . .......+.+++.+||+.||.+|||+.++++.|++.
T Consensus 232 ~~~i~-~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 232 IECIT-QGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHH-cCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111 111100 0 111235689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.50 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=202.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|+..+.||+|+||+||+|.+. +|+ .||+|.++..........+..|+.++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 456888899999999999999854 444 4899998766555556678899999999999999999999875 4578
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+++||+++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999876432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||+... ......++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLE----KGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCCc
Confidence 65332211 112234678999999988899999999999999999998 899985221 111112111 1100
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..........+.+++.+||+.||++||++.++++.|+..
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 230 ---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 001112345788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.17 Aligned_cols=256 Identities=26% Similarity=0.455 Sum_probs=204.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC---EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|+..+.||+|+||.||+|... ++. .+|+|.++..........+..|++++..++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 333 7999988765444445678899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+|||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987543 2389999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceee--ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 443 DYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 443 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
......... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~-- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGF-- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCC--
Confidence 433222111 1123457999999988889999999999999999997 999995221 112222211110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...........+.+++.+||+.+|++||++.+|++.|++
T Consensus 228 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 --------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=312.31 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=202.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc----cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|...+.||+|++|.||.+... +++.+|+|.+....... ....+.+|++++.+++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999865 68999999986543211 23468889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
++||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987643 388999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcee--eccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~---~~~~~~~~~~~--- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----A---MAAIFKIATQP--- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----h---HHHHHHHhccC---
Confidence 43222111 23457889999999999889999999999999999999999995221 0 01111111110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....+......+.+++..||..+|++|||+.++++.
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111122334578899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.11 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=200.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC--EEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 362 (613)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++..........+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999975 454 45778776544444456788999999999 89999999999999999999
Q ss_pred EEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 363 VYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
+|||+++++|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975431 123588999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 509 (613)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||.... ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 232 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHHH
Confidence 9999999986332111 1111224567999999988889999999999999999998 999995221 1111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.......... . ........+.+++.+||+.+|++||++.++++.|+.
T Consensus 233 ~~~~~~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 233 YEKLPQGYRL------E----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHHhcCCcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111110000 0 111123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.81 Aligned_cols=265 Identities=22% Similarity=0.374 Sum_probs=203.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-----------------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-----------------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 349 (613)
.++|++.+.||+|+||.||++... ++..+|+|.+...........+..|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 234689999876554444567899999999999999999
Q ss_pred eeEEEEcCCceEEEEecccCCcchhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
+++++..++..+++|||+.+++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 12478889999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh--CCCCccccccc
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 499 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt--g~~p~~~~~~~ 499 (613)
|+++.++.++|+|||+++.+...... ......++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 99999999999999999765432211 1122234678999999888889999999999999999998 7788852211
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.................... + ....+...+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 ----EQVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ----HHHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01111111111111000000 0 11123367899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.00 Aligned_cols=243 Identities=22% Similarity=0.281 Sum_probs=194.7
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.||+|+||.||++... +|+.||+|+++.... ......+..|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999975 789999999976432 223346778999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
+|..++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9998886543 38999999999999999999997 7 999999999999999999999999999875432221 2
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......... ... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~-~~~------~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILM-EEI------RF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhc-CCC------CC--
Confidence 233459999999999999999999999999999999999999995321 1111111110 000 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
+......+.+++.+|++.||++|+ ++.++++.
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112235688999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.58 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=204.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 357 (613)
.++|.+.+.||+|+||.||++... ++..+|+|.++..........+..|++++..+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999753 23469999997654444455688899999999 799999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 425 (613)
...++||||+.+|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976432 123589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCc
Q 007200 426 DEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 503 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~ 503 (613)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999987654322111 111224568999999998889999999999999999998 888885211
Q ss_pred chHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+.. ........ ...+......+.+++.+||..+|++|||+.++++.|+.
T Consensus 248 --~~~~~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 248 --VEELF-KLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred --HHHHH-HHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 11111 11111110 11122234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=311.39 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=194.7
Q ss_pred ccccCcCcEEEEEEeC---CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 295 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
.||+|+||.||+|.++ ++..+|+|+++..... .....+..|+.+++.+.|+||+++++++. ....+++|||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5788999998754322 23456889999999999999999999875 45678999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 450 (613)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986543 388999999999999999999999 999999999999999999999999999987654332211
Q ss_pred --eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 451 --TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 451 --~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
....++..|+|||.+....++.++|||||||++|||++ |+.||.... .. .+... ...... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~---~~~~~-i~~~~~-----~~- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GN---EVTQM-IESGER-----ME- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HH---HHHHH-HHCCCC-----CC-
Confidence 12224578999999988889999999999999999998 999996321 11 11111 111110 01
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+......+.+++.+||+.||++||++.+|++.|++
T Consensus 219 ---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 ---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=313.36 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=204.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-C---CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-D---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|.+.+.||+|+||.||+|.+. + +..+|+|.++..........+..|+.++..++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888899999999999999864 2 337999998765544445678999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+|||+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeec--cccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 443 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 443 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |+.||.... .......+ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-----~~~~~~~~---~~~~~- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-----NQDVIKAI---EEGYR- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-----HHHHHHHH---hCCCc-
Confidence 5432222211 223568999999998889999999999999999886 999985221 11111111 11100
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -----L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=312.67 Aligned_cols=260 Identities=21% Similarity=0.342 Sum_probs=207.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||.||++... +++.+|||.+..... ......+..|+.+++.+.|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999965 789999998864322 223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433344589999999999999999999999 999999999999999999999999999876643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ....
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~------~~~~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE------QCDY 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhh------cCCC
Confidence 3221 2234588899999999888899999999999999999999999952211 1111111111 1111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+... .......+.+++.+||+.||++|||+.+|++.++.
T Consensus 226 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111 12244678999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.66 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=197.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----ceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 361 (613)
+|+..+.||+|+||.||++.+. +|+.||+|.+..... ......+.+|+++++.++|+||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 789999999865422 223456889999999999999999999998776 789
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+|+||+. ++|.+.+.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57777765432 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCCCCHH
Confidence 644333333344578999999998774 478999999999999999999999963221 11111111110000000
Q ss_pred ----------c-cccCccC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 ----------Q-LVDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ----------~-~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. +...... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000 00111224568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.53 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccC-ccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 364 (613)
+|++.+.||+|+||.||+|... +++.||+|++..... ......+..|..++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999976 578999999975432 22345677889999988765 5888999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 388999999999999999999999 999999999999999999999999999875332
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... . .+.........
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~---~~~~~~i~~~~------- 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----E---DELFQSIMEHN------- 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHcCC-------
Confidence 222 2334568999999999999999999999999999999999999996321 1 11111111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
. ..+......+.+++.+|+..||++|++.
T Consensus 218 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 V----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 1111233568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.69 Aligned_cols=265 Identities=22% Similarity=0.390 Sum_probs=203.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC---------------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceee
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD---------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 351 (613)
.++|++.+.||+|+||.||++.... ...||+|.++..........+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578899999999999999987542 2258999987655444456789999999999999999999
Q ss_pred EEEEcCCceEEEEecccCCcchhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQ--------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
+++......++||||+.+++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112478999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh--CCCCcccccccC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLAN 500 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt--g~~p~~~~~~~~ 500 (613)
++++++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence 9999999999999999765332211 1122335678999999988889999999999999999998 566775221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.......+............. ......+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 --DEQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --hHHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111111000000 001112357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.96 Aligned_cols=245 Identities=25% Similarity=0.310 Sum_probs=193.0
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|... +++.||+|+++..... .....+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6789999999765322 2234577888988887 599999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998886543 389999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......++..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~--------- 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPIR--------- 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCCC---------
Confidence 33456999999999999999999999999999999999999999633211 1111222222222211110
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
.+......+.+++.+|++.||++||++.
T Consensus 222 -~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 -IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1112235678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.27 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=200.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCC--EEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 363 (613)
++|++.+.||+|+||.||+|... ++. .+++|.++..........+..|+.++.++ +||||+++++++.+....+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999876 333 47888887544443455788999999999 799999999999999999999
Q ss_pred EecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 007200 364 YPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 431 (613)
+||+++++|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 112488999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007200 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 510 (613)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998643211 11111223557999999988889999999999999999997 999995221 11111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
....... ....+......+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 229 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQGY----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111110 0011112335788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.27 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=204.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.+|...+.||+|+||.||+|... ++..+++|.+..... .....+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999743 345688998864432 23456889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 362 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+||||+++++|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975431 122489999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 9999999999765432211 1223346788999999999999999999999999999999 9999853221 1
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+... ....... .....+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 233 ~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECI-TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHH-hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1111111 0112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=313.18 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=196.8
Q ss_pred CCCCCccccCcCcEEEEEEeCC-CC--EEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcC------Cc
Q 007200 290 FSNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 359 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 359 (613)
|.+.+.||+|+||.||+|.+.+ +. .+|+|.++... .......+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999763 33 58999887543 223345688899999999999999999987532 24
Q ss_pred eEEEEecccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 360 RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
.+++|||+.+|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2223489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007200 438 LAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 438 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .. +.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~---~~~-~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-----NS---EIY-DYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-----HH---HHH-HHHH
Confidence 998764332211 112235678999999998899999999999999999999 888885211 11 111 1111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..... .........+.+++.+||+.||++|||+.++++.|+.
T Consensus 229 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 229 QGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11110 0111234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.72 Aligned_cols=245 Identities=26% Similarity=0.329 Sum_probs=195.4
Q ss_pred CccccCcCcEEEEEEe----CCCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 294 NILGRGGFGKVYKGRL----TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
+.||+|+||.||++.. .+|+.||+|+++..... .....+..|++++.+++||||+++++++.++...++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 25789999999754322 223457789999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999986543 389999999999999999999999 99999999999999999999999999997654322 2
Q ss_pred eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~-~--------- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAK-L--------- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCC-C---------
Confidence 2334568999999999998889999999999999999999999996321 111111111110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHH--HHHHhh
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSE--VVRMLE 565 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e--vl~~L~ 565 (613)
..+......+.+++.+||+.||++||++.+ +.+.++
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 011122356889999999999999999766 444444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=310.40 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=197.9
Q ss_pred CccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|.+.. +..+|+|.+...........+..|+.+++.+.|+||+++++++. ....+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998542 26899999986655445567899999999999999999999876 4568999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997654 489999999999999999999999 99999999999999999999999999998664433222
Q ss_pred eec--cccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 450 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 450 ~~~--~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ......++.. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~~---~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLES---GERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHc---CCcC-------
Confidence 111 123568999999998899999999999999999998 999996321 1112222211 1110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+......+.+++.+||..+|++||++.++++.|+++
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11112335788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=328.04 Aligned_cols=253 Identities=17% Similarity=0.242 Sum_probs=196.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||++... +++.||||++.... .......+..|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999876 78999999986532 1223446788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987543 388999999999999999999999 999999999999999999999999999864321
Q ss_pred CCCc----------------------------------------------eeeccccccccccccccccCCCCCcccchh
Q 007200 445 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478 (613)
Q Consensus 445 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS 478 (613)
.... ......||+.|+|||.+.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCC---C
Q 007200 479 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---P 555 (613)
Q Consensus 479 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---P 555 (613)
|||++|||++|+.||.... . .+.............+ + . .......+.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~-----~---~~~~~~i~~~~~~~~~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN-----S---HETYRKIINWRETLYF--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCC-----H---HHHHHHHHccCCccCC--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999995221 1 1111111110000000 0 0 01123567888999997 67765 5
Q ss_pred CHHHHHHH
Q 007200 556 KMSEVVRM 563 (613)
Q Consensus 556 t~~evl~~ 563 (613)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.30 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=200.6
Q ss_pred CCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCc-----
Q 007200 290 FSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 359 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 359 (613)
|.+.+.||+|+||.||+|.... +..||+|+++.... ......+..|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 36799999875433 2234578899999999999999999998876554
Q ss_pred -eEEEEecccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 360 -RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 360 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
.++++||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885532 1223589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007200 437 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 437 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... . .+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----N---HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHH
Confidence 9998664332211 112234678999999988889999999999999999999 888885221 1 11111111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..... ..+......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 230 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 11223346799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=311.46 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=204.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.++|+..+.||+|+||.||+|... |+.||+|.++.... ...++..|+.++..++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467888999999999999999876 88999999976543 456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.++++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999976542 2489999999999999999999999 99999999999999999999999999998653221
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
. ....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .+ +........
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~---~~-~~~~~~~~~------- 216 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----L---KD-VVPHVEKGY------- 216 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----H---HH-HHHHHhcCC-------
Confidence 1 2234668999999988889999999999999999997 999985221 0 11 111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+...+..+.+++.+|+..+|++|||+.+++++|+.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 001111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=317.94 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=205.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
..++|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999863 4678999998765544445678899999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007200 360 RLLVYPFMVNGSVASCLRERG------------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 421 (613)
.+++|||+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999987432 1123578999999999999999999999 9999999999
Q ss_pred ceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccccccc
Q 007200 422 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 499 (613)
Q Consensus 422 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~ 499 (613)
||++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 999999999999999998755322211 1122234667999999988899999999999999999998 888884221
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+...... ...... .+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 238 ------~~~~~~~~~-~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ------HEEVIYYVR-DGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHHHh-cCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112222211 111110 111234678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=313.92 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=196.2
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||.||++... +|+.||+|.+...... .....+..|++++.+++||||+++++++.++...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 6899999998653322 1233456799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 2488999999999999999999999 99999999999999999999999999997654322 2233
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..|+..|+|||.+.+..++.++||||+||++|||++|+.||.... ................ ... . .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~-----~~~--~---~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLEDE-----VKF--E---H 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhccc-----ccc--c---c
Confidence 458999999999999889999999999999999999999995221 1111111111111110 000 0 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......+.+++.+||+.||++||+++|+++.+..
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 1224568999999999999999999888765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=310.65 Aligned_cols=251 Identities=17% Similarity=0.283 Sum_probs=203.6
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
+|++.+.||+|+||.||++... ++..+|+|.++..........+..|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999976 688999999875544445567888999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++++|.+++..... ..+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998865322 3478999999999999999999999 999999999999999999999999999976643222
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~------ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVC-QGSYKP------ 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHh-cCCCCC------
Confidence 2233558899999999988889999999999999999999999996321 111111111 111110
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111233568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=307.96 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=209.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|+..+.||.|.-|+||+++.. ++..+|+|++.+.... ....+.+.|-++|+.++||.+..+|..++.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3456777889999999999999987 4689999999876533 234468889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+||||+||+|..+++.+... .|++..++.++..++-||+|||.. |||+|||||+||||.++|++.|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999876543 499999999999999999999999 9999999999999999999999999987433
Q ss_pred CCC--------------------------------C-C----------------------ceeecccccccccccccccc
Q 007200 443 DYK--------------------------------D-T----------------------HVTTAVRGTIGHIAPEYLST 467 (613)
Q Consensus 443 ~~~--------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~ 467 (613)
... . . ..+...+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 110 0 0 01123569999999999999
Q ss_pred CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHcc
Q 007200 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCT 547 (613)
Q Consensus 468 ~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 547 (613)
...+.++|.|+|||++|||+.|+.||.... +.+.+..++...+.-.........+.+||+..|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-----------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-----------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCC-----------------chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999996332 223333444444443333455678899999999
Q ss_pred CCCCCCCCC----HHHHHH
Q 007200 548 QGSPMERPK----MSEVVR 562 (613)
Q Consensus 548 ~~dP~~RPt----~~evl~ 562 (613)
.+||++|.. |.||-+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999998 666655
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.09 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=191.1
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhh-cccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|.+. +++.||+|.++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999976 578999999976432 2233445667777775 4899999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999987543 388999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . .+......... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~---~~~~~~i~~~~-------~~~-- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----E---EELFQSIRMDN-------PCY-- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCC-------CCC--
Confidence 234568999999999999999999999999999999999999996321 1 11111111000 101
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVR 562 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 562 (613)
+......+.+++.+||+.||++||++. ++.+
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111235678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=321.02 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=205.1
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 354 (613)
....++|.+.+.||+|+||.||++... .+..+|+|.++..........+..|+.++.++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344577888999999999999999742 24568999987654444456788999999999 599999999999
Q ss_pred EcCCceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 355 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
......+++|||+.+|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 998899999999999999999976421 123489999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--- 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---
Confidence 999999999999999998654322111 112224567999999998889999999999999999999 888885221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+ +.......... ..+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 242 -----~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 242 -----VEE-LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred -----HHH-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111 11111111110 1112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.05 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=199.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 68889999997655444455678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 78887765432 378999999999999999999999 99999999999999999999999999997654322
Q ss_pred Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc---cccc--
Q 007200 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLE-- 520 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 520 (613)
. ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+...... ....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 2 1223457899999998865 45789999999999999999999999532210 011111110000 0000
Q ss_pred ----ccccCccCC-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 ----QLVDSDMEG-------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ----~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...+..... .........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 001122356789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.42 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=205.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|...+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4457889999999999999999998778889999886532 234578899999999999999999999887 7789999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997643 23478999999999999999999999 999999999999999999999999999976643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+....++.++||||||+++|+++| |+.||.... ......++. ....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~----~~~~---- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALE----RGYR---- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHh----CCCC----
Confidence 32222223335678999999988889999999999999999999 999985221 111111111 1100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.19 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=190.6
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhh-cccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|++. +|+.||+|.++.... .........|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 688999999976432 2233456667777765 4899999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999887643 388999999999999999999999 99999999999999999999999999987532222 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . ........ .. .+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~---~~~~~~~~-~~------~~~~~- 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----E---DELFESIR-VD------TPHYP- 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH-hC------CCCCC-
Confidence 334568999999999999999999999999999999999999996221 1 11111111 10 01111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 561 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 561 (613)
......+.+++.+||+.||++||++. +++
T Consensus 217 ---~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 ---RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11235688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.21 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=204.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|++|.||+|... +++.|++|.+.... .......+..|+++++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999976 68899999986432 233455788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.++++... ...+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 23489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||.... . ......... ...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~~------- 218 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----Q---GALILKIIR-GVF------- 218 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHc-CCC-------
Confidence 22 233458889999999999999999999999999999999999996322 1 111111111 111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01111334678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=321.08 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=192.6
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+|...+.||+|+||.||+|+.. +++.||+|.++.... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 578999999875432 12233466677777766 5899999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999886543 388999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.... .. ........ ...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~---~~~~~i~~-~~~----- 218 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----ED---ELFQSIME-HNV----- 218 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HH---HHHHHHHh-CCC-----
Confidence 22 22334568999999999999999999999999999999999999996321 11 11111111 100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
..+......+.+++.+|++.||++|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112234578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.26 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=199.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++..++||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 357889999999999999999975 688999999865432 234467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.++++... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999987543 389999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .... ... ..
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~-~~~---~~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLM-SKS---NF 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heee-ecC---CC
Confidence 21 122345888999999884 34578899999999999999999999852211000 0000 000 00
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
..+.. .........+.+++..||+.+|++|||++++++.|
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 00112346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.44 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=194.2
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|.+. +++.||+|+++.... ......+..|.+++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999976 578999999975432 22344567888888877 699999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 99998887643 389999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... .............
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~~----------- 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDEV----------- 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCC-----------
Confidence 233458999999999999999999999999999999999999996321 1111111111110
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKM-----SEVVRM 563 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 563 (613)
..+......+.+++.+||+.||++||++ .++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0111234578899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.09 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=195.2
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
+|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++..++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999976 688999999865321 2234567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378899999999999999999999 9999999999999999999999999997533110
Q ss_pred C------------------------------------------CceeeccccccccccccccccCCCCCcccchhHHHHH
Q 007200 446 D------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483 (613)
Q Consensus 446 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il 483 (613)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 007200 484 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP---KMSEV 560 (613)
Q Consensus 484 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ev 560 (613)
|||++|+.||..... .+........... .. ..........+.+++.+|+ .+|.+|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~--------~~~~~~i~~~~~~---~~----~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTP--------AETQLKVINWETT---LH----IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCH--------HHHHHHHhccCcc---cc----CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999963221 1111111110000 00 0000112345666777765 4999999 88888
Q ss_pred HHH
Q 007200 561 VRM 563 (613)
Q Consensus 561 l~~ 563 (613)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.77 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=198.8
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
+|...+.||+|+||.||+|.+. +++.||+|.+...........+..|++++.+++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999865 788999999876544444557889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999986542 267889999999999999999999 9999999999999999999999999999765422
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ................ .+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ-GSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccc-cccchHHHHHHHhccC------CCCC
Confidence 1223458999999999999899999999999999999999999996422111 1111111111111110 0011
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. .......+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 11123468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.84 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=201.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEe------CCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 357 (613)
...++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++..+ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4457899999999999999999973 246789999997654443455688999999999 689999999988654
Q ss_pred -CceEEEEecccCCcchhhhhccCC-------------------------------------------------------
Q 007200 358 -TERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 381 (613)
Q Consensus 358 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 381 (613)
...+++|||+.+|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999999864321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc-eeec
Q 007200 382 --------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTA 452 (613)
Q Consensus 382 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~ 452 (613)
....+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012378888999999999999999999 9999999999999999999999999999765322211 1122
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCC
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (613)
..++..|+|||.+.+..++.++||||||+++|||++ |..||..... ... ........... ..+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~----~~~~~~~~~~~-----~~~--- 304 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEE----FCRRLKEGTRM-----RAP--- 304 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----cHH----HHHHHhccCCC-----CCC---
Confidence 335678999999988899999999999999999997 9999853211 001 11111111100 001
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 532 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 532 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......+.+++..||+.||++|||+.||++.|+.
T Consensus 305 -~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 305 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred -CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1122468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.70 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=203.1
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc-------HHHHHHHHHHHhhcc-cCccceeeEEEEc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAV-HRNLLRLRGFCMT 356 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 356 (613)
.-++|...+.+|.|..++|.++..+ +|..+|+|++........ .+.-.+|+.+|+++. ||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888899999999999999866 788999999864332211 223567899999875 9999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+...++|+|.|+.|.|.+++...- .++++...+|+.|+.+|++|||.. +||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999997654 399999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeecccccccccccccccc------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
|.++.+... ..-...+|||+|+|||.+.. ..|+..+|+||+|||||.++.|.+||.... ..-.+
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlML 237 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLML 237 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHH
Confidence 999977643 33456789999999999853 247889999999999999999999994211 01111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+ ++-.+.. ........+......+++.+|++.||.+|.|++|+++
T Consensus 238 R-~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 R-MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred H-HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 1111110 1122234455667889999999999999999999987
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.32 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=171.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.+++.++|+||+++++.+.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999976 688999999875422 2234468889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987643 388999999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------CceeeccccccccccccccccCCCCCcccchhH
Q 007200 446 D----------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479 (613)
Q Consensus 446 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~ 479 (613)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcc
Q 007200 480 GVMLLELITGQRAFD 494 (613)
Q Consensus 480 G~il~elltg~~p~~ 494 (613)
||++|||++|+.||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (382)
T cd05625 235 GVILYEMLVGQPPFL 249 (382)
T ss_pred hHHHHHHHhCCCCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=312.43 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=202.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CC---CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
..|.+.+.||+|+||.||+|... ++ ..||||.+...........+..|+.+++.+.||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35777899999999999999975 33 369999987655444556799999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.++++.... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999876432 389999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcee--eccc--cccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 444 YKDTHVT--TAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 444 ~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
....... .... .+..|+|||.+.+..++.++|||||||++|||++ |..||.... ......++. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~---~~~~ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE---QDYR 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH---cCCc
Confidence 3222111 1111 2457999999998899999999999999999886 999985221 111122211 1100
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.....+.+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01112234568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=334.08 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=192.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 357 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 357 (613)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457999999999999999999975 68899999885432 1245799999999999999999987432
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEecc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 436 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Df 436 (613)
...++||||+.+ ++.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999975 67777654333344589999999999999999999999 999999999999999664 7999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||.... .......+.....
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS-----SVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhC
Confidence 9998654322 12234589999999998764 68999999999999999999999995321 1111111111110
Q ss_pred cccc----------cccccCc-----cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 EKKL----------EQLVDSD-----MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 ~~~~----------~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.... ..+.-+. +...++......+.+++.+||..||.+|||+.|+++.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 0000000 0000111234578999999999999999999999863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=315.11 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=203.9
Q ss_pred hCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 360 (613)
..|...+.||+|+||.||.+.+ .++..||+|.++..........+.+|+.+++.+.||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567889999999999999974 257889999987655444456789999999999999999999998875 567
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999865432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc-------CCCcchHHHHHH
Q 007200 441 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-------NDDDVMLLDWVK 511 (613)
Q Consensus 441 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~ 511 (613)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|+..+... .........++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66533221 122344677899999998888999999999999999999988765321100 000111111111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .... ...........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 238 ~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 VL-EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HH-HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 11 1110 001112234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.36 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=195.5
Q ss_pred CccccCcCcEEEEEEeC-CCC--EEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|.+. ++. .+++|.++..........+..|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999976 344 46888887554444456788999999999 799999999999999999999999999
Q ss_pred CcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 370 GSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 370 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 122478999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
++....... .......+..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 999995221 11111111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
... .........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111 0111233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.18 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=189.0
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHH-HHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|.+. +|+.||+|++...... .....+..|.. +++.++||||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999976 6899999998754321 12234445544 46788999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999887543 388999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~------~~-- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-L------RL-- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-C------CC--
Confidence 334568999999999999999999999999999999999999995321 111111211110 0 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 560 (613)
.......+.+++.+|++.||++||++.+.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 11124568899999999999999998633
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.25 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=198.9
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcch
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (613)
++||+|+||.||++.+.+++.||+|.+...........+..|+++++++.|+||+++++++.+....+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999876554434567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCcee-ec
Q 007200 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 452 (613)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 452 (613)
+++..... .+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99876432 378999999999999999999999 999999999999999999999999999975542211111 11
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCC
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (613)
..++..|+|||.+.++.++.++||||||+++|||+| |..||.... ....... .... .....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-----~~~~~~~----~~~~---------~~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-----NQQTRER----IESG---------YRMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-----HHHHHHH----HhcC---------CCCCC
Confidence 224567999999988899999999999999999999 888885221 1111111 1110 00011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 532 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 532 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
+......+.+++.+|+..+|++|||+.|+++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1223457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.27 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=211.8
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 361 (613)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+..... ....+.+|+.+|+++. ||||+.+++.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999987 59999999998765443 3467899999999998 999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CcEEEeccc
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 437 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG 437 (613)
+|||++.||.|.+.+... .+++.++..++.|++.+++|||+. |||||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999776 189999999999999999999999 99999999999999643 479999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..... ..... .... .
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~----~~~~~----~i~~-~ 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE----FEIFL----AILR-G 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh----hHHHH----HHHc-C
Confidence 9998775 4456667899999999999999999999999999999999999999963321 11111 1111 1
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. ...............+++..|+..||..|+|+.++++.
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 22223344456788899999999999999999999994
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.77 Aligned_cols=264 Identities=28% Similarity=0.401 Sum_probs=206.9
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 354 (613)
++...+|.+.+.||+|+||.||+|... .+..||+|.++..........+.+|+.++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344467889999999999999999742 12368999887654444456788999999999 799999999999
Q ss_pred EcCCceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 355 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
..+...++++||+.+|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999875321 223588999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999998654322111 112224567999999999999999999999999999998 888885221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
..+...... .... ..........+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 242 -----~~~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 -----VEELFKLLK-EGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----HHHHHHHHH-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 112221111 1110 0111223457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.86 Aligned_cols=250 Identities=19% Similarity=0.311 Sum_probs=201.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.+|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+.|+||+++++++..+...++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 47888899999999999999965 6889999998754433 345688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998643 378999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... . ........... +
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~-~~~~~~~~~~~------~- 234 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------L-RALYLIATNGT------P- 234 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------H-HhHHHHhcCCC------C-
Confidence 21 2234588999999999888899999999999999999999999953221 0 11111111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...........+.+++.+||..+|++|||+.++++.
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 001122334568899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.91 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=201.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|+||.||++.+. ++..+|+|.+..........++.+|++++.+++||||+++++++.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999976 68889999887554443445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.++++... .+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997653 3889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc--------
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-------- 518 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 518 (613)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccc
Confidence 123345889999999998888999999999999999999999998532210 00010000000000
Q ss_pred ----------------ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 ----------------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...+.....+..........+.+++.+||..+|++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000001134568899999999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.06 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=199.5
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHh--hcccCccceeeEEEEcC----
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTP---- 357 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~---- 357 (613)
+.......+.+.||+|.||.||+|.++ |+.||||++... .+....+|.+++. .++|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 344456677889999999999999997 899999999643 2345566666665 67999999999876544
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCceeecCCCcEE
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-----HCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
.+.|||++|.+.|||.|+|... .++.....+++..+|.||++||. +.+|.|.|||||+.|||+.+++.+.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 4579999999999999999874 38999999999999999999995 4678999999999999999999999
Q ss_pred EeccccceecCCCCCc---eeeccccccccccccccccCCC------CCcccchhHHHHHHHHHhCC----------CCc
Q 007200 433 VGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQ----------RAF 493 (613)
Q Consensus 433 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~DVwS~G~il~elltg~----------~p~ 493 (613)
|+|+|+|...+..... .....+||.+|||||++...-. -..+||||||.++||++-+. .||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999876544322 2334569999999999865421 24689999999999987632 444
Q ss_pred ccccccCCCcchHHHHHHHHhhcccccccccCccCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 494 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..--. .+ ...+.++..+-..++ .|..+. -...+.+..+.++|+.||..+|.-|-|+-.+-+.|.++
T Consensus 437 yd~Vp---~D-Ps~eeMrkVVCv~~~----RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 437 YDVVP---SD-PSFEEMRKVVCVQKL----RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred ccCCC---CC-CCHHHHhcceeeccc----CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 31110 00 111222222211111 111111 12456788999999999999999999999999888754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.18 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=195.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+++.. +++.||+|++.... .......+..|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999976 68899999986432 1223445788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975332 388999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCc
Confidence 33322233458999999999863 457889999999999999999999995321 11222222111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQG--SPMERPKMSEVVRM 563 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~ 563 (613)
..+.. ........+.+++.+|+.. ++..||++.++++.
T Consensus 227 ~~~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11100 0111234567777776654 33347888888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.69 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=201.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+++++.+.|||++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46777889999999999999987788999998865432 3457889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.++++.... ++++..+..++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999875432 378999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ....+....... ....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~~~ 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAGF---RLYKPR 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCCC---CCCCCC
Confidence 21222235678999999998889999999999999999998 999985221 111111111110 011111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
.....+.+++.+||+.+|++|||+.++++.|
T Consensus 225 -------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 -------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.16 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=190.9
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHH-HHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|+.. +++.||+|++...... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 6889999998754321 12234555554 57889999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998886533 378899999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~---------- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK-PL---------- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC-CC----------
Confidence 234568999999999998899999999999999999999999995321 11111111111 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhcC
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVRMLEGD 567 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L~~~ 567 (613)
..+......+.+++.+|++.||.+||++. ++.+.++..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 01112235688999999999999999874 344444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.98 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=192.7
Q ss_pred CccccCcCcEEEEEEeCC---CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998653 45799998876554444557888999999999999999999999999999999999999
Q ss_pred cchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 371 SVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 371 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 122467788889999999999999999 99999999999999999999999999997543322211
Q ss_pred -eeccccccccccccccccC-------CCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 450 -TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 450 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.....++..|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..... .... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~---~~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLT---YTVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHH---HHhh-cccC
Confidence 1223467889999998643 35789999999999999996 9999953211 00001 0011 1111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
....+... ......+.+++..|| .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112345778899999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.39 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=191.1
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHH-HHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEV-EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|++. +++.||+|++...... .....+..|. .+++.++|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 5788999998754221 1222344444 356788999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999987643 378889999999999999999999 99999999999999999999999999997543222 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~---------- 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL---------- 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-Cc----------
Confidence 334569999999999999999999999999999999999999995221 11111111111 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.........+.+++.+|++.||.+||++.+.+..+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 0111223568899999999999999998865544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.97 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=204.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
++|.....||+|+||.||+|+.+ +...+++|.+...........+..|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 245799998865443334557899999999999999999999999989999
Q ss_pred EEEecccCCcchhhhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 362 LVYPFMVNGSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 12589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhh
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . ...+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~---~~~~~~~-~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D---EEVLNRL-Q 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h---HHHHHHH-H
Confidence 9987543322222333446778999999988888999999999999999999 788884211 1 1111111 1
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
..... ..........+.+++.+||+.+|++|||+.|+++.|.
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111 0011123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.13 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=197.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 357 (613)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999976 68899999986543 2345678899999988 699999999998753
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 457899999999999999876432 3489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||..... ..... .
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-~ 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-L 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH-H
Confidence 9986543222 223355889999999986 33578899999999999999999999952210 00100 0
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ..... ... ........+.+++.+||..+|.+|||+.++++
T Consensus 228 ~-~~~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 I-PRNPA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-hcCCC-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00000 000 01123356889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.58 Aligned_cols=251 Identities=32% Similarity=0.486 Sum_probs=203.8
Q ss_pred CccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|.... +..|++|.++..........+.+|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999763 7889999998765544466789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 370 GSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 370 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 445 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 445 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||.... ..+..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~---- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYR---- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC----
Confidence 321 11233447889999999988889999999999999999999 699996331 1111111111110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...+......+.+++.+|+..+|++|||+.|+++.|+
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.06 Aligned_cols=249 Identities=30% Similarity=0.429 Sum_probs=199.5
Q ss_pred CccccCcCcEEEEEEeCC--CC--EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLTD--GS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|++|.||+|.+.+ ++ .||+|.+...........+..|+.++++++|+||+++++++.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998653 33 6899999776554445678999999999999999999999988 889999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc-
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 448 (613)
++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999977542 3489999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEGER------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCCc-------
Confidence 1112346788999999998899999999999999999999 999995221 11111111111100
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=311.73 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=201.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
..+|...+.||+|+||.||++... ++..+|+|.+.... ......+..|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 356777899999999999999742 35678999876543 33455789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 361 LLVYPFMVNGSVASCLRERGQS-----------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+++|||+.+++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 9999999999999998764321 12488999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... . .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~---~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-----N---T 231 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----H---H
Confidence 9999999999765432211 1122235678999999999999999999999999999998 999985221 1 1
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
+.+......... ..+......+.+++.+||+.||++||++.+|++.|+
T Consensus 232 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111110 011123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=307.53 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=200.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE-cCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||.||++... |..+|+|.++... ....+..|+.++++++|+|++++++++. ++...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 457888899999999999999875 7889999886432 3456889999999999999999999765 4567899999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.++++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999876432 2488999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------ 217 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYK------ 217 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCC------
Confidence 2 12234668999999988889999999999999999998 999985221 1111111111100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.59 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=206.3
Q ss_pred CCCCccccCcCcEEEEEEeC--CCC--EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 291 SNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
...++||+|.||+|++|.|. +|+ .||||.++.........+|.+|+..|.+++|+|++++||...+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999986 455 5899999877655566789999999999999999999999887 678899999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
++.|+|.+.|+. ..+..|.......++.|||.||.||.++ ++|||||..+|+|+-....|||+|||+.+.+...+
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999988 3345689999999999999999999999 99999999999999999999999999999887554
Q ss_pred Cceee--ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..... ...-.+.|+|||.+..+.++.++|||+|||++|||+| |+-||-.-. . .+. -+.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g---~qI----------L~~i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----G---IQI----------LKNI 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----H---HHH----------HHhc
Confidence 43221 1224668999999999999999999999999999999 788884221 1 111 1122
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
|....-..+..+.+.++++++.||..+|++|||+..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22223334566789999999999999999999999997443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=310.18 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=200.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 360 (613)
.+|.+.+.||+|+||+||++... ++..||+|.+.... ......+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999742 57899999986543 2334578899999999999999999998754 3567
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+++++|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999975432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc------CC-CcchHHHHHH
Q 007200 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------ND-DDVMLLDWVK 511 (613)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~------~~-~~~~~~~~~~ 511 (613)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... .. ........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 764332211 11122345699999998888999999999999999999988776422100 00 0000000011
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.... ..............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLK---------NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHh---------cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111 1100011122345799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.98 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=202.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999976 6899999999754322 22456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 365 PFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
||++||+|.+++..... .....++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123467788899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----------------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007200 438 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (613)
Q Consensus 438 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~ 500 (613)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986621110 0112245899999999999999999999999999999999999999632110
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 566 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 566 (613)
. . .. ... ...+.. .....+.+..+.+++.+|++.||++|| +++++++.|+.
T Consensus 238 --k--i-~~------~~~---i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 --K--I-SY------RDV---ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred --h--h-hh------hhh---ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 00 000 000000 000112345688999999999999996 56677777654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.85 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=203.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||.|++|.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999976 68899999987654444456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.++++.. ++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998754 489999999999999999999999 99999999999999999999999999998775432
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ...... ..... .+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~-~~~~~-----~~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFL-IPKNN-----PPS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHH-hhhcC-----CCC
Confidence 2 22334578899999999988899999999999999999999999963220 111111 11111 111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... .....+.+++.+||..+|++|||++++++
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1110 13456889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.20 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=200.1
Q ss_pred ccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcch
Q 007200 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (613)
+||+|.||+||.|++. +...+|||-+...... ...-+..||.+.+.++|+|||+++|.+.+++..-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 5999999999999976 4567899988654332 2334788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEeccccceecCCCCCceeec
Q 007200 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
++++..-.. -+-.+.+.-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+..- ...+..
T Consensus 661 sLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 999875432 1127888999999999999999999 999999999999997 4689999999999877543 334556
Q ss_pred cccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC
Q 007200 453 VRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (613)
+.||..|||||++..++ |.+++|||||||++.||.||++||...... . ..+.+-+..+ .-..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------q----AAMFkVGmyK------vHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------Q----AAMFKVGMYK------VHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------h----Hhhhhhccee------cCCC
Confidence 77999999999997764 889999999999999999999999532211 0 0122222111 1223
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 531 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 531 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+++...+...+|.+|+.+||.+||+|+++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 46677888999999999999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.60 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=197.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||+++.. +++.||+|.+.... .......+..|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 68899999986532 1222345788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..........|++.|+|||.+.+ +.++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCc
Confidence 33333334569999999999875 467889999999999999999999996322 11111111111100
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
.. .+ .........+.+++.+|+..++++ |++++++++.
T Consensus 227 ~~-----~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQ-----FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc-----CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 00 001122456788888888765544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.90 Aligned_cols=256 Identities=22% Similarity=0.350 Sum_probs=202.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|...+.||+|+||.||+|.+.+ ...||+|.............+..|+.+++.+.||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567888999999999999998643 246899988765544455678999999999999999999998865 56789
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
+|||+++|+|.+++.... ..+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
............++..|+|||.+....++.++||||||+++||+++ |+.||.... ......+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~---~~~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIGR---IENGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH---HHcCCcC--
Confidence 5432222222234568999999988889999999999999999986 999995322 1111111 1111111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+......+.+++.+|+..+|++|||+.++++.|++.
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122345789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.64 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=200.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.|+..+.||+|+||.||+|.+. +++.||+|.+...........+..|+++++.++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556678999999999999876 578899999875544444567889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.+++... ++++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 388999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..... . ... .......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~---~~~-~~~~~~~--------- 217 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----M---RVL-FLIPKNS--------- 217 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----h---hHH-hhhhcCC---------
Confidence 12234578899999999988899999999999999999999999852210 0 000 0011010
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011112234578899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.23 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=203.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
..|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677788999999999999976 58899999987654444456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999988642 378899999999999999999999 99999999999999999999999999997664332
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~----------~~~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFL----------IPKN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhh----------hhcC
Confidence 2 222345788999999998888999999999999999999999999532110 00000 0011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
............+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112233456778999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=314.69 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=191.2
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHH-HHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|+.. +|+.||+|++..... ......+..|.. +++.++||||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999976 689999999865422 122334555554 46778999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|..++.... ++++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998886543 389999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~-~--~~~----- 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKP-L--VLR----- 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCC-c--cCC-----
Confidence 234568999999999999999999999999999999999999995321 111111111111 0 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
......+.+++.+|++.+|++||++.+.++.+.
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 112356789999999999999999875544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.74 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=199.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999976 68899999987654444455678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. ++|.+++..... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 588888865432 388999999999999999999999 99999999999999999999999999997543322
Q ss_pred CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---ccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKLEQL 522 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 522 (613)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+..... .......
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 1 12233478899999998654 478899999999999999999999963221 111111111110 0000000
Q ss_pred cc---------CccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VD---------SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~---------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +..... ........+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000 00112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=303.46 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=202.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... ...+.+|+++++.++|+||+++++++.++...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578889999999999999999874 78999999865432 56789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999986543 3489999999999999999999999 99999999999999999999999999998664332
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.. .... ..
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~-~~~~-------~~ 216 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFM-IPNK-------PP 216 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhh-hccC-------CC
Confidence 2 223344788999999999889999999999999999999999999632210 00000 0000 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
............+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001112223457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.08 Aligned_cols=249 Identities=33% Similarity=0.470 Sum_probs=191.3
Q ss_pred CccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc-CCceEEEEeccc
Q 007200 294 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFMV 368 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 368 (613)
+.||+|+||.||+|.+. .+..+|+|.+...........+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999988654333345578889999999999999999998764 556789999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+|+|.++++.... ..++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999975432 267788899999999999999999 9999999999999999999999999999755322111
Q ss_pred ---eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 449 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 449 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
......++..|+|||.+.+..++.++|||||||++|||++| .+||... . ..............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~---~~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----D---SFDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----C---HHHHHHHHhcCCCC-----
Confidence 11123356789999999888899999999999999999995 5555311 1 11111111111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.81 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=206.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||+||++... +|+.||+|++...........+.+|++++..++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999976 6889999988765444445678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++...+ ++++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999887643 3899999999999999999999732 8999999999999999999999999998654321
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC---CcchHHHHHHHHhhccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND---DDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 522 (613)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......+ ......+++........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---- 230 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence 1 2234589999999999888899999999999999999999999974322111 11112222222221110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
+... .......+.+++.+|++.||++|||+.|+++..
T Consensus 231 --~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 --PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 112345788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.74 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=192.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 364 (613)
+|+..+.||+|+||+||+|... +|+.||+|++..... ......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999976 688999999875432 223345777888888776 577888999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987543 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . ........... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~---~~~~~~i~~~~-~----- 218 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----E---DELFQSIMEHN-V----- 218 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCC-C-----
Confidence 22 12234558999999999999899999999999999999999999996321 1 11111111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
..+......+.+++.+|++.+|.+|++..
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 01112335678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.89 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=203.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
..+|...+.||+|+||.||+|.+. +|+ .+|+|.+...........+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999865 333 5899988766554445678899999999999999999999987 7889
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++|||+.+|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999876432 389999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcee-eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||+... ..+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCCC
Confidence 653322211 11223568999999988889999999999999999998 999996321 11111111111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+..+...+.+++.+||..+|++||++.++++.|+..
T Consensus 231 ----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111224688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.19 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=203.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 364 (613)
++|+..+.||.|++|.||++.+. +++.+|+|.+...........+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999986 68899999987654444456789999999999999999999998653 4679999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988765333344589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+..............++.. .. ...+.+
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MP-NPELKD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CC-chhhcc
Confidence 21 123447889999999998899999999999999999999999997443211111122222211 11 111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .. ........+.+++.+||..+|++|||+.|+++
T Consensus 231 ~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 00 00123467899999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.21 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=196.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
...|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+||+++++++..+...+++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446889999999999999999976 578899996422 235689999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
++. ++|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 688888765322 489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc---chHHHHHHHHhh-ccccc
Q 007200 446 DT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD---VMLLDWVKGLLK-EKKLE 520 (613)
Q Consensus 446 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~ 520 (613)
.. .......||..|+|||++.+..++.++|||||||++|||++|..|+.......... ..+...+..... .....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 22 12234569999999999999999999999999999999999887653221111111 111111111000 00000
Q ss_pred cc----------------ccCccCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QL----------------VDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~----------------~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. ..+....... ......+.+++.+||+.||++|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000000000 0112367889999999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.11 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=209.0
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
|.++++||+|+||.||+|.++ +|..+|||.+..+. ...++..|+.++.+...|+||+++|.+......|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 455688999999999999977 79999999986543 45678899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
.|+..+.++.+.. ++++.++..++...++||+|||.. .-+|||||..|||++.+|.+|++|||.|..+... -.
T Consensus 112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 9999999987654 599999999999999999999998 8899999999999999999999999999765432 22
Q ss_pred eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc-ccCcc
Q 007200 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL-VDSDM 527 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 527 (613)
.+..+.||+.|||||+++.-.|+.++||||+|+...||..|++||..... -..+..+ ..+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------------MRAIFMIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------------MRAIFMIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------------cceeEeccCCCCC
Confidence 34556799999999999999999999999999999999999999952111 0111111 12223
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....++.....+-+++++|+-..|++|-|+.++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 334466778899999999999999999999998875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.36 Aligned_cols=251 Identities=31% Similarity=0.489 Sum_probs=197.8
Q ss_pred CccccCcCcEEEEEEeCC-------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999886654444456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-----cEEEecccc
Q 007200 367 MVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 438 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DfGl 438 (613)
+++++|.++++.... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 123478999999999999999999999 999999999999999887 899999999
Q ss_pred ceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 439 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 439 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||.... .......+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~~----~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQHV----TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHHH----hc
Confidence 9755332211 1122235678999999999999999999999999999998 999985221 11111111 11
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.. ........+..+.+++.+||..+|++||++.++++.|+
T Consensus 229 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 10 00112233467889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=308.06 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=198.8
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.|+..+.||+|+||.||++... +++.||+|.+....... ....+..|+.++..++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999976 68899999986543222 23456789999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865432 2489999999999999999999999 9999999999999999999999999998765422
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .............. .
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~~------~ 222 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEVQ------E 222 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhhh------h
Confidence 21 12345899999999999999999999999999999999999999632110 00011111111000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
.........+.+++.+||+.||++||| +.|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011122356889999999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=306.64 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=199.3
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHH-HHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|+..+.||+|+||+||+++.. +++.||+|++.......... ....|+.++++++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 56689999998764432222 3456999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.+++.... .+++..+..++.|+++||++||++ +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998332 389999999999999999999999 99999999999999999999999999997642 222
Q ss_pred ceeeccccccccccccccc-cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......++..|+|||.+. +..++.++||||+|+++|+|++|+.||.... .......+.............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~--- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPLPSSSQ--- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHHHHHTT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccccccccc---
Confidence 2334456899999999998 7889999999999999999999999996331 001111111111100000000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........+.+++..||+.||++|||+.++++
T Consensus 225 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011268999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.77 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=196.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+++.. +++.+|+|++.+.. .......+..|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999976 57889999986432 1222345788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976432 389999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCcc
Confidence 3333333456999999999986 3457899999999999999999999996321 11222222111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
.. .. .........+.+++.+|+..+++. |+++.|+++.
T Consensus 227 ~~-----~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ-----FP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----CC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00 001123456777888877554443 7889888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.38 Aligned_cols=200 Identities=23% Similarity=0.360 Sum_probs=173.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||+||++... +++.||+|+++... .......+..|+.++..++|+||+++++.+.++...++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 68899999997532 1223456788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCC
Q 007200 445 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (613)
Q Consensus 445 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~ 490 (613)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCcc
Q 007200 491 RAFD 494 (613)
Q Consensus 491 ~p~~ 494 (613)
.||.
T Consensus 234 ~Pf~ 237 (360)
T cd05627 234 PPFC 237 (360)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=310.37 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=201.7
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE--
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM-- 355 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-- 355 (613)
++.+....++|++.+.||+|+||.||++... +++.+|+|.+..... ....+..|+.++..+ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3444556789999999999999999999876 688999998764322 234677899999998 6999999999874
Q ss_pred ---cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 356 ---TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 356 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
.+...+++|||+++++|.++++........+++..+..++.|+++||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998865333334588999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~ 507 (613)
|+|||+++....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||..... .
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--------~ 235 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------M 235 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--------h
Confidence 999999986643222 2223458999999998753 4478899999999999999999999953211 0
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+....... ...... +......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 RALFKIPRNP-PPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHhhccccC-CCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1010100000 000001 11123468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.19 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=190.0
Q ss_pred ccccCcCcEEEEEEeCC---CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 295 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.||+|+||+||+|...+ ...+|+|.+...........+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887655444345568899999999999999999999999999999999999999
Q ss_pred chhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce-
Q 007200 372 VASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 449 (613)
Q Consensus 372 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~- 449 (613)
|.+++...... ....++.....++.||+.||+|||++ +|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 22356788899999999999999999 99999999999999999999999999987543222111
Q ss_pred eecccccccccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 450 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... .. +.......... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~---~~~~~~~~~~~-~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----DE---QVLKQVVREQD-IK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----HH---HHHHHHhhccC-cc
Confidence 122335678999998743 356889999999999999999 788885221 11 11111111111 11
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...+.. .......+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1223356677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.05 Aligned_cols=249 Identities=19% Similarity=0.307 Sum_probs=201.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.+|...+.||+|+||.||+|... +++.||+|.+...... ....+..|+.+++.++|+||+++++++..+...++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 67888999999999999999965 7899999998654332 345678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998643 378899999999999999999999 99999999999999999999999999997654332
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ...... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~~~--------~~~ 232 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIAT--------NGT 232 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeeecc--------CCC
Confidence 21 2234588899999999988899999999999999999999999963221000 000000 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.....+......+.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112223456789999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=308.93 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=205.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 360 (613)
+.|...+.||+|+||.||+|.+. ++..+|||.+...........+..|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777789999999999999854 3678999999765443345679999999999999999999999887 5678
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC------cchHHHHHHH
Q 007200 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD------DVMLLDWVKG 512 (613)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~------~~~~~~~~~~ 512 (613)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11223556799999998889999999999999999999999998643211100 0000111111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..... ........+...+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 238 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 11111122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=305.37 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=201.6
Q ss_pred CCCCCCccccCcCcEEEEEEeCC--CCEEEEEEecccc---------CcccHHHHHHHHHHHhh-cccCccceeeEEEEc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER---------TQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 356 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 356 (613)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 6789999885322 11123456778887764 789999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886533333458999999999999999999996 5 899999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhh
Confidence 99998655432 2334558899999999998889999999999999999999999996322 1111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...... . .......+.+++.+||+.||++||++.|+.+++++
T Consensus 228 -~~~~~~-----~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 -AVYEPL-----P---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -ccCCcC-----C---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111100 0 01123578899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.01 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=197.1
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
|+..+.||+|+||+||+|.+. +++.||+|.+...... .....+.+|++++..++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999976 6889999998654322 1234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++..... .++++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 3499999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+........
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-----~~~~~~~~~~~~~~~-------- 221 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVKREEVDRRVLETE-------- 221 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhhhccc--------
Confidence 1 2234589999999999988999999999999999999999999963210 000111111111100
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
..........+.+++..|++.||++||+ +.+++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0111223356789999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.74 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=191.1
Q ss_pred ccccCcCcEEEEEEeCCC---CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 295 ILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.||+|+||+||+|...++ ..+++|.+...........+.+|+.++..++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34667776654444445678999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC-cee
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVT 450 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 450 (613)
|.++++.........++..+..++.||++||+|||+. +++||||||+|||++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976543333467788899999999999999999 999999999999999999999999999864321111 112
Q ss_pred ecccccccccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 451 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 451 ~~~~gt~~y~aPE~~~~-------~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
....++..|+|||.+.. ..++.++||||||+++|||++ |..||.... ..+.+........ ..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~~-~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQQ-VKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhcc-ccc
Confidence 23457889999998753 235789999999999999997 566774211 1122222222211 222
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.++..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 2356778889999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.85 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=192.8
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhc---ccCccceeeEEEEc-----CC
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT-----PT 358 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 358 (613)
+|++.+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 68899999987543222 223455677766655 69999999998864 24
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..+++|||+.+ +|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999974 88888865432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc--
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-- 516 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 516 (613)
++...... ......|+..|+|||.+.+..++.++|||||||++|||++|++||.... .......+......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~-----~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIFDLIGLPP 227 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC-----HHHHHHHHHHHhCCCC
Confidence 98654321 1223457899999999998899999999999999999999999995221 11111111111100
Q ss_pred -ccccc-------cccCccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 -KKLEQ-------LVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 -~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... ...+... ..........+.+++.+|++.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=320.38 Aligned_cols=244 Identities=26% Similarity=0.435 Sum_probs=198.7
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEec---cccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc--eEEEEec
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLK---EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVYPF 366 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 366 (613)
...||+|+|-+||+|.+. +|..||--.++ ....+....+|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999976 57777754333 22333345789999999999999999999999988655 7899999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~ 445 (613)
|..|+|..|+++.+. .+.+.++.|++||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|.|+|+.+...
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 78899999999999999999998 6789999999999999865 89999999999987643
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. ..+.|||.|||||.+. ..|+..+||||||++|+||+|+..||..-. ....+...|.+-.++..+..+-|+
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCHHHhhccCCH
Confidence 32 2367999999999986 789999999999999999999999995211 112233333333444444444443
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
++.++|.+|+.. .++|||+.|+|.
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 588999999999 999999999987
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.21 Aligned_cols=193 Identities=25% Similarity=0.389 Sum_probs=164.9
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
....+|.+.+.||+|+||.||+|... +++.||+|...... ...|+.++++++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999976 57789999754322 34689999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
+||+. ++|.+++.... .++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 68888886543 2489999999999999999999999 99999999999999999999999999997532
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~ 493 (613)
.. .......||..|+|||.+.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 1223355899999999999999999999999999999999865554
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.25 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=202.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccc-cCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 362 (613)
+....|++.++||+||.+.||++...+.+.||+|++... ........|..|+..|.++. |.+|+++++|-..++..||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344568899999999999999999887788888877543 33444557999999999996 9999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||= ..+|..+|+...... ..| .++.+..|++.++.++|.+ ||||.||||.|+|+-++ .+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 99975 569999998866542 334 8899999999999999999 99999999999999875 9999999999988
Q ss_pred CCCCCc-eeeccccccccccccccccC-----------CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 443 DYKDTH-VTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
...... .....+||+.||+||.+... ..++++||||+|||||+|+.|++||.... . .|
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n--~~- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------N--QI- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------H--HH-
Confidence 765443 45567899999999998532 24678999999999999999999995111 0 11
Q ss_pred HHHhhcccccccccCccCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.++..+.++...-.++.. ....++++|+.||+.||++|||+.++++.
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 123344444321111110 11239999999999999999999999984
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.34 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=199.0
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+.+++.+.....||+|+||.||+|.+. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..++..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 445566666778999999999999965 6778999988654322 34578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEecccccee
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 441 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~ 441 (613)
++||+.+++|.++++..... ...++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999764221 1127888999999999999999999 9999999999999986 67999999999876
Q ss_pred cCCCCCceeeccccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
...... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ....+......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~---- 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFK---- 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhc----
Confidence 543222 122334789999999986643 788999999999999999999999532110 00011000000
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.....+......+.+++.+||+.+|++|||+.|+++
T Consensus 229 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001112233457889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.45 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=195.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 358 (613)
..++|...+.||+|+||.||++.+. +|..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999976 689999999875432 223456788999999999999999999986543
Q ss_pred -ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
..++||||+.+ ++...++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999975 55555532 278899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccC----------CCcchHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----------DDDVMLL 507 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~----------~~~~~~~ 507 (613)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754322 12233458999999999999999999999999999999999999996322100 0000000
Q ss_pred HH----HHHHhhccc-c-----cccccCc-c--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 508 DW----VKGLLKEKK-L-----EQLVDSD-M--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 508 ~~----~~~~~~~~~-~-----~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. +..+..... . .+....- . ...........+.+++.+|+..||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 0 0000000 0 000011123568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.28 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=200.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|+..+.||+|+||.||+|.+. +|. .+|+|.+...........+.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778899999999999999864 444 57899887654444445688999999999999999999998754 467
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999875432 388999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+++ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~----~~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLL----EKGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----HCCCC
Confidence 6433221 1122335678999999998899999999999999999997 899985221 11111111 11110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. .....+...+.+++..||..+|++||+++++++.|+..
T Consensus 230 --~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 --L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00111235688999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=301.42 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=202.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|+||.||+|... +++.+++|.+...... ....+..|+++++.++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888999999999999999975 5788999998755333 456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++.... .++++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987642 2489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ....... .... ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~-~~~~---~~ 222 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLI-SKSN---FP 222 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-Hhcc---CC
Confidence 122334578899999999776 788999999999999999999999953221 0000000 0000 00
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ...........+.+++.+||..+|.+|||+.+|+.
T Consensus 223 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 01112334567899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.67 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=205.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999865 68899999886543 333455788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997643 23489999999999999999999999 99999999999999999999999999998664433
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+......... ...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~-~~~----- 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGN-YTP----- 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-CCC-----
Confidence 2 2233458999999999988888999999999999999999999995321 112222221111 110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
........+.+++.+||..+|++||++.++++.+
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122345788999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.66 Aligned_cols=249 Identities=23% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--------cHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
+|.....||+|++|.||+|... +++.+|+|.+....... ....+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999875 68899999886543221 12457889999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++|||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 388899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-----ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 440 KLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 440 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHh
Confidence 86642211 111224478899999999988899999999999999999999999963210 01111110
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ...+.. +......+.+++.+||+.||++||++.|+++
T Consensus 226 ~------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 111111 1223467889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=307.84 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=200.6
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
++.++....+.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 44555556788999999999999999999975 68899999885432 2334678889988888 69999999999853
Q ss_pred ------CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 357 ------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 357 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
....+++|||+.+|+|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 4567999999999999999876432 2478889999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~ 505 (613)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------ 232 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------ 232 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------
Confidence 99999999875532221 123345889999999885 345788999999999999999999999532110
Q ss_pred HHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+..... ..............+.+++.+||+.||.+|||+.|+++
T Consensus 233 --~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 --RALFLIPR---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hhhhhHhh---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000000 00000011123467999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.49 Aligned_cols=252 Identities=32% Similarity=0.492 Sum_probs=202.2
Q ss_pred CCCCCccccCcCcEEEEEEeCC-----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 290 FSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+++.+.||.|+||.||++.... +..||+|.++..........+..|+.++..++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999763 37899999976654445668899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998764321 189999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ..............
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~---- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYLKKGYRL---- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCCC----
Confidence 32222212336789999999988889999999999999999998 788885211 11111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
.........+.+++.+|+..||++|||+.|+++.|
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112346789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=305.27 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=198.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46777889999999999999865 688999999865432 2334578899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++...+ .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999987543 389999999999999999999999 99999999999999999999999999987654322
Q ss_pred Cceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.......|+..|+|||.+. ...++.++|||||||++|+|++|+.||...... ..+....... . .
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~~-~---~ 227 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKSN-F---Q 227 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhccC-C---C
Confidence 1223345899999999874 455788999999999999999999998422100 0000000000 0 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+.... .......+.+++.+|++.+|++|||++++++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 0112346889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.69 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=195.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHH-HhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||.||++++. +|+.||+|+++..........+..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 6999999998765443334456666665 566789999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888877654333456999999999999999999999853 7999999999999999999999999998765322
Q ss_pred CCceeecccccccccccccccc----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .. .+.+.......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~---~~~~~~~~~~~---- 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----TP---FQQLKQVVEEP---- 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc----cC---HHHHHHHHhcC----
Confidence 1 1222457889999998865 456889999999999999999999995211 00 01111111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+... .......+.+++.+||..+|++||++.++++
T Consensus 225 --~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00110 1123457899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.77 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=186.8
Q ss_pred CccccCcCcEEEEEEeCC-------------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 294 NILGRGGFGKVYKGRLTD-------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
+.||+|+||.||+|.... ...+++|.+.... ......+..|+.++..++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2258888876543 22344678889999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-------EEE
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 433 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl 433 (613)
+++|||+.+|+|..++.... .++++..+..++.||++||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999998886533 2489999999999999999999999 9999999999999987664 899
Q ss_pred eccccceecCCCCCceeeccccccccccccccc-cCCCCCcccchhHHHHHHHHH-hCCCCcccccccCCCcchHHHHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwS~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||..... .+. .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-H
Confidence 999998654321 2234788999999886 466899999999999999997 58888752211 000 0
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.+.... . . ........+.+++.+||+.||++||++.+|++.++
T Consensus 220 ~~~~~~-~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQ-C-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcC-c-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111100 0 0 01112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=339.20 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=199.8
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc--CCc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 359 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 359 (613)
....++|.+.+.||+|+||+||+|.+. ++..+|+|.+..... ......+..|+.++..++||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999976 577899998875432 2234568899999999999999999998864 356
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceeecC--------
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD----PKIIHRDVKAANILLDE-------- 427 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~NIll~~-------- 427 (613)
.++||||+.+|+|.+++.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997643333459999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEeccccceecCCCCCceeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007200 428 ---------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (613)
Q Consensus 428 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~~~ 496 (613)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998654322 2233468999999999854 45889999999999999999999999522
Q ss_pred cccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .....+... .... ... .......+.++|..||+.+|.+||++.|++.
T Consensus 247 ~-------~~~qli~~l-k~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 N-------NFSQLISEL-KRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred C-------cHHHHHHHH-hcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 111222111 1110 000 0112356889999999999999999999984
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.15 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=197.0
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|++|.||+|+.. ++..||+|.++..... .....+..|+.++..++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999976 6889999998654322 2345678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 688888765432 23589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh--cc------
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--EK------ 517 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------ 517 (613)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||...... ............ ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcch
Confidence 122233478899999988654 4788999999999999999999999632110 000000000000 00
Q ss_pred ---cccccccCccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 ---KLEQLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ---~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........... .........++.+++.+||+.||++|||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0000112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.20 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=194.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc----ccHHHHHHHHHHHhhcccCccceeeEEEEcC--Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 360 (613)
.+|...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999875 6889999988643221 2234688899999999999999999988753 567
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997543 378999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCC--CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 441 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 441 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~~~- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQP- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhcCC-
Confidence 654221 111223447889999999998889999999999999999999999996221 111111111100
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+ ..+......+..++ .||..+|++||+++||++
T Consensus 226 ----~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ----TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011 11222334566666 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.00 Aligned_cols=245 Identities=30% Similarity=0.438 Sum_probs=200.8
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc--HHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
|..++.||.|+||.||.|++. +.+.||||++.....+.. ..++..|+..|.+++|||++.+.|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455677999999999999976 678999999976554433 34789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|- |+-.+++.-... ++.+.++..|..+.+.||+|||+. +.+|||||..|||+++.|.||++|||.|....+.
T Consensus 108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 95 577888766543 488999999999999999999999 9999999999999999999999999999876653
Q ss_pred Cceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..++|||.|||||++. .+.|+-++||||+||+..|+...++|+-... . +...++ +.+--
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--------A---MSALYH---IAQNe 241 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------A---MSALYH---IAQNE 241 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--------H---HHHHHH---HHhcC
Confidence 3467999999999985 5789999999999999999999999963111 0 111111 11111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.|.+. ..+....+.+++..|+++-|.+|||.++++..
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22222 34567789999999999999999999998864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.25 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=199.7
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+|...+.||+|+||.||+|...+|+.+|+|.+...... .....+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999888999999988643221 1234588899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
+||+++++|.+++.... ++++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997643 378999999999999999999999 99999999999999999999999999987543
Q ss_pred CCC-----CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 444 YKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 444 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~-~~~~~~~~~ 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAA-MFYIGAHRG 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHH-HHHhhhccC
Confidence 211 1112234588999999999988899999999999999999999999953210 000 000000000
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+.. .......+.+++.+||+.+|++||++.++++
T Consensus 226 ----~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ----LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.11 Aligned_cols=196 Identities=23% Similarity=0.376 Sum_probs=159.6
Q ss_pred CCccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceEEEEecc
Q 007200 293 RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFM 367 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 367 (613)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999865 467899999865432 2356789999999999999999998864 45678999998
Q ss_pred cCCcchhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEecccc
Q 007200 368 VNGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 438 (613)
Q Consensus 368 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGl 438 (613)
. ++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 47777765321 1123489999999999999999999999 99999999999999 4567899999999
Q ss_pred ceecCCCCC--ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 439 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 439 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 987643221 122345689999999998774 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=303.10 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=198.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|++.+.||+|+||.||+|... ++..+++|.+.... ......+..|+.+++.++|+||+++++++..+...++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888999999999999999976 58899999986542 22355688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|..++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999888765332 389999999999999999999999 99999999999999999999999999987543221
Q ss_pred Cceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.......++..|+|||.+. ...++.++|||||||++|||++|+.||.... ....+........
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~--- 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEP--- 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHhcCCC---
Confidence 1122345788999999984 3456889999999999999999999995321 0111111111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+.. .........+.+++.+||..+|++||++.++++
T Consensus 233 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ---PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 011123356889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.77 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=203.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 364 (613)
+|++.+.||.|+||.||++... ++..+|+|.+..... ......+..|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 688999999875432 3334568889999999999999999998764 35578999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
||+.+++|.+++........++++..+..++.|++.||+||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444456999999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....... ......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASK-IKEGKF 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHH-HhcCCC
Confidence 876543321 233458999999999998889999999999999999999999996322 1111111 111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+|++.+|++|||+.+|++.
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122344678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.89 Aligned_cols=249 Identities=18% Similarity=0.311 Sum_probs=201.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.+|...+.||.|+||.||+|... +|+.||+|.+...... ....+..|+.+++.++|+||+++++++......++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 45888899999999999999865 7899999998654332 345688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988643 388999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+....... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~-~~~----- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-TPE----- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-Ccc-----
Confidence 21 2234588899999999988899999999999999999999999963321 11111111100 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...+......+.+++.+||..||++|||+.+++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0011223356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.59 Aligned_cols=198 Identities=22% Similarity=0.306 Sum_probs=164.6
Q ss_pred CCCccccC--cCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 292 NRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 292 ~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
+.++||+| +|++||++..+ +|+.||+|++...... .....+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 67899999876 7899999999765432 23346778999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 2389999999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 448 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 448 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0 0112236778999999976 458899999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=325.48 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=208.2
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
....++||+|+||+||+|.+- .|+ +||+|++..........++..|+-.|.+++|||+++++|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 334578999999999999864 443 689999988777777788999999999999999999999998766 88999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
+||+.|+|.++++.+.. .+--...+.|..|||+||.|||++ .+|||||..+||||.+...+||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999988543 488899999999999999999999 999999999999999999999999999998865
Q ss_pred CCCceee-ccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 445 KDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 445 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.+..... ...-.+.|||-|.+....++.++|||||||++||++| |..|++... .+-+...++.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------~~eI~dlle~g----- 916 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------AEEIPDLLEKG----- 916 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------HHHhhHHHhcc-----
Confidence 5433322 2223568999999999999999999999999999988 889986332 12222222221
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+-.-++.+..++..++.+||..|++.||+++++...+..
T Consensus 917 ----eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ----ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ----ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1222244566789999999999999999999999888764
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.65 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=205.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|+||.||++.+. +++.+|+|.+...........+.+|+++++.++||||+++++++..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999987 68899999987765554556788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
+.+++|.+++.... .++++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997643 348999999999999999999999 7 9999999999999999999999999998755322
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.+........ +
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~------~ 222 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPP------P 222 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCC------C
Confidence 111 155888999999999999999999999999999999999999633211 1112222222211110 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .......+.+++..||..||++|||+.+++.
T Consensus 223 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111 1114467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=303.36 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=201.1
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCC-----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 358 (613)
.+++|++.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999986 678999998865432 345788999999998 6999999999997644
Q ss_pred -ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
..+++|||+++++|.++++........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876443334589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
++........ ......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ......
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~ 229 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALFK 229 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--------HHHHHH
Confidence 9876543222 2233458889999998753 3467889999999999999999999952210 011111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... . + ...........+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~~-~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNP-P-----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccC-C-----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11110 0 0 11112234567889999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.78 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=200.8
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc-CCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 365 (613)
+|++.+.||+|++|.||++... +++.||+|.+..... ......+..|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999976 578999999865432 2334568889999999999999999998764 445789999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++.... ..++++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997632 23489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. ......+++.|+|||.+.+..++.++||||||+++++|++|+.||.... .......... ....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~----- 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE-GKLP----- 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-cCCC-----
Confidence 22 2233458899999999999999999999999999999999999996221 1111111111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+......+.+++.+|++.+|++|||+.++++.
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.12 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=205.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+||+++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 68899999987655444556789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.++++.... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12489999999999999999999999 99999999999999999999999999987665432
Q ss_pred Cc---eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 447 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 447 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.. ......|+..|+|||.+... .++.++||||||+++|||++|+.||..... ....... ....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~----~~~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----MKVLMLT----LQND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh----hhhHHHH----hcCC-----
Confidence 22 22334588999999998877 789999999999999999999999963221 0011111 1110
Q ss_pred ccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+..... ........+.+++..|+..||++|||+.++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001100 01234467899999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.54 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=199.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+..+.||+|+||.||+|++. +|+.||+|++..... ......+..|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999987 689999999865432 2233467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998887765432 389999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 515 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 515 (613)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.....
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhhh
Confidence 22 2223447889999999876 4578899999999999999999999952211 001111111000
Q ss_pred --ccc-ccccccCccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --EKK-LEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --~~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ......+...... .......+.+++.+||+.+|++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000000000 0112466889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.69 Aligned_cols=266 Identities=19% Similarity=0.227 Sum_probs=196.1
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 357 (613)
..++|...+.||+|+||.||++.+. .++.||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 6889999998754322 2345677899999999999999999988643
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...+++|||+.+ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346999999965 56665542 278899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc----------c---
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD----------V--- 504 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~----------~--- 504 (613)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.......... .
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865322 12233458999999999999899999999999999999999999996322100000 0
Q ss_pred -hHHHHHHHHhhcc-cccccccCc------c--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 505 -MLLDWVKGLLKEK-KLEQLVDSD------M--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 505 -~~~~~~~~~~~~~-~~~~~~~~~------~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....+..+.... .......+. . ...........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000110000 000000000 0 000111123567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.80 Aligned_cols=266 Identities=19% Similarity=0.218 Sum_probs=195.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 357 (613)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999976 688999999875432 22345678899999999999999999987543
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...++||||+.+ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 356999999965 66666642 278899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC----------cchHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD----------DVMLL 507 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~----------~~~~~ 507 (613)
+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .....
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654321 223345899999999999999999999999999999999999999632210000 00000
Q ss_pred H----HHHHHhhccc-c-----cccccCcc---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 508 D----WVKGLLKEKK-L-----EQLVDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 508 ~----~~~~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. .+........ . ........ ...........+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000000 0 00000000 000011123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.86 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=197.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++..++|||++++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5688899999999999999975 57889999986542 235688999999999999999999998654 579999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999999976432 3488999999999999999999999 9999999999999999999999999998754321
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ .....
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~~------- 215 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECV-EKGYR------- 215 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHH-hCCCC-------
Confidence 112224568999999988889999999999999999998 999985322 11111111 11100
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.......+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00111234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.30 Aligned_cols=255 Identities=20% Similarity=0.347 Sum_probs=200.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|+||.||++... +|..||+|.++..........+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 78999999887554443445788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|..+++... ....+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999887532 1234899999999999999999999632 8999999999999999999999999998755322
Q ss_pred CceeeccccccccccccccccCC------CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... .......+...... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~-~-- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAIVDG-D-- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHHhhc-C--
Confidence 122234788999999985543 4789999999999999999999995321 11111111111110 0
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...........+.+++.+||+.+|++||++.++++.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011122345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.02 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=197.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
..+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|+++++.++||||+++++++......+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 457999999999999999999754 35789999876432 345899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||++. ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99985 6888888433 2489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc--
Q 007200 444 YKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE-- 520 (613)
Q Consensus 444 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 520 (613)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. +..........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~-i~~~~~~~~~~~~ 314 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRS-IIRCMQVHPLEFP 314 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHH-HHHHhccCccccC
Confidence 3322 12234569999999999999999999999999999999999999996432211 0001111 11111000000
Q ss_pred ---------------ccccCccCCC-C--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 ---------------QLVDSDMEGN-Y--IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ---------------~~~~~~~~~~-~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....+..... . .......+.+++.+|+..||++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0 00123467889999999999999999999984
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.41 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=200.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc---cCccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 364 (613)
.|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.+++.+. |||++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999975 789999999876544445567889999999886 999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.++++.. ++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988653 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..... ...... .... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~-----~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKS-----K 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccC-----C
Confidence 3322 2334588999999988654 468899999999999999999999963221 111100 0000 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+.... ......+.+++.+||+.||++||++.+++.
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111 113457889999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=302.11 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+..|+++++.++|+||+++++++..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888899999999999999975 68899999986442 2234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++..... ++++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999876432 489999999999999999999999 9999999999999999999999999998755332
Q ss_pred CCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.||.... ....+........
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-- 225 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKILKSEP-- 225 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHHhcCCC--
Confidence 22 223345889999999875 3446789999999999999999999996321 1111111111110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+.. ..+......+.+++..||+.+|++||++.++++.
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0112234568899999999999999999999773
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.43 Aligned_cols=237 Identities=23% Similarity=0.270 Sum_probs=182.9
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc---ccCccceeeEEEEcCCceEEEEecccC
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
||+|+||+||+|+.. +++.||+|++...... .....+..|..++... .||||+++++++.++...++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 6899999998643221 1223445566666554 699999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999887543 389999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 450 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~-~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAF-GKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHc-CCC------CCC
Confidence 3345699999999998765 47899999999999999999999995321 1111111111 110 001
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
. ......+.+++.+||+.||++||++.
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 0 01235678899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.95 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=194.1
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC-----
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 357 (613)
...++|...+.||+|+||+||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999975 6889999998754322 2234577899999999999999999987543
Q ss_pred -CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 358 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 358 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 4568999987 78888877532 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
|+++..... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~ 233 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEVVG 233 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHhC
Confidence 999865432 223458999999999877 4688999999999999999999999953211 001111100000
Q ss_pred ccc-----------cccccc--CccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 EKK-----------LEQLVD--SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ~~~-----------~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ...... +..... ........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000 000000 00011234789999999999999999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=303.23 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=202.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|++.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999976 689999999876543 23345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+ +++|.+++.... .++++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987644 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc--------
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 517 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 517 (613)
........++..|+|||.+.+. .++.++||||+|+++|||++|++||.... +.....++.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhc
Confidence 2223344588999999998654 46899999999999999999988874211 111111111111000
Q ss_pred ----cccccccCccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 ----KLEQLVDSDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ----~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.......+.... ....+....+.+++.+|++.+|++|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0001224778999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.92 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=201.0
Q ss_pred HHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC-
Q 007200 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP- 357 (613)
Q Consensus 281 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 357 (613)
.++..+.++|...+.||+|+||.||++... +++.+|+|.+..... ....+..|+.++.++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 334445788999999999999999999975 688999999865322 234677889999888 799999999998754
Q ss_pred ----CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 007200 358 ----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 358 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 433 (613)
...++||||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEE
Confidence 357999999999999998875433334589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCceeeccccccccccccccccCC-----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.||.... . ..
T Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-----~---~~ 240 (291)
T cd06639 170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-----P---VK 240 (291)
T ss_pred eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-----H---HH
Confidence 99999876543221 122345888999999986433 6889999999999999999999995221 0 01
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+....+. ....+. ........+.+++.+||+.+|++||++.|+++.
T Consensus 241 ~~~~~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKIPRN-PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHhcC-CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111 011111 112233568999999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.69 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=202.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|+||.+|++... +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999975 68899999987543 223345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875432 2378999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....|+..|+|||.+.+..++.++|||||||++++|++|+.||.... ..+.+........
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~-------- 218 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSY-------- 218 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCC--------
Confidence 11 223347889999999998889999999999999999999999996321 1122222211111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...+......+.+++.+||+.+|++||++.+|++.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00112234578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.78 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=200.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|...+.||+|+||+||+|... +++.||+|.+....... ....+..|++++..++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 58999999997654332 3456888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 23489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007200 445 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (613)
Q Consensus 445 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~ 496 (613)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 011235788999999999888999999999999999999999999632
Q ss_pred cccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 007200 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK----MSEVVR 562 (613)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 562 (613)
.. . ....... ...............+.+++.+|+..||++||| +.|+++
T Consensus 236 ~~----~----~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NR----D----ETFSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ch----H----HHHHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 0 1111111 111111111114567999999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.95 Aligned_cols=195 Identities=26% Similarity=0.379 Sum_probs=169.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-c-----CccceeeEEEEcCCce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-H-----RNLLRLRGFCMTPTER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~ 360 (613)
-+|++.+.||+|.||.|-+|.+. +++.||||+++....- ..+...|+.+|..++ | -|+|+++++|.-.++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 38999999999999999999866 6999999999865322 345677899999887 3 3799999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CcEEEecccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGL 438 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfGl 438 (613)
|||+|.+ .-+|.++++.....+ ++...++.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999988 459999998876544 99999999999999999999999 99999999999999754 3799999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
|+..... .. ...-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.
T Consensus 338 Sc~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 338 SCFESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9865422 22 4456789999999999999999999999999999999988884
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.57 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=196.4
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+..|+++++.++||||+++++++..+...++|+||+.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999976 57788999885432 2334568889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+++|..++.... .++++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999998876532 2489999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred eeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 449 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
......++..|+|||.+. +..++.++|||||||++|||++|+.||.... ..+.+......... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPP-TLA 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCCC-CCC
Confidence 223345889999999984 3457789999999999999999999995221 11111111111100 000
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+......+.+++..||+.||++||++.++++.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233578999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.59 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=196.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC----cccHHHHHHHHHHHhhcccCccceeeEEEEcC--Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 360 (613)
++|++.+.||+|+||.||.|... +|+.||+|.+..... ......+.+|+.++++++|+||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999976 588999998864321 11234678899999999999999999998764 457
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 378899999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCC--ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 441 LMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 441 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQP- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--------hHHHHHHHhcCC-
Confidence 5532211 11223458889999999988889999999999999999999999995221 001111111000
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....+......+.+++.+|+. +|++||+++|+++.
T Consensus 226 --------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111223344677888898985 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.68 Aligned_cols=239 Identities=25% Similarity=0.371 Sum_probs=184.7
Q ss_pred ccccCcCcEEEEEEeCC-------------------------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccce
Q 007200 295 ILGRGGFGKVYKGRLTD-------------------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 349 (613)
+||+|+||.||+|.... ...|++|.+..... .....+..|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999997421 23588898865432 23346788899999999999999
Q ss_pred eeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+++++.++...++||||+++|+|..++..... .+++..+..++.|+++||+|||++ +|+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999998865322 388999999999999999999999 999999999999998643
Q ss_pred -------cEEEeccccceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHH-HhCCCCcccccccC
Q 007200 430 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLEL-ITGQRAFDLARLAN 500 (613)
Q Consensus 430 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~el-ltg~~p~~~~~~~~ 500 (613)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3799999988643221 12247788999998865 5689999999999999998 479999853211
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...... ..... ..+. .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 228 ---~~~~~~----~~~~~-------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERF----YEKKH-------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHH----HHhcc-------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001111 11000 0111 11246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.90 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=196.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68899999987654333334567899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+ +|.+++..... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 89888875432 488999999999999999999999 99999999999999999999999999987543222
Q ss_pred Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---ccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EKKLEQL 522 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 522 (613)
.. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .......+..... .......
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhh
Confidence 11 122346789999999875 4578999999999999999999999953220 0000000000000 0000000
Q ss_pred ------c---c-----CccCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 ------V---D-----SDMEGNY-IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ------~---~-----~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. . ....... .......+.+++.+|++.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 0000000 0001256789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=298.42 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=188.8
Q ss_pred CccccCcCcEEEEEEeCCCC-----------EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 294 NILGRGGFGKVYKGRLTDGS-----------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976432 4778876544322 5678899999999999999999999988 77899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-------cEEEec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 435 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~D 435 (613)
||||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999976542 489999999999999999999999 999999999999999887 799999
Q ss_pred cccceecCCCCCceeeccccccccccccccccC--CCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
||++..... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||..... ..+...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHH
Confidence 999986543 2223467789999999876 78999999999999999999 5777753210 011111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...... ... .....+.+++.+||..+|++|||+.++++.|+
T Consensus 219 ~~~~~~--------~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR--------LPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC--------CCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100000 000 01167899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=298.46 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=199.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC----cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+|...+.||+|+||.||+|... +++.|++|.+..... ......+..|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999977 789999998864331 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
+||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ...............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~-- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP-- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC--
Confidence 332 223445888999999987766 8899999999999999999999995321 111111111101110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+......+.+++.+||+.+|++||++.++++
T Consensus 222 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111123467889999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=301.94 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
-|...+.||+|+||.||+|... +++.||+|.............+.+|+..+..++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999875 688999998865444444557889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998643 388999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.... .......... ... +
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~-----~-- 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLIPK-NNP-----P-- 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHHhc-CCC-----C--
Confidence 1223457889999999988888999999999999999999999995221 0111111111 100 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 --TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.40 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=195.5
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|+||.||+|++. +|+.||+|.++..... .....+..|+++++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999976 6899999998754322 2234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. ++|.+++.... ..+++..+..++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 47777776432 2389999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc------c
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------L 519 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 519 (613)
. ......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+..... .......+........ +
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC----HHHHHHHHHHHhCCCChHHhHHh
Confidence 1 122334788999999987654 68999999999999999999998742211 0011111111100000 0
Q ss_pred cccccC----ccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDS----DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....+. .... .........+.+++.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 001123467789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=303.11 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=186.9
Q ss_pred CccccCcCcEEEEEEeCC--------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
+.||+|+||.||+|.... ...+|+|.+.... ......+..|+.+++.+.||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998642 2348888775432 2234467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--------EEEeccc
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 437 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~DfG 437 (613)
|+.+|+|.++++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999976543 489999999999999999999999 9999999999999987765 6999999
Q ss_pred cceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCC-CCcccccccCCCcchHHHHHHHHhh
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
++...... ....++..|+|||.+.+. .++.++||||||+++|||++|. .||.... . .... ....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~---~~~~-~~~~ 219 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----S---QKKL-QFYE 219 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----H---HHHH-HHHH
Confidence 88654321 224478899999999764 5789999999999999999995 5553211 0 0100 0111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.. ... +.....++.+++.+||+.||++|||++++++.|+
T Consensus 220 ~~-------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DR-------HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc-------ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011 1112356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.73 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=198.5
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc---------cHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG---------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
+|...+.||+|+||.||+|... +|+.+|+|.++...... ....+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 68899999886432110 1235778999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+.+++|.++++..+ ++++..+..++.|++.||.|||++ +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997653 488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC-ceeeccccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 439 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 439 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
++....... .......|+..|+|||.+.... ++.++||||||+++||+++|+.||.... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHHhhc
Confidence 976432211 1123345888999999987654 7899999999999999999999995221 0111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... ...............+.+++..||..+|++|||+.++++.
T Consensus 227 ~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccc-----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 110 0111111112335678999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.87 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=199.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+..+.||+|+||.||+|.+. +++.||+|.+....... ....+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 58899999886543322 34567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.++++..+..... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999888765432 389999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc--------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 516 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 516 (613)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|++||.... .......+......
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-----DIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc-----hHHHHHHHHHHhCCCchhhHHH
Confidence 32 22334578899999998753 46889999999999999999999985221 00000000000000
Q ss_pred ---cc-ccccccCccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 ---KK-LEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ---~~-~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ......+..... ........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000000000 01123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=298.09 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=200.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|...+.||+|+||.||+|... +++.|++|.++..... .....+..|+++++.++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999865 6889999998765432 2456789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987643 378899999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccee---eccccccccccccccccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 447 THVT---TAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 447 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.... ....++..|+|||.+.+.. .+.++||||||+++||+++|+.||.... ... ....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~---~~~~~~~-~~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEF---QIMFHVG-AGH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chH---HHHHHHh-cCC--
Confidence 2221 1345788999999998766 7899999999999999999999996321 000 1000000 000
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+..+. .......+.+++..||+.+|++|||+.+++.
T Consensus 224 ---~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001110 1112456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.00 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=196.4
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
|.....||+|+||.||++... ++..||||.+.... ......+..|+..+..++|+||+++++.+..++..+++|||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333467999999999999875 68899999886433 2234568899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988542 378999999999999999999999 999999999999999999999999999875543222
Q ss_pred eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... . ...+.... . .......
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~-~-----~~~~~~~ 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----P---LQAMRRIR-D-----NLPPRVK 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH-h-----cCCCccc
Confidence 1223458899999999988889999999999999999999999995321 1 11111110 0 0111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. .......+.+++..|+..||++|||++++++.
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11223467889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.85 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=211.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.-|.+.+.||+|.|++|-+|++- +|.+||||++.+..... ....+.+|+..|+.++|||||++|++.......|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999855 89999999998765443 34568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEeccccceecCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~ 444 (613)
.-.+|+|++|+-.+... +.+...++++.||+.|+.|+|+. .+|||||||+||.+- +-|-||+.|||++-.+.+
T Consensus 98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999776543 99999999999999999999999 999999999998765 568899999999976654
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
. ..-...+|+..|-|||++.+..| .+++||||+|||||-|+.|++||+.+. ..+.+..++
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-----------------DSETLTmIm 232 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-----------------DSETLTMIM 232 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-----------------chhhhhhhh
Confidence 3 33455679999999999999877 578999999999999999999997443 223344556
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
|... ..+.....++.++|..|+..||.+|.+.+||..
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 6543 346677788999999999999999999999876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=298.10 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=200.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+|+..+.||+|+||.||+|... +++.||+|.+...... .....+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999864 7899999998644321 123568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEecccccee
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 441 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~ 441 (613)
|+||+.+++|.+++.... ++++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997643 488999999999999999999999 999999999999998775 599999999876
Q ss_pred cCCCCC---ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 442 MDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 442 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIAS--- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhc---
Confidence 643211 112234578899999999888899999999999999999999999953221 111111111100
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......+......+.+++.+|+..+|++|||+.++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111222334567889999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=296.59 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=200.5
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|+||.||++... +++.+|+|.+.... .......+..|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 68899999986543 223355788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~ 445 (613)
+++++|.+++.... ...+++..+..++.++++||+|||++ +++|+||+|+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 23489999999999999999999999 99999999999999865 46899999999876433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ...+....... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~-~~~---- 220 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGT-FAP---- 220 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcC-CCC----
Confidence 21 2234578899999999988899999999999999999999999963221 11111111110 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........+.+++..||+.+|++|||+.|+++.
T Consensus 221 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 -----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=299.89 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=197.7
Q ss_pred CCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 290 FSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
|.+.+.||+|+||.||+|.+. ++..||||.+..... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999854 367899999876432 233556889999999999999999999886532
Q ss_pred ceEEEEecccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 359 ERLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
..+++++|+.+|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875322 1222478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007200 437 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 437 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||.... ......++ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~---~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYL---I 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHH---H
Confidence 999865432211 1122335678999999998889999999999999999999 888885221 11111111 1
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 ~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 0112345799999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=297.42 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=207.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|++|.||+|... +++.|++|++...........+..|+.++..++|+|++++++++..+...+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999987 58999999987665434456789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
+++++|.+++... .++++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 248999999999999999999999 8 9999999999999999999999999999866533
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.+........ .
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~------~ 221 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPP------P 221 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCC------C
Confidence 322 2234578899999999998899999999999999999999999963321 111122222111110 0
Q ss_pred ccCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..... ....+.+++..|+..+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 34689999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=322.44 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=191.0
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhccc------CccceeeEEE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH------RNLLRLRGFC 354 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~ 354 (613)
++....++|.+.+.||+|+||+||+|.+. +++.||||+++.... ....+..|+.++..++| .+++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455688999999999999999999976 578899999864321 22345567777766654 4588899988
Q ss_pred EcC-CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCC---
Q 007200 355 MTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEF--- 429 (613)
Q Consensus 355 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~--- 429 (613)
..+ ...++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5678999987 778888886543 38999999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 007200 430 -------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (613)
Q Consensus 430 -------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~ 496 (613)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 223456999999999999999999999999999999999999999632
Q ss_pred cccCCCcchHHHHHHHHhhc-----------cccccccc------CccCC---------C--CcHHHHHHHHHHHHHccC
Q 007200 497 RLANDDDVMLLDWVKGLLKE-----------KKLEQLVD------SDMEG---------N--YIEEEVEQLIQVALLCTQ 548 (613)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~---------~--~~~~~~~~l~~li~~cl~ 548 (613)
. .......+...... .....+.+ +.... . ........+.+++..||+
T Consensus 349 ~-----~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 349 D-----NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred C-----hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 2 11111111111000 00000000 00000 0 000112457899999999
Q ss_pred CCCCCCCCHHHHHH
Q 007200 549 GSPMERPKMSEVVR 562 (613)
Q Consensus 549 ~dP~~RPt~~evl~ 562 (613)
.||++|||++|+++
T Consensus 424 ~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 424 YDRQKRLNARQMTT 437 (467)
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999997
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.76 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=196.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
+++|...+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++|+||+++++++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999875 6889999998765444444567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+. +++.+++.... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 67776665432 2377888999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 515 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 515 (613)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+..... ......+.....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHcCCCChhhhhh
Confidence 21 12233478899999998764 4788999999999999999999999632210 000000000000
Q ss_pred ----cccccccccCccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 ----EKKLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ----~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
................ .......+.+++.+|+..||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 0011356789999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.43 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=201.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+..+.||+|+||.||+|.+. +++.||+|.++.... ......+.+|+++++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 588999998875432 2234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.++.+..+.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 2388999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 515 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 515 (613)
.........++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhh
Confidence 33233345578899999999888 789999999999999999999999953211 011111111000
Q ss_pred ---ccccc--ccccCccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 ---EKKLE--QLVDSDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ---~~~~~--~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... ........ ..........+.+++++||..+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000000 0011122577899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.07 Aligned_cols=250 Identities=19% Similarity=0.305 Sum_probs=201.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|...+.||+|+||.||++... ++..||+|.+...... ....+..|+.+++.++||||+++++++..++..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888999999999999999865 6789999998643322 345688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998653 278899999999999999999999 99999999999999999999999999987654333
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......+++.|+|||.+....++.++||||||+++|++++|+.||...... ..+...... ..
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~--------~~ 232 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATN--------GT 232 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhcC--------CC
Confidence 2 223345888999999998888999999999999999999999999632210 000000000 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
............+.+++..||..+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.27 Aligned_cols=195 Identities=24% Similarity=0.386 Sum_probs=158.6
Q ss_pred CccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceEEEEeccc
Q 007200 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFMV 368 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 368 (613)
.+||+|+||+||+|+.. ++..||+|.+..... ...+.+|+++++.++||||+++++++.. +...+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999965 357899998865432 2357789999999999999999998854 466789999986
Q ss_pred CCcchhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEeccccc
Q 007200 369 NGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (613)
Q Consensus 369 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGla 439 (613)
+ +|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777664321 1123488999999999999999999999 99999999999999 56679999999999
Q ss_pred eecCCCCCc--eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 440 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 440 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
+........ ......||+.|+|||.+.+. .++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 866433211 12334589999999998764 578999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.77 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=195.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+.|...+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+++++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999976 688999998864332 222346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+. |++.+++.... .++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 56666665432 2489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
. ....++..|+|||.+. ...++.++||||||+++|||+||+.||..... ..........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~----- 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN----- 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcC-----
Confidence 2 2234788999999874 45688899999999999999999999852210 0111111100
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.............+.+++.+||+.+|++||++.+++..
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 ----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.62 Aligned_cols=257 Identities=20% Similarity=0.288 Sum_probs=201.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|...+.||+|+||.||++... +++.||+|.+..... ......+..|++++..++||||+++++.+..+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999976 578999999875432 222346778999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.++++..+ ++++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999864211
Q ss_pred CCC--------------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 445 KDT--------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 445 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 100 01112347889999999988889999999999999999999999995211 11111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
....... ...+... ......+.+++.+||+.||++||++.++.+.|+..
T Consensus 226 ~~~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 GQVISDD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHhcc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111111 0001000 12335689999999999999999987777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.25 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=195.7
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
...||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++||||+++++++..++..++++||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 457999999999999975 689999999865432 234568889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceee
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 451 (613)
|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99877542 388999999999999999999999 999999999999999999999999999875443221 223
Q ss_pred ccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCC
Q 007200 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531 (613)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (613)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||.... . ...+.... ....... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~---~~~~~~~~-~~~~~~~-------~~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-----P---VQAMKRLR-DSPPPKL-------KN 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHh-ccCCCCc-------cc
Confidence 3458899999999988889999999999999999999999995221 1 11111111 1100000 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 532 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 532 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.......+.+++.+|++.+|++||+++++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.82 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=198.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+|...+.||+|+||.||+|... +|+.||+|.++..... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999976 6899999999755432 1234567899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+ +++|.+++.... ..+++..+..++.||++||+|||++ +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997643 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc-----
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK----- 517 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 517 (613)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||.... .......+.......
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-----DIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-----cHHHHHHHHHHcCCCchhhh
Confidence 43222 222346788999998865 457899999999999999999988775221 111111111100000
Q ss_pred ----cccccccCccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 ----KLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ----~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
............. ........+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 011234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=300.96 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=195.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|...+.||+|+||.||++... +++.+|+|.+...........+..|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34556678999999999999976 689999999876544444567889999999986 9999999999999999999999
Q ss_pred cccCCcchhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 366 FMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 366 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|+.. ++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 544433211 111234899999999999999999999732 899999999999999999999999999875432
Q ss_pred CCCceeeccccccccccccccccC---CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
... .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+.+........
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~--- 228 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGDP--- 228 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCCC---
Confidence 211 1223478899999998776 68899999999999999999999995221 11111111111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+.............+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.49 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=199.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|+..+.||+|+||.||++.+. +++.+|+|.+..... ......+.+|+++++++.||||+++++++.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999976 689999999865432 223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987653 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... . ......... ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----P---IQIYEKILE-GK------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHhc-CC------
Confidence 3 233458899999999988888999999999999999999999995322 0 111111111 10
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
... +......+.+++.+||..||.+|| +++|+++
T Consensus 215 ~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011 111245788999999999999999 6777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.13 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 363 (613)
++|+..+.||+|+||.||+|.+. +++.+|+|.++..... .....+.+|+.++.+++||||+++++++..+ ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999987 6889999998754322 2233567899999999999999999998877 889999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+ +|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 88888865432 489999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh-------
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK------- 515 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 515 (613)
..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+.....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-----IDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchHHH
Confidence 43221 22334788999999987654 68899999999999999999999963221 000000000000
Q ss_pred --------c--ccccccccCccCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --------E--KKLEQLVDSDMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --------~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ..............+... ....+.+++..||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000011111111 2466889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.11 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=203.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
..+.|+..+.||+|++|.||+|.+. ++..+++|.+..... ....+..|++++..++|+||+++++++..+...++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4466888889999999999999987 688999999875443 3556889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999999875543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . ......... ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~~~~~-- 236 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-----P---LRALFLITT-KGIPPL-- 236 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHh-cCCCCC--
Confidence 221 2223347889999999988889999999999999999999999985211 1 011111111 100000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+.+++.+|++.+|.+|||+.++++
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 -----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011123467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.35 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=199.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
+|+..+.||+|++|.||+|+.. +|+.||||.++..........+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 688999999976654444556778999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+ +|.+++..... ..++++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888765442 23589999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh--hccccccc--
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--KEKKLEQL-- 522 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-- 522 (613)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||..... ............ ....+..+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHHHhc
Confidence 12234478899999988664 468899999999999999999999963221 000000000000 00000000
Q ss_pred ---ccCccC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 ---VDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ---~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... ....+.....+.+++..|++.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=328.07 Aligned_cols=265 Identities=27% Similarity=0.416 Sum_probs=214.4
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC----C----CCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT----D----GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 352 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 352 (613)
.+++..++..+.+.+|+|.||.|++|... . ...||||.++..........+..|+++++.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56677777777789999999999999743 1 3469999999887776778899999999988 4999999999
Q ss_pred EEEcCCceEEEEecccCCcchhhhhccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007200 353 FCMTPTERLLVYPFMVNGSVASCLRERG---Q-------SQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 420 (613)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 420 (613)
+|.+....++|+||+..|+|.++++... . .. ..++..+...++.|||.|++||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 01 2389999999999999999999999 999999999
Q ss_pred CceeecCCCcEEEeccccceecCCCCCceeecccc--ccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccccc
Q 007200 421 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (613)
Q Consensus 421 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~ 497 (613)
+|||++++..+||+|||+|+............-.| ...|||||.+....|+.++|||||||+|||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999665444443222222 456999999999999999999999999999999 888884200
Q ss_pred ccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+.+ .++.+ .....+..+..++.++|+.||+.+|++||++.++.+.++.
T Consensus 527 ----~~~~l~~----~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 ----PTEELLE----FLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred ----cHHHHHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0111111 22222 1222234456789999999999999999999999999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.19 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|++|.||+|+.. +|+.||||.+..... ......+..|++++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999976 688999998875432 22335688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 688888865432 3489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc--------
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 517 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 517 (613)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.... ................
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 122234688999999887654 5889999999999999999999995221 1011111111000000
Q ss_pred -------cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 -------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......... ..........+.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=292.13 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=206.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|...+.||+|+||.||++.+. ++..+|+|++...... .....+..|+++++.++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999976 6889999998765432 3455788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.++++........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543334699999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ..+........ ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~----- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKG-QYPP----- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcC-CCCC-----
Confidence 22333458889999999988889999999999999999999999995322 11111111111 1111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+......+.+++.+||..+|++|||+.++++.
T Consensus 223 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=311.55 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=200.0
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCC-EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.|++...||.|+||+||+|+.++.. ..|.|++.. .......++.-||++|+..+||+||++++.|.-++..|+..|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3455667999999999999987444 446666643 33445668999999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.||-+...+-.-+ .++.+..+..+.+|++.||.|||++ +|+|||||+.|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STR 184 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHH
Confidence 9999998886654 3599999999999999999999999 99999999999999999999999999885432 223
Q ss_pred ceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 448 HVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.....+.|||+|||||+.. ..+|+.++|||||||+|.||..+.+|..... ....+..+.+.+.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSeP---- 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEP---- 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCC----
Confidence 3455678999999999874 5689999999999999999999999974221 1111111111111
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+. -.-+......+.+++..|+..||..||+++++++.
T Consensus 253 --PT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 --PT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --Cc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 01 11244566789999999999999999999999874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.16 Aligned_cols=274 Identities=20% Similarity=0.262 Sum_probs=189.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCC--CCEEEEEEec--------------cc--cCcccHHHHHHHHHHHhhcccCc
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLK--------------EE--RTQGGELQFQTEVEMISMAVHRN 346 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~--------------~~--~~~~~~~~~~~e~~~l~~l~h~n 346 (613)
...++|.+.+.||+|+||+||++..+. +..+++|.+. +. ........+.+|+.++..++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987542 2222222111 00 11112345789999999999999
Q ss_pred cceeeEEEEcCCceEEEEecccCCcchhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 007200 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (613)
Q Consensus 347 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 425 (613)
|+++++++...+..+++++++. ++|.+++...... ........+..++.||+.||+|||++ +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 5677766443211 11234567788999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007200 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~ 505 (613)
+.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|..++..... ......
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHHHH
Confidence 9999999999999987654433333445699999999999999999999999999999999998865421110 011111
Q ss_pred HHHHHHHHhh-ccc-------ccccccCc-c--CCCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 506 LLDWVKGLLK-EKK-------LEQLVDSD-M--EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 506 ~~~~~~~~~~-~~~-------~~~~~~~~-~--~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+...+..... .+. +...++.. . ...... .....+.+++.+|++.||++|||+.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111110000 000 00000000 0 000000 112356788999999999999999999873
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.70 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=195.8
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||.|++|.||+++.. +++.+|+|.+...... .....+..|+.+++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 5889999998754322 3345788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++.... .+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 388999999999999999999999 99999999999999999999999999998665332 2233
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ........... .......+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~~~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILK---------GNGKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhc---------cCCCCCCC
Confidence 4578899999999888899999999999999999999999963221 11122221111 00111112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222467999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.91 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=197.9
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
|...+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++..++|+||+++++++..++..++++||+.
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 445678999999999999965 688999998864322 234567889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+++|.+++... ++++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999998762 388999999999999999999999 999999999999999999999999998875433221
Q ss_pred eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ........... .. +...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~-~~-----~~~~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN-LP-----PKLK 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc-CC-----CCCc
Confidence 2233458899999999988889999999999999999999999985221 11222211111 00 0000
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........+.+++.+||+.+|++|||+.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01113357899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.99 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=204.6
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|++.+.||+|+||.||++... +++.+|+|.+..... ......+..|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999866 688999999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876443345689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ... .........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~-~~~~~~~~~------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDL-RYKVQRGKY------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH-HHHHhcCCC-------
Confidence 22234478899999999998899999999999999999999999963221 011 111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+|++.+|++|||+.++++.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122445679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=296.19 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=201.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
+|.+.+.||.|+||.||+|.+. +++.||+|.+...... .....+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 6899999999754322 235678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.+++... .++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998764 2488999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...++......
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc---------
Confidence 2 223345888999999998888999999999999999999999999633211 11222111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKM--SEVV 561 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 561 (613)
.....+......+.+++.+||+.||.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011122234678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=294.31 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=193.6
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcC--CceEEEEe
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 365 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 365 (613)
|++.+.||+|+||.||+|... +++.||+|.++.............|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999976 688999999876543333334557888888885 99999999999987 88999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+. +++.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 57777776533 2489999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 515 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 515 (613)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ......+......
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHh
Confidence 22 122447889999997654 557889999999999999999999995322 1111111111110
Q ss_pred --cccccccccCccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --EKKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+..... ........+.+++.+||+++|++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 01133578999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.10 Aligned_cols=272 Identities=23% Similarity=0.383 Sum_probs=206.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 365 (613)
++.+....||.|..|.|++++.. +|...|||.+..........++...++++.+.+ .|.||+.+|||..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 33444567999999999999977 588999999988776666677888888877665 8999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
.|.. .+..+++... .++++..+-++...++.||.||.++. +|+|||+||+|||+|+.|++|++|||++.++-..
T Consensus 172 lMs~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9844 4555555433 24899999999999999999999875 8999999999999999999999999999876432
Q ss_pred CCceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.......|.+.|||||.+.- ..|+-++|||||||.++||.||+.||..-. .+ .+.+...+.++. ..
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----td---Fe~ltkvln~eP--P~ 314 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TD---FEVLTKVLNEEP--PL 314 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----cc---HHHHHHHHhcCC--CC
Confidence 23344559999999999854 358889999999999999999999996321 11 122222222221 11
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh---hcCCcchhhHHHhhhhhh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML---EGDGLAERWEEWQKEEMF 582 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L---~~~~~~~~~~~~~~~~~~ 582 (613)
+.. .......+.+++..|+..|+.+||...++++.= .-+.+.-+-..|+.+...
T Consensus 315 L~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~ 371 (391)
T KOG0983|consen 315 LPG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMA 371 (391)
T ss_pred CCc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHh
Confidence 111 112456789999999999999999999998752 112333344555555543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.18 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=201.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|+||.||++... +|..+|+|.+..... ......+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999976 588999999865432 22345688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 445 (613)
+.+++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 2479999999999999999999999 999999999999999885 4699999999766433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+++....... .. +
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~----~ 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGY-FA----P 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccc-CC----C
Confidence 22 2223458889999999988889999999999999999999999995321 122222222111 11 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........+.+++.+|+..+|++|||+.++++.
T Consensus 222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011223578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=296.98 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCc-----
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 359 (613)
++|+..+.||+|+||.||+|.+. +++.||+|.++..... .....+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 6899999988654322 22346788999999995 6999999999887655
Q ss_pred eEEEEecccCCcchhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEeccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 437 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG 437 (613)
.+++|||+++ +|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 788887654322 34589999999999999999999999 9999999999999998 8899999999
Q ss_pred cceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh-
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK- 515 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 515 (613)
+++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.... . ......+..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-----~---~~~~~~~~~~ 227 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-----E---LQQLLHIFKL 227 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-----H---HHHHHHHHHH
Confidence 99765432211 122346788999998865 457899999999999999999999995321 0 011111110
Q ss_pred --ccc---cccc---cc----CccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 --EKK---LEQL---VD----SDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 --~~~---~~~~---~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .... .+ +... ....+.....+.+++..||..||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000 00 0000 0001123466889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.43 Aligned_cols=263 Identities=20% Similarity=0.329 Sum_probs=195.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 360 (613)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+...........+..|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999865 68999999986543333445678899999999999999999987654 357
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++++||+.+ ++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999964 777776542 389999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCc--eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 441 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 441 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 65432211 1123458899999998755 4688999999999999999999999953211 11111111111100
Q ss_pred ---cccccccCc-------cC--CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 ---KLEQLVDSD-------ME--GNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ---~~~~~~~~~-------~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+..+.+.. .. ... .+.....+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00 000 01124568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.86 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=197.7
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEEEe
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 365 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 365 (613)
|++.+.||+|+||.||+|+.. +++.+|+|.+.... .......+..|+++++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567788999999999999977 58899999998654 222345688899999999999999999999988 88999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+ +|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8888876542 2489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc---cccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KLEQ 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 521 (613)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+....... ....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-----ELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCchhhccc
Confidence 3222333446888999998765 457899999999999999999999996322 111111111111000 0000
Q ss_pred c--------ccCcc------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 L--------VDSDM------EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~--------~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ..... .......+...+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000 00000012567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=308.66 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=198.4
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC------CceEE
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERLL 362 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 362 (613)
+...+.||+|+||.||+|+.+ +|+.||||.++........++..+|++++++++|+|||++.++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 89999999999877666777889999999999999999999975543 35689
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC--cEEEecccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGL 438 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DfGl 438 (613)
+||||.+|||...++.-. ....+++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999997643 334599999999999999999999999 999999999999984 333 469999999
Q ss_pred ceecCCCCCceeeccccccccccccccc-cCCCCCcccchhHHHHHHHHHhCCCCcccccccC-CCcchHHHHHHHHhhc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-DDDVMLLDWVKGLLKE 516 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 516 (613)
|+.++... ...+.+||..|++||.+. .+.|+..+|.|||||++||++||..||....... ..+ ..|..-..+.
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~---~~~~~~tkkp 245 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE---IMWHIITKKP 245 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch---hhhhhhccCC
Confidence 99876443 567788999999999998 4889999999999999999999999996433211 111 1222111112
Q ss_pred ccccccccCccC------------CCCcHHHHHHHHHHHHHccCCCCCCCC
Q 007200 517 KKLEQLVDSDME------------GNYIEEEVEQLIQVALLCTQGSPMERP 555 (613)
Q Consensus 517 ~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RP 555 (613)
..+.....+..+ ..........+-+.+..++..+|++|-
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 222222222221 112334445666777778888899887
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.07 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=193.1
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC------
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 357 (613)
....+|+..+.||+||||.||+++.+ +|+.||||++...........+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999988 89999999998766454556788999999999999999997542100
Q ss_pred --------------------------------------------------------------------------------
Q 007200 358 -------------------------------------------------------------------------------- 357 (613)
Q Consensus 358 -------------------------------------------------------------------------------- 357 (613)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007200 358 ---------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404 (613)
Q Consensus 358 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 404 (613)
...|+-||||+..++.++++..... -.....++++++|++||+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHH
Confidence 0137889999998888888765421 1467889999999999999
Q ss_pred HHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC----C-------------CCCceeecccccccccccccccc
Q 007200 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----Y-------------KDTHVTTAVRGTIGHIAPEYLST 467 (613)
Q Consensus 405 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~ 467 (613)
+|++ |||||||||.||++++++.|||+|||+|+... . ......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 0 01112345669999999999976
Q ss_pred CC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC--CcHHHHHHHHHH
Q 007200 468 GK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN--YIEEEVEQLIQV 542 (613)
Q Consensus 468 ~~---~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 542 (613)
.. |+.|+|+||+|||++||+. ||... |.+-..+..+-+..++.. +..+....=.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----------------MERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS----------------MERASILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCch----------------HHHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence 54 9999999999999999996 56421 111112222222222222 122223344688
Q ss_pred HHHccCCCCCCCCCHHHHHH
Q 007200 543 ALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 543 i~~cl~~dP~~RPt~~evl~ 562 (613)
|+++++.||.+||||.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=291.16 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc----CcccHHHHHHHHHHHhhcccCccceeeEEEEcC--Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 360 (613)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999975 68999999875321 122345788999999999999999999998764 457
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 378899999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCC--CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 441 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 441 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
...... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~--- 223 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--------AMAAIFKIAT--- 223 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--------HHHHHHHHHc---
Confidence 653211 111223458899999999988889999999999999999999999995221 0111111111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.......+......+.+++..|+. +|..||++.+++..
T Consensus 224 ------~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 ------QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111223344678999999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.02 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=194.8
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
|...+.||+|+||.||+++.. ++..+|+|.+...... .....+..|+++++.++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999975 6889999998654322 2234688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. |++.+.+.... .++++..+..++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 47777765432 2489999999999999999999999 9999999999999999999999999998754322
Q ss_pred Cceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
....|+..|+|||.+. ++.++.++|||||||++|||++|+.||.... .............
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccC-----
Confidence 2234888999999974 4568899999999999999999999985221 1111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
...........+.+++.+||+.+|.+||++.++++.+-
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 01111223456889999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=296.15 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=198.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC----
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 358 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 358 (613)
...++|++.+.||+|+||.||+|..+ +|+.||+|.++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 588999999875432 223446778999999999999999999987654
Q ss_pred ------ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 359 ------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 359 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
..++++||+.+ ++...+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 6666665432 2489999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|++||.... .......+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHH
Confidence 999999987654332222233467889999988654 57889999999999999999999996322 111111111
Q ss_pred HHhhccc---ccccc--------cCccC-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 GLLKEKK---LEQLV--------DSDME-----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 ~~~~~~~---~~~~~--------~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... ...+. +.... ..........+.+++..||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111100 00000 00000 0000112467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=287.90 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=203.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+++++.++|+|++++++++..+...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999986 688999999976544 34567889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987643 2489999999999999999999998 999999999999999999999999999986654332
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... ........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~--- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLRN--- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcCc---
Confidence 234458889999999988889999999999999999999999996321 0111111111 11111111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.......+.+++..|++.||++|||+.++++.
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124578999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.88 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=196.8
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 357 (613)
..++|+..+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999976 789999999865432 22344677899999999999999999988643
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 4777776532 78899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC----------CcchHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND----------DDVMLL 507 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~----------~~~~~~ 507 (613)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ....+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 2234578899999999999999999999999999999999999953221000 000000
Q ss_pred HH----HHHHhhccc------ccccccCcc----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 508 DW----VKGLLKEKK------LEQLVDSDM----EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 508 ~~----~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. +........ ..+...... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 000000000 000011235568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=293.34 Aligned_cols=243 Identities=28% Similarity=0.338 Sum_probs=186.7
Q ss_pred ccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHh---hcccCccceeeEEEEcCCceEEEEeccc
Q 007200 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMIS---MAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
.||+|+||.||++... +++.+|+|.+....... ....+..|..++. ..+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 68899999886543221 1223444444333 3479999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999887543 389999999999999999999999 99999999999999999999999999987553222
Q ss_pred eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 449 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .. ..+...... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~------~~--- 215 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLT------VN--- 215 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CH-HHHHHHhhc------CC---
Confidence 123458999999999864 55789999999999999999999999632211 00 111111000 01
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
...+......+.+++.+|+..||++|| |++|+++.
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111223346788999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.29 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=196.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 362 (613)
.++|+..+.||+|+||.||+|.+. +|+.||+|.++..... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999976 6899999998754322 2233566899999999999999999998765 46799
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+ +|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 7888776532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc--c
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--L 519 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 519 (613)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... .......+........ .
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhh
Confidence 543222 122235778999999865 457899999999999999999999996321 1111111111111000 0
Q ss_pred ----------cccccCccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 ----------EQLVDSDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ----------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.....+....... ......+.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 112456789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.63 Aligned_cols=270 Identities=22% Similarity=0.303 Sum_probs=195.6
Q ss_pred CCCCCCccccCcCcEEEEEEeCC---CCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTD---GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 361 (613)
+|.+.+.||+|+||.||+|.... ++.||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999753 7899999997643 122234577899999999999999999999988 7899
Q ss_pred EEEecccCCcchhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----CCcEEEecc
Q 007200 362 LVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 436 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Df 436 (613)
+||||+.+ ++.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666665433222 23589999999999999999999999 9999999999999999 899999999
Q ss_pred ccceecCCCCC--ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc-----chHHH
Q 007200 437 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-----VMLLD 508 (613)
Q Consensus 437 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~-----~~~~~ 508 (613)
|+++....... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112234578899999988664 57899999999999999999999996433211000 00011
Q ss_pred HHHHHh-----------hccccccc----ccCccCCCCcH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 509 WVKGLL-----------KEKKLEQL----VDSDMEGNYIE-------EEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 509 ~~~~~~-----------~~~~~~~~----~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+..+. ........ ........... .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110000 00000000 00000000000 22356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=294.11 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=196.2
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|+..+.||.|++|.||+|.+. +|..||+|++...... .....+..|+++++.++|+|++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999976 7999999998754322 22346788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
. ++|.+++..... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689988865442 2489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc---------
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 517 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 517 (613)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .......+.......
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhhh
Confidence 1 1223468899999988664 568899999999999999999999953221 000111111000000
Q ss_pred --ccc-ccccC--ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 --KLE-QLVDS--DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 --~~~-~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ..... .............+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000 0000001122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.47 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=192.2
Q ss_pred CccccC--cCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
..||+| +||+||++.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999975 799999999875432 22345788899999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
+++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 2488999999999999999999999 99999999999999999999999998653322111100
Q ss_pred ------eeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH---------
Q 007200 450 ------TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 512 (613)
Q Consensus 450 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 512 (613)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ......+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccc
Confidence 0111245679999998764 4789999999999999999999999632100 000000000
Q ss_pred -----------------------HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 -----------------------LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..........................+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000011111111223345678899999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=294.37 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=182.8
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccH----------HHHHHHHHHHhhcccCccceee
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGE----------LQFQTEVEMISMAVHRNLLRLR 351 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~niv~l~ 351 (613)
..++|.+.+.||+|+||+||+|...+ +..+|+|........... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34679999999999999999999764 345666654322211100 0112233345567899999999
Q ss_pred EEEEcCC----ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 007200 352 GFCMTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (613)
Q Consensus 352 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 427 (613)
+++.... ..+++++++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 9766543 33677776633 5555554322 257888999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccceecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC
Q 007200 428 EFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501 (613)
Q Consensus 428 ~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~ 501 (613)
++.++|+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999866432211 12234599999999999999999999999999999999999999963321100
Q ss_pred C-cchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 502 D-DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 502 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
. .....+++.... ..... .......+.+++..|+..+|++||++.++++.++
T Consensus 242 ~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLH---------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhh---------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 000011111111 11111 1122467899999999999999999999998763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.62 Aligned_cols=254 Identities=23% Similarity=0.417 Sum_probs=194.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 363 (613)
..++|++.+.||+|+||.||+|.+. +++.||||.++..........+..|+.++.+.. |+||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3467888999999999999999987 488999999976544434455667777666665 99999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|||+. +++.+++..... ++++..+..++.|++.||+|||+ . +|+||||+|+||++++++.+||+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 466666654322 58999999999999999999997 5 8999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... . .+..........
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~---~~~~~~~~~~~~ 236 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----E---FEVLTKILQEEP 236 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----H---HHHHHHHhcCCC
Confidence 43221 12234788999999987554 78899999999999999999999953210 0 111111111110
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+... ........+.+++.+||+.||++||++.++++.
T Consensus 237 ------~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ------PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001234578999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.81 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=196.8
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||.||++++. +|+.+++|.+...... .....+..|++++.+++|+||+++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 5899999998654322 2345688899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC-----
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 447 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~----- 447 (613)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997644 389999999999999999999999 999999999999999999999999999875433211
Q ss_pred --ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 448 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 448 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.......++..|+|||...+...+.++||||||+++|++++|+.||.... .......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~------ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKI------ 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCc------
Confidence 12233457889999999988889999999999999999999999996322 1111111111 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000000124678999999999999999999777776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.58 Aligned_cols=245 Identities=26% Similarity=0.331 Sum_probs=192.2
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||+||++... +|+.||+|.+..... ......+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999866 688999999865332 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999876543 3489999999999999999999999 9999999999999999999999999998765431 12223
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+....... ....+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~----------~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-----EKEELKRRTLEM----------AVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-----cHHHHHhccccc----------cccCC
Confidence 457889999999988889999999999999999999999996332110 001111100000 00111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
......+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22345788999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=285.28 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=192.6
Q ss_pred HHHHHhhCCCCCCcc--ccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhh-cccCccceeeEEEEcC
Q 007200 282 ELQVATDNFSNRNIL--GRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTP 357 (613)
Q Consensus 282 ~~~~~~~~~~~~~~i--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 357 (613)
+.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+..... .+|+||+++++++..+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 334445677777776 99999999999975 68889999986542211 12222222 2699999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEecc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 436 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Df 436 (613)
+..++||||+++++|.+++.... ++++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999997653 489999999999999999999999 999999999999999998 9999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|++....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ........+.... .
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~ 224 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ--Q 224 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh--c
Confidence 9987654322 2358899999999999899999999999999999999999996221 1111122222111 0
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 562 (613)
... .........+.+++.+|++.+|.+||+ ++++++
T Consensus 225 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKL----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccC----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 111134467899999999999999996 588875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=285.14 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=204.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 364 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 364 (613)
+|...+.||+|++|.||+|... +++.|++|.+..... ......+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999977 688999999875542 23355788999999999999999999999988 8899999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997654 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|+.||.... .....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-------- 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGS-------- 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccc--------
Confidence 4321 1233458889999999988889999999999999999999999996322 11111111111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 -SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111122223567999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.66 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=194.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+..+.||+|++|+||+|... +|+.||+|.+...... .....+..|+++++.++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 6889999998654322 233567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEeccccceecCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~ 444 (613)
|+. +++.+++..... ..+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 578777754332 2368889999999999999999999 9999999999999985 56799999999976543
Q ss_pred CCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc---cccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLE 520 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 520 (613)
... ......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...... ..... +...... ..+.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~-~~~~~~~~~~~~~~ 229 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFK-IFRILGTPNEETWP 229 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHhCCCChhhcc
Confidence 221 12233478899999988664 5788999999999999999999999532110 00000 0000000 0000
Q ss_pred cc---cc-----CccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 QL---VD-----SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~~---~~-----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 00000 001122356889999999999999999999997
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=300.34 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=206.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
...|.+.+.||+|.|++|..|++. ++..||||.+.+..... ....+.+|++++..++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888999999999999999976 79999999998765432 3345889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|.+.+++...+. ..+.++..++.|+.+|++|||++ .|||||||++|||++.+.++||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999988765 44588899999999999999999 999999999999999999999999999998863
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+......-.. .++
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------------rvl 268 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------------RVL 268 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------------hhe
Confidence 334456779999999999998876 689999999999999999999997443221111 011
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... .+.-...++.+++++++-.+|.+|++.++++.
T Consensus 269 ~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111 11222346788899999999999999999976
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.33 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=201.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
+..+.|+.-++||+|+||.||-++.. +|+.||.|.+.+.+.. ..+.....|-.++.+++.+.||.+--.|++.+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44466888899999999999999866 7999999988654422 23445678999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+|+..|.||+|.-++.+.+. +.|++..+..++.+|+.||++||.. +||+|||||+|||+|+.|+++|+|.|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999887664 4599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
+.... .....+||.+|||||++.+..|+...|-||+||++|||+.|+.||....- -.+.+.+..
T Consensus 337 i~~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------------Kvk~eEvdr 400 (591)
T KOG0986|consen 337 IPEGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------------KVKREEVDR 400 (591)
T ss_pred cCCCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------------hhhHHHHHH
Confidence 76433 23334699999999999999999999999999999999999999952210 011111111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 556 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 556 (613)
... ..+..++....++...+....+..||++|..
T Consensus 401 r~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHh-cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 100 0112234455566777777788999999973
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=288.87 Aligned_cols=259 Identities=25% Similarity=0.308 Sum_probs=202.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC---cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
+|++.+.||+|+||.||++... +++.||||.++.... ......+..|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999743 578899999875321 22234678899999999 599999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986532 388999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCceeeccccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..... ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~-- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHcc--
Confidence 65544333333455889999999987665 68899999999999999999999952211 11111111111111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCc
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 569 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 569 (613)
... .+......+.+++.+||+.||++|||+.++.+.|+...+
T Consensus 228 -----~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 -----KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred -----CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 011 111223567899999999999999999999988876544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=292.80 Aligned_cols=259 Identities=24% Similarity=0.299 Sum_probs=189.0
Q ss_pred ccccCcCcEEEEEEeCCCCEEEEEEeccc-cCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcch
Q 007200 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (613)
.+|.|+++.||++.. +++.||||++... ........+..|+++++.++|+||+++++++.++...+++|||+.+|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444444444444 6899999998765 23334567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC------
Q 007200 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------ 447 (613)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~------ 447 (613)
++++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99976432 2388999999999999999999999 999999999999999999999999998875532211
Q ss_pred ceeeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc----c----
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE----K---- 517 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~---- 517 (613)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .....+.+.+.... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA----TQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCccccccCchhh
Confidence 111223467789999998763 578899999999999999999999963211 11111111100000 0
Q ss_pred ---cccc----cccCc----cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 ---KLEQ----LVDSD----MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ---~~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.... ..+.. ............+.+++..||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334678899999999999999999999883
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.97 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=193.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.|...+.||+|+||.||+|+.. ++..+|+|.+.... ......++..|+++++.++|+|++++++++..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999976 67889999886432 22233467789999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+. |++.+.+.... .++++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 57777765432 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||.... .............
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~---- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES---- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcCC----
Confidence 2234788999999974 3567889999999999999999999985211 0111111111110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
...........+.+++.+||+.+|++||++.++++.-
T Consensus 232 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0001122346688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.66 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=193.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
.++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999976 6889999988654322 22345678999999999999999999987654
Q ss_pred --ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 359 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 359 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
..++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999964 7777776543 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc---eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 437 GLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 437 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-----~~~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-----EQHQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHH
Confidence 999766432221 11233477889999988664 46889999999999999999999996322 1111111111
Q ss_pred Hhh---ccccccc-----ccC-ccCCCC---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 LLK---EKKLEQL-----VDS-DMEGNY---------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 ~~~---~~~~~~~-----~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+.. ....... .+. ...... .......+.+++.+||..||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 110 0000000 000 000000 0001245678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.22 Aligned_cols=245 Identities=21% Similarity=0.268 Sum_probs=189.7
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHH-hhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||.||+|... +|+.||+|.++..... .....+..|..++ ....|+|++++++++...+..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999975 6889999998654321 1122344454443 455899999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....++..|+|||.+.+..++.++||||||+++|||++|..||.... . ........ ..... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~-~~~~~------~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----P---DAVFDNIL-SRRIN------WPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHH-hcccC------CCC
Confidence 223458889999999988888999999999999999999999995321 1 11111111 11000 000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111123467899999999999999998877766655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=284.70 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=201.8
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|+..+.||+|++|.||++... +++.|++|.+...... .....+.+|++++.+++|+|++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 6789999999765432 2345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++.... ++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987652 489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... . ........... . ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~---~~~~~~~~~~~-~-----~~ 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----P---MAALFRIVQDD-H-----PP 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----H---HHHHHHHhccC-C-----CC
Confidence 32 233457889999999988888999999999999999999999995221 0 01111111100 0 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+......+.+++.+|+..+|++|||+.+++.
T Consensus 219 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 ----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122457889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.33 Aligned_cols=263 Identities=21% Similarity=0.325 Sum_probs=197.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEc----CCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 361 (613)
++|++.+.||+|+||.||+|... +|+.||+|++...... .....+..|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67899999999999999999976 6899999998754322 234567789999999999999999998763 34679
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68888886533 389999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc---eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc-
Q 007200 442 MDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 516 (613)
Q Consensus 442 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 516 (613)
....... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~g~~ 231 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-----VHQLKLILSVLGSP 231 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh-----HHHHHHHHHHhCCC
Confidence 5432211 1123458889999999865 4588999999999999999999999953211 1111111111000
Q ss_pred ----------ccccccccC-ccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 517 ----------KKLEQLVDS-DMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 517 ----------~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+....+. ...... .......+.+++..|++.+|++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 000000 11235678999999999999999999998883
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=288.86 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=194.0
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
..||+|+||.||++... +++.||+|.+.... ......+..|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999875 78899999885432 22445688999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9887542 378999999999999999999999 999999999999999999999999999876543221 2233
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.... ..... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~~~~~~~~~~~~---------~~~~~--~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNL---------PPKLK--NL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhhC---------CcccC--Cc
Confidence 458899999999988888999999999999999999999985221 111111111100 00000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112346788999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.92 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc----CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+|.+.+.||+|+||.||++.+. .+..+++|.++... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999876 34556666665322 222334577889999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876444445699999999999999999999999 9999999999999986 479999999987654
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ............
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~------ 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGP------ 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCC------
Confidence 3222 2233457889999999988888999999999999999999999995221 111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...........+.+++.+||..+|++||++.++++
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01112234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.36 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=199.1
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|+..+.||+|++|.||+|... +++.+++|.+...... .....+..|+++++.++|+||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999976 6889999998755432 23456888999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.+ ++.+++.... .++++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888876643 2489999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc---ccccccc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEQLV 523 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 523 (613)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||..... ......+...... .......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccch
Confidence 122234478899999998877 789999999999999999999999953221 0011111000000 0000000
Q ss_pred c-----------Ccc--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 D-----------SDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~-----------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+ ... ...........+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 00011234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=287.23 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=195.9
Q ss_pred CCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC---cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
+|++.+.||+|+||.||.+... +|..||+|+++.... ......+..|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4777889999999999999863 688999999875422 12235678899999999 599999999999998999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+++++|.+++.... ++++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987543 388999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC-
Confidence 6544332223345588999999998753 467899999999999999999999963211 111112211111110
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
+. .+......+.+++.+|++.||++|| ++.+++.
T Consensus 229 ------~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 1112335688999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=275.76 Aligned_cols=274 Identities=22% Similarity=0.300 Sum_probs=201.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC-----CCEEEEEEeccccCccc-HHHHHHHHHHHhhcccCccceeeEEEEc-CC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 358 (613)
....|+....||+|.||.||+|...+ ...+|+|.++.+..... .....+|+.+++.++||||+.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 44678999999999999999996442 23689999987654333 2356789999999999999999998887 78
Q ss_pred ceEEEEecccCCcchhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CcEEE
Q 007200 359 ERLLVYPFMVNGSVASCLRERG-QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVV 433 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl 433 (613)
..++++||.+. +|...++-+. .....++...++.|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 89999999977 7777775432 2224589999999999999999999999 79999999999999877 89999
Q ss_pred eccccceecCCCCCc--eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc-chHHHH
Q 007200 434 GDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-VMLLDW 509 (613)
Q Consensus 434 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~-~~~~~~ 509 (613)
+|||+++.+...-.. ....++.|+.|+|||.+.+. .||++.||||.|||+.||+|-++.|.......... ....+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999987643222 23345679999999999886 58999999999999999999999996543222111 222222
Q ss_pred HH---HHhhcc---cccccccC-cc-------C-CCC-c---HH-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 510 VK---GLLKEK---KLEQLVDS-DM-------E-GNY-I---EE-------EVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 510 ~~---~~~~~~---~~~~~~~~-~~-------~-~~~-~---~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+. ..+.-. .+..+..- +. . ... . .. ....-.+++.+++..||.+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22 222111 11000000 00 0 000 0 00 01236788999999999999999998874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.16 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=199.1
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++.....||.|.||.||.|... +|+..|+|-++-... ........+|+.++..++|||+|+++|+-...+..++.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 4555678999999999999954 799999998764322 22344578899999999999999999999889999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|++|+|.+.++..+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999976443 67788888999999999999999 99999999999999999999999999998776543
Q ss_pred Cc---eeeccccccccccccccccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 447 TH---VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 447 ~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.. .-....||+.|||||++.+.. ...+.||||+||++.||+||+.||.... .+|...+ +-..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~aIMy-~V~~-- 1456 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWAIMY-HVAA-- 1456 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhHHHh-HHhc--
Confidence 21 123456999999999997654 4678999999999999999999996222 1222111 1110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
......+......-.+++..|+..||++|.++.|+++.
T Consensus 1457 -----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11112233355667889999999999999999888774
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=288.63 Aligned_cols=266 Identities=26% Similarity=0.358 Sum_probs=197.3
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|.+.+.||+|++|+||+|... +++.|+||++.............+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999986 578899999876544333445567899999999 999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
+|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889998887654 23489999999999999999999999 999999999999999999999999999986543221
Q ss_pred ceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC--------CcchHHHHHHHHhhccc
Q 007200 448 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 518 (613)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123447889999998754 4578999999999999999999999953221000 00000011111111111
Q ss_pred ccccccCccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........... .........+.+++..||+.+|++|||++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11000000000 0001113678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=291.93 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=192.3
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
|...+.||+|+||+||+|+.. +|+.|++|.+...... .....+..|+++++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999975 6889999998654322 2234678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. |++.+++.... .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 57777775433 2489999999999999999999999 999999999999999999999999999864322
Q ss_pred Cceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||.... . ...+........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~~~~~----- 237 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----A---MSALYHIAQNDS----- 237 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----h---HHHHHHHHhcCC-----
Confidence 12345888999999984 4567889999999999999999999985221 1 111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+. .........+.+++.+||+.+|++||++.++++.
T Consensus 238 -~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111223468899999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.50 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=196.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC--Cce
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TER 360 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 360 (613)
..++|+..+.||+|+||.||+|.+. +|+.+|+|++.... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999976 68899999886432 222334577899999999 999999999998653 467
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+. ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5888888653 378999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC----ceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH--
Q 007200 441 LMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-- 513 (613)
Q Consensus 441 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 513 (613)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~ 230 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIG 230 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhC
Confidence 6643322 12233458899999998765 45788999999999999999999999532110 000000000
Q ss_pred -------------hhcccccccccCccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 514 -------------LKEKKLEQLVDSDME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 514 -------------~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....+......... ..........+.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 00011134678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=273.99 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=198.3
Q ss_pred HhhCCCCC-CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC----C
Q 007200 286 ATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----T 358 (613)
Q Consensus 286 ~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~ 358 (613)
.+++|.+. ++||-|-.|.|..+..+ +|+++|+|++.... ...+|+++.-+. .|||||.++++|.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 34556654 57999999999999876 79999999986432 345788876555 499999999998753 4
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEec
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGD 435 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D 435 (613)
..++|||.|+||.|.+.+++++.. .|++.++..|+.||..|+.|||+. +|.||||||+|+|.+. |..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 568999999999999999987654 499999999999999999999999 9999999999999974 55799999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
||+|+.-... ......+-|+.|.|||++...+|+...|+||+||++|-|+.|.+||.... +..+..-++..++
T Consensus 208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h-----g~aispgMk~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKRRIR 280 (400)
T ss_pred cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC-----CccCChhHHhHhh
Confidence 9999865432 22334457999999999998999999999999999999999999996221 1111111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+. -..+.......++...++|+..+..+|.+|.|+.+++..
T Consensus 281 ~gq------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccC------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111 112233445567778899999999999999999999874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.19 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=196.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 359 (613)
.++|.+.+.||+|+||+||+|... +++.||||.+.... .......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999975 68999999987542 222344577899999999999999999987654 34
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68888876533 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 515 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 515 (613)
+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 8654332 22233457889999998865 4688999999999999999999999953210 000000000000
Q ss_pred --------ccccccccc-------CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 --------EKKLEQLVD-------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 --------~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
......... .... .........+.+++.+||+.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 0000 0011234668899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=286.46 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=186.0
Q ss_pred ccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHH---HHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
.||+|+||.||+|... +++.||+|.+....... ....+..|.. .++...||||+++++++..++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 68899999986543221 1222333433 3444579999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+|+|..++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999998886533 489999999999999999999999 99999999999999999999999999987553222
Q ss_pred eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 449 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........ .. ....... .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~------~~~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRMTLT------MAVEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HH-HHHHhhc------cCCCC
Confidence 2234589999999998754 588999999999999999999999963321110 00 0000000 01111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. ......+.+++.+|+..+|++|| ++.++++
T Consensus 219 ~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 P----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 12246788999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.59 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=192.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
.++|++.+.||+|+||.||+|... +++.+|+|.+....... ....+.+|+++++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999976 68899999986543222 2345678999999999999999999875543
Q ss_pred --ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 359 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 359 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
..++++||+.+ ++...+.... ..+++..+..++.|+++||+|||++ +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 45999999865 5666665432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc----------eeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007200 437 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505 (613)
Q Consensus 437 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~ 505 (613)
|+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|++||..... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----ID 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 999765432211 11223468889999987654 578999999999999999999999953221 11
Q ss_pred HHHHHHHHhhccc---------ccccc----cCccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 506 LLDWVKGLLKEKK---------LEQLV----DSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 506 ~~~~~~~~~~~~~---------~~~~~----~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....+........ ..... ....... ........+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111111100000 00000 0000000 00112256889999999999999999999886
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=283.93 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=194.2
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhc---ccCccceeeEEEEcCCc-----
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 359 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 359 (613)
|++.+.||+|+||.||+|+.+ +++.||+|.++...... ....+..|+.++.++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999987 58999999997543322 233466777776655 59999999999988766
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 78888865432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
........ .....++..|+|||.+.+..++.++|||||||++|||++|++||..... .................
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChH
Confidence 77643321 1223478899999999998999999999999999999999999863211 11111111111000000
Q ss_pred ---c------ccccCccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 ---E------QLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ---~------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ........ ..........+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 0111233467789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.95 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=201.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 363 (613)
++|...+.||+|+||.||+|... +|..||+|++..... ......+..|.+++.++. |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 789999999875322 223456788999999998 99999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 499999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC-------------------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc
Q 007200 444 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504 (613)
Q Consensus 444 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~ 504 (613)
.... .......++..|+|||...+...+.++||||||++++++++|+.||.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~- 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E- 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H-
Confidence 3321 12223457889999999988889999999999999999999999996332 0
Q ss_pred hHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 007200 505 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM----SEVVR 562 (613)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 562 (613)
.......... ....+......+.+++..||+.+|++||++ +++++
T Consensus 228 --~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --YLTFQKILKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHHhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111111110 001112224578999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.99 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=196.0
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhh-cccCccceeeEEEEcCCceEEEEecccCC
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+..||.|+||+|++-.++ .|+..|||+++.........++..|.+...+ -+.||||+++|.+..+...|+.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 457999999999999977 7999999999988776667788888887654 4689999999999999999999999943
Q ss_pred cchhhhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 371 SVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 371 sL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
++..+-.. .......+++..+-.|..-.+.||.||.+.. +|+|||+||+|||++..|.+|+||||++..+.. +..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 55443221 1122234888888899999999999999876 899999999999999999999999999865432 222
Q ss_pred eeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 450 TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
.+.-.|...|||||.+... .|+-+|||||+|++|||+.||+.|+.... +..+.+..........-..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~~--- 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLFD--- 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecCc---
Confidence 3344588999999999643 48899999999999999999999996221 13333333332222111111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....+....+.+++.-|+.+|-+.||...++..+
T Consensus 294 --~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 --KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123455778999999999999999999998764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.18 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc--HHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
+..++|..+++||+|.||+|.+++-+ +|+.||+|+++++..... ...-..|-.+|...+||.+..+.-.|+..+..+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34567888899999999999999966 799999999988754322 334567889999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||..||.|.-++.... .+++...+.+...|+.||.|||++ +||+||||.+|.|+|++|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999998887643 388999999999999999999999 999999999999999999999999999974
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
-- ..+.....++|||.|+|||++....|..++|.|.+||++|||+.|+.||.... ...+.+.+
T Consensus 318 ~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kLFeLI----------- 380 (516)
T KOG0690|consen 318 EI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKLFELI----------- 380 (516)
T ss_pred cc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHHHHHH-----------
Confidence 32 33445667899999999999999999999999999999999999999996222 11111111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
+-.++ .++.....+...++.-.+..||.+|. .++||.+
T Consensus 381 -l~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 381 -LMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -Hhhhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 00011 11222223455666677889999997 4555544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=293.17 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=199.3
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----ceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 361 (613)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ......+..|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999976 589999999876542 333457889999999999999999999988765 789
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++|||+. ++|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 47888886543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc--
Q 007200 442 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-- 516 (613)
Q Consensus 442 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 516 (613)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHhcCCCC
Confidence 654321 112334578899999999888 789999999999999999999999953221 0000111110000
Q ss_pred ---------ccccccccC-ccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 517 ---------KKLEQLVDS-DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 517 ---------~~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
......+.. .... .........+.+++..||+.+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 0000 0011134678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=273.51 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=196.9
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEE-eCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcC
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 357 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 357 (613)
+.++...++ +.||+|+|+.|.-++ ..+|..||||++.+.. .....+..+|++++.+.. |+||++++++|+++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 455554443 679999999999988 5589999999998763 335667889999998885 99999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEe
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 434 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~ 434 (613)
...|+|||.|.||.|..+++++.. |++.++.++..+|+.||.+||.+ ||.||||||+|||..... -+||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999987654 99999999999999999999999 999999999999997654 47999
Q ss_pred ccccceecCCC------CCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccc---ccC
Q 007200 435 DFGLAKLMDYK------DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLAR---LAN 500 (613)
Q Consensus 435 DfGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~---~~~ 500 (613)
||.+..-+... ....-...+|+..|||||+.. ...|+++.|.||+|||+|-|++|++||...= -..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 99987533211 111223456888999999763 3468999999999999999999999996321 111
Q ss_pred CCcc----hHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 501 DDDV----MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 501 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+.+. -....... +.++.. +.+............+++...+..||.+|.++.++++
T Consensus 302 drGe~Cr~CQ~~LFes-IQEGkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFES-IQEGKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHH-HhccCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1110 01111111 111111 1111112233455567777777899999999999887
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.56 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=197.0
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc-CCce
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 360 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 360 (613)
...+++|+..+.||.|+||.||+|... +++.||+|++..... ......+..|++++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999866 789999998865332 2234567889999999999999999999875 5678
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++++||+ +++|.++++.. ++++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 56888877642 378888999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC-------CcchHHHHHHH
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKG 512 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~ 512 (613)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 122347889999998766 5689999999999999999999999953211000 00000111111
Q ss_pred HhhcccccccccCccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........-..........+ ......+.+++.+|++.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10000000000000000001 1123678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=293.00 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=194.5
Q ss_pred hCCCC-CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc-------------HHHHHHHHHHHhhcccCccceeeE
Q 007200 288 DNFSN-RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------------ELQFQTEVEMISMAVHRNLLRLRG 352 (613)
Q Consensus 288 ~~~~~-~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~niv~l~~ 352 (613)
++|.. .+.||+|+||+||+|.+. +++.||||.+........ ...+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999976 689999999865432210 124678999999999999999999
Q ss_pred EEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 68888886532 388999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCC-------------CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007200 433 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (613)
Q Consensus 433 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~ 498 (613)
|+|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999997654111 1111223467889999998764 46889999999999999999999995322
Q ss_pred cCCCcchHHHHHHHHhhccccc---ccc--------cCccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 499 ANDDDVMLLDWVKGLLKEKKLE---QLV--------DSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......+.......... ... ...... .........+.+++..|++.+|++|||++|++.
T Consensus 239 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 ----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111121111111000 000 000000 001122456889999999999999999999997
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=285.25 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=197.9
Q ss_pred CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|+..+.||+|++|.||+|+.. +++.+|+|.+..... ......+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999977 589999999976542 223456778999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
. ++|.+++.... ..+++..+..++.+++.||+|||+. +|+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999997653 2489999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc---c---c
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L---E 520 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~ 520 (613)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+........ . .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-----EIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHHHhCCCcHHHHHhhc
Confidence 12223467789999998776 78999999999999999999999995321 1111111111110000 0 0
Q ss_pred cc--ccCccC---C----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 QL--VDSDME---G----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~~--~~~~~~---~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .+.... . .........+.+++..||..||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 000000 0 001112467999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.98 Aligned_cols=277 Identities=21% Similarity=0.294 Sum_probs=216.6
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
...+++...++|.+.++||+|+||.|..++++ +++.||+|++.+.. .......|..|-++|..-+.+-|+.++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35678888899999999999999999999987 68899999998632 2234557899999999999999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
++...|+|||||+||+|-.++...+ ++++..++.++..|+-||.-||+. |+|||||||+|||+|..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999998765 389999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
||.+-.++....-.....+|||.|++||++.. +.|++.+|.||+||++|||+.|..||...+ +++-.
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY 290 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETY 290 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHH
Confidence 99988777555555566779999999999852 568999999999999999999999996433 22222
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhhcCCcchhhHHHhhhh
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK---MSEVVRMLEGDGLAERWEEWQKEE 580 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~~~~~~~~~~~~~~~ 580 (613)
..+..-+....+.+. .+.++...++|..-+ -+|+.|.. +.++...-- -..-.|...+...
T Consensus 291 ~KIm~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpF--F~g~~W~~iR~~~ 353 (1317)
T KOG0612|consen 291 GKIMNHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPF--FEGIDWDNIRESV 353 (1317)
T ss_pred HHHhchhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCcc--ccCCChhhhhhcC
Confidence 222222211111110 112344555555443 37888887 777766421 1234576665554
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.67 Aligned_cols=268 Identities=21% Similarity=0.253 Sum_probs=197.6
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
...++....++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 44566778899999999999999999999865 688999999875432 2224467789999999999999999998764
Q ss_pred C------CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 357 P------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 357 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467788876 78888877542 388999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 509 (613)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLI 230 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999998754321 223457889999999866 4678899999999999999999999952211 0000000
Q ss_pred HHHH----------hhccccccc---ccCccCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 510 VKGL----------LKEKKLEQL---VDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 510 ~~~~----------~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+... ......... ......... .......+.+++..|++.||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000000 000000000 00123467899999999999999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.20 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=190.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC------C
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 358 (613)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368989999999999999999975 689999999875432 22234678899999999999999999998754 3
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++++||+.. ++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999864 5655442 1388999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh---
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--- 514 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 514 (613)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 234 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVP 234 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 8754321 123357889999999876 4588999999999999999999999963211 00000000000
Q ss_pred --------hccccccccc--CccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 515 --------KEKKLEQLVD--SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 515 --------~~~~~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.......... +..... ........+.+++..||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000 001123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.88 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=190.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC---------
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------- 357 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 357 (613)
.+|...+.||.|+||.||+|... +|..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 67888999999999999999976 688999999865443 3445688899999999999999999876543
Q ss_pred -----CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcE
Q 007200 358 -----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEA 431 (613)
Q Consensus 358 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ 431 (613)
...+++|||+. ++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 5888877532 388999999999999999999999 9999999999999974 5678
Q ss_pred EEeccccceecCCCCCc--eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 432 VVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
|++|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH
Confidence 99999999765432111 1122347889999998754 567889999999999999999999995322100 0000
Q ss_pred HHHH-----------HhhcccccccccCccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 509 WVKG-----------LLKEKKLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 509 ~~~~-----------~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... .... ............. ........+.+++.+|++.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000 0000000000000 00112356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=287.41 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=193.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC-----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 358 (613)
..++|...+.||+|+||.||++... +|..||||++..... ......+..|+.+++.++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999865 789999999865432 222346788999999999999999999987543
Q ss_pred -ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 77888887542 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCC-------CcchHHHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDW 509 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~ 509 (613)
++...... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||........ .......+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99755322 123347889999999876 4578899999999999999999999963211000 00000000
Q ss_pred HHHHhhccccccccc--CccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 510 VKGLLKEKKLEQLVD--SDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... ........ +... ..........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000 0000 0001122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=276.73 Aligned_cols=237 Identities=29% Similarity=0.337 Sum_probs=192.4
Q ss_pred cccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
||+|+||.||++... +++.+|+|.+...... .....+..|+.+++.++|+||+++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 5889999998765432 2345788899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeec
Q 007200 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (613)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 452 (613)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997643 389999999999999999999998 99999999999999999999999999997654332 12233
Q ss_pred cccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
..++..|+|||...+...+.++|+||||+++|++++|+.||.... . ......... .. . ..+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~------~----~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----R---KEIYEKILK-DP------L----RFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHhc-CC------C----CCC
Confidence 457889999999988888999999999999999999999995322 1 111111111 00 0 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSE 559 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~e 559 (613)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112467889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=274.16 Aligned_cols=265 Identities=26% Similarity=0.353 Sum_probs=216.3
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
.+++.+...++....++.+|.||.||.|.+. +.+.|.+|.++....+-....+.+|.-++..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4677788888999999999999999999654 3456788888877766666678899989999999999999999
Q ss_pred EEcC-CceEEEEecccCCcchhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 354 CMTP-TERLLVYPFMVNGSVASCLRERGQ----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 354 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
+.++ ...++++.++.-|+|..++..... ....++..+...++.|++.|++|||+. +|||.||..+|+++++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8764 567899999999999999984321 223477788889999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCcee-eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007200 429 FEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVML 506 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~ 506 (613)
.++||+|=.+++.+.+.+.+.- .....+..||+||.+.+..|+.++||||||++||||+| |+.|+...+ .
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--------P 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--------P 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--------H
Confidence 9999999999998876654432 33446779999999999999999999999999999988 999985221 1
Q ss_pred HHHHHHHhhcc-cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 507 LDWVKGLLKEK-KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 507 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+ +..+++++ ++. -+..++++++.+|..||..+|++||+++|++.-|.+
T Consensus 505 fE-m~~ylkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 FE-MEHYLKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HH-HHHHHhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 22222222 222 234567899999999999999999999999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.35 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=194.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCc----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 359 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 359 (613)
..++|...+.||+|++|.||+|... +++.||+|++..... ......+.+|+.+++.++|+|++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999976 688999999865422 2233457789999999999999999998766554
Q ss_pred --eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 360 --RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 360 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
.++|+||+ +++|.+++... ++++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67898888642 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
++...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-----~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD-----HIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCC
Confidence 99765422 2233578899999998653 67889999999999999999999995221 11111111110000
Q ss_pred -----------ccccccccC---ccCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 -----------KKLEQLVDS---DMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 -----------~~~~~~~~~---~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
......... ....... ......+.+++.+|++.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 0000000 112467899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.63 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=197.2
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+|...++||+|.||+||+|+.. +++.||+|+++-.... +......+|+-+++.+.|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566788999999999999965 6889999999765433 3345678999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|. .+|..+....... ++...++.++.|+++||.++|++ ++.|||+||.|.+++.+|++|++|||+++.++..
T Consensus 83 cd-qdlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 95 4788777654432 88899999999999999999999 9999999999999999999999999999977643
Q ss_pred CceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc---cc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL---EQ 521 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 521 (613)
.......+.|..|.+|.++.+.. |+...|+||.||++.|+.. |++.|.... .+++..-+-|+-+...+..+ .+
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d--vddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc--HHHHHHHHHHHhCCCccccCCcccc
Confidence 23344455799999999998865 7889999999999999988 454453111 11122222222222222221 11
Q ss_pred cccCccCCCCc-----HHH----HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYI-----EEE----VEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~-----~~~----~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+.|-.....++ .+. ...-.+++++.+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22221111111 111 122357777788889999999999887
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=285.83 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=189.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-C--CCEEEEEEeccccCc-ccHHHHHHHHHHHhhc-ccCccceeeEEEEcC----Cc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-D--GSLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 359 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 359 (613)
+|+..+.||+|+||.||++... . +..||+|.+...... .....+.+|++++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999976 4 778999998754322 2244677899999998 599999999875432 45
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++++|+. ++|.+++.... .+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688888885 68888886432 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc---eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH----
Q 007200 440 KLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---- 511 (613)
Q Consensus 440 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---- 511 (613)
+........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 227 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLG 227 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhC
Confidence 865432211 1223458899999998765 4688999999999999999999999963221 00111000
Q ss_pred --------HHhhccc--ccccccCccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 --------GLLKEKK--LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 --------~~~~~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... ........... .........+.+++.+|++.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 000112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.05 Aligned_cols=146 Identities=32% Similarity=0.455 Sum_probs=130.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||+|.+. +++.||||+++.... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999977 689999999975432 222356888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
||+.+++|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 378899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=270.95 Aligned_cols=220 Identities=21% Similarity=0.169 Sum_probs=176.0
Q ss_pred CcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcchhhhh
Q 007200 299 GGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377 (613)
Q Consensus 299 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 377 (613)
|.+|.||++.+. +++.||+|.++... .+..|...+....||||+++++++.+....+++|||+.+|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999976 68899999987543 22344455555679999999999999999999999999999999987
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeecccccc
Q 007200 378 ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457 (613)
Q Consensus 378 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 457 (613)
... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 543 389999999999999999999999 9999999999999999999999999987654322 12234577
Q ss_pred ccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHH
Q 007200 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 537 (613)
Q Consensus 458 ~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (613)
.|+|||.+.+..++.++||||+|+++|||++|+.|+....... ...... ..+.....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~~----~~~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTTL----NIPEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------cccccc----CCcccCCH
Confidence 8999999988889999999999999999999998875221000 000000 01112335
Q ss_pred HHHHHHHHccCCCCCCCCCHH
Q 007200 538 QLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 538 ~l~~li~~cl~~dP~~RPt~~ 558 (613)
.+.+++.+|++.||++||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=250.30 Aligned_cols=212 Identities=24% Similarity=0.366 Sum_probs=176.0
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhh-cccCccceeeEEEE
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCM 355 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~ 355 (613)
...+.+++..+.......||+|+||.|-+.++. +|...|+|+++........++...|+.+..+ ..+|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 334446666777777888999999999998865 8999999999877665556678888887654 46999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
.....++.||.|. .||..+-++.-..+..+++..+-+|+..+.+||.|||++. .++|||+||+|||++.+|++||||
T Consensus 116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 9999999999995 4777766554334445899999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccccccccc----CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
||++..+..+ -..+.-.|...|||||.+.. ..|+-++||||+|+.+.||.+++.||+
T Consensus 193 FGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 193 FGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 9999766432 12233458899999998853 368899999999999999999999996
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.44 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCC
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
.+.||+|.||+||-|+++ +|+.||||++.+.+-. ..+.++..|+.+|..+.||.||.+.-.|+.++..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 378999999999999976 8999999999876533 345678999999999999999999999999999999999995 5
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEeccccceecCCCCC
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~~~~~~~ 447 (613)
++.+++-..... .+++...+.++.||+.||.|||.+ +|||+||||+|||+... -++||+|||.|++++..
T Consensus 648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 666666544333 389999999999999999999999 99999999999999754 47999999999988643
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
..+..++||+.|+|||++.++.|...-|+||.|||+|--++|..||.... .+.+.++. .+++.+.-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------dIndQIQN-------AaFMyPp~ 786 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------DINDQIQN-------AAFMYPPN 786 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-------chhHHhhc-------cccccCCC
Confidence 34566789999999999999999999999999999999999999996221 12222221 12222222
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+ ..+.....+++|...++..=++|-|...-+.
T Consensus 787 P---W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 P---WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred c---hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2 2334455677777788888888888776554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=291.67 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=208.2
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE-----c
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM-----T 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~ 356 (613)
...++.|++.+.||.|.+|.||+++.. +++.+|+|++...... .+..+.|.++++.. .|||++.++|++. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 344567888999999999999999955 7899999998765543 34566788888766 5999999999986 3
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
++++|||||||.+||..++++... +..+.|..+..|+..+++|+.+||.+ .++|||+|-.|||++.++.||++||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 588999999999999999998765 45699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
|.+..++.. ...+....||+.|||||++... .|+.++|+||+|++..||.-|.+|+....
T Consensus 168 GvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------------- 232 (953)
T KOG0587|consen 168 GVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------------- 232 (953)
T ss_pred eeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc--------------
Confidence 999877643 3344556699999999998643 46778999999999999999999984211
Q ss_pred HHhhccccccc-ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 512 GLLKEKKLEQL-VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 512 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+-..+..+ ..+...-..+....+++.++|..|+..|.++||++.++++.
T Consensus 233 ---PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 233 ---PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111111 12222333466778999999999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=269.95 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=200.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--Cc----cceeeEEEEcC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RN----LLRLRGFCMTP 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~ 357 (613)
..+++|.+...+|+|.||.|-.+.+. .+..||||+++.... -.++..-|++++.++.+ |+ ++.+.+++.-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 34789999999999999999999866 578999999875432 23456779999998842 22 77888888889
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-----------
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD----------- 426 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~----------- 426 (613)
++.++|+|.+ |-|+.+++...+. .+++...+..|+.|+++++++||+. +++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 6699999987543 4599999999999999999999999 999999999999984
Q ss_pred ---------CCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007200 427 ---------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (613)
Q Consensus 427 ---------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~ 497 (613)
++..+|++|||.|++-.... ..++.|..|.|||++.+-.++..+||||+||||.|+.||...|+...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 13458999999998644322 45668999999999999999999999999999999999999996332
Q ss_pred ccCCCcchHHHHHHHHhhcccccc----------------------------cccCccC----CCCcHHHHHHHHHHHHH
Q 007200 498 LANDDDVMLLDWVKGLLKEKKLEQ----------------------------LVDSDME----GNYIEEEVEQLIQVALL 545 (613)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~----~~~~~~~~~~l~~li~~ 545 (613)
+.-....++..+.+-.-.. +.++..+ ......+...|+++++.
T Consensus 314 -----n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 314 -----NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred -----cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 2222223322222111000 0000000 01123445679999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 007200 546 CTQGSPMERPKMSEVVR 562 (613)
Q Consensus 546 cl~~dP~~RPt~~evl~ 562 (613)
|+..||.+|+|+.|+++
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=286.29 Aligned_cols=239 Identities=23% Similarity=0.299 Sum_probs=191.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++.|+....+|.|+|+.|-.+.+. +++..++|++.+... +-..|+.++... .||||+++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999999866 688899999976522 233566555544 6999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCcEEEeccccceecC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfGla~~~~ 443 (613)
|.+.++-+.+.+..... +. ..+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988887765432 33 77788999999999999999 99999999999999 688999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. ....+-|..|.|||++....|++++|+||||++||+|++|+.||...... ..+...+...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~------ 529 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMP------ 529 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCC------
Confidence 43 12223577899999999999999999999999999999999999733211 1111222222
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+....+....+++.+|++.||.+||+|.++..
T Consensus 530 ------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 ------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ------ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 122334467889999999999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-34 Score=263.71 Aligned_cols=267 Identities=23% Similarity=0.375 Sum_probs=195.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcC--------
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 357 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 357 (613)
..|+...+||+|.||.||+|+.+ +|+.||+|++--+. ..+-.....+|++++..+.|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999976 57888988764332 222234567999999999999999999987532
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...++||.+|+. +|.-++.+... .++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999976 77777765432 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC---ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 438 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 438 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+++.+..... ...+..+.|..|++||.+.+. .|+++.|||..|||+.||.||.+-++... +.....++..+.+-
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs 247 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGS 247 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhcc
Confidence 9986643322 123344568999999998875 58999999999999999999999886221 11122222222222
Q ss_pred hhcccccccccCcc---------CC-C--CcHHHH------HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 514 LKEKKLEQLVDSDM---------EG-N--YIEEEV------EQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 514 ~~~~~~~~~~~~~~---------~~-~--~~~~~~------~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...+.+-.+..-++ .. . ..++.. ....+++..++..||.+|+++.+++..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 22222222111111 00 0 011111 256788889999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=293.52 Aligned_cols=264 Identities=18% Similarity=0.191 Sum_probs=171.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-C----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEE------E
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------C 354 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~ 354 (613)
..++|...+.||+|+||.||+|++. + +..||+|++...... .....+ .+....+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999976 4 689999987643211 111111 1111122222222111 2
Q ss_pred EcCCceEEEEecccCCcchhhhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007200 355 MTPTERLLVYPFMVNGSVASCLRERGQS----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (613)
..+...++||||+.+++|.++++..... ........+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4567889999999999999998753210 00122345678999999999999999 9999999
Q ss_pred CCCceeecC-CCcEEEeccccceecCCCCCceeeccccccccccccccccC----------------------CCCCccc
Q 007200 419 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----------------------KSSEKTD 475 (613)
Q Consensus 419 k~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 475 (613)
||+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986654433344456689999999966432 2345679
Q ss_pred chhHHHHHHHHHhCCCCcccccc-----cCCCcchHHHHHHHHhhcccccccccCccCC--CCcHHHHHHHHHHHHHccC
Q 007200 476 VFGYGVMLLELITGQRAFDLARL-----ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQ 548 (613)
Q Consensus 476 VwS~G~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~ 548 (613)
||||||++|||+++..+++.... ....+.....|....... ..+.... ...........+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999997766531100 000011112221111000 0000000 0000112245689999999
Q ss_pred CCCCCCCCHHHHHHH
Q 007200 549 GSPMERPKMSEVVRM 563 (613)
Q Consensus 549 ~dP~~RPt~~evl~~ 563 (613)
.||++|||+.|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999984
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=267.17 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=196.5
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc--HHHHHHHHHHHhhc-ccCccceeeEEEEcCCc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 359 (613)
++-..+|..+.+||+|+||+|.+|..+ +.+.||||++++...... .+.-..|-++|+.. +-|.+++++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455567888999999999999999876 577899999987653321 22233455666655 47889999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.|+||||+.||+|--.+++.+. +.+..+..++..||-||-+||++ ||++||||..|||++.+|.+||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999999988765 77788899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+.-- -+...+...+||+.|+|||++...+|+.++|.|||||+||||+.|++||+... +..+.+
T Consensus 498 KEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-----E~elF~----------- 560 (683)
T KOG0696|consen 498 KENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQ----------- 560 (683)
T ss_pred cccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHH-----------
Confidence 7432 23344667889999999999999999999999999999999999999997322 111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 555 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 555 (613)
.+.+. +..++...+.+...+...-+...|.+|.
T Consensus 561 -aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 -AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -HHHHc--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11222 1223444556777888888899999996
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=269.65 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=197.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cH----HHHHHHHHHHhhcccCccceeeEEEE-cCC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GE----LQFQTEVEMISMAVHRNLLRLRGFCM-TPT 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~----~~~~~e~~~l~~l~h~niv~l~~~~~-~~~ 358 (613)
.++|-.+.+||+|||+.||+|.+- ..+.||||+-....... .. +...+|..+.+.++||.||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356777889999999999999854 57889999865332221 11 23567999999999999999999986 456
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEec
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGD 435 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D 435 (613)
.++-|.|||+|.+|.-|++.... +++.+++.|+.||+.||.||.+. +++|+|-||||.|||+.+ .|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 78899999999999999987654 89999999999999999999987 668999999999999964 47899999
Q ss_pred cccceecCCCCCc------eeeccccccccccccccccC----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007200 436 FGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505 (613)
Q Consensus 436 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~ 505 (613)
||++++++..... .+....||..|++||.+.-+ ..+.|+||||.|||+|..+.|+.||.... ..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq----sQ-- 690 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ----SQ-- 690 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch----hH--
Confidence 9999998754322 34456799999999988644 46789999999999999999999996321 11
Q ss_pred HHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..++....+.....-..+. -+........+|++|+++.-++|....++..
T Consensus 691 -----QdILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 -----QDILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -----HHHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1122222222111111111 1122345678899999999999988777654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=260.87 Aligned_cols=239 Identities=29% Similarity=0.385 Sum_probs=192.8
Q ss_pred cCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcchhhhhc
Q 007200 300 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 378 (613)
Q Consensus 300 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 378 (613)
+||.||+|... +|+.+|+|++...........+..|++.+++++|+||+++++++..+...++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 58999999997655443256889999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeeccccccc
Q 007200 379 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458 (613)
Q Consensus 379 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 458 (613)
... +++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 432 78999999999999999999999 99999999999999999999999999998765432 2234457889
Q ss_pred cccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHH
Q 007200 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 538 (613)
Q Consensus 459 y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (613)
|++||.+.+..++.++||||||+++|++++|..||.... ......++. ........ .........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~----~~~~~~~~-------~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKI----GKPKPPFP-------PPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHH----hccCCCCc-------cccccCCHH
Confidence 999999988888999999999999999999999996321 111111111 11110000 000003357
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 007200 539 LIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 539 l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=278.50 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=200.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCC-EEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
...++.....||-|+||.|-++..+... .+|+|++++.... ...+....|-.+|...+.|.||++|--|.++...|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3445566678999999999999877433 4899998765432 334567789999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
.||-|-||.+...+++++. |+..+.+.++..+++|++|||++ +||+|||||+|.+++.+|-+||.|||.|+.+
T Consensus 498 LmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999998775 89999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ..+-.++||+.|.|||++.++..+.++|.||+|+++|||++|++||...... .... .+++.-...
T Consensus 571 ~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----ktYn---~ILkGid~i-- 638 (732)
T KOG0614|consen 571 GSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----KTYN---LILKGIDKI-- 638 (732)
T ss_pred ccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----HHHH---HHHhhhhhh--
Confidence 643 3455688999999999999999999999999999999999999999744321 1111 111111111
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 556 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 556 (613)
.++....+...+++++.+..+|.+|..
T Consensus 639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -------EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 222333456778888888999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=279.88 Aligned_cols=265 Identities=22% Similarity=0.246 Sum_probs=181.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEe-----------------CCCCEEEEEEeccccCcc-------------cHHHHHH
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRL-----------------TDGSLVAVKRLKEERTQG-------------GELQFQT 334 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~ 334 (613)
...++|++.++||+|+||+||+|.+ ..++.||||++....... .......
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3467899999999999999999964 235679999986432210 1112344
Q ss_pred HHHHHhhcccCcc-----ceeeEEEEc--------CCceEEEEecccCCcchhhhhccCC--------------------
Q 007200 335 EVEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPFMVNGSVASCLRERGQ-------------------- 381 (613)
Q Consensus 335 e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 381 (613)
|+.++.+++|.++ ++++++|.. ....++||||+.+++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766554 677777653 3568999999999999999874321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeecccccccccc
Q 007200 382 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461 (613)
Q Consensus 382 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 461 (613)
....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112357888999999999999999999 99999999999999999999999999997654322211122235789999
Q ss_pred ccccccCCC----------------------CCcccchhHHHHHHHHHhCCC-CcccccccCC----CcchHHHHHHHHh
Q 007200 462 PEYLSTGKS----------------------SEKTDVFGYGVMLLELITGQR-AFDLARLAND----DDVMLLDWVKGLL 514 (613)
Q Consensus 462 PE~~~~~~~----------------------~~~~DVwS~G~il~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~ 514 (613)
||.+..... ..+.||||+||++++|++|.. ||........ .......|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence 998754321 234799999999999999875 6642211100 0111111110 0
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP---MERPKMSEVVR 562 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 562 (613)
.... ..............+++.+++..+| .+|+|++|+++
T Consensus 457 ~~~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 0111112234567888888888765 68999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=251.28 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=196.2
Q ss_pred CCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC-----CceEEEE
Q 007200 292 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVY 364 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 364 (613)
..+.||.|+||.||...+. +|+.||.|++...... .+.+++-+|++++..++|.|++..+++..-+ .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3478999999999999976 7999999988653321 2345688999999999999999999886544 3457888
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|.|.. +|...+- ...+++-..++.++.||++||.|||+. +|.||||||.|.|++.+..+||+|||+++..+.
T Consensus 137 ELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88743 5555543 334588899999999999999999999 999999999999999999999999999998877
Q ss_pred CCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc--
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ-- 521 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 521 (613)
.+....+..+.|..|.|||.+.+. .|+.+.||||.|||+.|++.++..|+.... ....+.+...+....+..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-----iqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-----IEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-----HHHHHHHHHHhCCCcHHHHH
Confidence 666666667789999999999886 589999999999999999999999974332 222233322222111111
Q ss_pred ---------cccCccCC-------C--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 522 ---------LVDSDMEG-------N--YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 522 ---------~~~~~~~~-------~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
++...... . .....-..-..+.+.++..||+.|.+..+.+..+.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111110 0 01122234456777899999999999999988663
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=249.41 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=201.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc--HHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
...++|....+||+|+|++|..+++. +.+.||+|+++++..... ..=.+.|-.+..+. +||.+|.++.+|..+...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44578999999999999999999976 678899999987643322 22355666666544 699999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++|.||++||+|--++++.. +++++.++.+...|.-||.|||+. ||++||||..|+|+|..|.+|++|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999988886543 499999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.-- ..+..+..++||+.|.|||++.+..|...+|.|++||+++||+.|+.||+.-.. ...+.+..+++.+.+-++.+.
T Consensus 400 e~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 400 EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred cCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhccc
Confidence 532 344556778999999999999999999999999999999999999999986553 233334444444444333222
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 555 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 555 (613)
- +....-+...+++.-+++||.+|.
T Consensus 478 i----------prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 I----------PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c----------cceeehhhHHHHHHhhcCCcHHhc
Confidence 1 111223445667778899999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=280.31 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=187.0
Q ss_pred CCCCCccccCcCc-EEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecc
Q 007200 290 FSNRNILGRGGFG-KVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 290 ~~~~~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
|...+.+|.|+.| .||+|... |+.||||++-.+. ....++|+..+..-+ ||||+++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4445678999987 67999986 8999999885432 335678999998775 999999999888889999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---C--CcEEEeccccceec
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKLM 442 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DfGla~~~ 442 (613)
..+|.++++................++.|++.||++||+. +||||||||.|||++. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5699999987422111122245678889999999999998 9999999999999976 3 46899999999988
Q ss_pred CCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhcc-c
Q 007200 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEK-K 518 (613)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 518 (613)
+...... .....||.+|+|||++....-+.++||||+||++|+.++| +.||...- +.-..++... .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~----------~R~~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL----------ERQANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH----------HhhhhhhcCccc
Confidence 7654333 3345699999999999999889999999999999998885 99995211 0000111111 1
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+.. +.+ ..++ ...++|.+|++++|..||+|.+|+..
T Consensus 732 L~~-L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVH-LEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eee-ecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 111 0111 67889999999999999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=252.76 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=194.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-----c---CccceeeEEEE--
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----H---RNLLRLRGFCM-- 355 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~-- 355 (613)
..+|.+.++||-|.|++||++-+. +.+.||+|+.+.... -.+....||++|++++ | .+||++++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 478999999999999999999865 677899999875432 2345678999998875 3 36999999986
Q ss_pred --cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----
Q 007200 356 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----- 428 (613)
Q Consensus 356 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----- 428 (613)
++.+.+||+|++ |.+|..++...... .++...+++|++||+.||.|||.+| +|+|.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 457889999998 77899998876544 3889999999999999999999999 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 007200 429 -------------------------------------------------------------------------------- 428 (613)
Q Consensus 429 -------------------------------------------------------------------------------- 428 (613)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 007200 429 -------------------------------------------------------------------------------- 428 (613)
Q Consensus 429 -------------------------------------------------------------------------------- 428 (613)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred -CcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccC-CCcchH
Q 007200 429 -FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-DDDVML 506 (613)
Q Consensus 429 -~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~-~~~~~~ 506 (613)
-++||+|||-|+-... ..+.-.-|..|+|||++.+..|++.+||||++|+++||+||...|++.+... ..+...
T Consensus 390 di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred ceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0123333333321110 1111225778999999999999999999999999999999999998654322 112222
Q ss_pred HHHHHHHh---------hcccccccccCcc-------------------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 507 LDWVKGLL---------KEKKLEQLVDSDM-------------------EGNYIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 507 ~~~~~~~~---------~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
+..+...+ ..+.-.+++++.- ....+.+...++.+++.-||+.+|++||||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 22221111 1112222332211 1234567788999999999999999999999
Q ss_pred HHHH
Q 007200 559 EVVR 562 (613)
Q Consensus 559 evl~ 562 (613)
+.++
T Consensus 546 ~cl~ 549 (590)
T KOG1290|consen 546 QCLK 549 (590)
T ss_pred HHhc
Confidence 9987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=262.76 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=171.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.-|..++.||-|+||.|.+++-. +...||.|.+++.. ........+.|-++|...+++-||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 44667788999999999999844 46678999987542 2223445788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
+|++||++-++|-+.+. |.+..++.++..+..|+++.|.. |+|||||||+|||||.+|.+||+||||++-+.=
T Consensus 709 dYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999977664 88999999999999999999999 999999999999999999999999999853310
Q ss_pred --------CCCce---------------------------------eeccccccccccccccccCCCCCcccchhHHHHH
Q 007200 445 --------KDTHV---------------------------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483 (613)
Q Consensus 445 --------~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il 483 (613)
...+. ....+||+.|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00000 0124599999999999999999999999999999
Q ss_pred HHHHhCCCCcccc
Q 007200 484 LELITGQRAFDLA 496 (613)
Q Consensus 484 ~elltg~~p~~~~ 496 (613)
|||+.|++||-..
T Consensus 862 ~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 862 YEMLVGQPPFLAD 874 (1034)
T ss_pred HHHhhCCCCccCC
Confidence 9999999999643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=233.68 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=192.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEe-CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcC--CceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 362 (613)
.++|++.+++|+|.|+.||.|.. .+.++++||+++... .+.+.+|+.+|..+. ||||+++++...++ ....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35788889999999999999984 468899999997543 456889999999998 99999999998875 44579
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEecccccee
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 441 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~ 441 (613)
|+||+.+.+...+-. .++..++..++.+++.||.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 999999887666543 378889999999999999999999 99999999999999864 5799999999988
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
+.+. ......+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||-....+ ......+...+....+.
T Consensus 183 YHp~--~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN----~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 183 YHPG--KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVKIAKVLGTDELY 256 (338)
T ss_pred cCCC--ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC----HHHHHHHHHHhChHHHH
Confidence 6543 233444467789999998765 4788899999999999999999999533321 11111111111111111
Q ss_pred c-------cccCccCC---CC-------------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 Q-------LVDSDMEG---NY-------------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~-------~~~~~~~~---~~-------------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .+++.... .. ..-...+.++++.+.+..|..+|||++|.+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 02221110 00 0001246788888999999999999999887
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=232.71 Aligned_cols=211 Identities=35% Similarity=0.517 Sum_probs=184.1
Q ss_pred cccCcCcEEEEEEeCC-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcchh
Q 007200 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374 (613)
Q Consensus 296 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 374 (613)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.+.|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765443234678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEeccccceecCCCCCceeecc
Q 007200 375 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 453 (613)
Q Consensus 375 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 453 (613)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987653 2488999999999999999999999 9999999999999999 89999999999986654321 12234
Q ss_pred ccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCc
Q 007200 454 RGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532 (613)
Q Consensus 454 ~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (613)
.+...|++||.+... ..+.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 788999999999999998
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 533 EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 533 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=256.56 Aligned_cols=196 Identities=22% Similarity=0.316 Sum_probs=167.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc-------HHHHHHHHHHHhhcc---cCccceeeEEEEcC
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAV---HRNLLRLRGFCMTP 357 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 357 (613)
+|+..+.+|+|+||.|+.|.++ +...|+||.+.+++.-.. .-..-.||.+|+.++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5888899999999999999988 456789998876642111 112456999999998 99999999999999
Q ss_pred CceEEEEecc-cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 358 TERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 358 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+..|++||-. ++-+|.++++... .+++.+++.|++|++.|+++||++ +|||||||-+|+.++.+|-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999975 5668999997654 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~ 494 (613)
|.+..... .....++||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 715 gsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99865432 23455779999999999998887 567899999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=237.84 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=193.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC------Cc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 359 (613)
.+|..+..+|.|.- .|..+.+. .++.||+|++..+.. .....+..+|...+..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999998 66667655 689999998865532 22345678999999999999999999998633 45
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.|+|||+| .++|...++.. ++-.++..|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 69999999 45888877632 77889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc----------CCCcchHHHH
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA----------NDDDVMLLDW 509 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~----------~~~~~~~~~~ 509 (613)
+.-+.. ...+..+.|..|.|||++.+..+...+||||.||++.||++|+..|.....- +..+..+.+.
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865432 3445567899999999999999999999999999999999999999522110 0011111111
Q ss_pred HHH----Hhhcc--cc----cc-cccCccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 510 VKG----LLKEK--KL----EQ-LVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 510 ~~~----~~~~~--~~----~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+.. +.+.. .. .+ +.|..... ....-......+++.+|+-.||++|.++.++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111 00000 00 00 00000000 0111233557889999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=230.41 Aligned_cols=276 Identities=19% Similarity=0.280 Sum_probs=197.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEE-EEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF-CMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 364 (613)
+.|.+.+.+|+|.||.+-+++++ +.+.+++|.++.+... ..+|.+|..---.+ .|.||+.-++. |+..+..++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 56888899999999999999987 6778999999876543 56788887754334 58999987765 45567778999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCcEEEeccccceec
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLM 442 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfGla~~~ 442 (613)
||++.|+|.+-+...+ +-+...+.++.|++.||.|+|++ ++||||||.+|||+- +..++|++|||+.+..
T Consensus 102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999887654 77899999999999999999999 999999999999984 3358999999998754
Q ss_pred CCCCCceeeccccccccccccccccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+..-. ...-+-.|.+||..... ...+.+|||.|||+++.++||+.||+.+.........+.+|..+.
T Consensus 174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk---- 245 (378)
T KOG1345|consen 174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK---- 245 (378)
T ss_pred Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc----
Confidence 42111 11235579999977533 246789999999999999999999985544333333333333221
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCcchhhHHHhhhhhhcccccCCCCCC
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPN 593 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (613)
...+ +..- ......+.++.++-+.++|++|-...++..... ..|-+-......+.|.+.+.+++
T Consensus 246 -~~~~--P~~F----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk-----~~w~E~~i~t~k~~ee~~~tn~d 309 (378)
T KOG1345|consen 246 -NPAL--PKKF----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK-----CLWKEKLIKTVKRPEEDYYTNID 309 (378)
T ss_pred -CccC--chhh----cccCHHHHHHHHHhcCCcccccchhHHHHHHHH-----HHHHHhhhccccChhhccccccC
Confidence 1111 1111 112346677788889999999976666666543 34554444444444444443433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=255.68 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=200.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|+....+|+|.||.||++++. +++..|+|+++-+... ...-.++|+-+++..+|+||+.++|.+...+..|++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 367888899999999999999976 7999999999866433 34457789999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||.+|+|.+.-+..+ ++++..+..+.+..++||+|||++ +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence 999999999877654 489999999999999999999999 889999999999999999999999999876543
Q ss_pred CCceeecccccccccccccc---ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
....+..+.||+.|||||+. ..+.|..++|||+.|+...|+---++|.... ...+...-+-+ ..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--------hpmr~l~LmTk-----S~ 231 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--------HPMRALFLMTK-----SG 231 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--------chHHHHHHhhc-----cC
Confidence 22334557799999999976 3556889999999999999998877774211 01111111100 11
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.++... .........+.++++.|+..+|++|||++.+++
T Consensus 232 ~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111111 011223456889999999999999999998876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=228.40 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=171.5
Q ss_pred CCCCCccccCcCcEEEEEEeCC-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEeccc
Q 007200 290 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (613)
|...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999874 889999999765433245678899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 448 (613)
+++|.+++...... +++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998764321 78899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeecccccccccccccc-ccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 449 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 449 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334578889999998 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=246.31 Aligned_cols=206 Identities=22% Similarity=0.257 Sum_probs=171.7
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc------cCccceee
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLR 351 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~ 351 (613)
.+.-.+....+|.+....|+|-|++|..|.+. .|..||||++.....- ...=+.|+++|++|+ --|.++++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 34445566788999999999999999999976 5889999999764321 223357999999986 34789999
Q ss_pred EEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-c
Q 007200 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-E 430 (613)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~ 430 (613)
-.|...+++|||+|-+ .-+|.+.+...+.. ..+....+..++.|+.-||..|... +|+|.||||.|||+++.. .
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 9999999999999987 45899999887653 4589999999999999999999998 999999999999999864 5
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
+||||||.|....... -+.+..+..|.|||++.+.+|+...|+||.||+|||+.||+..|.
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 7999999997654332 122335667999999999999999999999999999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=229.61 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=166.5
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcC
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 357 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 357 (613)
.....+.|...++||+|.|++||++.+. .++.||+|.+...... .+...|+++|..+. +.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445567889999999999999999854 3678999998765443 46789999999886 99999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEecc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 436 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df 436 (613)
+...+|+||++..+..++... ++..++..++..++.||+++|.+ |||||||||+|+|.+.. +.-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999988888765 67889999999999999999999 99999999999999864 56789999
Q ss_pred ccceecCCCC---------------------------------C----------ceeeccccccccccccccccC-CCCC
Q 007200 437 GLAKLMDYKD---------------------------------T----------HVTTAVRGTIGHIAPEYLSTG-KSSE 472 (613)
Q Consensus 437 Gla~~~~~~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~~-~~~~ 472 (613)
|+|...+... . .......||++|.|||++..- ..++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9986211000 0 001124599999999998764 4688
Q ss_pred cccchhHHHHHHHHHhCCCCccc
Q 007200 473 KTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 473 ~~DVwS~G~il~elltg~~p~~~ 495 (613)
++||||.|||+..+++++.||-.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccceeeccceeehhhcccccccc
Confidence 99999999999999999999953
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=266.75 Aligned_cols=195 Identities=14% Similarity=0.131 Sum_probs=138.0
Q ss_pred hccc-CccceeeEEE-------EcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007200 341 MAVH-RNLLRLRGFC-------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412 (613)
Q Consensus 341 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 412 (613)
.+.| .||+++++++ ......+.++||+ +++|.+++.... .++++..++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 5788888876 2234567788887 669999997432 3489999999999999999999999 9
Q ss_pred eEecCCCCCceeecC-------------------CCcEEEeccccceecCCCCC---------------ceeeccccccc
Q 007200 413 IIHRDVKAANILLDE-------------------EFEAVVGDFGLAKLMDYKDT---------------HVTTAVRGTIG 458 (613)
Q Consensus 413 ivH~Dlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~ 458 (613)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 44566666666653211000 00111347889
Q ss_pred cccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHH
Q 007200 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 538 (613)
Q Consensus 459 y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (613)
|||||++.+..++.++|||||||++|||++|.+|+.... ..+..... . ...+.. ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~-~----~~~~~~-----~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH-R----VLPPQI-----LLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH-h----hcChhh-----hhcCHH
Confidence 999999999999999999999999999999988874211 01111100 0 011100 111234
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 007200 539 LIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 539 l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...++.+||+++|.+||++.|+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 567888999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=207.75 Aligned_cols=166 Identities=22% Similarity=0.268 Sum_probs=124.8
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.++++..+ .++++..+..++.|+++||+|||++ + ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68888887643 2499999999999999999999998 6 999999999999999 99998764322
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..... .......+....... .+.. .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~-------~~~~-~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPAD-------DPRD-R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccC-------Cccc-c
Confidence 2488999999999999999999999999999999999999953221 011111111111100 0000 0
Q ss_pred CCcHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 530 NYIEEEVE--QLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 530 ~~~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........ .+.+++..||+.+|++||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01122222 68999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=205.67 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=187.7
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccc-cCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.-+|.+...|..|+|+++ |..+++|++.-. .+.....+|..|.-.++.+.||||+.++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888999999999998 666777877643 233334579999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceee
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 451 (613)
|+..+++.. ....+..++.+++.++|+|++|||+. .+-|.---|.+..+++|++.+.+|+ ++-+++- ....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs-----fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-----FQEV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee-----eecc
Confidence 999998753 33477888999999999999999996 4445556789999999999888875 1111110 0111
Q ss_pred ccccccccccccccccCCC---CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccC
Q 007200 452 AVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528 (613)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~---~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (613)
...-.+.||+||.++..+. -.++|+|||++++||+.|...||...+..+. + .++.-..+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------g-------mkialeglr 407 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------G-------MKIALEGLR 407 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------h-------hhhhhcccc
Confidence 1123678999999987764 3578999999999999999999963321110 0 112222333
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 529 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...++.....+.+++.-|++.||.+||.+..|+-.||.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 34455556678888888999999999999999998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=213.89 Aligned_cols=176 Identities=22% Similarity=0.221 Sum_probs=134.0
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC--CCCEEEEEEecccc----CcccHHHHHHHHHHHhhcccCccce-eeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLR-LRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~ 356 (613)
....++|...+.||+|+||+||+|.+. +++.+|||++.... .......+.+|+++++.++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999865 57778999875331 1223456899999999999999985 4432
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCcEEEec
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGD 435 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~D 435 (613)
...++||||++|++|.. +.. .. ...++.++++||+|||+. ||+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 45799999999999963 211 11 146788999999999999 9999999 99999999999999999
Q ss_pred cccceecCCCCCcee-------eccccccccccccccccCC------CCCcccch
Q 007200 436 FGLAKLMDYKDTHVT-------TAVRGTIGHIAPEYLSTGK------SSEKTDVF 477 (613)
Q Consensus 436 fGla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~DVw 477 (613)
||+++.+........ ....+++.|+|||.+.... .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999987654321111 2355888999999986443 23346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=208.33 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=191.8
Q ss_pred CCCCCCccccCcCcEEEEEEeCCC--CEEEEEEeccccCcccHHHHHHHHHHHhhccc----CccceeeEEE-EcCCceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~ 361 (613)
+|.+.+.||+|+||.||.+..... ..+|+|........... .+..|..++..+.. +++..+++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 799999999999999999997653 47899987765433222 57778888887763 6899999998 4777889
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----CcEEEecc
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 436 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Df 436 (613)
+||+.+ |.+|.++..... ...++..+...|+.|++.+|++||+. |++||||||.|+++... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999977 889999886654 34599999999999999999999999 99999999999999865 46999999
Q ss_pred ccceecC--CCCCc----e---eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007200 437 GLAKLMD--YKDTH----V---TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 437 Gla~~~~--~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~ 507 (613)
|+++... ..... . .....||..|+++....+...+++.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998322 11111 1 2335599999999999999999999999999999999999999953321111 1
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+........... ........+.++...+-..+..++|....+...+++
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 11111111111110 111122345555555556899999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-24 Score=229.18 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=185.8
Q ss_pred CCCccccCcCcEEEEEEeC-CCCEEEEEEec----cccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 292 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..+.+|.|++|.|+..... ..+..+.|... ..... .....+..|+-+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4577999999988877644 34444554433 11111 111125556667778899999888887777666666699
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||++ +|..++...+ .+...++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999987652 278889999999999999999999 9999999999999999999999999999877544
Q ss_pred CC---ceeeccccccccccccccccCCCCC-cccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 446 DT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 446 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.. .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||..+....... ....... +
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~---~ 543 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSD---Q 543 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccc---c
Confidence 33 3456677999999999999988865 5799999999999999999998665332211 0000000 0
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.-...-........+..-..++..|+++||.+|.|+++|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011122334456788999999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-21 Score=196.88 Aligned_cols=262 Identities=28% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCccc--HHHHHHHHHHHhhcccC-ccceeeEEEEcCCceEEEEec
Q 007200 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 366 (613)
|...+.||.|+||.||++... ..+++|.+........ ...+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 7899999987665543 66799999999999988 799999999777778999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 445 (613)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776654321 2488999999999999999999999 999999999999999998 7999999999865543
Q ss_pred CCc-----eeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 446 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 446 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILEL 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhc
Confidence 322 2355669999999999987 57889999999999999999999997533210 0011111111111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... .................+.+++..|+..+|..|.++.+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 000000000002223568889999999999999999887764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=234.65 Aligned_cols=177 Identities=34% Similarity=0.621 Sum_probs=129.4
Q ss_pred CchHHHHHHHHHHhcCCCCCCCCCCCCCCCCCccceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccC
Q 007200 26 SNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI 105 (613)
Q Consensus 26 ~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~C~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 105 (613)
.+.|+.||++||+.+.||.+.+.+|+. ..++|.|.||+|+..++|+.|+|++|++++.++..|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 558999999999999999888999975 4689999999998778999999999999999999999999999999999999
Q ss_pred CCCCccccc-cCCcCCeEeccCccCCCC----------------------CCcccccccccccccccCccccCccccccc
Q 007200 106 SGKVPEELG-NLTNLVSLDLYLNNLNGP----------------------IPTTLGKLSKLRFLRLNNNSLMGEIPRSLT 162 (613)
Q Consensus 106 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~----------------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 162 (613)
++.+|..+. .+++|++|+|++|.+++. +|..++++++|++|+|++|.+.+.+|..+.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 888876544 677777777777766554 444455555555555555555555555555
Q ss_pred cccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 163 NVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
++++|++|+|++|.+.+.+|. .+.+++|+.|++++|.+...
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 227 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCc
Confidence 555555555555555544433 24555555666666555543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=183.46 Aligned_cols=256 Identities=17% Similarity=0.234 Sum_probs=191.3
Q ss_pred hCCCCCCccccCcCcEEEEEE-eCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 365 (613)
-+|.+.++||+|.||.++.|+ +-+++.||||.-.... ..-++..|....+.+. .++|..++-|..++.+..||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 468899999999999999998 4479999999764332 2336778888888876 6899999988888889999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----CcEEEeccccce
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDFGLAK 440 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~DfGla~ 440 (613)
.+ |.+|.++..-++. .|+.+++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 87 8899998876654 499999999999999999999999 99999999999999743 358999999999
Q ss_pred ecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 441 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 441 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
.+...... ...+..||.+||+--...++..+.+.|.=|+|-++.+.+-|..||+...... ...-.+.+....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~kYeKIGe~K 255 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKEKYEKIGETK 255 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHHHHHHhcccc
Confidence 77543322 2345669999999999999999999999999999999999999997443211 101111111100
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 564 (613)
+...+.. .+...++++..-+...-..+-++-|..+-+...+
T Consensus 256 r~T~i~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 256 RSTPIEV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred ccCCHHH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 0011111 1122334555555555577888888877665544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=182.26 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=196.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEe-CCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc-CccceeeEEEEcCCceEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l 362 (613)
+...+|.+.++||+|+||.+|.|.. .+|+.||||.-...... .++..|..+...+++ ..|..+.-|..+.....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3456899999999999999999984 48999999987654332 356788889988875 567777888888899999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEeccccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 439 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla 439 (613)
||+.. |.+|.+++.-... .++..+++-++.|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|
T Consensus 89 VMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 99987 8899998876543 389999999999999999999999 99999999999999754 36889999999
Q ss_pred eecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 440 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 440 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+.+...... ......||.+|.+--...+...+.+.|+=|+|.+|.++--|..||+....... ....+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk------~QKyEk 235 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK------KQKYEK 235 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH------HHHHHH
Confidence 876433221 12345699999998888888888999999999999999999999974331110 111111
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
+.+.++...+.. .+...+.++...+..|-..--++-|...-+-+..+
T Consensus 236 I~EkK~s~~ie~-----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 236 ISEKKMSTPIEV-----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHhhcCCCHHH-----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 222222211111 12233456777888898888899998877766654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=179.33 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=109.3
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc-c------------------------HHHHHHHHHHHhhcccCcc
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-G------------------------ELQFQTEVEMISMAVHRNL 347 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~l~h~ni 347 (613)
...||+|+||.||+|...+|+.||||+++...... . ......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999997543211 0 0122458999999988877
Q ss_pred ceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceeec
Q 007200 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLD 426 (613)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~NIll~ 426 (613)
.....+.. ...++||||+.++++....... .+++...+..++.|++.+|+|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 2348999999988776543222 2488999999999999999999 688 999999999999998
Q ss_pred CCCcEEEeccccceecC
Q 007200 427 EEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 427 ~~~~~kl~DfGla~~~~ 443 (613)
+ +.++|+|||+|....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=197.14 Aligned_cols=215 Identities=23% Similarity=0.385 Sum_probs=163.7
Q ss_pred HhhcccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 007200 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI-IHRD 417 (613)
Q Consensus 339 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~D 417 (613)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..... .+++.....++++|+.||+|+|+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3568899999999999999999999999999999999987443 489999999999999999999997 55 8999
Q ss_pred CCCCceeecCCCcEEEeccccceecCCC-CCceeeccccccccccccccccCC-------CCCcccchhHHHHHHHHHhC
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGVMLLELITG 489 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DVwS~G~il~elltg 489 (613)
++++|++++....+||+|||+....... .........-..-|.|||.+.+.. .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766421 111111222345699999987641 46779999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 490 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+.||+......+. ...+.++.. .-...+.+...... +....+..++..||..+|++||++++|-..++..
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999855433332 122222222 11112222221111 3334789999999999999999999999888765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=212.32 Aligned_cols=256 Identities=23% Similarity=0.272 Sum_probs=185.4
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHH--HhhcccCccceeeEEEEcCCceEEEEec
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++...+.+|++.|=+|.+|++..|. |+||++.+....-....|.++++- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666788999999999999998787 999998765544343444443332 5566899999988776667777888888
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec--CC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DY 444 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~--~~ 444 (613)
..+ +|++.+..+ +-+...+.+-|+.|++.||.-+|.. ||+|||||.+|||++.=.=+.|+||.--+-. +.
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 854 788887543 3478888899999999999999999 9999999999999999878899999865422 22
Q ss_pred CCCce----eeccccccccccccccccC----------C-CCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007200 445 KDTHV----TTAVRGTIGHIAPEYLSTG----------K-SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 445 ~~~~~----~~~~~gt~~y~aPE~~~~~----------~-~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 508 (613)
.+... ......-..|+|||.+... . .+++.||||+||++.|+++ |++||...++-.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-------- 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-------- 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh--------
Confidence 21111 1122234479999988642 1 4788999999999999888 799997544211
Q ss_pred HHHHHhhcc--cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCcchhh
Q 007200 509 WVKGLLKEK--KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 573 (613)
Q Consensus 509 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 573 (613)
+-... ....++.. +. ...+.+++..|++.||++|.++++.++.-++..+++=+
T Consensus 247 ----Yr~~~~~~~e~~Le~-Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yF 301 (1431)
T KOG1240|consen 247 ----YRSGNADDPEQLLEK-IE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYF 301 (1431)
T ss_pred ----HhccCccCHHHHHHh-Cc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHH
Confidence 11110 00001110 00 12588999999999999999999999999887766543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=179.76 Aligned_cols=173 Identities=10% Similarity=0.094 Sum_probs=134.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccH--HH------HHHHHHHHhhcccCccceeeEEEEc
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
+..++|...+++|.|+||.||.+.. ++..+|||.++........ .. +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4567899999999999999999766 5778999999765433221 12 6789999999999999999998663
Q ss_pred C--------CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 357 P--------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 357 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
. ...+++|||++|.+|.++.. ++. ....+++.++..+|.. |++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999977631 232 2455889999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHH
Q 007200 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ell 487 (613)
+ ++++|||..+....... .......+.+..++||||||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 8 99999998864421110 011334555667899999999987554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=172.53 Aligned_cols=140 Identities=19% Similarity=0.208 Sum_probs=111.5
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc--------------------c-----HHHHHHHHHHHhhcccCcc
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--------------------G-----ELQFQTEVEMISMAVHRNL 347 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~l~h~ni 347 (613)
...||+|++|.||+|...+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999987643110 0 1124578899999999987
Q ss_pred ceeeEEEEcCCceEEEEecccCCcchhh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceee
Q 007200 348 LRLRGFCMTPTERLLVYPFMVNGSVASC-LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 425 (613)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll 425 (613)
.....+... ..++||||++++++... +.. .+++......++.+++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655544433 34899999998865443 322 136788999999999999999999 8 99999999999999
Q ss_pred cCCCcEEEeccccceecC
Q 007200 426 DEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~ 443 (613)
+ ++.++|+|||+++..+
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=203.96 Aligned_cols=134 Identities=37% Similarity=0.674 Sum_probs=116.9
Q ss_pred cCchHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc-----cceeEEeCCC-----CCeEEEEcCCCCcccccchhhhCCCC
Q 007200 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPC-----TWFHVTCNSE-----NSVTRVDLGNANLSGQLVSQLGQLTN 94 (613)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~C-----~~~gv~c~~~-----~~l~~L~l~~n~l~~~~~~~~~~l~~ 94 (613)
....|..||+.+|..+.+|.. .+|++ +|| .|.||.|+.. ..|+.|+|++|+++|.+|..+.++++
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 345789999999999977643 48964 456 7999999532 24899999999999999999999999
Q ss_pred CCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccccccc
Q 007200 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN 163 (613)
Q Consensus 95 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 163 (613)
|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 999999999999999999999999999999999999999999999999999999999999988887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=164.07 Aligned_cols=184 Identities=17% Similarity=0.069 Sum_probs=137.3
Q ss_pred CCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc---cHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecc
Q 007200 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG---GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
....|++|+||+||.+.. .+.+++.+.+....... ....+.+|+++++++. |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999997766 57888888776543311 1225789999999996 5889999886 4579999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCcEEEeccccceecCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
.|.+|...... ....++.+++++|+++|++ ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99988654311 1134678899999999999 9999999 7999999999999999999998655332
Q ss_pred Cc----e--------eecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 447 TH----V--------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 447 ~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
.. . +.-...++.|++|+.-.- ...-.+.+.++-|.-+|.++|+..++-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 11 0 011125677888875322 122245688899999999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-20 Score=191.89 Aligned_cols=247 Identities=25% Similarity=0.272 Sum_probs=189.0
Q ss_pred cccCcCcEEEEEE----eCCCCEEEEEEeccccCccc-HHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecccC
Q 007200 296 LGRGGFGKVYKGR----LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 296 ig~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+|+|.||.|+.++ ...|..+|.|.+++...... ......|..++...+ ||.++++.-.++.+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999765 22477899998876543222 114456777888887 99999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99998886654 378888888889999999999999 9999999999999999999999999999865332221
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
+||..|||||++. ....++|-||||++++||+||..||.. +.+..+++.+ .
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~-----------~ 204 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE-----------L 204 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-----------c
Confidence 7999999999987 567789999999999999999999962 1111221111 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHhhcCCc-chhhHHHhhh
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKM--SEVVRMLEGDGL-AERWEEWQKE 579 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~~~~~-~~~~~~~~~~ 579 (613)
..+.+.......++..+...+|..|--. ..+.+..+...+ ...|.+-...
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r 257 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEAR 257 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhc
Confidence 2244555667788888899999999865 455555554422 3446644333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=173.53 Aligned_cols=233 Identities=23% Similarity=0.305 Sum_probs=147.6
Q ss_pred CCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcc----------cCccceeeEEEE--
Q 007200 291 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAV----------HRNLLRLRGFCM-- 355 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~-- 355 (613)
...+.||.|+++.||.+++. +|+.+|+|++...... ...+++++|.-....+. |-.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999987 5899999998654422 22445666655444422 222333333322
Q ss_pred -------cCC--------ceEEEEecccCCcchhhhhc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007200 356 -------TPT--------ERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (613)
Q Consensus 356 -------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (613)
... ..+++|+-+ .+||.+++.. .......+....+..+..|+++.+++||+. |+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 235677777 5678777542 222222345566677889999999999999 999999
Q ss_pred CCCCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccC--------CCCCcccchhHHHHHHHHHhC
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--------KSSEKTDVFGYGVMLLELITG 489 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DVwS~G~il~elltg 489 (613)
|+|+|++++.+|.+.|+||+.....+. .......+..|.+||..... .++.+.|.|++|+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999998765432 11113356789999976442 468889999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 007200 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER 554 (613)
Q Consensus 490 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 554 (613)
+.||+.......... ....+.+.++.+..+|..+++.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~-----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999974432221110 111222567889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=162.18 Aligned_cols=137 Identities=19% Similarity=0.194 Sum_probs=105.3
Q ss_pred CCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-----ccCccceeeEEEEcCC---c-e
Q 007200 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---E-R 360 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 360 (613)
++..+.||+|+||.||. +......+||++...... ....+.+|+.++..+ .||||++++|++.++. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34467899999999996 443333479988654322 345789999999999 5799999999998864 3 3
Q ss_pred EEEEec--ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeecC----CCcEEE
Q 007200 361 LLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL-AYLHDHCDPKIIHRDVKAANILLDE----EFEAVV 433 (613)
Q Consensus 361 ~lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl 433 (613)
.+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 378999 56899999996532 4444 35677888777 999999 9999999999999974 347999
Q ss_pred eccccc
Q 007200 434 GDFGLA 439 (613)
Q Consensus 434 ~DfGla 439 (613)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-19 Score=196.40 Aligned_cols=202 Identities=21% Similarity=0.245 Sum_probs=162.2
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc---cCccceeeEEEEc
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMT 356 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 356 (613)
..+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+..... +|.-=.+++.+|+ -+.|..+..++.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34556677889999999999999999999888999999987765433 2222223333443 3445666666666
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------CC
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------EF 429 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~ 429 (613)
.+..++|+||.+.|+|.+++...+ ..+|..+..++.|+++.+++||.. +|||+||||+|+|+.. ..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CCcceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 788899999999999999998433 388999999999999999999999 9999999999999942 34
Q ss_pred cEEEeccccceecCC-CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 007200 430 EAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492 (613)
Q Consensus 430 ~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p 492 (613)
.++|+|||.+..+.. .+........+|-.+-.+|...|+++++..|-|.++-+++-|+.|+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 589999999865532 233345566789999999999999999999999999999999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=167.72 Aligned_cols=197 Identities=22% Similarity=0.295 Sum_probs=136.3
Q ss_pred ccCccceeeEEEEc---------------------------CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHH
Q 007200 343 VHRNLLRLRGFCMT---------------------------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395 (613)
Q Consensus 343 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 395 (613)
+|||||++.++|.+ +...|+||..+. .+|..++-... .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999987643 234578888774 47888876543 5667788899
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC--cEEEeccccceecCCCC-----Cceeeccccccccccccccc
Q 007200 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYLS 466 (613)
Q Consensus 396 ~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 466 (613)
.|+++|+.|||.+ ||.|||+|++|||+. +|+ .+.|+|||++-..+... ....-...|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999984 343 46899999875433211 11112234777899999986
Q ss_pred cCCC------CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHH
Q 007200 467 TGKS------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLI 540 (613)
Q Consensus 467 ~~~~------~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 540 (613)
..+- -.|+|.|+.|-+.||+++...||..-. . .+ +......+.--+. .++.+...+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-----e-m~-------L~~r~Yqe~qLPa----lp~~vpp~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-----E-ML-------LDTRTYQESQLPA----LPSRVPPVAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-----h-he-------echhhhhhhhCCC----CcccCChHHH
Confidence 5432 357999999999999999999996311 0 00 0000011111111 1223334677
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 541 QVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 541 ~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
+++...++.||++|++..-....|.
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 8888899999999999877666664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=160.08 Aligned_cols=143 Identities=15% Similarity=0.101 Sum_probs=111.1
Q ss_pred CCCCCCccccCcCcEEEEEE--eCCCCEEEEEEeccccCcc-----------------------cHHHHHHHHHHHhhcc
Q 007200 289 NFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQG-----------------------GELQFQTEVEMISMAV 343 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 343 (613)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999998 4589999999987542110 0123568999999997
Q ss_pred cCc--cceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 007200 344 HRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKA 420 (613)
Q Consensus 344 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~ 420 (613)
+.. +.+++++ ...++||||+.++++........ ++.......++.|++.++++||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3444443 23589999999988876653221 255667789999999999999999 9 99999999
Q ss_pred CceeecCCCcEEEeccccceecC
Q 007200 421 ANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 421 ~NIll~~~~~~kl~DfGla~~~~ 443 (613)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=154.71 Aligned_cols=145 Identities=20% Similarity=0.152 Sum_probs=112.2
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc---------------------ccHHHHHHHHHHHhh
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISM 341 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~ 341 (613)
+......|...+.||+|+||.||++...+|+.||||++...... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447888999999999999999888999999987643210 011235678888888
Q ss_pred cccCc--cceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007200 342 AVHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK 419 (613)
Q Consensus 342 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 419 (613)
+.|++ +...++. ...+++|||+++++|...... .....++.+++.++.++|+. +++|||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88874 4444432 455899999999998765421 23467888999999999998 99999999
Q ss_pred CCceeecCCCcEEEeccccceecCC
Q 007200 420 AANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 420 ~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|+||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=155.73 Aligned_cols=135 Identities=20% Similarity=0.320 Sum_probs=114.1
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcc-------cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.||+|++|.||+|.. .|..+++|......... ....+.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999866433211 123577899999999999998888887778888999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++|++|.+++.... . .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 7889999999999999999 999999999999999 78999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-18 Score=176.02 Aligned_cols=174 Identities=25% Similarity=0.373 Sum_probs=130.5
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++.|++|...+|.+|+..... ....++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46899999999999999975432 3447889999999999999999 6 899999999999999999999999999
Q ss_pred ceecCCCC-----CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007200 439 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 439 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
........ ........||..||+||.+.+..|+.++||||+|++++|+++ =..+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 98765443 223345569999999999999999999999999999999987 222221
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 560 (613)
+...+..+-+..++..+..+. ..=..++.+++.+.|.+||++.+.
T Consensus 465 --r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 111222222222221111111 123578888999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=154.55 Aligned_cols=131 Identities=18% Similarity=0.313 Sum_probs=107.4
Q ss_pred ccccCcCcEEEEEEeCCCCEEEEEEeccccCcc-------cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.||+|+||.||+|.+ +|..+++|......... ...++.+|++++..+.|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 47889999865432111 1245778999999999887766666666777789999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+|++|.+++.... . .++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~--------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN--------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH--------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7889999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=173.30 Aligned_cols=140 Identities=17% Similarity=0.246 Sum_probs=112.8
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEe-ccccCc------ccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQ------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
....|...+.||+|+||+||+|.+... .+++|+. .+.... .....+.+|++++..++|++++....++..+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556788999999999999987643 4444432 221111 11245789999999999999998888888778
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+||++ +++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999998875 3467899999999999999 99999999999999 567999999999
Q ss_pred ceec
Q 007200 439 AKLM 442 (613)
Q Consensus 439 a~~~ 442 (613)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-16 Score=170.91 Aligned_cols=214 Identities=21% Similarity=0.294 Sum_probs=142.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.+|+.++.|..|+||.||..+++ ..+.+|+| +.+.... .+- ++....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hhc--cccccCCccee------------------
Confidence 56888999999999999999987 45677884 3322110 110 22222333332
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|+-...++..+. ++... +.+++|||+. +|||||+||+|.+++.-|.+|+.|||+++......
T Consensus 136 ---gDc~tllk~~g~----lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP----LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccCCC----Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 455555554332 22222 6789999999 99999999999999999999999999886542211
Q ss_pred --------------CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 447 --------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 447 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
......++||+.|+|||++..+.|.+-+|.|++|+|+||.+-|+.||.... .+..+. .
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt----peelfg----~ 269 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEELFG----Q 269 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC----HHHHHh----h
Confidence 111234679999999999999999999999999999999999999996321 111111 1
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
++.+... -++. ......+..+++.+.++.+|..|--....++
T Consensus 270 visd~i~----wpE~----dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 270 VISDDIE----WPEE----DEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hhhhhcc----cccc----CcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 1111110 0000 1112345677777888999999974444333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=140.09 Aligned_cols=137 Identities=20% Similarity=0.206 Sum_probs=98.8
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCccc-HHH----------------------HHHHHHHHhhcccCc--c
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG-ELQ----------------------FQTEVEMISMAVHRN--L 347 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~e~~~l~~l~h~n--i 347 (613)
.+.||+|+||+||+|...+|+.||||+++....... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999875422111 111 134555555554432 4
Q ss_pred ceeeEEEEcCCceEEEEecccCCcchhh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceee
Q 007200 348 LRLRGFCMTPTERLLVYPFMVNGSVASC-LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 425 (613)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll 425 (613)
.+.+++ ...+++|||++++++... +.... .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 346899999999654321 21111 11 5678899999999999999 7 99999999999999
Q ss_pred cCCCcEEEeccccceecC
Q 007200 426 DEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~ 443 (613)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.7e-15 Score=132.24 Aligned_cols=135 Identities=18% Similarity=0.137 Sum_probs=113.8
Q ss_pred CCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--CccceeeEEEEcCCceEEEEecccC
Q 007200 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..+.| .++.+++++....+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35679999999999999864 7899998865433 4568899999999986 5899999988888889999999998
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 876654 4466778899999999999986334799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.6e-17 Score=140.47 Aligned_cols=135 Identities=27% Similarity=0.456 Sum_probs=116.0
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
.+.+++.|.||+|+|+ .+|+.+..|.+|+.|++++|+|+ .+|..++.|++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3467899999999998 67778889999999999999998 78888999999999999999988 789999999999999
Q ss_pred cccCccccC-ccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 147 RLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 147 ~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
||.+|++.. .+|+.|..+..|+.|+|++|.+.-.|++.+.+++|+.|.+..|.+...|
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lp 166 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLP 166 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCc
Confidence 999998874 5788888888889999999998888888888888888888888765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-16 Score=173.86 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=189.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC--CCEEEEEEecccc-CcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 363 (613)
..|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++.+++....+...+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346667779999999998887643 4456667665443 2222334556777777777 99999999999999999999
Q ss_pred EecccCCcchhhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceeecCCC-cEEEeccccce
Q 007200 364 YPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 440 (613)
Q Consensus 364 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~ 440 (613)
.+|..++++.+-+ +.... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888 43321 2556677788999999999999 77 999999999999999999 99999999998
Q ss_pred ecCC--CCCceeecccc-ccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 441 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 441 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
.+.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.+...... ...|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---YSSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---ceeecccc---
Confidence 7765 22333344568 9999999999884 5578899999999999999999999866533211 11221110
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ...............++..+++..+|+.|.+.+++..
T Consensus 248 ~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0001112223345778888899999999999988765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=140.14 Aligned_cols=136 Identities=19% Similarity=0.206 Sum_probs=105.4
Q ss_pred CCccc-cCcCcEEEEEEeCCCCEEEEEEecccc------------CcccHHHHHHHHHHHhhcccCcc--ceeeEEEEcC
Q 007200 293 RNILG-RGGFGKVYKGRLTDGSLVAVKRLKEER------------TQGGELQFQTEVEMISMAVHRNL--LRLRGFCMTP 357 (613)
Q Consensus 293 ~~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 357 (613)
...|| .|+.|+||.+... +..++||.+.... .......+.+|++++..+.|++| .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999885 7789999885321 01123467889999999998875 6777765433
Q ss_pred Cc----eEEEEecccC-CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 358 TE----RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 358 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
.. .++|||++++ .+|.+++... +++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 6888887542 24443 356789999999999 999999999999999988999
Q ss_pred Eecccccee
Q 007200 433 VGDFGLAKL 441 (613)
Q Consensus 433 l~DfGla~~ 441 (613)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-16 Score=138.43 Aligned_cols=136 Identities=26% Similarity=0.442 Sum_probs=127.3
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCC-CCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 147 (613)
.+++.|++.+|+|+ .+|..+..++.|+.|+++-|++. ..|..|+.++.|+.|||++|++.. .+|..|..|..|+-|+
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 47899999999999 78999999999999999999998 899999999999999999999873 5799999999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~~ 207 (613)
|++|.+. .+|..++.+++|+.|.+.+|.+-..|...+.++.|+.|.++||.++..||.-
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vlppel 192 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLPPEL 192 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeecChhh
Confidence 9999999 8899999999999999999999999999999999999999999998877653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-14 Score=137.53 Aligned_cols=212 Identities=17% Similarity=0.260 Sum_probs=147.1
Q ss_pred HHHHHHHHhhcccCccceeeEEEEcC-----CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007200 332 FQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406 (613)
Q Consensus 332 ~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 406 (613)
...-+.-+-.+.|-||++++.|+.+. ....+++|||..|++..+|++....+..+....-+++..||..||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 33445556678899999999998654 4568999999999999999887666666888899999999999999999
Q ss_pred hcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC----CCceeeccccccccccccccccCCCCCcccchhHHHH
Q 007200 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482 (613)
Q Consensus 407 ~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~i 482 (613)
+ |.|.|+|+++..+-|++..+|-+||.--- -....+. ....+....+-++|.|||.-.....+.++|||+||+.
T Consensus 194 s-~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 194 S-CDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred c-cCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 9 47789999999999999988888874211 1111000 0111222336789999998766677889999999999
Q ss_pred HHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 483 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 483 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..||..+..--.........+......+ ..+... .=...+..|++..|..||+|.+++.
T Consensus 272 AlemailEiq~tnseS~~~~ee~ia~~i----------~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSESKVEVEENIANVI----------IGLENG-----------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHHHheeccCCCcceeehhhhhhhhe----------eeccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence 9999887653211111000000000000 000000 0134677899999999999999887
Q ss_pred Hhhc
Q 007200 563 MLEG 566 (613)
Q Consensus 563 ~L~~ 566 (613)
..--
T Consensus 331 Hpll 334 (458)
T KOG1266|consen 331 HPLL 334 (458)
T ss_pred Ccee
Confidence 6543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-14 Score=148.89 Aligned_cols=136 Identities=25% Similarity=0.265 Sum_probs=107.4
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.|+|+.|+++..-.+++.+|+.|+.|+||+|.|..+-++.+...++|++|+||+|+|+...+..|..|..|++|+|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 36788888888888777778888888888888888888877888888888888888888888777777888888888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC----CCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN----GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~i~~~~ 204 (613)
+.|.++..-...|..+++|+.|||++|.|+..+++. .++++|+.|.+.||++...+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~ 408 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP 408 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc
Confidence 888887666667778888888888888887766643 44677777778888765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.8e-13 Score=140.91 Aligned_cols=142 Identities=23% Similarity=0.239 Sum_probs=99.8
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCccc---------------------------------------HHHHHH
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 334 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 334 (613)
+.||.|++|.||+|+..+|+.||||+.+......- +.+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864421100 012444
Q ss_pred HHHHHhhcc----cCccceeeEEE-EcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 007200 335 EVEMISMAV----HRNLLRLRGFC-MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR-GLAYLHDH 408 (613)
Q Consensus 335 e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~ 408 (613)
|...+.++. |.+-+.+-..+ .-....++||||++|++|.+........ . .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence 555444442 22222322222 2245679999999999999876532111 2 23456666655 46888988
Q ss_pred CCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 409 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|++|+|+||.||+++.+++++++|||++..++.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-14 Score=148.41 Aligned_cols=138 Identities=22% Similarity=0.269 Sum_probs=124.6
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
+.++.|+||+|.|..+-++.+...++|++|+|++|+|+...+..|..|..|++|+|++|+|+..-...|..+++|+.|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 46889999999999888899999999999999999999888999999999999999999999777788999999999999
Q ss_pred cCccccCcccc---ccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCC
Q 007200 149 NNNSLMGEIPR---SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 149 ~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
.+|.|++.+.+ .|.+|++|+.|+|.+|+|..++... .++..|+.|+|.+|.|...-+.
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccc
Confidence 99999987654 6788999999999999999877654 7889999999999998776443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-13 Score=141.68 Aligned_cols=249 Identities=21% Similarity=0.200 Sum_probs=180.1
Q ss_pred hCCCCCCcccc--CcCcEEEEEEe--C-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCce
Q 007200 288 DNFSNRNILGR--GGFGKVYKGRL--T-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (613)
Q Consensus 288 ~~~~~~~~ig~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 360 (613)
..|.....+|. |.+|.||.+.. . ++..+|+|.-+..... .....-.+|+...+.++ |+|.++.+..+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556678899 99999999987 3 6888999985443321 11223346677666665 99999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEec
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----GLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGD 435 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~D 435 (613)
++-+|++. .++.++.+.... .++...++.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999985 678777765433 2566777777777777 99999999 99999999999999999 8899999
Q ss_pred cccceecCCCCC----ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 436 FGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 436 fGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
||+...+....- .......|...|++||.. ++.++.++|||++|.++.+..++..++..... ..|.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWS- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcc-
Confidence 999987764431 111222477889999987 45678899999999999999998877643210 0111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
++-...++..+......++...+..|++.+|-.|++.+.+..
T Consensus 337 ---------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ---------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000001122222233345556888899999999999887765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-13 Score=142.19 Aligned_cols=134 Identities=31% Similarity=0.358 Sum_probs=82.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.++..+|||.|+|. .+|+.+.++++|+.|+||+|+|+ .+.-......+|+.|+||+|+++ .+|+.+++|++|+.|++
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 45667777777776 66777777777777777777776 34444455566666666666666 56666666666666666
Q ss_pred cCccccC------------------------ccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMG------------------------EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~------------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
.+|+++- ..|+++..++.|+.|.|+.|++-..|..+.-++.|+.|++..|+-.-.|
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMP 378 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMP 378 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCC
Confidence 6666541 3445555555555555555555555555555556666666666554444
Q ss_pred C
Q 007200 205 P 205 (613)
Q Consensus 205 ~ 205 (613)
|
T Consensus 379 P 379 (1255)
T KOG0444|consen 379 P 379 (1255)
T ss_pred C
Confidence 4
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-13 Score=140.88 Aligned_cols=130 Identities=32% Similarity=0.447 Sum_probs=70.3
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCC-------------------
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN------------------- 130 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~------------------- 130 (613)
+...|+||+|+|..++...|-+|+.|-.||||+|++. .+|.....|.+|+.|+||+|.+.
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 4455566666665444444556666666666666665 34444555555555555555542
Q ss_pred ------CCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCC
Q 007200 131 ------GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (613)
Q Consensus 131 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~ 201 (613)
..+|.++..|.+|..+|||.|.+. ..|+.+-++++|+.|+||+|+|+..--..+.+.+|+.|+++.|+++
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc
Confidence 124555555555666666666655 5555555556666666666655544443344444555555555443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-12 Score=138.70 Aligned_cols=146 Identities=22% Similarity=0.240 Sum_probs=95.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC-CCEEEEEEeccccCcc---------------------------------c-----
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG---------------------------------G----- 328 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---------------------------------~----- 328 (613)
..|+. +.||+|++|.||+|++++ |+.||||+.+...... -
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999986 9999999997542110 0
Q ss_pred -HHHHHHHHHHHhhcc----cCccceeeEEEEc-CCceEEEEecccCCcchhh--hhccCCCCCCCCHHHHHHHHHHHHH
Q 007200 329 -ELQFQTEVEMISMAV----HRNLLRLRGFCMT-PTERLLVYPFMVNGSVASC--LRERGQSQPPLNWSVRKQIALGAAR 400 (613)
Q Consensus 329 -~~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 400 (613)
+.++.+|...+.++. +.+.+.+-..+.+ ....++||||+.|+.+.+. +...+.....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 012344444444442 3333333333332 4567899999999999874 22222111113333333333333
Q ss_pred HHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEeccccceecCC
Q 007200 401 GLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMDY 444 (613)
Q Consensus 401 ~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfGla~~~~~ 444 (613)
... |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999987754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-13 Score=134.58 Aligned_cols=131 Identities=31% Similarity=0.468 Sum_probs=109.4
Q ss_pred CeEEEEcCCCCccc-----------------------ccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 70 SVTRVDLGNANLSG-----------------------QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 70 ~l~~L~l~~n~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
-|+.++++.|+|.. .+|..++.+++|..|+|++|-+. .+|..+..+..|+.||||.
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 37777777777652 34556677888888888888887 7888888888888888888
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
|+|. .+|..+-.+..|+.+-.++|++....|..+.++.+|..|||.+|.|..+||..+++.+|+.|.+.||+|.-
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccCC
Confidence 8887 77887777777777777788888677777999999999999999999999999999999999999999983
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-11 Score=128.14 Aligned_cols=232 Identities=17% Similarity=0.174 Sum_probs=153.5
Q ss_pred CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHH
Q 007200 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 389 (613)
Q Consensus 310 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 389 (613)
.++.+|.|+..+.... .......+.++.++.++||||+++++.+..+...|+|+|.+. -|..++.+. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3677888887765443 233456778889999999999999999999999999999874 355566553 346
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCC
Q 007200 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469 (613)
Q Consensus 390 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 469 (613)
...-.+.||+.||.+||..+ +++|++|....|+++..|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66778899999999999776 899999999999999999999999998865432221 011111223466676553332
Q ss_pred CCCcccchhHHHHHHHHHhCCCCcccccc-cCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccC
Q 007200 470 SSEKTDVFGYGVMLLELITGQRAFDLARL-ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQ 548 (613)
Q Consensus 470 ~~~~~DVwS~G~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 548 (613)
-..|.|-|||++||++.|..+-..... ...-....+..... ++..... .... ..+++..|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k--------~~~~~~~------~r~n-~~~~~~~~~~ 244 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCK--------KLGATEL------KRPN-KLRFILECRL 244 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHH--------Hhccccc------cccc-hhhHHHHHHh
Confidence 246999999999999999332210000 00000000000000 0000000 0011 5667777887
Q ss_pred CCCCCCCCHHHHHHHhhcCCcch
Q 007200 549 GSPMERPKMSEVVRMLEGDGLAE 571 (613)
Q Consensus 549 ~dP~~RPt~~evl~~L~~~~~~~ 571 (613)
...-.|=.+-+++..|+++.+.+
T Consensus 245 ~~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 245 LGGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred ccccccchHHHHHHHHHhcccCc
Confidence 78888888888888888775543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.1e-11 Score=114.61 Aligned_cols=130 Identities=20% Similarity=0.156 Sum_probs=96.4
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccc-eeeEEEEcCCceEEEEecccCCc
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.+.++.|.++.||++... +..|++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999875 78899998765432 123467899999888765544 444433 334589999999988
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
+.... . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 0 11345678999999999982 12369999999999999 6689999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-13 Score=132.29 Aligned_cols=137 Identities=26% Similarity=0.296 Sum_probs=123.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC-ccCCCCCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 147 (613)
...+.|+|+.|+|+.+.+++|..+++|+.||||+|+|+.+-|++|.+|.+|..|-+.+ |+|+....+.|.+|..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3689999999999988889999999999999999999999999999999999887766 999977777899999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+.-|++.-...+.|..+++|..|.+-+|.+..+... ...+..++.+.+..|++.|..-
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 999999977788999999999999999999977663 4778889999999999877643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-13 Score=127.45 Aligned_cols=130 Identities=26% Similarity=0.288 Sum_probs=112.6
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.-+++||||+|.|+ .+..+..-+|.++.|+||+|.|. .+- .++.|++|+.||||+|.++ .+-.+-.+|.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 35899999999999 67888889999999999999998 443 4999999999999999998 56667778999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCC--CCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+.|.|.. -.++..+-+|..||+++|+|...- ..+++++.|+.+.+.+||+...+
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999973 256778889999999999998543 45699999999999999998754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-13 Score=135.17 Aligned_cols=132 Identities=28% Similarity=0.399 Sum_probs=101.7
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|++.+|.+....|..+. ++.|++||..+|.++ .+|..++.|.+|+.|||.+|+|. .+| .|..|..|++|+++
T Consensus 161 ~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 567788888888854444444 888888888888887 67777888888888888888887 566 78888888888888
Q ss_pred CccccCccccc-cccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCC
Q 007200 150 NNSLMGEIPRS-LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 150 ~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
.|+|. .+|.. ..++++|.+|||.+|+++..|.+...+.+|..|++++|.|+..|+.
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~s 293 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYS 293 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcc
Confidence 88887 44544 4478888888888888888777777778888888888888776553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-10 Score=108.55 Aligned_cols=137 Identities=15% Similarity=0.119 Sum_probs=100.0
Q ss_pred CccccCcCcEEEEEEeCC-------CCEEEEEEeccccC---------------------cccHHHH----HHHHHHHhh
Q 007200 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERT---------------------QGGELQF----QTEVEMISM 341 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~ 341 (613)
..||.|.-+.||.|...+ +..+|||+.+.... ......+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998653 47899998862210 0011222 378889988
Q ss_pred ccc--CccceeeEEEEcCCceEEEEecccCCcchh-hhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 007200 342 AVH--RNLLRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRD 417 (613)
Q Consensus 342 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D 417 (613)
+.. -++.+++++ ...++||||+.++.+.. .+++. .++......+..+++.+|..| |.. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 864 456666664 56789999997654422 23221 245566778889999999999 787 999999
Q ss_pred CCCCceeecCCCcEEEeccccceecC
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|++.||++++ +.+.|+|||.+...+
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 589999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.6e-12 Score=117.11 Aligned_cols=121 Identities=26% Similarity=0.340 Sum_probs=44.7
Q ss_pred CeEEEEcCCCCcccccchhhh-CCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccc-cccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-GKLSKLRFLR 147 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 147 (613)
.++.|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+ .++ .+..++.|++|+|++|+|+. +.+.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 567888888888732 3454 5778888888888888 444 37788888888888888884 44444 4678888888
Q ss_pred ccCccccCcc-ccccccccchhhhhhcCCCcccCCCC----CCCCCccccccc
Q 007200 148 LNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISF 195 (613)
Q Consensus 148 L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l 195 (613)
|++|+|.... -..+..+++|+.|+|.+|+++..... ...+++|+.||.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8888887421 24566778888888888888754221 134556666553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-11 Score=128.81 Aligned_cols=248 Identities=19% Similarity=0.198 Sum_probs=175.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC--CCCEEEEEEeccccCcccH-HHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGE-LQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
....+|..+..||.|.|+.|+....+ ++..|++|.+......... ..-..|+.+...+ .|.+++.+...+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 44567888899999999999998744 6788999988665433222 2234566665555 488899888888888888
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla 439 (613)
++--|||.++++....... ..++...++.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 8999999999988776322 1277788899999999999999999 99999999999999986 77899999998
Q ss_pred eecCCCCCceeeccccccccc--cccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+.+.... ......-+++ +++......+..+.|+||||.-+.|..++...-.... .|.
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~------- 473 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSL------- 473 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cce-------
Confidence 7432111 1111233344 5556666678899999999999999999875432110 010
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
.+...... . .......+..+.+.+..+++..||.+.++....+
T Consensus 474 ---~i~~~~~p-~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 ---TIRSGDTP-N-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---eeeccccc-C-CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000000 0 1111255667777788999999999988876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=109.68 Aligned_cols=143 Identities=20% Similarity=0.248 Sum_probs=110.4
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--CccceeeEEEEcCC---ceEEEEeccc
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPT---ERLLVYPFMV 368 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 368 (613)
+.|+.|.++.||++...+|+.+++|.............+..|.+++..+.+ .++.+++.+..... ..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999876789999987654332234467899999998875 34577777765532 5689999999
Q ss_pred CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 007200 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH---------------------------------------- 408 (613)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 408 (613)
|.++.+.+.. ..++......++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876532 1367777888888888888888852
Q ss_pred -------------CCCCeEecCCCCCceeecC--CCcEEEecccccee
Q 007200 409 -------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 441 (613)
Q Consensus 409 -------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~ 441 (613)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-12 Score=115.62 Aligned_cols=120 Identities=31% Similarity=0.385 Sum_probs=42.5
Q ss_pred cCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccc-cCCcCCeEeccCccCCCCCCcccccccccccccccCcccc
Q 007200 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154 (613)
Q Consensus 76 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 154 (613)
|..+.|.. . ..+.+..++++|+|++|.|+ .+. .++ .+.+|+.|||++|.|+.. +.+..+++|++|+|++|+|+
T Consensus 4 lt~~~i~~-~-~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIEQ-I-AQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred cccccccc-c-cccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence 44445541 2 34566778999999999999 454 466 689999999999999954 46889999999999999999
Q ss_pred Ccccccc-ccccchhhhhhcCCCcccCCC--CCCCCCccccccccCCCCCC
Q 007200 155 GEIPRSL-TNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 155 ~~~~~~~-~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~ 202 (613)
.+...+ ..+++|+.|+|++|+|...-. ....+++|+.|++.+||++.
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 444444 468999999999999986433 23678999999999998863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-12 Score=138.33 Aligned_cols=129 Identities=27% Similarity=0.392 Sum_probs=114.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..|..|.|.+|.|+...-+.+.++.+|+.|+|++|+|.......+.++..|++|+||+|+++ .+|+.+.+++.|++|..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 36889999999999877788999999999999999999655567899999999999999999 78999999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCC-CCCCCCCccccccccCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI-PTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~l~~l~l~~N~i 200 (613)
.+|+|. ..| .+..+++|+.+||+.|.|+... +.....++|++|+++||..
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999998 777 7899999999999999998543 4434458999999999985
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-09 Score=98.00 Aligned_cols=132 Identities=20% Similarity=0.294 Sum_probs=100.3
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEec-cccCccc------HHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
..+++|+-+.+|.+.+. |..+++|.-. +...... ..+-.+|+.++.++.--.|.-.+=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775 5556666432 2222111 12456789999888766666666667788888999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++|..|.+.+... ...++..+-.-+.-||.. +|||+||.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 134555666677889999 999999999999999874 99999999974
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.1e-11 Score=130.03 Aligned_cols=117 Identities=31% Similarity=0.518 Sum_probs=105.7
Q ss_pred CCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhc
Q 007200 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (613)
Q Consensus 94 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (613)
.++.|+|++|.++|.+|..+..|++|+.|+|++|.|+|.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCC-CC-CCccccccccCCCCCCCCCCCCCC
Q 007200 174 NNKLTGDIPTN-GS-FSLFTPISFANNQLNNPPPSPPPP 210 (613)
Q Consensus 174 ~N~l~~~~~~~-~~-~~~l~~l~l~~N~i~~~~~~~~~~ 210 (613)
+|.++|.+|.. +. +.++..+++.+|+..|+.+....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 99999988864 22 345678899999999986654444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-09 Score=95.03 Aligned_cols=144 Identities=17% Similarity=0.242 Sum_probs=106.3
Q ss_pred CCCccccCcCcEEEEEEeCCCCEEEEEEecc-ccCc------ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQ------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~-~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
....+-+|+-+.|+++.+. |+...||.-.. .... -...+..+|+..+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999986 78777774322 2111 12345778999999887666666666677777889999
Q ss_pred ecccC-CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEeccccce
Q 007200 365 PFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 440 (613)
Q Consensus 365 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~ 440 (613)
||++| .++.+++....... .........+..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 47777776543321 22233367788888899999999 999999999999997665 35899999985
Q ss_pred e
Q 007200 441 L 441 (613)
Q Consensus 441 ~ 441 (613)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.2e-10 Score=125.83 Aligned_cols=59 Identities=24% Similarity=0.240 Sum_probs=34.8
Q ss_pred ccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 142 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+.+|.....++.|..|++++|++++..
T Consensus 403 ~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 403 ELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred CCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchH
Confidence 3444555555554 23322 23566677777777765555566777777777777776543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.9e-11 Score=123.10 Aligned_cols=130 Identities=32% Similarity=0.498 Sum_probs=105.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.|. .+|..++.+.+|+.|++
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 46788888999988 6777788777 888889999988 77888888888889999999888 67888888888888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
..|++. .+|..+..|+ |..||++.|+|+.+|..+..++.|.+|.|.+|++..+|
T Consensus 197 rRn~l~-~lp~El~~Lp-Li~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLP-LIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhh-hCCHHHhCCc-eeeeecccCceeecchhhhhhhhheeeeeccCCCCCCh
Confidence 888887 5666666553 67788888888887777788888888888888876654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.7e-11 Score=126.59 Aligned_cols=136 Identities=26% Similarity=0.299 Sum_probs=113.8
Q ss_pred CCeEEEEcCCCCcccccchhhh-------------------------CCCCCCEEEcccccCCCCCccccccCCcCCeEe
Q 007200 69 NSVTRVDLGNANLSGQLVSQLG-------------------------QLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~-------------------------~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~ 123 (613)
+++++|+|..|+|....+..+. .++.|+.|+|.+|.++...-..|.+..+|+.|+
T Consensus 310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 4789999999998743222221 124478899999999977666799999999999
Q ss_pred ccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|+|.......+.++..|++|+||+|+++ .+|..+..++.|++|...+|+|...| ....++.|+.++++.|.++..
T Consensus 390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhh
Confidence 9999999554556889999999999999999 88999999999999999999999877 778899999999999999876
Q ss_pred CCC
Q 007200 204 PPS 206 (613)
Q Consensus 204 ~~~ 206 (613)
.-+
T Consensus 468 ~l~ 470 (1081)
T KOG0618|consen 468 TLP 470 (1081)
T ss_pred hhh
Confidence 543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=5e-09 Score=97.19 Aligned_cols=127 Identities=22% Similarity=0.265 Sum_probs=83.1
Q ss_pred EEEEEEeCCCCEEEEEEeccccC--------------------cc-----cHHHHHHHHHHHhhcccC--ccceeeEEEE
Q 007200 303 KVYKGRLTDGSLVAVKRLKEERT--------------------QG-----GELQFQTEVEMISMAVHR--NLLRLRGFCM 355 (613)
Q Consensus 303 ~V~~~~~~~~~~vavK~~~~~~~--------------------~~-----~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 355 (613)
.||.|...+|..+|||+.+.... .. .....++|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998863210 00 122467899999999865 566666552
Q ss_pred cCCceEEEEeccc--CCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 356 TPTERLLVYPFMV--NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY-LHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 356 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
..++||||+. |..+.. +.... ++......++.+++..+.. +|.. ||||+||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4589999998 544444 33322 1123456667777775555 4677 99999999999999998 999
Q ss_pred EeccccceecC
Q 007200 433 VGDFGLAKLMD 443 (613)
Q Consensus 433 l~DfGla~~~~ 443 (613)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.2e-10 Score=85.91 Aligned_cols=60 Identities=42% Similarity=0.646 Sum_probs=31.5
Q ss_pred CCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccc
Q 007200 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153 (613)
Q Consensus 94 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 153 (613)
+|++|+|++|+|+...++.|.++++|++|+|++|.|+...|..|.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544344555555555555555555544444555555555555555543
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-10 Score=126.35 Aligned_cols=252 Identities=19% Similarity=0.195 Sum_probs=164.9
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
.....+.+.+.+-+-+|.++.++.+.-. .|...++|.......-. .......+-.++-..++|-++...--+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4455667777788889999999988744 35444444433211100 00111112222222234555443333334566
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++++|..+++|...++..+. .+..........+.++++|||.. .+.|+|++|.|++...++..+++|||..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence 7899999999999999987652 45555666677788999999998 7999999999999999999999999843
Q ss_pred eecCCC---C---------------------C------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhC
Q 007200 440 KLMDYK---D---------------------T------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489 (613)
Q Consensus 440 ~~~~~~---~---------------------~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg 489 (613)
...... . . .......||+.|.+||.+.+......+|.|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 222100 0 0 012234589999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 490 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
.+||...... .....+......+. .+.+......+++..-+..+|.+|-.|.
T Consensus 1032 ~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999743311 11112222222221 1223334556666667788999998776
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-09 Score=121.88 Aligned_cols=121 Identities=26% Similarity=0.417 Sum_probs=77.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
++++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 36888888888888 4555443 46788888888887 5666554 47788888888887 4566554 47777888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|+|+ .+|..+. ++|+.|++++|.|+..+... .++|+.|++++|.+++.
T Consensus 291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~Lt~L 340 (754)
T PRK15370 291 YDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETL--PPGLKTLEAGENALTSL 340 (754)
T ss_pred CCCccc-cCcccch--hhHHHHHhcCCccccCCccc--cccceeccccCCccccC
Confidence 888777 3444332 35666677777666544322 23455555555555543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.1e-09 Score=97.91 Aligned_cols=136 Identities=21% Similarity=0.162 Sum_probs=99.3
Q ss_pred CCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC---------------------cccHHHHHHHHHHHhhcccC--c
Q 007200 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------------------QGGELQFQTEVEMISMAVHR--N 346 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--n 346 (613)
..+.+.||-|.-+.||.|..++|.++|||.-+...+ ..+....++|++.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999996542110 11233568899999988755 6
Q ss_pred cceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 007200 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426 (613)
Q Consensus 347 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 426 (613)
|.+.+++ +...+||||++|--|...- ++......++..|++-+..+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777665 5678999999886655432 12233444455555555544466 999999999999999
Q ss_pred CCCcEEEecccccee
Q 007200 427 EEFEAVVGDFGLAKL 441 (613)
Q Consensus 427 ~~~~~kl~DfGla~~ 441 (613)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.8e-08 Score=103.14 Aligned_cols=170 Identities=19% Similarity=0.252 Sum_probs=128.9
Q ss_pred cCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE----cCCceEEEEecccC-Ccch
Q 007200 300 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTERLLVYPFMVN-GSVA 373 (613)
Q Consensus 300 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~ 373 (613)
-..+.|++... +|..|++|+++..+..... ....-+++++++.|+|||++.+++. .+...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34588999855 8999999999655433221 1234578899999999999999876 35678999999875 4565
Q ss_pred hhhhcc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 374 SCLRER-----------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 374 ~~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
++--.. .......++..++.++.|+..||.++|+. |+..+-|.+++|+++.+.+++|+.+|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 543211 12234578999999999999999999999 9999999999999999999999999988766
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCC
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~ 491 (613)
..... |.+.+ ..+-|.=.||.++..|.||..
T Consensus 444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 54320 11111 235688899999999999854
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-09 Score=120.08 Aligned_cols=123 Identities=25% Similarity=0.363 Sum_probs=92.9
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 46888999999988 4555443 58889999999988 5666554 47889999999988 6677665 57889999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|+|+ .+|..+. ++|+.|+|++|+|++.+... .++|..|++++|.+...|.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l--p~sL~~L~Ls~N~Lt~LP~ 321 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHL--PSGITHLNVQSNSLTALPE 321 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccCcccc--hhhHHHHHhcCCccccCCc
Confidence 999988 5676553 57888999999988765432 2468888889988876543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.7e-10 Score=84.09 Aligned_cols=61 Identities=43% Similarity=0.567 Sum_probs=55.9
Q ss_pred CcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCc
Q 007200 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKL 177 (613)
Q Consensus 117 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 177 (613)
++|++|+|++|+|+...+..|.++++|++|+|++|+++...+..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999976678899999999999999999977788999999999999999986
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.2e-08 Score=98.64 Aligned_cols=141 Identities=14% Similarity=0.090 Sum_probs=100.4
Q ss_pred ccccCcCcEEEEEEeCCCCEEEEEEeccccCc----------ccHHHHHHHHHHHhhcccCc--cceeeEEEEc-----C
Q 007200 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ----------GGELQFQTEVEMISMAVHRN--LLRLRGFCMT-----P 357 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~ 357 (613)
.+-......|.+... +|+.|.||........ .....+.+|...+.++...+ ...++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445667766 4788999977543311 11124778999888875333 3445556543 2
Q ss_pred CceEEEEecccCC-cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------CC
Q 007200 358 TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------EF 429 (613)
Q Consensus 358 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~ 429 (613)
...++|||++++. +|.+++..... .+.+......++.+++..+.-||.. ||+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3468999999886 78888754221 2255677889999999999999999 9999999999999985 46
Q ss_pred cEEEecccccee
Q 007200 430 EAVVGDFGLAKL 441 (613)
Q Consensus 430 ~~kl~DfGla~~ 441 (613)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998853
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.2e-10 Score=105.73 Aligned_cols=109 Identities=26% Similarity=0.313 Sum_probs=94.4
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
+.++.|++|+|+|... +.+..|++|+.||||+|.++ .+-+.-..|.+++.|.|+.|.|... ..+.+|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccc
Confidence 4799999999999843 44889999999999999998 5666667899999999999999844 67888999999999
Q ss_pred cCccccCc-cccccccccchhhhhhcCCCcccCCC
Q 007200 149 NNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP 182 (613)
Q Consensus 149 ~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (613)
++|+|... .-..++++|.|+.|.|.+|+|.+.+.
T Consensus 382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred cccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999843 24578999999999999999998765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.9e-10 Score=111.01 Aligned_cols=131 Identities=23% Similarity=0.233 Sum_probs=109.0
Q ss_pred EEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccC-c
Q 007200 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN-N 151 (613)
Q Consensus 73 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N 151 (613)
.++-++-+|+ .+|..+ -+.-..|+|..|+|+.+.|.+|+.+++|+.||||+|+|+-+-|+.|..+++|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3444455666 455443 24677899999999988889999999999999999999988899999999998887766 9
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+|+....+.|.+|.+|+.|.+.-|++.+..... ..++++..|++.+|.+......
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~ 182 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKG 182 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccc
Confidence 999766778999999999999999999887765 6788899999999988765543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-09 Score=72.98 Aligned_cols=40 Identities=45% Similarity=0.939 Sum_probs=31.2
Q ss_pred chHHHHHHHHHHhcC-CCCCCCCCCCCCC-CCCccceeEEeC
Q 007200 27 NAEGDALNALKTNLA-DPNNVLQSWDATL-VNPCTWFHVTCN 66 (613)
Q Consensus 27 ~~~~~~l~~~k~~~~-~~~~~~~~w~~~~-~~~C~~~gv~c~ 66 (613)
+.|++||++||+.+. +|.+.+.+|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999999 5778999998764 899999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.1e-07 Score=91.94 Aligned_cols=264 Identities=16% Similarity=0.134 Sum_probs=155.6
Q ss_pred CCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHh-hcccCccceeeEEE----E--cC-CceEEE
Q 007200 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGFC----M--TP-TERLLV 363 (613)
Q Consensus 292 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~----~--~~-~~~~lv 363 (613)
....||+|+-+.+|-.--- ..-+.|+....... .+- +.++.|. .-.||-+-.=+.+- . +. ...-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa---~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA---AQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCch---HHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999965321 12355666554322 111 2223333 33455433211110 1 11 224567
Q ss_pred EecccCCcchhhhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 364 YPFMVNGSVASCLR---ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 364 ~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
|..+.+..--..+- .+....+-.+|...+..++.++.+.+.||+. |.+-+|+.++|+|+.+++.|.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77766542222221 1223345589999999999999999999999 99999999999999999999999865433
Q ss_pred ecCCCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHH-H
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKG-L 513 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~-~ 513 (613)
.. .........+|...|.+||.-. +...+...|-|.+|+++++++.| +.||.......+....+...+.. .
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2333455567899999999753 23456789999999999998886 99997544333322222211111 0
Q ss_pred hhcccccccccCccCCCCc-HHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhhc
Q 007200 514 LKEKKLEQLVDSDMEGNYI-EEEVEQLIQVALLCTQG--SPMERPKMSEVVRMLEG 566 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~ 566 (613)
.....-...-....+...+ .-....+..+..+|+.. .+.-|||++-.+..|..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0000000000000011111 11234566677778754 35689999998887753
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.1e-10 Score=114.15 Aligned_cols=135 Identities=28% Similarity=0.363 Sum_probs=99.4
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCC---CCEEEcccccCCC----CCccccccC-CcCCeEeccCccCCCC----CCc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTN---LQYLELYSNNISG----KVPEELGNL-TNLVSLDLYLNNLNGP----IPT 135 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~---L~~L~L~~N~i~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~ 135 (613)
..+++.|+|++|.+.+..+..+..+.+ |+.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 458999999999998666666666655 9999999998873 334456666 8899999999998843 344
Q ss_pred ccccccccccccccCccccCc----cccccccccchhhhhhcCCCcccCCC-----CCCCCCccccccccCCCCCC
Q 007200 136 TLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIP-----TNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~~~l~~l~l~~N~i~~ 202 (613)
.+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++... ....+++|+.|++++|++..
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 566778899999999988742 33445566789999999998874321 22456788999999887653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-10 Score=122.11 Aligned_cols=128 Identities=30% Similarity=0.346 Sum_probs=102.3
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcc-cccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT-LGKLSKLRFLRL 148 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L 148 (613)
.+...+++.|.|. .+..++.-++.|+.|||++|+++.. +.+..|++|++|||++|++. .+|.. ...+ .|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 5777888888888 6677888899999999999999843 37899999999999999998 44543 2334 4999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCC--CCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~i~~~~ 204 (613)
.+|.++.. ..+.+|++|+.|||++|-|.+--.- ...+..|..|.|.|||+.|.|
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99998732 4577899999999999999864332 366778899999999998864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-08 Score=113.67 Aligned_cols=114 Identities=27% Similarity=0.320 Sum_probs=65.9
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ .+|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 56677777777763 332 2466777777777776 34532 356667777777766 344322 456667777
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
+|+|+ .+|. .+++|+.|+|++|+|++.+.. .+.|..|++++|.+..
T Consensus 291 ~N~Lt-~LP~---~p~~L~~LdLS~N~L~~Lp~l---p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 291 GNQLT-SLPV---LPPGLQELSVSDNQLASLPAL---PSELCKLWAYNNQLTS 336 (788)
T ss_pred CCccc-cccc---cccccceeECCCCccccCCCC---cccccccccccCcccc
Confidence 77776 3443 235677777777777765431 1234445555555443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.1e-10 Score=94.93 Aligned_cols=137 Identities=21% Similarity=0.238 Sum_probs=84.9
Q ss_pred EeCCCCCeEEEEcCCCCcccccchhh---hCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccc
Q 007200 64 TCNSENSVTRVDLGNANLSGQLVSQL---GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140 (613)
Q Consensus 64 ~c~~~~~l~~L~l~~n~l~~~~~~~~---~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 140 (613)
+|.....+..++|+++.|- .+++.. .....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..+
T Consensus 22 rcedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 22 RCEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hhHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 3554455666777777765 344433 34445666677777777433332233457777777777777 667777777
Q ss_pred cccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+.|+.|+++.|.|. ..|..+..|.+|-.|+..+|.+..++-...--+..-...+.++++...
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCccccc
Confidence 77777888777777 666767677777777777777765544421112223344555555544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-08 Score=120.89 Aligned_cols=127 Identities=23% Similarity=0.275 Sum_probs=98.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 367888888887777788888888888888888875444677655 7888888888887655455543 357888889
Q ss_pred cCccccCccccccccccchhhhhhcC-CCcccCCCCCCCCCccccccccCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~l~~l~l~~N~i 200 (613)
++|.|+ .+|..+..+++|+.|+|++ |.+...+.....++.|+.++++++.-
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~ 905 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGA 905 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcc
Confidence 998888 6788888888999998877 66777766667788888888887753
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.1e-10 Score=113.58 Aligned_cols=129 Identities=25% Similarity=0.389 Sum_probs=94.7
Q ss_pred eEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccC
Q 007200 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (613)
Q Consensus 71 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 150 (613)
|..+.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+.
T Consensus 100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 455556666665 56667777777777777777777 5666666654 777777777777 6777777778888888888
Q ss_pred ccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 151 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|.+. .+|..++++.+|+.|++..|++...++....+ .|..|+++.|.++..|.
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis~iPv 228 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKISYLPV 228 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCceeecch
Confidence 8887 67777888888888888888888777776633 46788889998877654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-09 Score=110.42 Aligned_cols=133 Identities=25% Similarity=0.252 Sum_probs=92.5
Q ss_pred CCeEEEEcCCCCccc------ccchhhhCCCCCCEEEcccccCCCCCccccccCCc---CCeEeccCccCCC----CCCc
Q 007200 69 NSVTRVDLGNANLSG------QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN---LVSLDLYLNNLNG----PIPT 135 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~------~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~ 135 (613)
++++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|+|++|+++. .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457888888877762 33456677888888888888887666666666655 8888888888873 2334
Q ss_pred ccccc-cccccccccCccccCc----cccccccccchhhhhhcCCCcccCC-----CCCCCCCccccccccCCCCC
Q 007200 136 TLGKL-SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLN 201 (613)
Q Consensus 136 ~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~i~ 201 (613)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. .....++.|+.|++++|.+.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 45566 7888888888888742 2334556678888888888887421 11234467888888888765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.69 E-value=4e-08 Score=117.04 Aligned_cols=127 Identities=22% Similarity=0.278 Sum_probs=72.6
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.++.|.+.++.+. .+|..| .+.+|+.|+|++|++. .+|..+..+++|++|+|++|...+.+|. ++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 3555555555554 344444 3456666666666665 4555566666666666666543334543 5666666666666
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i 200 (613)
+|.....+|..+.++++|+.|++++|.--+.+|....+++|+.|++++|..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 665444566666666666666666643222233323456666666666543
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.1e-09 Score=109.18 Aligned_cols=130 Identities=33% Similarity=0.560 Sum_probs=105.6
Q ss_pred CCeEEEEcCCCCcccccchhhhCCC-CCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLT-NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
+.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 46899999999998 5666677774 8999999999998 67667899999999999999999 6777666889999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
+++|+++ .+|.....+..|+.|.+++|++...+.....+..+..+.+.+|.+..
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 9999998 66766556667899999999766566666777777777788887765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.9e-09 Score=110.04 Aligned_cols=151 Identities=17% Similarity=0.278 Sum_probs=102.4
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc--------eeecccccccccccccccc
Q 007200 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEYLST 467 (613)
Q Consensus 396 ~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 467 (613)
.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+......... ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999874 8999999999999999999999999987644331111 1111224557999999999
Q ss_pred CCCCCcccchhHHHHHHHHH-hCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHc
Q 007200 468 GKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 546 (613)
Q Consensus 468 ~~~~~~~DVwS~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 546 (613)
...+.++|+||+|+++|.+. .|+.-+....... ..... ...+.--...+....+.++.+=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFS----------RNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhh----------hcccccccccccccCcHHHHHHHHHH
Confidence 88899999999999999998 5665554221110 00000 00011111112234456677777888
Q ss_pred cCCCCCCCCCHHHHHHH
Q 007200 547 TQGSPMERPKMSEVVRM 563 (613)
Q Consensus 547 l~~dP~~RPt~~evl~~ 563 (613)
+..++.-||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999987776654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-08 Score=106.99 Aligned_cols=123 Identities=37% Similarity=0.538 Sum_probs=102.2
Q ss_pred EEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCC-cCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 73 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
.|+++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 58888888852 3345666788999999999999 6666667774 9999999999998 67778899999999999999
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 199 (613)
+++ .+|.....+++|+.|++++|+++..++.......|+.+.+++|+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCc
Confidence 999 66666668899999999999999887765566779999999995
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-08 Score=86.05 Aligned_cols=111 Identities=28% Similarity=0.343 Sum_probs=92.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.++|++|.+....+..-..++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 47899999999999555555556779999999999999 78989999999999999999999 67888888999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (613)
.+|.+. .+|-.+..-+.+-...+.+|++.+.-+
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999998 666555444455566778888886544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.9e-07 Score=87.70 Aligned_cols=124 Identities=20% Similarity=0.170 Sum_probs=91.4
Q ss_pred CCEEEEEEeccccCc------ccHHHHHHHHHHHhhccc--CccceeeEEEEcC----CceEEEEecccCC-cchhhhhc
Q 007200 312 GSLVAVKRLKEERTQ------GGELQFQTEVEMISMAVH--RNLLRLRGFCMTP----TERLLVYPFMVNG-SVASCLRE 378 (613)
Q Consensus 312 ~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~ 378 (613)
++.+.+|........ .......+|...+..+.. -.+.+.+++.... ...++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 123457788888777753 3356666666543 2348999999884 78888876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEeccccceec
Q 007200 379 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLM 442 (613)
Q Consensus 379 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~~ 442 (613)
... .+......++.++++.++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 112 ~~~----~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQ----LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcc----cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 332 45567889999999999999999 999999999999999887 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.7e-07 Score=96.66 Aligned_cols=142 Identities=19% Similarity=0.228 Sum_probs=93.2
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCccc---------------------------------------HHHHHH
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 334 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 334 (613)
+.|+.++-|.||+|++++|+.||||+.+....+.- +.++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998863321100 112344
Q ss_pred HHHHHhhcc-----cCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 007200 335 EVEMISMAV-----HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG-LAYLHDH 408 (613)
Q Consensus 335 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~ 408 (613)
|..-+.+++ .++|.=..=|..-.....|+|||++|-.+.+...-... .++.+ .++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHH---HHHHHHHHHHHHHHHhc
Confidence 444444432 23332222222335677999999999999887432221 14433 333333332 2333334
Q ss_pred CCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 409 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|+.|.|.+|.||+++.+|++.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.8e-06 Score=79.38 Aligned_cols=138 Identities=20% Similarity=0.120 Sum_probs=101.8
Q ss_pred ccCcCcEEEEEEeCCCCEEEEEEeccccC-----cccHHHHHHHHHHHhhcccC--ccceeeEEEEc----CCceEEEEe
Q 007200 297 GRGGFGKVYKGRLTDGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHR--NLLRLRGFCMT----PTERLLVYP 365 (613)
Q Consensus 297 g~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~e 365 (613)
|+||-+.|+..... |..+-+|+-..... +-....|.+|+..+..+... .+.+++.+... ...-+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 67888899998775 55789997752211 33566799999999988632 35555522211 123579999
Q ss_pred cccC-CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--EEEeccccce
Q 007200 366 FMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 440 (613)
Q Consensus 366 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~ 440 (613)
-+.+ -+|.+++.+.... +.+......++.++++.++-||.. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 7753 5788787654322 357778889999999999999999 9999999999999986666 9999998765
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.9e-08 Score=97.81 Aligned_cols=134 Identities=25% Similarity=0.259 Sum_probs=65.1
Q ss_pred CCCCCeEEEEcCCCCcccccch-hhhCCCCCCEEEcccccCCCC-CccccccCCcCCeEeccCccCCCCCCccccccccc
Q 007200 66 NSENSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (613)
Q Consensus 66 ~~~~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (613)
...++++.|+|+.|.+.-.... .-..+++|+.|.|+.+.|+-. +-..+..+++|+.|+|..|..-+.-.....-+..|
T Consensus 169 eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L 248 (505)
T KOG3207|consen 169 EQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL 248 (505)
T ss_pred HhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH
Confidence 3345666666666666421111 122455566666666666521 11223345566666666664222223333344556
Q ss_pred ccccccCccccCccc--cccccccchhhhhhcCCCcccCC-CC------CCCCCccccccccCCCC
Q 007200 144 RFLRLNNNSLMGEIP--RSLTNVNSLQVLDLSNNKLTGDI-PT------NGSFSLFTPISFANNQL 200 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~-~~------~~~~~~l~~l~l~~N~i 200 (613)
+.|||++|++. ..+ ...+.++.|+.|+++.|.|..+- +. ...+++|++|++..|+|
T Consensus 249 ~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 249 QELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 66666666654 222 23445566666666666555321 11 13345556666666655
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.9e-08 Score=97.78 Aligned_cols=131 Identities=24% Similarity=0.244 Sum_probs=51.1
Q ss_pred CeEEEEcCCCCcccc--cchhhhCCCCCCEEEcccccCCCCCcccc-ccCCcCCeEeccCccCCCC-CCccccccccccc
Q 007200 70 SVTRVDLGNANLSGQ--LVSQLGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGP-IPTTLGKLSKLRF 145 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~ 145 (613)
+|+.|||++|-+..- +......|++|+.|+|+.|++........ ..+++|+.|.|+.|.|+-. +...+..+|+|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 344444444444321 11223344444444444444442111111 1234444444444444411 1112223444555
Q ss_pred ccccCccccCccccccccccchhhhhhcCCCcccCC--CCCCCCCccccccccCCCC
Q 007200 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 146 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~i 200 (613)
|+|..|............+..|+.|||++|++-... +..+.++.|..|+++.+.+
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi 283 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGI 283 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCc
Confidence 555444321122222233444455555555544333 2234444444444444433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.9e-08 Score=101.60 Aligned_cols=128 Identities=27% Similarity=0.304 Sum_probs=65.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|.+|+|.+. ...+..+++|++|+|++|.|+...+ +..++.|+.|++++|.|+.. ..+..+++|+.|++
T Consensus 95 ~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccC
Confidence 3556666666666532 2224555666666666666653322 45555566666666666532 34444566666666
Q ss_pred cCccccCccc-cccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|++....+ . +..+.+|+.+.+.+|.+... .....+..+..+++.+|.+...
T Consensus 170 ~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i-~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 170 SYNRIVDIENDE-LSELISLEELDLGGNSIREI-EGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred Ccchhhhhhhhh-hhhccchHHHhccCCchhcc-cchHHHHHHHHhhcccccceec
Confidence 6666653222 1 34555666666666665532 1122223333344555544443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.8e-06 Score=80.35 Aligned_cols=139 Identities=13% Similarity=0.105 Sum_probs=85.7
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc--cceeeEEEEcCCceEEEEecccCCc
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++........++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 25567888876433 2345688999998886433 4677777777777889999999863
Q ss_pred -chhh---------------------hhccCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhc-CCCCeEecC
Q 007200 372 -VASC---------------------LRERGQSQPPLNWSVRKQIALG----------AAR-GLAYLHDH-CDPKIIHRD 417 (613)
Q Consensus 372 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~~----------i~~-~L~~LH~~-~~~~ivH~D 417 (613)
+... +|........+.... ..+..+ +.+ ..++|... ..+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1111 111111111111000 001000 111 12222221 133678999
Q ss_pred CCCCceeecCCCcEEEeccccce
Q 007200 418 VKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~ 440 (613)
+.|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.7e-06 Score=79.58 Aligned_cols=156 Identities=19% Similarity=0.210 Sum_probs=102.3
Q ss_pred cccCHHHHHHHhhCCCCCCc---cccCcCcEEEEEEeCCCCEEEEEEeccccCccc------------------HHH---
Q 007200 276 KRFSLRELQVATDNFSNRNI---LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG------------------ELQ--- 331 (613)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~---ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------~~~--- 331 (613)
...++..+....++..+... |..|.-+.||+|...++..+|||+++....... ..+
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34455556666666665554 556777799999988899999999874321110 011
Q ss_pred --HHHHHHHHhhcc--cCccceeeEEEEcCCceEEEEecccCC-cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007200 332 --FQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406 (613)
Q Consensus 332 --~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 406 (613)
..+|+.-|.++. +-.+.+.+++ ....|||||+... .-.-.|.+.. +...+...+..++++.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv~-----~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDVP-----LELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccCC-----cCchhHHHHHHHHHHHHHHHH
Confidence 234555566554 3344455554 2457999998553 1122222221 223366777788888888887
Q ss_pred hcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 407 ~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
..+ ++||+||+.-|||+. ++.+.|+|+|-|....
T Consensus 184 ~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred Hhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 733 999999999999999 7799999999987654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.2e-08 Score=102.31 Aligned_cols=129 Identities=26% Similarity=0.406 Sum_probs=92.2
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.+..+++..|.+.. .-..+..+++|..|+|.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence 45566677777763 3344677788888888888887 3444477788888888888888855 456667778888888
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|.|+.. ..+..+++|+.+++++|++...... ...+..++.+.+.+|.+....
T Consensus 149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~ 202 (414)
T KOG0531|consen 149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE 202 (414)
T ss_pred cCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc
Confidence 8888732 3455678888888888888865542 356677788888888776543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.6e-07 Score=98.63 Aligned_cols=182 Identities=20% Similarity=0.155 Sum_probs=133.7
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc-cceeeEEEEcCCceEEEEecccCC-c
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPFMVNG-S 371 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-s 371 (613)
+-+++|++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...++.++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 457899999999998654444446655433 33456889999999999 777777777788889999999887 3
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceee
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 451 (613)
....+... ...+.......+.+.-+++++++|+. .-+|+| ||+..+ +..+..||+....+.... ...
T Consensus 322 ~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEMTVS---EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccCChh---hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 22222111 11133344455555667899999997 568998 777776 589999999987665432 334
Q ss_pred ccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
...+++.++|||......+....|+|+.|+-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999988778877777653
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.5e-07 Score=82.77 Aligned_cols=122 Identities=23% Similarity=0.249 Sum_probs=77.9
Q ss_pred EEEEcCCCCcccccchhhh-CCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccC
Q 007200 72 TRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 150 (613)
..++|.+.++.... .++ -+.+...+||++|.+. .++ .|..++.|.+|.|++|+|+.+-|..-.-+++|+.|.|.+
T Consensus 22 ~e~~LR~lkip~ie--nlg~~~d~~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPVIE--NLGATLDQFDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccchh--hccccccccceecccccchh-hcc-cCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 45556555554211 121 2345667888888886 343 478888888888888888866565555677788888888
Q ss_pred ccccCcc-ccccccccchhhhhhcCCCcccCCCC----CCCCCccccccccC
Q 007200 151 NSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFAN 197 (613)
Q Consensus 151 N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~ 197 (613)
|.|.... -..+..+|+|++|.+-+|+++....- ...+++|+.|++++
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 8876321 23456778888888888887744321 14566777777654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 613 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-180 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-172 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 632 bits (1633), Expect = 0.0
Identities = 305/326 (93%), Positives = 317/326 (97%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 318
FFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 319 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 378
RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 379 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438
R +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 499 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 558
ANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 559 EVVRMLEGDGLAERWEEWQKEEMFRQ 584
EVVRMLEGDGLAERWEEWQKEEMFRQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-153
Identities = 113/314 (35%), Positives = 173/314 (55%), Gaps = 22/314 (7%)
Query: 265 EEDPEVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVK 318
+ EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 319 RLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASC 375
+L + QF E+++++ H NL+ L GF + LVY +M NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 376 LRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435
L PPL+W +R +IA GAA G+ +LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 436 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +GV+LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 495 LARLANDDDVMLLDWVKGLLKEKK-LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME 553
R + +LLD + + E+K +E +D M + VE + VA C +
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 554 RPKMSEVVRMLEGD 567
RP + +V ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-140
Identities = 115/306 (37%), Positives = 173/306 (56%), Gaps = 7/306 (2%)
Query: 263 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 322
A + + R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 323 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 382
E +QG +F+TE+E +S H +L+ L GFC E +L+Y +M NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
++W R +I +GAARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 443 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
D TH++T V+GT+G+I PEY G+ +EK+DV+ +GV+L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561
+ V L +W +LEQ+VD ++ E + + A+ C S +RP M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 562 RMLEGD 567
LE
Sbjct: 308 WKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 7e-79
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 33/311 (10%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 337
L + + RG FG V+K +L VAVK + Q Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVY 70
Query: 338 MISMAVHRNLLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
+ H N+L+ G + L+ F GS++ L+ ++W+
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 394 IALGAARGLAYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 445
IA ARGLAYLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 446 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500
T GT ++APE L + + D++ G++L EL + A D +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVD 243
Query: 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE------QLIQVALLCTQGSPMER 554
+ + + + + ++++V + + + + L + C R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 555 PKMSEVVRMLE 565
V +
Sbjct: 304 LSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-61
Identities = 71/322 (22%), Positives = 115/322 (35%), Gaps = 44/322 (13%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 337
+ E + DN ++GRG +G VYKG L D VAVK Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKN 57
Query: 338 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+ + + H N+ R E LLV + NGS+ L +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 391 RKQIALGAARGLAYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
++A RGLAYLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 445 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGVMLLELITGQ 490
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 491 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD-------MEGNYIEEEVEQLIQVA 543
+ + V + ++ LV + V L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 544 LLCTQGSPMERPKMSEVVRMLE 565
C R +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-61
Identities = 77/314 (24%), Positives = 145/314 (46%), Gaps = 23/314 (7%)
Query: 254 KPEDHFFDVPAEEDPEVHLGQLK-RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
K H + + P + ++ + + + + +G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 313 SLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
S VAVK L E+ + F EV ++ H N++ G P +V ++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
+ L + G ++ L+ R +A A+G+ YLH + +P I+HR++K+ N+L+D+++
Sbjct: 121 LYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
V DFGL++L + + GT +APE L S+EK+DV+ +GV+L EL T Q+
Sbjct: 179 KVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 551
+ ++ V + + K ++ + + +V +I+ C P
Sbjct: 238 PW--------GNLNPAQVVAAVGFKCKRLEIPRN------LNPQVAAIIE---GCWTNEP 280
Query: 552 MERPKMSEVVRMLE 565
+RP + ++ +L
Sbjct: 281 WKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-59
Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 40/308 (12%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
++GRG FG V K + VA+K+++ E + F E+ +S H N+++L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGA 69
Query: 354 CMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
C+ P E + GS+ + L P + L ++G+AYLH
Sbjct: 70 CLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 410 DPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+IHRD+K N+LL + + DFG A + T +G+ +APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
SEK DVF +G++L E+IT ++ FD + + + + + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPP--LIKN-- 228
Query: 529 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH 588
+ + +E L+ C P +RP M E+V+++ L + +E + H
Sbjct: 229 ---LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT--HLMRYFP--GADEPLQYPCQH 278
Query: 589 TPHPNNTW 596
+ P
Sbjct: 279 SLPPGEDG 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 47/290 (16%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL------QFQTEVEMISMAVHRN 346
+G+GGFG V+KGR + D S+VA+K L ++G +FQ EV ++S H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 347 LLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
+++L G P E F+ G + L ++ P+ WSV+ ++ L A G+
Sbjct: 85 IVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 457
Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNF 190
Query: 458 GHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515
+APE + +EK D + + ++L ++TG+ FD + + ++ + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIKFINMIRE 244
Query: 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E + + + +I+ LC G P +RP S +V+ L
Sbjct: 245 EGLRPTIPED------CPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 7e-58
Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRL 350
I+G GGFGKVY+ G VAVK + + + + E ++ +M H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
RG C+ LV F G + L + + + A+ ARG+ YLHD
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 411 PKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAP 183
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
E + S+ +DV+ YGV+L EL+TG+ F + L G+ K +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------RGIDGLAVAYGVAMNKLALPI 235
Query: 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ E +L++ C P RP + ++ L
Sbjct: 236 PST------CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 72/325 (22%), Positives = 129/325 (39%), Gaps = 42/325 (12%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL 314
PE + + A P L+E + + ++G+G FG+VY GR G
Sbjct: 2 PEMNLSLLSARSFPRKA--SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE- 57
Query: 315 VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
VA++ + ER +L+ F+ EV H N++ G CM+P ++ ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
S +R+ L+ + +QIA +G+ YLH I+H+D+K+ N+ D + V+
Sbjct: 118 SVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVI 170
Query: 434 GDFGLAKLMD----YKDTHVTTAVRGTIGHIAPEYLSTGKS---------SEKTDVFGYG 480
DFGL + + G + H+APE + S+ +DVF G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 481 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLI 540
+ EL + F + + + L + +E+ ++
Sbjct: 231 TIWYELHAREWPFKT---------QPAEAIIWQMGTGMKPNLSQIG-----MGKEISDIL 276
Query: 541 QVALLCTQGSPMERPKMSEVVRMLE 565
C ERP ++++ MLE
Sbjct: 277 L---FCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-54
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 45/290 (15%)
Query: 294 NILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+LG+G FG+ K G ++ +K L + + F EV+++ H N+L+ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ ++ G++ ++ WS R A A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIGH 459
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519
+APE ++ EK DVF +G++L E+I A D++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-------------DYL-------PR 228
Query: 520 EQLVDSDMEGNY---IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ G + + C P +RP ++ LE
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-54
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
L G+++KGR G+ + VK LK + + F E + + H N+L + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 353 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
C +P + +M GS+ + L E + ++ S + AL ARG+A+LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
P I + + ++++DE+ A + + + +APE L
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPE 185
Query: 471 ---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
D++ + V+L EL+T + F D+ ++ + E +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPF--------ADLSNMEIGMKVALEGLRPTIPPG-- 235
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
I V +L++ +C P +RPK +V +LE
Sbjct: 236 ----ISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-54
Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 41/282 (14%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 355 MTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
P T+ + S+ L IA ARG+ YLH
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPE---YL 465
IIHRD+K+ NI L E+ +GDFGLA +H + G+I +APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEQLV 523
+ S ++DV+ +G++L EL+TGQ + + + N D ++ + +G L +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQII---EMVGRGSLSPDLSKVRS 252
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ + +++L+ C + ERP ++ +E
Sbjct: 253 NCP-------KRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 26 SNAEGDALNALKTNLADPNNVLQSWDATL-VNPCTWFHVTCNSENSVTRV---DLGNANL 81
+ + AL +K +L +P L SW T TW V C+++ RV DL NL
Sbjct: 4 NPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 82 SGQLV--SQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
S L L L +L + NN+ G +P + LT L L + N++G IP L
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 139 KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSF-SLFTPISFA 196
++ L L + N+L G +P S++++ +L + N+++G IP + GSF LFT ++ +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 197 NNQLNNP-PPS 206
N+L PP+
Sbjct: 183 RNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 2/133 (1%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+ T + + L+G++ L NL +++L N + G G+ N + L
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+L + +G L L L NN + G +P+ LT + L L++S N L G+IP G
Sbjct: 230 KNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 186 SFSLFTPISFANN 198
+ F ++ANN
Sbjct: 289 NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 2/130 (1%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV-SLDLYLNNLN 130
+D LSG L + L NL + N ISG +P+ G+ + L S+ + N L
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
G IP T L+ L F+ L+ N L G+ + + Q + L+ N L D+ G
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 191 TPISFANNQL 200
+ NN++
Sbjct: 247 NGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 3/67 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +DL N + G L L QL L L + NN+ G++P+ GNL N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303
Query: 130 --NGPIP 134
P+P
Sbjct: 304 LCGSPLP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 9e-50
Identities = 62/298 (20%), Positives = 119/298 (39%), Gaps = 39/298 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 352 GFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
MT T+ L+ + GS+ L+ L+ +I L A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 459
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 460 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDVML---L 507
+APE + S ++ D++ +G++L E+ + + + D V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ ++ ++ + + + + + +L++ C +P R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 352 GFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
+ T+ L+ + NGS+ L+ L+ ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 459
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 460 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 507
+ PE + +S D++ +G++L E+ + + +L D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ ++ ++ KKL + + ++ +L+ C +P R V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 352 GFCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
T T+ LV + +GS+ L + + ++AL A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 459
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 460 IAPEYL------STGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 507
+APE L +S ++ D++ G++ E+ + +L D V +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ ++ ++ E+KL + + + + ++++ C + R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 296 LGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL + VAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V + G + LR G L Q+ AA G+ YL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHIAPEYLSTG 468
HRD+ A N L+ E+ + DFG+++ + + V+ T APE L+ G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT----APEALNYG 290
Query: 469 KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ S ++DV+ +G++L E + G + +Q +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY---------------------PNLSNQQTREFVE 329
Query: 528 EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+G + + V +L+ C P +RP S + + L+
Sbjct: 330 KGGRLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 348
ILG G FG V +G L VAVK +K + + E++ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 349 RLRGFC-----MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 401
RL G C + +++ PFM G + + L P + ++ + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 460
+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 461 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
A E L+ + K+DV+ +GV + E+ T G + + N
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--PGVQN--------------- 255
Query: 516 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ D + G+ ++ +E+ +++ C + P++RP S + LE
Sbjct: 256 ----HEMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 69/288 (23%), Positives = 111/288 (38%), Gaps = 34/288 (11%)
Query: 294 NILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV G +VAVK LK + ++ E++++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ +G C LV ++ GS+ L L A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 463
IHRD+ A N+LLD + +GDFGLAK + + + APE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPE 207
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
L K +DV+ +GV L EL+T + L+ + + + +L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 524 DSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ G + EV L+ C + RP ++ +L+
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILK 306
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 350 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L G C+ L+V P+M +G + + +R L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 465
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDITV 243
Query: 525 SDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++G + + + L +V L C RP SE+V +
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-38
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ + G ++ +L++ N +SG +P+E+G++ L L+L N++
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+G IP +G L L L L++N L G IP++++ + L +DLSNN L+G IP G F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 190 FTPISFANNQLNNPPPSPP----PPLQPTPPGASSGNS 223
F P F NN P PL P + G +
Sbjct: 729 FPPAKFLNN---------PGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-38
Identities = 51/142 (35%), Positives = 75/142 (52%), Gaps = 1/142 (0%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N +N++ + L N +G++ L + L L L N +SG +P LG+L+ L L L+
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN- 184
LN L G IP L + L L L+ N L GEIP L+N +L + LSNN+LTG+IP
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 185 GSFSLFTPISFANNQLNNPPPS 206
G + +NN + P+
Sbjct: 511 GRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-37
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 1/133 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + L LSG + S LG L+ L+ L+L+ N + G++P+EL + L +L L N+L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFS 188
G IP+ L + L ++ L+NN L GEIP+ + + +L +L LSNN +G+IP G
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 189 LFTPISFANNQLN 201
+ N N
Sbjct: 539 SLIWLDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-37
Identities = 60/139 (43%), Positives = 82/139 (58%), Gaps = 3/139 (2%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQ--LTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
N S+ +DL + N SG ++ L Q LQ L L +N +GK+P L N + LVSL
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L N L+G IP++LG LSKLR L+L N L GEIP+ L V +L+ L L N LTG+IP+
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 184 N-GSFSLFTPISFANNQLN 201
+ + IS +NN+L
Sbjct: 485 GLSNCTNLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-37
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 3/160 (1%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + L L G++ +L + L+ L L N+++G++P L N TNL + L N L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
G IP +G+L L L+L+NNS G IP L + SL LDL+ N G IP +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFK 560
Query: 190 FTPISFANNQLNNPPPS-PPPPLQPTPPGASSGNSATGAI 228
+ AN ++ GA + G
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 51/237 (21%), Positives = 90/237 (37%), Gaps = 59/237 (24%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCN------------------ 66
+ E L + K L D N +L W + NPCT+ VTC
Sbjct: 9 SLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCRDDKVTSIDLSSKPLNVGF 66
Query: 67 ------------------SEN-------------SVTRVDLGNANLSGQL--VSQLGQLT 93
S + S+T +DL +LSG + ++ LG +
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 94 NLQYLELYSNNISGKVP-EELGNLTNLVSLDLYLNNLNGPIPTTL---GKLSKLRFLRLN 149
L++L + SN + L +L LDL N+++G +L+ L ++
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
N + G++ ++ +L+ LD+S+N + IP G S + + N+L+
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 6/136 (4%)
Query: 72 TRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ L +G++ G L L+L N+ G VP G+ + L SL L NN +
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 131 GPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNV-NSLQVLDLSNNKLTGDIPT---NG 185
G +P TL K+ L+ L L+ N GE+P SLTN+ SL LDLS+N +G I
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 186 SFSLFTPISFANNQLN 201
+ + NN
Sbjct: 392 PKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 46/137 (33%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++T +DL + G + G + L+ L L SNN SG++P + L + L LDL N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 129 LNGPIPTTLGKLS-KLRFLRLNNNSLMGEIPRSLTNV--NSLQVLDLSNNKLTGDIPTN- 184
+G +P +L LS L L L++N+ G I +L N+LQ L L NN TG IP
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 185 GSFSLFTPISFANNQLN 201
+ S + + N L+
Sbjct: 415 SNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 5/134 (3%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +D+ + N S + LG + LQ+L++ N +SG + T L L++ N
Sbjct: 201 NLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLT-NVNSLQVLDLSNNKLTGDIPTN-GSF 187
GPIP L L++L L N GEIP L+ ++L LDLS N G +P GS
Sbjct: 260 VGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 188 SLFTPISFANNQLN 201
SL ++ ++N +
Sbjct: 318 SLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 2/112 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSN--NISGKVPEELGNLTNLVSLDLYLNNLNGP 132
+ ++G+ + + N G E+L L+ ++ G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
T + FL ++ N L G IP+ + ++ L +L+L +N ++G IP
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 7/140 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + L N L+G++ +G+L NL L+L +N+ SG +P ELG+ +L+ LDL N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN--KLTGDIPTN-GS 186
NG IP + K S + N + G+ + N + + N + G
Sbjct: 551 NGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 187 FSLFTPISFANNQLNNPPPS 206
S P + +
Sbjct: 607 LSTRNPCNITSRVYGGHTSP 626
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 14/71 (19%), Positives = 29/71 (40%)
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
K++ + N + SL ++ L+ L LSN+ + G + + T + +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 198 NQLNNPPPSPP 208
N L+ P +
Sbjct: 110 NSLSGPVTTLT 120
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 266 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKR 319
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 380 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 437 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 491 R 491
+
Sbjct: 218 K 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 56/297 (18%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 348
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 349 RLRGFC------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAAR 400
+L G +++ PFM +G + + L + P N ++ + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRG 455
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 514
A E L+ + +DV+ +GV + E++T GQ + A + N
Sbjct: 206 L----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIEN-------------- 245
Query: 515 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ + + GN ++ EEV L+ C P +RP + + LE
Sbjct: 246 -----AEIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELE 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV R G VAVK LK E + E+E++ H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ +G C L+ F+ +GS+ L + +N + + A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 463
+ +HRD+ A N+L++ E + +GDFGL K + D T + APE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPE 199
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
L K +DV+ +GV L EL+T L M+ + + +L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQM----TVTRL 252
Query: 523 VDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
V++ EG + +EV QL+ C + P R ++ E
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L G C +E L+V P+M +G + + +R L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 464
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
L T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDIT 306
Query: 524 DSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++G + + + L +V L C RP SE+V +
Sbjct: 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 82/321 (25%), Positives = 131/321 (40%), Gaps = 42/321 (13%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG+G FG V R G+LVAVK+L+ + FQ E++++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIV 87
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ RG P + LV ++ +G + L+ L +S QI +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS--QIC----KGME 141
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIA 461
YL + +HRD+ A NIL++ E + DFGLAKL+ + V + I A
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
PE LS S ++DV+ +GV+L EL T ++ + D L
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-------ALS 251
Query: 521 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 574
+L++ EG + EV +L+ LC SP +RP S + L D L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQL--DMLWSG-S 305
Query: 575 EWQKEEMFRQDFNHTPHPNNT 595
+ F H +
Sbjct: 306 RGCETHAFTAHPEGKHHSLSF 326
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L G P E ++ P+M +G + +R L ARG+ YL +
Sbjct: 87 LIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE 142
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 464
K +HRD+ A N +LDE F V DFGLA+ + +Y R + A E
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT 488
L T + + K+DV+ +GV+L EL+T
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 61/312 (19%), Positives = 124/312 (39%), Gaps = 44/312 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQF-QTEVEMISMAVH 344
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L ++H +++HRD+K AN+ + +GD GL + K T + V GT ++
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
+PE + + K+D++ G +L E+ Q F + ++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLY--------------- 244
Query: 521 QLVDSDMEGNY--IEEEV--EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEW 576
L + +Y + + E+L Q+ +C P +RP ++ V + A+R
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV------AKRMHAC 298
Query: 577 QKEEMFRQDFNH 588
+ +H
Sbjct: 299 TASSLEHHHHHH 310
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 55/326 (16%)
Query: 264 AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS------LVAV 317
+P +V N + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 318 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
K L E ++ EL F E +IS H+N++R G + R ++ M G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 378 E-RGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 433
E R + P + ++ +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 434 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLEL 486
GDFG+A+ + + +G + PE G + KTD + +GV+L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 487 IT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQL 539
+ G + +N +++++ G ++ V ++
Sbjct: 239 FSLGYMPY--PSKSN-------------------QEVLEFVTSGGRMDPPKNCPGPVYRI 277
Query: 540 IQVALLCTQGSPMERPKMSEVVRMLE 565
+ C Q P +RP + ++ +E
Sbjct: 278 M---TQCWQHQPEDRPNFAIILERIE 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 128
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 460
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWY 184
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
APE L+ K S +DV+ +GV+L EL T + + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVF 239
Query: 521 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
L++ + +E+ ++ C + +RP ++ ++
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 74/300 (24%), Positives = 128/300 (42%), Gaps = 63/300 (21%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG+G FG VY+G VA+K + E + ++F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARG 401
+RL G L++ M G + S LR P + S Q+A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 460
+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 461 ----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVK 511
+PE L G + +DV+ +GV+L E+ T LA L+N
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSN----------- 246
Query: 512 GLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
EQ++ MEG ++ + + +L+ +C Q +P RP E++ ++
Sbjct: 247 --------EQVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIK 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 159
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 460
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWY 215
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
APE L+ K S +DV+ +GV+L EL T + ++ +E
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLIE 274
Query: 521 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
L + +E+ ++ C + +RP ++ ++
Sbjct: 275 LL----KNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 352
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 353 FCMTPTE---RLLVYP-FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ + +++ M +G++ + L+ + V + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR 148
Query: 409 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 468 GKSSEKTDVFGYGVMLLELITGQ 490
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 266 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKR 319
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 380 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 437 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 491 R 491
+
Sbjct: 218 K 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 43/311 (13%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARG 401
N+++ R +V + G + + + L+W V QI L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
PE + K+D++ G +L EL T + AF+ A ++
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE----AGS-----------------MKN 232
Query: 522 LVDSDMEGNY--IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQK 578
LV + G++ + L + + +P +RP ++ + LE +A+R E++
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLS 289
Query: 579 EEMFRQDFNHT 589
++ ++F
Sbjct: 290 PQLIAEEFCLK 300
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 57/292 (19%)
Query: 293 RNILGRGGFGKVYKGRLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG V +G VA+K LK+ + + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C +LV G + L + + + S ++ + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 467
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K S ++DV+ YGV + E ++ GQ+ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK-------------------------------K 216
Query: 527 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 565
M+G + +EQ L + C +RP V + +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+LG G FG V+KG V +K ++++ + + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 405
RL G C + LV ++ GS+ +R+ + P LNW V QIA +G+ YL
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIA----KGMYYL 131
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 460
+H ++HR++ A N+LL + V DFG+A L+ D + + ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
A E + GK + ++DV+ YGV + EL+T G
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 55/296 (18%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FG+VY+G+++ VAVK L E ++ EL F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLAY 404
+R G + R ++ M G + S LRE R + P + ++ +A A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLMDYKDTHVTTAVRGTIGHI- 460
L ++ IHRD+ A N LL V GDFG+A+ + + +G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 461 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 515
PE G + KTD + +GV+L E+ + G + +N
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSN--------------- 292
Query: 516 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+++++ G ++ V +++ C Q P +RP + ++ +E
Sbjct: 293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 262 VPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK 321
+ ++ P ++ + + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 322 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ 381
E E +F E +++ H L++L G C ++ +M NG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR- 114
Query: 382 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
++ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 115 --HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 442 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ D + ++ VR + PE L K S K+D++ +GV++ E+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ +V +M GS+ L+ L V +A A G+AY+
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM---NY 301
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 474 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 532
+DV+ +G++L EL T G+ + + N + + ++ G +
Sbjct: 362 SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE-------------------RGYRM 400
Query: 533 E------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E + L+ C + P ERP + LE
Sbjct: 401 PCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE 436
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 346 NLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQIAL 396
N++R + T L ++V G +AS + + + + L+ V Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 397 GAARGLAYLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
L H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V
Sbjct: 123 A----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514
GT +++PE ++ +EK+D++ G +L EL F A
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFS------------- 220
Query: 515 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
++L EG + +E+ ++I RP + E++
Sbjct: 221 ----QKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 64/297 (21%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVN 65
Query: 347 LLRLRGF-------------CMTPTERLLVYPFM---VNGSVASCLRERGQSQPP--LNW 388
++ G + ++ ++ M G++ + +R + L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
+ +QI G + Y+H K+I+RD+K +NI L + + +GDFGL +
Sbjct: 126 ELFEQITKG----VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLL 507
+ GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 179 TRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD------ 230
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
L++ + + D + L+Q P +RP SE++R L
Sbjct: 231 ------LRDGIISDIFDKKE---------KTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-35
Identities = 77/397 (19%), Positives = 134/397 (33%), Gaps = 70/397 (17%)
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIAL 247
L ++ + +P P P+ T G I
Sbjct: 249 CLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDG-------YTPEPARITS 301
Query: 248 AYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+ P D DPE +LK L + + LG G FG V +G
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPE----ELKDKKLFLKR--DNLLIADIELGCGNFGSVRQG 355
Query: 308 RLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364
VA+K LK+ + + E +++ + ++RL G C +LV
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVM 414
Query: 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + L + + + S ++ + G+ YL + +HR++ A N+L
Sbjct: 415 EMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVL 468
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVM 482
L A + DFGL+K + D++ T G + APE ++ K S ++DV+ YGV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 483 LLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ--- 538
+ E ++ GQ+ + M+G + +EQ
Sbjct: 529 MWEALSYGQKPYK-------------------------------KMKGPEVMAFIEQGKR 557
Query: 539 ----------LIQVALLCTQGSPMERPKMSEVVRMLE 565
L + C +RP V + +
Sbjct: 558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 72/319 (22%)
Query: 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 392
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 502
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 311
Query: 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 556
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 312 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 351
Query: 557 MSEVVRMLEGDGLAERWEE 575
++V L+ EE
Sbjct: 352 FKQLVEDLDRILTLTTNEE 370
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 256 EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL- 314
+ H + +P+ + +++ ++++G G FG+V K R+ L
Sbjct: 2 KKHHHHHHGKNNPDPTI--YPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR 52
Query: 315 --VAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
A+KR+KE ++ F E+E + + H N++ L G C L + +G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 372 VASCLRERGQSQPPLNWSVRK------------QIALGAARGLAYLHDHCDPKIIHRDVK 419
+ LR+ + +++ A ARG+ YL + IHRD+
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLA 169
Query: 420 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKT 474
A NIL+ E + A + DFGL++ + V+ T+G + A E L+ + +
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 475 DVFGYGVMLLELIT 488
DV+ YGV+L E+++
Sbjct: 223 DVWSYGVLLWEIVS 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G FG V+ G + VA+K ++E E F E E++ H L++L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
C+ LV FM +G ++ LR + + L G+AYL + +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTG 468
IHRD+ A N L+ E V DFG+ + + D + ++ V+ +PE S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 469 KSSEKTDVFGYGVMLLELIT 488
+ S K+DV+ +GV++ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
ILG G FG+VY+G T+ VAVK K++ T + +F +E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 351 RGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G PT ++ G + L S L +L + +AYL
Sbjct: 79 IGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI- 132
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYL 465
+HRD+ NIL+ +GDFGL++ ++ +D + + ++ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQR 491
+ + + +DV+ + V + E+++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 70/304 (23%)
Query: 296 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIALG 397
G C ++V+ +M +G + LR G L + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----- 452
A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLL 507
+R PE + K + ++DV+ +GV+L E+ T + L+N
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSN------- 241
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVV 561
++++ +G +E +EV ++ L C Q P +R + E+
Sbjct: 242 ------------TEVIECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIY 286
Query: 562 RMLE 565
++L
Sbjct: 287 KILH 290
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 69/309 (22%), Positives = 118/309 (38%), Gaps = 72/309 (23%)
Query: 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 392
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 502
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 265
Query: 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 556
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 266 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 305
Query: 557 MSEVVRMLE 565
++V L+
Sbjct: 306 FKQLVEDLD 314
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G FG V G+ VAVK +KE E +F E + + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V ++ NG + + LR G+ L S ++ G+A+L H + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGK 469
HRD+ A N L+D + V DFG+ + + D +V++ V+ + APE K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 470 SSEKTDVFGYGVMLLELIT 488
S K+DV+ +G+++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEV 336
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+ H ++++L G ++ G + S L+ R L+ + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAY 498
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 452
+ LAYL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 511
++ APE ++ + + +DV+ +GV + E++ G + F + N
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN----------- 598
Query: 512 GLLKEKKLEQLVDSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ G + L + C P RP+ +E+ L
Sbjct: 599 --------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 59/306 (19%), Positives = 109/306 (35%), Gaps = 69/306 (22%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG FGKVYKG L + VA+K LK++ +F+ E + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIA 395
+ L G +++ + +G + L R + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 452
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 453 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVM 505
+R APE + GK S +D++ YGV+L E+ + +N
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPYCGYSN----- 236
Query: 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSE 559
+ +V+ + V L+ + C P RP+ +
Sbjct: 237 --------------QDVVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKD 279
Query: 560 VVRMLE 565
+ L
Sbjct: 280 IHSRLR 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 62/299 (20%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQ 333
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
E + H ++++L G ++ G + S L+ R L+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLIL 120
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453
A + LAYL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512
+ I +APE ++ + + +DV+ +GV + E++ G + F + N +DV+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN-NDVI------- 227
Query: 513 LLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++E G + + L+ C P RP+ +E+ L
Sbjct: 228 ----GRIEN-------GERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 31/275 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+E +V +M GS+ L+ L V +A A G+AY+
Sbjct: 331 V---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM--- 382
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 472 EKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530
K+DV+ +G++L EL T G+ + + N + + ++ +G ++ +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE--RGY----RMPCPPECP---- 490
Query: 531 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E L + C + P ERP + LE
Sbjct: 491 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 72/307 (23%)
Query: 296 LGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FG+V + VAVK LK + T+ +E+E M + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 394
++ L G C ++ + G++ L+ R +++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 452
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 453 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDV 504
V+ APE L + ++DV+ +GV+L E+ T L +
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPV---- 299
Query: 505 MLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMS 558
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 300 ---------------EELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFK 341
Query: 559 EVVRMLE 565
++V L+
Sbjct: 342 QLVEDLD 348
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRL 350
LG G FG V KG + VAVK LK E E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 408
G C + +LV G + L++ + + Q++ G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVS----MGMKYLEES 136
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLS 466
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 467 TGKSSEKTDVFGYGVMLLELIT-GQR 491
K S K+DV+ +GV++ E + GQ+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 70/308 (22%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LGRG FG+V + VAVK LKE T +E++ +I + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 347 LLRLRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------Q 393
++ L G C P +++ F G++++ LR + P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 452
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 453 ----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDD 503
++ APE + + ++DV+ +GV+L E+ + L + D++
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE 259
Query: 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKM 557
++L++ G + E+ Q + L C G P +RP
Sbjct: 260 FC-----------RRLKE-------GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTF 298
Query: 558 SEVVRMLE 565
SE+V L
Sbjct: 299 SELVEHLG 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 61/301 (20%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FGKV+ + LVAVK LKE ++ FQ E E+++M H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER-----------GQSQPPLNWSVRKQIAL 396
+R G C L+V+ +M +G + LR + PL +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTT 451
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 510
+R PE + K + ++DV+ +GV+L E+ T G++ + +L+N
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSN---------- 266
Query: 511 KGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 564
+ +D +G +E EV ++ C Q P +R + +V L
Sbjct: 267 ---------TEAIDCITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARL 314
Query: 565 E 565
+
Sbjct: 315 Q 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 137
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 193
Query: 473 KTDVFGYGVMLLELIT 488
K+DV+ +G++L E+ +
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ LG G +G+VY+G SL VAVK LKE+ + +F E ++ H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 338
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
IHR++ A N L+ E V DFGL++LM + I APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 473 KTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 531
K+DV+ +GV+L E+ T G + + LL+ K ++E+
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLE--KDY----RMERPEGC------ 444
Query: 532 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E++ ++ C Q +P +RP +E+ + E
Sbjct: 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 82/341 (24%), Positives = 135/341 (39%), Gaps = 70/341 (20%)
Query: 249 YWRKRKPEDHFFDVPAE-EDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
Y++ + PE F+ P E+P + R RE++ I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYG 68
Query: 308 RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423
+M NGS+ + LR + G G+ YL D +HRD+ A N+
Sbjct: 129 TEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV 182
Query: 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFG 478
L+D V DFGL++++ D G G I APE ++ S +DV+
Sbjct: 183 LVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWS 239
Query: 479 YGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 537
+GV++ E++ G+R + +M + VE
Sbjct: 240 FGVVMWEVLAYGERPYW-------------------------------NMTNRDVISSVE 268
Query: 538 Q-------------LIQVALLCTQGSPMERPKMSEVVRMLE 565
+ L Q+ L C +RP+ S++V +L+
Sbjct: 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 348
LG G FG V +G S VAVK LK + E F EV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 405
RL G +TP +V GS+ LR+ ++V Q+A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA----EGMGYL 137
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPE 463
+ IHRD+ A N+LL +GDFGL + + D H APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
L T S +D + +GV L E+ T GQ
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G FG+V+ G + VAVK LK+ F E ++ H+ L+RL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAV 76
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
T+ ++ +M NGS+ L+ + +N + +A A G+A++ +
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFIEER--- 128
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLS 466
IHRD++AANIL+ + + DFGLA+L+ + + ++ T APE ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 183
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
G + K+DV+ +G++L E++T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 38/302 (12%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 339
+ + ++ LG GGF V L DG A+KR+ Q E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 340 SMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
+ H N+LRL +C+ L+ PF G++ + + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 454
LG RGL +H HRD+K NILL +E + V+ D G A+
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 455 -------GTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503
TI + APE L + +S E+TDV+ G +L ++ G+ +D+
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ----- 251
Query: 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
KG ++ + + + QL+ + P +RP + ++
Sbjct: 252 -------KGDSVALAVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPHIPLLLSQ 300
Query: 564 LE 565
LE
Sbjct: 301 LE 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 62/261 (23%), Positives = 88/261 (33%), Gaps = 25/261 (9%)
Query: 240 FAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRG 299
+ + +P F A E + R Q +F + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 300 GFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 355
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 356 TPTERLLVYPFM--VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLHDHCDPK 412
+Y S+ G S P W + L LA+LH
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ---G 177
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
++H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGT 234
Query: 473 KTDVFGYGVMLLELITGQRAF 493
DVF G+ +LE+
Sbjct: 235 AADVFSLGLTILEVACNMELP 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 309
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 365
Query: 473 KTDVFGYGVMLLELIT 488
K+DV+ +G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 74/356 (20%), Positives = 132/356 (37%), Gaps = 87/356 (24%)
Query: 252 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
+ P + +P +P+ L L+ +N +G G FG+V++ R
Sbjct: 21 RLHPNPMYQRMPLLLNPK----------LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 312 G------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365
++VAVK LKEE + + FQ E +++ + N+++L G C L++
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRK--------------------QIALGAARGLAYL 405
+M G + LR IA A G+AYL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI----- 460
+ K +HRD+ N L+ E + DFGL++ + D + I
Sbjct: 191 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWM 243
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVKGLLK 515
PE + + + ++DV+ YGV+L E+ + +A+
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYYGMAH--------------- 282
Query: 516 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E+++ +GN + E+ L+ LC P +RP + R+L+
Sbjct: 283 ----EEVIYYVRDGNILACPENCPLELYNLM---RLCWSKLPADRPSFCSIHRILQ 331
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 294 NILGRGGFGKVYKGRLTDG------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FGKV K + VAVK LKE + +E ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--------------- 392
++L G C LL+ + GS+ LRE + P S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 393 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
A ++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 448 HVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 497
+ V+ + G I A E L + ++DV+ +GV+L E++T L
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 255
Query: 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 551
+ E+L + G+ +E EE+ +L+ L C + P
Sbjct: 256 IPP-------------------ERLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQEP 293
Query: 552 MERPKMSEVVRMLE 565
+RP +++ + LE
Sbjct: 294 DKRPVFADISKDLE 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 78/333 (23%), Positives = 133/333 (39%), Gaps = 65/333 (19%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V GRL S VA+K LK T+ F E ++ H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G ++V +M NGS+ S LR+ + G A G+ YL D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A NIL++ V DFGL +++ D + + T + I +PE ++
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K + +DV+ YG++L E+++ G+R + +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYW-------------------------------E 253
Query: 527 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 573
M + + V++ L Q+ L C Q RPK ++V +L+
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD-------- 305
Query: 574 EEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQP 606
+ + + + P+N + S I
Sbjct: 306 KLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 49/285 (17%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 76
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 131
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLST 467
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAY 186
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K S K+DV+ +GV+L E+ T G + + Q+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDL-------------------SQVYELL 225
Query: 527 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ +E E+V +L+ C Q +P +RP +E+ + E
Sbjct: 226 EKDYRMERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-33
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G FG+V+ + VAVK +K F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T ++ FM GS+ L+ S+ PL + + A G+A++
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQR---NY 305
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 474 TDVFGYGVMLLELIT 488
+DV+ +G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 19/248 (7%)
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR- 308
W + E++ V L + + E + +++ +GRG FG+V++ +
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
G AVK+++ E + E+ + ++ L G + +
Sbjct: 80 KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
GS+ +++ G Q L GL YLH +I+H DVKA N+LL +
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQA-L---EGLEYLHTR---RILHGDVKADNVLLSSD 186
Query: 429 FEAV-VGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ DFG A + + + GT H+APE + K D++ M+
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 484 LELITGQR 491
L ++ G
Sbjct: 247 LHMLNGCH 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 67/305 (21%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FGKV + VAVK LK + +E++ M + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIAL 396
++ L G C L++ + G + + LR + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---- 452
A+G+A+L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 453 -VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVML 506
V+ APE + + ++DV+ YG++L E+ + L + +
Sbjct: 229 PVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFY- 277
Query: 507 LDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEV 560
K ++ +G + + + ++ C P RP ++
Sbjct: 278 ----------KLVK-------DGYQMAQPAFAPKNIYSIM---QACWALEPTHRPTFQQI 317
Query: 561 VRMLE 565
L+
Sbjct: 318 CSFLQ 322
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/304 (23%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+F +LG+G FG+V K R D A+K+++ T+ +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 346 NLLRLRGF--------CMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP-LNWSVR 391
++R + F+ NG++ + +Q W +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY------- 444
+QI L+Y+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 445 -------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496
++T+A+ GT ++A E L TG +EK D++ G++ E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST-- 230
Query: 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 556
+ +L L+ +E D + N ++ E +++I+ L+ P +RP
Sbjct: 231 --GMERVNILKK-----LRSVSIE--FPPDFDDNKMKVE-KKIIR-LLIDH--DPNKRPG 277
Query: 557 MSEV 560
+
Sbjct: 278 ARTL 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 66/296 (22%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+VYKG L S VA+K LK T+ + F E ++ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G +++ +M NG++ LRE+ + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGTIGHIAPE 463
+HRD+ A NIL++ V DFGL++++ D + TT+ +R T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
+S K + +DV+ +G+++ E++T G+R +
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------------------- 252
Query: 523 VDSDMEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 565
++ + + + + + Q+ + C Q RPK +++V +L+
Sbjct: 253 ---ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+F LGRGGFG V++ + D A+KR++ + + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 347 LLRLRG-------FCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP---LNWSVR 391
++R VY ++ ++ + R + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
QIA + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 125 LQIAEA----VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 452 AVR-----------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500
GT +++PE + S K D+F G++L EL+ F
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS----TQ 230
Query: 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ V L + L + E ++Q SPMERP+ +
Sbjct: 231 MERVRTL---------TDVRNLKFPPLFTQKYPCEY-VMVQ---DMLSPSPMERPEAINI 277
Query: 561 VR 562
+
Sbjct: 278 IE 279
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 58/293 (19%)
Query: 295 ILGRGGFGKVYKGRLTDGSL--------VAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
LG+G F K++KG + V +K L + + F M+S H++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ G C+ E +LV F+ GS+ + L++ + + W + ++A A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKL--EVAKQLAAAMHFLE 130
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIG 458
++ +IH +V A NILL E + + D G++ + + +
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV-- 184
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 516
PE + K+ + TD + +G L E+ + G + L +
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----------------ALDSQ 225
Query: 517 KKLEQLVDSDMEGNYIEE----EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+KL+ + + + E+ LI C P RP ++R L
Sbjct: 226 RKLQFY----EDRHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLN 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340
E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHK 74
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 397
H+N+++ G + + GS+++ LR + ++ KQI L
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L- 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGT 456
GL YLHD+ +I+HRD+K N+L++ + + DFG +K + + T GT
Sbjct: 133 --EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
Query: 457 IGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQR 491
+ ++APE + G + D++ G ++E+ TG+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 71/309 (22%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FGKV + VAVK LK +E++ + + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 392
++ L G C L++ + G + + LR + S S
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
+ A+G+A+L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 502
V+ APE + + ++DV+ YG+ L EL + L + D
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPGMPVDS 255
Query: 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 556
K ++ EG + E+ ++ C P++RP
Sbjct: 256 KFY-----------KMIK-------EGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPT 294
Query: 557 MSEVVRMLE 565
++V+++E
Sbjct: 295 FKQIVQLIE 303
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 65/314 (20%), Positives = 110/314 (35%), Gaps = 76/314 (24%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
+LG G FGKV S VAVK LKE+ +E++ M + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 392
++ L G C L++ + G + + LR + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 393 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
A A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 448 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 497
+V V+ APE L G + K+DV+ YG++L E+ + L
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYPG 277
Query: 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 551
+ D + K ++ G ++ EE+ ++ C
Sbjct: 278 IPVDANFY-----------KLIQ-------NGFKMDQPFYATEEIYIIM---QSCWAFDS 316
Query: 552 MERPKMSEVVRMLE 565
+RP + L
Sbjct: 317 RKRPSFPNLTSFLG 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 61/310 (19%), Positives = 123/310 (39%), Gaps = 60/310 (19%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQGGELQFQT 334
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 335 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSV 390
E+ ++ + +RL + +T +Y M N + S L+++ P
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---R 129
Query: 391 R---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYK 445
+ K + + +H H I+H D+K AN L+ + ++ DFG+A M
Sbjct: 130 KSYWKNM----LEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPD 179
Query: 446 DTHVT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGVMLLELITGQRAF 493
T V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 494 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGS 550
+ + KL ++D + E + E++++ +++ C +
Sbjct: 240 Q-----QIINQI-----------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRD 280
Query: 551 PMERPKMSEV 560
P +R + E+
Sbjct: 281 PKQRISIPEL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 52/281 (18%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
GF +V S+ + R P R QI G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 132
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
S + DV+ G ++ L+ G+ F+ + ++++
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET--------YLRIKK----- 229
Query: 527 MEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
Y I LIQ +L Q P RP ++E++
Sbjct: 230 --NEYSIPKHINPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 36/301 (11%), Positives = 75/301 (24%), Gaps = 50/301 (16%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
L G V+ R + A+K + E ++ + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 352 GFC--------------------------MTPTERLLVYPFMV--NGSVASCLRERGQSQ 383
LL+ P + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
+ R A L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 444 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAND 501
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561
W + L+ + L + + V+ LI L R E +
Sbjct: 302 G-----SWKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIG-RFLNFD--RRRRLLPLEAM 351
Query: 562 R 562
Sbjct: 352 E 352
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMISMAVHRNLLRLRG 352
LG+G F VY+ + G VA+K + K+ + G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN-WSVRK---QIALGAARGLAYLHDH 408
+ LV NG + L+ R + P + R QI G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQII----TGMLYLHSH 131
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 528
++DV+ G M L+ G+ FD D V L ++V +D E
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNT-----------LNKVVLADYE 230
Query: 529 G-NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+++ E + LI LL + +P +R +S V+
Sbjct: 231 MPSFLSIEAKDLIH-QLL--RRNPADRLSLSSVLD 262
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 60/292 (20%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 350
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 405
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 124
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 462
H H I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ P
Sbjct: 125 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 463 EYL-----------STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
E + S K S K+DV+ G +L + G+ F + +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 227
Query: 512 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 560
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 228 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
GF +V S+ + R P R QI G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 158
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 214
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
S + DV+ G ++ L+ G+ F+ + L+ KK E +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSIPK- 262
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+I LIQ +L Q P RP ++E++
Sbjct: 263 ----HINPVAASLIQ-KML--QTDPTARPTINELLN 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 57/292 (19%), Positives = 115/292 (39%), Gaps = 60/292 (20%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 350
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 405
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 171
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 462
H H I+H D+K AN L+ + ++ DFG+A M T V + G + ++ P
Sbjct: 172 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 463 EYLS-----------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
E + K S K+DV+ G +L + G+ F + +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 274
Query: 512 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 560
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 275 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR-KQIAL---GAARGL 402
++ + E LV + GSV ++ + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 459
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 460 -IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+APE + + K D++ +G+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 43/311 (13%), Positives = 88/311 (28%), Gaps = 74/311 (23%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 331
+LG+ + G V ++KEE + L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 332 -----FQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPFMV--NGSVASCLRERGQS 382
F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 443 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQR 491
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 551
D + +W+ K I + V L++ L
Sbjct: 312 PIT-----KDAALGGSEWIFRSCKN---------------IPQPVRALLE-GFLRYP--K 348
Query: 552 MERPKMSEVVR 562
+R + +
Sbjct: 349 EDRLLPLQAME 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 52/307 (16%), Positives = 96/307 (31%), Gaps = 68/307 (22%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-- 343
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 344 -HRNLLRLRGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLN----WSVRKQIA 395
H +++R E + GS+A + E + + Q+
Sbjct: 69 QHSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDF 436
G L Y+H ++H D+K +NI + GD
Sbjct: 126 RG----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 495
G + G +A E L + K D+F + ++ +
Sbjct: 179 GHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 496 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 555
W + +++ +L ++ +E ++ + P RP
Sbjct: 234 GDQ----------WHE--IRQGRLPRI-----PQVLSQE----FTELLKVMIHPDPERRP 272
Query: 556 KMSEVVR 562
+V+
Sbjct: 273 SAMALVK 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
+ + G + T+ ++ ++ GS L + QIA +GL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATILREILKGL 132
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH K IHRD+KAAN+LL E E + DFG+A + T V GT +AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E + K D++ G+ +EL G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 4e-29
Identities = 42/305 (13%), Positives = 84/305 (27%), Gaps = 63/305 (20%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 331
+LG+ + G V ++KEE + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 332 -----FQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPFMV--NGSVASCLRERGQS 382
F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 443 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557
D + +W+ K I + V L++ L + +R
Sbjct: 320 ---DAALGGSEWIFRSCKN---------------IPQPVRALLEGFL---RYPKEDRLLP 358
Query: 558 SEVVR 562
+ +
Sbjct: 359 LQAME 363
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMIS 340
Q A ++F LG+G FG VY R ++A+K L K + + G E Q + EVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
H N+LRL G+ T L+ + G+V L++ + + ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--- 121
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L+Y H ++IHRD+K N+LL E + DFG + GT+ ++
Sbjct: 122 -LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYL 174
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE + EK D++ GV+ E + G+ F+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 47/293 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMA 342
V +F +++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLN-WSVRKQIALGAA 399
H N++R Y + ++ + ++ + L ++ +Q
Sbjct: 76 EHPNVIRYFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQT----T 128
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTT 451
GLA+LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 452 AVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507
GT G IAPE LS + D+F G + +I+ G F
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQA 238
Query: 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ + G L+ L + + +LI+ ++ P +RP V
Sbjct: 239 NILLG---ACSLDCLHPEK----HEDVIARELIE-KMIAMD--PQKRPSAKHV 281
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 24/140 (17%), Positives = 53/140 (37%), Gaps = 2/140 (1%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S +DL L LQ L+L I +L++L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG-DIPTN-GS 186
+ LS L+ L +L + ++ +L+ L++++N + +P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 187 FSLFTPISFANNQLNNPPPS 206
+ + ++N++ + +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 1/115 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNN 128
++ +D+ + + L++L+ L++ N+ P+ L NL LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L PT LS L+ L +++N+ +NSLQVLD S N +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 22/110 (20%), Positives = 43/110 (39%), Gaps = 2/110 (1%)
Query: 75 DLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+ + + +L NL +L+L + P +L++L L++ NN
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV-NSLQVLDLSNNKLTGDIP 182
L+ L+ L + N +M + L + +SL L+L+ N
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 30/143 (20%), Positives = 53/143 (37%), Gaps = 8/143 (5%)
Query: 70 SVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
S+ +DL LS G T+L+YL+L N + + L L LD +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 128 NLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-- 184
NL L L +L +++ ++SL+VL ++ N + +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 185 -GSFSLFTPISFANNQLNNPPPS 206
+L + + QL P+
Sbjct: 467 TELRNLTF-LDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 11/143 (7%)
Query: 70 SVTRVDL-GNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ +++ N S +L LTNL++L+L SN I +L L + +SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDI-- 181
LN +N P ++ L L L NN + + + + L+V L + +
Sbjct: 185 SLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 182 --PTNGSFSLFTPISFANNQLNN 202
+ ++ +L
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAY 266
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 25/166 (15%), Positives = 46/166 (27%), Gaps = 12/166 (7%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGN 115
CT V +DL ++ + + L L L +N S V + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 116 LTNLVSLDLYLNNLNG------PIPTTLGKLSKLRFLRLNNNSL---MGEIPRSLTNVNS 166
L L L L + L L L L + +I + +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L + + + +F + N + P L+
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQH-LELVNCKFGQFPTLKLKSLK 328
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 27/144 (18%), Positives = 45/144 (31%), Gaps = 16/144 (11%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
E + +D ++ LTN+ L S I ++ L+L
Sbjct: 260 EEFRLAYLDY----YLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVN 313
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
L L +L F S ++ SL+ LDLS N L+ + S
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 187 F----SLFTPISFANNQLNNPPPS 206
SL + + N + +
Sbjct: 369 DFGTTSLKY-LDLSFNGVITMSSN 391
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 52/329 (15%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQ 393
H+N+++L T R + ++ GS+ + L E + L V +
Sbjct: 65 NHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +L ++ I+HR++K NI+ D + + DFG A+ ++ D
Sbjct: 121 V----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF 172
Query: 450 TTAVRGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLAND 501
+ GT ++ P+ D++ GV TG F
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561
+ K ++ + + + E + S + ++ V+
Sbjct: 232 N--------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 562 R-MLEGDGLAERWEEWQKEEMFRQDFNHT 589
+LE D + W F Q F T
Sbjct: 284 ANILEADQ-EKCW-------GFDQFFAET 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 51/300 (17%), Positives = 100/300 (33%), Gaps = 53/300 (17%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLK----------------EERTQGGELQFQTEVEMI 339
L +G F K+ A+K+ + + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG-----QSQPPLNWSVRK-- 392
+ + L G E ++Y +M N S+ + ++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 393 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+ +Y+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 158 KSVLNS----FSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 452 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL-- 507
+ GT + PE+ S + K D++ G+ L + F ++ L
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFN 263
Query: 508 -------DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
++ S N++ E ++ L P ER +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFLRKN--PAERITSEDA 320
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 271 HLGQLKRFSLRELQVATDNFSNRNILGRG--GFGKVYKGR-LTDGSLVAVKRLKEERTQG 327
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 328 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL 386
+ F Q E+ + + H N++ R + E +V FM GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GM 125
Query: 387 NWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
N IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 126 N---ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 444 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGVMLLELITGQ 490
+ V + ++ + +PE L K+D++ G+ EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 43/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 260 FDVPAEEDPEVHLGQLKRFSL-RELQVATDNFSNRNILGRGGFGKVYKGRLTD------G 312
V + + +L E Q+ + ++LG G F +VY+ D
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+K K + Q +E + ++ ++ + +LV G++
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 373 ASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------ 425
+ + + + + A+ + +HD +IIH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 426 -----DEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479
D + D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 480 GVMLLELITGQRAF 493
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG+G FG VY R + ++A+K L + + + + Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L+ F G + L++ G+ + + +++A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA----LHYCHER---K 134
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 473 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
K D++ GV+ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/335 (17%), Positives = 112/335 (33%), Gaps = 44/335 (13%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 343 VHRNLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 397
H+N+++L T R L+ F GS+ + L E + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG- 123
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAV 453
G+ +L ++ I+HR++K NI+ + + DFG A+ ++ D +
Sbjct: 124 ---GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY 176
Query: 454 RGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT ++ P+ D++ GV TG F +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--- 232
Query: 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR-ML 564
K ++ + + + E + S + ++ V+ +L
Sbjct: 233 -----KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 565 EGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVD 599
E D + W F Q F T + ++
Sbjct: 288 EAD-QEKCW-------GFDQFFAETSDILHRMVIH 314
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 56/304 (18%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
+ + ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 347 LLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARG 401
++R T + + N ++ + + S L A G
Sbjct: 71 VIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 402 LAYLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD----Y 444
+A+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 445 KDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496
T++ GT G APE L + + D+F G + +++ G+ F
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-D 242
Query: 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 556
+ + + +++ +G+ +++ L D + E LI ++ P++RP
Sbjct: 243 KYSRESNII-----RGIFSLDEMKCLHDRS-----LIAEATDLIS-QMIDHD--PLKRPT 289
Query: 557 MSEV 560
+V
Sbjct: 290 AMKV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 21/205 (10%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 354 CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
++V G L+ + P+ ++ L L+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 470 SSEKTDVFGYGVMLLELITGQRAFD 494
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 76/261 (29%), Positives = 111/261 (42%), Gaps = 38/261 (14%)
Query: 253 RKPEDHFFDVPAEEDP-----------EVHLGQLKRFSLRELQVATD---NFSNRNILGR 298
H +D+P E+ G LK + EL D FS+ +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 299 GGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
G FG VY R + + +VA+K+ +++ EV + H N ++ RG +
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDPK 412
LV + GS + L + PL +IA GA +GLAYLH H
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK---PLQ---EVEIAAVTHGALQGLAYLHSH---N 174
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRDVKA NILL E +GDFG A +M ++ V GT +APE + +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229
Query: 473 ---KTDVFGYGVMLLELITGQ 490
K DV+ G+ +EL +
Sbjct: 230 YDGKVDVWSLGITCIELAERK 250
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
LG GG VY D L VA+K + + E F+ EV S H+N++ +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 351 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
E Y M + G L E +S PL+ G+ + H
Sbjct: 77 IDVD-----EEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D +I+HRD+K NIL+D + DFG+AK + T V GT+ + +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ E TD++ G++L E++ G+ F+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 32/149 (21%), Positives = 56/149 (37%), Gaps = 5/149 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T ++L + L + + + L L++ N IS PE L L L+L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L+ T + L L L +NS+ +L LDLS+N L+ G+
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL--GTQV 142
Query: 189 LFTP---ISFANNQLNNPPPSPPPPLQPT 214
+ +NN++ +
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-25
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 6/143 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++T + L + ++ + + NL L+L N +S L NL L L N +
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 130 NGPIPTTLG--KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L S L+ L L++N + P + L L L+N +L +
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 188 SLFTP----ISFANNQLNNPPPS 206
L +S +N+QL+ +
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 38/137 (27%), Positives = 54/137 (39%), Gaps = 7/137 (5%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+L + LS TNL L L SN+I NL++LDL N L+
Sbjct: 79 NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPTNGSFSLFTP 192
T +L L+ L L+NN + L SL+ L+LS+N++ P G F
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP--GCFHAIGR 196
Query: 193 ---ISFANNQLNNPPPS 206
+ N QL
Sbjct: 197 LFGLFLNNVQLGPSLTE 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 17/153 (11%)
Query: 70 SVTRVDLGNANLSGQLVSQLG---QLTNLQYLELYSNNISGKVPEELGNL--TNLVSLDL 124
+ + L N L L +L T+++ L L ++ +S L TNL LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
NNLN + L +L + L N++ SL + +++ L+L + I
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 185 GSFSLFTPISFAN-----------NQLNNPPPS 206
S SF N + +
Sbjct: 316 -SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 14/151 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY---- 125
++T +DL NL+ L L+Y L NNI L L N+ L+L
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 126 -----LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
L +L + L L L + +N + G T + +L+ L LSN+ +
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 181 IPTNGSFSLFTPIS-----FANNQLNNPPPS 206
TN +F N+++
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 10/145 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--------GKVPEELGNLTNLVSLD 123
T +DL N N++ L L L+ L+L NN++ G L L++L L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L N + L +L+ + L N+L N SL+ L+L N +T
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 184 --NGSFSLFTPISFANNQLNNPPPS 206
+F T + N + S
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-22
Identities = 31/146 (21%), Positives = 53/146 (36%), Gaps = 8/146 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S D + L+ Q+ L TN+ L L N + + L SLD+ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ P KL L+ L L +N L ++ +L L L +N + F
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN--NPFVK 119
Query: 190 FT---PISFANNQLNNPPPSPPPPLQ 212
+ ++N L++ L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLE 145
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 30/156 (19%), Positives = 51/156 (32%), Gaps = 12/156 (7%)
Query: 69 NSVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+ +DLG + +L + L N+ + L N + +L L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 128 NLNG--PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT---GDIP 182
L P+ L L L L+NN++ L + L++LDL +N L
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524
Query: 183 TNGSFSLFTP------ISFANNQLNNPPPSPPPPLQ 212
G ++ +N + P L
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-21
Identities = 30/122 (24%), Positives = 44/122 (36%), Gaps = 3/122 (2%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
N++ R L G + L L++L L L SN E +L L +DL L
Sbjct: 512 QHNNLAR--LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNG 185
NNLN + L+ L L N + + +L LD+ N +
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
Query: 186 SF 187
F
Sbjct: 630 WF 631
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-21
Identities = 32/145 (22%), Positives = 48/145 (33%), Gaps = 12/145 (8%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
S + + L N + L L L N IS + L +L LDL L
Sbjct: 361 SNSFTSLRTLTNETFVSL------AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 127 NNLNGPIP-TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
N + + L + + L+ N + S V SLQ L L L +
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 186 SF----SLFTPISFANNQLNNPPPS 206
F +L + +NN + N
Sbjct: 475 PFQPLRNLTI-LDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 6/112 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++L + V L L+ ++L NN++ N +L SL+L N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 130 NGPIPTTLGK-LSKLRFLRLNNNSLMGEIP-----RSLTNVNSLQVLDLSNN 175
G L L + N + N + +LS++
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 32/240 (13%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL---KEERTQGGELQFQTEV 336
+ +++ R +L GGF VY+ + + G A+KRL +EE+ + EV
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR----AIIQEV 76
Query: 337 E-MISMAVHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNW 388
M ++ H N+++ E L+ + G + L++ +S+ PL+
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSC 135
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
+I R + ++H P IIHRD+K N+LL + + DFG A + + +
Sbjct: 136 DTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 449 VTTA-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFD 494
+A T + PE + + EK D++ G +L L Q F+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 1e-26
Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LG GGFG V + G VA+K+ ++E + ++ E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 346 NLLRLRGFCMTPTE-RLLVYPFMV-----NGSVASCLRERGQSQPPLNWSVR---KQIAL 396
N++ R + P + G + L + +R I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAV 453
L YLH++ +IIHRD+K NI+L + + + D G AK +D + T V
Sbjct: 133 A----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV 184
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDD 503
GT+ ++APE L K + D + +G + E ITG R F R +++
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+++ D + G +K + L + + ++E+ +Q L +R +
Sbjct: 244 IVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
L L L+ F ++G G +G+VYKGR + G L A+K + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEE 65
Query: 332 -FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQ 383
+ E+ M+ + HRN+ ++ ++L LV F GSV ++
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKG 123
Query: 384 PPLNWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
L + IA RGL++LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 124 NTLK---EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
+D T + GT +APE ++ ++ + K+D++ G+ +E+ G
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 351 --RGFCMTPTERLLVYPFM--VNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
G +Y M +NG +A+ LR +G PL I L
Sbjct: 100 HDFG-----EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAA 150
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPE 463
H HRDVK NIL+ + A + DFG+A D +T GT+ ++APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE 205
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
S ++ + D++ +L E +TG +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
LG GG +V+ R D VAVK L+ + + F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 351 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
G TP L Y M V+G LR+ ++ P+ ++ A + L + H
Sbjct: 78 YDTGEAETPAGP-LPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEY 464
+ IIHRDVK ANI++ V DFG+A+ + VT AV GT +++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++DV+ G +L E++TG+ F
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LG G FGKVYK + G+L A K ++ + + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
+++L G + ++ F G+V + + E + L QI + L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLT---EPQIQVVCRQMLEAL 130
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIG 458
+LH +IIHRD+KA N+L+ E + + DFG K + +D+ + GT
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 459 HIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
+APE + + K D++ G+ L+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 14/229 (6%)
Query: 265 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE 323
+E L + ++ D+F + LG G G V+K G ++A K + E
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 324 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ 383
Q E++++ ++ G + E + M GS+ L++ G
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 126
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 442
+ + ++++ +GL YL + KI+HRDVK +NIL++ E + DFG++ +L+
Sbjct: 127 -RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 443 DYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
D ++ V GT +++PE L S ++D++ G+ L+E+ G+
Sbjct: 184 DSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 31/152 (20%), Positives = 54/152 (35%), Gaps = 13/152 (8%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N + A L +L +ELY+ ++P+ L +L L SL++
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 126 LNNLNGP---------IPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSN 174
N + K++ + N+L E P S L + L +LD +
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVH 582
Query: 175 NKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
NK+ + G+ T + NQ+ P
Sbjct: 583 NKVR-HLEAFGTNVKLTDLKLDYNQIEEIPED 613
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-21
Identities = 30/152 (19%), Positives = 54/152 (35%), Gaps = 12/152 (7%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE--LGNLTNLVSLDL 124
+ N A+ + +L +Q + NN+ P L + L LD
Sbjct: 523 ACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDC 580
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPT 183
N + G KL L+L+ N + EIP + ++ L S+NKL IP
Sbjct: 581 VHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPN 636
Query: 184 NGSFSLFTP---ISFANNQLNNPPPSPPPPLQ 212
+ + F+ N++ + + +
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-21
Identities = 22/146 (15%), Positives = 45/146 (30%), Gaps = 18/146 (12%)
Query: 75 DLGNANLSGQLVS---QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
D NL+ ++ + +LT LQ + ++ + + +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYE 481
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
+ L L + L N M ++P L ++ LQ L+++ N+ ++
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 192 P----------ISFANNQLNNPPPSP 207
N L P S
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 8e-21
Identities = 27/156 (17%), Positives = 58/156 (37%), Gaps = 16/156 (10%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEEL--GNLTNLVSLDL 124
S N +T + N L ++L N ++ + ++ L L ++D+
Sbjct: 705 SNNLMTSI---PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDV 760
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRL------NNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
N + PT S+L+ + N ++ + P +T SL L + +N +
Sbjct: 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 179 GDIPTNGSFSLFTPISFANNQLNN-PPPSPPPPLQP 213
+ + L+ + A+N + S P ++
Sbjct: 820 K-VDEKLTPQLYI-LDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 22/160 (13%), Positives = 48/160 (30%), Gaps = 19/160 (11%)
Query: 64 TCNSENSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELG------NL 116
C + V + + L + + + ++ N I +
Sbjct: 614 FCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKG 672
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQV 169
N ++ L N + S + + L+NN + + + N L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 170 LDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPS 206
+DL NKLT + + + + + N ++ P
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-19
Identities = 30/180 (16%), Positives = 52/180 (28%), Gaps = 15/180 (8%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDA-TLVNPCTWFHVTCNSENSVTRVDLGNANLSG 83
+ AL A+ L N S ++ W N +D+
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW--------NFNKELDM----WGD 313
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
Q L + L L G+VP+ +G LT L L ++ +
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 144 RFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
+ + + L L + DL + + P + IS + Q+ N
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGN 432
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 17/115 (14%), Positives = 40/115 (34%), Gaps = 10/115 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLEL------YSNNISGKVPEELGNLTNLVSLD 123
++ +D+ S +Q + L+ + N I + P + +L+ L
Sbjct: 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ N++ + L +L L + +N + S+ + L +K
Sbjct: 813 IGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+ F LG G +G VYK G +VA+K++ E Q + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDS 83
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARG 401
++++ G T+ +V + GSV+ +R R + L +IA +G
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLT---EDEIATILQSTLKG 137
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L YLH + IHRD+KA NILL+ E A + DFG+A + T + GT +A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE + + D++ G+ +E+ G+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
G+LK + ++ + +GRG +G V K G ++AVKR++ + + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 332 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-PLNWS 389
+++++ + +++ G + + M + S + +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTH 448
+ +I L + L +L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 126 ILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----- 178
Query: 449 VTTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQ 490
+ A G ++APE + S ++DV+ G+ L EL TG+
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++ +G+G G VY + G VA++++ ++ EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
N++ + E +V ++ GS+ + E + QIA + L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQAL 129
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
+LH + ++IHRD+K+ NILL + + DFG + + + +T V GT +AP
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E ++ K D++ G+M +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ +G G G V R G VAVK + + Q EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
N++ + + E ++ F+ G++ + + LN +QIA + L
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLN---EEQIATVCEAVLQAL 154
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
AYLH +IHRD+K+ +ILL + + DFG + + V GT +AP
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E +S + + D++ G+M++E++ G+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 21/235 (8%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
++V D+ LGRG +G V K R G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 342 AV--HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
+ G + + M + S+ ++ + + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMD--YKDTHVTTAVRGT 456
+ L +LH +IHRDVK +N+L++ + + DFG+ L+D KD G
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GC 172
Query: 457 IGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
++APE ++ + S K+D++ G+ ++EL + F +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 48/280 (17%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISM----AVHR 345
LG+GGFG V+ G LTD VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++RL + T +LV + + + E+G + Q+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQH 154
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
H ++HRD+K NIL+D + DFG L+ D T GT + PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYSPPE 208
Query: 464 YLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
++S + + V+ G++L +++ G F+ D +++ + L
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL-----EAELHFPA---- 254
Query: 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
++ + LI+ L P RP + E++
Sbjct: 255 --------HVSPDCCALIR-RCLAP--KPSSRPSLEEILL 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 15/147 (10%)
Query: 72 TRVDLGNANL-SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +G NL + + + L ++ L LE N + G G+ L SL+L N +
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT 366
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL--TNVNSLQVLDLSNNKLTGDIPTNGSFS 188
G ++ L +N L IP +V+ + +D S N++ +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGS-VDGKNFDP 424
Query: 189 LFTPI---------SFANNQLNNPPPS 206
L + +NNQ++ P
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKE 451
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 18/166 (10%), Positives = 44/166 (26%), Gaps = 30/166 (18%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + + + + + SNNI+ V + + LT L + +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 130 NGPIPTT-------------------LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVL 170
L L + + N + ++P L + +Q++
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 171 DLSNNKLTGDIPTNGSFSLFTPIS---------FANNQLNN-PPPS 206
+++ N+ + N L P +
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 23/156 (14%), Positives = 48/156 (30%), Gaps = 19/156 (12%)
Query: 69 NSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISG-------KVPEELGNLTNLV 120
V + + L + ++ + ++ N I + N+
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQVLDLS 173
S++L N ++ S L + L N L + + + N L +DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 174 NNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPPS 206
NKLT + + + + + N + P
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 23/191 (12%), Positives = 45/191 (23%), Gaps = 7/191 (3%)
Query: 23 RVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLS 82
+ +A + L+ L + +
Sbjct: 11 ALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG 70
Query: 83 GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP----IPTTLG 138
Q L + L L SG+VP+ +G LT L L L + P +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 139 KLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPT-NGSFSLFTPISF 195
+ + L ++++ I + T I
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 196 ANNQLNNPPPS 206
+N + +
Sbjct: 191 LSNNITFVSKA 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 11/121 (9%)
Query: 70 SVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL------ 122
+T +DL L+ + L L ++L N+ S P + N + L
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
D N P + L L++ +N + ++ +T ++ VLD+ +N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITP--NISVLDIKDNPNISIDL 604
Query: 183 T 183
+
Sbjct: 605 S 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 15/110 (13%), Positives = 35/110 (31%), Gaps = 10/110 (9%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLEL------YSNNISGKVPEELGNLTNLVSLDLYLNN 128
DL + S +Q + L+ + N + PE + +L L + N+
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ + + + L + +N + + + L +K
Sbjct: 578 IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK 318
F E D Q K L + ++FS I+GRGGFG+VY R D G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 319 RLKEER--TQGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
L ++R + GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
L + G +I LG L ++H+ +++RD+K ANILLDE +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRA 492
D GLA K H +V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 493 FDLARLANDDDVM 505
F + + ++
Sbjct: 391 FRQHKTKDKHEID 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 340
V + F +LG+GGFG+V ++ G + A K+L+++R + GE E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGA 398
R ++ L T LV M G + + GQ+ P +V +I G
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
L LH +I++RD+K NILLD+ + D GLA + T GT+G
Sbjct: 299 ---LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++APE + + + D + G +L E+I GQ F
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 30/145 (20%), Positives = 50/145 (34%), Gaps = 1/145 (0%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS ++ L + +L NL +L+L I + + L +L L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG-DIPTNGSF 187
L T L L+ L + L N +L+ L L +N ++ +P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQ 212
+ F NN ++ LQ
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQ 177
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 30/145 (20%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
E SV ++L + + LQ L+L + ++S ++P L L+ L L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPTN 184
N + L L + N+ E+ L N+ +L+ LDLS++ + N
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 185 GSF----SLFTPISFANNQLNNPPP 205
L + ++ + N+ +
Sbjct: 370 LQLRNLSHLQS-LNLSYNEPLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 26/150 (17%), Positives = 45/150 (30%), Gaps = 6/150 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + +S L L+ L L SN+IS + L LD N +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 130 NGPIPTTLGKLSKLR--FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ + L + L LN N + I + Q L+ + I
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 188 SLFT---PISFANNQLNNPPPSPPPPLQPT 214
S +F + + P+ L
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 7/143 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++ ++ L +L +L + N ++ L NL NL LDL ++
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 129 LN--GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
+ L LS L+ L L+ N + + L++LDL+ +L
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSP 420
Query: 187 FSLFT---PISFANNQLNNPPPS 206
F ++ +++ L+
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-20
Identities = 28/145 (19%), Positives = 45/145 (31%), Gaps = 13/145 (8%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
S + + D N L L++LQ L L N E L LDL
Sbjct: 358 SHDDIETSDCCNLQLRN--------LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 127 NNLNG-PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TN 184
L + L L+ L L+++ L + + +LQ L+L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 185 GSFSLFTPISF---ANNQLNNPPPS 206
S + + L++
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 25/151 (16%), Positives = 46/151 (30%), Gaps = 10/151 (6%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
N + N L+ ++ L + + LE N + L NL LD
Sbjct: 9 IEKEVNKT--YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L + T +L L L N L+ +L+ +L+ L ++ I
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-ID- 121
Query: 184 NGSFSLFTP---ISFANNQLNNPPPSPPPPL 211
+ +N +++ P
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 2/134 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L L + L L++L IS L N L SL L N+++
Sbjct: 87 VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV--LDLSNNKLTGDIPTNGSFSLFTP 192
KL+ L NN++ ++++ L+L+ N + G P ++F
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS 206
Query: 193 ISFANNQLNNPPPS 206
++F Q
Sbjct: 207 LNFGGTQNLLVIFK 220
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 4/144 (2%)
Query: 72 TRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+DL L + S L L+ L L + + + L L L+L N+
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 131 GPI---PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+L L +L L L+ L + T++ + +DLS+N+LT S
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 188 SLFTPISFANNQLNNPPPSPPPPL 211
++ A+N ++ PS P L
Sbjct: 523 LKGIYLNLASNHISIILPSLLPIL 546
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 25/136 (18%), Positives = 54/136 (39%), Gaps = 6/136 (4%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
D+ + ++S + L ++ +++ + L + + L LDL +L+ +P
Sbjct: 237 DMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LP 294
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFT 191
+ L LS L+ L L+ N S +N SL L + N ++ T +L
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 192 PISFANNQLNNPPPSP 207
+ +++ +
Sbjct: 355 -LDLSHDDIETSDCCN 369
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 4/115 (3%)
Query: 69 NSVTRVDLGNANLSG---QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
++ ++L + Q + L L L+ L L ++S +L + +DL
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
N L L L + L L +N + +P L ++ + ++L N L
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 21/135 (15%), Positives = 41/135 (30%), Gaps = 8/135 (5%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN--LTNLVSLDLYLNNLNGPIPT 135
N N + Q L + + L N + +L + P
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 136 TLGKLSK--LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--T 191
L + + + L + + + LQ LDL+ L+ ++P +G L
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP-SGLVGLSTLK 304
Query: 192 PISFANNQLNNPPPS 206
+ + N+ N
Sbjct: 305 KLVLSANKFENLCQI 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 340
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R + G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIA 395
R ++ L + L LV M G + + + P QI
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 454
G L +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 300 SG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
GT G +APE L + D F GV L E+I + F
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 28/151 (18%), Positives = 53/151 (35%), Gaps = 4/151 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+S +DL L + LQ+L+L I + L +L +L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ P + L+ L L L + + +L+ L++++N + FS
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFS 150
Query: 189 LFT---PISFANNQLNNPPPSPPPPLQPTPP 216
T + + N + + L+ P
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 6/136 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
+ +D+ N LT+L L++ N+ N TNL LDL
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L L +L+ L +++N+L+ + SL LD S N++
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SK-GILQH 542
Query: 189 LFTPISF---ANNQLN 201
++F NN +
Sbjct: 543 FPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 28/149 (18%), Positives = 51/149 (34%), Gaps = 8/149 (5%)
Query: 70 SVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
S++ +DL LS G +L++L+L N + L L LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 128 NLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-- 184
L L KL +L ++ + + + SL L ++ N + +N
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 185 -GSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ +L + + QL L
Sbjct: 470 ANTTNLTF-LDLSKCQLEQISWGVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 28/165 (16%), Positives = 48/165 (29%), Gaps = 11/165 (6%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGN 115
+ +D+ N + Q Q L L L N S + + L N
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSL-NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 116 LTNLVSLDLY------LNNLNGPIPTTLGKLSKLRF--LRLNNNSLMGEIPRSLTNVNSL 167
L L L NL P+ + L + RL + + + ++
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L+ + F + +S QL P P L+
Sbjct: 288 SAMSLAGVSIKYLEDVPKHFKWQS-LSIIRCQLKQFPTLDLPFLK 331
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 29/143 (20%), Positives = 55/143 (38%), Gaps = 11/143 (7%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ ++++ + + +L + LTNL +++L N I +L L +SLD+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGD--- 180
LN ++ I + KL L L N I + L N+ L V L + +
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 181 -IPTNGSFSLFTPISFANNQLNN 202
I ++ +L
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTY 270
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 30/139 (21%), Positives = 53/139 (38%), Gaps = 11/139 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V+ + L ++ + + + Q L + + P +L L SL L +N
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKG 340
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPT-NGS 186
+ I L L +L L+ N+L S +++ SL+ LDLS N G
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGL 398
Query: 187 FSLFTPISFANNQLNNPPP 205
L + F ++ L
Sbjct: 399 EELQH-LDFQHSTLKRVTE 416
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHR--NL 347
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 348 LRLRGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+RL + P +L+ + + ERG Q L S Q+ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCH 166
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
+ ++HRD+K NIL+D + + DFG L+ KDT T GT + PE++
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPEWI 220
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 264
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ E + LI+ L P +RP E+
Sbjct: 265 ------RVSSECQHLIR-WCLAL--RPSDRPTFEEIQN 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++L F LV G L + + N + KQ+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQV----LS 147
Query: 401 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
G+ YLH H I+HRD+K N+LL +++ + DFGL+ + +++ GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA 202
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+IAPE L K EK DV+ GV+L L+ G F
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 44/303 (14%)
Query: 194 SFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKR 253
S +N+ N ++ P + + + A A L + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLP-NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 254 KPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTD 311
E+ +F ED K F + ++++GRG V + R T
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRAT- 118
Query: 312 GSLVAVK-------RLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLV 363
G AVK RL E+ + + E + +A H +++ L + + LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 364 YPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417
+ M G L E+ S+ + + +++LH + I+HRD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR------SIMRSLL----EAVSFLHAN---NIVHRD 225
Query: 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 477
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 478 GYG 480
GYG
Sbjct: 281 GYG 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE 337
+ Q ++ N +G G G+V+K R G ++AVK+++ + + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 338 -MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
++ +++ G +T T+ + M + R +G P+ + ++ +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+ L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGC 187
Query: 457 IGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
++APE + ++ + DV+ G+ L+EL TGQ
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 343
+D + + +LG+G FG+V + G AVK + + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 399
H N+++L F LV G L + S+ + + +Q+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQV----L 136
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
G+ Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGT 191
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516
+IAPE L G EK DV+ GV+L L++G F+ ++ +L +
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN----GANEYDIL---------K 237
Query: 517 KKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
K + ++ + E + LI+ +L P R +
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIR-KMLTY--VPSMRISARDA 279
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 3/147 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + L + L + + L NL+ L++ ++ +S + + +L L LDL
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
P G + L+ L L + S + +P + + L+ LDL +P+
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 189 LFTPISFANNQLNNPPPSPPPPLQPTP 215
I + P P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 30/151 (19%), Positives = 54/151 (35%), Gaps = 18/151 (11%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLT--NLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
N+ L L T LEL S + + P++ L++L + +
Sbjct: 56 NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS-NNKLTGDIPTN- 184
L +P T+ + + L L L N L +P S+ ++N L+ L + +LT ++P
Sbjct: 114 AGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPL 170
Query: 185 GSFSLFTPISF---------ANNQLNNPPPS 206
S + + P S
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 15/116 (12%)
Query: 80 NLSG-QLVS---QLGQLTNLQYLELYSNNISGKVPEELGN---------LTNLVSLDLYL 126
L+ L + + L L+ L + + ++PE L + L NL SL L
Sbjct: 133 TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+ +P ++ L L+ L++ N+ L + ++ ++ L+ LDL + P
Sbjct: 193 TGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 76 LGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT--NLVSLDLYLNNLNGP 132
NA+ + + N Q + + L + T V+L+L L
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ- 95
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P +LS L+ + ++ LM E+P ++ L+ L L+ N L
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 12/121 (9%), Positives = 27/121 (22%), Gaps = 9/121 (7%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
+ + L + + L + D + + +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63
Query: 149 NNNSLMGEIPRSLTNVNS--LQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205
+L L + L+L + L P S ++ L P
Sbjct: 64 TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPD 121
Query: 206 S 206
+
Sbjct: 122 T 122
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEER-------TQGGELQFQTEVEMISMAVHRNL 347
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 348 LRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ LV +G + + + + PL + +Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM 202
Query: 467 TGKSSE--KTDVFGYGVMLLELITGQRAFD 494
G + +++ GV L L+ + F
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 21/107 (19%), Positives = 49/107 (45%), Gaps = 3/107 (2%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ + N + + + + L+NL+ L + +++ L LT+L LD+ + +
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
I T + L K+ + L+ N + +I L + L+ L++ + +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 23/134 (17%), Positives = 58/134 (43%), Gaps = 4/134 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS+T + L N N++ ++ + N++ L + + + + + L+NL L + +
Sbjct: 44 NSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ L L+ L L +++++ I + + + +DLS N DI +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 189 LFTPISFANNQLNN 202
++ + +++
Sbjct: 160 ELKSLNIQFDGVHD 173
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 21/95 (22%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
Q+ +L Y+ L + N++ + N+ L + + P + LS L LR+
Sbjct: 41 AQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
+ + +L+ + SL +LD+S++ I T
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 14/118 (11%), Positives = 41/118 (34%), Gaps = 8/118 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L ++ + + +L + L N+ + ++ L +NN
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSP 207
P ++ +++L+ L + +T D N + T + +++ ++ +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 44/248 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK--------RLKEERTQGGELQFQTEV 336
+N+ + ILGRG V + + T AVK E Q EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 337 E-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWS 389
+ + ++ H N+++L+ T T LV+ M G L E+
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------K 128
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ + + + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 129 IMRALL----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 179
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKT------DVFGYGVMLLELITGQRAFDLARLANDDD 503
V GT ++APE + + D++ GV++ L+ G F +
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQ 234
Query: 504 VMLLDWVK 511
+++L +
Sbjct: 235 MLMLRMIM 242
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK---RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG G +GKV + AVK + K R GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLA 403
++ + +MV ++E L+ K+ + A GL
Sbjct: 73 DVLYNEEKQKM---YMVMEYCVCGMQEM------LDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAP 462
YLH I+H+D+K N+LL + G+A+ + + +G+ P
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 463 EYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
E + S K D++ GV L + TG F+ D++ L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 26/141 (18%), Positives = 52/141 (36%), Gaps = 4/141 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S +DL L LQ L+L I +L++L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ LS L+ L +L + ++ +L+ L++++N + FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 189 LFT---PISFANNQLNNPPPS 206
T + ++N++ + +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCT 167
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 8/125 (6%)
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRF 145
T+L+YL+L N + + L L LD +NL + L L +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
L +++ ++SL+VL ++ N + F +L + + QL
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTF-LDLSQCQLE 483
Query: 202 NPPPS 206
P+
Sbjct: 484 QLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 1/114 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++ +D+ + + L++L+ L++ N+ + L NL LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L PT LS L+ L + +N L + SLQ + L N P
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 31/148 (20%), Positives = 58/148 (39%), Gaps = 11/148 (7%)
Query: 70 SVTRVDLGNANL-SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ +++ + + S +L LTNL++L+L SN I +L L + +SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGD--- 180
LN +N I K +L L L NN + + + + L+V L + +
Sbjct: 185 SLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 181 -IPTNGSFSLFTPISFANNQLNNPPPSP 207
+ ++ +L
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYL 271
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 40/172 (23%), Positives = 58/172 (33%), Gaps = 17/172 (9%)
Query: 38 TNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQY 97
NL L D L + F+ N V+ L + + V Q+
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTN----VSSFSLVSVTIER--VKDFSYNFGWQH 308
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MG 155
LEL + P L +L L N + L L FL L+ N L G
Sbjct: 309 LELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKG 363
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPPP 205
+S SL+ LDLS N + + +N G L + F ++ L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSE 413
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 29/160 (18%), Positives = 52/160 (32%), Gaps = 14/160 (8%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQ-LGQLTNLQYLELY------SNNISGK 108
NP + E + ++ L N S ++ + L L+ L N+
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 109 VPEELGNLTNLVSLDLYLNNLNG---PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
L L NL + L L+ I L+ + L + ++ + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNF 304
Query: 166 SLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
Q L+L N K PT ++F +N+ N
Sbjct: 305 GWQHLELVNCKFG-QFPTL-KLKSLKRLTFTSNKGGNAFS 342
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 37/129 (28%), Positives = 60/129 (46%), Gaps = 7/129 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ +GN ++ +S L L+ L +LE+ +N IS + +LT L L++ N ++
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
L LS+L L LNNN L E + + +L L LS N +T P + +
Sbjct: 280 ISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDS 337
Query: 192 PISFANNQL 200
FAN +
Sbjct: 338 -ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S+T++ + ++ + + LTNL+YL L N I+ L NL L +L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNK 99
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ + L L+ LR L LN +++ P L N+ + L+L N D+ + +
Sbjct: 100 IT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT 155
Query: 189 LFTPISFANNQLNNPPP 205
++ +++ + P
Sbjct: 156 GLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 29/134 (21%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ + + + V+ + LT+L L L N I L +LT+L Y+N +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD 213
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
P + +++L L++ NN + P L N++ L L++ N+++ DI +
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINAVKDLTKLK 268
Query: 192 PISFANNQLNNPPP 205
++ +NQ+++
Sbjct: 269 MLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T +++G +S ++ + LT L+ L + SN IS L NL+ L SL L N L
Sbjct: 246 TWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+G L+ L L L+ N + P L +++ + D +N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L L +++ L ++ L + + + L+ L +
Sbjct: 15 IFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEY 70
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L LN N + P L+N+ L L + NK+T DI + + + + +++ P
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 16/111 (14%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L I+ +L + L ++ + +L + L + +
Sbjct: 2 AATLATLPAPIN--QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
I + + +L+ L+L+ N++T DI + T + N++ +
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNKITDISA 105
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++L + +V G L + + + + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVF----S 132
Query: 401 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++ GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517
+IAPE L G EK DV+ GV+L L++G F ++ +L ++
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY----GKNEYDIL---------KR 233
Query: 518 KLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
D+ I ++ + LI+ +L P R ++
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIR-KMLTFH--PSLRITATQC 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 279 SLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ 333
S RE + LG G FG V+ + G +K + ++R+Q Q +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG----------SVASCLRERGQSQ 383
E+E++ H N++++ +V G + L E ++
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
+ KQ+ LAY H ++H+D+K NIL + DFGLA+
Sbjct: 129 ------LMKQMM----NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L D H T A GT ++APE + K D++ GV++ L+TG F
Sbjct: 176 LFK-SDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 51/280 (18%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G+G F KV R LT G VA+K + K + + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHC 409
T L+ + G V L G+ + R QI + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---ARSKFRQIV----SAVQYCHQKR 134
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I+HRD+KA N+LLD + + DFG + + G + APE GK
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELFQ-GK 188
Query: 470 SSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ + DV+ GV+L L++G FD ++ L +++ +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKEL--------RERV-------L 227
Query: 528 EGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
G Y + + E L++ L +P++R + ++++
Sbjct: 228 RGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 44/210 (20%), Positives = 78/210 (37%), Gaps = 43/210 (20%)
Query: 369 NGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
++ + R + + + QIA + +LH ++HRD+K +NI
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSK---GLMHRDLKPSNIFF 197
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR-----------GTIGHIAPEYLSTGKSSEKT 474
+ VGDFGL MD + T GT +++PE + S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 475 DVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE 533
D+F G++L EL+ + R+ D ++ K L
Sbjct: 258 DIFSLGLILFELLYSFSTQMERVRIITD------------VRNLKFPLLFT-----QKYP 300
Query: 534 EEVEQLIQVALLCTQGSPMERPKMSEVVRM 563
+E ++Q SP ERP+ ++++
Sbjct: 301 QEH-MMVQ---DMLSPSPTERPEATDIIEN 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ LG N++ L + L+ I + + L NL ++ N L
Sbjct: 25 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 80
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
P L L+KL + +NNN + P L N+ +L L L NN++T DI + +
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDPLKNLTN 135
Query: 190 FTPISFANNQLNNPPP 205
+ ++N +++
Sbjct: 136 LNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 9/134 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T +DL N +S ++ L LT L L+L +N IS L LT L +L+L N L
Sbjct: 246 TDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED 301
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
P + L L +L L N++ P ++++ LQ L NNK++ D+ + + +
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNIN 356
Query: 192 PISFANNQLNNPPP 205
+S +NQ+++ P
Sbjct: 357 WLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ R++L + +S +S L LT+LQ L N ++ + L NLT L LD+ N +
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ L KL+ L L NN + P L + +L L L+ N+L DI T S +
Sbjct: 190 SDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTN 244
Query: 190 FTPISFANNQLNNPPP 205
T + ANNQ++N P
Sbjct: 245 LTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 32/136 (23%), Positives = 52/136 (38%), Gaps = 8/136 (5%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T ++L L +S + L NL YL LY NNIS + +LT L L Y N
Sbjct: 287 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNK 342
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
++ L L+ + +L +N + P L N+ + L L++ T +
Sbjct: 343 VSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398
Query: 189 LFTPISFANNQLNNPP 204
P
Sbjct: 399 SIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-17
Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L L N++ V +L + +L + + L+ L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQ 72
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+ +NN L P L N+ L + ++NN++ DI + + T ++ NNQ+ + P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 6/132 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ R+ N +S VS L LTN+ +L N IS L NLT + L L
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAW 387
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+S ++ +L+ P ++++ S D++ N + + +FS
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQ 445
Query: 190 FTPISFANNQLN 201
I +
Sbjct: 446 PVTIGKGTTTFS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 19/107 (17%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 99 ELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+ + L + L N+ + L ++ L+ + + +
Sbjct: 6 ATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSI 61
Query: 159 RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+ +N+L ++ SNN+LT DI + + I NNQ+ + P
Sbjct: 62 DGVEYLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 13/114 (11%), Positives = 32/114 (28%), Gaps = 5/114 (4%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++ + G+ +S ++ L LT + L L + N++ ++
Sbjct: 353 TNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L P T+ + N + + +G +
Sbjct: 411 LI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 470
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 531 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 49/294 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK------------EERTQGGELQFQ 333
+++ LG G +G+V + S A+K +K + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WS 389
E+ ++ H N+++L LV F G L E+ ++ + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 446
+ KQI G+ YLH H I+HRD+K NILL + + DFGL+ +
Sbjct: 151 IMKQI----LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSK 201
Query: 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+ GT +IAPE L K +EK DV+ GV++ L+ G F +D
Sbjct: 202 DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFG----GQND---- 252
Query: 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ ++K+ + + + I +E ++LI+ +L +R E
Sbjct: 253 ----QDIIKKVEKGKYYFDFNDWKNISDEAKELIK-LMLTY--DYNKRCTAEEA 299
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 337
D + LG G G+V R T VA++ + R L +TE+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFM--VNGS------VAS-CLRERGQSQPPLNW 388
++ H +++++ F Y + + G V + L+E
Sbjct: 193 ILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKVVGNKRLKEATCK------ 242
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 445
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++
Sbjct: 243 LYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293
Query: 446 DTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITG 489
+T + + GT ++APE L + + + D + GV+L ++G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EV---E 337
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 338 MISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK 392
+ H N++RL C T LV+ + + + + L + P L K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKA--PPPGLPAETIK 123
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 448
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 449 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 57/233 (24%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQF-QTEVEMIS 340
V D+F +G+G FGKV + D + A+K + K++ + E++ E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQ-SQPPLNWSVR---KQIA 395
H L+ L + E + +V ++ G + L++ + +V+ ++
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICELV 125
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ L YL + +IIHRD+K NILLDE + DF +A ++ + T A G
Sbjct: 126 MA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--G 176
Query: 456 TIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T ++APE S+ K + + D + GV EL+ G+R + + + +++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 52/248 (20%), Positives = 81/248 (32%), Gaps = 53/248 (21%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
+G+G +G V ++ A+K + + +TEV ++ H N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG------------- 397
LV G + L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 398 ----------------AAR-------GLAYLHDHCDPKIIHRDVKAANILL--DEEFEAV 432
+ L YLH+ I HRD+K N L ++ FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 433 VGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLEL 486
+ DFGL+K + +TT GT +APE L+T K D + GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 487 ITGQRAFD 494
+ G F
Sbjct: 270 LMGAVPFP 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 470
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 530
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 531 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 35/137 (25%), Positives = 57/137 (41%), Gaps = 9/137 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + +++L L S N++ L+L N +S +L T L L+L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + L LS LR L LNNN + + L S++ L +NN ++ + +
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS-RGQ 120
Query: 189 LFTPISFANNQLNNPPP 205
I ANN++
Sbjct: 121 GKKNIYLANNKITMLRD 137
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++L L N I V ++ L +LDL N L + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
NN L+ I ++L +L+ DL N + + A +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 6/121 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ ++ +++ + + N+ LDL N L+ L +KL L L++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
L E L ++++L+ LDL+NN + ++ S+ + ANN ++ S
Sbjct: 69 VL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGP--SI-ETLHAANNNISRVSCSRGQGK 122
Query: 212 Q 212
+
Sbjct: 123 K 123
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLR 147
+ + + L +N I+ + G + + LDL LN ++ L L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206
L N + ++ L+ LDLS+NKL + S + T IS NN+L +
Sbjct: 176 LQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 1/98 (1%)
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
E N + ++L + + ++ L L+ N L L L++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 170 LDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
L+LS+N L + S S + NN + P
Sbjct: 63 LNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGP 99
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 14/76 (18%), Positives = 32/76 (42%), Gaps = 5/76 (6%)
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT- 191
I ++ + ++ ++SL + + +++ LDLS N L+ I + FT
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS-AADLAPFTK 59
Query: 192 --PISFANNQLNNPPP 205
++ ++N L
Sbjct: 60 LELLNLSSNVLYETLD 75
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 48/225 (21%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 335
++++++ ++F ++GRG FG+V +L + + A+K L K E + E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQ 393
+++ + + L LV + V G + + L + + + P + +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAE 183
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453
+ + + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 184 MVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 454 RGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAF 493
GT +I+PE L + + D + GV + E++ G+ F
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N+++L + +V G E ++ + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVF--- 131
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++T + + G
Sbjct: 132 -SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-G 185
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
T +IAPE L G EK DV+ GV+L L++G F
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 63/321 (19%), Positives = 110/321 (34%), Gaps = 52/321 (16%)
Query: 197 NNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 256
N + P P P+ G + G +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGT------------VSSNYD 133
Query: 257 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTDGSL 314
++ FD+ + P+ + D++ LG G FG V++ R T G+
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVL--------DHYDIHEELGTGAFGVVHRVTERAT-GNN 184
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG---- 370
A K + E + E++ +S+ H L+ L E +++Y FM G
Sbjct: 185 FAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 371 ---SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
+ + E + +Q+ +GL ++H++ +H D+K NI+
Sbjct: 244 KVADEHNKMSEDEAVE------YMRQV----CKGLCHMHEN---NYVHLDLKPENIMFTT 290
Query: 428 EFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 485
+ + DFGL +D V GT APE TD++ GV+
Sbjct: 291 KRSNELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 486 LITGQRAFDLARLANDDDVML 506
L++G F +DD L
Sbjct: 349 LLSGLSPF----GGENDDETL 365
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 67/300 (22%), Positives = 105/300 (35%), Gaps = 56/300 (18%)
Query: 293 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRL 350
++LG G +V L AVK ++++ + EVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAY 404
F LV+ M GS+ S + +R S V + +A L +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVA----SALDF 126
Query: 405 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV-------TTAVR 454
LH+ I HRD+K NIL ++ + DF L + T
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182
Query: 455 GTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
G+ ++APE + D++ GV+L L++G F W
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV------GRCGSDCGW 236
Query: 510 VKGLLKEKKLEQLVDSDMEGNY---------IEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+G L +S EG Y I + LI LL +R ++V
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS-KLLVR--DAKQRLSAAQV 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 19/216 (8%)
Query: 287 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
+ + N +GRG +G+V A K++ + + + +F+ E+E++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKS 62
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H N++RL T+ LV G + + + + + K +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----SA 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
+AY H + HRD+K N L + + DFGLA + GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPY 173
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+++P+ L G + D + GVM+ L+ G F
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 66/282 (23%), Positives = 102/282 (36%), Gaps = 50/282 (17%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDP 411
+TPT ++ + G + + G+ R Q+ G++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS----GVSYCHSM--- 135
Query: 412 KIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+I HRD+K N LLD + DFG +K + + V GT +IAPE L +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPEVLL-RQ 192
Query: 470 --SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ DV+ GV L ++ G F+ D + +K Q + +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD--------YRKTIQRI---L 235
Query: 528 EGNY-------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
Y I E LI P R + E+
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIF---VADPATRISIPEIKT 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 53/229 (23%), Positives = 86/229 (37%), Gaps = 26/229 (11%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G F V + G AVK + E + M H +++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAARGLAYL 405
L + +V+ FM + + +R + + +QI L A L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI-LEA---LRYC 146
Query: 406 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
HD+ IIHRDVK +LL + +G FG+A + V GT +AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
E + + DV+G GV+L L++G F L + +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY------GTKERLFEGII 245
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 25/239 (10%)
Query: 263 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL- 320
AE P Q + + + ++F ILG G F V R A+K L
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 321 KEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
K + ++ + E +++S H ++L + + NG + +R+
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 124
Query: 380 GQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435
G + + + +I L YLH IIHRD+K NILL+E+ + D
Sbjct: 125 GS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNEDMHIQITD 173
Query: 436 FGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQ 490
FG AK L + GT +++PE L+ KSS D++ G ++ +L+ G
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 337
D + LG G G+V R T VA+K + R L +TE+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVR 391
++ H +++++ F + +V M G L+E
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL------YF 120
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 448
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T
Sbjct: 121 YQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 171
Query: 449 VTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVML 483
+ + GT ++APE L + + + D + GV+L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 34/234 (14%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTE 335
L+E+++ D+F ++GRG F +V ++ G + A+K + K + + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
+++ R + +L F L LV + V G + + L + G ++I
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-----------ERI 159
Query: 395 ALGAAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
AR + +H +HRD+K NILLD + DFG +
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG-------YGVMLLELITGQRAF 493
T + GT +++PE L T +G GV E+ GQ F
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 6e-19
Identities = 35/137 (25%), Positives = 56/137 (40%), Gaps = 9/137 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + +++L L S N++ L+L N +S +L T L L+L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + L LS LR L LNNN + + L S++ L +NN ++ +
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC-SRGQ 120
Query: 189 LFTPISFANNQLNNPPP 205
I ANN++
Sbjct: 121 GKKNIYLANNKITMLRD 137
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 23/124 (18%), Positives = 41/124 (33%), Gaps = 4/124 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++L L N I V ++ L +LDL N L + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
NN L+ I ++L +L+ DL N + + A +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 209 PPLQ 212
Sbjct: 281 EECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 26/121 (21%), Positives = 52/121 (42%), Gaps = 6/121 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ ++ +++ + + N+ LDL N L+ L +KL L L++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
L E L ++++L+ LDL+NN + ++ S + ANN ++ S
Sbjct: 69 VL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGPS---IETLHAANNNISRVSCSRGQGK 122
Query: 212 Q 212
+
Sbjct: 123 K 123
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 22/135 (16%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+L + L L L+ L+ L+L +N + EL ++ +L NN++ +
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS 115
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT--- 191
+ + + L NN + + +Q LDL N++ + +
Sbjct: 116 --CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLE 172
Query: 192 PISFANNQLNNPPPS 206
++ N + +
Sbjct: 173 HLNLQYNFIYDVKGQ 187
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 27/135 (20%), Positives = 47/135 (34%), Gaps = 6/135 (4%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG-KVPEELGNLTNLVSLDLYLN 127
+ L N ++ G + +QYL+L N I E + L L+L N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GS 186
+ + + +KL+ L L++N L + + + + L NNKL I
Sbjct: 180 FIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 187 FSLFTPISFANNQLN 201
N +
Sbjct: 236 SQNLEHFDLRGNGFH 250
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 1/99 (1%)
Query: 109 VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168
+ E N + ++L + + ++ L L+ N L L L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
+L+LS+N L + S S + NN + P
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGP 99
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 12/102 (11%), Positives = 25/102 (24%), Gaps = 1/102 (0%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTT 136
L+GQ + T Y ++ + L L L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
++ R + I + + L+ L
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 13/158 (8%), Positives = 40/158 (25%), Gaps = 1/158 (0%)
Query: 21 LLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNAN 80
+ VA + P P + + + G +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 81 LSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140
+ +L + + ++ + + ++L+ L+ +
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
++L + E+ + + LQ+L +
Sbjct: 384 AELDGTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 16/146 (10%), Positives = 36/146 (24%), Gaps = 4/146 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELY-SNNISGKVPEELGNLTNLVSLD 123
C +L +L L ++ L + + ++ E N +D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP---RSLTNVNSLQVLDLSNNKLTGD 180
I + L +L ++ R+ ++ + +L
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
Query: 181 IPTNGSFSLFTPISFANNQLNNPPPS 206
L I ++ S
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQS 428
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGGELQFQTEVEMI 339
+ + ++N ++G G FG V++ +L + VA+K+ L+++R + ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 340 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 392
H N++ L+ F + ++ LV ++ +V R + + + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 393 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTH 448
Q+ R LAY+H I HRD+K N+LLD + + DFG AK
Sbjct: 146 YMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-------- 190
Query: 449 VTTAVRGTIGHI------APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+ A + +I APE + + + D++ G ++ EL+ GQ
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 344
+ + N ++G G +G V K R G +VA+K+ E ++ E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
NL+ L C LV+ F+ + ++ L L++ V ++ G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGF 139
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGH 459
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-19
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 287 TDNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 339
+ FS+ LG+G F V + + T G A K + ++ + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQ 393
H N++RL + LV+ + G E S +Q
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQ 113
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVT 450
I +AY H + I+HR++K N+LL + + DFGLA + D+
Sbjct: 114 IL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAW 164
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
GT G+++PE L S+ D++ GV+L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 50/245 (20%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-------------------------RLKEERTQGGE 329
+G+G +G V D + A+K + +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 330 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRERGQSQPP 385
Q E+ ++ H N+++L P E L +MV N +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSED 137
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
+ + G + YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 138 QARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 446 DTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDD 502
D ++ V GT +APE LS + S + DV+ GV L + GQ F D+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DE 243
Query: 503 DVMLL 507
+M L
Sbjct: 244 RIMCL 248
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGAA 399
N++ L + T LV + G E+ S V +Q+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVL---- 116
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVML 483
G++APE L+ S+ D + GV+
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQI 394
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 335
+R+L++ +++ ++GRG FG+V R + A+K L K E + + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 392
++++ A +++L +V +M G + + + + R
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTA 175
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
++ L L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 453 VRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAF 493
GT +I+PE L + D + GV L E++ G F
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 35/241 (14%)
Query: 281 RELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTE 335
++L + F++ +G G + + AVK + + + E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----E 65
Query: 336 VEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNW 388
+E++ H N++ L+ +V M G + ER S
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----- 120
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDY 444
V I + + YLH ++HRD+K +NIL E++ + DFG AK +
Sbjct: 121 -VLFTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
++ + T T +APE L D++ GV+L ++TG F +++
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 505 M 505
+
Sbjct: 232 L 232
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 25/208 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N++RL L++ + G E S +QI
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQIL--- 120
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 121 -EAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVML 483
T G+++PE L + D++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + +G G +G VYK + + G +VA+KR++ + G + E+ ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ L + LV+ FM + L E L S K RG+A+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHC 135
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 460
H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 461 APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L K S D++ G + E+ITG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG G FGKV G G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TPT+ +V ++ G + + + G+ + + +QI + Y H H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDYCHRH---M 131
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--S 470
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 188
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ D++ GV+L L+ G FD D+ V L
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 45/308 (14%)
Query: 198 NQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 257
+ ++ L S + + + ++
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSA 61
Query: 258 HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN------RNILGRGGFGKVYKGR-LT 310
D+PA P F R + ++ ILG G FG+V+K
Sbjct: 62 LAVDIPAPPAP---------FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 311 DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370
G +A K +K + E + + E+ +++ H NL++L + + +LV ++ G
Sbjct: 113 TGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 371 -------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423
+ L E KQI G+ ++H I+H D+K NI
Sbjct: 172 ELFDRIIDESYNLTELDTI------LFMKQIC----EGIRHMHQM---YILHLDLKPENI 218
Query: 424 LLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
L + DFGLA+ + GT +APE ++ S TD++ GV
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 482 MLLELITG 489
+ L++G
Sbjct: 277 IAYMLLSG 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 31/219 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D++ LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
H N++ L T+ +L+ + G L E +Q KQI
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQI 117
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH +I H D+K NI+L + + + DFG+A ++
Sbjct: 118 L----DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK 169
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
GT +APE ++ + D++ GV+ L++G
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 26/223 (11%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL 330
+G+ F + +DN+ + LG+G F V + T G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 331 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQ 383
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
+QI +AY H + I+HR++K N+LL + + DFGLA
Sbjct: 132 -----HCIQQIL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ D+ GT G+++PE L S+ D++ GV+L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 43/282 (15%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 353 FCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
LV + G E S + +++ ++++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLV----SAVSHMH 123
Query: 407 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
D ++HRD+K N+L ++ E + DFG A+L + + T T+ + APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
L+ E D++ GV+L +++GQ F + D + ++K+ K
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ-----SHDRSLTCTSAVEIMKKIKKGDF- 233
Query: 524 DSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
EG + +E + LIQ LL P +R KMS +
Sbjct: 234 --SFEGEAWKNVSQEAKDLIQ-GLLTV--DPNKRLKMSGLRY 270
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 29/249 (11%)
Query: 251 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-L 309
+ P+ + +D E+ + ++ Q + D + LG G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEK 73
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
G + K + + E+ +++ H L+ L E +L+ F+
Sbjct: 74 ATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 370 G-------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422
G + + E +Q GL ++H+H I+H D+K N
Sbjct: 133 GELFDRIAAEDYKMSEAEVIN------YMRQAC----EGLKHMHEH---SIVHLDIKPEN 179
Query: 423 ILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 480
I+ + + + V DFGLA ++ D V T APE + TD++ G
Sbjct: 180 IMCETKKASSVKIIDFGLATKLN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 481 VMLLELITG 489
V+ L++G
Sbjct: 238 VLGYVLLSG 246
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ + + LG G + VYKG+ +LVA+K ++ E +G EV ++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV+ ++ + + L + G +N K RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIGH 459
K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR----- 167
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 344
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 345 RNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QI 394
N++RLR F + E+ LV ++ +V R +++ L K Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV 453
R LAY+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 F----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 217
Query: 454 -----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
R APE + + DV+ G +L EL+ GQ
Sbjct: 218 CSRYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGG-------E---LQFQTE 335
+ +G G +GKV+K R G VA+KR++ + + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+ H N++RL C LV+ + + + + L + + P +
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE--PGVPTET 121
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 446
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 447 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 87.2 bits (215), Expect = 6e-18
Identities = 58/359 (16%), Positives = 109/359 (30%), Gaps = 95/359 (26%)
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL--GRGGFGKVYKGRLTDGSLVAV 317
++V + +L++ +L EL+ +N+L G G GK + VA+
Sbjct: 129 YNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---------TWVAL 168
Query: 318 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSV 372
+ Q + ++ +++ C +P L L+Y N
Sbjct: 169 DVCLSYKVQ---CKMDFKIFWLNL----------KNCNSPETVLEMLQKLLYQIDPNW-- 213
Query: 373 ASCLRERGQSQPPLNW-SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
R S L S++ ++ R L + + ++ +V+ A F
Sbjct: 214 --TSRSDHSSNIKLRIHSIQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW--NAF-- 262
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
+ L+ + VT + T HI+ ++ S + ++ LL
Sbjct: 263 ---NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV------KSLLLKYLDC 313
Query: 491 RAFDLARLAND--------------DDVMLLDWVKGLLKEKK-------LEQLVDSDMEG 529
R DL R D + D K + +K L L ++
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 530 NYIE-----EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 583
+ I LL + + + VV L L E+ KE
Sbjct: 374 MFDRLSVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK---QPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 88/575 (15%), Positives = 171/575 (29%), Gaps = 178/575 (30%)
Query: 37 KTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96
KT +A +V S+ V C + + ++L N N + L L L
Sbjct: 163 KTWVA--LDVCLSYK-----------VQCKMDFKIFWLNLKNCNSPETV---LEMLQKLL 206
Query: 97 YLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156
Y I N S + +N+ I + +L +L + N L+
Sbjct: 207 Y------QIDP----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-- 248
Query: 157 IPRSLTNVNSLQVLDLSNNK-----LTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
+ L NV + + + N T + +S A L
Sbjct: 249 V---LLNVQNAKAWNAFNLSCKILLTTRFK------QVTDFLSAATTT--------HISL 291
Query: 212 QPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEE---DP 268
+ + L + +P+ D+P E +P
Sbjct: 292 DHHSMTLTPDEVKS-------------LLLK-------YLDCRPQ----DLPREVLTTNP 327
Query: 269 EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG 328
L + S+R+ DN+ + N +LT ++ L+
Sbjct: 328 -RRLSIIAE-SIRDGLATWDNWKHVNC-----------DKLTTIIESSLNVLEPA----- 369
Query: 329 ELQ--------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG 380
E + F I + L L F + ++ ++ +VN L E+
Sbjct: 370 EYRKMFDRLSVFPPSAH-IPTIL----LSLIWFDVIKSDVMV----VVNKLHKYSLVEK- 419
Query: 381 QSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVG----D 435
I + + + K+ + A + + + + D
Sbjct: 420 -------QPKESTI---------SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463
Query: 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL--ITGQ-RA 492
L Y +H IGH +L + E+ +F ++ L+ + + R
Sbjct: 464 LIPPYLDQYFYSH--------IGH----HLKNIEHPERMTLF--RMVFLDFRFLEQKIRH 509
Query: 493 FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPM 552
A A+ +L+ ++ L K + D+D E V ++ L +
Sbjct: 510 DSTAWNASGS---ILNTLQQLKFYKP--YICDND---PKYERLVNAILD--FLPKIEENL 559
Query: 553 ERPKMSEVVR---MLEGDGLAERWEEWQKEEMFRQ 584
K ++++R M E + + EE +Q
Sbjct: 560 ICSKYTDLLRIALMAEDEAIF--------EEAHKQ 586
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLRG 352
LG G FGKV VA+K + + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TPT+ ++V + G + + E+ + +QI + Y H H K
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH---K 128
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
I+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE ++ GK
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIN-GKLYA 185
Query: 473 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ DV+ G++L ++ G+ FD D+ + L
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 8e-18
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 27/217 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 344
+ +G G +G V+K + +VA+KR++ + G + E+ ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+N++RL + + LV+ F + + L+ + K +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGF 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTI 457
H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR--- 168
Query: 458 GHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
P+ L K S D++ G + EL R
Sbjct: 169 ---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 35/218 (16%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 343
+ + +G G +G V+K R G +VA+K+ E + E+ M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H NL+ L LV+ + + +V L + + + K I + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVN 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIG 458
+ H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR---- 169
Query: 459 HIAPEYL------STGKSSEKTDVFGYGVMLLELITGQ 490
+PE L DV+ G + EL++G
Sbjct: 170 --SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 9e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + +G G +G VYK + G A+K+++ E+ G + T E+ ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L T +LV+ + + + L L K L G+AY
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYC 116
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 458
HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR---- 167
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L K S D++ G + E++ G
Sbjct: 168 --APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 344
D F + G+G FG V G+ G VA+K+ +++ R + ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 345 RNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----Q 393
N+++L+ + T ER +V ++ ++ C R + Q + K Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA 452
+ R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 453 V----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
R APE + + + D++ G + E++ G+
Sbjct: 193 CSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 39/246 (15%)
Query: 268 PEVHLGQLKRFSLRELQVAT--DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEER 324
E S+ AT D + LG G +G+VYK VA+KR++ E
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 325 TQGGELQF-QT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG 380
+ G T EV ++ HRN++ L+ L++ + + L++
Sbjct: 72 EEEG---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYM 123
Query: 381 QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----D 435
P ++ V K G+ + H + +HRD+K N+LL + D
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 436 FGLAKLM-----DYKDTH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 487
FGLA+ + TH +T R PE L + S D++ + E++
Sbjct: 181 FGLARAFGIPIRQF--THEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 488 TGQRAF 493
F
Sbjct: 233 MKTPLF 238
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 31/219 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
H N++ L T+ +L+ + G L E ++ KQI
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH +I H D+K NI+L + + + DFGLA +D
Sbjct: 124 L----NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
GT +APE ++ + D++ GV+ L++G
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
++ F LG G + VYKG T G VA+K +K + +G E+ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARGL 402
N++RL T + LV+ FM + + + R G + L ++ K +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTAVRG 455
A+ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYR- 175
Query: 456 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L ++ S D++ G +L E+ITG+
Sbjct: 176 -----APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 64/314 (20%), Positives = 113/314 (35%), Gaps = 59/314 (18%)
Query: 271 HLGQLKRFSLRELQVATDNFSN-----RNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEE 323
H + + ++ + +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 324 RTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRE 378
+ + EV+ + +++ + L++ M G L
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFS 115
Query: 379 RGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEF 429
R Q + ++ R + I + +LH H I HRDVK N+L +++
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIG----TAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ DFG AK + T T ++APE L K + D++ GV++ L+ G
Sbjct: 169 VLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLC 546
F +N G+ + +L Q + E+ +QLI+ LL
Sbjct: 226 FPPFY----SNTGQ----AISPGMKRRIRLGQY---GFPNPEWSEVSEDAKQLIR-LLLK 273
Query: 547 TQGSPMERPKMSEV 560
T P ER +++
Sbjct: 274 TD--PTERLTITQF 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 342
+ + LG G F VYK R +VA+K++K + +T E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
H N++ L + LV+ FM + +++ L S K L +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGL 125
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
LGRG F V + + G A K L K R Q + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 353 FCMTPTERLLVYPFMVNG--------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+E +L+ + G +A + E + + KQI G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQIL----EGVYY 146
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITG 489
PE L+ + TD++ G++ L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 342
+ +G+G FG+V+K R G VA+K++ E + G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 343 VHRNLLRLRGFCMTPTERL--------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
H N++ L C T LV+ F + +A L S K++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRV 129
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-------T 447
GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 448 H--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+ VT R PE L + D++G G ++ E+ T
Sbjct: 187 NRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG G FGKV G+ G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TP++ +V ++ G + + + G+ + + +QI G + Y H H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDYCHRH---M 136
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 193
Query: 473 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ D++ GV+L L+ G FD DD V L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 252 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
K+ E + E L + + S Q+ D F LG G FG+V + +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 312 -GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
G+ A+K L K++ + +++ E ++ L++L + +V ++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 369 NGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + S LR G+ + + QI L YLH +I+RD+K N+L
Sbjct: 125 GGEMFSHLRRIGR----FSEPHARFYAAQIVLT----FEYLHSL---DLIYRDLKPENLL 173
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGV 481
+D++ V DFG AK + T + GT +APE + + K+ D + GV
Sbjct: 174 IDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA---VDWWALGV 226
Query: 482 MLLELITGQRAFDLARLANDDDVMLL 507
++ E+ G F D + +
Sbjct: 227 LIYEMAAGYPPFF------ADQPIQI 246
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 37/150 (24%), Positives = 61/150 (40%), Gaps = 8/150 (5%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLN 127
+ + L L ++ L ++ +LQ L L N S ++ +L L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 128 NLNGPIPT-----TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L T LS L+ L LN+N L P +++ +L+ L L++N+LT +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 183 TNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
N + + + NQL P P L
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLS 550
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 30/148 (20%), Positives = 50/148 (33%), Gaps = 10/148 (6%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+C+ + + NL+ V Q+ L + L L N I L L L+
Sbjct: 1 SCSFDGRI--AFYRFCNLTQ--VPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 124 LYLNNLNGPI-PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L I L LR L L ++ + P + + L L L L+ +
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 183 TNGSFSLFT---PISFANNQLNNPPPSP 207
+G F + + NQ+ + P
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHP 142
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-16
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 4/135 (2%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+SV +DL + + L +L+ L L N I+ E L NL L+L N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L + L K+ ++ L N + ++ + LQ LDL +N LT
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIP 384
Query: 188 SLFTPISFANNQLNN 202
+F + N+L
Sbjct: 385 DIF----LSGNKLVT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 9/153 (5%)
Query: 67 SENSVTRVDLGNA--NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL--TNLVSL 122
S N T GN +S L ++ +NI L +++ L
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
DL + L L+ L L N + + +++LQVL+LS N L ++
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELY 330
Query: 183 TNGSFSLFTP---ISFANNQLNNPPPSPPPPLQ 212
+ +F I N + L+
Sbjct: 331 -SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 24/133 (18%), Positives = 49/133 (36%), Gaps = 19/133 (14%)
Query: 91 QLTNLQYLELYSNNISGKVP------------EELGNLTNLVSLDLYLNNLNGPIPTTLG 138
+ L+ L++ N + + L +++ +N+ P T
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 139 KL--SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---I 193
L S +R L L++ + R + L+VL+L+ NK+ I + +F +
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIA-DEAFYGLDNLQVL 319
Query: 194 SFANNQLNNPPPS 206
+ + N L S
Sbjct: 320 NLSYNLLGELYSS 332
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 29/163 (17%), Positives = 53/163 (32%), Gaps = 28/163 (17%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT--NLVSLDLYL 126
++TR+DL + L G+L +L+ ++ SN I EL L L L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 127 NNLNGPIPTTLGKLSK------LRFLRLNNNSLMGEIPR------------SLTNVNSLQ 168
N+L + GK L L ++ N +I SL + +
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTPIS-----FANNQLNNPPPS 206
+ + P +F+ S ++ + +
Sbjct: 244 GAGFGFHNIK--DPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 14/136 (10%)
Query: 44 NNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN 103
N+LQ T + + ++ + + L + L+ LT L+ L L SN
Sbjct: 460 ENMLQLAWETELCWDVFEGLS-----HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 104 NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP----R 159
++ + NL LD+ N L P P L L + +N + E
Sbjct: 515 RLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFI 569
Query: 160 SLTNVNSLQVLDLSNN 175
+ N ++ + +
Sbjct: 570 NWLNHTNVTIAGPPAD 585
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 1e-16
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L +L C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG- 454
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTI 457
L +L II+RD+K N++LD E + DFG+ K + T T GT
Sbjct: 455 ---LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTP 506
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
+IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 27/137 (19%), Positives = 52/137 (37%), Gaps = 12/137 (8%)
Query: 80 NLSGQLVSQL-----GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PI 133
L ++ + L +L++L+L N++S G L++L L+L N +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
+ L+ L+ LR+ N EI R + SL L++ L + + S
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQ-SQSLKSIRD 173
Query: 193 I---SFANNQLNNPPPS 206
I + ++
Sbjct: 174 IHHLTLHLSESAFLLEI 190
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 28/159 (17%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNLTNLVSLDL 124
SEN + L N+ G +LQ L L N++ K E L L NL SLD+
Sbjct: 342 SENLMVEEYLKNSAC-------KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVN--------------SL 167
N + P+P + K+RFL L++ + IP++L ++ L
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRL 453
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
Q L +S NKL +P F + + + NQL + P
Sbjct: 454 QELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDG 491
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 26/126 (20%), Positives = 48/126 (38%), Gaps = 7/126 (5%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
++C++ D + + + + S L ++ L+L N I+ +L NL L
Sbjct: 2 LSCDASGVC---DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVL 55
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L + +N L L L L++N L ++SL+ L+L N +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLG 114
Query: 183 TNGSFS 188
F
Sbjct: 115 VTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 28/151 (18%), Positives = 55/151 (36%), Gaps = 11/151 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ R+ + L L + L ++ + + ++ + +L +L LDL N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 130 NGPIPTT---LGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
G L+ L L+ N L M + L + +L LD+S N +P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP-- 403
Query: 185 GSFSLFTPISF---ANNQLNNPPPSPPPPLQ 212
S + F ++ + P L+
Sbjct: 404 DSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE 434
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 22/134 (16%), Positives = 54/134 (40%), Gaps = 3/134 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++ + +GN ++ LT+L LE+ + ++ + L ++ ++ L L+L+
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ LS +R+L L + +L L + + + + T+ SF+
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS--VLTDESFN 241
Query: 189 LFTPISFANNQLNN 202
+ +L+
Sbjct: 242 ELLKLLRYILELSE 255
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 30/197 (15%), Positives = 65/197 (32%), Gaps = 11/197 (5%)
Query: 22 LRVASNAEGDALNALKT-NLADPN-NVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA 79
D L++++ L D N Q + + + +T
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 80 NLSGQLVSQLGQLT----NLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIP 134
+ + +L ++ L L ++ + S V E + L + L +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP-- 192
T L K++ + + N+ + ++ SL+ LDLS N + + N + P
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 193 --ISFANNQLNNPPPSP 207
+ + N L + +
Sbjct: 364 QTLVLSQNHLRSMQKTG 380
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 22/125 (17%), Positives = 42/125 (33%), Gaps = 9/125 (7%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
N +C + ++L + + V + L+ L++ +NN+
Sbjct: 397 NTFHPMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSL---F 449
Query: 116 LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L L L + N L +L L ++++ N L + SLQ + L N
Sbjct: 450 LPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 176 KLTGD 180
Sbjct: 508 PWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 16/144 (11%), Positives = 50/144 (34%), Gaps = 11/144 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S+ +++ +L L + ++ +L L+ + + + L+++ L+L NL
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSL----------MGEIPRSLTNVNSLQVLDLSNNKLTG 179
+ L ++ + ++ R + ++ ++ D + N L
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 180 -DIPTNGSFSLFTPISFANNQLNN 202
+ + S + + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLH 292
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
VT + +T + ++ + + L NL LEL N I+ L NLT + L
Sbjct: 35 VTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQIT--DLAPLKNLTKITEL 90
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+L N L + L ++ L L + + P L +++LQVL L N++T +I
Sbjct: 91 ELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS 145
Query: 183 TNGSFSLFTPISFANNQLNNPPP 205
+ +S N Q+++ P
Sbjct: 146 PLAGLTNLQYLSIGNAQVSDLTP 168
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 30/136 (22%), Positives = 60/136 (44%), Gaps = 9/136 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ G +N++ L + L + ++ E + L NL+ L+L N +
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
P L L+K+ L L+ N L + ++ + S++ LDL++ ++T D+ S
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTPLAGLSN 130
Query: 190 FTPISFANNQLNNPPP 205
+ NQ+ N P
Sbjct: 131 LQVLYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+++ + L ++ +S L LTNLQYL + + +S L NL+ L +L N
Sbjct: 129 SNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNK 184
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
++ P L L L + L NN + P L N ++L ++ L+N +T + P + +
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFYNNN 239
Query: 189 LFTPISFANNQLNNPPPS 206
L P P+
Sbjct: 240 LVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 19/120 (15%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L N + +N++ +L + +L + + + L+ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIG 67
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + ++ L N+ + L+LS N L ++ + + Q+ + P
Sbjct: 68 LELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 28/121 (23%), Positives = 52/121 (42%), Gaps = 8/121 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + +GNA +S ++ L L+ L L+ N IS L +L NL+ + L N +
Sbjct: 152 NLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQI 207
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT--GDIPTNGSF 187
+ P L S L + L N ++ + N+ V+ + I NG++
Sbjct: 208 SDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTY 265
Query: 188 S 188
+
Sbjct: 266 A 266
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+D F + LGRG VY+ + A+K LK + +TE+ ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHP 108
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAA 399
N+++L+ TPTE LV + G V ER + KQI
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQIL---- 158
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+AYLH++ I+HRD+K N+L + + DFGL+K+++++ T GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GT 213
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVML 483
G+ APE L + D++ G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 36/126 (28%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L L L+ L L N IS L +L L SL L N + T L +L+KL
Sbjct: 105 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 160
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + +I L + LQ L LS N ++ D+ + + + N P
Sbjct: 161 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPI 217
Query: 206 SPPPPL 211
+ L
Sbjct: 218 NHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ +L ++ + +++I V + + L N+ L L N L
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
P L L L +L L+ N + ++ SL ++ L+ L L +N ++ DI
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQL 136
Query: 191 TPISFANNQLNNPPP 205
+ NN++ +
Sbjct: 137 ESLYLGNNKITDITV 151
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 20/117 (17%), Positives = 43/117 (36%), Gaps = 7/117 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L +++ V L ++ + +++ + L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
L LN N L +I L N+ +L L L NK+ D+ + +S +N +++
Sbjct: 73 LFLNGNKL-TDIK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGISD 126
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ LGN ++ ++ L +LT L L L N IS + L LT L +L L N+++
Sbjct: 137 ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD 192
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L L L L + + + +N+ + ++ L
Sbjct: 193 LRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNG-------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N+L L + E ++++ F+ + A L ER S Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVC--- 112
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGT 456
L +LH H I H D++ NI+ + + +FG A+ + +
Sbjct: 113 -EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLF-TA 166
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ APE S TD++ G ++ L++G F
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 38/169 (22%), Positives = 65/169 (38%), Gaps = 19/169 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ T +DL N ++S L +L L L +N IS
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNS 166
+ L L L + N+L IP L S L LR+++N + ++P+ + + +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRI-RKVPKGVFSGLRN 148
Query: 167 LQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPPPSPPPPLQ 212
+ +++ N L G+F L + + +L P P L
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNY-LRISEAKLTGIPKDLPETLN 196
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 26/122 (21%), Positives = 41/122 (33%), Gaps = 14/122 (11%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L + + L L L N I L L L L L N L+ +P L L L+ + L
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYL 271
Query: 149 NNNSLMGEIP-------RSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFAN 197
+ N++ ++ + L NN + +F I F N
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA-IQFGN 329
Query: 198 NQ 199
+
Sbjct: 330 YK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 31/142 (21%), Positives = 54/142 (38%), Gaps = 13/142 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNN 128
S+ + + + + L N+ +E+ N + + + L L +
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L G IP L L L L++N + I L + L L L +N++ I NGS
Sbjct: 184 LTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIE-NGSL 237
Query: 188 ----SLFTPISFANNQLNNPPP 205
+L + NN+L+ P
Sbjct: 238 SFLPTLRE-LHLDNNKLSRVPA 258
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 48/279 (17%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRN------------ILGRGG 300
H +D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 301 FGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 356
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 357 PTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----------GLAYL 405
RL V + VNG G L + +++Q L L YL
Sbjct: 124 TESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEY 464
H+ II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503
L D + GV++ E++ G+ FD+ +++ D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 11/149 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG---NLTNLVSLDLYL 126
+D N L+ + G LT L+ L L N + ++ + + +L LD+
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQ 383
Query: 127 NNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+++ L L +++N L I R L ++VLDL +NK+ IP
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIP-KQ 439
Query: 186 SFSL--FTPISFANNQLNNPPPSPPPPLQ 212
L ++ A+NQL + P L
Sbjct: 440 VVKLEALQELNVASNQLKSVPDGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 7/124 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
L + N IS ++ +L+ L L + N + + +L +L L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPSPPP 209
L+ N L+ LDLS N +P F + + + L P
Sbjct: 81 LVKISCHPTVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 210 PLQP 213
L
Sbjct: 137 HLNI 140
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 28/135 (20%), Positives = 46/135 (34%), Gaps = 11/135 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
T +++ +S S + L+ L+ L + N I L LDL N L
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIPTNGSF 187
I L+ L L+ N+ +P N++ L+ L LS L S
Sbjct: 82 VK-IS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHL-----EKSSV 132
Query: 188 SLFTPISFANNQLNN 202
++ + L
Sbjct: 133 LPIAHLNISKVLLVL 147
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 30/158 (18%), Positives = 57/158 (36%), Gaps = 7/158 (4%)
Query: 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120
F + S +++ + + +N+ + ++ +
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
LD N L + G L++L L L N L + +I T + SLQ LD+S N ++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 179 GDIPTNGSFSLFTPISF---ANNQL-NNPPPSPPPPLQ 212
D G S + ++N L + PP ++
Sbjct: 388 YDEK-KGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK 424
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 27/117 (23%), Positives = 41/117 (35%), Gaps = 5/117 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLRLN 149
L+YL+L N + K+ NL LDL N + PI G +S+L+FL L+
Sbjct: 67 FNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
L + ++N +VL + F S N
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP-EGLQDFNTESLHIVFPTNKEFH 179
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 27/198 (13%), Positives = 55/198 (27%), Gaps = 5/198 (2%)
Query: 12 LVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSV 71
+ +L + S N +NL N + W T S+
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW--HTTVWYFSI 254
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ V L L L ++ S+ +N+ + ++
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
K+S L +NN L + + ++ L+ L L N+L +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 192 P---ISFANNQLNNPPPS 206
+ + N ++
Sbjct: 375 SLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 70 SVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S+ ++D+ ++S +L L + SN ++ + L + LDL+ N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+ IP + KL L+ L + +N L +P + SLQ + L N
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 19/90 (21%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C+ S+ +++ + L+ + L ++ L+L+SN I +P+++ L L L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
+ N L +L+ L+ + L+ N
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 15/134 (11%), Positives = 46/134 (34%), Gaps = 3/134 (2%)
Query: 62 HVTCNSENSVTRVDLGNANL-SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120
++C+ ++ +DL + + + G ++ L++L L + ++ + +L
Sbjct: 83 KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142
Query: 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
L + L L+ + + +V+ V +L + +
Sbjct: 143 VLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 181 IPTNGSFSLFTPIS 194
+ N + ++
Sbjct: 201 LEDNKCSYFLSILA 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 7e-16
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ +L ++ + +++I V + + L N+ L L N L
Sbjct: 23 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 78
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
I L L L +L L+ N + ++ SL ++ L+ L L +N ++ DI
Sbjct: 79 D-I-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQL 133
Query: 191 TPISFANNQLNNPPP 205
+ NN++ +
Sbjct: 134 ESLYLGNNKITDITV 148
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L L L+ L L N IS L +L L SL L N + L +L+KL
Sbjct: 102 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDT 157
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + +I L + LQ L LS N ++ D+ + + + N P
Sbjct: 158 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPI 214
Query: 206 SPPPPL 211
+ L
Sbjct: 215 NHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 4e-15
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
VT N NS+ ++ N+++ V + L N+ L L N ++ + L NL NL L
Sbjct: 37 VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLT--DIKPLTNLKNLGWL 92
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L N + L L KL+ L L +N + +I L ++ L+ L L NNK+T DI
Sbjct: 93 FLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT 147
Query: 183 TNGSFSLFTPISFANNQLNNPPP 205
+ +S +NQ+++ P
Sbjct: 148 VLSRLTKLDTLSLEDNQISDIVP 170
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 28/263 (10%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD- 311
+P++ P Q+ +F ++G+G FGKV R
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPFM 367
AVK L+++ + + E ++ H L+ L F ++L V ++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 368 VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + L+ P R +IA L YLH I++RD+K NIL
Sbjct: 122 NGGELFYHLQRERCFLEPR---ARFYAAEIASA----LGYLHSL---NIVYRDLKPENIL 171
Query: 425 LDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVM 482
LD + V+ DFGL K +++ T T+ GT ++APE L + ++T D + G +
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAV 228
Query: 483 LLELITGQRAFDLARLANDDDVM 505
L E++ G F + + M
Sbjct: 229 LYEMLYGLPPFY----SRNTAEM 247
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 296 LGRGGFGKVYKGR---LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+GRG +G VYK + D A+K+++ G + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 353 FCMTPTERL--LVYPFM---VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLH 406
++ +R L++ + + + + +P L + K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTIGH 459
+ ++HRD+K ANIL+ E + D G A+L + + V T +
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
APE L + ++ D++ G + EL+T +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK---------EERTQGGELQFQ 333
+ + +F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 392
E M+S+ H ++R+ G + ++ ++ G + S LR+ + P V K
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKF 110
Query: 393 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
++ L L YLH II+RD+K NILLD+ + DFG AK V
Sbjct: 111 YAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDV 159
Query: 450 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
T + GT +IAPE +ST KS D + +G+++ E++ G F D + M
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DSNTMK 210
Query: 507 L 507
Sbjct: 211 T 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L +L C +RL V + VNG G L + +++
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEY-VNG---------GD----LMYHIQQVGRFKE 120
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
GL +L II+RD+K N++LD E + DFG+ K + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 20/170 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ +DL N ++ L NL L L +N IS
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNS 166
P L L L L N L +P + L+ LR++ N + ++ + +N
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEI-TKVRKSVFNGLNQ 146
Query: 167 LQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPSPPPPLQ 212
+ V++L N L NG+F L + I A+ + P PP L
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKL-SYIRIADTNITTIPQGLPPSLT 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 90 GQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
G +L L L N I+ KV L L NL L L N+++ +L LR L L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
NNN L+ ++P L + +QV+ L NN ++
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L NL L L N+IS L N +L L L N L +P L ++ + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL 270
Query: 149 NNNSLMGEIPRS-------LTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+NN++ I + T S + L +N + +F
Sbjct: 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 14/143 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI-SGKVPEE-LGNLTNLVSLDLYLN 127
++ + + ++ S L + +EL +N + S + + L + +
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
N+ IP L L L L+ N + ++ SL +N+L L LS N ++ + NGS
Sbjct: 182 NITT-IPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVD-NGS 235
Query: 187 F----SLFTPISFANNQLNNPPP 205
L + NN+L P
Sbjct: 236 LANTPHLRE-LHLNNNKLVKVPG 257
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG------PIPTTLGKLSKLRF 145
+L+ L L +N + KVP L + + + L+ NN++ P K +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 146 LRLNNNSL-MGEIPRSL-TNVNSLQVLDLSNNK 176
+ L +N + EI S V + L N K
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 261 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVA 316
D + H + + +V +NF +LG G +GKV+ R G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 317 VKRLKEER-TQGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPFMVNGS 371
+K LK+ Q + T E + + ++ L+ L + +L L+ ++ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 372 VASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
+ + L +R + V+ +I L L +LH II+RD+K NILLD
Sbjct: 146 LFTHLSQRERFTEHE---VQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGVMLLEL 486
V+ DFGL+K +T GTI ++AP+ + G S V + GV++ EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 487 ITGQRAFDLARLANDDDVM 505
+TG F + N +
Sbjct: 256 LTGASPFTVDGEKNSQAEI 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 26/264 (9%)
Query: 251 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT 310
+K+ + F + D + + +V + F +LG+G FGKV +
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 311 D-GSLVAVKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPF 366
G A+K LK+E + T E ++ + H L L+ + +RL V +
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 367 MVNGSVASCL-RERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422
G + L RER S+ R +I L YLH + +++RD+K N
Sbjct: 230 ANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLEN 279
Query: 423 ILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
++LD++ + DFGL K + T GT ++APE L D +G GV
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 482 MLLELITGQRAFDLARLANDDDVM 505
++ E++ G+ F D + +
Sbjct: 338 VMYEMMCGRLPFY----NQDHEKL 357
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 41/252 (16%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR-----NILGRGGFGKVYKG 307
+ P PA+ P + LQ+ + + +LG G GKV +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 308 R-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER---- 360
A+K L + + EVE + +++R+
Sbjct: 82 FNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 361 LLVYPFMVNGSVASCLRERGQSQPPLNWS------VRKQIALGAARGLAYLHDHCDPKII 414
L+V + G L R Q + ++ + K I + YLH I
Sbjct: 135 LIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLHSI---NIA 183
Query: 415 HRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
HRDVK N+L + A++ DFG AK +TT T ++APE L K
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPEKYD 241
Query: 472 EKTDVFGYGVML 483
+ D++ GV++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 32/158 (20%), Positives = 53/158 (33%), Gaps = 15/158 (9%)
Query: 69 NSVTRVDLGNANLSG--QLVSQLGQL--TNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
+ ++L N + + +++L Q L+ L + + E++ L +LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 125 YLNNLNGPIP----TTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVNSLQVLDLSNNKL 177
N G K L+ L L N + G LQ LDLS+N L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 178 TGDIPTNGSFSLFTPISF---ANNQLNNPPPSPPPPLQ 212
S + ++ + L P P L
Sbjct: 241 RD-AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 33/143 (23%), Positives = 52/143 (36%), Gaps = 12/143 (8%)
Query: 69 NSVTRVDLGNANLSGQL----VSQLGQLTNLQYLELYSNN---ISGKVPEELGNLTNLVS 121
+++ +DL + G+ + LQ L L + SG L
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 122 LDLYLNNLNG-PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
LDL N+L + S+L L L+ L ++P+ L L VLDLS N+L
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLPA--KLSVLDLSYNRLDR- 288
Query: 181 IPTNGSFSLFTPISFANNQLNNP 203
P+ +S N +
Sbjct: 289 NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 30/169 (17%), Positives = 51/169 (30%), Gaps = 13/169 (7%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNAN--LSGQLVSQLGQLTNLQYLELYSNNISGKVP-EEL 113
PC +C+ S + D +A L V G +L+YL + + ++
Sbjct: 5 PCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI 64
Query: 114 GNLTNLVSLDLYLNNLNGPIPTTLGKL---SKLRFLRLNNNSLMGEIPRSLTNV--NSLQ 168
+L L + + I ++ S L+ L L N + G P L L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTP-----ISFANNQLNNPPPSPPPPLQ 212
+L+L N + +S A N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L++L+ L++ N+ + L NL LDL L PT LS L+ L +++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLN 201
N+ +NSLQVLD S N + + ++F N
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 8/142 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE--LGNLTNLVSLDLYLN 127
S+ +DL + + S L L++L+ +N+ ++ E +L NL+ LD+
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGS 186
+ LS L L++ NS T + +L LDLS +L +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 187 FSLF--TPISFANNQLNNPPPS 206
SL ++ ++N +
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTF 217
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 7/121 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S T + + L+ V G ++ LEL SN + LT L L L N L
Sbjct: 8 SGTEIRCNSKGLTS--VPT-GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 130 N--GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ G + + L++L L+ N + + + + L+ LD ++ L + F
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122
Query: 188 S 188
Sbjct: 123 L 123
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 8/120 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKLSKLRFLRLNN 150
L NL YL++ + L++L L + N+ +P +L L FL L+
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 151 NSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFTPISFANNQLNNPPPS 206
L ++ + +++SLQVL++S+N + T SL + ++ N +
Sbjct: 185 CQL-EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQV-LDYSLNHIMTSKKQ 241
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 27/232 (11%)
Query: 284 QVATDNFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+ F +LG+G FGKV+ L A+K LK+ ++ + E ++
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 339 ISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQI 394
+ H +++L + +L L+ F+ G + + L + V+ ++
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLAEL 135
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAV 453
AL L +LH II+RD+K NILLDEE + DFGL+K +D++ +
Sbjct: 136 ALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 186
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT+ ++APE ++ ++ D + +GV++ E++TG F D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRKET 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
++ DNF +LG+G FGKV R+ + G L AVK LK++ + T E ++
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 343 VHRN---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ RN L +L C +RL V F VNG G L + ++K
Sbjct: 79 LARNHPFLTQLF-CCFQTPDRLFFVMEF-VNG---------GD----LMFHIQKSRRFDE 123
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
AR L +LHD II+RD+K N+LLD E + DFG+ K + T
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE L D + GV+L E++ G F+ A ++D +
Sbjct: 181 --TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDDL 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 15/139 (10%)
Query: 62 HVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPE 111
+C + + R+ L +S + NL L L+SN ++
Sbjct: 15 TTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 112 ELGNLTNLVSLDLYLNNLNGPIP-TTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQV 169
L L LDL N + T L +L L L+ L E+ + +LQ
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 170 LDLSNNKLTGDIPTNGSFS 188
L L +N L +P + +F
Sbjct: 134 LYLQDNALQ-ALP-DDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L LQYL L N + +P++ +L NL L L+ N ++ L L L L+
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
N + P + ++ L L L N L+
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 26/84 (30%), Positives = 38/84 (45%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L NL +L L+ N IS L +L L L+ N + P L +L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNN 175
+L +L + +LQ L L++N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 21/62 (33%), Positives = 33/62 (53%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +L L L+ N ++ P +L L++L L+ NNL+ L L L++LRLN+N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 152 SL 153
Sbjct: 236 PW 237
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 30/125 (24%), Positives = 50/125 (40%), Gaps = 7/125 (5%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
L L+L NN++ L N LV +DL N L + K+ +L L ++
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--TPISFANNQLNNPPPSP 207
NN L+ + + +L+VLDLS+N L + + +N + S
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE-RNQPQFDRLENLYLDHNSIVTLKLST 337
Query: 208 PPPLQ 212
L+
Sbjct: 338 HHTLK 342
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 27/176 (15%), Positives = 55/176 (31%), Gaps = 26/176 (14%)
Query: 39 NLADPNNVLQSWDATLVNPCTW--FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96
N+ + D+ L C + H+ +++ + L N +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-------------LNNQK 48
Query: 97 YLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156
+ ++ + L + + L+L + ++ L + N++
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 108
Query: 157 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP------ISFANNQLNNPPPS 206
P NV L VL L N L+ +P +F +S +NN L
Sbjct: 109 PPHVFQNVPLLTVLVLERNDLS-SLPRG----IFHNTPKLTTLSMSNNNLERIEDD 159
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 5/109 (4%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
VDL L + ++ L+ L + +N + + + L LDL N+L
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 309
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ + +L L L++NS++ + S ++L+ L LS+N +
Sbjct: 310 -VERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 10/116 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L + +NN+ + T+L +L L N L + L + L +
Sbjct: 137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV 193
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
+ N L +L +++ LD S+N + + + L T + +N L +
Sbjct: 194 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVEL-TILKLQHNNLTDTA 242
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 33/143 (23%), Positives = 57/143 (39%), Gaps = 14/143 (9%)
Query: 58 CTW--FHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI 105
C+ V C+ + +DLG + + +L+ LEL N +
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 106 SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
S P NL NL +L L N L LS L L ++ N ++ + ++
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 166 SLQVLDLSNNKLTGDIPTNGSFS 188
+L+ L++ +N L I + +FS
Sbjct: 129 NLKSLEVGDNDLV-YIS-HRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L NL+ L L SN + +P L+NL LD+ N + + L L+ L + +
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 151 NSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPS 206
N L+ I R+ + +NSL+ L L LT IPT + S + + +N
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPT-EALSHLHGLIVLRLRHLNINAIRDY 194
Query: 207 PPPPLQ 212
L
Sbjct: 195 SFKRLY 200
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 27/135 (20%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLN 130
+++ + + NL L + N++ VP + +L L L+L N ++
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ L +L +L+ ++L L + + +N L+VL++S N+LT + F
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHS 318
Query: 190 FTP---ISFANNQLN 201
+ +N L
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 1/93 (1%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +L+ L L N++ E L +L L+ L L N+N + +L +L+ L +++
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
+ + + +L L +++ LT +P
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 25/121 (20%), Positives = 45/121 (37%), Gaps = 4/121 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS+ ++ L NL+ L L L L L NI+ L L L++
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ L L + + +L +P ++ ++ L+ L+LS N ++ I
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE-GSML 268
Query: 188 S 188
Sbjct: 269 H 269
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 15/152 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQ--LGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYL 126
+DL + NLS +L ++ +LTNL L L N+++ + E + NL LDL
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+L+ L L L L NN + + R + ++ LQ L LS N+++ P
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFP-VE 154
Query: 186 SFSLFTPISF------ANNQLNNPPPSPPPPL 211
+ ++N+L P + L
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 91 QLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+ NL+YL+L SN++ + E +L L L LY N++ +++L+ L L+
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNP 203
N + P + + L +LDLS+NKL +P L NNP
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVKNGLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 93 TNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L+L NN+S E LTNL SL L N+LN + LR+L L++N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPP 205
L + +++ +L+VL L NN + + +F L + + NQ++ P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVD-RNAFEDMAQL-QKLYLSQNQISRFPV 153
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 25/68 (36%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 92 LTNLQYLELYSNNISGKVPEE----LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL--RF 145
+ LQ L L N IS + P E L L+ LDL N L T L KL
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 146 LRLNNNSL 153
L L+NN L
Sbjct: 194 LYLHNNPL 201
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
+ +F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ H L+ L C RL V + VNG G L + +++Q L
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPE 109
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
L YLH+ II+RD+K N+LLD E + D+G+ K + DT
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDD 503
T+ GT +IAPE L G+ + D + GV++ E++ G+ FD+ +++ D
Sbjct: 167 --TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 8/144 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +D + +++ V + L L+L NN++ L N LV +DL N L
Sbjct: 212 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
+ K+ +L L ++NN L+ + + +L+VLDLS+N L + N F
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
Query: 189 LFTPISFANNQLNNPPPSPPPPLQ 212
+ +N + S L+
Sbjct: 325 RLENLYLDHNSIVTLKLSTHHTLK 348
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
VDL L + ++ L+ L + +N + + + L LDL N+L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 315
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ + +L L L++NS++ + L+ ++L+ L LS+N +
Sbjct: 316 -VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 360
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 22/121 (18%), Positives = 41/121 (33%), Gaps = 11/121 (9%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L N + + ++ + L + + L+L + ++ L + N
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP------ISFANNQLNNPPP 205
++ P NV L VL L N L+ +P +F +S +NN L
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG----IFHNTPKLTTLSMSNNNLERIED 164
Query: 206 S 206
Sbjct: 165 D 165
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 10/116 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L + +NN+ + T+L +L L N L + L + L +
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV 199
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
+ N L +L +++ LD S+N + + + L T + +N L +
Sbjct: 200 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVEL-TILKLQHNNLTDTA 248
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 40/238 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE-MISM 341
++ ++F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 342 AVHRN--LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ L + E L V + +NG G L + ++
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEY-LNG---------GD----LMYHIQSCHKFDL 117
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
+R GL +LH I++RD+K NILLD++ + DFG+ K M
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE L K + D + +GV+L E++ GQ F D++ +
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 41/238 (17%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER-TQGGELQF-QTEVEMIS 340
+V ++F +LG+G FGKV R G A+K L++E E+ TE ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H L L+ + +RL V + NG G+ L + + ++
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEY-ANG---------GE----LFFHLSRERVFTEE 105
Query: 400 R----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTH 448
R L YLH +++RD+K N++LD++ + DFGL K + T
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT ++APE L + D +G GV++ E++ G+ F D + +
Sbjct: 162 -MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHERL 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TT 451
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 197 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE + + ++DV+ +GV+L E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MIS 340
D LGRG FG+V + VAVK LKE T +E++ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 341 MAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLN 387
+ H N++ L G C P L+V F G++++ LR + P
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 3/108 (2%)
Query: 72 TRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
R+DLG + L NL+YL L NI +P L L L L++ N+
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP 231
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P + LS L+ L + N+ + + + SL L+L++N L+
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 34/127 (26%), Positives = 55/127 (43%), Gaps = 11/127 (8%)
Query: 65 CNSENSVTRVDLGNANLSG--QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
C+ N ++V LS Q + +N +YL L NNI + +L +L L
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIP-----SNTRYLNLMENNIQMIQADTFRHLHHLEVL 104
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDI 181
L N++ L+ L L L +N L IP + ++ L+ L L NN + I
Sbjct: 105 QLGRNSIRQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SI 162
Query: 182 PTNGSFS 188
P + +F+
Sbjct: 163 P-SYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 34/151 (22%), Positives = 63/151 (41%), Gaps = 13/151 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
+ + L N + ++ +L L+L + E L NL L+L + N
Sbjct: 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF- 187
+ +P L L L L ++ N P S ++SL+ L + N++++ I +F
Sbjct: 208 IKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE-RNAFD 263
Query: 188 ---SLFTPISFANNQLNNPPP---SPPPPLQ 212
SL ++ A+N L++ P +P L
Sbjct: 264 GLASLVE-LNLAHNNLSSLPHDLFTPLRYLV 293
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+LG N+ + L L L+ LE+ N+ P L++L L + + ++
Sbjct: 202 NLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L+ L L L +N+L T + L L L +N
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 28/163 (17%), Positives = 55/163 (33%), Gaps = 18/163 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C N S +DL L LQ L+L I
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 108 KVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
+ + +L++L +L L N + LS L+ L +L + ++ +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 167 LQVLDLSNNKLTGDIPTNGSFS----LFTPISFANNQLNNPPP 205
L+ L++++N + FS L + ++N++ +
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLTNL-EHLDLSSNKIQSIYC 166
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 31/94 (32%), Positives = 41/94 (43%), Gaps = 6/94 (6%)
Query: 90 GQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF--- 145
G L L+ L + N I S K+PE NLTNL LDL N + T L L ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 146 -LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L+ N + I L+ L L N+L
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 29/234 (12%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVE- 337
++ + F +LG+GG+GKV++ R G + A+K LK+ + + T+ E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 338 -MISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 392
++ H ++ L + +L L+ ++ G + L G
Sbjct: 73 NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT---ACFYLA 128
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 451
+I++ L +LH II+RD+K NI+L+ + + DFGL K + T
Sbjct: 129 EISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--TH 179
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GTI ++APE L + D + G ++ +++TG F +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENRKKT 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T +D N++++ ++ + +LT L L SNNI+ +L TNL L N
Sbjct: 42 ATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNK 96
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + + L+KL +L + N L ++ ++ L L+ + N LT +I + +
Sbjct: 97 LTN-LD--VTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQ 149
Query: 189 LFTPISFANNQLNNPPP 205
L T + N+
Sbjct: 150 L-TELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+N + V + +S QL L L+ ++++I+ + LT L L N
Sbjct: 18 DNFASEVAAAFEMQATDTIS-EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSN 74
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N+ + L + + L +L ++N L + +T + L L+ NKLT + + +
Sbjct: 75 NITT-LD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLDVSQNP 127
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQ 212
L T ++ A N L S L
Sbjct: 128 LL-TYLNCARNTLTEIDVSHNTQLT 151
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
N +T++D+ N + L + T L L+ + N ++ T
Sbjct: 114 DTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQ 171
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +LD N + + + L L + N++ ++ L L LD S+NKLT
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+I L + N L S L
Sbjct: 226 -EIDVTPLTQLTY-FDCSVNPLTELDVSTLSKLT 257
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 31/148 (20%), Positives = 53/148 (35%), Gaps = 17/148 (11%)
Query: 67 SENSVTRVDLG-NANL------SGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
S N +T +D+ + L L+ L T L Y + ++ ++ + T
Sbjct: 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQ 298
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L LD + + L + KL +L LNN L E+ +++ L+ L N +
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPS 206
D + G A Q P
Sbjct: 353 -DFSSVGKIPALNNNFEAEGQTITMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 29/154 (18%), Positives = 59/154 (38%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
+ N++T +DL +L + + LT L YL +N ++ ++
Sbjct: 72 TSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L+ N L + ++L L + N + ++ +T L LD S NK+T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + L ++ N + + L
Sbjct: 184 -ELDVSQNKLL-NRLNCDTNNITKLDLNQNIQLT 215
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 17/142 (11%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL--GKLSKLRFL 146
+ T L L+ + I+ +L LV L L L T L +KL+ L
Sbjct: 293 VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL-----TELDVSHNTKLKSL 344
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
N + + S+ + +L + + +P + I+ + + L+
Sbjct: 345 SCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQ---- 397
Query: 207 PPPPLQPTPPGASSGNSATGAI 228
P+ P + AT I
Sbjct: 398 FGNPMNIEPGDGGVYDQATNTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 29/154 (18%), Positives = 62/154 (40%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
N++T++DL + S +L + LT L Y + N ++ ++ + L+
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +L +L I L ++L + + + E+ +T+ L +LD +T
Sbjct: 256 LTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + L + N +L S L+
Sbjct: 311 -ELDLSQNPKLVY-LYLNNTELTELDVSHNTKLK 342
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 19/111 (17%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 102 SNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL 161
+ + + P++ N + V+ + + + +L+ L L +N+S+ ++ +
Sbjct: 8 TQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI-TDMT-GI 60
Query: 162 TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L L ++N +T + + + +L T ++ +N+L N +P L
Sbjct: 61 EKLTGLTKLICTSNNIT-TLDLSQNTNL-TYLACDSNKLTNLDVTPLTKLT 109
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 3/108 (2%)
Query: 72 TRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
R+DLG + L+NL+YL L N+ ++P L L L LDL N+L+
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P + L L+ L + + + + N+ SL ++L++N LT
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 2/122 (1%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L NL LEL+ N ++ L+ L L L N + ++ LR L L
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPP 210
+ I + +++L+ L+L+ L +IP + + N L+ P
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 211 LQ 212
L
Sbjct: 230 LM 231
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 11/127 (8%)
Query: 65 CNSENSVTRVDLGNANLSG--QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
C+ N ++V NL +S TN + L L+ N I +L +L L
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGIS-----TNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDI 181
L N++ L+ L L L +N L IP + ++ L+ L L NN + I
Sbjct: 94 QLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 182 PTNGSFS 188
P+ +F+
Sbjct: 152 PS-YAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 35/128 (27%), Positives = 54/128 (42%), Gaps = 11/128 (8%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
+ +L+ L+L + E L+NL L+L + NL IP L L KL L L+
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSG 216
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPP-- 205
N L P S + LQ L + +++ I +F I+ A+N L P
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 206 -SPPPPLQ 212
+P L+
Sbjct: 275 FTPLHHLE 282
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 2/106 (1%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ ++L NL + L L L L+L N++S P L +L L + + +
Sbjct: 186 NLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L L + L +N+L T ++ L+ + L +N
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 17/62 (27%), Positives = 26/62 (41%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +LQ L + + I NL +LV ++L NNL L L + L++N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 152 SL 153
Sbjct: 290 PW 291
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 31/142 (21%), Positives = 54/142 (38%), Gaps = 9/142 (6%)
Query: 72 TRVDLGNANLSGQLVSQL-GQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNL 129
+ + + + L++L L+L N ++ L NL L L NL
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115
Query: 130 NGPI--PTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLT---GDIPT 183
+G + L+ L L L +N++ P S N+ VLDL+ NK+ +
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 184 NGSFSLFTPISFANNQLNNPPP 205
N FT + ++ L +
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNE 197
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 7/142 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNN 128
V VDL +++ + +L +LQ+L++ + L++L+ L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEI--PRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
L+ L L L +L G + + SL++L L +N + I
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASF 149
Query: 187 FSL---FTPISFANNQLNNPPP 205
F F + N++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICE 171
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 6/124 (4%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLY 125
+ V DL + + L S T+L+ L L N I+ K+ + LT+L+ L+L
Sbjct: 273 EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLS 331
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTN 184
N L L KL L L+ N + + +S + +L+ L L N+L +P +
Sbjct: 332 QNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVP-D 388
Query: 185 GSFS 188
G F
Sbjct: 389 GIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 8/114 (7%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNN 151
++ Y++L N+I+ L +L L + I T LS L L+L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 152 SLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQL 200
++ + + +L+VL L+ L G + + F SL + +N +
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL-EMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 34/147 (23%), Positives = 48/147 (32%), Gaps = 14/147 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQ--LGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYL 126
++ + L NL G ++S LT+L+ L L NNI P N+ LDL
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 127 NNLNGPIPTTLGKLSKLRFLRL----------NNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
N + L F L N L E + S+ LDLS N
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 177 LTGDIPTNGSFSLFTPISFANNQLNNP 203
+ F + L+N
Sbjct: 224 FK-ESMAKRFFDAIAGTKIQSLILSNS 249
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
LT+L L L N + NL L LDL N++ + L L+ L L+
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380
Query: 151 NSLMGEIPRS-LTNVNSLQVLDLSNN 175
N L +P + SLQ + L N
Sbjct: 381 NQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 29/198 (14%), Positives = 63/198 (31%), Gaps = 31/198 (15%)
Query: 31 DALNALKT-NLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQL 89
+ +L N ++S + H T +S+T D+ L +
Sbjct: 151 LNMRRFHVLDLT--FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSL-------------DLYLNNLNGPIPTT 136
+ T++ L+L N + + + + N P T
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 137 LGKL--SKLRFLRLNNNSLM---GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF---- 187
L S ++ L+ + + + T+ L+ L L+ N++ I + +F
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTD---LEQLTLAQNEIN-KID-DNAFWGLT 323
Query: 188 SLFTPISFANNQLNNPPP 205
L ++ + N L +
Sbjct: 324 HL-LKLNLSQNFLGSIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 17/63 (26%), Positives = 26/63 (41%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L L+ L+L N+I + L NL L L N L +L+ L+ + L+
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404
Query: 151 NSL 153
N
Sbjct: 405 NPW 407
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 21/131 (16%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS--------- 141
T LQ +S+N++ ++P E N+ + + P G+
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 142 ----KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
+ L LNN L +P + L+ L S N LT ++P + N
Sbjct: 68 CLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPE--LPQSLKSLLVDN 120
Query: 198 NQLNNPPPSPP 208
N L PP
Sbjct: 121 NNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 28/131 (21%), Positives = 49/131 (37%), Gaps = 14/131 (10%)
Query: 80 NLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL- 137
++ L +L+++ +N + ++PE L NL L ++ N+L L
Sbjct: 159 DVDNNSLKKLPDLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL-----KKLP 211
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
L + NN L E L N+ L + NN L +P ++ +
Sbjct: 212 DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD--LPPSLEALNVRD 266
Query: 198 NQLNNPPPSPP 208
N L + P P
Sbjct: 267 NYLTDLPELPQ 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 24/143 (16%)
Query: 80 NLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
L + +L+ L + N ++ +PE +LT L + + L+ +P L
Sbjct: 243 YADNNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLY 300
Query: 139 KL--------------SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
L L L ++NN L+ E+P L+ L S N L ++P
Sbjct: 301 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL 355
Query: 185 GSFSLFTPISFANNQLNNPPPSP 207
+L + N L P P
Sbjct: 356 PQ-NL-KQLHVEYNPLREFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 34/195 (17%), Positives = 68/195 (34%), Gaps = 34/195 (17%)
Query: 38 TNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRV--DLGNANLSG-QLVSQLGQLTN 94
L +N L + T+ V+ N + ++ + +L N S ++ S +
Sbjct: 260 EALNVRDNYLTDLPELPQS-LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 318
Query: 95 LQYLELYSNNISGKVPEELGNLT-----------------NLVSLDLYLNNLNGPIPTTL 137
L+ L + +N + ++P L NL L + N L P
Sbjct: 319 LEELNVSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLRE-FPDIP 376
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
+ LR +N++ E+P N L+ L + N L + P + S+ + +
Sbjct: 377 ESVEDLR---MNSHL--AEVPELPQN---LKQLHVETNPLR-EFP-DIPESV-EDLRMNS 425
Query: 198 NQLNNPPPSPPPPLQ 212
++ +P
Sbjct: 426 ERVVDPYEFAHETTD 440
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 13/129 (10%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
L N + + +S L L+YL + +N + K+PE L N + L +D+ N+L +P
Sbjct: 116 LLVDNNNLKALSDL--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD 170
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF 195
L F+ NN L E+P L N+ L + NN L +P + SL I
Sbjct: 171 LPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP-DLPLSL-ESIVA 222
Query: 196 ANNQLNNPP 204
NN L P
Sbjct: 223 GNNILEELP 231
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 29/172 (16%), Positives = 51/172 (29%), Gaps = 35/172 (20%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL--------- 116
S + ++NL+ ++ + + + + P G
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 117 ----TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDL 172
L+L L+ +P L L + NSL E+P ++ SL V +
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 173 SNNKLTG----------------DIPTNGSFSLFTPISFANNQLNNPPPSPP 208
+ L+ +P + S I NN L P PP
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 20/168 (11%)
Query: 44 NNVLQSWDATLVNPCTWFHVTCNSENSVTRV--DLGNANLSGQLVSQLGQL-TNLQYLEL 100
NN+L++ + +V N + + L ++S + S L +L NL YL
Sbjct: 246 NNLLKTLPDLPPS-LEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS 160
SN I + + +L L++ N L +P +L +L + N L E+P
Sbjct: 305 SSNEIR-SLCDLPPSLE---ELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPEL 355
Query: 161 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
N L+ L + N L + P + N+ L P P
Sbjct: 356 PQN---LKQLHVEYNPLR-EFPD--IPESVEDLRM-NSHLAEVPELPQ 396
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 13/105 (12%), Positives = 34/105 (32%), Gaps = 23/105 (21%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL---------- 140
NL+ L + N + + P+ ++ +L +N+ +P L
Sbjct: 355 LPQNLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQNLKQLHVETNPL 408
Query: 141 -------SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ LR+N+ ++ + + L+ ++
Sbjct: 409 REFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 61 FHVTC-NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNLT 117
H+ C S +S T ++ + + L LQ L L N + KV N++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 118 NLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
+L +LD+ LN+LN T + L L++N L G + R L ++VLDL NN+
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNR 461
Query: 177 LTGDIPTNGSFSLF--TPISFANNQLNNPPPSPPPPLQ 212
+ IP L ++ A+NQL + P L
Sbjct: 462 IM-SIP-KDVTHLQALQELNVASNQLKSVPDGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 28/124 (22%), Positives = 44/124 (35%), Gaps = 9/124 (7%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ L L N+IS ++ L+ L L L N + L +L +++N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPSPP 208
L I + SL+ LDLS N +P F L T + + + P
Sbjct: 112 L-QNISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKL-TFLGLSAAKFRQLDLLPV 166
Query: 209 PPLQ 212
L
Sbjct: 167 AHLH 170
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 15/145 (10%), Positives = 35/145 (24%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
++ + + + L +L + + + L +
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
++ S FL N + + + + LQ L L N L
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 187 FSLFTPISFANNQLNNPPPSPPPPL 211
+ + + LN+
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRT 423
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 5/85 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
++ L L SN ++G V L + LDL+ N + IP + L L+ L + +N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASN 483
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNN 175
L +P + SLQ + L +N
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 3/122 (2%)
Query: 84 QLVS-QLGQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141
+L + + +L++L+L N+ V +E GNLT L L L + L
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 142 -KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200
L L + + G SL N+ + + + + N S + + +N +L
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230
Query: 201 NN 202
N+
Sbjct: 231 ND 232
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 24/123 (19%), Positives = 51/123 (41%), Gaps = 8/123 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
LT L+ LE+ ++++ P+ L ++ N+ L L++ + + S + L L +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 152 SL----MGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L E+ SL + + + +++ L + S + F+ NQL +
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV 292
Query: 204 PPS 206
P
Sbjct: 293 PDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 7/118 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
++ L+L +N I+ +L NL +L L N +N + L L L L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 153 LMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPP 205
L + S ++SL L+L N + F L +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 19/113 (16%), Positives = 48/113 (42%), Gaps = 9/113 (7%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
++ ++L L + N+ +L L+ + + +++ L+L +L+
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 135 T--------TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
+ +L K R +++ + SL ++ + L ++ L L+ S N+L
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
L++L +L L N L +LT L L + + I L+ L L ++
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPS 206
+ L P+SL ++ ++ L L + + + + + + L+ S
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL-EIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 207 PPPPL 211
Sbjct: 241 ELSTG 245
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 35/165 (21%), Positives = 54/165 (32%), Gaps = 31/165 (18%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +DL N ++ S L + NLQ L L SN I+ + +L +L LDL N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLM-------------------------GEIP-RSLTN 163
+ + LS L FL L N +I +
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 164 VNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPP 205
+ L+ L++ + L S +S Q
Sbjct: 173 LTFLEELEIDASDLQ-SYE-PKSLKSIQNVSHLILHMKQHILLLE 215
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 11/96 (11%)
Query: 92 LTNLQYLELYSNNISGK--------VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
++++ LEL ++ L ++ + +L + L ++S L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 144 RFLRLNNNSLMGEIPRS-LTNVNSLQVLDLSNNKLT 178
L + N L +P + SLQ + L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 23/206 (11%), Positives = 56/206 (27%), Gaps = 48/206 (23%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
G + ++ D +L VA+ + + ++ + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T L+V + G L+E + P ++R A H
Sbjct: 97 LDVVHTRAGGLVV---AEWIRGGS---LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA 148
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ + + + + + V+ +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD- 178
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFD 494
++ + D+ G G L L+ +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLP 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 8/119 (6%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L LT L+ L + N + + + L L L N L L L L
Sbjct: 78 LSPLKDLTKLEELSVNRNRLK--NLNGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLEI 132
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
L + NN L I L ++ L+VLDL N++T + I + N P
Sbjct: 133 LSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQKCVNEP 188
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 14/135 (10%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + +LG +++ + +L+ +Q ++NI + + TNL L L N +
Sbjct: 20 NAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQI 75
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPTNGSF 187
+ P L L+KL L +N N L ++L + L L L NN+L D +
Sbjct: 76 SDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR-DTDSLIHL 127
Query: 188 SLFTPISFANNQLNN 202
+S NN+L +
Sbjct: 128 KNLEILSIRNNKLKS 142
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 21/120 (17%), Positives = 50/120 (41%), Gaps = 8/120 (6%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
V L N L +++ V L+ + + + +N+ + + L+
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKE 67
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L++N + ++ L ++ L+ L ++ N+L ++ S L + + NN+L +
Sbjct: 68 LHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACL-SRLFLDNNELRDTDS 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 30/141 (21%), Positives = 53/141 (37%), Gaps = 18/141 (12%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
N +++G + L+ L L ++ L + NN++ +P L L++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L +P L +L L P + L L + N+LT +P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-SLPV--LP 140
Query: 188 SLFTPISFANNQLNNPPPSPP 208
+S ++NQL + P P
Sbjct: 141 PGLQELSVSDNQLASLPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 32/125 (25%), Positives = 46/125 (36%), Gaps = 15/125 (12%)
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
L S L+ LE+ N ++ +P L L L +L L S L
Sbjct: 72 NLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL-----PAL--PSGL 123
Query: 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L + N L +P LQ L +S+N+L +P S + NNQL +
Sbjct: 124 CKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-SLP--ALPSELCKLWAYNNQLTSL 176
Query: 204 PPSPP 208
P P
Sbjct: 177 PMLPS 181
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 22/136 (16%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL----------- 140
+ LQ L + N ++ +P L L + + L +L +P+ L +L
Sbjct: 180 PSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLP-ALPSGLKELIVSGNRLTSLP 237
Query: 141 ---SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFA 196
S+L+ L ++ N L +P + L L + N+LT +P + S T ++
Sbjct: 238 VLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 197 NNQLNNPPPSPPPPLQ 212
N L+ +
Sbjct: 293 GNPLSERTLQALREIT 308
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 15/125 (12%)
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
QL S + L L Y+N ++ +P L L + N L +PT +L K
Sbjct: 152 QLASLPALPSELCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLAS-LPTLPSELYK- 205
Query: 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L NN L +P + L+ L +S N+LT +P S + + N+L +
Sbjct: 206 --LWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPV--LPSELKELMVSGNRLTSL 256
Query: 204 PPSPP 208
P P
Sbjct: 257 PMLPS 261
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L+ L + N ++ +P L SL +Y N L +P +L LS + L N
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLTR-LPESLIHLSSETTVNLEGN 294
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLT-GDIPTNGSFSLFTPISFANNQLNNPPP 205
L E + + + + D+ + + A P
Sbjct: 295 PLS-ERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 6e-13
Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 12/122 (9%)
Query: 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120
V V + L + +L+ ++ L QL + +L+L N + +P L L L
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489
Query: 121 SLDL---YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNK 176
L L N++G + L +L+ L L NN L + L + L +L+L N
Sbjct: 490 VLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
Query: 177 LT 178
L
Sbjct: 545 LC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 2/130 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L + Q S L + ++ L + + + L+L + + +
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
L +L + L L++N L +P +L + L+VL S+N L ++ + +
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELL 514
Query: 195 FANNQLNNPP 204
NN+L
Sbjct: 515 LCNNRLQQSA 524
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 23/148 (15%), Positives = 49/148 (33%), Gaps = 14/148 (9%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C+ E + ++ + L + Q L+L ++ NL N+ +
Sbjct: 9 ECHQE---EDFRVTCKDIQR--IPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 124 LYLNNLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRS-LTNVNSLQVLDLSNNKLTGDI 181
+ ++ + + + LSK+ + + N + I L + L+ L + N L
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 182 PTNGSF----SLFTPISFANNQLNNPPP 205
P F N + + P
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 6/104 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTN-LVSLDLYLNNLNGPIPTTLGKLSKL 143
++++ LE+ N +P L N ++L LY N + +KL
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKL 181
Query: 144 RFLRLNNNSLMGEIPR-SLTNVNS-LQVLDLSNNKLTGDIPTNG 185
+ LN N + I + + V S +LD+S +T +P+ G
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 46/260 (17%), Positives = 93/260 (35%), Gaps = 68/260 (26%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT-EVEMIS 340
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------- 392
+ H N+++L + T + P + + G + + V
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 393 ---------------------------------QIALGAARGLAYLHDHCDPKIIHRDVK 419
Q+ R + ++H I HRD+K
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIK 168
Query: 420 AANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEK 473
N+L++ + + + DFG AK + + V R APE + +
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPS 222
Query: 474 TDVFGYGVMLLELITGQRAF 493
D++ G + ELI G+ F
Sbjct: 223 IDLWSIGCVFGELILGKPLF 242
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 6/116 (5%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSL 122
+ + + G + + L NL L + + + L L L +L
Sbjct: 6 CPHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ + L P +L L L+ N+L + SLQ L LS N L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 18/142 (12%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T+++L A L + G L L L+L N + +P L L LD+ N L
Sbjct: 58 TQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS 114
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L L +L+ L L N L +P L+ L L+NN LT ++P G
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK---LEKLSLANNNLT-ELP-AGLL 168
Query: 188 ----SLFTPISFANNQLNNPPP 205
+L + N L P
Sbjct: 169 NGLENL-DTLLLQENSLYTIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 35/145 (24%), Positives = 54/145 (37%), Gaps = 11/145 (7%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+ S V+ NL+ + + L L N + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA--LPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L L + G L L L L++N L +P + +L VLD+S N+LT +P
Sbjct: 62 LDRAELTK-LQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLP- 116
Query: 184 NGSFSLFTPI---SFANNQLNNPPP 205
G+ + N+L PP
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPP 141
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 27/85 (31%), Positives = 30/85 (35%), Gaps = 1/85 (1%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L LQ L L N + P L L L L NNL L L L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
NSL IP+ + L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 45/233 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT---------EV 336
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+++ H N+L LR E LV M +A + ++ + ++
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ---RIVISPQH 135
Query: 391 RK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ I GL LH+ ++HRD+ NILL + + + DF LA+ D
Sbjct: 136 IQYFMYHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-AD 187
Query: 447 THVTTAV-----RGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ T V R APE + ++ D++ G ++ E+ + F
Sbjct: 188 ANKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-12
Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 45/223 (20%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 332
Q + T+ +G G FG+V++ D + VA+K + E
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 333 QTEVEMISMAV----------------HRNLLRLRGFCM----TPTERLLVYPFM--VNG 370
Q E I + + L P L + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 371 SVASCLRERGQSQPPL-------------------NWSVRKQIALGAARGLAYLHDHCDP 411
S Q + + + K I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 38/123 (30%), Positives = 54/123 (43%), Gaps = 15/123 (12%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+L NL+ L + N + +P + L NL L L N L P L+KL +L L
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNN 202
N L +P LT+ L+ L L NN+L +P G+F + + NNQL
Sbjct: 142 YNEL-QSLPKGVFDKLTS---LKELRLYNNQLKR-VP-EGAFDKLTELKTLKLDNNQLKR 195
Query: 203 PPP 205
P
Sbjct: 196 VPE 198
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 39/123 (31%), Positives = 52/123 (42%), Gaps = 15/123 (12%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+LT L+ L L N + +P + L NL +L + N L +L L LRL+
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117
Query: 150 NN---SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNN 202
N SL + SLT L L L N+L +P G F SL + NNQL
Sbjct: 118 RNQLKSLPPRVFDSLTK---LTYLSLGYNELQ-SLP-KGVFDKLTSL-KELRLYNNQLKR 171
Query: 203 PPP 205
P
Sbjct: 172 VPE 174
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 11/119 (9%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ + L+L SN +S + LT L L L N L +L L L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 153 LM---GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPP 205
L + L N L L L N+L +P F T +++ N+L + P
Sbjct: 97 LQALPIGVFDQLVN---LAELRLDRNQLK-SLP-PRVFDSLTKLTYLSLGYNELQSLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
LT L YL L N + +P+ + LT+L L LY N L KL++L+ L+L+N
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + ++ L++L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+LT+L+ L LY+N + +VPE LT L +L L N L L KL+ L+L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 150 NN 151
N
Sbjct: 214 EN 215
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGG 90
Query: 345 RNLLRLRGFCMTPTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVR---KQIALGAAR 400
N++ L P R F VN + ++ Q+ + +R +I +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYD--IRFYMYEIL----K 141
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L Y H I+HRDVK N+++D E + + D+GLA+ + V +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYF 196
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
PE L + D++ G ML +I + F
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 7/114 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L+ ++L +N IS P+ L +L SL LY N + + L L+ L LN N
Sbjct: 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNP 203
+ + + ++++L +L L +NKL I G+FS I L NP
Sbjct: 115 KI-NCLRVDAFQDLHNLNLLSLYDNKLQT-IA-KGTFSPLRAIQTM--HLAQNP 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 22/85 (25%), Positives = 34/85 (40%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +L L LY N I+ L +L L L N +N L L L L +
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + + + ++Q + L+ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 28/121 (23%), Positives = 45/121 (37%), Gaps = 15/121 (12%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ + L N I P L +DL N ++ P L L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 153 LMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPP 204
+ E+P L + LQ+L L+ NK+ + +F +L +S +N+L
Sbjct: 92 I-TELPKSLFEGLFS---LQLLLLNANKINC-LR-VDAFQDLHNL-NLLSLYDNKLQTIA 144
Query: 205 P 205
Sbjct: 145 K 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 20/160 (12%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNIS 106
C V C+++ + L N + + +L L+ + +N I+
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVN 165
+ + + L N L L L+ L L +N + + S ++
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLS 129
Query: 166 SLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
S+++L L +N++T + G+F SL T ++ N N
Sbjct: 130 SVRLLSLYDNQITT-VA-PGAFDTLHSLST-LNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 24/121 (19%), Positives = 43/121 (35%), Gaps = 14/121 (11%)
Query: 93 TNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L L +N + L L ++ N + S + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 152 SLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
L + + L + L+ L L +N++T + N SF S +S +NQ+
Sbjct: 92 RL-ENVQHKMFKGLES---LKTLMLRSNRIT-CVG-NDSFIGLSSVRLLSLYDNQITTVA 145
Query: 205 P 205
P
Sbjct: 146 P 146
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 37/140 (26%), Positives = 56/140 (40%), Gaps = 18/140 (12%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + + L NLS L L + LE+ N + +PE +L L D N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNR 111
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L+ +P L L ++NN L +P L+ ++ NN+LT +P +
Sbjct: 112 LST-LPELPASLKHLD---VDNNQLT-MLPELPAL---LEYINADNNQLT-MLPE--LPT 160
Query: 189 LFTPISFANNQLNNPPPSPP 208
+S NNQL P P
Sbjct: 161 SLEVLSVRNNQLTFLPELPE 180
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 27/142 (19%), Positives = 50/142 (35%), Gaps = 11/142 (7%)
Query: 80 NLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
N QL T+L+ L + +N ++ +PE +L +LD+ N L +P
Sbjct: 146 NADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPESLE---ALDVSTNLLES-LPAVPV 200
Query: 139 KLSKLR----FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
+ F R N + IP ++ +++ + L +N L+ I + S P
Sbjct: 201 RNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 195 FANNQLNNPPPSPPPPLQPTPP 216
+ L
Sbjct: 260 HGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 15/119 (12%), Positives = 34/119 (28%), Gaps = 4/119 (3%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL---NNLNGPIPTTLGKLSKLRFLR 147
+L+ L++ +N + +P + +++ N IP + L +
Sbjct: 178 LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTII 236
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
L +N L I SL+ + + + + N
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 9/113 (7%)
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL--GKLSKLRFLRLNNNSLMG 155
+ N ISG + L N N + L +++ L+LN +L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNE-AVSLLKECLINQFSELQLNRLNLS- 72
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
+P +L + VL+++ N L +P + + +N+L+ P P
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPE--LPASLEYLDACDNRLSTLPELPA 120
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 15/101 (14%), Positives = 33/101 (32%), Gaps = 6/101 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQ----YLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+D+ L L + + + + + N I+ +PE + +L ++ L N
Sbjct: 183 EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168
L+ I +L + + + T L
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 19/97 (19%), Positives = 32/97 (32%), Gaps = 6/97 (6%)
Query: 114 GNLTNLVSLDLY--LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
N +L Y ++ + K K N N + + L +N L
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQ 65
Query: 172 LSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
L+ L+ +P N + T + N L + P P
Sbjct: 66 LNRLNLS-SLPDNLPPQI-TVLEITQNALISLPELPA 100
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 39/225 (17%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83
Query: 354 CMTPTERLLVYPFMVNGSVAS--C---------LRE--RGQSQPPLNWSVRKQIALGAAR 400
+LL + F G L + + KQI+
Sbjct: 84 GANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYKDTHVTTAV- 453
GL Y+H C IIH D+K N+L++ + + D G A + D H T ++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 454 ----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
R +PE L D++ ++ ELITG F+
Sbjct: 198 TREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 19/166 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C+ C + + L +L+ +E+ N++
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 108 KVPEE-LGNLTNLVSLDL-YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNV 164
+ + NL L + + NNL P L L++L ++N + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHS 127
Query: 165 NSLQVLDLSNNKLTGDIPTNGSFSLFTP----ISFANNQLNNPPPS 206
+LD+ +N I SF + + N + S
Sbjct: 128 LQKVLLDIQDNINIHTIE-RNSFVGLSFESVILWLNKNGIQEIHNS 172
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 12/122 (9%)
Query: 92 LTNLQYLEL-YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L L + + +NN+ PE NL NL L + + + L + +
Sbjct: 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137
Query: 151 NSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNP 203
N + I L+ +L L+ N + +I N +F L NN L
Sbjct: 138 NINIHTIERNSFVGLS--FESVILWLNKNGIQ-EIH-NSAFNGTQLDELNLSDNNNLEEL 193
Query: 204 PP 205
P
Sbjct: 194 PN 195
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 5/118 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEE-LGNLT-NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++ N + L+ V L L N + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 149 NNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+NN+L E+P + +LD+S ++ +P+ G +L + + L P
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 91 QLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
T L L L NN ++P + + V LD+ ++ L L KLR
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNN 175
N ++P +L + +L L+
Sbjct: 235 NLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 16/61 (26%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L++ I L NL L + NL +PT L KL L L
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-LPT-LEKLVALMEASLTYP 256
Query: 152 S 152
S
Sbjct: 257 S 257
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H+N++ L TP + L +V M + ++ ++ L+
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP L LV PFM + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMG-----LKFSEEK 127
Query: 390 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
++ Q+ +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D +
Sbjct: 128 IQYLVYQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 447 TH--VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 181 TGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 32/161 (19%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 78
Query: 353 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGL 402
L+V + G L R Q + ++ R K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAI 130
Query: 403 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
YLH I HRDVK N+L + DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 43/193 (22%), Positives = 66/193 (34%), Gaps = 31/193 (16%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV-------EMISMAVHRNL 347
+G GGFG +Y A +K E + G L + + + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 348 LRLRGF-----CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L G + Y FMV + + G S Q+ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRM 160
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTAVR 454
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQEN 215
Query: 455 GTIGHI-APEYLS 466
GH E+ S
Sbjct: 216 PRKGHNGTIEFTS 228
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
+ L L ++L L +NNI K+ L + NL L L N + I L L
Sbjct: 42 ATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEEL 98
Query: 147 RLNNNSLMGEIPRSLTNVN---SLQVLDLSNNKLT 178
++ N + SL+ + +L+VL +SNNK+T
Sbjct: 99 WISYNQI-----ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 14/106 (13%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTN-LVSLDLYLNN---LNGPIPTTLGKLSKLR 144
L + NL+ L L N I K E L + + L L + N L+G + KL LR
Sbjct: 66 LSGMENLRILSLGRNLI--KKIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLR 118
Query: 145 FLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L ++NN + GEI L ++ L+ L L+ N L D N + S
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 10/91 (10%)
Query: 92 LTNLQYLELY--SNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT--TLGKLSKLRFLR 147
T + +EL+ I K+ L L L L NN I +L + LR L
Sbjct: 22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILS 76
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L N + +I ++L+ L +S N++
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG---NLTNLVSL 122
N NS+ ++ N+++ + V + L N++YL L N + ++ LTNL L
Sbjct: 38 NELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYL 90
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
L N L KL+ L+ L L N SL + LTN L L+L++N+L
Sbjct: 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN---LTYLNLAHNQLQ- 146
Query: 180 DIPTNGSF-SL--FTPISFANNQLNNPPP 205
+P G F L T + + NQL + P
Sbjct: 147 SLP-KGVFDKLTNLTELDLSYNQLQSLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 12/121 (9%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN-LTNLVSLDLYLNNLN 130
T + L L +LTNL+ L L N + +P+ + + LTNL L+L N L
Sbjct: 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGS 186
KL+ L L L+ N L +P LT L+ L L N+L +P +G
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ---LKDLRLYQNQLKS-VP-DGV 200
Query: 187 F 187
F
Sbjct: 201 F 201
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 16/93 (17%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLG---KLSKLRFL 146
+LTNL YL L N + +P+ + LTNL LDL N L +P G KL++L+ L
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKDL 186
Query: 147 RLNNNSLMGEIPR----SLTNVNSLQVLDLSNN 175
RL N L +P LT SLQ + L +N
Sbjct: 187 RLYQNQLKS-VPDGVFDRLT---SLQYIWLHDN 215
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H+N++ L TP + L LV M + ++ ++ L+
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM-DANLCQVIQM------ELDHE 164
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 219
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T + APE + E D++ G ++ E++ + F
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 50/230 (21%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + N + +G G +G V T G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP L LV M + L + Q +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 390 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
V+ QI RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ +
Sbjct: 134 VQFLIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 447 T--HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 187 TGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP E L LV PFM + L + + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEK-LGED 128
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 449 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EV 336
D + R+++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVR 391
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 392 KQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQ-LTNLQYLELYSNNISGK----VPEELGNLTNLVSLDL 124
+ +D+ LS ++L L Q + L ++ + L L L+L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 125 YLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNN 175
N L + + K++ L L N L G + +L + +LQ L LS+N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 176 KLTGD 180
L
Sbjct: 124 LLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 28/127 (22%), Positives = 49/127 (38%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNLV 120
+ + N +++ V L Q L+ L+L S ++ + + + +L
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLR 230
Query: 121 SLDLYLNNLNGP-----IPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLD 171
L L N L P L S+LR L + + G++ R L SL+ L
Sbjct: 231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290
Query: 172 LSNNKLT 178
L+ N+L
Sbjct: 291 LAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLN----GPIPTTLGKLSKLRFLR 147
++Q L++ +S EL L + L L I + L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 148 LNNNSL----MGEIPRSLTNVN-SLQVLDLSNNKLTGD 180
L +N L + + + L + +Q L L N LTG
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 100
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 28/128 (21%), Positives = 45/128 (35%), Gaps = 18/128 (14%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNL 119
S+ + L L + L + L+ L + S + + L L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVL 170
+ L + N L L + S LR L L + + + +L +SL+ L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 171 DLSNNKLT 178
DLSNN L
Sbjct: 404 DLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 23/134 (17%), Positives = 45/134 (33%), Gaps = 18/134 (13%)
Query: 65 CNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELGN----- 115
+S + + L + ++ L + +L+ L L SN + EL
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 116 LTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVN-S 166
+ L +L ++ + + L L+ L L N L E + +L
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 167 LQVLDLSNNKLTGD 180
L+ L + + T
Sbjct: 315 LESLWVKSCSFTAA 328
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 22/134 (16%), Positives = 48/134 (35%), Gaps = 18/134 (13%)
Query: 65 CNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELGNL---- 116
+ + + + + ++ + L L +L+ L L N + + L
Sbjct: 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311
Query: 117 -TNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNS- 166
L SL + + + L + L L+++NN L + + L S
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371
Query: 167 LQVLDLSNNKLTGD 180
L+VL L++ ++
Sbjct: 372 LRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 26/127 (20%), Positives = 45/127 (35%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQ-----LTNLQYLELYSNNISGK----VPEELGNLTNLV 120
S+ + LG+ L +++L + L+ L ++ I+ K + L +L
Sbjct: 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 287
Query: 121 SLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLD 171
L L N L L + +L L + + S L L L
Sbjct: 288 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 347
Query: 172 LSNNKLT 178
+SNN+L
Sbjct: 348 ISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELG-----NLTNLV 120
+ + + + + + S L Q L L++ +N + EL + L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 121 SLDLYLNNLN----GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNS-LQVLD 171
L L +++ + TL LR L L+NN L + ++ S+ L+ L
Sbjct: 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433
Query: 172 LSNNKLT 178
L + +
Sbjct: 434 LYDIYWS 440
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 64/267 (23%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GS 313
H A PE+ GQ F + ++N + +G G +G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQ--VFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKV 53
Query: 314 LVAVKRLKEERTQGGELQFQT---------EVEMISMAVHRNLLRLRGFCMTPTERL--- 361
VA+K++ F+ E++++ H N++ + +
Sbjct: 54 RVAIKKIS---------PFEHQTYCQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMK 103
Query: 362 ---LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDPKIIH 415
+V M + L + ++Q N + QI RGL Y+H ++H
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL----RGLKYIHS---ANVLH 151
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEY-LS 466
RD+K +N+LL+ + + DFGLA++ D H T R APE L+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR------APEIMLN 205
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
+ ++ D++ G +L E+++ + F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 59/236 (25%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
D+ + R ++G+G FG+V K VA+K ++ E Q E+ ++
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRIL 147
Query: 340 SMAVHR------NLLRL------RG-FCMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 384
+ N++ + R CMT E L + L E +
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMT-FELL-----------SMNLYELIKKNKFQ 195
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 442
+ + ++ A + L LH + +IIH D+K NILL ++ + V DFG +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC-- 250
Query: 443 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
Y+ V T + R APE + + D++ G +L EL+TG
Sbjct: 251 -YEHQRVYTYIQSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN- 151
+ + L+L S ++ LT L L+L N L L++L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 152 --SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF-SL--FTPISFANNQL 200
SL + LT L L L N+L +P +G F L + NQL
Sbjct: 95 LASLPLGVFDHLTQ---LDKLYLGGNQLKS-LP-SGVFDRLTKLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
LT L L L +N ++ +P + +LT L L L N L +L+KL+ LRLN
Sbjct: 81 DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N L IP LTN LQ L LS N+L +P +G+F
Sbjct: 140 TNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQS-VP-HGAF 175
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 28/88 (31%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRL 148
LT L L L N + +P + LT L L L N L IP KL+ L+ L L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162
Query: 149 NNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+ N L +P + + LQ + L N
Sbjct: 163 STNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 28/96 (29%), Positives = 38/96 (39%), Gaps = 13/96 (13%)
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDL 172
+ LDL L T L+KL +L L+ N L + LT L L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTE---LGTLGL 90
Query: 173 SNNKLTGDIPTNGSFSLFTPI---SFANNQLNNPPP 205
+NN+L +P G F T + NQL + P
Sbjct: 91 ANNQLA-SLP-LGVFDHLTQLDKLYLGGNQLKSLPS 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 25/103 (24%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 80 NLSGQLV---SQLGQLTNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIPT 135
L+ +L+ +Q + L+L I V E LG L ++D N + +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KL-D 58
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +L+ L +NNN + + L L L+NN L
Sbjct: 59 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L ++ N I K+ + L L +L + N + L L L L NN
Sbjct: 41 LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 152 SL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
SL +G++ L ++ SL L + N +T
Sbjct: 99 SLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 16/67 (23%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP-IPTTLGKLSKLR 144
+ L L+ L + +N I L +L L L N+L L L L
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 145 FLRLNNN 151
+L + N
Sbjct: 117 YLCILRN 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-09
Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 5/105 (4%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
+ + G+L + L++L + ++ + L L L L+L N ++G +
Sbjct: 25 DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEV 82
Query: 136 TLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
K L L L+ N + + I L + +L+ LDL N ++T
Sbjct: 83 LAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 92 LTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDL---YLNNLNGPIPTTLGKLSKLRFLR 147
++++ L L ++ + GK+ L L L ++ L KL+KL+ L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKLE 70
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L++N + G + +L L+LS NK+
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 20/94 (21%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 115 NLTNLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV---NSLQVL 170
+++ L L + N G + + +L FL N L S+ N+ N L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69
Query: 171 DLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203
+LS+N+++G + T ++ + N++ +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 41/182 (22%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKR---LKEERTQGGELQFQTEV-------EMISMAVHR 345
+G+GGFG +Y + V +K E + G L + + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 346 NLLRLRGFCM-----TPTERLLVYPFMVNGSVASCLRER-GQS-QPPLNWSVRK------ 392
L+ G + Y FM+ +R G Q + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI--------MDRFGSDLQKIYEANAKRFSRKTV 154
Query: 393 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--T 447
Q++L L Y+H+H +H D+KA+N+LL+ + V D+GLA Y
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY--RYCPEGV 209
Query: 448 HV 449
H
Sbjct: 210 HK 211
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 1e-08
Identities = 25/138 (18%), Positives = 46/138 (33%), Gaps = 16/138 (11%)
Query: 59 TWFHVTCNSENSVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELG-- 114
+W S L N + L NL+ LE+ S + V E++
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLS---------KLRFLRLNNNSLMGEIPRSL---T 162
+L NL L LY+ + + L++L + + +
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 163 NVNSLQVLDLSNNKLTGD 180
+ L+ +D+S LT +
Sbjct: 277 ILPQLETMDISAGVLTDE 294
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 2e-06
Identities = 20/164 (12%), Positives = 50/164 (30%), Gaps = 21/164 (12%)
Query: 38 TNLADPNNVLQSWDA---TLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLG--QL 92
D + VL + + + ++ +++ + L +V + L
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 93 TNLQYLELY---SNNISGKVPEEL------GNLTNLVSLDLYLNNLNGPIPTTLGK---L 140
NL+ L LY + NL L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 141 SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+L + ++ L + + + L+ +++ N L+ +
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 21/101 (20%), Positives = 42/101 (41%), Gaps = 10/101 (9%)
Query: 88 QLGQLTNLQYLELYSNNISGKVPEELGN---LTNLVSLDLYLNNLNG----PIPTTLGKL 140
+ NL++L + V E L L ++D+ L + + K+
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQV-LDLSNNKLTGD 180
L+F+ + N L E+ + L SL + +D+S+++ D
Sbjct: 307 KHLKFINMKYNYLSDEMKKELQ--KSLPMKIDVSDSQEYDD 345
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 16/117 (13%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
++ L L N + VP+EL N +L +DL N ++ + +++L L L+ N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 153 LMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
L IP L + L++L L N ++ +P G+F +L + ++ N L
Sbjct: 90 LR-CIPPRTFDGLKS---LRLLSLHGNDISV-VP-EGAFNDLSAL-SHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
VT + L + N + +L +L ++L +N IS + N+T L++L L N L
Sbjct: 32 DVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
P T L LR L L+ N + +P + ++++L L + N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 77 GNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT 136
+ G++ + NL++L L + + V L L L L+L N + G +
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDML 90
Query: 137 LGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
KL L L L+ N L + + L + L+ LDL N ++T
Sbjct: 91 AEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 7/101 (6%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL 137
+ L + + + +L L+ +N GK+ NL L L L + L
Sbjct: 15 HLELRNRTPAAVRELV----LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNL 67
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
KL KL+ L L+ N + G + + +L L+LS NKL
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 115 NLTNLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173
+ L L N G I + L FL L N L+ + +L + L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 174 NNKLTGDIPTNG-SFSLFTPISFANNQLNNP 203
N++ G + T ++ + N+L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 45/201 (22%)
Query: 280 LRELQVATDNFSNR----NILGRGGFGKVYKGR---------LTDGSLVAVKRLKEERTQ 326
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 327 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPFMVNGSVASCLRER- 379
E F Q + + + + L + PT Y F+V
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLV--------LPSL 140
Query: 380 GQS-QPPLNWSVRK--------QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430
G+S Q L+ S + Q+A L +LH++ +H +V A NI +D E +
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 431 AVV--GDFGLAKLMDYKDTHV 449
+ V +G A Y +
Sbjct: 198 SQVTLAGYGFAFR--YCPSGK 216
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L NL+ L L SN + +P + +LT L LDL N L +L L+ L +
Sbjct: 63 LINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKL 177
N L E+PR + + L L L N+L
Sbjct: 122 NKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
LT L L+L +N ++ +P + L +L L + N L +P + +L+ L L L+
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALD 143
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + ++SL L N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 37/122 (30%), Positives = 49/122 (40%), Gaps = 20/122 (16%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLR 147
TN Q L L+ N I+ P +L NL L L N L L L++L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----GALPVGVFDSLTQLTVLD 94
Query: 148 LNNNSLMGEIPR---SLTNVNSLQVLDLSNNKLTGDIPTNGSFSL--FTPISFANNQLNN 202
L N L L + L+ L + NKLT +P G L T ++ NQL +
Sbjct: 95 LGTNQLTVLPSAVFDRLVH---LKELFMCCNKLTE-LP-RGIERLTHLTHLALDQNQLKS 149
Query: 203 PP 204
P
Sbjct: 150 IP 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 38/123 (30%), Positives = 55/123 (44%), Gaps = 12/123 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN-LTNLVSLDLYLNN 128
T +DL +L +LT+L L L N + +P + N LT+L L+L N
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQ 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTN 184
L KL++L+ L LN N L +P LT L+ L L N+L +P +
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQLKS-VP-D 141
Query: 185 GSF 187
G F
Sbjct: 142 GVF 144
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 13/119 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
YL+L +N++ LT+L L L N L KL+ L +L L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 153 LMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
L +P LT L+ L L+ N+L +P +G F + + NQL + P
Sbjct: 88 LQ-SLPNGVFDKLTQ---LKELALNTNQLQS-LP-DGVFDKLTQLKDLRLYQNQLKSVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 30/89 (33%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG---KLSKLRFLR 147
+LT+L YL L +N + LT L L L N L +P G KL++L+ LR
Sbjct: 74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPD--GVFDKLTQLKDLR 130
Query: 148 LNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
L N L +P + SLQ + L +N
Sbjct: 131 LYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 29/95 (30%), Positives = 40/95 (42%), Gaps = 11/95 (11%)
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVNSLQVLDLS 173
LDL N+L +L+ L L L N SL + LT+ L L+LS
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS---LTYLNLS 84
Query: 174 NNKLTGDIPTNGSF-SL--FTPISFANNQLNNPPP 205
N+L +P NG F L ++ NQL + P
Sbjct: 85 TNQLQ-SLP-NGVFDKLTQLKELALNTNQLQSLPD 117
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 22/88 (25%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRL 148
+L +L LEL N ++ + +++ L L N + I L +L+ L L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNL 109
Query: 149 NNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+N + + S ++NSL L+L++N
Sbjct: 110 YDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 23/93 (24%), Positives = 34/93 (36%), Gaps = 14/93 (15%)
Query: 121 SLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNN 175
L L N L G+L L L L N L I ++ +Q L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH---IQELQLGEN 88
Query: 176 KLTGDIPTNGSF---SLFTPISFANNQLNNPPP 205
K+ +I N F ++ +NQ++ P
Sbjct: 89 KIK-EIS-NKMFLGLHQLKTLNLYDNQISCVMP 119
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
+ + +R +++G+G FG+V K + VA+K +K + Q Q EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLL 104
Query: 340 SM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 384
+ + ++ L+ C+ E L + L + R +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFR 152
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 442
++ ++ ++ A L +L + IIH D+K NILL + + DFG +
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-- 209
Query: 443 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + R +PE L D++ G +L+E+ TG+ F
Sbjct: 210 -QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 450
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 451 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 460 I----------APEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/248 (17%), Positives = 77/248 (31%), Gaps = 71/248 (28%)
Query: 288 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 338
D R LG G FGKV + S VA+K ++ R + E+ +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINV 69
Query: 339 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 383
+ + + + C+ E L E + +
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNF 117
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 439
P + +A L +LH++ ++ H D+K NIL + + +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 440 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
++ D + H TT V R PE + ++ DV+ G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCI 228
Query: 483 LLELITGQ 490
L E G
Sbjct: 229 LFEYYRGF 236
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 22/131 (16%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVS 121
S+ L ++ + + + L + +++ + L N I + + E + + +L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 122 LDLYLNNLNGPIPTT----------LGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSL 167
+ L K KL +RL++N+ + L+ L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 168 QVLDLSNNKLT 178
+ L L NN L
Sbjct: 125 EHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 15/118 (12%), Positives = 40/118 (33%), Gaps = 13/118 (11%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLN- 130
+ A + + L+ + N + + + L ++ + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 131 ----GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ L +L+ L L +N+ + +L + +L+ L L++ L+
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/131 (19%), Positives = 40/131 (30%), Gaps = 21/131 (16%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGK-----VPEELGNLTNLV 120
+ + G L L +++ N I + + E L L
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 121 SLDLYLNNLNGP-----IPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVN--SLQV 169
LDL N + L LR L LN+ L + + + + LQ
Sbjct: 220 VLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 170 LDLSNNKLTGD 180
L L N++ D
Sbjct: 279 LRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 24/135 (17%), Positives = 39/135 (28%), Gaps = 21/135 (15%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL----TNLVSL 122
S+ RV L+ L + L + L N E L + T L L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 127
Query: 123 DLYLNNL-------------NGPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVN 165
L+ N L + LR + N L M E ++ +
Sbjct: 128 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187
Query: 166 SLQVLDLSNNKLTGD 180
L + + N + +
Sbjct: 188 LLHTVKMVQNGIRPE 202
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 15/119 (12%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLN 130
+ + L+ L L+ L+L N + + L + NL L L L+
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 131 GP----IPTTLGKLS--KLRFLRLNNNSLMGE----IPRSL-TNVNSLQVLDLSNNKLT 178
+ KL L+ LRL N + + + + + L L+L+ N+ +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 44/258 (17%), Positives = 80/258 (31%), Gaps = 87/258 (33%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
+N +G G FG+V + + + AVK ++ + E +++
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADIL 85
Query: 340 SM-----AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQPP 385
+ N+++ G C+ E L L E +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNG 133
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA------ 439
+ K + + L YL + H D+K NILLD+ +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 440 -----------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSE 472
KL+D +K + + + R APE +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DV 238
Query: 473 KTDVFGYGVMLLELITGQ 490
+D++ +G +L EL TG
Sbjct: 239 SSDMWSFGCVLAELYTGS 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 46/254 (18%), Positives = 89/254 (35%), Gaps = 75/254 (29%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
DN+ ++++GRG +G VY + VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+++ ++RL + P + L +V L
Sbjct: 77 TILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA---------------DSDLKKLF 120
Query: 391 RKQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
+ I L G ++H+ IIHRD+K AN LL+++ V DFGLA+
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 441 LMDYKDTHVTTAVRGTIGHI---------------------APEYLSTGKS-SEKTDVFG 478
++ + APE + ++ ++ D++
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 479 YGVMLLELITGQRA 492
G + EL+ ++
Sbjct: 238 TGCIFAELLNMLQS 251
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 32/129 (24%), Positives = 49/129 (37%), Gaps = 20/129 (15%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELG-----NLTNL 119
VT +DL NL +L Q ++ L L N++ K +EL N+
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVN-SLQV 169
SL+L N L+ L K + L L N E ++ +N+ S+
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 170 LDLSNNKLT 178
L+L N L
Sbjct: 143 LNLRGNDLG 151
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 15/105 (14%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELG-----NLTNLVSLDLYLNNLNGPIPTTLGKL--- 140
+ L+L NN+ EL ++ SL+L N+L L ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 141 --SKLRFLRLNNNSL----MGEIPRSLTNVN-SLQVLDLSNNKLT 178
+ + L L+ N L E+ ++L + ++ VLDL N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 25/132 (18%), Positives = 57/132 (43%), Gaps = 21/132 (15%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELG-----NLTNL 119
+V ++L NL+ + ++L + ++ L+L +N + K EL ++
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 120 VSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQ 168
VSL+L LN L+GP + L L+ + L+ + + + + N+ +
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 169 VLDLSNNKLTGD 180
++D + ++
Sbjct: 288 LVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 19/128 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGNL-----TNL 119
S+T ++L +L + +L Q+ N+ L L NN++ K EL ++
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVL 170
SLDL N L L + + + L L N L + + ++ LQ +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 171 DLSNNKLT 178
L + +
Sbjct: 259 YLDYDIVK 266
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 83/254 (32%)
Query: 288 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 338
D S R + LG G FGKV + G VAVK +K ++E+++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQV 64
Query: 339 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 383
+ +++ + C+ E L + +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIV-FELL-----------GLSTYDFIKENGF 112
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 439
P +++A + + +LH + K+ H D+K NIL + + +
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 440 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDV 476
K++D Y D H +T V R APE + S+ DV
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILALGW------SQPCDV 217
Query: 477 FGYGVMLLELITGQ 490
+ G +L+E G
Sbjct: 218 WSIGCILIEYYLGF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 460 I--------------------APEY-LSTGKSSEKTDVFGYGVMLLELITGQ 490
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 67/375 (17%), Positives = 105/375 (28%), Gaps = 116/375 (30%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
D F+ R LG G F V+ + VA+K +K E+ + +
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIR-LLKS 89
Query: 343 VHRNLLRLRGFCMTPTER-------------LLVYPFMVNGSVASCLRERGQSQPPLNWS 389
V + M +V+ + G + Q L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG-LPLP 146
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------------------ 425
K+I +GL YLH C +IIH D+K NILL
Sbjct: 147 CVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 426 -------------------------DEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTIG 458
E+ + + D G A + T T R
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR---- 260
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDD-----VMLL--- 507
+ E L + D++ M EL TG F+ D+D + LL
Sbjct: 261 --SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318
Query: 508 --DWVKG------------------LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCT 547
+ LK L +++ E + +EE L
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS--QEEAAGFTDFLLPML 376
Query: 548 QGSPMERPKMSEVVR 562
+ P +R +E +R
Sbjct: 377 ELIPEKRATAAECLR 391
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
+LT L L L N I LT L L L+ N L +P KL++L+ L L+
Sbjct: 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALD 108
Query: 150 NNSLMGEIPR-SLTNVNSLQVLDLSNN 175
N L +P + SLQ + L N
Sbjct: 109 TNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 11/94 (11%)
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR---SLTNVNSLQVLDLS 173
++ L+L N L KL++L L L+ N + LT L +L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK---LTILYLH 84
Query: 174 NNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
NKL +P NG F + ++ NQL + P
Sbjct: 85 ENKLQS-LP-NGVFDKLTQLKELALDTNQLKSVP 116
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 36/92 (39%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLR 144
G T Q L LY N I+ P LT L LDL N L T L KL++L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-----TVLPAGVFDKLTQLT 81
Query: 145 FLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
L LN+N L IPR + N+ SL + L NN
Sbjct: 82 QLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 24/124 (19%), Positives = 42/124 (33%), Gaps = 15/124 (12%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGN-LTNLVSLD 123
S+ +++L ++ + + + L + L S + L L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 124 LYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSN 174
L LN+L L L ++ LRL+NN L + L S+ L L +
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLH 192
Query: 175 NKLT 178
L
Sbjct: 193 TGLG 196
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 19/127 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNLV 120
++ L +L + L L + L L +N ++ + E L T++
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186
Query: 121 SLDLYLNNLNGP-----IPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLD 171
L L L G + L + +L+ L + N + R+ SL++L
Sbjct: 187 HLSLLHTGL-GDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLH 245
Query: 172 LSNNKLT 178
L N+L+
Sbjct: 246 LYFNELS 252
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 12/89 (13%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLR 147
T+ Q L L +N I+ P +L NL L N L T + KL++L L
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-----TAIPTGVFDKLTQLTQLD 87
Query: 148 LNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
LN+N L IPR + N+ SL + L NN
Sbjct: 88 LNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 59/300 (19%), Positives = 99/300 (33%), Gaps = 83/300 (27%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGF 353
+G G FG +++G L + VA+K E + Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK-------QIALGAARGLAYL 405
+LV + G S L + RK A + +
Sbjct: 75 GQEGLHNVLVIDLL------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD----THV----TTA 452
H+ +++RD+K N L+ V DFG+ K Y+D H+
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRDPVTKQHIPYREKKN 177
Query: 453 VRGTIGHIAPEYLS----TGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ GT Y+S G+ S + D+ G + + + G L
Sbjct: 178 LSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS----------------L 216
Query: 508 DW--VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
W +K ++K E++ E +Q + LC G P E K R L
Sbjct: 217 PWQGLKAATNKQKYERIG-----------EKKQSTPLRELC-AGFPEEFYKYMHYARNLA 264
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 41/183 (22%), Positives = 61/183 (33%), Gaps = 36/183 (19%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE 337
S+ L V NF +G G FG++ G+ L VA+K E + Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 338 MISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK--- 392
+ ++ F +V + G S L + R
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL------------GPSLEDLFDLCDRTFSL 104
Query: 393 ----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMD 443
IA+ + Y+H +I+RDVK N L+ DF LAK +
Sbjct: 105 KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--E 159
Query: 444 YKD 446
Y D
Sbjct: 160 YID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 42/167 (25%), Positives = 61/167 (36%), Gaps = 39/167 (23%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG +Y G + G VA+K E + Q E + +++ + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESK-----IYKMMQGGVGIP 68
Query: 355 MTPTERLLVYPFMVNGS----VASCLRERGQSQPPL-NWSVRK-------QIALGAARGL 402
+ G V L G S L N+ RK +A +
Sbjct: 69 T-------IRWCGAEGDYNVMVMELL---GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 403 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 446
Y+H IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 12/114 (10%)
Query: 70 SVTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL-YLN 127
V +DL N+ + L L Q + LQ L L +S + L +NLV L+L +
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 128 NL-NGPIPTTLGKLSKLRFL------RLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
+ T L S+L L + + + L+LS
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET---ITQLNLSG 204
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 19/159 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGF 353
+G G FG++Y G + VA+K E + Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 354 CMTPTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ +LV + G S+ + L+ +A + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 413 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 448
+HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.86 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.74 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.69 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.66 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.65 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.65 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.64 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.64 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.64 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.64 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.64 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.64 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.63 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.63 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.63 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.63 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.63 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.62 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.62 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.6 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.6 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.6 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.6 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.59 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.55 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.54 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.54 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.54 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.53 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.53 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.52 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.51 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.51 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.51 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.5 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.5 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.5 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.49 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.49 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.49 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.47 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.45 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.44 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.43 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.43 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.42 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.38 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.35 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.3 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.3 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.3 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.26 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.25 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.24 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.22 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.2 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.2 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.95 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.94 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.84 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.82 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.76 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.65 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.58 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.54 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.04 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.73 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.72 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.4 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.2 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.01 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.75 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.25 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.41 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.18 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.02 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.39 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-55 Score=439.31 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=211.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
+++...+.||+|+||+||+|++. +++.||||+++..........|.+|+.++++++|||||+++|+|.++...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999863 467899999987665556778999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 362 LVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
+|||||++|+|.++++..... ...++|..+..|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999754321 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 507 (613)
++||+|||+++.....+. .......||+.|||||++.++.++.++|||||||++|||+| |+.||.... . .
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~---~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----N---Q 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----H---H
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----H---H
Confidence 999999999987644332 22344569999999999999999999999999999999999 899995221 1 1
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+.+.. +..+... ..+..++..+.+++.+||+.||++||||+||++.|+..
T Consensus 255 ~~~~~-i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEM-IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHH-HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222 2211111 11223456789999999999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=436.92 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=209.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
++|.+.+.||+|+||+||+|++. ++..||||+++... .....+|.+|++++++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56788899999999999999864 46789999997543 334567999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 362 LVYPFMVNGSVASCLRERG---------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
+|||||++|+|.++++..+ .....++|..+..|+.||++||+|||++ +||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997643 2234699999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 510 (613)
|+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~ 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 240 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998765433322 233458999999999999999999999999999999999 899996321 11222
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......... ..+..++..+.+++.+||+.||++|||++||.+.|++
T Consensus 241 ~~i~~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 241 ECITQGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222221111 1122344678999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=428.97 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=203.4
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++..+++.+.+.||+|+||+||+|++. ..||||+++... .......|.+|+.++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344567888899999999999999875 359999987543 23345679999999999999999999998865 56899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|||||++|+|.++++.... ++++..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999976432 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-Cceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 443 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 443 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
.... ........||+.|||||++.+ ++|+.++|||||||++|||+||+.||.... . ...+........
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~---~~~~~~~~~~~~ 254 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N---RDQIIFMVGRGY 254 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHTTC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcCC
Confidence 5332 223345679999999999964 468999999999999999999999995221 1 111112221111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. .+.. ......++..+.+++.+||+.||++||||.||++.|+.
T Consensus 255 ~----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 255 A----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp C----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred C----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1111 11122345678999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=436.50 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=204.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
++|.+.++||+|+||+||+|++. +++.||||+++.. ......+|.+|++++++++|||||+++|+|.++...+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677789999999999999864 4778999999754 3334567999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 362 LVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
+|||||++|+|.++++.... ...+++|..+..|+.||++||+|||++ +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999976432 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007200 431 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 508 (613)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 99999999987654332 22344569999999999999999999999999999999999 899996321 112
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.+......... . .+..++..+.+++.+||+.||++||||+||++.|+.+
T Consensus 269 ~~~~i~~g~~~------~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGREL------E----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCCC------C----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCC------C----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22222221111 1 1223346789999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=432.74 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=203.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999976 799999999976543 3335678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
||+||+|.+++..... ..+++..++.|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999976432 2479999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+.+........ .
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~-~----- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSF-P----- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCC-C-----
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCC-C-----
Confidence 122344679999999999999999999999999999999999999996321 2222222222211 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1123457889999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=428.49 Aligned_cols=325 Identities=94% Similarity=1.423 Sum_probs=274.9
Q ss_pred ccCCCCCCcccccCcccccCHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHH
Q 007200 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMI 339 (613)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l 339 (613)
++.+.++++....+..+.++..++....++|...+.||+|+||.||+|...+|+.||||++...........+.+|++++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l 81 (326)
T 3uim_A 2 FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81 (326)
T ss_dssp -------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGG
T ss_pred CCCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHH
Confidence 35566777778888899999999999999999999999999999999998889999999998765444444789999999
Q ss_pred hhcccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007200 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK 419 (613)
Q Consensus 340 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 419 (613)
+.++||||+++++++.++...++||||+.+|+|.++++.......++++..+..++.|++.||+|||+++.++|+|||||
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 99999999999999999999999999999999999998876666679999999999999999999999877789999999
Q ss_pred CCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc
Q 007200 420 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (613)
Q Consensus 420 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~ 499 (613)
|+||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+.....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 99999999999999999999987665555556667999999999999989999999999999999999999999877666
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCcchhhHHHhhh
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKE 579 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 579 (613)
........+|+.............+.........+....+.+++..||+.||++|||+.||++.|++..+.+.|.++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 321 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKE 321 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-----
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHH
Confidence 77778888999888888888888888888888899999999999999999999999999999999999999999999988
Q ss_pred hhhcc
Q 007200 580 EMFRQ 584 (613)
Q Consensus 580 ~~~~~ 584 (613)
+..+|
T Consensus 322 ~~~~q 326 (326)
T 3uim_A 322 EMFRQ 326 (326)
T ss_dssp -----
T ss_pred HhhcC
Confidence 87664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=425.02 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=207.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|+..+.||+|+||+||+|++. +|+.||||++...... ....+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999986 7999999999754332 344688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|++|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999753 389999999999999999999999 99999999999999999999999999998775432
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... .. .+.+........ +.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~---~~~~~~i~~~~~------~~ 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PP---LKAMKMIRDNLP------PR 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CH---HHHHHHHHHSSC------CC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CH---HHHHHHHHcCCC------CC
Confidence 2344567999999999999999999999999999999999999999522 11 111111111110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..........+.+++.+||+.||++|||+.|+++
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112233467889999999999999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=432.99 Aligned_cols=269 Identities=27% Similarity=0.399 Sum_probs=219.1
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCcccHHHHHHHHHHHhhccc-Ccccee
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRL 350 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 350 (613)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||.++..........|.+|++++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456788888999999999999999999998642 357999999876666566789999999999975 899999
Q ss_pred eEEEEcC-CceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007200 351 RGFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (613)
Q Consensus 351 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (613)
+|+|.++ ...++|||||++|+|.++++.... ....+++..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccc
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~ 495 (613)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3445679999999999999999999999999999999998 9999953
Q ss_pred ccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 496 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .. +.+...+..+.. .. .+..+...+.+++.+||+.||++|||+.||++.|+.
T Consensus 291 ~~----~~----~~~~~~i~~g~~-----~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VK----ID----EEFCRRLKEGTR-----MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CC----CS----HHHHHHHHHTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----HH----HHHHHHHHcCCC-----CC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 21 11 112222222111 11 112234578899999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=423.60 Aligned_cols=250 Identities=22% Similarity=0.245 Sum_probs=203.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|...++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999976 699999999976432 24799999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 445 (613)
|+||+|.++++..+ ++++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998754 399999999999999999999999 999999999999999987 6999999999977543
Q ss_pred CCc----eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 446 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 446 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..... . .+...+ .......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~-~~~~~i---~~~~~~~- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR----G-PLCLKI---ASEPPPI- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC----S-CCHHHH---HHSCCGG-
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----H-HHHHHH---HcCCCCc-
Confidence 211 12335799999999999999999999999999999999999999963221 1 111111 1111000
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+......+.+++.+||+.||++|||+.|+++.|..
T Consensus 276 -------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01122234678899999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=415.53 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=196.1
Q ss_pred CCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEc----CCceEEEE
Q 007200 291 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 364 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 364 (613)
...+.||+|+||+||+|.+. ++..||+|++.... .......|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999976 68899999997544 33345679999999999999999999999865 34579999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecC-CCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDE-EFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~-~~~~kl~DfGla~~ 441 (613)
|||++|+|.++++... ++++..+..++.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998754 389999999999999999999998 6 999999999999984 78999999999985
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ......... .......
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i-~~~~~~~ 249 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRV-TSGVKPA 249 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHH-TTTCCCG
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHH-HcCCCCC
Confidence 432 22345679999999998865 69999999999999999999999995221 111111111 1111100
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||+.||++|||++|+++
T Consensus 250 ~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 1112246889999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=416.48 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=208.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999976 79999999997543 2234567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||+||+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998754 399999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+......... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE-Y---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-C----
Confidence 33 233456789999999999999999999999999999999999999996321 112222222211 1
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 561 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 561 (613)
..+ ......+.+++.+||+.||++|||++|++
T Consensus 252 --~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111 12235688999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=423.71 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=207.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|+..+.||+|+||+||+|++. +|+.||||++...... ....+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999986 7999999999754332 345688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|+||+|.++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999753 289999999999999999999999 99999999999999999999999999998775432
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... .. .+.+........ +.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~---~~~~~~i~~~~~------~~ 366 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PP---LKAMKMIRDNLP------PR 366 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CH---HHHHHHHHHSCC------CC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CH---HHHHHHHHcCCC------CC
Confidence 2344567999999999999999999999999999999999999999522 11 111111111110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .........+.+++.+||..||++|||+.|+++
T Consensus 367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 111123357889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=415.34 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC----ceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 363 (613)
++|.+.+.||+|+||+||+|++. |+.||||+++.... ....++.|+..+.+++||||++++|++.+++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45777889999999999999984 89999999965421 1223445666677899999999999998654 57999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
||||++|+|.++++.. +++|..+.+++.|+++||+|||+++ .++||||||||+|||++.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999764 3899999999999999999999762 45899999999999999999999999999
Q ss_pred ceecCCCCCce---eeccccccccccccccccC------CCCCcccchhHHHHHHHHHhCCCCcccccccCC------Cc
Q 007200 439 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLAND------DD 503 (613)
Q Consensus 439 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~------~~ 503 (613)
|+......... .....||+.|||||++.+. .++.++|||||||++|||+||++||........ ..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98775443322 2345699999999999764 367899999999999999999988753221110 00
Q ss_pred chHHHHHHHHhhcccccccccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......+........ .++..+.. ...+....+.+++.+||+.||++||||.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111222222221111 22222211 123566789999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=399.66 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=191.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999976 799999999975432 233567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+ +|+|.+++...+ ++++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999997654 399999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ............ .
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~~-~---- 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNGV-Y---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C----
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-C----
Confidence 2 22344679999999999988876 589999999999999999999996321 112222221111 1
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||+.||++|||++|+++
T Consensus 230 --~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 1122356889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=407.78 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=194.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 478999999975432 2223467889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|||||+||+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998754 399999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.+....... .
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~-~--- 243 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAK-L--- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C---
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-C---
Confidence 4322 22345679999999999999999999999999999999999999996321 112222222211 1
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
. .+...+..+.+++.+||+.||++|||+
T Consensus 244 ---~----~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---G----MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---C----CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 111233568899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=406.65 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=191.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC--------
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 358 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 358 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++..........+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999976 799999999976655555667999999999999999999999987544
Q ss_pred ----ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEe
Q 007200 359 ----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (613)
Q Consensus 359 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 434 (613)
..++|||||++|+|.++++..... ...++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999865432 2356778899999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc-----------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007200 435 DFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503 (613)
Q Consensus 435 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~ 503 (613)
|||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999876543221 1233569999999999999999999999999999999996 774211
Q ss_pred chHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.....+... .... .+ ...........+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~-~~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDV-RNLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHH-HTTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHH-hcCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111 1110 00 011223345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=394.92 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=200.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEc------CCc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 359 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 7999999999765432 234568899999999999999999998764 357
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.|+|||||. |+|.+++...+ ++++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 68999987643 499999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 440 KLMDYKD---THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 440 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|++||... ........+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-----~~~~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-----NYVHQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-----SHHHHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHhcC
Confidence 8764321 2233456799999999998875 5699999999999999999999999532 11122222221111
Q ss_pred cccccc-----------cccCc-cCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 EKKLEQ-----------LVDSD-MEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ~~~~~~-----------~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... ..... ...... ......+.+++.+||..||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 00000 000000 012356789999999999999999999887
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=386.94 Aligned_cols=196 Identities=23% Similarity=0.403 Sum_probs=169.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
..++|++.+.||+|+||+||+|+.+ +++.||||.+.... ...++.+|++++..+ +||||+++++++.+++..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999863 46789999986543 345678999999988 699999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla 439 (613)
++||||+++|+|.++++. +++.+++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999842 89999999999999999999999 99999999999999877 79999999999
Q ss_pred eecCCCCC---------------------------ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCC
Q 007200 440 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQR 491 (613)
Q Consensus 440 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~ 491 (613)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 112335699999999999876 48999999999999999999999
Q ss_pred Ccc
Q 007200 492 AFD 494 (613)
Q Consensus 492 p~~ 494 (613)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.25 Aligned_cols=278 Identities=40% Similarity=0.670 Sum_probs=237.8
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+....++|...+.||+|+||+||+|.+.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 3345688999999999999999999988899999998876533 345678999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999977655445699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC-CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........|.........+..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccccccHHH
Confidence 4322 2223344589999999999999999999999999999999999999964332 233345566666666666677
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..++........+....+.+++.+||+.||++|||+.|+++.|+.
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 777777667778889999999999999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=398.40 Aligned_cols=250 Identities=27% Similarity=0.338 Sum_probs=199.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHH---HHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+... ......... ++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999977 799999999975421 112223333 45667778999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998764 399999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||...... .............
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~-- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMA-- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCC--
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCC--
Confidence 765332 345679999999999975 57999999999999999999999999633211 1111111111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
.. .+......+.+++..||+.||++|++ ++||++
T Consensus 411 -----~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -----VE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01 11123356889999999999999998 566654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=400.00 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=207.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||+||+|.++ +|+.||+|++.... ......+.+|+.+|+.++||||+++++++.++...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999986 79999999987543 2234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfGla~~~~ 443 (613)
||+||+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 235 ~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999865432 489999999999999999999999 99999999999999854 899999999999875
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.+........
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~----- 373 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDW----- 373 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCC-----
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCC-----
Confidence 432 3344579999999999999999999999999999999999999996321 1122222111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.............+.+++.+||+.||++|||+.|+++
T Consensus 374 --~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111122356889999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=352.83 Aligned_cols=250 Identities=19% Similarity=0.307 Sum_probs=207.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|...+.||+|+||+||+|.+. +|+.||||++...... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 367999999999999999999965 7899999998755433 45678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999764 289999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~------ 234 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP------ 234 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC------
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC------
Confidence 32 2344569999999999999999999999999999999999999995221 11111111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....+......+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00112223457889999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=370.93 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=211.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 357 (613)
.++|.+.+.||+|+||+||+|.+. ++..||||+++..........+.+|+.+++.+ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 35579999998765555566799999999999 899999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 425 (613)
...++||||+.+|+|.++++.... ....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986532 123489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCc
Q 007200 426 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 503 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~ 503 (613)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----H
Confidence 99999999999999876543221 2233447889999999999999999999999999999999 999996321 1
Q ss_pred chHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
......+ .... ....+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 312 ~~~~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 312 EELFKLL----KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGHHHHH----HTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH----hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 1111 0111222345789999999999999999999999999853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=354.48 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=208.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|...+.||+|+||+||+|.+. +++.||+|.+... .......+.+|+++++.++||||+++++++.++...++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 467888999999999999999986 6899999988543 33345678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999987432 489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCce-------------eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-cchHHHHHH
Q 007200 446 DTHV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVK 511 (613)
Q Consensus 446 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~ 511 (613)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|..||......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11456999999999999999999999999999999999999998633221111 111111111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.. . +......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 242 ~~-------------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RY-------------C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HT-------------C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-------------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 0 111224588999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=364.23 Aligned_cols=265 Identities=27% Similarity=0.417 Sum_probs=203.1
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
...++.+..++|++.+.||+|+||+||+|++ +|+.||||++..... ......+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344445567899999999999999999987 488999999876543 23345788999999999999999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEEec
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
...++||||+.+|+|.+++..... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999976432 12389999999999999999999999 8 99999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.......
T Consensus 183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~ 253 (309)
T 3p86_A 183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGF 253 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHH
T ss_pred CCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 99997544322 22334569999999999999999999999999999999999999996321 1111111110
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
... ....+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 254 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 254 KCK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp SCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 110 001112233578999999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=349.24 Aligned_cols=283 Identities=39% Similarity=0.635 Sum_probs=228.1
Q ss_pred cccccCHHHHHHHhhCCCCC------CccccCcCcEEEEEEeCCCCEEEEEEecccc---CcccHHHHHHHHHHHhhccc
Q 007200 274 QLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLKEER---TQGGELQFQTEVEMISMAVH 344 (613)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h 344 (613)
....++..++..++++|... +.||+|+||.||+|.. +++.||||++.... .......+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8899999999999987 58899999987543 22335678999999999999
Q ss_pred CccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 007200 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (613)
Q Consensus 345 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 424 (613)
|||+++++++.+....++||||+++++|.+++..... ..++++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875432 23599999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007200 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503 (613)
Q Consensus 425 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~ 503 (613)
++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP---- 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----
Confidence 999999999999999876543222 2334568999999998864 5789999999999999999999999743311
Q ss_pred chHHHHHHHHhhc-ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 504 VMLLDWVKGLLKE-KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 504 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.....+....... ..+...++... ..........+.+++..||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1112222222221 12223333332 234566778899999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.31 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=208.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|.+.+.||+|+||+||+|.+. .+..||||+++..........+.+|+.+++.++||||+++++++.++...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999975 3446999999876555556789999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999975432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYR- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCC-
Confidence 543222 2222346778999999998999999999999999999999 999995221 1111111111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+......+.+++..||+.||++|||+.+|++.|+..
T Consensus 273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122346789999999999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.59 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=212.2
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..++|.+.+.||+|+||.||+|.+.++..||+|+++.... ....+.+|++++..++||||+++++++.++...++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3567889999999999999999998888999999976443 34678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999976532 389999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .............. ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~---~~ 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHRL---YR 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCCC---CC
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCCCC---CC
Confidence 4333444456778999999999899999999999999999999 999996322 11111111111110 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+......+.+++..||+.||++|||+.|+++.|+..
T Consensus 227 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 227 -------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp -------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred -------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111235688999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=351.34 Aligned_cols=272 Identities=19% Similarity=0.224 Sum_probs=216.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC--ceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 363 (613)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999987 589999999987655555677889999999999999999999998765 67999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEeccccc
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGla 439 (613)
|||+++++|.+++...... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999865332 2389999999999999999999999 99999999999999 77888999999999
Q ss_pred eecCCCCCceeeccccccccccccccc--------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+....... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||....... .....+.
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMY 237 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHH
Confidence 87654332 23455999999999986 5778999999999999999999999996332111 1122222
Q ss_pred HHhhccc---ccccc-----------cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 512 GLLKEKK---LEQLV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 512 ~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
....... +..+. +..............+.+++..||+.||++|||++|+++...+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2222211 11100 001122345677888999999999999999999999999887644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=373.31 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=210.4
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.+..++|.+.+.||+|+||.||+|.+. +++.||||.++..........+.+|+.+++.++||||+++++++..+...++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344577888999999999999999987 7899999999765444444568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.++++..+. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999976432 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcee-eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
........ ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||.... . ..+........
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~----~~~~~~~~~~~-- 332 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----N----QQTREFVEKGG-- 332 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----H----HHHHHHHHTTC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----H----HHHHHHHHcCC--
Confidence 43211111 11235778999999998999999999999999999998 999995321 1 11111111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
....+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0111122345788999999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.02 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=205.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999985 799999999976543 233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCC-CcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. ......||+.|+|||.+.+..++ .++||||+||++|||++|+.||.... .............
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~----- 231 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGKY----- 231 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-----
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----
Confidence 32 23445699999999999888764 79999999999999999999996322 1122222221111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||..||++|||++|+++
T Consensus 232 --~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01 1112356889999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.25 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=210.2
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..++|...+.||+|+||+||+|.+.+++.||+|++..... ....+.+|++++++++||||+++++++.++...++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3467888999999999999999998889999999976543 34678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976432 489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~~------ 225 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR------ 225 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCcc------
Confidence 2222333447788999999999999999999999999999999 999996321 1111212111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .+......+.+++..||+.||++|||+.++++.|+.
T Consensus 226 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 226 LY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 00 111123568999999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.33 Aligned_cols=257 Identities=29% Similarity=0.434 Sum_probs=199.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|.+.+.||+|+||.||+|++. ++..||||+++..........+.+|+.++++++||||+++++++.++...++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999865 4778999999876555556679999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.++++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
....... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~~~- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGYR- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTTEE-
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC-
Confidence 5432211 122235778999999999999999999999999999998 999995221 1111111111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..........+.+++..||+.||++||++.+|++.|+..
T Consensus 269 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 011122346789999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=352.92 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=205.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.++..++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999976 6899999998654332 2345789999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.+++...+ ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............... .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~-~- 232 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSVPN-V- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCCCC-H-
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccCCC-c-
Confidence 443333444569999999999999999999999999999999999999996322 111111111111100 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGD 567 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 567 (613)
... .....+..+.+++.+|++.||++|| ++.++.+.|+..
T Consensus 233 ~~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 TTD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred chh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 000 1112236789999999999999999 899999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=349.29 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=211.6
Q ss_pred cccCHHHHHHHhhC----------CCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhccc
Q 007200 276 KRFSLRELQVATDN----------FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344 (613)
Q Consensus 276 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 344 (613)
..++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.+++.++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 34677777766654 566678999999999999987 799999999875433 345678899999999999
Q ss_pred CccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 007200 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (613)
Q Consensus 345 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 424 (613)
|||+++++++......++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998643 389999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcc
Q 007200 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504 (613)
Q Consensus 425 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~ 504 (613)
++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-----~- 246 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-----P- 246 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----H-
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H-
Confidence 99999999999999987654322 2334569999999999999999999999999999999999999995321 1
Q ss_pred hHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 505 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+.+....... .... .........+.+++.+||+.||++|||+.|+++.
T Consensus 247 --~~~~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 --VQAMKRLRDSP-PPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHHHHHSS-CCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHhcCC-CCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111 0000 0111223568899999999999999999999873
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.01 Aligned_cols=269 Identities=27% Similarity=0.411 Sum_probs=215.7
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCcccee
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 350 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 350 (613)
+...++++..++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 456677788899999999999999999999732 46789999998765555566799999999999 79999999
Q ss_pred eEEEEcCCc-eEEEEecccCCcchhhhhccCCC-----------------------------------------------
Q 007200 351 RGFCMTPTE-RLLVYPFMVNGSVASCLRERGQS----------------------------------------------- 382 (613)
Q Consensus 351 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 382 (613)
++++.++.. .++||||+.+|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999765321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 383 ---------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 383 ---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999986643322
Q ss_pred -ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 448 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 448 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..... .........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~----~~~~~~~~~----- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFC----RRLKEGTRM----- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHH----HHHHHTCCC-----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHH----HHHHcCCCC-----
Confidence 23344568899999999999999999999999999999998 9999963221 11111 111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. .+......+.+++..||+.||++|||+.|+++.|+.
T Consensus 316 ~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0 111123568899999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=357.47 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=202.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|.+.+.||+|+||+||+|.+. +++.||||++...........+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 67889999999999999999977 78999999997654444445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999997543 389999999999999999999999 99999999999999999999999999998664322
Q ss_pred C-ceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 447 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... .......+.. .... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~----~~~~---~- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----KKTY---L- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT---TSHHHHHHHT----TCTT---S-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhc----cccc---C-
Confidence 1 22334569999999999988775 7889999999999999999999963321 1111111111 1000 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011223567899999999999999999999763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=377.66 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=214.1
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++..++|.+.+.||+|+||.||+|.+. ++..||||.++.... ....+.+|+.++++++||||+++++++......++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 344567888999999999999999987 488999999976433 35679999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999986432 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
............++..|+|||.+.+..++.++|||||||++|||+| |+.||.... .......+. ..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~---- 435 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE----KD---- 435 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHH----TT----
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----cC----
Confidence 5433222333446789999999999999999999999999999999 999996322 111111111 11
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 569 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 569 (613)
.....+..+...+.+++.+||+.||++|||+.+|++.|+..-.
T Consensus 436 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111122334678999999999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=353.09 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=197.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
+..++|++.+.||+|+||.||+|.+.. +..||+|.++..........+.+|+.+++.++||||+++++++ .++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 345788899999999999999998753 4579999987655555566789999999999999999999997 45678
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999999997653 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~i---~~~~~~ 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGERL 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHHH---HcCCCC
Confidence 765443333334447789999999999999999999999999999997 999996322 11112211 111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 237 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 237 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1112234678899999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=358.06 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=212.6
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
....++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.+++.++||||+++++++.++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 344578899999999999999999862 45789999998665555566789999999999999999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (613)
...++||||+.+|+|.+++..... ....+++..+..++.||++||+|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999986543 123489999999999999999999999 999999
Q ss_pred CCCCceeecCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccc
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~ 495 (613)
|||+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765433222 223447788999999999999999999999999999999 9999963
Q ss_pred ccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 496 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .......+. .... ..........+.+++.+||+.||++|||+.++++.|+.
T Consensus 256 ~~-----~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 256 IP-----PERLFNLLK----TGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CC-----GGGHHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----HHHHHHHhh----cCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22 111111111 1110 01112234678999999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=365.87 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=209.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||+||+|.+. +++.||||+++..........+.+|+.+++.++||||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999843 46689999997665555566789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEe
Q 007200 361 LLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 434 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~ 434 (613)
++||||+.+|+|.++++.... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986542 223589999999999999999999999 999999999999999554 59999
Q ss_pred ccccceecCCCC-CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHH
Q 007200 435 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 435 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.... . .+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----~---~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N---QEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H---HHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHH
Confidence 999997553221 122233457899999999999999999999999999999998 999995321 1 111111
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....... ..+......+.+++..||+.||++|||+.+|++.|+.
T Consensus 299 i~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 299 VTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111111 1112233568899999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=351.10 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=207.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|...+.||+|+||+||+|.+.++..||+|+++.... ....+.+|++++..++||||+++++++.++...++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34578888999999999999999998888999999976543 3467899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999976332 389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... .............
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~----- 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLR----- 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCC-----
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhcccC-----
Confidence 32222333446788999999999999999999999999999998 999996322 1111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .+......+.+++.+||+.||++|||+.++++.|++
T Consensus 240 -~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 240 -LY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 111123578899999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=349.78 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=201.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|++.+|+.||+|++....... ....+.+|+++++.++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999999889999999997554332 24568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 7887776543 2489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc---
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ--- 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 521 (613)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+...........
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT-----DDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----TTTHHHHHHHHHCCCCTTTSGG
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHHCCCChHHhhh
Confidence 22 2333458999999999876 568999999999999999999999996322 1112222222221111000
Q ss_pred ccc------Cc---cCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVD------SD---MEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~------~~---~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+ .. .... ........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00 0000 01112356889999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.75 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=212.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
..++|.+.+.||+|+||+||+|++. .+..||||+++..........+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999853 23579999998766555567799999999999 89999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 424 (613)
+...++||||+.+|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999986542 123599999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCC
Q 007200 425 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 502 (613)
Q Consensus 425 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~ 502 (613)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----- 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 99999999999999986654322 22333457889999999999999999999999999999999 999995221
Q ss_pred cchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+........... . .+......+.+++..||+.||++|||+.||++.|+.+
T Consensus 299 ---~~~~~~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 ---VEELFKLLKEGHRM------D----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ---HHHHHHHHHTTCCC------C----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHcCCCC------C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222111111111 0 1112335789999999999999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=362.44 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=214.1
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
.+....++|.+.+.||+|+||.||+|++. +++.||||+++..........+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455688999999999999999999975 347899999987655555667999999999999999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 415 (613)
++...++||||+++|+|.+++...... ..++++..++.++.||++||+|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999764321 14699999999999999999999999 9999
Q ss_pred cCCCCCceeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCc
Q 007200 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493 (613)
Q Consensus 416 ~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~ 493 (613)
|||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543221 12233457889999999999999999999999999999999 99999
Q ss_pred ccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 494 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.... ..+.... ........ .+......+.+++..||+.||++|||+.++++.|++.
T Consensus 278 ~~~~--------~~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 278 YGMA--------HEEVIYY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTSC--------HHHHHHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCC--------hHHHHHH-HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 5221 1111111 11111111 1112335789999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=358.32 Aligned_cols=274 Identities=23% Similarity=0.309 Sum_probs=209.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 361 (613)
..++|++.+.||+|+||+||+|+.. +++.||+|++++..... ....+..|..++.++ +||||+++++++.++...+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999977 57899999997654322 223577899998876 8999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999998654 389999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||................+..........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 3322 22344567999999999999999999999999999999999999999643222111111122222222111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH---HHHHHhhcCCc-chhhHHHh
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS---EVVRMLEGDGL-AERWEEWQ 577 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~---evl~~L~~~~~-~~~~~~~~ 577 (613)
.+......+.+++..||+.||++||++. .+.+.++...+ .-+|+...
T Consensus 281 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 281 ---------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred ---------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 1112335688999999999999999962 33444443333 22355443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=378.71 Aligned_cols=260 Identities=23% Similarity=0.418 Sum_probs=211.9
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
++++..++|.+.+.||+|+||+||+|.+.++..||||+++... .....+.+|+.+++.++||||+++++++. ....+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 3455667899999999999999999999888899999997643 24668999999999999999999999986 56789
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 99999999999999975421 1378999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............++..|+|||.+....++.++|||||||++|||+| |+.||.... ..+...........
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~- 404 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRM- 404 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTCCC-
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC-
Confidence 64322222233346788999999999999999999999999999999 999995221 11212121111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+..++..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 405 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 405 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11122346789999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.61 Aligned_cols=269 Identities=27% Similarity=0.314 Sum_probs=206.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc----eE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----RL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~ 361 (613)
..++|.+.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++..++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4568999999999999999999986 8899999996543 233456678889999999999999999987543 69
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCceeecCCCcEEEe
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-------DPKIIHRDVKAANILLDEEFEAVVG 434 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~NIll~~~~~~kl~ 434 (613)
+||||+++|+|.++++.. ++++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999764 2899999999999999999999862 3389999999999999999999999
Q ss_pred ccccceecCCCCCc-eeeccccccccccccccccC-----CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc-----
Q 007200 435 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD----- 503 (613)
Q Consensus 435 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~----- 503 (613)
|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||..........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 23335699999999999763 45678899999999999999999996432111100
Q ss_pred ---chHHHHHHHHhhcccccccccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 504 ---VMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 504 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.....+..... .... .+..... ........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVV-HKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHT-TSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhh-cccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111111 1111 1111110 1124556799999999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=357.38 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=205.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-----cHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||+||+|... +|+.||+|+++...... ....+.+|+.++..++||||+++++++.++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999987 68999999997654321 356789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEecc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 436 (613)
++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997543 499999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+........
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAV 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765422 2334569999999999999999999999999999999999999995321 11111111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. . .++. ........+.+++..||..||++|||+.|+++
T Consensus 234 ~~-~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-D--FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-C--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-C--CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 0000 00112356889999999999999999999886
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.80 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=201.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhh--cccCccceeeEEEEcC----Cce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP----TER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 360 (613)
.++|.+.+.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46899999999999999999998 5899999998643 23455667776665 7899999999987543 457
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceeecCCCcEE
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
++||||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 8999999999999999643 3899999999999999999999 77 999999999999999999999
Q ss_pred EeccccceecCCCCCce---eeccccccccccccccccC------CCCCcccchhHHHHHHHHHhC----------CCCc
Q 007200 433 VGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG----------QRAF 493 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DVwS~G~il~elltg----------~~p~ 493 (613)
|+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998765443322 2234699999999999876 455799999999999999999 7777
Q ss_pred ccccccCCCcchHHHHHHHHhhcccccccccCccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 494 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME-GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
........ .. ..+......... .+... ..........+.+++..||+.||++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~---~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDP---SF-EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSC---CH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCc---ch-hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43221111 11 111111111110 11111 112335678899999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.24 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=206.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|+..+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467889999999999999999976 69999999997542 223455788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997654 389999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~---- 222 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE-I---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C----
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-C----
Confidence 222 22344669999999999999999999999999999999999999995321 111111111111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
. .+......+.+++.+||+.||++|| +++|+++.
T Consensus 223 --~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 --R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 1112235788999999999999999 89988764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=357.57 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=200.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|+..+.||+|+||+||+|++. +++ +||+|.++..........+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367888999999999999999965 444 368888876555556678999999999999999999999998754 78
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+++||+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... .......+. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~----~~~- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE----KGE- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHH----cCC-
Confidence 6543322 2233446889999999999999999999999999999999 999996322 111111111 110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
....+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111122345789999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=353.84 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=202.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 359 (613)
.++|++.+.||+|+||.||+|++. +|+.||||+++..........+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367889999999999999999987 7999999999866555556789999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEecccCCcchhhhhccCCCCCCCCH
Q 007200 360 ---------------------------------------------------RLLVYPFMVNGSVASCLRERGQSQPPLNW 388 (613)
Q Consensus 360 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 388 (613)
.++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7999999999999999987543 234677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC-----------ceeecccccc
Q 007200 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTI 457 (613)
Q Consensus 389 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 457 (613)
..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987754321 1223346999
Q ss_pred ccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHH
Q 007200 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 537 (613)
Q Consensus 458 ~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (613)
.|+|||.+.+..++.++|||||||++|||++|..|+.... ...... ..... .........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~-~~~~~---------~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDV-RNLKF---------PLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHH-HTTCC---------CHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHh-hccCC---------CcccccCCh
Confidence 9999999999999999999999999999999988763111 111111 11100 011223345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 538 QLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 538 ~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=360.32 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=210.0
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEc
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
+.++....++|++.+.||+|+||+||+|++. +++.||+|+++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999987 688999999965321 1122347889999999999999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+...++||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999754 289999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCC----CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHH
Confidence 999877654433444667999999999998765 7899999999999999999999996321 1122222
Q ss_pred HhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
............ .......+.+++..|+..+|.+ ||+++||++.
T Consensus 285 i~~~~~~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTHHHHCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhccccccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 221110000000 0112356889999999999988 9999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.53 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=196.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-------------------------ccHHHHHHHHHHHh
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------------------GGELQFQTEVEMIS 340 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~ 340 (613)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467899999999999999999976 6889999998654321 11245889999999
Q ss_pred hcccCccceeeEEEEc--CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007200 341 MAVHRNLLRLRGFCMT--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (613)
Q Consensus 341 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (613)
.++||||+++++++.+ ....++||||+++++|.+++.. .++++..+..++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 5678999999999999987643 2489999999999999999999999 9999999
Q ss_pred CCCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCC---CCCcccchhHHHHHHHHHhCCCCccc
Q 007200 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 419 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456999999999997765 37889999999999999999999953
Q ss_pred ccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 496 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ......... ..... . + . .......+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~--------~~~~~~~~~-~~~~~-~--~-~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER--------IMCLHSKIK-SQALE-F--P-D----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS--------HHHHHHHHH-HCCCC-C--C-S----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--------HHHHHHHHh-cccCC-C--C-C----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 111111111 11110 0 0 0 1112356899999999999999999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=348.49 Aligned_cols=266 Identities=24% Similarity=0.361 Sum_probs=192.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|+..+.||+|+||+||+|... +|+.||+|+++..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999976 6899999999765544445678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|+. |+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 2223589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc---cc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KL 519 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 519 (613)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+....... ..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhHh
Confidence 3322 22334589999999999764 68999999999999999999999996321 111122221111100 00
Q ss_pred ccc-----ccCccC----C--------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQL-----VDSDME----G--------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~-----~~~~~~----~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ..+... . .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 0 000112357899999999999999999999886
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.11 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=205.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc----CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999976 68999999986432 1123567899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEecccc
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGL 438 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGl 438 (613)
+||||+++++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865443344589999999999999999999999 9999999999999987654 99999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCC
Confidence 98765432 22334569999999999999999999999999999999999999996321 111111111110
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ..+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 250 -~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -K--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -C--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -C--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0112357889999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=351.85 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=214.9
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
+++..++|.+.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++.++...+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3445678999999999999999999987 488899999975432 3567889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999976433 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-----~~~~~~~~~~---~---- 228 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK---D---- 228 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT---T----
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhc---c----
Confidence 76554444455557889999999999999999999999999999999 999996322 1111111111 1
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.....+......+.+++..|++.||++|||+.++++.|+..
T Consensus 229 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 01111122346789999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=354.44 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=213.0
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEe------CCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
+...++|...+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34457899999999999999999985 246789999998665554566799999999999 89999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQS--------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
+...++||||+++|+|.+++...... ..++++..+..++.|++.||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999765421 23589999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
|+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--- 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc---
Confidence 99999999999999999876543322 2233457889999999999999999999999999999999 999996322
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........ ..... .. .........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 253 -~~~~~~~~----~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 -VDSKFYKM----IKEGF-----RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -SSHHHHHH----HHHTC-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -chhHHHHH----hccCC-----CC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111111 11110 00 0111223578999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=358.73 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=201.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCE----EEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|...+.||+|+||+||+|.+. +++. ||+|.+...........+.+|+.+++.++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999975 4443 78888765443333445778999999999999999999886 567899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997642 2488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... .......+. ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~---~~~~~~ 237 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLE---KGERLA 237 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHH---TTCBCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHH---cCCCCC
Confidence 543322 2334557889999999999999999999999999999999 999996322 111111111 111100
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
.+......+.+++.+||+.||++|||+.++++.|+...
T Consensus 238 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 ----------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112235788999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.50 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=210.1
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 355 (613)
+++..++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.++.++ .||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4456688999999999999999999962 45689999998654444456789999999999 8999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 416 (613)
.++..++||||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999765321 12489999999999999999999999 99999
Q ss_pred CCCCCceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcc
Q 007200 417 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494 (613)
Q Consensus 417 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~ 494 (613)
||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866543322 2334457889999999999999999999999999999998 999996
Q ss_pred cccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 495 LARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
... ....... ...... ....+......+.+++..||+.||++|||+.++++.|+..
T Consensus 277 ~~~----~~~~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIP----VDANFYK----LIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCC----CSHHHHH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----cHHHHHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 322 1111111 111110 0011112246789999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.61 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=205.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|.+. +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 367889999999999999999977 68899999986432 234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~ 443 (613)
|+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997543 2489999999999999999999999 9999999999999997 7899999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+.+..........
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~--- 222 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTF--- 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCC---
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCCC---
Confidence 432 2344569999999999998889999999999999999999999996321 112222221111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ........+.+++.+||..||++|||+.|+++
T Consensus 223 ~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 00112357889999999999999999999988
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=352.17 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=201.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 362 (613)
.++|+..+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|..++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999986 6889999999765432 2344678899999887 89999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997654 389999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................+..........
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 237 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 237 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--
Confidence 3222 2234457999999999999999999999999999999999999999643221111111112222211111110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
.+......+.+++.+||+.||++||++
T Consensus 238 --------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 --------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111233578899999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=358.67 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=212.7
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeCC-C-----CEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 354 (613)
+++...++|...+.||+|+||.||+|.+.. + ..||+|.+...........+.+|+.++..+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667889999999999999999999752 2 479999998766555566799999999999 899999999999
Q ss_pred EcCCceEEEEecccCCcchhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 007200 355 MTPTERLLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 424 (613)
.++...++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999875321 123489999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCC
Q 007200 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 502 (613)
Q Consensus 425 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~ 502 (613)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.... .
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~ 272 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----V 272 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----S
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----h
Confidence 999999999999999866433222 2333457889999999999999999999999999999999 999996321 1
Q ss_pred cchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...... ....... . ..+......+.+++..||+.||++|||+.|+++.|+.
T Consensus 273 ~~~~~~----~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 273 NSKFYK----LVKDGYQ-----M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp SHHHHH----HHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHH----HHhcCCC-----C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 111111 1111110 0 0011123578999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.07 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=199.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|.+.+.||+|+||+||+|...+|+.||+|++...... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999988999999999754322 2345688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 8988887543 2489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc---ccc-
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LEQ- 521 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 521 (613)
. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+........ ...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHCCCChhhchhh
Confidence 2 22334589999999999764 58999999999999999999999996321 1111111111111000 000
Q ss_pred ----cccCccC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 ----LVDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ----~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0011123467889999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.57 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=205.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999986 6899999999754322 1356789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEecc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 436 (613)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997543 489999999999999999999999 999999999999999887 7999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+.+......
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 232 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHT
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2234569999999999998999999999999999999999999995221 11111111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. .............+.+++..||+.||++|||+.|+++.
T Consensus 233 ~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY-------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000001123568899999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.58 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=194.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc---ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|+..+.||+|+||.||+|.+. |+.||||+++..... .....+.+|+++++.++||||+++++++.++...++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467888999999999999999986 889999998754322 2345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--------CCcEEEec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--------EFEAVVGD 435 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~D 435 (613)
|||+++++|.+++... .+++..+..++.|++.||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 3899999999999999999999992112999999999999986 67899999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
||+++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... . .........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~---~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----G---LAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----H---HHHHHHHHT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHhhhc
Confidence 99998654322 223458999999999999999999999999999999999999996321 0 111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .....+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 229 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 1111122234678999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=353.63 Aligned_cols=251 Identities=28% Similarity=0.368 Sum_probs=200.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
...++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++..+ +||||+++++++.++...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999976 68999999997542 222345678899999987 699999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~-- 241 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEV-- 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC--
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCC--
Confidence 54322 223345679999999999999899999999999999999999999996322 1122222222111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM------SEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 562 (613)
.++......+.+++.+||+.||++||++ .|+++
T Consensus 242 ---------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111223568899999999999999998 66665
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.58 Aligned_cols=255 Identities=17% Similarity=0.244 Sum_probs=205.3
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
..++|.+.+.||+|+||+||+|... +|+.||+|++...... .....+.+|+.+++.++||||+++++++.++...++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999976 7899999999765432 2345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEEEeccccce
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 440 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~ 440 (613)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999997654 389999999999999999999999 999999999999998 56789999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... . ......... ....
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~---~~~~~~i~~-~~~~ 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----Q---HRLYQQIKA-GAYD 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHHHHHH-TCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----H---HHHHHHHHh-CCCC
Confidence 7654322 2334569999999999999999999999999999999999999995221 1 111111111 1110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 232 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 001111223578899999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.74 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=204.2
Q ss_pred HhhCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--C
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--T 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 358 (613)
..++|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 346788999999999999999984 268899999987543 33445789999999999999999999998653 5
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 68999999999999999976532 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC--ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc------C-CCcchHHHH
Q 007200 439 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------N-DDDVMLLDW 509 (613)
Q Consensus 439 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~------~-~~~~~~~~~ 509 (613)
++....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+...... . .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987653322 1222344777899999999999999999999999999999999998633210 0 001111111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+....... .....+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 241 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 241 LIELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11111111 1111122334679999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.01 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=203.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++..++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367889999999999999999976 68899999987543 223456788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. .
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~-~- 237 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFETTV-V- 237 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHHHCC-C-
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhhcc-c-
Confidence 33 22345669999999999974 4589999999999999999999999963221 11112111111110 0
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 562 (613)
..+......+.+++..||+.||++||+ +.++++
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011223457899999999999999998 666654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.28 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=205.4
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC-ceEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLV 363 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 363 (613)
+..++|.+.+.||+|+||.||+|.+. |+.||||+++... ....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 44567888999999999999999986 7899999997653 3457899999999999999999999987765 78999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+|+|.++++..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999987543 2378999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+ .....
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i---~~~~~---- 404 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRV---EKGYK---- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHHH---HTTCC----
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH---HcCCC----
Confidence 221 12247889999999999999999999999999999998 9999963221 1111111 11111
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+..++..+.+++..||+.||++|||+.++++.|+.
T Consensus 405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11122334678999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=370.52 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=204.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|.+.+.||+|+||.||+|.+.++..||||+++.... ....+.+|+.++++++||||+++++++.+ ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 44567888899999999999999998778899999976442 35679999999999999999999999876 6789999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999975321 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
..........++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~----- 399 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYR----- 399 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC-----
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC-----
Confidence 33223334457889999999999999999999999999999999 999995221 1111212111111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 400 -----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 400 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=340.48 Aligned_cols=263 Identities=20% Similarity=0.288 Sum_probs=201.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999986 68999999997654332 34578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 5555554432 2499999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc---ccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LEQ 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 521 (613)
.. ......||+.|+|||.+.+.. ++.++|||||||++|||++|..||.... ........+........ ...
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhh
Confidence 22 233455899999999998766 7999999999999999999988863211 11111121111111100 000
Q ss_pred ccc------------CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVD------------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ..............+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00000111233467889999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.60 Aligned_cols=265 Identities=19% Similarity=0.266 Sum_probs=210.9
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
.+.++....++|++.+.||+|+||+||+|++. +++.||+|+++..... .....+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667789999999999999999999987 5789999999753211 11224788999999999999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
++...++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997642 2499999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHH
Confidence 9999877654444445567999999999997 4568999999999999999999999996321 11111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 563 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 563 (613)
........... -+... ......+.+++.+|+..+|++ ||+++|+++.
T Consensus 291 ~~i~~~~~~~~--~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 291 GKIMNHKERFQ--FPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHTHHHHCC--CCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Hhhhhcccccc--CCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 12211110000 01000 112356888999999888888 9999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.50 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=201.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccH------HHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
.++|+..+.||+|+||+||+|++. +++.||+|++......... ..+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888999999999999999975 7899999998754433221 56889999999999999999999986554
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCc-----EE
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 432 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~k 432 (613)
++||||+++|+|.+++.... .++++..+..++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886543 2499999999999999999999999 8 999999999999988776 99
Q ss_pred EeccccceecCCCCCceeeccccccccccccccc--cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
|+|||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||..... ......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFI 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHH
Confidence 999999974332 234456999999999984 45578899999999999999999999963221 111111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........ ....+......+.+++..||+.||++|||+.|+++.|+.
T Consensus 240 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEGL---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccCC---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111111 111122234678999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.79 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=209.4
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+++..++|.+.+.||+|+||.||+|...++..||+|.++.... ....+.+|+++++.++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445578899999999999999999988888999999975432 3567899999999999999999999876 456899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999999999975321 1389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~~--- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYR--- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcccC---
Confidence 5443333334457789999999998889999999999999999999 999995221 1111111111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .+......+.+++..|++.||++|||+.++++.|++
T Consensus 229 ---~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ---MV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 00 111223578999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=342.01 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=204.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||+||+|+.. +|+.||+|+++.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367888999999999999999976 799999999975431 22355678899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998643 389999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~----- 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAEL----- 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCC-----
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----
Confidence 32 234569999999999999999999999999999999999999995321 1122222222110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. .+......+.+++.+|+..||++|| +++++++
T Consensus 221 --~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --C----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 1112235788999999999999999 8888875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.70 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=209.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..++|...+.||+|+||.||+|.+.+++.||+|++..... ....+.+|+++++.++||||+++++++.++...++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3467888999999999999999998888999999976543 34678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999976532 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .............
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~------ 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR------ 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCc------
Confidence 2222233447788999999998999999999999999999999 899996321 1122222111111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 224 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 224 LY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 011123578899999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.78 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=207.3
Q ss_pred CCCCCccccCcCcEEEEEEeC-----CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEE
Q 007200 290 FSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 362 (613)
|.+.+.||+|+||+||++.+. +++.||||+++..........+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988643 57889999998765555566799999999999999999999999874 66799
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 89999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc------CCCcchHHHHHHHHh
Q 007200 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------NDDDVMLLDWVKGLL 514 (613)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~ 514 (613)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 261 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT--- 261 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH---
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH---
Confidence 544322 223345788899999999999999999999999999999999999643210 000000001111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+..........+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 262 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 262 ------ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111112223344679999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=351.64 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=211.2
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 355 (613)
+..++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999863 46789999998765555566789999999999 8999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
++...++||||+.+|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999765421 22489999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 501 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~ 501 (613)
+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 9999999999999999876543322 1223347789999999998889999999999999999999 999995321
Q ss_pred CcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+........... . .+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 265 ----~~~~~~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ----VEELFKLLKEGHRM------D----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHHTCCC------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCC------C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111110 0 1112335789999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=343.76 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=204.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
..++|.+.+.||+|+||+||+|.+.. +..||+|.+...........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678899999999999999998642 335999999876555556789999999999999999999999764 5678
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999976532 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~~---~~~~- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLEK---GDRL- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHHH---TCCC-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHhc---CCCC-
Confidence 65443333344457889999999999999999999999999999998 999995322 1111211111 1100
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. .+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 234 -----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 -----P----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 1111235689999999999999999999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.46 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=205.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.++...++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999976 689999999975543 23345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEeccccce
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 440 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~ 440 (613)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999887543 489999999999999999999999 99999999999999865 459999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... . ......... ....
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~---~~~~~~i~~-~~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----Q---HRLYAQIKA-GAYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHH-TCCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHHh-CCCC
Confidence 665322 2234569999999999999899999999999999999999999995221 1 111111111 1100
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000111224578899999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.41 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=194.2
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeCC-CC---EEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GS---LVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
.+..++|.+.+.||+|+||+||+|.+.. +. .||||+++... .......+.+|+++++.++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3455789999999999999999999763 32 79999997653 2234567899999999999999999999998776
Q ss_pred ce------EEEEecccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 359 ER------LLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 359 ~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
.. ++||||+.+|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 99999999999999986543 2223589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHH
Q 007200 431 AVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 508 (613)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIYN 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHHH
Confidence 999999999866433221 2223446789999999999999999999999999999999 999996322 111111
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. ....... .........+.+++.+||+.||++|||+.++++.|+++
T Consensus 251 ~---~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 251 Y---LIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H---HHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1111110 11122335789999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.06 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce---
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 360 (613)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... .....+.+|+.++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467999999999999999999975 7889999999765432 2245688999999999999999999998765443
Q ss_pred -EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 361 -LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 361 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
++||||+++++|.++++..+ ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997654 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 440 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 440 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC
Confidence 86653322 12233558999999999999999999999999999999999999995322 111111211111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... . .......+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~---~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPPSA---R----HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCHHH---H----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCccc---c----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 111000 0 0112357889999999999999998877765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=350.17 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=201.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||+||+|.+. +++.||||++...... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999999999999975 7899999998654211 22346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+ +|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999887654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. ......||+.|+|||.+.+..+ ++++|||||||++|+|++|+.||+....... ...+.
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~i~ 221 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKKVN 221 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCCCC
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHHH
Confidence 32 2234569999999999988776 7899999999999999999999963321100 00110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ...+......+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 0112223456889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=337.82 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=201.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|... ++..+|+|++...........+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367889999999999999999976 6889999999877666567789999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEeccccceec
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~ 442 (613)
|+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865432234599999999999999999999999 99999999999999 45678999999999765
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.... .................
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPNYAV 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCccccc
Confidence 4322 233455899999999875 568899999999999999999999996322 11111111111100000
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. . ......+.+++.+||+.||++|||+.|+++
T Consensus 247 -~---~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -E---C----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -c---c----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 012356889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.01 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=216.2
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceee
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 351 (613)
+...++++..++|.+.+.||+|+||.||+|.+. +++.||||.+...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556677789999999999999999999864 36789999998665555556789999999999999999999
Q ss_pred EEEEcCCceEEEEecccCCcchhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 007200 352 GFCMTPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (613)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 425 (613)
+++.++...++||||+.+|+|.++++... ....++++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987532 1123479999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCc
Q 007200 426 DEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 503 (613)
Q Consensus 426 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~ 503 (613)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 999999999999998654322211 122346889999999999999999999999999999999 899985321
Q ss_pred chHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+......... .. .........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 246 --~~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 --NEQVLRFVMEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HHHHHHHHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 111111111111 10 01112345789999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.48 Aligned_cols=270 Identities=27% Similarity=0.411 Sum_probs=216.0
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEe------CCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCcccee
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 350 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 350 (613)
+...++....++|.+.+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566777788999999999999999999984 246789999998765555556789999999999 69999999
Q ss_pred eEEEEcCC-ceEEEEecccCCcchhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007200 351 RGFCMTPT-ERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (613)
Q Consensus 351 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (613)
++++..++ ..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 489999999999999999765432 22388999999999999999999999 999999
Q ss_pred CCCCceeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCccc
Q 007200 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (613)
Q Consensus 418 lk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~ 495 (613)
|||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654332 22334557889999999999999999999999999999998 9999963
Q ss_pred ccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 496 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
... ...... ........ .. +......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 254 ~~~----~~~~~~----~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKI----DEEFCR----RLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCC----SHHHHH----HHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cch----hHHHHH----HhccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221 111111 11111100 01 111235689999999999999999999999999853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=344.48 Aligned_cols=259 Identities=17% Similarity=0.193 Sum_probs=206.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||+||+|... +|+.||||++...... ..+..|+.+++.+ +||||+++++++..+...++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 467889999999999999999975 7899999998754322 3578999999999 8999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----EEEeccccc
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 439 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfGla 439 (613)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999998642 2499999999999999999999999 9999999999999999887 999999999
Q ss_pred eecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 440 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 440 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i 232 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKI 232 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHH
Confidence 876443221 1234569999999999999999999999999999999999999996332 11111111111
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
........ . ..... ..+ .+.+++..||+.||.+||++.+|++.|++.
T Consensus 233 ~~~~~~~~-~-~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 233 GDTKRATP-I-EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHSC-H-HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhhhccCC-H-HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 11100000 0 00000 012 789999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.69 Aligned_cols=266 Identities=17% Similarity=0.198 Sum_probs=202.0
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC------CCEEEEEEeccccCccc----------HHHHHHHHHHHhhcccCccce
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVHRNLLR 349 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~ 349 (613)
..++|.+.+.||+|+||+||+|.+.. ++.||||++........ ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34679999999999999999999764 47899999865432100 012334556677788999999
Q ss_pred eeEEEEcC----CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 007200 350 LRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (613)
Q Consensus 350 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 425 (613)
+++++... ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4479999999 999999997643 2499999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeccccceecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 007200 426 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (613)
Q Consensus 426 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~ 497 (613)
+ .++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876533211 1133459999999999999999999999999999999999999997321
Q ss_pred ccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.............. ..+..+.++.... ...+..+.+++..||+.||++||++.+|++.|++
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 ----KDPKYVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ----TCHHHHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----cCHHHHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11122222221111 1122222221111 1123578999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=360.78 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=208.9
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
.+++.....++|++.+.||+|+||+||+|+.. +|+.||+|++++... ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566667789999999999999999999986 799999999975321 112234788999999999999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
++...++||||+++|+|.+++...+. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999986532 389999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccc-------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
||+++..............||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAE 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHH
Confidence 9999877654433344567999999999997 3568999999999999999999999996321 111
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---PKMSEVVR 562 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~ 562 (613)
........... ...+.. .......+.+++.+||. +|++| |+++|+++
T Consensus 278 ~~~~i~~~~~~--~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEH--LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccC--cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11122111100 000100 11223578999999999 99998 58888876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=340.42 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=204.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC--CceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 363 (613)
.++|...+.||+|+||.||+|++. ++.||||+++.... ......+.+|+.+++.++||||+++++++.++ ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999986 88999999976542 23345789999999999999999999999887 778999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEEecccccee
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
|||+++|+|.++++.... .++++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 2489999999999999999999998 7 99999999999999999999999998764
Q ss_pred cCCCCCceeeccccccccccccccccCCCCC---cccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.... .............
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGL 228 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCC
Confidence 322 2235899999999998766544 7999999999999999999996221 1111111111111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.+. .+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 229 -----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 -----RPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111 1122345789999999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.69 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred hhCCCCCC-ccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 8999999999999864 57789999998765555566799999999999999999999999 4567899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997533 3489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~---~i~~~~~- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMA---FIEQGKR- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHH---HHHTTCC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HHHHHH---HHhcCCc-
Confidence 5433222 222346889999999998889999999999999999998 999996321 111111 1111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+......+.+++..||+.||++||++.++++.|+.
T Consensus 232 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01112234678999999999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=344.97 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=204.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|...+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 68999999996543 1223557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC-C-----
Confidence 2 234569999999999999999999999999999999999999996321 112222222111 1
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
. .+......+.+++.+||+.||++||+ ++|+++
T Consensus 256 -~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -C----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 11122357899999999999999998 777765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.22 Aligned_cols=265 Identities=26% Similarity=0.382 Sum_probs=207.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC--Cc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 359 (613)
.+.|+..+.||+|+||.||+|++ .+++.||+|+++..........+.+|+.+++.++||||+++++++..+ ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688889999999999999983 368899999998766555667899999999999999999999999876 66
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999966432 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccc------cCCCcchHHHHHH
Q 007200 440 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------ANDDDVMLLDWVK 511 (613)
Q Consensus 440 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~------~~~~~~~~~~~~~ 511 (613)
+........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 877544322 22344588889999999999999999999999999999999999753210 0011111111111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...... .....+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 254 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111111 1111122334678999999999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=353.58 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=203.5
Q ss_pred hhCCCCCCccccC--cCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|++.+.||+| +||+||+|++. +|+.||||++...... .....+.+|+.+++.++||||+++++++.++...++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999987 7999999999765433 234568889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999976532 2389999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCC------ceeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 443 DYKDT------HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 443 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~ 254 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKLNGTV 254 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST----THHHHC-----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCC
Confidence 32111 11122358899999999987 57899999999999999999999999632211 01111000000
Q ss_pred hc---------cc-------------ccccccC---------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 515 KE---------KK-------------LEQLVDS---------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 515 ~~---------~~-------------~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. .. ....... .............+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00 0000000 00001122234678999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=349.77 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=200.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+...........+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367889999999999999999975 444 358888766555556778999999999999999999999998754 88
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++++|+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999986543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 442 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 442 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~----~~~- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE----KGE- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH----cCC-
Confidence 6433221 2223446789999999999999999999999999999999 999996322 111111111 110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
....+......+.+++..||+.||++|||+.|+++.|+..
T Consensus 237 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 --------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111122335689999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.91 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=203.3
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 359 (613)
....++|.+.+.||+|+||+||+|+.+ +|+.||+|+++.... ......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999986 688999999976431 22345677889988876 89999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998654 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDN-- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC--
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 8543222 22345679999999999999999999999999999999999999996321 111111111111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 561 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 561 (613)
... +......+.+++.+||..||++||++. +++
T Consensus 235 -----~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011 112235788999999999999999997 554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.94 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=195.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|.+.+.||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.++...++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888999999999999999987 78999999997554332222455799999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+. |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 589888876532 489999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc---cccc
Q 007200 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LEQL 522 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 522 (613)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+........ +...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 2 2233458999999999876 568999999999999999999999996322 1112222222111110 0000
Q ss_pred ccC---------ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDS---------DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~---------~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ...... .......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 000000 0112356889999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=350.55 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=205.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 367999999999999999999976 688999999875432 234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~ 443 (613)
|+.+|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999987543 2489999999999999999999999 9999999999999974 4689999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .+.+......... .
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~---~~~~~~i~~~~~~---~ 269 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----D---LETLQNVKRCDWE---F 269 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHHHHHHHHCCCC---C
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCCCC---C
Confidence 4322 233469999999999999999999999999999999999999996321 1 1112221111100 1
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... ........+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Ccc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111 111234578899999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=353.90 Aligned_cols=271 Identities=19% Similarity=0.230 Sum_probs=215.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC--ceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 363 (613)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357889999999999999999987 589999999987655555677889999999999999999999998765 67999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEeccccc
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGla 439 (613)
|||+++|+|.++++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999765322 2389999999999999999999999 99999999999999 77788999999999
Q ss_pred eecCCCCCceeecccccccccccccccc--------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.+.
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~~~~~ 237 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMY 237 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----HHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----HHHHH
Confidence 8765332 2234569999999999865 56788999999999999999999999643321111 22222
Q ss_pred HHhhcccc---cccc-----------cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 512 GLLKEKKL---EQLV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 512 ~~~~~~~~---~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
........ ..+. +..............+.+++..||+.||++|||+.|+++.++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22222111 1000 00111234467788899999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.37 Aligned_cols=259 Identities=15% Similarity=0.195 Sum_probs=206.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... ..+.+|+.++..+ .|+|++++++++.++...++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 467999999999999999999974 7899999998654322 3477899999998 7999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----EEEeccccc
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 439 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfGla 439 (613)
||+ +++|.+++..... ++++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 9999999986532 489999999999999999999999 9999999999999987776 999999999
Q ss_pred eecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 440 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 440 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA--ATNKQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS--CCHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc--cccHHHHHHHHhh
Confidence 876543221 23445699999999999999999999999999999999999999964221 1111111111111
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.......... ...+..+.+++..||+.||++|||+.+|++.|+.
T Consensus 237 ~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 237 KQSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccCccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 1111111100 0123578999999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.46 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=194.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 362 (613)
..++|+..++||+|+||+||+|.+. +|+.||||++...... .....+..|+..+..+ .||||+++++++.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999987 7999999998654322 2333455566655555 89999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+ +++|.+++..... ++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 7789988876542 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . .... ......
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~-~~~~-~~~~~~-- 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------G-WQQL-RQGYLP-- 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------H-HHHH-TTTCCC--
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------H-HHHH-hccCCC--
Confidence 4322 2334559999999999875 78999999999999999999977664211 0 0111 111100
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+. ........+.+++.+||+.||++|||+.|+++
T Consensus 271 --~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 --PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 01112367899999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.06 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=201.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC-----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.++|...+.||+|+||+||+|.+.. +..||||.++..........+.+|+.+++.++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998652 23599999986655555667899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999976432 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 442 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 442 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCc
Confidence 6533221 1222336788999999999999999999999999999999 999995221 1111111111111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. .........+.+++.+||+.||++||++.++++.|+..
T Consensus 269 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 L----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 01112345789999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=335.67 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=205.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999986 7899999999765554456778999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999986542 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-ceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 446 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 446 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... .......+.. .... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----~~~~---~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----KKTY---L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHHHT----TCTT---S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHhhh----cccc---c
Confidence 21 12234568999999999987765 7889999999999999999999963321 1111111111 1000 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122356889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.35 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=199.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|.+. +++.||+|++....... ....+.+|+.++..++||||+++++++..+...++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999976 68899999997653322 235788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.+++.... ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 389999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+..........
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~--- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAIPR--- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCCCC---
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCCCC---
Confidence 4333333445689999999999999999999999999999999999999963221 1111111111100
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcCC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGDG 568 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 568 (613)
. ..........+.+++.+||+.||++|| +++++++.|+..-
T Consensus 254 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 -P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0 001112234688999999999999999 9999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.40 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=194.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEe----CCCCEEEEEEeccccC---cccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
.++|++.+.||+|+||.||+++. .+|+.||+|+++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 4789999999976532 1233457889999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997654 388999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....... .
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-~ 238 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK-L 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-C
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-C
Confidence 7543222 22344569999999999999999999999999999999999999996321 111122222111 0
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. .+......+.+++.+||+.||++|| ++.|+++
T Consensus 239 ------~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 1112235788999999999999999 6777766
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.08 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=183.2
Q ss_pred cccccCHHHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-----cCcc
Q 007200 274 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HRNL 347 (613)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni 347 (613)
....+++.+.....++|.+.+.||+|+||+||+|++. +++.||||+++.. ......+..|+.++..+. ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3456677777788899999999999999999999985 6899999999743 223456778999998886 9999
Q ss_pred ceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 007200 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (613)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 427 (613)
+++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 99999999865432 489999999999999999999999 9999999999999975
Q ss_pred -------------------------CCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHH
Q 007200 428 -------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482 (613)
Q Consensus 428 -------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~i 482 (613)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999
Q ss_pred HHHHHhCCCCcc
Q 007200 483 LLELITGQRAFD 494 (613)
Q Consensus 483 l~elltg~~p~~ 494 (613)
+|||++|+.||.
T Consensus 249 l~ell~g~~pf~ 260 (360)
T 3llt_A 249 LAELYTGSLLFR 260 (360)
T ss_dssp HHHHHHSSCSCC
T ss_pred HHHHHHCCCCCC
Confidence 999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.68 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=195.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+++.. +++.||||++...... ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467999999999999999999987 7899999999754332 3468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--EEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~~~~ 443 (613)
|+.+|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997654 389999999999999999999999 9999999999999987765 9999999997433
Q ss_pred CCCCceeeccccccccccccccccCCCCCc-ccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.. .......||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||..... .......+.........
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~--- 240 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVKYS--- 240 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCC---
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCCCC---
Confidence 22 12234469999999999988877655 8999999999999999999963321 11122222222211110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ------IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000123568899999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.74 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=197.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhccc--CccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 363 (613)
.++|++.+.||+|+||.||++...+++.||||++..... ......+.+|+.++..+.| +||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 467889999999999999999998899999999875433 2234578899999999986 9999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|| +.+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999998753 389999999999999999999999 999999999999997 5689999999998765
Q ss_pred CCCCc-eeecccccccccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 444 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 444 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHHH
Confidence 43222 2334569999999999865 678899999999999999999999995211 1111122
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
...... .....+......+.+++..||+.||++|||+.|+++.
T Consensus 232 ~~~~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 221111 1111111123568899999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.61 Aligned_cols=261 Identities=21% Similarity=0.217 Sum_probs=202.6
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc----CcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
....++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 455678999999999999999999976 68899999987542 2334567899999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQS------------------------------------QPPLNWSVRKQIALGAARGL 402 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~L 402 (613)
..++||||+++|+|.+++...... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998531110 11246778899999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeecCCC--cEEEeccccceecCCCCC---ceeecccccccccccccccc--CCCCCccc
Q 007200 403 AYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLST--GKSSEKTD 475 (613)
Q Consensus 403 ~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 475 (613)
+|||++ +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999987643221 12344569999999999975 67899999
Q ss_pred chhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 007200 476 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 555 (613)
Q Consensus 476 VwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 555 (613)
||||||++|||++|+.||.... ..+.+........... . .........+.+++..||+.||++||
T Consensus 259 iwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCFE--N-----PNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCTT--S-----GGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcccccC--C-----cccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999995322 1122222222111100 0 01112235788999999999999999
Q ss_pred CHHHHHH
Q 007200 556 KMSEVVR 562 (613)
Q Consensus 556 t~~evl~ 562 (613)
|+.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=342.87 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=181.0
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecccCC
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
.+.||+|+||+||+|.+. +|+.||||++... ....+.+|+.++..+. ||||+++++++.++...++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 378999999999999986 6899999998643 3456788999999997 999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEeccccceecCCCCC
Q 007200 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~~~~~~~ 447 (613)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999998653 489999999999999999999999 999999999999998765 899999999986654322
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCcc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (613)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......+....... .... .
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~-~~~~------~ 235 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKK-GDFS------F 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTT-TCCC------C
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHc-CCCC------C
Confidence 2334558999999999999999999999999999999999999996432111 11111222222111 1100 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 528 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...........+.+++..||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00011223467899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=376.59 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=210.9
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
.+++..++|.+.+.||+|+||.||+|.+.++..||||+++.... ....|.+|+++++.++|+||+++++++.+ ...+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34456678889999999999999999998778899999976542 35679999999999999999999999876 6789
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+.+|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999999975321 2389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+.+........+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~- 483 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRM- 483 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHHTTCCC-
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC-
Confidence 54322112223346789999999999999999999999999999999 999995221 11112121111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+..+...+.++|.+||+.||++|||+.+|++.|+..
T Consensus 484 ---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 484 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11123346789999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=357.41 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=195.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|++.+.||+|+||.||+|... +|+.||||+++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999976 68999999997542 222344678899999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999997654 38999999999999999999998 7 9999999999999999999999999999754
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~--- 366 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEE-I--- 366 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C---
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCC-C---
Confidence 3222 22344669999999999999999999999999999999999999995321 111111111111 0
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. .+......+.+++..||+.||++|| +++|+++
T Consensus 367 ---~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ---R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 1112235788999999999999999 9999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=340.42 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=199.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc----ccHHHHHHHHHHHhhcc---cCccceeeEEEEc
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV---HRNLLRLRGFCMT 356 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 356 (613)
...++|++.+.||+|+||+||+|++. +|+.||||++...... .....+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45678999999999999999999975 7899999998744321 12345667877777665 9999999999987
Q ss_pred CC-----ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 007200 357 PT-----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (613)
Q Consensus 357 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 431 (613)
.. ..+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 4789999997 599999976543 2389999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 999999998654322 2344568999999999999999999999999999999999999995321 111222222
Q ss_pred HHhhcccccccc------cCccC--CC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 GLLKEKKLEQLV------DSDME--GN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 ~~~~~~~~~~~~------~~~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
............ ..... .. ...+....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111000000 00000 00 00122367889999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.97 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=189.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
..++|++.+.||+|+||+||+|++. +++.||||+++... ....+.+|+.++++++||||+++++++.++...++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3467999999999999999999987 58899999997543 2346788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGla~~ 441 (613)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999987643 389999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .. ............ .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~---~~~~~~i~~~~~-~- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GD---QFMFRRILNCEY-Y- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CH---HHHHHHHHTTCC-C-
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----cc---HHHHHHHHhCCC-c-
Confidence 5432 12234568999999999999999999999999999999999999995221 11 011111111110 0
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 F-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001112234578899999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.08 Aligned_cols=254 Identities=32% Similarity=0.479 Sum_probs=193.4
Q ss_pred CCCCCCccccCcCcEEEEEEeC--CC--CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc-CCceEEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 363 (613)
.|...+.||+|+||+||+|.+. ++ ..||||.++..........+.+|+.++++++||||+++++++.+ +...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566788999999999999864 22 36899998765555556789999999999999999999998765 4578999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++|+|.++++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999976432 488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 444 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 444 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
..... ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||.... .......+. .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~~---~~~~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL---QGRRL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHHH---TTCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHHH---cCCCC
Confidence 32211 1233447789999999999999999999999999999999 677775221 111111111 11110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. .+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 316 ---~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 316 ---L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp ---C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 011233578999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.29 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=203.0
Q ss_pred HHhhCCCCCC-ccccCcCcEEEEEEeC---CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 285 VATDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 285 ~~~~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
+..++|.+.+ .||+|+||+||+|.+. +++.||||+++...... ....+.+|+.+++.++||||+++++++ ....
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456777777 9999999999999643 46789999997654322 256789999999999999999999999 5677
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 899999999999999998643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcee--eccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 440 KLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 440 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
........... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... . .+ +......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~---~~-~~~~~~~ 235 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----G---SE-VTAMLEK 235 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H---HH-HHHHHHT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HH-HHHHHHc
Confidence 87754433222 22336788999999998889999999999999999999 999996321 1 11 1111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
... . ..+......+.+++..||+.||++|||+.++++.|+.
T Consensus 236 ~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 236 GER-----M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TCC-----C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 110 0 1112234678999999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.30 Aligned_cols=261 Identities=21% Similarity=0.343 Sum_probs=198.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357889999999999999999975 78999999997532 223345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976433344589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........... ......
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~-- 257 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-QCDYPP-- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHH-TTCSCC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhh-cccCCC--
Confidence 3222 2233458999999999999999999999999999999999999995321 11112221111 111111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .......+.+++.+||+.||++|||+.++++.|+.
T Consensus 258 ---~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 258 ---LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp ---CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00 11223578999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.74 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=198.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|.+.+.||+|+||+||+|.+. +|+.||+|++....... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 58999999986654332 24568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh---------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 515 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 515 (613)
.. ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.... .......+.....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-----DVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhcccccccccc
Confidence 22 2234458999999999976 568999999999999999999999995322 1111111111110
Q ss_pred ---cccccccccCccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 ---EKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ---~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+....... ......+.+++..||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000000 123456889999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.65 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=197.0
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+..++|.+.+.||+|+||+||+|++. ..||+|+++.... ......+.+|+.+++.++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34578999999999999999999865 3599999976543 23345789999999999999999999965 55678999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999996543 2489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-Cceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 444 YKD-THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 444 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||.... .. ..+.........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~----~~~~~~~~~~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NR----DQIIEMVGRGSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CH----HHHHHHHHHTSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hH----HHHHHHhccccc
Confidence 322 22233456899999999986 5678889999999999999999999996321 11 111222222111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
..... ......+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 244 ~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11100 111223467999999999999999999999999998653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=374.11 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=200.7
Q ss_pred CCCCCC-ccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 289 NFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 289 ~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|+.+++.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999864 4567999999876555567789999999999999999999999976 5689999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999997543 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ...... .......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~~~---~i~~~~~--- 557 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMA---FIEQGKR--- 557 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SHHHHH---HHHTTCC---
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH---HHHcCCC---
Confidence 32211 122335689999999999999999999999999999998 999996321 111111 1111111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+..+...+.+++..||+.||++||++.+|++.|+.
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11122344679999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=346.40 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=203.4
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCce
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 360 (613)
...++|...+.||+|+||+||+|+.. +|+.||+|+++... .......+..|..++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44578999999999999999999987 57899999997543 123355678899999887 799999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998654 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~- 238 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-V- 238 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC-C-
Confidence 54322 222345669999999999999999999999999999999999999996321 112222222111 0
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
. .+......+.+++..||..||++||+ +.++++
T Consensus 239 -----~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -----A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 11123457889999999999999996 466654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=340.02 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=206.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.++...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999975 68999999997665555667899999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++++|.+++... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998642 389999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... .. .+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~-----~~~ 238 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPK-NN-----PPT 238 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-SC-----CCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhc-CC-----CCC
Confidence 2 2234568999999999999999999999999999999999999995321 1111111111 11 011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... .....+.+++..||+.||++|||+.++++.
T Consensus 239 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Ccc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 123568999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.35 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=201.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|.+.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999999999999976 577999999865432 1234568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997654 389999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~----- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC-----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCC-----
Confidence 322 2234568999999999999999999999999999999999999996321 111111111110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .+......+.+++.+||+.||++|||+.|+++
T Consensus 224 --~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 --FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --CC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 11112356889999999999999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.29 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=191.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcc-cCccceeeEEEEcCC--c
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--E 359 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 359 (613)
...++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++..+. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999976 789999999865432 233456788999999997 999999999997544 6
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++|||||. ++|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 5899888763 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC--------------------Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007200 440 KLMDYKD--------------------THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (613)
Q Consensus 440 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~ 498 (613)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~- 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS- 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 8654211 112234569999999999986 678999999999999999999999995321
Q ss_pred cCCCcchHHHHHHHHhhccccccc---c------------------cCccCCCC------------cHHHHHHHHHHHHH
Q 007200 499 ANDDDVMLLDWVKGLLKEKKLEQL---V------------------DSDMEGNY------------IEEEVEQLIQVALL 545 (613)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~---~------------------~~~~~~~~------------~~~~~~~l~~li~~ 545 (613)
.......+...........+ . .......+ .......+.+++.+
T Consensus 236 ----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 236 ----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp ----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred ----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 11111111111110000000 0 00000000 00123568899999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 007200 546 CTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 546 cl~~dP~~RPt~~evl~~ 563 (613)
||+.||++|||++|+++.
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=346.80 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=203.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEE--EEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLV--AVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 362 (613)
.++|...+.||+|+||.||+|++. ++..+ |+|.++..........+.+|++++.++ +||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367888999999999999999976 56644 999987654444556789999999999 89999999999999999999
Q ss_pred EEecccCCcchhhhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 363 VYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
||||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997653 2234589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 509 (613)
+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 250 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHH
Confidence 9999999997432211 1223346889999999998889999999999999999998 999995322 1111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......... . .........+.+++.+||+.||++|||+.++++.|+.
T Consensus 251 ~~~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 251 YEKLPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHHGGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcCCC------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111100 0 1111233578999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.42 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=203.0
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhh--cccCccceeeEEEEcC
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP 357 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~ 357 (613)
........++|.+.+.||+|+||.||+|++. |+.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3444556688999999999999999999986 8999999985432 3344555555554 4899999999999877
Q ss_pred ----CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCC
Q 007200 358 ----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 358 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~ 428 (613)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+++ .++|+||||||+||+++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 6789999999999999999764 3899999999999999999999762 3389999999999999999
Q ss_pred CcEEEeccccceecCCCCCce---eeccccccccccccccccCCCCCc------ccchhHHHHHHHHHhC----------
Q 007200 429 FEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGVMLLELITG---------- 489 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DVwS~G~il~elltg---------- 489 (613)
+.+||+|||+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998664332221 124469999999999988776665 9999999999999999
Q ss_pred CCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 490 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 490 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
+.||....... .....+......... .+.... .....+...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 259 ~~p~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 259 QLPYHDLVPSD----PSYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCTTTTTSCSS----CCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccHhhhcCCC----CchhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 55553221111 111112222211111 111111 1123667889999999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.67 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CC---CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce-EEE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 363 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 363 (613)
.|...+.||+|+||+||+|.+. ++ ..+|+|.+...........+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555688999999999999854 22 379999998665555566789999999999999999999999876655 999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 3489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC---CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 444 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 444 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
... ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+... .........+.. ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~----~~~~~~~~~~~~---~~~-- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH----IDPFDLTHFLAQ---GRR-- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCGGGHHHHHHT---TCC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc----CCHHHHHHHhhc---CCC--
Confidence 322 11223345788999999999999999999999999999999966554311 111112221111 110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+......+.+++..||+.||++|||+.++++.|+.
T Consensus 247 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 --------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00111223578999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=353.43 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=198.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcc--cCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||+||+|...+++.||||++..... ......+.+|+.++..+. ||||+++++++..+...++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356999999999999999999988899999999875432 333467899999999996 59999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|| +.+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 67889999998654 388999999999999999999999 999999999999996 5799999999998765
Q ss_pred CCCCc-eeecccccccccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 444 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 444 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 33221 2344569999999999865 368899999999999999999999995211 1112222
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....... ....+......+.+++..||+.||++|||+.|+++.
T Consensus 279 ~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2221111 111111113568899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.27 Aligned_cols=264 Identities=27% Similarity=0.344 Sum_probs=205.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE----cCCc
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTE 359 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~ 359 (613)
+..++|.+.+.||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34578999999999999999999974 78999999986532 334567889999999999999999999987 3357
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+.+|+|.+++........++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 7999999999999999987543445699999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCc--------eeeccccccccccccccccCC---CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 440 KLMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 440 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
......... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhH
Confidence 765321110 012234799999999987654 688999999999999999999999632211110 111
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
.+ ... ............+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 259 ~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AV----QNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH----HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hh----hcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 000 000011122357899999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=330.64 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=204.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999976 689999999976543 233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGla~~ 441 (613)
||+.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887653 389999999999999999999999 9999999999999986655 99999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... . ......... ....
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~---~~~~~~~~~-~~~~- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----Q---HRLYAQIKA-GAYD- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHH-TCCC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----h---hHHHHHHHh-cccc-
Confidence 65332 2234568999999999999999999999999999999999999995221 1 111111111 1110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 001122356889999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=345.05 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=200.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 363 (613)
..++|++.+.||+|+||+||+|.+. +|+.||||++...... ..+|++++.++ +||||+++++++.++...++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999987 6889999999765432 34688888877 799999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CcEEEeccccc
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLA 439 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla 439 (613)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+..+ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999997643 389999999999999999999999 99999999999998543 35999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+....... ...
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~-~~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGS-GKF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHH-CCC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHcc-CCc
Confidence 87654332 2334568999999999988889999999999999999999999996321 1111222222211 111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ............+.+++.+||..||++|||+.++++
T Consensus 241 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 S------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 011111223467889999999999999999999886
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=342.00 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=205.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 362 (613)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367888999999999999999986 689999999975442 3345578999999999999999999998754 567899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceeecCCCcEEEeccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
||||+++++|.+++.........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544445599999999999999999999999 7 9999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... . .+.... +...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~-i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----Q---KELAGK-IREG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHH-HHHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----H---HHHHHH-Hhhc
Confidence 9976543221 1223458999999999999899999999999999999999999996321 1 111111 1111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
... .. +......+.+++.+||+.||++|||+.|+++.+.
T Consensus 232 ~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 232 KFR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ccc-----cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111 11 1123357899999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=347.83 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=199.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+.|...+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+++++.++||||+++++++.++...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999975 7899999999754332 22346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+. |+|.+++.... .++++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 67888776543 2489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
. ....||+.|+|||.+. +..++.++|||||||++|||++|+.||.... ....+........
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~--- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES--- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCC---
Confidence 2 2346999999999985 5678999999999999999999999995221 1122222222111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+... .......+.+++.+||+.||++|||+.++++.
T Consensus 271 ---~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 11223568899999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.54 Aligned_cols=267 Identities=18% Similarity=0.213 Sum_probs=199.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccCcc----------cHHHHHHHHHHHhhcccCccceeeE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNLLRLRG 352 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~ 352 (613)
.++|.+.+.||+|+||+||+|.+. ++..+|||++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999976 57789999987543221 1123567888899999999999999
Q ss_pred EEEc----CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 353 FCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 353 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67889999999 999999997654 489999999999999999999999 99999999999999988
Q ss_pred C--cEEEeccccceecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccC
Q 007200 429 F--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (613)
Q Consensus 429 ~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~ 500 (613)
+ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--- 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---
Confidence 7 9999999999876432211 1134469999999999999999999999999999999999999995221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 569 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 569 (613)
...................... .... .......+.+++..||+.||++|||+.+|++.|+...+
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 -KDPVAVQTAKTNLLDELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TCHHHHHHHHHHHHHTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHhhcccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111111111100000 0000 00123579999999999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.16 Aligned_cols=255 Identities=32% Similarity=0.464 Sum_probs=200.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE-cCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l 362 (613)
.+|...+.||+|+||+||+|.+.+ ...+|+|.+...........+.+|+.++++++||||+++++++. .+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998652 23589999987655555677999999999999999999999865 4567899
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC---ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 443 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 443 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.... .......+. ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~~~---~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL---QGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHHHHH---TTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh---cCCC
Confidence 43221 12233457889999999999999999999999999999999 555664221 111111111 1110
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. . .+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 251 ~------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 L------L----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp C------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 0 011123568999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.45 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-----cHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.++...... ....+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999986 68999999997543322 356789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEecc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 436 (613)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997643 489999999999999999999999 999999999999999888 7999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.+......
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765432 2234458999999999999999999999999999999999999995321 11111111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.. ...+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY---DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC---CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc---ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 01123568899999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.58 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=183.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999975 789999999965421 123457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++.... .++++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999997643 2489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .. ....
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~---------~~~~ 226 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LN---------KVVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HH---------HHhh
Confidence 3222 2334589999999999988999999999999999999999999963321100 00 0000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ..+......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 011122357889999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.21 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=202.2
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-------cHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
..++|.+.+.||+|+||+||+|.+. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999975 68899999997653211 223467899999999999999999999999
Q ss_pred CceEEEEecccCC-cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 358 TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 358 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
...++||||+.+| +|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999987643 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
|+++....... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654322 234569999999999988876 88999999999999999999999532100
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
....... + ......+.+++..||+.||++|||+.++++.
T Consensus 237 ---~~~~~~~--~----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIHP--P----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCCC--S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccCC--C----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0 1123568999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.10 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=204.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|.+.+.||+|+||.||+|++. +|+.||||++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999987 799999999975432 123457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997543 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+... . ........... .
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~---~~~~~~i~~~~-~---- 233 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----V---PTLFKKICDGI-F---- 233 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----S---HHHHHHHHTTC-C----
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----H---HHHHHHHhcCC-c----
Confidence 22 2334569999999999988765 689999999999999999999996321 1 11111111111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++..||+.||++|||+.|+++
T Consensus 234 --~~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YT----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CC----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00 1112356889999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.44 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=194.9
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccCCc
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999975 689999999976432 245678999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--cCCCcEEEeccccceecCCCCCce
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999886543 2389999999999999999999999 99999999999999 5678999999999987654322
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 529 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (613)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+......... ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~---~~~~--- 310 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRWD---LEDE--- 310 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---SCSG---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCC---CChh---
Confidence 233459999999999998889999999999999999999999996321 11222222221110 0000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 530 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 530 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........+.+++.+||+.||++|||+.|+++
T Consensus 311 -~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 -EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01122357899999999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.31 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=202.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+++++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467899999999999999999977 5779999998765433 45678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEeccccceec
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~ 442 (613)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999987654 389999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.... ..+.......... . .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-~-~ 226 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIREGTF-T-F 226 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-C-C
T ss_pred cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC-C-C
Confidence 5332 2234459999999999865 48999999999999999999999996322 1111111111110 0 0
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ........+.+++.+|++.||++|||+.++++
T Consensus 227 ~~~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEK-----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cch-----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00012357899999999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=345.12 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=201.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHH-HhhcccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
.++|+..+.||+|+||+||+|+.. +++.||+|+++..... .....+..|..+ ++.++||||+++++++.+....++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367889999999999999999987 6889999999765422 223345667666 567899999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997654 388999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~--- 256 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP-L--- 256 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSC-C---
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcc-c---
Confidence 322 223345679999999999999999999999999999999999999996322 112222222111 0
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCc--chhhHHHh
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL--AERWEEWQ 577 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~--~~~~~~~~ 577 (613)
.. .......+.+++.+||+.||++||++.+.++.+....+ .-+|+...
T Consensus 257 ---~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~ 306 (373)
T 2r5t_A 257 ---QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI 306 (373)
T ss_dssp ---CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred ---CC----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence 01 11123568899999999999999998765555544322 12355543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.31 Aligned_cols=265 Identities=27% Similarity=0.371 Sum_probs=209.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 359 (613)
.++|...+.||+|+||.||+|++ .+++.||||++.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 36788899999999999999984 368899999997543 3344568999999999999999999999874 466
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 8899999999999999976432 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc------CCCcchHHHHHH
Q 007200 440 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------NDDDVMLLDWVK 511 (613)
Q Consensus 440 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~------~~~~~~~~~~~~ 511 (613)
+........ ......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 877543322 122344788899999999999999999999999999999999999633210 000001111111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.... ..............+.+++..||+.||++|||+.|+++.|+..
T Consensus 255 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 255 ELLE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHhh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 1111112223446789999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=340.84 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=196.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
.++|++.+.||+|+||+||+|++. ++.||||.+... .....+.+|+.++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 357888899999999999999986 788999998643 23567899999999999999999999876 457999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-EEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DfGla~~~~~~ 445 (613)
+++|+|.++++.... ...+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999976532 224789999999999999999999932128999999999999998886 799999999755322
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (613)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ............. +
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~--~~~~~~~~~~~~~------~ 223 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG----GP--AFRIMWAVHNGTR------P 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC----SS--HHHHHHHHHTTCC------C
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC----cc--HHHHHHHHhcCCC------C
Confidence 223458999999999999999999999999999999999999996321 11 1111111111110 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 526 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. ........+.+++.+||+.||++|||+.++++.|+..
T Consensus 224 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 224 P----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp C----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 1112235688999999999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.83 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=206.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|...+.||+|+||.||+|+.. +|+.||+|++..... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999986 699999999975432 22345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987654455699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............... .
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~-~---- 410 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQA-V---- 410 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCC-C----
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcc-c----
Confidence 4322 23345799999999999999999999999999999999999999963321 111122222222111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 558 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 558 (613)
.++......+.+++..||+.||++||++.
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 01122345788999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.45 Aligned_cols=269 Identities=25% Similarity=0.351 Sum_probs=197.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHH--HhhcccCccceeeEEEEc-----CC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCMT-----PT 358 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~ 358 (613)
..++|.+.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 346788999999999999999987 58999999986432 2334444444 556899999999986542 23
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceeecCCCcEE
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------DPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
..++||||+++|+|.+++.... .++..+..++.||++||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 5689999999999999997643 588999999999999999999873 23899999999999999999999
Q ss_pred EeccccceecCCCC-------Cceeecccccccccccccccc-------CCCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007200 433 VGDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (613)
Q Consensus 433 l~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwS~G~il~elltg~~p~~~~~~ 498 (613)
|+|||+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765322 112224469999999999976 3566789999999999999999888753332
Q ss_pred cCCCcchHH---------HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 499 ANDDDVMLL---------DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 499 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......... ..+............+.. ...........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 211111111 111111111111110100 111223466789999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=343.93 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=205.1
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
..++|.+.+.||+|+||.||+|++. +++.||||.+...........+.+|+.+++.++||||+++++++.++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4578999999999999999999842 5778999999765555556678999999999999999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEE
Q 007200 360 RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 433 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl 433 (613)
.++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999865421 23489999999999999999999999 9999999999999994 456999
Q ss_pred eccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHH
Q 007200 434 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 434 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||+| |+.||.... . .....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~---~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N---QEVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H---HHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----H---HHHHH
Confidence 99999975533221 12233457889999999999999999999999999999998 999995221 1 11111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........ . ........+.+++..||+.||++|||+.++++.|+.
T Consensus 257 ~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 257 FVTSGGRM------D----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHTTCCC------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCCC------C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111110 0 111223578899999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=330.34 Aligned_cols=260 Identities=18% Similarity=0.231 Sum_probs=200.1
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEE-EcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 363 (613)
..++|.+.+.||+|+||+||+|.+. +++.||||++...... ..+..|+.++..+.|++++..++++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3578999999999999999999974 7889999987554322 2477899999999988877766665 567778999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEeccccce
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~ 440 (613)
|||+ +++|.+++..... ++++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 9999999975432 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 441 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 441 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 234 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhhhhhhhccc
Confidence 76543321 22345689999999999999999999999999999999999999964332111 11111111111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....... .. ...+..+.+++..||+.||++|||+.++++.|++
T Consensus 235 ~~~~~~~-~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 235 MSTPIEV-LC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHSCHHH-HT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ccchhhh-hh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0110000 00 0113578999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.85 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=190.8
Q ss_pred hCCCCC-CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHh-hcccCccceeeEEEEc----CCce
Q 007200 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMT----PTER 360 (613)
Q Consensus 288 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~ 360 (613)
++|... +.||+|+||+||+|.+. +|+.||||++... ..+.+|++++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456555 68999999999999976 6899999998632 34667888774 5589999999999875 5668
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEeccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 437 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG 437 (613)
++||||+.+|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999986432 3499999999999999999999999 9999999999999998 7899999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+. ..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~----~~ 282 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIR----MG 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHH----HT
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHH----cC
Confidence 998654322 22345689999999999999999999999999999999999999964321111111 111111 11
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
... ............+.+++..||+.||++|||+.|+++.
T Consensus 283 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100 0000111234578999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=342.80 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=199.1
Q ss_pred HHHHHHhhCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 281 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
.++.+..++|.+.+.||+|+||.||+|.+. ++..||+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344456678999999999999999999864 244899999875533 333456899999999999999999999998
Q ss_pred cCCc-----eEEEEecccCCcchhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 356 TPTE-----RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 356 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
+... .++||||+++|+|.+++.... .....+++..++.++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7543 499999999999999985432 2234599999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchH
Q 007200 429 FEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVML 506 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~ 506 (613)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEM 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHH
Confidence 9999999999986643321 11223447889999999999999999999999999999999 899985322 1111
Q ss_pred HHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
... ...... ...+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 259 ~~~---~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 259 YDY---LLHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHH---HHTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH---HHcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 111111 01112233578999999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.39 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=200.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CC-------CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DG-------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
.++|.+.+.||+|+||+||+|.+. ++ ..||+|++.... ......+.+|+.+++.++||||+++++++.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 467888999999999999999865 33 479999986543 234567899999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--------
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------- 430 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------- 430 (613)
..++||||+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999976432 389999999999999999999999 9999999999999998887
Q ss_pred EEEeccccceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 509 (613)
+||+|||++..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+.... . ....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----D---SQRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----C---HHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----c---hHHH
Confidence 99999999865432 123448899999999987 678999999999999999999655442111 1 1111
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
........... . .....+.+++..||+.||++|||+.++++.|+.+-
T Consensus 228 ~~~~~~~~~~~----~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 228 LQFYEDRHQLP----A--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHHHTTCCCC----C--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHHhhccCCCC----C--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111110 0 01235889999999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=335.98 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=199.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|++.+.||+|+||+||+|.+. +++.||+|+++.... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999987 799999999976533 23355788899999988 899999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---------------
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--------------- 428 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--------------- 428 (613)
|||+++++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976533234589999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeccccceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCc
Q 007200 429 ----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503 (613)
Q Consensus 429 ----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~ 503 (613)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765432 23489999999999776 56789999999999999999998764211
Q ss_pred chHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .. ..... +... ......+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~---~~-~~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --QWH---EI-RQGRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --HHH---HH-HTTCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHH---HH-HcCCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 11 11111 1111 122357899999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.00 Aligned_cols=261 Identities=22% Similarity=0.256 Sum_probs=196.4
Q ss_pred hCCCCC-CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+.|.+. +.||+|+||+||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+++..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 567774 78999999999999965 78999999997553 23456788999999884 7999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGla~~ 441 (613)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999997653 389999999999999999999999 9999999999999998776 99999999976
Q ss_pred cCCCCC------ceeecccccccccccccccc-----CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCc---c---
Q 007200 442 MDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD---V--- 504 (613)
Q Consensus 442 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~---~--- 504 (613)
...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 11223458999999999875 457899999999999999999999996432111000 0
Q ss_pred hHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 505 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.....+.......... .... ........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYE-FPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCC-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcc-cCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111111111100 0000 00112357899999999999999999999988
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.40 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=206.8
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++..++||||+++++++.+....++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999986 79999999997542 12235568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+++|+|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976542 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+.........
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~-~~i~~~i~~~~~--- 406 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKR-EEVERLVKEVPE--- 406 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCH-HHHHHHHHHCCC---
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhH-HHHHHHhhcccc---
Confidence 5332 233457999999999999989999999999999999999999999633211 011 111111111110
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
.++......+.+++..||+.||++|| ++.|+++
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11122235789999999999999999 6777775
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.19 Aligned_cols=256 Identities=26% Similarity=0.336 Sum_probs=204.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEe----CCCCEEEEEEeccccC---cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 358 (613)
.++|.+.+.||+|+||+||+|+. .+|+.||||+++.... ......+.+|+.++..+ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999997 3689999999875431 12234567899999999 5999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998654 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhcc
Confidence 987654333334456799999999999863 478999999999999999999999963321 11122222222211
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRML 564 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 564 (613)
. +. .+......+.+++.+||..||++|| |+.|+++..
T Consensus 282 ~-------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 E-------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C-------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred C-------CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 11 1122335688999999999999999 899998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.84 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=210.4
Q ss_pred cCHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhh--cccCccceeeEEEE
Q 007200 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCM 355 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~ 355 (613)
.++.......++|.+.+.||+|+||+||+|++. |+.||||++... ....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344445667789999999999999999999984 899999998643 34567788888877 78999999999998
Q ss_pred cCC----ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCce
Q 007200 356 TPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANI 423 (613)
Q Consensus 356 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NI 423 (613)
.+. ..++||||+.+|+|.+++... ++++..+..++.|++.||+||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 876 789999999999999999764 3899999999999999999999 77 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCc---eeeccccccccccccccccCC------CCCcccchhHHHHHHHHHhC-----
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITG----- 489 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwS~G~il~elltg----- 489 (613)
+++.++.+||+|||+++........ ......||+.|+|||.+.+.. ++.++|||||||++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999876544322 123446899999999997763 34689999999999999999
Q ss_pred -----CCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 490 -----QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 490 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
+.||...... ......+..... ... ..+..... ...+....+.+++.+||+.||++|||+.+|++.
T Consensus 259 ~~~~~~~p~~~~~~~---~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPS---DPSVEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCS---SCCHHHHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcC---cccHHHHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6677532211 111222222211 111 11111111 123567789999999999999999999999999
Q ss_pred hhcC
Q 007200 564 LEGD 567 (613)
Q Consensus 564 L~~~ 567 (613)
|+.+
T Consensus 331 L~~i 334 (342)
T 1b6c_B 331 LSQL 334 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.68 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=176.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||+||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++.++...++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467889999999999999999987 7899999999876555556678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 3899999999999999999999832 7999999999999999999999999998754321
Q ss_pred CCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334689999999999999999999999999999999999999963
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.45 Aligned_cols=259 Identities=18% Similarity=0.232 Sum_probs=203.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEE-EcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||.||+|++. +|+.||||++...... ..+.+|+.++..+.|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 467999999999999999999974 7899999998654332 3578999999999998877666655 5567789999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~ 441 (613)
||+ +++|.+++..... ++++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 9999999975432 499999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 442 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 442 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhccccc
Confidence 6543321 12345699999999999999999999999999999999999999974322111 111111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...... .. ...+..+.+++..||+.||++|||+.++++.|+.
T Consensus 236 ~~~~~~-~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 236 STPIEV-LC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HSCHHH-HT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCchHH-HH--------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 110000 00 1123578999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.01 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=193.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
...++|.+.+.||+|+||+||+|.+. +++.||||+++...... ....+.+|+.+++.++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999976 78899999997554332 23457799999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-----CCCcEEEeccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-----EEFEAVVGDFG 437 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-----~~~~~kl~DfG 437 (613)
||||+. |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999997 59999987654 389999999999999999999999 999999999999994 55569999999
Q ss_pred cceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+......
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS-----EIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC-----HHHHHHHHHHHhCC
Confidence 9986643322 22334589999999999875 48999999999999999999999995321 11111111111100
Q ss_pred c---cccccc--------cCccCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 K---KLEQLV--------DSDMEGNYIE-----EEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~---~~~~~~--------~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ...... .+........ .....+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 000000 0000000001 12357889999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.11 Aligned_cols=260 Identities=19% Similarity=0.221 Sum_probs=194.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcC------C
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 358 (613)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999976 68899999997543 233355788999999999999999999999654 3
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+.++ +.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999765 5555532 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc-
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 517 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 517 (613)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-----~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCSCC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 9865432 22344569999999999999999999999999999999999999996321 111111111110000
Q ss_pred --cc-------ccccc---------------Ccc-CC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 --KL-------EQLVD---------------SDM-EG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 --~~-------~~~~~---------------~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.+ ..... ... .. .........+.+++.+||..||++|||++|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 000 00 0011225678999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=335.50 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=197.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-CceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 364 (613)
..++|++.+.||+|+||+||+|... |+.||||+++... ....+.+|+.+++.++||||+++++++.+. ...++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3567889999999999999999885 8899999987543 345788999999999999999999997654 4789999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999976432 1278899999999999999999999 999999999999999999999999999975443
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... ......
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~---~~~~~~------ 231 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP---RVEKGY------ 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHH---HHTTTC------
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---HHhcCC------
Confidence 2 122347889999999999999999999999999999998 9999963221 11111 111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...........+.+++.+||+.||++|||+.++++.|+.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 ----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111122346789999999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.15 Aligned_cols=252 Identities=17% Similarity=0.195 Sum_probs=202.6
Q ss_pred HHhhCCCCCCccccCcCcEEEEEE------eCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc---cCccceeeEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 355 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 355 (613)
...++|.+.+.||+|+||+||+|. ..+++.||||+++.. ....+..|+.++..+. |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 445779999999999999999994 346889999999654 3446777888777776 999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE------- 427 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~------- 427 (613)
.++..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975322 234599999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeccccceecCC-CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC
Q 007200 428 ----EFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 502 (613)
Q Consensus 428 ----~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~ 502 (613)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999986542 2233445567999999999999999999999999999999999999999633210
Q ss_pred cchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhc
Q 007200 503 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER-PKMSEVVRMLEG 566 (613)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~ 566 (613)
.......+ ... ...+.+.+++..|++.+|.+| |++.++.+.|++
T Consensus 292 -------------~~~~~~~~----~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 -------------ECKPEGLF----RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------EEEECSCC----TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------ceeechhc----ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00011111 111 113467788889999999998 578888887764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.32 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=205.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|...+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999987 588999999875532 23345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+......... .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~---- 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE-Y---- 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC-C----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhcc-C----
Confidence 3322 2334568999999999999889999999999999999999999996322 111111111111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 --SI----PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CC----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01 1122356889999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.13 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=204.4
Q ss_pred HHHHHHhhCCCCC-CccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcc-cCccceeeEEEEc
Q 007200 281 RELQVATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 356 (613)
Q Consensus 281 ~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 356 (613)
...+...++|.+. +.||+|+||+||+|... +|+.||+|++..... ......+.+|+.++..+. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345556777777 88999999999999977 689999999976543 334667899999999885 6999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEE
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 433 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl 433 (613)
....++||||+.+|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999986532 23489999999999999999999999 9999999999999998 789999
Q ss_pred eccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . .+.....
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~---~~~~~~i 245 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-----N---QETYLNI 245 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHH
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----c---hHHHHHH
Confidence 9999998765322 2233569999999999999999999999999999999999999995322 1 1111111
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... ..............+.+++.+||+.||++|||++++++
T Consensus 246 ~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 SQVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Hhcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1100 00011111223456889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.81 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=199.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|+..+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999987 58999999986554332 24457899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.+++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988765433 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH-----------
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----------- 513 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 513 (613)
.. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+...
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-----DIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHHHhCCCChhhhhH
Confidence 22 23344589999999999875 68999999999999999999999996322 11111111100
Q ss_pred -hhcccccccccCccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 514 -LKEKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 514 -~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...........+....... ......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0001111111111111111 123467899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.49 Aligned_cols=270 Identities=19% Similarity=0.261 Sum_probs=199.9
Q ss_pred CHHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc----------cHHHHHHHHHHHhhcccCccc
Q 007200 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNLL 348 (613)
Q Consensus 279 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv 348 (613)
...++....++|.+.+.||+|+||.||+|.+.+|+.||||++....... ....+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888889999999999999999999998889999999996543221 125789999999999999999
Q ss_pred eeeEEEEc-----CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 349 RLRGFCMT-----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 349 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
++++++.. ....++||||+. |+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999854 235799999997 68888887543 2489999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 502 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~ 502 (613)
+++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----- 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----- 238 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-----
Confidence 99999999999999997543222 2234558999999999877 678999999999999999999999996322
Q ss_pred cchHHHHHHHHhhccccc-----------ccccCc---cCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 503 DVMLLDWVKGLLKEKKLE-----------QLVDSD---MEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......+.......... ...... ..... .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111111110000 000000 00000 1112356889999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=328.60 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=203.2
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-------- 356 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 356 (613)
..++|+..+.||+|+||.||+|.+. +|+.||+|.+.... ..+.+|++++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4467899999999999999999987 79999999997543 246789999999999999999998854
Q ss_pred --------CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 007200 357 --------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (613)
Q Consensus 357 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 428 (613)
....++||||+++++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 3457999999999999999976432 2489999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 429 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
+.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------K 226 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------H
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------H
Confidence 9999999999987654321 233458999999999999999999999999999999999999884211 1
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.... ..... ... .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 227 ~~~~-~~~~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTD-LRDGI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHH-HHTTC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-hhccc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 11111 111 1224688999999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=339.72 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=196.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc----HHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
..++|.+.+.||+|+||.||+|.+. +|+.||||++........ ...+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999976 689999999975432211 23578999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 8888886543 2488899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc-
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK- 518 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 518 (613)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|.+||.... .......+........
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-----~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHcCCCCh
Confidence 7643322 23345689999999999764 48899999999999999999999985321 1111111111111100
Q ss_pred --cccc---ccC---ccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 --LEQL---VDS---DMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 --~~~~---~~~---~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.... .+. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000 0000001 1223678999999999999999999999883
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.78 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=202.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|.+.+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467889999999999999999987 6899999998754322 2356789999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEecc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 436 (613)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999999877 8999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhc
Confidence 9998764322 2233458999999999999999999999999999999999999996321 11111111110
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .. .... ........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~-~~--~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 N-YD--FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-CC--CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cC--Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00 0000 00112356889999999999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.22 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=186.6
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
+.+..++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++..++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999965 689999999876554445567889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 362 LVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
+||||+++++|.+++... ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998642 11223589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC----ceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHH
Q 007200 438 LAKLMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512 (613)
Q Consensus 438 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 512 (613)
++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~---~ 238 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----MKVLM---L 238 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHH---H
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-----hhHHH---H
Confidence 9876543211 12234468999999999876 5689999999999999999999999963221 11111 1
Q ss_pred Hhhccc--c-cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 513 LLKEKK--L-EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 513 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... . ....+.... ......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQNDPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSSCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111110 0 001111111 122356889999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.10 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=207.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEe-----CCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC--c
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--E 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 359 (613)
.++|.+.+.||+|+||.||+|++ .+|+.||||++.... ......+.+|+++++.++||||+++++++.... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 46788899999999999999984 368899999997643 334567899999999999999999999987643 6
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 8999999999999999986532 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccc------cCC-CcchHHHHH
Q 007200 440 KLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------AND-DDVMLLDWV 510 (613)
Q Consensus 440 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~------~~~-~~~~~~~~~ 510 (613)
+......... .....++..|+|||.+.+..++.++||||||+++|||+||..||..... ... ........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8775443221 2223467789999999988899999999999999999999999863210 000 001111111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
........ ....+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 273 ~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 273 IELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111111 111122334678999999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.93 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=194.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++..+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367888999999999999999975 7999999999654332 23456889999999999999999999997653
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+ +++|.++++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999998763 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... .......+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCC
Confidence 9875432 234568999999999887 679999999999999999999999996322 111111111110000
Q ss_pred c------------------ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 K------------------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. +........ ..........+.+++.+||..||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 000000000 0011122457889999999999999999999988
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.74 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=192.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-------ccHHHHHHHHHHHhhcccCccceeeEEEEc
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 356 (613)
...++|.+.+.||+|+||+||+|.+. +++.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999976 6899999998754211 112247899999999999999999999754
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEE
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 433 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl 433 (613)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 55799999999999999887543 489999999999999999999999 999999999999997544 5999
Q ss_pred eccccceecCCCCCceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHH
Confidence 999999876432 22334569999999999864 567889999999999999999999996322 111122211
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ....... +. ........+.+++.+||+.||++|||+.|+++
T Consensus 358 ~----~~~~~~~--~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 T----SGKYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----TTCCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred h----cCCCCCC--ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 1110000 00 00112357899999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.87 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=204.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367888999999999999999976 578899999865421 22345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997654 389999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~------ 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNVD------ 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhccc------
Confidence 322 234568999999999999999999999999999999999999996322 111111111110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... +......+.+++.+|++.||++|||+.++++
T Consensus 229 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -LKF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 011 1122357889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.16 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=196.7
Q ss_pred CccccCcCcEEEEEEeC---CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
+.||+|+||+||+|.+. .++.||||+++.... ......+.+|+.++++++||||+++++++.. ...++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976543 2345679999999999999999999999864 568899999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCc-
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 448 (613)
|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 389999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... . .+ +...+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~---~~-~~~~i~~~~-------- 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----G---SE-VTAMLEKGE-------- 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H---HH-HHHHHHTTC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----H---HH-HHHHHHcCC--------
Confidence 2223346789999999999999999999999999999998 999995321 1 11 111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+..+...+.+++..||+.||++|||+.+|++.|++
T Consensus 590 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111122334678999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=336.16 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=205.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||++.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999987 588999999875532 23345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+......... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~-~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE-Y---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC-C----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCC-C----
Confidence 3322 2334568999999999999999999999999999999999999996322 111111111111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ......+.+++.+||+.||++|||+.|+++
T Consensus 259 --~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 --SIP----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 112356889999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.20 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=188.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHH-HHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
..++|++.+.||+|+||+||+|.+. +|+.||+|+++.......... +..+...++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3577899999999999999999975 789999999976544433333 44445557888999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+. |+|.+++.........+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 5888877653333345999999999999999999999853 89999999999999999999999999998654
Q ss_pred CCCCceeecccccccccccccc----ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.... . ....+.........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~-~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------T-PFQQLKQVVEEPSP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------C-HHHHHHHHHHSCCC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------c-hHHHHHHHhccCCC
Confidence 322 22334589999999996 55678999999999999999999999996211 0 11111122211111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. . ........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~------~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 Q------L---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C------C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C------c---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 0 01122356899999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.49 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=199.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEc--CCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 363 (613)
++|++.+.||+|+||+||+|.+. +++.||||+++.. ....+.+|+.++..+. ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 67889999999999999999875 7899999998643 3457889999999997 9999999999987 5678999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccceec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~ 442 (613)
|||+.+++|.++++. +++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998853 78999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ........+...........
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~----~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS----SHHHHHHHHHHHHCHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC----chHHHHHHHHHhcCCchhhh
Confidence 54322 234458999999999977 668999999999999999999999994221 11111111111111000000
Q ss_pred c-----------------------ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 L-----------------------VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ................+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000011111223467899999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.30 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=197.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc----CCceE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 361 (613)
..|.+.+.||+|+||+||+|.+. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788999999999999976 688999999875543 3345578999999999999999999999865 35579
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeec-CCCcEEEecccc
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGL 438 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfGl 438 (613)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997653 389999999999999999999999 7 99999999999998 788999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
+...... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.... ..............
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHhccCC
Confidence 9754432 223456899999999886 458999999999999999999999995221 11122212111111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .. .......+.+++..||+.||++|||+.|+++
T Consensus 248 ~~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PA-SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CG-GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-cc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 01 1111246899999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=336.71 Aligned_cols=258 Identities=29% Similarity=0.391 Sum_probs=196.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--CCC--EEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|++.+.||+|+||+||+|++. +++ .||||+++.... ......+.+|+.+++.++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467889999999999999999853 333 689999875432 233557899999999999999999999987754 8
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.+++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 999999999999999976432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC
Confidence 765433221 223447888999999998889999999999999999999 999995321 112222221111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
.. ..........+.+++.+||+.||++|||+.++++.|+...
T Consensus 242 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 0111223467899999999999999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.16 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=198.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|.....||+|+||.||+|.+. +++.||||.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34555668999999999999975 688999999875532 3456788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEeccccceecCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~ 445 (613)
+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999976532 23478999999999999999999999 9999999999999987 899999999999876532
Q ss_pred CCceeeccccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.. ......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||..... . .......... . .
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-~~~~~~~~~~-~-----~ 243 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----P-QAAMFKVGMF-K-----V 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----H-HHHHHHHHHH-C-----C
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----h-hHHHHhhccc-c-----c
Confidence 21 223455899999999997654 78999999999999999999999963210 0 0010000000 0 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+.. +......+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 1223357889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=344.36 Aligned_cols=263 Identities=18% Similarity=0.240 Sum_probs=195.8
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 357 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 357 (613)
....++|.+.+.||+|+||+||+|.+. +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678999999999999999999975 7999999998654332 23799999999999999999998543
Q ss_pred ---------------------------------CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007200 358 ---------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404 (613)
Q Consensus 358 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 404 (613)
...++||||+. |+|.+.+.........+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999998 58887776533333459999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCceeec-CCCcEEEeccccceecCCCCCceeeccccccccccccccccCC-CCCcccchhHHHH
Q 007200 405 LHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVM 482 (613)
Q Consensus 405 LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~i 482 (613)
||+. +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999998 688999999999987643322 23445899999999987754 8999999999999
Q ss_pred HHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc----------cccccCccCCC-----CcHHHHHHHHHHHHHcc
Q 007200 483 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL----------EQLVDSDMEGN-----YIEEEVEQLIQVALLCT 547 (613)
Q Consensus 483 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~l~~li~~cl 547 (613)
+|||++|+.||.... .......+......... ....-+..... .+......+.+++.+||
T Consensus 232 l~ell~g~~pf~~~~-----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 232 FGELILGKPLFSGET-----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999999996321 11111111111110000 00000000000 11123456899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 007200 548 QGSPMERPKMSEVVR 562 (613)
Q Consensus 548 ~~dP~~RPt~~evl~ 562 (613)
+.||++|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=351.06 Aligned_cols=244 Identities=14% Similarity=0.121 Sum_probs=190.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHH---HHhhcccCccceee-------EE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVE---MISMAVHRNLLRLR-------GF 353 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~ 353 (613)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888899999999999999964 69999999997542 2234567889994 55566899999998 76
Q ss_pred EEcCCc-----------------eEEEEecccCCcchhhhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007200 354 CMTPTE-----------------RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413 (613)
Q Consensus 354 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 413 (613)
+.+++. .+++|||+ +|+|.+++...... ...+++..+..++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 68999999764221 11244688899999999999999999 99
Q ss_pred EecCCCCCceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccC-----------CCCCcccchhHHHH
Q 007200 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVM 482 (613)
Q Consensus 414 vH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVwS~G~i 482 (613)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3344557 999999999887 89999999999999
Q ss_pred HHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 483 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 483 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+|||++|+.||....... ....+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~-----------------~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----------------chhhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999996322110 011111100 112357889999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.64 Aligned_cols=260 Identities=18% Similarity=0.212 Sum_probs=202.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCC---------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccce--------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-------- 349 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 349 (613)
.++|.+.+.||+|+||.||+|++.. ++.||+|++... ..+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3678999999999999999999763 789999998654 24778999999999999988
Q ss_pred -------eeEEEEc-CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007200 350 -------LRGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (613)
Q Consensus 350 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 421 (613)
+++++.. +...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 6777765 67889999999 999999998642 12499999999999999999999999 9999999999
Q ss_pred ceeecCCC--cEEEeccccceecCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007200 422 NILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (613)
Q Consensus 422 NIll~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~ 493 (613)
||+++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999866532211 123346999999999999999999999999999999999999999
Q ss_pred ccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 494 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..... .............. ....+...... .......+.+++..||+.||++|||+.++++.|++
T Consensus 269 ~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLP---NTEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTT---CHHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCc---CHHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 64321 11111222111111 11111111100 01123578999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.51 Aligned_cols=194 Identities=24% Similarity=0.369 Sum_probs=154.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 360 (613)
++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999976 7899999999754332 2345788999999999999999999998543 568
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 578999887543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--------------------------ceeecccccccccccccc-ccCCCCCcccchhHHHHHHHHHhC
Q 007200 441 LMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITG 489 (613)
Q Consensus 441 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwS~G~il~elltg 489 (613)
....... .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 122345689999999986 456799999999999999999993
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=327.43 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=199.6
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ....+.+|+.++..++||||+++++++..+...++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567999999999999999999986 58999999997543 2356889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999987433 2489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............. ...
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-~~~-- 245 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTNPP-PTF-- 245 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-CCC--
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCC-ccc--
Confidence 322 2234458999999999999999999999999999999999999996321 1111111111110 000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.........+.+++.+||+.||++|||+.++++
T Consensus 246 -----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122357899999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.36 Aligned_cols=257 Identities=20% Similarity=0.333 Sum_probs=205.0
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-------cHHHHHHHHHHHhhc-ccCccceeeE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMA-VHRNLLRLRG 352 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l-~h~niv~l~~ 352 (613)
......++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++..+ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999986 79999999987543211 134578899999999 7999999999
Q ss_pred EEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
++......++||||+.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999997643 389999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCceeecccccccccccccccc------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~ 506 (613)
|+|||++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~--- 310 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----Q--- 310 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----H---
Confidence 99999998765432 2234569999999999864 357889999999999999999999995321 1
Q ss_pred HHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
......... .... ...+. .......+.+++.+||+.||++|||+.|+++
T Consensus 311 ~~~~~~i~~-~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ILMLRMIME-GQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHH-TCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHh-CCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 1100 00000 0012356889999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.56 Aligned_cols=262 Identities=20% Similarity=0.306 Sum_probs=201.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 360 (613)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|++++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999976 68899999997655444456789999999999999999999999764 367
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+. |+|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5899988753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCce--eecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 441 LMDYKDTHV--TTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
......... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 765332211 233469999999998755 458999999999999999999999996322 111222221111111
Q ss_pred ccc---cc--------ccC-ccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 KLE---QL--------VDS-DMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~~~---~~--------~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .. ... ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 000 000000 0112356889999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.29 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=201.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|.+.+.||+|+||.||+++.. +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467889999999999999999976 7899999999754322 33568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEeccccceec
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~ 442 (613)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999987654 389999999999999999999999 99999999999999 78889999999999754
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... . ........... ..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~---~~~~~~i~~~~-~~-- 225 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----E---SKLFEKIKEGY-YE-- 225 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----H---HHHHHHHHHCC-CC--
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHHcCC-CC--
Confidence 322 1233458999999999999999999999999999999999999995321 1 11111111111 00
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
............+.+++.+||+.||++|||+.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 ----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111123457899999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.62 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC--------
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 357 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 357 (613)
++|.+.+.||+|+||+||+|++. +|+.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 67899999999999999999985 7899999998655432 2345678999999999999999999998863
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...++||||+.+ +|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999975 77777655432 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC---Cceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 438 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 438 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 998765322 122234568999999999876 457999999999999999999999996321 11122222221
Q ss_pred hhcc---cccccccCc---------cCCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 514 LKEK---KLEQLVDSD---------MEGNYIEEE------VEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 514 ~~~~---~~~~~~~~~---------~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... ......... ......... ...+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111 000000000 000011111 245889999999999999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=346.20 Aligned_cols=254 Identities=11% Similarity=0.017 Sum_probs=181.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhc--ccCccceee-------EEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA--VHRNLLRLR-------GFCM 355 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 355 (613)
.+|...+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888899999999999999976 7899999999875432 2344577785555544 699987755 4544
Q ss_pred cC-----------------CceEEEEecccCCcchhhhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 007200 356 TP-----------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPK 412 (613)
Q Consensus 356 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ 412 (613)
.+ ...++||||+. |+|.+++...+. .+.+..+ ..++.||+.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 33 23799999998 899999986432 2444555 67789999999999999 9
Q ss_pred eEecCCCCCceeecCCCcEEEeccccceecCCCCCceeecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCC
Q 007200 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQ 490 (613)
Q Consensus 413 ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~ 490 (613)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986542 1224457799999999987 67899999999999999999999
Q ss_pred CCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 491 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 491 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.||.......... .........................+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997432111000 0000000001111111111233467899999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.77 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=198.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 467899999999999999999987 58999999987543 3345678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999876432 389999999999999999999999 9999999999999999999999999987533211
Q ss_pred CCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
........|++.|+|||.+. +..++.++||||||+++|+|++|+.||.... ...............
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPPT 241 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCcc
Confidence 11122345899999999983 6678999999999999999999999996322 111111211111110
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .........+.+++..||+.||++|||+.++++
T Consensus 242 -~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -L-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -c-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011223457899999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.97 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=197.1
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc---
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--- 356 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 356 (613)
++....++|.+.+.||+|+||.||+|.+. +|+.||||++..... ....+.+|+.++..+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445678999999999999999999975 789999999865432 345788999999998 79999999999976
Q ss_pred ---CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 007200 357 ---PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 357 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 433 (613)
....++||||+.+|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999997643 22489999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
+|||++........ ......|++.|+|||.+. +..++.++|||||||++|+|++|+.||.... ...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~ 241 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMR 241 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHH
Confidence 99999986543221 223345899999999987 5668999999999999999999999995221 111
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
......... ..... .......+.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~-~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALFLIPRNP-APRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHSC-CCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhcCc-cccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111 11110 1112357889999999999999999999988
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.56 Aligned_cols=200 Identities=23% Similarity=0.322 Sum_probs=167.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 359 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 6889999999754332 2345788999999999999999999998765 56
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+. |+|.++++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999987543 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc---------------------eeecccccccccccccc-ccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 440 KLMDYKDTH---------------------VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 440 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
+........ ......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876533211 12456699999999986 55669999999999999999998666553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.58 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=202.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999986 78999999986543 2234567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~ 441 (613)
||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999887654 389999999999999999999999 999999999999995 456799999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ..+.+...........
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAFD 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSC
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 54322 2334569999999999875 58999999999999999999999995321 1111222111111000
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111234578899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=348.81 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=200.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc------------ccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ------------GGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
.++|.+.+.||+|+||+||+|... +++.||+|++...... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999976 6889999999754322 234578899999999999999999999
Q ss_pred EEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---c
Q 007200 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---E 430 (613)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~ 430 (613)
+.++...++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999987654 389999999999999999999999 999999999999999876 6
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
+||+|||+++...... ......||+.|+|||.+. +.++.++||||+||++|+|++|+.||.... ..+.+
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDII 256 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 9999999998765432 233456999999999986 568999999999999999999999996321 11222
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
............ . ........+.+++..||+.||++|||+.|+++
T Consensus 257 ~~i~~~~~~~~~---~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYFDF---N----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCCCH---H----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCc---c----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222111110000 0 00112357899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.66 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=196.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.++...++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467889999999999999999987 79999999986542 12235578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997654 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ........ .....
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKI-RGGVF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHCCC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHh-hcCcc--
Confidence 4322 2233458999999999987765 689999999999999999999996321 11111111 11110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ----YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 1112356889999999999999999999988
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.58 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=185.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEE--------
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM-------- 355 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 355 (613)
...+|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457889999999999999999976 78999999985542 334557889999999996 999999999984
Q ss_pred cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEE
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl 433 (613)
.....+++|||+. |+|.+++..... ..++++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 2344789999995 799998865322 22499999999999999999999998 8 999999999999999999999
Q ss_pred eccccceecCCCCCce-----------eecccccccccccccc---ccCCCCCcccchhHHHHHHHHHhCCCCccccccc
Q 007200 434 GDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~ 499 (613)
+|||+++......... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432211 1134589999999998 5667889999999999999999999999632210
Q ss_pred CCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+... . ... ........+.+++..||+.||++|||+.|+++.|+..
T Consensus 260 --------~~~~~~-----~----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 260 --------RIVNGK-----Y----SIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -------------------C----CCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HhhcCc-----c----cCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000 0 000 0011123478899999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=349.00 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=198.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|...+.||+|+||+||+|++. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999986 788999999976532 223457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~ 441 (613)
||+.+|+|.+++.... ++++..+..++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887654 389999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.... ..+...........
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~-- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGKYT-- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCC--
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC--
Confidence 65332 233456999999999885 568999999999999999999999996322 11222222111110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... ........+.+++..||+.||++|||+.|+++
T Consensus 256 -~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 -FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 01122356889999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=368.90 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=206.5
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
+..+..++|.+.+.||+|+||+||+|.+.. +..||||.++..........+.+|+.+++.++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344455778889999999999999998752 45799999876555545567999999999999999999999984 4
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
+..++||||+++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 678999999999999999976432 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
+++..............+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.+......
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcC
Confidence 998765443333334457789999999999999999999999999999997 999996321 11112121111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
... ..+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 0112234678999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.82 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=204.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
..++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999987 789999999865432 3346678999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEeccccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 439 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla 439 (613)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999987643 389999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... . .+.+.........
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~---~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----E---YDILKKVEKGKYT 245 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCCCC
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHHcCCCC
Confidence 8665332 2234569999999999866 68999999999999999999999996321 1 1112222111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 0011223457889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.04 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=203.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhccc-CccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ..+..|++++..+.| +++..+..++......++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 468999999999999999999975 7899999988654332 247789999999987 55666666777788889999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~ 441 (613)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999975432 499999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 442 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 442 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKV 233 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSHHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc--hhHHHHHHHHhhccc
Confidence 6543321 12245699999999999999999999999999999999999999963221 111111111111111
Q ss_pred cccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 516 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...+..+. ......+.+++..||+.||++||++.+|++.|++.
T Consensus 234 ~~~~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111110 11235789999999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=338.26 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=203.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCccc----------------HHHHHHHHHHHhhcccCcccee
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG----------------ELQFQTEVEMISMAVHRNLLRL 350 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~l 350 (613)
.++|.+.+.||+|+||.||+|.+ +|+.||||.+........ ...+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 899999999975432111 1678999999999999999999
Q ss_pred eEEEEcCCceEEEEecccCCcchhh------hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCce
Q 007200 351 RGFCMTPTERLLVYPFMVNGSVASC------LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANI 423 (613)
Q Consensus 351 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NI 423 (613)
++++.+++..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 54321 3459999999999999999999999 8 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCceeeccccccccccccccccC-CCCC-cccchhHHHHHHHHHhCCCCcccccccCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 501 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DVwS~G~il~elltg~~p~~~~~~~~~ 501 (613)
+++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS--- 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---
Confidence 9999999999999999876432 33445689999999999887 5665 99999999999999999999963221
Q ss_pred CcchHHHHHHHHhhccccccccc------CccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 502 DDVMLLDWVKGLLKEKKLEQLVD------SDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .+........ ......+ +... ..........+.+++.+||+.||++|||+.|+++
T Consensus 258 -~---~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 -L---VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -S---HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H---HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1111111111 1100000 0000 0001223467899999999999999999999988
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.20 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=196.9
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-------cccHHHHHHHHHHHhhcccCccceeeEEEEcC
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 357 (613)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+++++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999976 688999999875431 11223578999999999999999999998765
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEe
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 434 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~ 434 (613)
. .++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999886543 489999999999999999999999 9999999999999987654 9999
Q ss_pred ccccceecCCCCCceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 435 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 435 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
|||+++..... .......||+.|+|||.+. ...++.++|||||||++|+|++|+.||..... .......+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHHH
Confidence 99999876432 1223445899999999974 45688999999999999999999999963221 111222111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. ..... .+.. .......+.+++.+||+.||++|||+.++++.
T Consensus 234 ~----~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 S----GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp H----TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h----Ccccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 11000 0000 01123578999999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.27 Aligned_cols=265 Identities=21% Similarity=0.243 Sum_probs=201.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc--------cCccceeeEEEE--
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--------HRNLLRLRGFCM-- 355 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-- 355 (613)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 478999999999999999999976 6889999999743 223456889999999886 788999999987
Q ss_pred --cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----
Q 007200 356 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---- 429 (613)
Q Consensus 356 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---- 429 (613)
+....++||||+ ++++.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 5566666654322 24899999999999999999999964 799999999999999775
Q ss_pred ---------------------------------------------cEEEeccccceecCCCCCceeeccccccccccccc
Q 007200 430 ---------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464 (613)
Q Consensus 430 ---------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 464 (613)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876432 233458999999999
Q ss_pred cccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-cchHHHHHHHHhhcc---------cccccccCc--------
Q 007200 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLKEK---------KLEQLVDSD-------- 526 (613)
Q Consensus 465 ~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~-------- 526 (613)
+.+..++.++|||||||++|||++|+.||......... .......+....... .........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999643221110 111111111111100 000000000
Q ss_pred -----------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 -----------MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
............+.+++.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234566788999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.20 Aligned_cols=196 Identities=20% Similarity=0.271 Sum_probs=170.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhc------ccCccceeeEEEEcCCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 359 (613)
..+|++.+.||+|+||+||+|.+. +++.||||+++... .....+..|+.++..+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457899999999999999999876 58899999997532 2234677788888776 57799999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--EEEeccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 437 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG 437 (613)
.++||||+. ++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 689998876543 2489999999999999999999999 9999999999999999987 9999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 99765422 233568999999999999999999999999999999999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.61 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=183.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcC------C
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 358 (613)
.++|...+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999975 688999999975432 23345788999999999999999999998754 5
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++++|++ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 78999988652 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCC
Confidence 9865422 234568999999999887 678999999999999999999999995321 111112111111100
Q ss_pred c---ccc--------cccC--ccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 518 K---LEQ--------LVDS--DMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 518 ~---~~~--------~~~~--~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
. +.. .... ....... ......+.+++.+||..||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0000 0000000 0123568899999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=359.48 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=204.4
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 359 (613)
....++|++.+.||+|+||+||+|++. +++.||||+++... .......+..|..++..+ +||||+++++++.+...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345578999999999999999999976 68899999997542 122345677889998877 69999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 999999999999999998754 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-- 558 (674)
T 3pfq_A 490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-- 558 (674)
T ss_dssp EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSC--
T ss_pred eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 8643222 23445679999999999999999999999999999999999999996321 112222222111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM-----SEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 562 (613)
. .++......+.+++..||+.||++||++ +||++
T Consensus 559 -------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 -------V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------C--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------C--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 1112234678999999999999999997 55554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.55 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=198.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC---cccHHHHHHHHHHHhhcccCccceeeEEEE--cCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 360 (613)
.++|.+.+.||+|+||.||+|.+. +++.||+|+++.... ......+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999976 688999999975431 234567899999999999999999999985 44678
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+.++ |.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999877 6676665432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-CceeeccccccccccccccccCC--CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 441 LMDYKD-THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 441 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
...... ........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~-~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGK-G 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-C
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhc-C
Confidence 765322 22233455899999999987654 3779999999999999999999996321 1111111111 1
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ... ......+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~------~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 SY------AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC------CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 111 122357889999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.69 Aligned_cols=256 Identities=20% Similarity=0.244 Sum_probs=191.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999976 688999999975432 233456889999999999999999999997654
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 78777752 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc--
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-- 516 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 516 (613)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~ 243 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--------IDQWNKVIEQLG 243 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHC-CC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 9865432 122345689999999999999999999999999999999999999963221 0111111100
Q ss_pred --------------------cc------ccccccCcc-CC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 --------------------KK------LEQLVDSDM-EG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 --------------------~~------~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ......... +. .........+.+++.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 000000000 00 011233567899999999999999999999988
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.32 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=199.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 360 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999976 68899999997655444456788999999999999999999988654 678
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+. ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 6899988763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc---------eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 441 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 441 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD-----YRHQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHH
Confidence 76532211 1123458999999998765 678999999999999999999999996322 11111111
Q ss_pred HHHhhccccc------------ccccC--ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 KGLLKEKKLE------------QLVDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ~~~~~~~~~~------------~~~~~--~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......... +.... ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111100000 00000 000000 0122457889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.80 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=192.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC------Cce
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 360 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 360 (613)
.+|...+.||+|+||+||+|++. +|+.||||++...... ..+|+++++.++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35888899999999999999986 6899999998654322 34799999999999999999998542 235
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla 439 (613)
++||||+.+ ++.+.+.........+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999976 56665543222234599999999999999999999999 99999999999999965 57899999999
Q ss_pred eecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc-
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 517 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 517 (613)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+. .....
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~-~lg~p~ 277 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIK-VLGTPT 277 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-HHCSCC
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH-HhCCCC
Confidence 87643322 2345689999999999765 689999999999999999999999963210 011111111 11000
Q ss_pred ---------cccccccCccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 ---------KLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ---------~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......+..... +.......+.+++.+||..||++|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0001101111000 01122467899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.76 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=202.2
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCC
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 358 (613)
..++.+..++|.+.+.||+|+||.||+|.+.+ .+|+|+++..... .....+.+|+.+++.++||||+++++++.++.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455566889999999999999999999863 4999998754322 22345778999999999999999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..+++|||+.+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997643 2489999999999999999999999 999999999999998 67999999999
Q ss_pred ceecCCCC----Cceeecccccccccccccccc---------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcch
Q 007200 439 AKLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505 (613)
Q Consensus 439 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~ 505 (613)
++...... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------- 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------- 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 87553211 112223458999999999864 357889999999999999999999996321
Q ss_pred HHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
........... ........ .....+.+++..||+.||++|||+.++++.|+...
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 248 AEAIIWQMGTG-MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHHHHTT-CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHHHHhccC-CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111111111 11111110 11245889999999999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.31 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=203.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--------cccHHHHHHHHHHHhhcc-cCccceeeEEEEc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--------QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 356 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 356 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467899999999999999999986 688999999865431 112346788999999996 9999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 436 (613)
+...++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999997653 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccc------cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 510 (613)
|++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||.... .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~ 238 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLML 238 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHH
Confidence 9998765332 223455899999999985 4567899999999999999999999995321 11111
Q ss_pred HHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... .. ............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111 00 000111223467899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=328.89 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=197.6
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcc--cCccceeeEEEEcCCc
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 359 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 359 (613)
+....++|.+.+.||+|+||.||++.+.+++.||||++..... ......+.+|+.++..+. |+||+++++++.++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3345578999999999999999999988899999999975432 233457899999999997 4999999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||| +.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 66889999998653 489999999999999999999999 9999999999999975 79999999999
Q ss_pred eecCCCCCc-eeecccccccccccccccc-----------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007200 440 KLMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 440 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~ 507 (613)
+........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~ 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQI 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHH
Confidence 866433221 2234458999999999875 467889999999999999999999995221 111
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..+........ ....+......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLHAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11222221111 11111112357889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=333.08 Aligned_cols=269 Identities=21% Similarity=0.262 Sum_probs=189.4
Q ss_pred HHHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc
Q 007200 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (613)
Q Consensus 281 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 359 (613)
.......++|.+.+.||+|+||+||+|.+. +|+.||||++...... ...+.+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345667789999999999999999999986 6899999998654322 2345678888889999999999999875433
Q ss_pred -------eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCceeecC-CC
Q 007200 360 -------RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--DHCDPKIIHRDVKAANILLDE-EF 429 (613)
Q Consensus 360 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~NIll~~-~~ 429 (613)
.++||||+.+ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 454444432223345899999999999999999999 88 9999999999999997 89
Q ss_pred cEEEeccccceecCCCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
.+||+|||+++...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.... ......
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~~~~ 242 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-----SAGQLH 242 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-----hHHHHH
Confidence 99999999998765332 223455899999999987654 8999999999999999999999996321 111111
Q ss_pred HHHHHhhcc------------cccccccCc------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 509 WVKGLLKEK------------KLEQLVDSD------MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 509 ~~~~~~~~~------------~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+....... ......+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111110000 000000000 000111123567999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.34 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=202.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEe-C-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc------cceeeEEEEcCC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRL-T-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 358 (613)
.++|.+.+.||+|+||+||+|.+ . +++.||||+++... .....+.+|+.++..++|++ ++++++++....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46899999999999999999987 3 68899999996432 23456888999999887765 999999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----------
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----------- 427 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----------- 427 (613)
..++||||+ +++|.+++..... .++++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8899999976543 2489999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc
Q 007200 428 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (613)
Q Consensus 428 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~ 499 (613)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-- 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Confidence 668999999999865432 233568999999999999999999999999999999999999996321
Q ss_pred CCCcchHHHHHHHHhhcccc--------cccc-cCcc---------------------CCCCcHHHHHHHHHHHHHccCC
Q 007200 500 NDDDVMLLDWVKGLLKEKKL--------EQLV-DSDM---------------------EGNYIEEEVEQLIQVALLCTQG 549 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~---------------------~~~~~~~~~~~l~~li~~cl~~ 549 (613)
.......+......... .... .... ...........+.+++.+||+.
T Consensus 239 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 ---SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ---HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 11111111111110000 0000 0000 0011234567899999999999
Q ss_pred CCCCCCCHHHHHH
Q 007200 550 SPMERPKMSEVVR 562 (613)
Q Consensus 550 dP~~RPt~~evl~ 562 (613)
||++|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=339.10 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=192.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc------eE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------RL 361 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 361 (613)
.+|...+.||+|+||+||+|++..+..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 568889999999999999999987777999988654322 2369999999999999999999865433 78
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEeccccce
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 440 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~ 440 (613)
+||||+.++.+..... .......+++..++.++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHHHHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999998754443332 111223589999999999999999999999 999999999999999 78999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc-
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK- 518 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 518 (613)
....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+........
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-----GIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCH
Confidence 7643322 2345689999999998765 58999999999999999999999996321 1111111111110000
Q ss_pred ---------ccccccCccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 519 ---------LEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 519 ---------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.....-+..... ........+.+++.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000 011134578999999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=339.05 Aligned_cols=268 Identities=20% Similarity=0.289 Sum_probs=182.9
Q ss_pred hCCCC-CCccccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceE
Q 007200 288 DNFSN-RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERL 361 (613)
Q Consensus 288 ~~~~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 361 (613)
+.|++ .++||+|+||+||+|++. +++.||||++..... ...+.+|+.+++.++||||+++++++.. +...+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34555 457999999999999965 578899999975432 2467899999999999999999999954 67889
Q ss_pred EEEecccCCcchhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEE
Q 007200 362 LVYPFMVNGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAV 432 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~k 432 (613)
+||||+. |+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 47877775321 1222489999999999999999999999 99999999999999 6778999
Q ss_pred EeccccceecCCCCC--ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccC----CCcch
Q 007200 433 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLAN----DDDVM 505 (613)
Q Consensus 433 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~----~~~~~ 505 (613)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653221 223345689999999999874 58999999999999999999999996332110 00111
Q ss_pred HHHHHHHHhhcc---cccccc-------------cCccCCCCcH--------HHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 007200 506 LLDWVKGLLKEK---KLEQLV-------------DSDMEGNYIE--------EEVEQLIQVALLCTQGSPMERPKMSEVV 561 (613)
Q Consensus 506 ~~~~~~~~~~~~---~~~~~~-------------~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPt~~evl 561 (613)
....+....... .+..+. .......... .....+.+++.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111111100 000000 0000000000 0134678999999999999999999998
Q ss_pred H
Q 007200 562 R 562 (613)
Q Consensus 562 ~ 562 (613)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=330.99 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=194.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce----
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 360 (613)
.++|...+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 367888999999999999999976 6899999999765432 2345788999999999999999999999877654
Q ss_pred --EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 361 --LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 361 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588777632 289999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVP 261 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 9855422 234568999999999987 678999999999999999999999996321 111111111100000
Q ss_pred c---ccc--------c---ccCccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 K---LEQ--------L---VDSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~---~~~--------~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ... . ........ ........+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 000 0 00000000 00112467899999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.22 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=199.3
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-----------cCccceeeEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFC 354 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 354 (613)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... .....+.+|+.++.++. |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 367999999999999999999975 78899999997432 23456788999988876 89999999998
Q ss_pred EcCC----ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec----
Q 007200 355 MTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---- 426 (613)
Q Consensus 355 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---- 426 (613)
.... ..+++|||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7643 679999999 8999999976433 23899999999999999999999953 899999999999994
Q ss_pred --CCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCC-Cc
Q 007200 427 --EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-DD 503 (613)
Q Consensus 427 --~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~-~~ 503 (613)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 2234589999999999999999999999999999999999999974321110 01
Q ss_pred chHHHHHHHHhhcc------------------c-ccccccC---------ccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 007200 504 VMLLDWVKGLLKEK------------------K-LEQLVDS---------DMEGNYIEEEVEQLIQVALLCTQGSPMERP 555 (613)
Q Consensus 504 ~~~~~~~~~~~~~~------------------~-~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 555 (613)
......+....... . ...+... .............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111111000 0 0000000 001123456778899999999999999999
Q ss_pred CHHHHHH
Q 007200 556 KMSEVVR 562 (613)
Q Consensus 556 t~~evl~ 562 (613)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=327.67 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=199.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC--CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhc---ccCccceeeEEEE----
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMA---VHRNLLRLRGFCM---- 355 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 355 (613)
..++|.+.+.||+|+||.||+|.+. +|+.||+|+++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999973 6789999998754322 1123456777777666 8999999999987
Q ss_pred -cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEe
Q 007200 356 -TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (613)
Q Consensus 356 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 434 (613)
.....++||||+. |+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 699999876543 2489999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHh
Q 007200 435 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 435 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHHc
Confidence 999998654322 2234558999999999999999999999999999999999999996322 111111111111
Q ss_pred hcc---cccc-------cccC---ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 515 KEK---KLEQ-------LVDS---DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 515 ~~~---~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .... .... .............+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 100 0000 0000 0000111223467889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=325.40 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=192.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc---------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 356 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 356 (613)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467889999999999999999976 7899999998643 2234578899999999999999999998865
Q ss_pred ----CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 007200 357 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (613)
Q Consensus 357 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 432 (613)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 356789999999999999997643 2378899999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCC-------------CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccc
Q 007200 433 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (613)
Q Consensus 433 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~ 498 (613)
|+|||+++...... ........|++.|+|||.+.+. .++.++|||||||++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999997654221 1122344589999999999765 68999999999999999998 553111
Q ss_pred cCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 499 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
........... . ....+..........+.+++..||+.||++|||+.++++.
T Consensus 233 ------~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ------ERVNILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ------HHHHHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------hHHHHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01111111111 0 0111112223334568899999999999999999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=329.39 Aligned_cols=200 Identities=24% Similarity=0.322 Sum_probs=169.3
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cC-----ccceeeEEEEcC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMTP 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 357 (613)
...++|.+.+.||+|+||+||+|.+. +++.||||+++... .....+..|+.++..+. |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34578999999999999999999976 68899999997432 22446777888888775 44 499999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCcEEEec
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGD 435 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~D 435 (613)
...++||||+. |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 599999976542 2489999999999999999999952 12899999999999995 477899999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999876432 233568999999999999999999999999999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.51 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=194.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCc------
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 359 (613)
++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999976 6899999999765432 234568899999999999999999999987654
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+. ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588887743 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc-
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 517 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 517 (613)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVPG 244 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBCC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCC
Confidence 764422 233468999999999877 6789999999999999999999999963221 11111111110000
Q ss_pred --ccc------------cc---ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 --KLE------------QL---VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 --~~~------------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .+ ..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 00000 0111233467899999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=315.77 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=202.7
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
...++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 789999999875432 3346678999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEeccccc
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 439 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla 439 (613)
||||+.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887653 389999999999999999999999 99999999999999764 47999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+...........
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYA 240 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 76543221 223348899999999865 48899999999999999999999996321 11112221111110
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. .. ........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~---~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FD---LP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC---SG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---ch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00 00122357899999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.17 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=180.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHH-HHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|...+.||+|+||.||+|... +|+.||||+++..........+..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999986 789999999976654444455666666 677789999999999999999999999
Q ss_pred ecccCCcchhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 365 PFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 365 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||+.+ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 777776531 111235899999999999999999999953 79999999999999999999999999997654
Q ss_pred CCCCceeecccccccccccccc----ccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... .+.+.....
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~---- 244 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVK---- 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCC----
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhc----
Confidence 322 12233589999999998 4567899999999999999999999999632110 000000000
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
-..+.............+.+++.+||+.||++|||+.++++
T Consensus 245 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 --GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011111111123457899999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.75 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=186.8
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEecc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.|...+.||+|+||+||.+...+|+.||||++.... ...+.+|+.++..+ +||||+++++++.++...++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344567899999999987766689999999986532 34577899999876 8999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-------------CcE
Q 007200 368 VNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 431 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~ 431 (613)
. |+|.+++......... ..+..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999765432211 13345678999999999999999 99999999999999754 489
Q ss_pred EEeccccceecCCCCCc---eeecccccccccccccccc-------CCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 432 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 432 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--- 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--- 244 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT---
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch---
Confidence 99999999877543222 1234569999999999976 568999999999999999999 999995221
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
......+..... .+.............+.+++.+||+.||++|||+.++++
T Consensus 245 ---~~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 ---SRESNIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---THHHHHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhHHHHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 011111111100 011111223456678999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=327.77 Aligned_cols=245 Identities=22% Similarity=0.382 Sum_probs=199.4
Q ss_pred HHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-----cHHHHHHHHHHHhhcc--cCccceeeEEE
Q 007200 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFC 354 (613)
Q Consensus 283 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~ 354 (613)
.....++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+..|+.+++.+. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999975 68899999997653221 1234667999999996 59999999999
Q ss_pred EcCCceEEEEecccC-CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEE
Q 007200 355 MTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAV 432 (613)
Q Consensus 355 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k 432 (613)
..+...++|+|++.+ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 89999997653 389999999999999999999999 999999999999999 788999
Q ss_pred EeccccceecCCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 433 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
|+|||+++...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------- 253 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------- 253 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------
Confidence 99999998765322 233458999999999987775 688999999999999999999996321
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... .. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~---~~----~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 EIIRGQV---FF----RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHCCC---CC----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhcccc---cc----cc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111100 00 11 12356889999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.12 Aligned_cols=252 Identities=23% Similarity=0.257 Sum_probs=173.2
Q ss_pred hhCCCCCC-ccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc----CCce
Q 007200 287 TDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 360 (613)
Q Consensus 287 ~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 360 (613)
.++|.+.+ .||+|+||+||+|.+. +|+.||||++.... .........+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 46788854 6999999999999987 69999999986431 122223334567789999999999876 4457
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEeccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 437 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG 437 (613)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999986542 3599999999999999999999999 9999999999999986 4559999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+++..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~ 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-----SPGMKRRIRLG 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-----hhhHHHhhhcc
Confidence 99865432 22334589999999999888899999999999999999999999963321100 00000000000
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ..............+.+++..||+.||++|||+.|+++
T Consensus 249 ---~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 ---Q---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---c---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00011111223467889999999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.07 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=191.8
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-----cHHHHHHHHHHHhhc----ccCccceee
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMA----VHRNLLRLR 351 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~niv~l~ 351 (613)
+.....++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999875 68899999997543221 122356789998888 899999999
Q ss_pred EEEEcCCceEEEEec-ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCC
Q 007200 352 GFCMTPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEF 429 (613)
Q Consensus 352 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~ 429 (613)
+++...+..++|+|| +.+++|.+++.... ++++..+..++.|++.||+|||++ +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 78999999998754 389999999999999999999999 999999999999999 889
Q ss_pred cEEEeccccceecCCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHH
Q 007200 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 508 (613)
.+||+|||+++...... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~ 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H
Confidence 99999999998765432 234558999999999987766 458999999999999999999996221 0
Q ss_pred HHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.... .. . ........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ----~~~~-~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ----ILEA-EL------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HHHT-CC------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----Hhhh-cc------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 0 111223568899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.38 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=190.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE----------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 355 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------- 355 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 367889999999999999999987 58999999986542 334567889999999999999999999874
Q ss_pred ----cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCc
Q 007200 356 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFE 430 (613)
Q Consensus 356 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~ 430 (613)
+....++||||+. |+|.++++.. ++++..+..++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467799999997 6999988642 389999999999999999999999 999999999999997 5679
Q ss_pred EEEeccccceecCCCCC--ceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHH
Q 007200 431 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~ 507 (613)
+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... . .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~---~ 231 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-----E---L 231 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-----H---H
Confidence 99999999986643211 12233457899999998865 678999999999999999999999996322 1 1
Q ss_pred HHHHHHhhcccc------cc-------cccCccC--CC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 508 DWVKGLLKEKKL------EQ-------LVDSDME--GN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 508 ~~~~~~~~~~~~------~~-------~~~~~~~--~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
+........... .+ ....... .. ........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111110000 00 0000000 00 00112467899999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.31 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=199.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CC-CEEEEEEeccccCcccHHHHHHHHHHHhhcccCc------cceeeEEEEcCC
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DG-SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 358 (613)
.++|.+.+.||+|+||+||+|.+. ++ +.||+|+++... .....+.+|+.+++.+.|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 478999999999999999999975 44 689999997432 23456888999999998766 899999999999
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-------------
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------- 425 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll------------- 425 (613)
..++||||+ ++++.+++..... .++++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777765432 2489999999999999999999999 99999999999999
Q ss_pred ------cCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccccccc
Q 007200 426 ------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (613)
Q Consensus 426 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~ 499 (613)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE-- 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC--
Confidence 56789999999999865432 233568999999999999999999999999999999999999996321
Q ss_pred CCCcchHHHHHHHHhhcccc---------cccccCcc---------------------CCCCcHHHHHHHHHHHHHccCC
Q 007200 500 NDDDVMLLDWVKGLLKEKKL---------EQLVDSDM---------------------EGNYIEEEVEQLIQVALLCTQG 549 (613)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~ 549 (613)
.......+......... ........ ...........+.+++.+||+.
T Consensus 244 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 ---NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 11111111111110000 00000000 0011223456789999999999
Q ss_pred CCCCCCCHHHHHH
Q 007200 550 SPMERPKMSEVVR 562 (613)
Q Consensus 550 dP~~RPt~~evl~ 562 (613)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.57 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=180.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHH-HHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|+..+.||+|+||.||+|.+. +|+.||||++..........+ +..+..+++.++||||+++++++.++...++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999986 789999999976554433333 344455678889999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||+ ++.+..+..... ..+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555555444322 248999999999999999999998 6 89999999999999999999999999997654
Q ss_pred CCCCceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||.... . ....+........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~---~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----T---DFEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----S---HHHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----c---cHHHHHHHhccCC
Confidence 322 223345899999999984 4568899999999999999999999996311 1 1122222222111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ... .......+.+++.+||+.||++|||+.++++
T Consensus 248 ~~------~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PL------LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC------CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC------CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 10 000 0112356889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.84 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=199.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc------CCc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 359 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++..........+.+|+++++.++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999975 6899999999776555556679999999999999999999998765 667
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEecc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDF 436 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Df 436 (613)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7999999999999999986543 23488999999999999999999999 9999999999999997765 999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....|.......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~ 239 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREK 239 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC--
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhcc
Confidence 9998765332 2234569999999999999999999999999999999999999995321 011111000000
Q ss_pred ccc----ccccc------C--ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 007200 517 KKL----EQLVD------S--DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560 (613)
Q Consensus 517 ~~~----~~~~~------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 560 (613)
... ..... . .............+.+++..||..||++|||+.|+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 00000 0 01112334466789999999999999999999774
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.29 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=186.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 365 (613)
..+|...+.||+|+||+||.....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3468888999999999976555567999999999654332 245899999998 79999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCcEEEeccccce
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLAK 440 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfGla~ 440 (613)
|+. |+|.+++...... +.+..+..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 6999999765432 44456678999999999999999 9999999999999953 2358899999998
Q ss_pred ecCCCCC--ceeeccccccccccccccc---cCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHh
Q 007200 441 LMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 514 (613)
Q Consensus 441 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 514 (613)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||.... . .......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-----~----~~~~~~~ 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-----Q----RQANILL 242 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-----T----HHHHHHT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-----H----HHHHHHh
Confidence 7653321 2233456999999999997 4567889999999999999999 999995211 0 1111111
Q ss_pred hcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... .. .........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~-~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSLD-CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCCT-TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCcc-cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111110 00 011233456789999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=347.31 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=193.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCc-----
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 359 (613)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999976 5889999998765444455678899999999999999999999987655
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++++|.+++.. ++++..+..++.||+.||+|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987754 389999999999999999999999 99999999999999986 9999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 876532 3355999999999987664 889999999999999999999885321100
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhh
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLE 565 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~ 565 (613)
+. ...........+.+++.+||+.||++||+ ++++...|.
T Consensus 284 --~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 --LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 00011223357889999999999999995 555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.30 Aligned_cols=229 Identities=12% Similarity=0.043 Sum_probs=182.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999986 5899999999765432 2345789999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.++++.. ....++..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999998542 34567889999999999999999 99999999999999999999997443
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
|++ .++.++|||||||++|||+||+.||.......... ......
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDT 218 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHh
Confidence 333 36789999999999999999999996432111000 000000
Q ss_pred cCccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 524 DSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 524 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
...... .........+.+++.+||+.||++| |+.|+++.|+..
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 000000 0011233568999999999999999 999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.50 Aligned_cols=243 Identities=16% Similarity=0.179 Sum_probs=186.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-------cccHHHHHHHHHHHhhcc---------cCccce
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAV---------HRNLLR 349 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~niv~ 349 (613)
..++|.+.+.||+|+||+||+|++ +|+.||||+++.... ......+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 689999999976532 223467889999988886 777777
Q ss_pred eeEEEE------------------------------cCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHH
Q 007200 350 LRGFCM------------------------------TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399 (613)
Q Consensus 350 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~ 399 (613)
+.+.+. +....++||||+.+|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 766542 26789999999999987777743 2389999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCceeecCCC--------------------cEEEeccccceecCCCCCceeeccccccc
Q 007200 400 RGLAYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458 (613)
Q Consensus 400 ~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 458 (613)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999876532 2359999
Q ss_pred cccccccccCCCCCcccchhHHHH-HHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc-cccCccCCCCcHHHH
Q 007200 459 HIAPEYLSTGKSSEKTDVFGYGVM-LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ-LVDSDMEGNYIEEEV 536 (613)
Q Consensus 459 y~aPE~~~~~~~~~~~DVwS~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 536 (613)
|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|...... ..... ...............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTD-KMLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHH-HHHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHH-hhhhhhccCcccchhhhhhcC
Confidence 99999998766 889999998777 7789999999952 112111110 00000 011111111234567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHH
Q 007200 537 EQLIQVALLCTQGSPMERPKMSEVV 561 (613)
Q Consensus 537 ~~l~~li~~cl~~dP~~RPt~~evl 561 (613)
..+.+++.+||+.| |++|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 88999999999976 999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.62 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=177.4
Q ss_pred hCCCCC-CccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHH-hhcccCccceeeEEEEc----CCce
Q 007200 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 360 (613)
Q Consensus 288 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 360 (613)
++|.+. +.||+|+||.||+|.+. +++.||+|++... ..+.+|+.++ +...||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 77999999999999975 7899999998532 3466888887 56689999999999876 6778
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEeccc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 437 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG 437 (613)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987542 2489999999999999999999999 9999999999999998 7899999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++.... +..++.++|||||||++|||++|+.||....... ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------------~~~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------ISPG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------------hhHH
Confidence 986432 2346778999999999999999999995322100 0000
Q ss_pred cccccccCccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 KLEQLVDSDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......... ..+ ......+.+++..||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 011 123467899999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.85 Aligned_cols=243 Identities=14% Similarity=0.097 Sum_probs=179.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhccc-Ccc---------ceeeEE-
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVH-RNL---------LRLRGF- 353 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h-~ni---------v~l~~~- 353 (613)
..|...+.||+|+||+||+|.+. +|+.||||+++...... ....+.+|+.++..+.| +|. +...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34667789999999999999965 79999999987433222 24578899999998876 221 111111
Q ss_pred -----------EEc-----CCceEEEEecccCCcchhhhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007200 354 -----------CMT-----PTERLLVYPFMVNGSVASCLRER---GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414 (613)
Q Consensus 354 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 414 (613)
+.. ....+++|+++ +++|.++++.. .....++++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12346666655 68999888521 22233588899999999999999999999 999
Q ss_pred ecCCCCCceeecCCCcEEEeccccceecCCCCCceeecccccccccccccc----------ccCCCCCcccchhHHHHHH
Q 007200 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGVMLL 484 (613)
Q Consensus 415 H~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DVwS~G~il~ 484 (613)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||.+ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865422 344557 999999999 5556888999999999999
Q ss_pred HHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 485 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 485 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
||++|+.||....... .....+.... ..+..+.+++..||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~-----------------~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG-----------------GSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGS-----------------CSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhh-----------------hHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999996332111 1111111100 11257899999999999999999988865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=277.85 Aligned_cols=187 Identities=15% Similarity=0.063 Sum_probs=131.7
Q ss_pred ccccCcCcEEEEEEe-CCCCEEEEEEeccccC---------cccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEEE
Q 007200 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 363 (613)
..+.|+.|.+..++. ..|+.+|+|++..... +....+|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356666666665542 2588999999975421 12234689999999999 699999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||++|++|.+++...+ +++.. +|+.||+.||+|+|++ |||||||||+|||+++++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998654 25553 5889999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~ 493 (613)
... ......+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 23345679999999999865 4677899999999988887766554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=236.19 Aligned_cols=179 Identities=31% Similarity=0.593 Sum_probs=163.8
Q ss_pred ccCchHHHHHHHHHHhcCCCCCCCCCCCCCCCCCcc--ceeEEeCCC---CCeEEEEcCCCCccc--ccchhhhCCCCCC
Q 007200 24 VASNAEGDALNALKTNLADPNNVLQSWDATLVNPCT--WFHVTCNSE---NSVTRVDLGNANLSG--QLVSQLGQLTNLQ 96 (613)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~C~--~~gv~c~~~---~~l~~L~l~~n~l~~--~~~~~~~~l~~L~ 96 (613)
.|.+.|++||++||+.+.||. .+++|+. +.+||. |.||+|+.. .+|+.|+|++|++++ .+|..+.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 467889999999999999886 7899975 478998 999999764 689999999999999 8999999999999
Q ss_pred EEEccc-ccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCC
Q 007200 97 YLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (613)
Q Consensus 97 ~L~L~~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (613)
+|+|++ |.+++.+|..|.++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..+..+++|+.|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCC-CCCCC-ccccccccCCCCCCCC
Q 007200 176 KLTGDIPT-NGSFS-LFTPISFANNQLNNPP 204 (613)
Q Consensus 176 ~l~~~~~~-~~~~~-~l~~l~l~~N~i~~~~ 204 (613)
+|++.++. ...++ .|+.|++++|.+....
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~ 190 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccC
Confidence 99966654 46776 8999999999887543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=251.95 Aligned_cols=185 Identities=14% Similarity=0.213 Sum_probs=146.3
Q ss_pred CCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcc-------cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
...+.||+|+||+||+|.. .++.+++|......... ...++.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 47889999875432211 123578999999999999999777777777888999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458899999999999999 9999999999999999 99999999999875
Q ss_pred CCCCce------eecccccccccccccccc--CCCCCcccchhHHHHHHHHHhCCCCc
Q 007200 444 YKDTHV------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 493 (613)
Q Consensus 444 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DVwS~G~il~elltg~~p~ 493 (613)
...... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 235679999999999977 56788899999999888888777766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=207.59 Aligned_cols=153 Identities=14% Similarity=0.055 Sum_probs=121.6
Q ss_pred HHHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-----------------ccHHHHHHHHHHHhhcc
Q 007200 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAV 343 (613)
Q Consensus 281 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~ 343 (613)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|.++..... .....+.+|+.+++.++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444445567777999999999999999977999999999643221 12456889999999998
Q ss_pred cCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 344 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+. +|+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4 666665433 56699999999999998 421 12457999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCCceeeccccccccccccccc
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 466 (613)
|++ ++.+||+|||+++ .+..|+|||.+.
T Consensus 225 Ll~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSV--------------EVGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCE--------------ETTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCe--------------ECCCCCHHHHHH
Confidence 999 9999999999997 344578999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-24 Score=241.46 Aligned_cols=178 Identities=29% Similarity=0.389 Sum_probs=129.8
Q ss_pred hccCchHHHHHHHHHHhcCCCCCCCCCCCCCCCCCccceeEEeCCCCCeEEEEcCCCCcccc---cch------------
Q 007200 23 RVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQ---LVS------------ 87 (613)
Q Consensus 23 ~~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~C~~~gv~c~~~~~l~~L~l~~n~l~~~---~~~------------ 87 (613)
+.+.+.|++||++||+++.||. .+++|+ .+.+||.|.||+|+ .++|+.|+|+++++.|. ++.
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 3345679999999999999998 899997 45789999999998 67999999999999886 554
Q ss_pred -----------hhhCCCCCCEEEcccccCCCCCcc--ccccCCcCCeEeccCccCCCCCCccc-ccccccccccccCccc
Q 007200 88 -----------QLGQLTNLQYLELYSNNISGKVPE--ELGNLTNLVSLDLYLNNLNGPIPTTL-GKLSKLRFLRLNNNSL 153 (613)
Q Consensus 88 -----------~~~~l~~L~~L~L~~N~i~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l 153 (613)
.++++++|++|+|++|.++|.+|. .+.++++|++|+|++|.+++.+|..+ .++++|++|+|++|++
T Consensus 84 ~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 163 (768)
T 3rgz_A 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163 (768)
T ss_dssp CTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCC
T ss_pred CcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCcc
Confidence 556667777777777777776776 67777777777777777776666654 6677777777777777
Q ss_pred cCccccc---cccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 154 MGEIPRS---LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 154 ~~~~~~~---~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++..|.. +.++++|+.|++++|.+++.++. ..+++|+.|++++|.+...+
T Consensus 164 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~l~~~~ 216 (768)
T 3rgz_A 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNFSTGI 216 (768)
T ss_dssp EEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSCCCSCC
T ss_pred CCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCcCCCCC
Confidence 6655554 55566666666666666554433 45566666666666665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-23 Score=236.40 Aligned_cols=172 Identities=20% Similarity=0.256 Sum_probs=149.8
Q ss_pred CchHHHHHHHHHHhcCCCCCCCCCCCCCC----CCC--ccc------------eeEEeCCCCCeEEEEcCCCCcccccch
Q 007200 26 SNAEGDALNALKTNLADPNNVLQSWDATL----VNP--CTW------------FHVTCNSENSVTRVDLGNANLSGQLVS 87 (613)
Q Consensus 26 ~~~~~~~l~~~k~~~~~~~~~~~~w~~~~----~~~--C~~------------~gv~c~~~~~l~~L~l~~n~l~~~~~~ 87 (613)
...|++||++||+++.+| +|+... .+| |.| .||+|+...+|+.|+|++|+|+|.+|.
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 346999999999999887 886654 466 999 999998778999999999999999999
Q ss_pred hhhCCCCCCEEEc-ccccCCCC----------------------------------------------------------
Q 007200 88 QLGQLTNLQYLEL-YSNNISGK---------------------------------------------------------- 108 (613)
Q Consensus 88 ~~~~l~~L~~L~L-~~N~i~~~---------------------------------------------------------- 108 (613)
.|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 77765443
Q ss_pred ------------------CccccccCCcCCeEeccCccCCC-----------------CCCcccc--cccccccccccCc
Q 007200 109 ------------------VPEELGNLTNLVSLDLYLNNLNG-----------------PIPTTLG--KLSKLRFLRLNNN 151 (613)
Q Consensus 109 ------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N 151 (613)
+|..|.+|++|++|+|++|+|++ .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 78889999999999999999998 3898877 9999999999999
Q ss_pred cccCccccccccccchhhhhhcCCC-ccc-CCC-CC-------CCCCccccccccCCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNK-LTG-DIP-TN-------GSFSLFTPISFANNQLNN 202 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~-~~-------~~~~~l~~l~l~~N~i~~ 202 (613)
++.+.+|..|.++++|+.|+|++|+ +++ .+| .. ..+++|+.|++++|.+..
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ 562 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc
Confidence 9999999999999999999999998 887 333 22 344588999999998883
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=224.86 Aligned_cols=174 Identities=22% Similarity=0.288 Sum_probs=152.4
Q ss_pred chHHHHHHHHHHhcCCCC-C-------CCCCCCCCCCCCccc---eeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCC
Q 007200 27 NAEGDALNALKTNLADPN-N-------VLQSWDATLVNPCTW---FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNL 95 (613)
Q Consensus 27 ~~~~~~l~~~k~~~~~~~-~-------~~~~w~~~~~~~C~~---~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L 95 (613)
..|++||.+|+.++..++ . ...+|+.. .++|.| .||+|+..++|+.|+|++|+++|.+|..+++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 368999999999987542 2 23489864 899999 99999887899999999999999999999999999
Q ss_pred CEEEccccc-----------------------------------------------------------------------
Q 007200 96 QYLELYSNN----------------------------------------------------------------------- 104 (613)
Q Consensus 96 ~~L~L~~N~----------------------------------------------------------------------- 104 (613)
+.|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999994
Q ss_pred -------CCCCCccccccCCcCCeEeccCccCCCC-----------------CCcccc--cccccccccccCccccCccc
Q 007200 105 -------ISGKVPEELGNLTNLVSLDLYLNNLNGP-----------------IPTTLG--KLSKLRFLRLNNNSLMGEIP 158 (613)
Q Consensus 105 -------i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~~ 158 (613)
+++ +|..|+++++|++|+|++|.|++. +|..++ ++++|++|+|++|++.+.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 345 788899999999999999999985 999999 99999999999999999999
Q ss_pred cccccccchhhhhhcCCC-ccc-CCC-CCCCC------CccccccccCCCCCC
Q 007200 159 RSLTNVNSLQVLDLSNNK-LTG-DIP-TNGSF------SLFTPISFANNQLNN 202 (613)
Q Consensus 159 ~~~~~l~~L~~L~l~~N~-l~~-~~~-~~~~~------~~l~~l~l~~N~i~~ 202 (613)
..+.++++|+.|+|++|+ +++ .+| ..+.+ ++|+.|++++|.+..
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ 319 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCc
Confidence 999999999999999998 987 444 33444 889999999999884
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-22 Score=206.00 Aligned_cols=177 Identities=20% Similarity=0.281 Sum_probs=151.5
Q ss_pred cCchHHHHHHHHHHhc-CCCCCCCCCCC---CCCCCCccceeEEeCC---------CCCeEEEEcCCCCcccccchhhhC
Q 007200 25 ASNAEGDALNALKTNL-ADPNNVLQSWD---ATLVNPCTWFHVTCNS---------ENSVTRVDLGNANLSGQLVSQLGQ 91 (613)
Q Consensus 25 ~~~~~~~~l~~~k~~~-~~~~~~~~~w~---~~~~~~C~~~gv~c~~---------~~~l~~L~l~~n~l~~~~~~~~~~ 91 (613)
+...+++||++||..+ .||.+.+++|. ....++|.|.|+.|.. ..+|+.|+|++|+++ .+|..+.+
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 4467999999999988 47877788994 4567899999999942 368999999999998 67788888
Q ss_pred CCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccccccc--------
Q 007200 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN-------- 163 (613)
Q Consensus 92 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------- 163 (613)
+++|++|+|++|.|+ .+|..+..+++|++|+|++|.|+ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 999999999999999 88888999999999999999999 78989999999999999998888888877654
Q ss_pred -ccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 164 -VNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 164 -l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+++|+.|+|++|.|+..+.....+++|+.|++++|.+...+
T Consensus 181 ~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~ 222 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALG 222 (328)
T ss_dssp ESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCC
T ss_pred cCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCc
Confidence 88899999999998866666677888889999998887543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-21 Score=184.53 Aligned_cols=150 Identities=24% Similarity=0.249 Sum_probs=136.7
Q ss_pred CCCCccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEe
Q 007200 54 LVNPCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123 (613)
Q Consensus 54 ~~~~C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~ 123 (613)
....|.|.+|.|+.. .+++.|+|++|.|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence 357899999999652 4799999999999998899999999999999999999977677789999999999
Q ss_pred ccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCC
Q 007200 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~ 202 (613)
|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999999877788999999999999999999 7889999999999999999999988875 4778999999999999988
Q ss_pred CC
Q 007200 203 PP 204 (613)
Q Consensus 203 ~~ 204 (613)
..
T Consensus 174 ~c 175 (229)
T 3e6j_A 174 EC 175 (229)
T ss_dssp TB
T ss_pred Cc
Confidence 64
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=179.88 Aligned_cols=147 Identities=22% Similarity=0.302 Sum_probs=134.6
Q ss_pred CccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 57 PCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 57 ~C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
.|.|..|.|... .+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|+.|.++++|++|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 368889999642 3799999999999988888999999999999999999988899999999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
|+|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999977677789999999999999999988899999999999999999999998876 47789999999999999885
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.4e-20 Score=173.72 Aligned_cols=148 Identities=24% Similarity=0.264 Sum_probs=133.2
Q ss_pred CccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 57 PCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 57 ~C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
.|.|.+|.|+.. .+++.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 478999999642 3699999999999987777899999999999999999977777789999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|.|++.++.. ..+++|+.|++++|++.+..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999777777999999999999999999777777899999999999999999888764 77899999999999888754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-20 Score=176.78 Aligned_cols=147 Identities=18% Similarity=0.251 Sum_probs=133.0
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCcccccc-hhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
|.|..+.|+.. ..++.|+|++|+|++..+ ..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 68888999642 258899999999998755 5689999999999999999988888999999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 999988888899999999999999999988899999999999999999999998665 477899999999999998853
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-19 Score=173.61 Aligned_cols=137 Identities=23% Similarity=0.275 Sum_probs=124.1
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 36899999999999888889999999999999999999888888999999999999999999887888999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|+|++..+..|..+++|+.|+|++|.|++.++. ...+++|+.|++++|.+...++
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 99999977777788999999999999999988875 4788999999999999987654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=176.05 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=106.2
Q ss_pred CCCCCccccCcCcEEEEEEe-CCCCE--EEEEEeccccCc-----------------------ccHHHHHHHHHHHhhcc
Q 007200 290 FSNRNILGRGGFGKVYKGRL-TDGSL--VAVKRLKEERTQ-----------------------GGELQFQTEVEMISMAV 343 (613)
Q Consensus 290 ~~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 343 (613)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... .....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 57888 999987543211 01135788999999999
Q ss_pred cCcc--ceeeEEEEcCCceEEEEecccC-C----cchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 007200 344 HRNL--LRLRGFCMTPTERLLVYPFMVN-G----SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIH 415 (613)
Q Consensus 344 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH 415 (613)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 344432 367899999942 4 44444322 224467889999999999999 88 9999
Q ss_pred cCCCCCceeecCCCcEEEeccccceecC
Q 007200 416 RDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 416 ~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||||+|||++. .++|+|||+|....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999997543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-18 Score=167.78 Aligned_cols=136 Identities=26% Similarity=0.275 Sum_probs=126.3
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999998888899999999999999999988888899999999999999999987777899999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|+|++..+..|..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999977777899999999999999999998875 47789999999999999886
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-18 Score=168.60 Aligned_cols=136 Identities=26% Similarity=0.295 Sum_probs=105.4
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|+|++|++++..+..|.++++|++|+|++|.|+...+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 47788888888876666678888888888888888886556667778888888888888886666677788888888888
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+|++++..+..|..+++|+.|+|++|.|++.++.. ..+++|+.|++++|.+...++
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 88888766777778888888888888888776653 667788888888887776544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-19 Score=164.94 Aligned_cols=128 Identities=23% Similarity=0.351 Sum_probs=64.6
Q ss_pred EEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCcc-ccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 73 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
.|++++|+|+ .+|..+. .+|+.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4444455554 3333222 1455555555555543332 2555555555555555555555555555555555555555
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++..+..|.++++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 555444444555555555555555555544332 4445555555555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.1e-19 Score=189.91 Aligned_cols=129 Identities=27% Similarity=0.197 Sum_probs=80.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccc-ccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG-KLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 147 (613)
++++.|+|++|.|++..+. .+++|+.|+|++|.|++..|..|..+++|++|+|++|.|++.+|..+. .+++|++|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 4566666666666654433 345666666666666666666666666666666666666666666554 566666666
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
|++|.|++. |. +..+++|+.|+|++|.|++.++....+++|+.|++++|.+..
T Consensus 176 Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE
T ss_pred cCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc
Confidence 666666644 22 234666666666666666666655566666666666666664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.4e-18 Score=190.54 Aligned_cols=165 Identities=18% Similarity=0.186 Sum_probs=132.0
Q ss_pred CCCCCCCCCCCCC---CCCCccce----eEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccc
Q 007200 41 ADPNNVLQSWDAT---LVNPCTWF----HVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN 103 (613)
Q Consensus 41 ~~~~~~~~~w~~~---~~~~C~~~----gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 103 (613)
+|+...+++|+.. ..+||.+. .|.|.. +.+++.|||++|.|++..+..|.++++|++|+|++|
T Consensus 7 ~~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N 86 (635)
T 4g8a_A 7 KDDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 86 (635)
T ss_dssp ------------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CCCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCC
Confidence 3555556666432 23467553 478964 247999999999999888889999999999999999
Q ss_pred cCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCC-C
Q 007200 104 NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI-P 182 (613)
Q Consensus 104 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~ 182 (613)
+|++..|++|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|+.|+|++|.|++.. +
T Consensus 87 ~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 87 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence 999888889999999999999999999777788999999999999999999777778999999999999999998643 3
Q ss_pred C-CCCCCccccccccCCCCCCCCC
Q 007200 183 T-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 183 ~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
. ...++.|+.|++++|.+...++
T Consensus 167 ~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECG
T ss_pred hhhccchhhhhhcccCcccccccc
Confidence 3 4778999999999999987654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=165.48 Aligned_cols=135 Identities=30% Similarity=0.354 Sum_probs=88.1
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
++++.|+|++|.+++. ..+.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 63 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 4666777777766642 35666667777777777776655555666677777777777766655556666667777777
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|++++..+..+..+++|+.|++++|+|++.++.. ..+++|+.|++++|.+...++
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 777666555555666667777777777766665543 556666677777766665443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.8e-18 Score=173.93 Aligned_cols=147 Identities=25% Similarity=0.277 Sum_probs=130.6
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCcccccchhhh-CCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
|.+..|.|... ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56777888542 3588999999999988888887 999999999999999988888899999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC----CCCCccccccccCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN----GSFSLFTPISFANNQLNN 202 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~i~~ 202 (613)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+... ..+++|+.|++++|.+..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 9999877888999999999999999999888899999999999999999999887764 468999999999999886
Q ss_pred CC
Q 007200 203 PP 204 (613)
Q Consensus 203 ~~ 204 (613)
.+
T Consensus 178 l~ 179 (361)
T 2xot_A 178 LP 179 (361)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=156.39 Aligned_cols=147 Identities=22% Similarity=0.277 Sum_probs=123.2
Q ss_pred CccceeEEeCCC----------CCeEEEEcCCCCcccccch-hhhCCCCCCEEEcccccCCCCCccccccCCcCCeEecc
Q 007200 57 PCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125 (613)
Q Consensus 57 ~C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls 125 (613)
-|.|..+.|+.. .+++.|+|++|.|++..+. .|.++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 368888999642 3799999999999977664 58999999999999999999989999999999999999
Q ss_pred CccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|+|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+.......+....+.++...|.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 999998888889999999999999999999889999999999999999999997654321112233334445544444
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=190.51 Aligned_cols=120 Identities=36% Similarity=0.602 Sum_probs=112.5
Q ss_pred CCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhh
Q 007200 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVL 170 (613)
Q Consensus 91 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 170 (613)
++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|..+..+++|+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 35779999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCcccCCCCCCCCCccccccccCCCCCCCCCCCCCCC
Q 007200 171 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211 (613)
Q Consensus 171 ~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~~~~~~ 211 (613)
+|++|+++|.+|..+.+..+...++.||+..|++|.+ +|.
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~ 749 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD 749 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence 9999999999999888999999999999999987654 453
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.4e-17 Score=163.95 Aligned_cols=135 Identities=28% Similarity=0.310 Sum_probs=109.7
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|+|++|.|++..+. ..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|
T Consensus 53 ~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 53 PYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 346788889988888854432 67888888888888888 677778888888888888888887777788888888888
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|++|+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...+
T Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip 188 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (290)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccC
Confidence 88888888776777788888888888888888877765 56788888888888887544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-17 Score=153.88 Aligned_cols=128 Identities=25% Similarity=0.304 Sum_probs=113.5
Q ss_pred EEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
+.+++++|+|+ .+|..+ .++|+.|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46788888988 455544 368999999999998 78889999999999999999999888889999999999999999
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++..+..|..+++|+.|+|++|.|+..++. ...+++|+.|++++|++.|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99988888899999999999999999988876 46789999999999999875
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.9e-17 Score=160.59 Aligned_cols=138 Identities=25% Similarity=0.285 Sum_probs=120.0
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.|+...+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|++++..+..|..+++|++|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 45899999999999977677788999999999999999977777889999999999999999988888889999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|+|++..+..|..+++|+.|+|++|.|++.++. ...+++|+.|++++|.+...++
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCH
Confidence 999999976666788999999999999999988775 3678899999999998886554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-17 Score=151.96 Aligned_cols=135 Identities=23% Similarity=0.281 Sum_probs=121.8
Q ss_pred CCeEEEEcCCCCcc-cccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
.+++.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 58999999999998 77888899999999999999999965 6799999999999999999987888888999999999
Q ss_pred ccCccccCcc-ccccccccchhhhhhcCCCcccCCC----CCCCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|+|++.. +..+..+++|+.|++++|++++.++ ....+++|+.|++++|.+...+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 9999999643 3789999999999999999998887 45789999999999998876543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=151.59 Aligned_cols=133 Identities=23% Similarity=0.287 Sum_probs=87.7
Q ss_pred ccceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccc
Q 007200 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL 137 (613)
Q Consensus 58 C~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 137 (613)
|.|.++.|+ +|+++. +|..+ .++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|
T Consensus 7 C~~~~l~~~-----------~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCN-----------SKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECC-----------SSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEec-----------CCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 566666664 445552 33222 3567777777777776555566777777777777777775555566
Q ss_pred ccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCC
Q 007200 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 138 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
..+++|++|+|++|+|++..+..+..+++|+.|+|++|.|++.++.. ..+++|+.|++++|++.|..
T Consensus 73 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 77777777777777777555556667777777777777777666654 45677777777777776654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-17 Score=169.86 Aligned_cols=133 Identities=27% Similarity=0.437 Sum_probs=78.1
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.++.|+|++|.+++.+|..+..++ |+.|+|++|.+++.+|..|..+++|++|+|++|.+++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 344444444444444444444444 55555555555545555555555666666666666544443 5556666666666
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|+|++.+|..+..+++|+.|+|++|+|++.+|....+++|+.+++++|+..|+.
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCC
Confidence 6666666666666666666666666666666666566666666666666655554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.9e-17 Score=162.43 Aligned_cols=134 Identities=17% Similarity=0.149 Sum_probs=121.0
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|+|++|++++..+..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 69999999999998877799999999999999999997777789999999999999999998888899999999999999
Q ss_pred CccccCccccccccccchhhhhhcCCCcccC--CCCCCCCCccccccccCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD--IPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++++..+..+..+++|+.|++++|.+++. +.....+++|+.|++++|.+...
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 9999977777899999999999999999873 34457889999999999988764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.6e-17 Score=168.22 Aligned_cols=140 Identities=15% Similarity=0.109 Sum_probs=101.7
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-------------ccHH--------HHHHHHHHHhhcccCcc
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------------GGEL--------QFQTEVEMISMAVHRNL 347 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------~~~~--------~~~~e~~~l~~l~h~ni 347 (613)
-|++.+.||+|++|.||+|...+|+.||||+++..... .... ...+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48889999999999999999989999999987632110 0011 12345666666655443
Q ss_pred ceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 007200 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (613)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 427 (613)
.-..-+.. ...++||||+.|++|..+... .....++.|++.+|.|||+. |||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 22211111 234799999999988765421 12456789999999999999 9999999999999998
Q ss_pred CC----------cEEEeccccceecC
Q 007200 428 EF----------EAVVGDFGLAKLMD 443 (613)
Q Consensus 428 ~~----------~~kl~DfGla~~~~ 443 (613)
++ .+.|+||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38999999876543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=6e-17 Score=173.11 Aligned_cols=137 Identities=24% Similarity=0.269 Sum_probs=128.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..+..+.++++|+.|+|++|.|++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888989999999999999999999888899999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|++++..|..+..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|..+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999988765 788999999999999998765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-16 Score=156.76 Aligned_cols=138 Identities=24% Similarity=0.224 Sum_probs=124.9
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 46899999999999988888899999999999999999988888899999999999999999987788889999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|++++..+..+..+++|+.|++++|+|++.++.. ..+++|+.|++++|++.|..+
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999877778899999999999999999988764 778999999999999987643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=149.66 Aligned_cols=124 Identities=26% Similarity=0.375 Sum_probs=111.9
Q ss_pred CccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 57 PCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 57 ~C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
.|.|..+.|+.. .+++.|+|++|.|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 357778888642 37999999999999 6778999999999999999999988888999999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI 181 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 181 (613)
|+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|++.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999888889999999999999999999766678999999999999999998653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.3e-17 Score=172.46 Aligned_cols=152 Identities=19% Similarity=0.284 Sum_probs=132.8
Q ss_pred CCCcccee--EEeCCC---------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCC-ccccccCCcCCeE
Q 007200 55 VNPCTWFH--VTCNSE---------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSL 122 (613)
Q Consensus 55 ~~~C~~~g--v~c~~~---------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L 122 (613)
...|.|.+ |.|... .+++.|+|++|.+++..+..|.++++|++|+|++|.+.+.+ +..|.++++|++|
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34576666 888642 47999999999999888999999999999999999998655 5679999999999
Q ss_pred eccCccCCCCCCcccccccccccccccCccccCccccc--cccccchhhhhhcCCCcccCCCC--CCCCCccccccccCC
Q 007200 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANN 198 (613)
Q Consensus 123 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N 198 (613)
+|++|++++..|..|.++++|++|+|++|++++.++.. +..+++|+.|+|++|.+++..+. ...+++|+.|++++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999888999999999999999999999766554 89999999999999999998665 478899999999999
Q ss_pred CCCCCCCC
Q 007200 199 QLNNPPPS 206 (613)
Q Consensus 199 ~i~~~~~~ 206 (613)
.+....+.
T Consensus 165 ~l~~~~~~ 172 (455)
T 3v47_A 165 KVKSICEE 172 (455)
T ss_dssp CBSCCCTT
T ss_pred cccccChh
Confidence 99876543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=177.46 Aligned_cols=152 Identities=18% Similarity=0.213 Sum_probs=133.8
Q ss_pred CCCccce----eEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCC
Q 007200 55 VNPCTWF----HVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120 (613)
Q Consensus 55 ~~~C~~~----gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~ 120 (613)
.+||.+. .|.|.. ..+++.|+|++|.+++..+..|.++++|++|+|++|.|++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 4567663 588854 24799999999999988888999999999999999999988899999999999
Q ss_pred eEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCccc--CCCCCCCCCccccccccCC
Q 007200 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG--DIPTNGSFSLFTPISFANN 198 (613)
Q Consensus 121 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~~l~~l~l~~N 198 (613)
+|+|++|.|++..|..|+++++|++|+|++|++++..+..+..+++|+.|++++|.+++ .+.....+++|+.|++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998889999999999999999999997777889999999999999999986 3445688999999999999
Q ss_pred CCCCCCCC
Q 007200 199 QLNNPPPS 206 (613)
Q Consensus 199 ~i~~~~~~ 206 (613)
.+...++.
T Consensus 164 ~l~~~~~~ 171 (606)
T 3vq2_A 164 YIQTITVN 171 (606)
T ss_dssp CCCEECTT
T ss_pred cceecChh
Confidence 98876543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=159.37 Aligned_cols=137 Identities=24% Similarity=0.233 Sum_probs=122.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCcc-CCCCCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 147 (613)
.+++.|+|++|.+++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|. ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 479999999999998877889999999999999999998888899999999999999997 8876688999999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|++++..|..+..+++|+.|++++|.+++.++. ...+++|+.|++++|.+...++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 999999988788899999999999999999988776 4778999999999998876543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.4e-17 Score=146.71 Aligned_cols=127 Identities=21% Similarity=0.265 Sum_probs=114.3
Q ss_pred CCeEEEEcCCCCcc-cccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 69 NSVTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
.+++.|++++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|.|++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999998 78888899999999999999999965 6799999999999999999987898898999999999
Q ss_pred ccCccccCc-cccccccccchhhhhhcCCCcccCCC----CCCCCCccccccccC
Q 007200 148 LNNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISFAN 197 (613)
Q Consensus 148 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~ 197 (613)
|++|++++. .+..+..+++|+.|++++|++++.++ ....+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999964 34789999999999999999998876 346788899988764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=146.47 Aligned_cols=115 Identities=28% Similarity=0.287 Sum_probs=105.2
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 35899999999999987778899999999999999999977777789999999999999999988778899999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (613)
|++|+|++..+..+..+++|+.|+|++|++.+..+
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999997666677899999999999999998765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=162.77 Aligned_cols=136 Identities=21% Similarity=0.319 Sum_probs=122.1
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccc--------
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK-------- 139 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 139 (613)
..+++.|+|++|.++ .+|..+.++++|++|+|++|.|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 357999999999999 78888999999999999999999 78888999999999999999988889887765
Q ss_pred -ccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCC
Q 007200 140 -LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 140 -l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+++.++....+++|+.|++++|.+....+.
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~ 247 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPP 247 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCC
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHH
Confidence 999999999999999 888889999999999999999998887778889999999999988876554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.2e-16 Score=155.70 Aligned_cols=138 Identities=20% Similarity=0.222 Sum_probs=120.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEccccc-CCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
..+++.|+|++|.+++..+..|.++++|++|+|++|. ++...|..|..+++|++|+|++|++++..|..|.++++|++|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 4589999999999998888899999999999999997 876668889999999999999999998888889999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+|++|++++..+..+..+++|+.|+|++|.|++.++. ...+++|+.|++++|.+....+
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 9999999977677788999999999999999987775 4778899999999998876543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-16 Score=155.81 Aligned_cols=135 Identities=27% Similarity=0.255 Sum_probs=116.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.|++..+..|.++++|+.|+|++|.|++. +. ...+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 4789999999999988888899999999999999999854 43 378899999999999998 67888889999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
++|+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...++.
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 166 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHH
Confidence 999999777788999999999999999999887765 6788999999999998876553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=150.33 Aligned_cols=140 Identities=26% Similarity=0.246 Sum_probs=122.9
Q ss_pred cceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccc
Q 007200 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138 (613)
Q Consensus 59 ~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 138 (613)
.+....|+. +.+++++++++ .+|..+ .++|+.|+|++|+|++..|..|..+++|++|+|++|+|+...+..|.
T Consensus 13 ~~~~~~Cs~----~~v~c~~~~l~-~ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 13 CPSQCSCSG----TTVDCRSKRHA-SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp CCTTCEEET----TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCCEEeC----CEeEccCCCcC-ccCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 344567853 57999999998 455544 38999999999999998899999999999999999999977677889
Q ss_pred cccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 139 KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 139 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
.+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+..+.....+++|+.|++++|.+...++
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 9999999999999999777778899999999999999999887777889999999999999987654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=165.10 Aligned_cols=150 Identities=24% Similarity=0.262 Sum_probs=127.6
Q ss_pred CCCccceeE-EeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEe
Q 007200 55 VNPCTWFHV-TCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123 (613)
Q Consensus 55 ~~~C~~~gv-~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~ 123 (613)
..+|.|.|+ .|+. ..+++.|+|++|++++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+
T Consensus 27 ~~~C~~~~~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CCEECTTSEEECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCCeEeeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 456888776 2221 23799999999999987777999999999999999999988888999999999999
Q ss_pred ccCccCCCCCCcccccccccccccccCccccCccc-cccccccchhhhhhcCC-CcccCCCC-CCCCCccccccccCCCC
Q 007200 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNN-KLTGDIPT-NGSFSLFTPISFANNQL 200 (613)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~-~~~~~~l~~l~l~~N~i 200 (613)
|++|+|++..+..|.++++|++|+|++|++++..+ ..+..+++|+.|++++| .+.+.++. ...+++|+.|++++|.+
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 99999996655669999999999999999995444 47899999999999999 57776554 47889999999999998
Q ss_pred CCCC
Q 007200 201 NNPP 204 (613)
Q Consensus 201 ~~~~ 204 (613)
....
T Consensus 187 ~~~~ 190 (353)
T 2z80_A 187 QSYE 190 (353)
T ss_dssp CEEC
T ss_pred CccC
Confidence 7653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-17 Score=181.91 Aligned_cols=175 Identities=18% Similarity=0.150 Sum_probs=108.4
Q ss_pred CchHHHHHHHHHHhcC-CCCCCCCCCCCCCCCCccceeEEeCCCCCeEE------------------EEcCCCCccc---
Q 007200 26 SNAEGDALNALKTNLA-DPNNVLQSWDATLVNPCTWFHVTCNSENSVTR------------------VDLGNANLSG--- 83 (613)
Q Consensus 26 ~~~~~~~l~~~k~~~~-~~~~~~~~w~~~~~~~C~~~gv~c~~~~~l~~------------------L~l~~n~l~~--- 83 (613)
.+.++++|+++...+. .....-.+|.......+.|.++.++. ++++. ++|++|.|.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~ 208 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD 208 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhhcCccCcccccCccc
Confidence 3467789999987664 22233446755555566787766644 23333 3344444332
Q ss_pred ------ccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcc
Q 007200 84 ------QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEI 157 (613)
Q Consensus 84 ------~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 157 (613)
..+..+..++.|+.|+|++|.|. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+
T Consensus 209 ~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 209 IENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 23566788888999999999988 67777778999999999999998 78888899999999999999998 77
Q ss_pred ccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 158 PRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 158 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|..|..|++|+.|+|++|.|+.++..++.+++|+.|++++|.+.+.+
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~ 332 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQF 332 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHH
T ss_pred ChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCC
Confidence 88888999999999999999877777788889999999999887643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-16 Score=149.14 Aligned_cols=142 Identities=22% Similarity=0.265 Sum_probs=123.6
Q ss_pred CccceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcc
Q 007200 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT 136 (613)
Q Consensus 57 ~C~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 136 (613)
.|.- +.+|.. +.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..
T Consensus 4 ~CP~-~C~C~~----~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 4 HCPA-ACTCSN----NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp CSCT-TSEEET----TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred CCCC-CCEECC----CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 4543 577863 57999999999 4555443 78999999999999877788999999999999999999888999
Q ss_pred cccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCC
Q 007200 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
|.++++|++|+|++|+|+...+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...++.
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 999999999999999999666667899999999999999999987654 7889999999999999887653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.6e-16 Score=174.07 Aligned_cols=136 Identities=18% Similarity=0.179 Sum_probs=122.9
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++++|.++...+..|.++++|+.|+|++|.|++..|..|..+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 46789999999999777778899999999999999999888889999999999999999999888888999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|.|++..+..|.++++|+.|+|++|.|++.++. ...+++|+.|++++|.+...+
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC
Confidence 99999966666679999999999999999998875 478899999999999987754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=174.96 Aligned_cols=148 Identities=23% Similarity=0.271 Sum_probs=130.1
Q ss_pred CccceeEEeCC------------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEec
Q 007200 57 PCTWFHVTCNS------------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124 (613)
Q Consensus 57 ~C~~~gv~c~~------------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L 124 (613)
.|.|.|+ |+. ..+++.|+|++|++++..+..|.++++|++|+|++|+|++..|+.|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4889887 742 137999999999999888899999999999999999999888899999999999999
Q ss_pred cCccCCCCCCcccccccccccccccCccccC-ccccccccccchhhhhhcCCCc-ccCCC-CCCCCCccccccccCCCCC
Q 007200 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKL-TGDIP-TNGSFSLFTPISFANNQLN 201 (613)
Q Consensus 125 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l-~~~~~-~~~~~~~l~~l~l~~N~i~ 201 (613)
++|++++..|..|+++++|++|+|++|++++ ..|..+.++++|+.|++++|.+ ...++ ....+++|+.|++++|.+.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998878889999999999999999986 3577899999999999999994 44443 4578999999999999988
Q ss_pred CCCC
Q 007200 202 NPPP 205 (613)
Q Consensus 202 ~~~~ 205 (613)
...+
T Consensus 162 ~~~~ 165 (549)
T 2z81_A 162 NYQS 165 (549)
T ss_dssp EECT
T ss_pred ccCh
Confidence 7543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-16 Score=168.07 Aligned_cols=146 Identities=21% Similarity=0.263 Sum_probs=130.0
Q ss_pred cceeEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCcc
Q 007200 59 TWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128 (613)
Q Consensus 59 ~~~gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~ 128 (613)
.|..|.|.. ..+++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 356788854 2378999999999998888999999999999999999998889999999999999999999
Q ss_pred CCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+. ...+++|+.|++++|.+...+
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 9976667789999999999999999988888999999999999999999987664 477899999999999887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.2e-16 Score=150.15 Aligned_cols=116 Identities=18% Similarity=0.232 Sum_probs=109.1
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|+|++|.|++..+..|.++++|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|..+++|++|
T Consensus 55 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp GCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred cCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 34689999999999998888899999999999999999998888889999999999999999999889999999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (613)
+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999998889999999999999999999997644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.6e-16 Score=152.97 Aligned_cols=140 Identities=22% Similarity=0.279 Sum_probs=123.4
Q ss_pred EEeCC-------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEccccc-CCCCCccccccCCcCCeEeccC-ccCCCCC
Q 007200 63 VTCNS-------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNLTNLVSLDLYL-NNLNGPI 133 (613)
Q Consensus 63 v~c~~-------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 133 (613)
|.|.. ..+++.|+|++|++++..+..|.++++|+.|+|++|. +++..+..|.++++|++|+|++ |+|++..
T Consensus 18 v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp EEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred eEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 66864 3479999999999998888899999999999999997 8877777899999999999999 9999777
Q ss_pred CcccccccccccccccCccccCccccccccccchh---hhhhcCC-CcccCCCC-CCCCCccc-cccccCCCCCCCC
Q 007200 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ---VLDLSNN-KLTGDIPT-NGSFSLFT-PISFANNQLNNPP 204 (613)
Q Consensus 134 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~-~~~~~~l~-~l~l~~N~i~~~~ 204 (613)
+..|.++++|++|+|++|++++ +|. +..+++|+ .|++++| .+++.++. ...+++|+ .|++++|.+...+
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~ 172 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ 172 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEEC
T ss_pred HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccC
Confidence 7889999999999999999995 666 88888888 9999999 99988876 47789999 9999999887543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=159.35 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=125.2
Q ss_pred CCCCeEEEEcCCCCcccccc-hhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCC-CCCcccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLR 144 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~ 144 (613)
...+++.|+|++|.+++..+ ..+.++++|+.|+|++|.+++..+..|..+++|++|+|++|.+++ .+|..+..+++|+
T Consensus 99 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 178 (306)
T 2z66_A 99 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178 (306)
T ss_dssp TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCC
Confidence 45789999999999997665 678999999999999999998888889999999999999999986 5788999999999
Q ss_pred cccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCCC
Q 007200 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 145 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+|+|++|++++..|..+..+++|+.|+|++|.+++.++. ...+++|+.|++++|.+...++.
T Consensus 179 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred EEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence 999999999988788999999999999999999987764 47789999999999999876553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=7e-16 Score=164.16 Aligned_cols=145 Identities=24% Similarity=0.277 Sum_probs=123.4
Q ss_pred ceeEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccC
Q 007200 60 WFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129 (613)
Q Consensus 60 ~~gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l 129 (613)
+..|.|.. ..+++.|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 45788854 24689999999999988889999999999999999999988888999999999999999999
Q ss_pred CCCCCcccccccccccccccCccccCccccccccccchhhhhhcC-CCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+...+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++ |.+...++. ...+++|+.|++++|.+...+
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 977777899999999999999999977677888899999999988 445544443 367888888999988887543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.1e-16 Score=148.06 Aligned_cols=134 Identities=25% Similarity=0.245 Sum_probs=120.2
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999987777889999999999999999977777789999999999999999987777899999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~~ 207 (613)
|++|++++..+..+..+++|+.|++++|++.+. ++.|+.|+++.|.+.+..|..
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCT
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeecc
Confidence 999999977777789999999999999998864 457899999999999877643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=163.12 Aligned_cols=135 Identities=18% Similarity=0.182 Sum_probs=121.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++++|.++...+..+.++++|+.|+|++|.|++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 47899999999999766677899999999999999999877889999999999999999999888889999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|+++...+..|..+++|+.|++++|.+++.++. ...+++|+.|++++|.+...
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 99999955555578999999999999999988776 47889999999999998765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-16 Score=165.22 Aligned_cols=137 Identities=23% Similarity=0.214 Sum_probs=119.6
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 44689999999999998888899999999999999999998778889999999999999999998889999999999999
Q ss_pred cccCccccCcccccc---ccccchhhhhhcCCCcccCCCCC-CCCCc--cccccccCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSL---TNVNSLQVLDLSNNKLTGDIPTN-GSFSL--FTPISFANNQLNNP 203 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~~-~~~~~--l~~l~l~~N~i~~~ 203 (613)
+|++|+|++..+..| ..+++|+.|+|++|+|++.+... ..++. ++.|++++|++.|.
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 999999996555555 57999999999999999876532 44554 47899999999885
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.8e-16 Score=164.36 Aligned_cols=145 Identities=23% Similarity=0.251 Sum_probs=126.8
Q ss_pred ceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccC
Q 007200 60 WFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129 (613)
Q Consensus 60 ~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l 129 (613)
|..|.|... .+++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 467888542 4799999999999998899999999999999999999988889999999999999999999
Q ss_pred CCCCCcccccccccccccccCccccCccccccccccchhhhhhcC-CCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+|++ |.+...++. ...+++|+.|++++|.+...+
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP 212 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc
Confidence 977777899999999999999999977677889999999999998 556555543 467889999999999887653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=5.4e-16 Score=172.03 Aligned_cols=137 Identities=20% Similarity=0.171 Sum_probs=126.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.|+|++|.|++..+..|.++++|++|+|++|.+++..|+.|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47999999999999888999999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCC-CCCCCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI-PTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|++++..+..+.++++|++|++++|.+++.. +....+++|+.|++++|.+...++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 999999777888999999999999999999853 555668999999999999876543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=150.69 Aligned_cols=113 Identities=24% Similarity=0.289 Sum_probs=64.9
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..+..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..+..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 35666666666665555555666666666666666665555555555666666666666655544445555556666666
Q ss_pred cCccccCc-cccccccccchhhhhhcCCCcccCC
Q 007200 149 NNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDI 181 (613)
Q Consensus 149 ~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~ 181 (613)
++|++++. +|..+..+++|+.|+|++|+|++.+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 66655542 3555555555555555555555443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.5e-16 Score=145.85 Aligned_cols=130 Identities=18% Similarity=0.269 Sum_probs=83.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++++|+++ .++ .+..+++|+.|+|++|.++ .+ ..+..+++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 35666777777766 333 4666677777777777554 22 34666677777777777776656666666777777777
Q ss_pred cCccccCccccccccccchhhhhhcCCC-cccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNK-LTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|++++..+..+..+++|+.|++++|. ++.. +....+++|+.|++++|.+...
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCCC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcCh
Confidence 7777766566666666777777777776 4433 3445566667777777666553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=7e-16 Score=155.76 Aligned_cols=137 Identities=23% Similarity=0.298 Sum_probs=123.1
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCc-cccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
..+++.|+|++|.++ .++..+.++++|+.|+|++|.+++..+ ..+..+++|++|+|++|.+++..+..|..+++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 468999999999998 466679999999999999999996655 579999999999999999998889999999999999
Q ss_pred cccCccccC-ccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 147 RLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 147 ~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+|++|.+++ .+|..+..+++|+.|+|++|.|++.++. ...+++|+.|++++|.+...++
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 999999986 5788999999999999999999988664 4788999999999999987654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=170.38 Aligned_cols=137 Identities=23% Similarity=0.235 Sum_probs=121.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47999999999999888888999999999999999999888999999999999999999999665667999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|++++..|..|.++++|+.|+|++|.+++.++.. ..+++|+.|++++|.+...++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 999999777788999999999999999999877654 678899999999998876543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-16 Score=171.55 Aligned_cols=135 Identities=19% Similarity=0.237 Sum_probs=89.0
Q ss_pred CCeEEEEcCCCCcccccc-hhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCC-CCCcccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFL 146 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 146 (613)
.+++.|+|++|.+++..+ ..+.++++|+.|+|++|.+++..|..|..+++|++|+|++|.+++ .+|..|..+++|++|
T Consensus 399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 478 (606)
T 3vq2_A 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478 (606)
T ss_dssp TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence 466777777777766555 466666777777777777666666666666677777777776665 356666666677777
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++|++++..|..+..+++|+.|+|++|++++.++. ...+++|+.|++++|.+...
T Consensus 479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 536 (606)
T 3vq2_A 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCE
T ss_pred ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCccc
Confidence 7777766666666666666666777776666665443 35566666666666666643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.3e-16 Score=176.93 Aligned_cols=146 Identities=27% Similarity=0.270 Sum_probs=125.2
Q ss_pred ccceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCC-ccccccCCcCCeEeccCccCCCCCCcc
Q 007200 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNNLNGPIPTT 136 (613)
Q Consensus 58 C~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 136 (613)
|.|..|.+ ..++++.|+|++|.|++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666666 5578999999999999888899999999999999999666555 788999999999999999999888999
Q ss_pred cccccccccccccCccccCccccc--cccccchhhhhhcCCCcccCCC--CCCCCCccccccccCCCCCCCC
Q 007200 137 LGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|.++++|++|+|++|.+++.+|.. +.++++|+.|+|++|.+++..+ ....+++|+.|++++|.+....
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 999999999999999999766664 8899999999999999988754 3478889999999999887654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=154.99 Aligned_cols=130 Identities=27% Similarity=0.189 Sum_probs=89.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccc-ccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG-KLSKLRFLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 147 (613)
.+++.|++++|.+++..+. .+++|+.|+|++|++++..+..+..+++|++|+|++|.|++..+..+. .+++|++|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 4667777777777655443 256677777777777766666677777777777777777766566553 577777777
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|+|++. +. ...+++|+.|+|++|+|++.++....+++|+.|++++|.+...
T Consensus 176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l 229 (317)
T 3o53_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI 229 (317)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEE
T ss_pred CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccch
Confidence 777777743 32 2346777777777777777666666667777777777777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=138.13 Aligned_cols=110 Identities=28% Similarity=0.278 Sum_probs=97.3
Q ss_pred EEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 5666553 89999999999999888999999999999999999999776777899999999999999
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 184 (613)
+|++..+..|..+++|+.|+|++|+|.+.+...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence 999766667999999999999999999776543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=143.05 Aligned_cols=130 Identities=17% Similarity=0.297 Sum_probs=113.8
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|++++|.++. +..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+++|++|+
T Consensus 65 l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 3589999999998763 34789999999999999999987888899999999999999999988889999999999999
Q ss_pred ccCcc-ccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 148 LNNNS-LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 148 L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
|++|+ ++ .+| .+..+++|+.|++++|+|++.+ ....+++|+.|++++|++..
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 99998 66 555 6899999999999999999865 56788999999999998753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=151.24 Aligned_cols=144 Identities=23% Similarity=0.313 Sum_probs=124.4
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCc
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N 127 (613)
|.|..+.|... .+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999642 37999999999999888889999999999999999999888999999999999999999
Q ss_pred cCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCccc--CCCCC-CCCCccccccccCCCCCCCC
Q 007200 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG--DIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 128 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|.++. ..+.. ..+ +|+.|++++|.+...+
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP 188 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC
Confidence 999 5666655 899999999999997777779999999999999999974 44433 444 8999999999988754
Q ss_pred C
Q 007200 205 P 205 (613)
Q Consensus 205 ~ 205 (613)
.
T Consensus 189 ~ 189 (332)
T 2ft3_A 189 K 189 (332)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=168.60 Aligned_cols=136 Identities=24% Similarity=0.324 Sum_probs=118.6
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCC-CCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...++.++++.|.+++..+..+..++.|+.|+|++|.+. +.+|+.|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 346788899999998888888899999999999998744 4578889999999999999999998888999999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCC-CccccccccCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSF-SLFTPISFANNQLNNP 203 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~l~~l~l~~N~i~~~ 203 (613)
+|++|+|++..|..|.++++|+.|+|++|+|++.++.. ..+ ++|+.|++++|++.|.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999888888999999999999999999888765 455 6899999999999886
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-15 Score=141.03 Aligned_cols=130 Identities=20% Similarity=0.167 Sum_probs=110.4
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|+++. ++......++|+.|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 4589999999999995 454333444999999999999965 5799999999999999999966556679999999999
Q ss_pred ccCccccCcccc--ccccccchhhhhhcCCCcccCCCC----CCCCCccccccccCCCCC
Q 007200 148 LNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFANNQLN 201 (613)
Q Consensus 148 L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~i~ 201 (613)
|++|+|+ .+|. .+..+++|+.|++++|+++..+.. ...+++|+.|++++|.+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999997 5665 788999999999999999977664 577899999999998653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6.7e-15 Score=150.24 Aligned_cols=145 Identities=23% Similarity=0.334 Sum_probs=126.1
Q ss_pred CccceeEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 57 PCTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 57 ~C~~~gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
.|.|..+.|.. ...++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 46889999964 24789999999999988888999999999999999999988899999999999999999
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCccc--CCC-CCCCCCccccccccCCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG--DIP-TNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~-~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|+|+ .+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|.++. ..+ ....+++|+.|++++|.+...
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 9999 5666654 799999999999997777789999999999999999974 333 346788999999999998764
Q ss_pred C
Q 007200 204 P 204 (613)
Q Consensus 204 ~ 204 (613)
+
T Consensus 187 ~ 187 (330)
T 1xku_A 187 P 187 (330)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=137.08 Aligned_cols=109 Identities=31% Similarity=0.330 Sum_probs=97.1
Q ss_pred EEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
+.|++++|+|+. +|..+ .++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 578889999984 55555 388999999999999888999999999999999999999877778899999999999999
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 183 (613)
+|++..+..|..+++|+.|+|++|++++..+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99977777899999999999999999977653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=159.15 Aligned_cols=137 Identities=24% Similarity=0.253 Sum_probs=106.2
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccc-cCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
..+++.|+|++|.|+...+..|.++++|+.|+|++| .++...+..|.++++|++|+|++|+|+ .+| .+..+++|++|
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L 212 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEE
T ss_pred cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEE
Confidence 357999999999999777778888888888888884 444344456888888888888888887 444 47778888888
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+|++|+|++..|..|.++++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...++.
T Consensus 213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 88888888777778888888888888888888776653 6677888888888887765543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=164.69 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=118.9
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..+..|.++++|+.|+|++|++++..|+.|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47899999999999888888999999999999999999877888999999999999999999777889999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccC--CCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD--IPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|++++..+..+.++++|++|++++|.+++. +.....+++|+.|++++|.+...+
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence 99999866665789999999999999999873 444577899999999999887654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-15 Score=145.53 Aligned_cols=135 Identities=17% Similarity=0.181 Sum_probs=114.6
Q ss_pred CCCeEEEEcCCCC-cccccchhhhCCCCCCEEEccc-ccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccc-
Q 007200 68 ENSVTRVDLGNAN-LSGQLVSQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR- 144 (613)
Q Consensus 68 ~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 144 (613)
..+++.|+|++|. ++...+..|.++++|+.|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4689999999997 8877777899999999999998 99997777889999999999999999985 666 88888888
Q ss_pred --cccccCc-cccCccccccccccchh-hhhhcCCCcccCCCCCCCCCccccccccCCC-CCCCC
Q 007200 145 --FLRLNNN-SLMGEIPRSLTNVNSLQ-VLDLSNNKLTGDIPTNGSFSLFTPISFANNQ-LNNPP 204 (613)
Q Consensus 145 --~L~L~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~-i~~~~ 204 (613)
+|+|++| ++++..+..|..+++|+ .|++++|.|+..++.....++|+.|++++|+ +...+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~ 196 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVID 196 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEEC
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCC
Confidence 9999999 89866667788999999 9999999999776665555789999999995 76543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-15 Score=161.12 Aligned_cols=138 Identities=21% Similarity=0.201 Sum_probs=124.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 46899999999999988899999999999999999999976667789999999999999999988899999999999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|.+++..+..|..+++|+.|+|++|.+++.++. ...+++|+.|++++|.+...++
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 999999988888999999999999999999987754 3778899999999998876544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.6e-16 Score=155.59 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=86.7
Q ss_pred CCeEEEEcCCCCcccccchhh--hCCCCCCEEEcccccCCCCCccccccC-----CcCCeEeccCccCCCCCCccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQL--GQLTNLQYLELYSNNISGKVPEELGNL-----TNLVSLDLYLNNLNGPIPTTLGKLS 141 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~ 141 (613)
.+++.|+|++|++++..|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|.+++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 466777777777776666654 6677777777777777755 6666665 6777777777777766666777777
Q ss_pred ccccccccCccccCc--ccccc--ccccchhhhhhcCCCcccCCC---CC-CCCCccccccccCCCCCCCC
Q 007200 142 KLRFLRLNNNSLMGE--IPRSL--TNVNSLQVLDLSNNKLTGDIP---TN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 142 ~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~l~~N~l~~~~~---~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|++|+|++|++.+. .+..+ ..+++|+.|+|++|.|++.+. .. ..+++|+.|++++|.+...+
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 777777777776543 22333 566777777777777763221 11 24566677777777666644
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-15 Score=153.25 Aligned_cols=136 Identities=21% Similarity=0.205 Sum_probs=112.8
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCC-----CCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCC--CCccc--
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP--IPTTL-- 137 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~-- 137 (613)
...+++.|+|++|.+++. |..+..+ ++|++|+|++|+|++..|..|..+++|++|+|++|++.+. ++..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 346899999999999977 7778777 8999999999999988888999999999999999998765 23444
Q ss_pred ccccccccccccCccccCc--cc-cccccccchhhhhhcCCCcccCCC--CCCCCCccccccccCCCCCCC
Q 007200 138 GKLSKLRFLRLNNNSLMGE--IP-RSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 138 ~~l~~L~~L~L~~N~l~~~--~~-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~~ 203 (613)
.++++|++|+|++|+|++. ++ ..+..+++|+.|+|++|+|++.++ ....+++|+.|++++|.+...
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~i 268 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV 268 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSC
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChh
Confidence 8899999999999999832 22 344578999999999999998763 335678999999999998843
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.3e-15 Score=163.41 Aligned_cols=138 Identities=25% Similarity=0.319 Sum_probs=113.0
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCc-cccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
..+++.|+|++|.+++..+. +..+++|+.|+|++|.+++..| ..+..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 372 ~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 372 TTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp CSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred cCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 45788999999998865554 8888889999999988887655 467888888999999988888888888888888888
Q ss_pred cccCcccc-CccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCCCC
Q 007200 147 RLNNNSLM-GEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 147 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+|++|+++ +.+|..+..+++|+.|+|++|++++.++. ...+++|+.|++++|.+...++.
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 512 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHH
Confidence 88888887 56788888888888888888888887554 47788888888888888776543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6.5e-15 Score=157.19 Aligned_cols=137 Identities=18% Similarity=0.203 Sum_probs=119.2
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+...+..|.++++|++|+
T Consensus 98 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 45899999999999988889999999999999999999977777899999999999999999977777899999999999
Q ss_pred ccCc-cccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 148 LNNN-SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 148 L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++| .+....+..|.++++|+.|+|++|.|++. +....+++|+.|++++|.+...++
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 235 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRP 235 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECG
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCc
Confidence 9984 55544445788999999999999999876 456788899999999998876544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=148.79 Aligned_cols=133 Identities=23% Similarity=0.256 Sum_probs=62.2
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCC--CCCccccccC--------------------CcCCeEeccCc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNL--------------------TNLVSLDLYLN 127 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~p~~~~~l--------------------~~L~~L~Ls~N 127 (613)
+++.|+|++|.+++..+..|.++++|+.|+|++|.++ +..|..|..+ ++|++|+|++|
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSS
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCC
Confidence 4455555555555444444555666666666666553 2334444433 23333333333
Q ss_pred cCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 128 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
.+++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+|+..+.....+++|+.|++++|.+..
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCB
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCc
Confidence 333333344444444444444444444444444444444444444444444433333444444445555444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=6.7e-15 Score=160.73 Aligned_cols=120 Identities=26% Similarity=0.314 Sum_probs=103.5
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.++.|+|++|+|++ +|. +.++++|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++ +| .|+++++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999986 555 899999999999999998 788899999999999999999996 66 89999999999999
Q ss_pred CccccCcc-ccccccccchhhhhhcCCCcccCCCCCCC----CCcccccc
Q 007200 150 NNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPTNGS----FSLFTPIS 194 (613)
Q Consensus 150 ~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~~~l~~l~ 194 (613)
+|+|++.. |..+..+++|+.|+|++|+|++.++.... +++|+.|+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 99999776 88999999999999999999988776532 56666664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.4e-15 Score=162.42 Aligned_cols=133 Identities=23% Similarity=0.163 Sum_probs=120.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.|++..+..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 57999999999999888889999999999999999999988888999999999999999999766667899999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|.+++..|..|..+++|+.|+|++|.|++.+ ...+++|..|++++|.+...
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEE
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCccccc
Confidence 999999888889999999999999999999864 34677888888888877653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.9e-15 Score=151.67 Aligned_cols=134 Identities=18% Similarity=0.183 Sum_probs=118.1
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCC-cccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP-TTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 146 (613)
..+++.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence 4689999999999998888899999999999999999997666669999999999999999995444 479999999999
Q ss_pred cccCc-cccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCC
Q 007200 147 RLNNN-SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLN 201 (613)
Q Consensus 147 ~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~ 201 (613)
+|++| .+.+..+..+..+++|+.|++++|.+++.++. ...+++|+.|++++|.+.
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 99999 47766678899999999999999999988554 478899999999999763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=5.5e-15 Score=160.74 Aligned_cols=137 Identities=25% Similarity=0.304 Sum_probs=116.5
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCC--CCccccccCCcCCeEeccCccCCCCCCc-cccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKL 143 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L 143 (613)
...+++.|+|++|.+++..|..+.++++|+.|+|++|+|++ .+|..+..+++|++|+|++|.+++.+|. .+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 45689999999999998888889999999999999999986 4567789999999999999999975665 48888999
Q ss_pred ccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|+|++|++++.+|..+. ++|+.|+|++|+|+..+.....+++|+.|++++|.+...++
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~ 461 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPD 461 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCH
Confidence 9999999999877776654 78999999999999776666788999999999998886543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=151.85 Aligned_cols=133 Identities=23% Similarity=0.163 Sum_probs=119.9
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
++++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 57999999999999888889999999999999999999888888999999999999999999655556799999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|++++..+..+..+++|+.|++++|.+++.. ...+++|+.|++++|.+...
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeeccccccccc
Confidence 999999888888999999999999999999763 35678888899998877653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=146.81 Aligned_cols=135 Identities=19% Similarity=0.195 Sum_probs=79.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCC--CCccccccCCcCCeEeccCccCC----------------
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLN---------------- 130 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~---------------- 130 (613)
.+++.|++++|.+++..+..+.++++|+.|+|++|.++. ..+..|..+++|++|+|++|.++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~ 200 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECT
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECC
Confidence 467777787777776666667777777777777777752 55566666666666666665555
Q ss_pred -----CCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 131 -----GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 131 -----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+|+..+.....+++|+.|++++|.+...
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCcc
Confidence 3334445555555555555555554444445555555555555555554444444455555555555555443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=159.60 Aligned_cols=138 Identities=27% Similarity=0.323 Sum_probs=120.1
Q ss_pred CCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCC--CccccccCCcCCeEeccCccCCCCCCc-ccccccc
Q 007200 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK--VPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSK 142 (613)
Q Consensus 66 ~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~ 142 (613)
....+++.|+|++|.+++..|..+.++++|+.|+|++|+|++. +|..|.++++|++|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 3456899999999999988899999999999999999999963 356789999999999999999985554 5888999
Q ss_pred cccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 143 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
|++|+|++|++++.+|..+. ++|+.|+|++|+|+..++....+++|+.|++++|.+...++
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~ 490 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPD 490 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCH
Confidence 99999999999877776554 78999999999999888777889999999999999986544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-15 Score=168.91 Aligned_cols=133 Identities=23% Similarity=0.389 Sum_probs=117.9
Q ss_pred CCCeEEEEcCCCCcccc-----------------cchhhh--CCCCCCEEEcccccCCCCCccccccCCcCCeEeccCcc
Q 007200 68 ENSVTRVDLGNANLSGQ-----------------LVSQLG--QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~ 128 (613)
.++++.|+|++|.+++. +|..++ ++++|++|+|++|.+.+.+|..|.++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 46899999999999985 888888 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCcccccc------cccccccccCccccCcccc--ccccccchhhhhhcCCCcccCCCCCCCCCccccccccCC
Q 007200 129 -LNG-PIPTTLGKL------SKLRFLRLNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN 198 (613)
Q Consensus 129 -l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 198 (613)
+++ .+|..++++ ++|++|+|++|+++ .+|. .+..+++|+.|++++|.++|.++....+++|+.|++++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 988 788888876 89999999999998 7887 888999999999999999966666677788888888888
Q ss_pred CCC
Q 007200 199 QLN 201 (613)
Q Consensus 199 ~i~ 201 (613)
.+.
T Consensus 364 ~l~ 366 (636)
T 4eco_A 364 QIT 366 (636)
T ss_dssp EEE
T ss_pred ccc
Confidence 877
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=132.59 Aligned_cols=107 Identities=22% Similarity=0.250 Sum_probs=97.4
Q ss_pred CCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcC
Q 007200 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174 (613)
Q Consensus 95 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 174 (613)
.+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 5776553 8999999999999988899999999999999999999977777889999999999999
Q ss_pred CCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 175 NKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 175 N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|+|++.++. ...+++|+.|++++|++.|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999998886 478999999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.8e-15 Score=163.69 Aligned_cols=137 Identities=20% Similarity=0.215 Sum_probs=111.1
Q ss_pred CCCeEEEEcCCCCcccccch-hhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCC---CCccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP---IPTTLGKLSKL 143 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L 143 (613)
.++++.|+|++|.+++..+. .+.++++|+.|+|++|.+++..|..|..+++|++|+|++|.+++. .+..+..+++|
T Consensus 399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 35788899999888876554 488888899999999988888888888888899999998888762 33568888888
Q ss_pred ccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|+|++|++++..|..|..+++|+.|+|++|++++.++.. ..++.| .|++++|.+...++
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~ 540 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCG
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCH
Confidence 88888888888777888888888888888888888776643 677788 88888888876544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=157.07 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=119.7
Q ss_pred CCCeEEEEcCCCCccc--ccchhhhCCCCCCEEEcccccCCCCCcc-ccccCCcCCeEeccCccCCCCCCcccccccccc
Q 007200 68 ENSVTRVDLGNANLSG--QLVSQLGQLTNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR 144 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 144 (613)
..+++.|+|++|.+++ .+|..+.++++|+.|+|++|.+++.+|. .+..+++|++|+|++|++++.+|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 4589999999999997 5567899999999999999999985665 488999999999999999988777665 7999
Q ss_pred cccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCC
Q 007200 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 145 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|.
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 9999999999 7888888999999999999999987776 57889999999999999885
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=143.07 Aligned_cols=126 Identities=25% Similarity=0.377 Sum_probs=96.3
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..+ +.++++|+.|+|++|.+++ +| .+..+++|++|+|++|+|++. +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEc
Confidence 578888888888876544 7788888888888888874 34 378888888888888888753 46777888888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|++++. ..+..+++|+.|++++|+|++.++ ...+++|+.|++++|.+...
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCC
Confidence 88888754 567778888888888888887665 66777888888888877653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.1e-15 Score=167.81 Aligned_cols=134 Identities=23% Similarity=0.348 Sum_probs=120.9
Q ss_pred CCCCeEEEEcCCCCccc-----------------ccchhhh--CCCCCCEEEcccccCCCCCccccccCCcCCeEeccCc
Q 007200 67 SENSVTRVDLGNANLSG-----------------QLVSQLG--QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N 127 (613)
..++++.|+|++|.|++ .+|..++ ++++|+.|+|++|++.+.+|..|.+|++|++|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 35689999999999998 3888877 9999999999999999999999999999999999999
Q ss_pred c-CCC-CCCccccccc-------ccccccccCccccCcccc--ccccccchhhhhhcCCCcccCCCCCCCCCcccccccc
Q 007200 128 N-LNG-PIPTTLGKLS-------KLRFLRLNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFA 196 (613)
Q Consensus 128 ~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~ 196 (613)
+ |++ .+|..+++++ +|++|+|++|+++ .+|. .+.++++|+.|+|++|.|+. +|....+++|+.|+++
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~-lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCB-CCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCccc-chhhcCCCcceEEECc
Confidence 8 998 7888887776 9999999999999 8888 89999999999999999994 4477889999999999
Q ss_pred CCCCCC
Q 007200 197 NNQLNN 202 (613)
Q Consensus 197 ~N~i~~ 202 (613)
+|.+..
T Consensus 604 ~N~l~~ 609 (876)
T 4ecn_A 604 YNQIEE 609 (876)
T ss_dssp SSCCSC
T ss_pred CCcccc
Confidence 999883
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-14 Score=132.14 Aligned_cols=106 Identities=22% Similarity=0.223 Sum_probs=96.5
Q ss_pred CEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCC
Q 007200 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (613)
Q Consensus 96 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (613)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 6777664 89999999999999988999999999999999999999766667899999999999999
Q ss_pred CcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 176 KLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 176 ~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|++.++. ...+++|+.|++++|++.|.+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 99998886 578999999999999998864
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=146.70 Aligned_cols=135 Identities=19% Similarity=0.169 Sum_probs=84.3
Q ss_pred CCCeEEEEcCCCCcccccc----hhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCC--C--Cccccc
Q 007200 68 ENSVTRVDLGNANLSGQLV----SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP--I--PTTLGK 139 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~ 139 (613)
..+++.|+|++|.+++..+ ..+..+++|++|+|++|.|++..|..|..+++|++|+|++|++.+. + +..+..
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3467777777777765433 3345677777777777777766666777777777777777776532 1 222356
Q ss_pred ccccccccccCccccCcccc----ccccccchhhhhhcCCCcccCC-CCCCCC---CccccccccCCCCCCC
Q 007200 140 LSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNNKLTGDI-PTNGSF---SLFTPISFANNQLNNP 203 (613)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~-~~~~~~---~~l~~l~l~~N~i~~~ 203 (613)
+++|++|+|++|+++ .++. .+..+++|+.|+|++|+|++.. +....+ ++|+.|++++|.+...
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l 266 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV 266 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch
Confidence 677777777777775 2222 2355677777777777777663 333333 5677777777776643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.7e-15 Score=158.35 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=82.1
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCcc----------------ccccCCcCCeEeccCccCCCC
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPE----------------ELGNLTNLVSLDLYLNNLNGP 132 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~----------------~~~~l~~L~~L~Ls~N~l~~~ 132 (613)
++++.|+|++|.+++..+ +..+++|+.|+|++|.|++..+. ....+++|++|+|++|.|++.
T Consensus 58 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~ 135 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (487)
T ss_dssp TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence 456666666666665444 55566666665555555422110 011234556666666666666
Q ss_pred CCcccccccccccccccCccccCccccccc-cccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLT-NVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 133 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
.|..|+++++|++|+|++|.|++.+|..+. .+++|+.|+|++|.|++.++. ..+++|+.|++++|.+...++
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECG
T ss_pred CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccccc-ccCCCCCEEECCCCCCCCCCH
Confidence 666677777777777777777766666665 577777777777777766433 346777777777777766543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.3e-14 Score=157.42 Aligned_cols=135 Identities=20% Similarity=0.291 Sum_probs=119.0
Q ss_pred CCCCeEEEEcCCCCcccc--cchhhhCCCCCCEEEcccccCCCCCcc-ccccCCcCCeEeccCccCCCCCCccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQ--LVSQLGQLTNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (613)
...+++.|+|++|.+++. .|..+.++++|+.|+|++|.+++.+|. .+..+++|++|+|++|+|++.+|..+. ++|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 346899999999999973 356799999999999999999985554 588999999999999999987776655 799
Q ss_pred ccccccCccccCccccccccccchhhhhhcCCCcccCCCC-CCCCCccccccccCCCCCCCC
Q 007200 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. ...+++|+.|++++|++.|..
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 99999999999 7788777999999999999999988777 678899999999999998853
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-14 Score=162.04 Aligned_cols=137 Identities=25% Similarity=0.249 Sum_probs=124.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 58999999999999999999999999999999999999666667999999999999999999887889999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC---CCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|.+++..|..+.++++|+.|++++|.+++.++.. ..+++|+.|++++|.+...++
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 188 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCT
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccCh
Confidence 999999888999999999999999999999877643 345899999999999877654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.6e-15 Score=167.09 Aligned_cols=137 Identities=24% Similarity=0.344 Sum_probs=119.5
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
....++.|+|++|.|. .+|..+.++++|+.|+|++|.|+ .+|..|.+|++|++|+|++|.|+ .+|..|++|++|++|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 3468999999999999 67777779999999999999999 88999999999999999999999 789999999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCCCC-C-CccccccccCCCCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS-F-SLFTPISFANNQLNNPPPSP 207 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~-~~l~~l~l~~N~i~~~~~~~ 207 (613)
+|++|.|+ .+|..|..+++|+.|+|++|+|++.++.... + ..+..+++++|.+.+..|..
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 99999998 7888899999999999999999988776422 1 12234789999998776553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.1e-14 Score=141.42 Aligned_cols=126 Identities=25% Similarity=0.299 Sum_probs=81.5
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.|++..+ +.++++|+.|+|++|+|++ +|. +.. ++|++|+|++|+|++. +.+.++++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEEC
Confidence 466777777777765443 6667777777777777764 333 222 6677777777777643 34667777777777
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|+|++. + .+..+++|+.|+|++|+|++. .....+++|+.|++++|++.+.+
T Consensus 136 s~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 136 RNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp TTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCCc
Confidence 77777643 3 466677777777777777765 44566667777777777766553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.2e-14 Score=144.90 Aligned_cols=129 Identities=28% Similarity=0.444 Sum_probs=108.4
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|+|++|.+++. ..+..+++|+.|+|++|+|++ ++. +..+++|++|+|++|++++..+ +..+++|++|
T Consensus 83 ~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence 346899999999999864 368899999999999999985 444 8999999999999999986543 8889999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|++|++++..+ +..+++|+.|++++|.+++.++ ...+++|+.|++++|.+...+
T Consensus 157 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred EccCCcCCCChh--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc
Confidence 999999985443 8889999999999999987665 567888999999999887765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.2e-14 Score=142.43 Aligned_cols=129 Identities=28% Similarity=0.345 Sum_probs=114.2
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|+|++|.+++ + ..+..+++|+.|+|++|+|++ + ..+..+++|++|+|++|++++. ..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 45689999999999986 3 349999999999999999995 4 4589999999999999999965 689999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|++|++++..+ +..+++|+.|+|++|.|++.+ ....+++|+.|++++|++...+
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccCCc
Confidence 999999996655 899999999999999999864 4678999999999999987754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=4.5e-14 Score=142.55 Aligned_cols=128 Identities=24% Similarity=0.383 Sum_probs=100.8
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.+++..+ +.++++|+.|+|++|.+++ ++ .+..+++|++|+|++|++++. + .+..+++|++|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEE
Confidence 4578888888888885544 8888888888888888874 44 588888888888888888854 3 388888888888
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|++|++++..+ +..+++|+.|+|++|.+++.++ ...+++|+.|++++|.+...+
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcCh
Confidence 88888885443 7788888888888888887655 667788888888888886654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.7e-15 Score=148.03 Aligned_cols=136 Identities=14% Similarity=0.102 Sum_probs=115.7
Q ss_pred CeEEEEcCCCCcccccchhh--hCCCCCCEEEcccccCCCCCc----cccccCCcCCeEeccCccCCCCCCccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQL--GQLTNLQYLELYSNNISGKVP----EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (613)
+++.|+|++|.+++..|..+ .++++|+.|+|++|.+++..+ ..+..+++|++|+|++|+|++..+..|.++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 59999999999999998887 899999999999999997655 345679999999999999998888999999999
Q ss_pred ccccccCccccCc--c--ccccccccchhhhhhcCCCcccCCCC----CCCCCccccccccCCCCCCCCC
Q 007200 144 RFLRLNNNSLMGE--I--PRSLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 144 ~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|+|++|++.+. + +..+..+++|++|+|++|.|+..+.. ...+++|+.|++++|.+....|
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p 241 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVN 241 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccch
Confidence 9999999998753 2 23347899999999999999854432 2467899999999999988743
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-14 Score=131.12 Aligned_cols=113 Identities=24% Similarity=0.260 Sum_probs=101.9
Q ss_pred hCCCCCCEEEcccccCC-CCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchh
Q 007200 90 GQLTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168 (613)
Q Consensus 90 ~~l~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 168 (613)
...++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34588999999999998 78898899999999999999999966 8899999999999999999977888888899999
Q ss_pred hhhhcCCCcccCC--CCCCCCCccccccccCCCCCCCC
Q 007200 169 VLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 169 ~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
.|+|++|.|++.+ .....+++|+.|++++|++...+
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 136 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTST
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchH
Confidence 9999999999865 55688999999999999987654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-14 Score=130.26 Aligned_cols=112 Identities=21% Similarity=0.237 Sum_probs=101.2
Q ss_pred CCCCCCEEEcccccCC-CCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhh
Q 007200 91 QLTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169 (613)
Q Consensus 91 ~l~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 169 (613)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..+.++++|++|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78898899999999999999999976 78999999999999999999778888888999999
Q ss_pred hhhcCCCcccCC--CCCCCCCccccccccCCCCCCCC
Q 007200 170 LDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 170 L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
|++++|.|++.+ .....+++|+.|++++|++...+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 129 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence 999999999854 55688999999999999887653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.2e-14 Score=138.08 Aligned_cols=126 Identities=30% Similarity=0.395 Sum_probs=109.5
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|++++|+|+. ++ .+..+++|+.|+|++|+|++..+ +..+++|++|+|++|+|++ +|.. .. ++|++|+
T Consensus 40 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEE
T ss_pred cCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEE
Confidence 3589999999999984 44 78999999999999999996544 9999999999999999996 4433 33 9999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|+|++. + .+..+++|+.|+|++|+|++.+ ....+++|+.|++++|.+...
T Consensus 113 L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 113 LDNNELRDT-D-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC
T ss_pred ccCCccCCC-h-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch
Confidence 999999953 3 5899999999999999999874 567889999999999999876
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.47 E-value=4.6e-15 Score=161.27 Aligned_cols=138 Identities=28% Similarity=0.352 Sum_probs=105.9
Q ss_pred CCCCCCCCCCCc-----cceeE-EeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCC
Q 007200 47 LQSWDATLVNPC-----TWFHV-TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120 (613)
Q Consensus 47 ~~~w~~~~~~~C-----~~~gv-~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~ 120 (613)
+.+|.. ..+|| .|.|+ .|. .++++.|+|++|+|++ +|..+ +++|+.|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 456754 36778 79998 675 3579999999999986 55544 378999999999998 567 4578899
Q ss_pred eEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCC
Q 007200 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 121 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i 200 (613)
+|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|.|++.+. .+++|+.|++++|.+
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCC
Confidence 99999999886 666 655 88888888888885 555 57888888888888887554 567788888888887
Q ss_pred CCCC
Q 007200 201 NNPP 204 (613)
Q Consensus 201 ~~~~ 204 (613)
...+
T Consensus 173 ~~lp 176 (571)
T 3cvr_A 173 TFLP 176 (571)
T ss_dssp SCCC
T ss_pred CCcc
Confidence 7643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.9e-14 Score=144.19 Aligned_cols=126 Identities=22% Similarity=0.324 Sum_probs=60.2
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|++++|.+++..+ +..+++|+.|+|++|.+++. +. +..+++|++|+|++|.+++. +.+..+++|++|+|+
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~ 273 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVG 273 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEcc
Confidence 45555555555553322 44555555555555555432 22 45555555555555555432 334445555555555
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++++. ..+..+++|+.|++++|++++.++.. ..+++|+.|++++|++...
T Consensus 274 ~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 274 SNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 5555432 23444555555555555554443321 3444555555555554443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=4.5e-14 Score=154.59 Aligned_cols=131 Identities=19% Similarity=0.221 Sum_probs=108.8
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCC-CCcccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP-IPTTLGKLSKLRFL 146 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 146 (613)
.++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++. .|..+.++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 46899999999999988889999999999999999999988888899999999999999999863 57789999999999
Q ss_pred cccCccccCccc-cccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCC
Q 007200 147 RLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANN 198 (613)
Q Consensus 147 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N 198 (613)
+|++|++.+.+| ..+..+++|+.|++++|.+++..+.. ..+++|+.|++++|
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence 999999544554 68899999999999999999865543 44444444433333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.5e-14 Score=145.93 Aligned_cols=135 Identities=19% Similarity=0.147 Sum_probs=104.2
Q ss_pred ccceeEEeCCCCCeEEEEcCCC-CcccccchhhhCCCCCCEEEccc-ccCCCCCccccccCCcCCeEeccCccCCCCCCc
Q 007200 58 CTWFHVTCNSENSVTRVDLGNA-NLSGQLVSQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135 (613)
Q Consensus 58 C~~~gv~c~~~~~l~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 135 (613)
|.|.+|.|+ ++ +|++ +|. +..+++|+.|+|++ |+|++..+..|.+|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~-----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 666666654 45 7874 666 99999999999996 999988888999999999999999999998899
Q ss_pred ccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC--CCCCccccccccCCCCCCCCCC
Q 007200 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
.|.+|++|++|+|++|+|++..+..+..++ |+.|+|++|+|.+..... ..+.......+..+.+.|..+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999999999999999999976666676666 999999999998654311 1111112333445566665443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=151.61 Aligned_cols=127 Identities=26% Similarity=0.365 Sum_probs=92.4
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+|+.|+|++|.|++..+ +..+++|+.|+|++|.|++ +| .|..|++|++|+|++|+|++. +.+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEE
Confidence 3577888888888876544 7778888888888888774 33 477777888888888877753 4577777777777
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|+|++. ..+..+++|+.|+|++|.|++.++ ...+++|+.|++++|.+...
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC
Confidence 777777744 456777777777777777777665 66677777777777777654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.8e-14 Score=143.00 Aligned_cols=125 Identities=19% Similarity=0.168 Sum_probs=59.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.|++.. .+++|+.|+|++|.|++..+. .+++|++|+|++|++++..+..+..+++|++|+|
T Consensus 80 ~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 151 (317)
T 3o53_A 80 STLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (317)
T ss_dssp TTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEEC
T ss_pred CCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEEC
Confidence 34555555555554322 224555555555555533222 2344555555555555444445555555555555
Q ss_pred cCccccCccccccc-cccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 149 NNNSLMGEIPRSLT-NVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 149 ~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
++|++++..+..+. .+++|+.|+|++|.|++.+. ...+++|+.|++++|.+..
T Consensus 152 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~ 205 (317)
T 3o53_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF 205 (317)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCE
T ss_pred CCCCCCcccHHHHhhccCcCCEEECCCCcCccccc-ccccccCCEEECCCCcCCc
Confidence 55555544444332 44555555555555554422 2234555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.43 E-value=8.7e-16 Score=144.63 Aligned_cols=130 Identities=25% Similarity=0.293 Sum_probs=99.4
Q ss_pred CeEEEEcCCCCcccccch------hhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVS------QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~------~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (613)
.++.++++.+.++|..|. .+.++++|+.|+|++|.|++ +| .+..+++|++|+|++|.|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 445555555555555544 78888888888888888885 66 7888888888888888888 677777778888
Q ss_pred ccccccCccccCccccccccccchhhhhhcCCCcccCCC--CCCCCCccccccccCCCCCCCC
Q 007200 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|+|++|++++ +| .+..+++|+.|++++|+|++.+. ....+++|+.|++++|++.+.+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 888888888885 44 57788888888888888886543 4467788888888888776653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=151.06 Aligned_cols=130 Identities=27% Similarity=0.323 Sum_probs=115.7
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+|+.|+|++|.|++. ..+..+++|+.|+|++|.|++ ++ .+..|++|+.|+|++|+|++. ..+..|++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 346899999999999963 378999999999999999995 44 599999999999999999965 789999999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+|++|+|++..| +..+++|+.|+|++|+|++. +....+++|+.|++++|++...+.
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCC
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCcc
Confidence 999999997766 89999999999999999986 457889999999999999987654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.1e-13 Score=156.83 Aligned_cols=132 Identities=26% Similarity=0.283 Sum_probs=120.2
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+.+..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+++..|..|..+++|++|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 47999999999999888899999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|++++..+..|..+++|+.|+|++|.|++... +++|+.|++++|.+...+
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~~l~ 397 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNKLVTLP 397 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCCCCCCC
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCCccccc
Confidence 9999998878889999999999999999986543 677888888888887543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-13 Score=141.62 Aligned_cols=147 Identities=14% Similarity=0.129 Sum_probs=116.8
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCc-cccccCCcCCe-Eecc
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNLVS-LDLY 125 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~-L~Ls 125 (613)
|.+..|.|++. .+++.|+|++|+|+...+..|.++++|++|+|++|++.+.+| +.|.++++|++ ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67888999542 368999999999997666789999999999999999876665 57889988875 6777
Q ss_pred CccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcC-CCcccCCCCC-CCC-CccccccccCCCCCC
Q 007200 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPTN-GSF-SLFTPISFANNQLNN 202 (613)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~-~~~-~~l~~l~l~~N~i~~ 202 (613)
+|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.+ |.+...++.. ..+ ..+..|++++|.+..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999987788999999999999999999966666666777777888855 5677665543 233 457788888888875
Q ss_pred CC
Q 007200 203 PP 204 (613)
Q Consensus 203 ~~ 204 (613)
.+
T Consensus 169 i~ 170 (350)
T 4ay9_X 169 IH 170 (350)
T ss_dssp EC
T ss_pred CC
Confidence 44
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=143.91 Aligned_cols=128 Identities=31% Similarity=0.425 Sum_probs=93.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 467888888888876544 7778888888888888875433 7777888888888888775433 677778888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|++++..| +..+++|+.|++++|++++. +....+++|+.|++++|.+.+.++
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch
Confidence 8888776554 56777777777777777765 345667777777777777766543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=5e-13 Score=143.12 Aligned_cols=127 Identities=31% Similarity=0.433 Sum_probs=108.4
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.+++. +.+..+++|+.|+|++|.+++..| +..+++|++|+|++|.+++..+ +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 35799999999999854 468889999999999999986554 8899999999999999996544 88899999999
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|++|++++..+ +..+++|+.|+|++|++++.++ ...+++|+.|++++|.+.+.
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 99999986544 7889999999999999998776 56788999999999988775
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-13 Score=127.16 Aligned_cols=112 Identities=21% Similarity=0.183 Sum_probs=96.0
Q ss_pred hhhCCCCCCEEEcccccCCCCCccccccCC-cCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccc
Q 007200 88 QLGQLTNLQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166 (613)
Q Consensus 88 ~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 166 (613)
.+.++++|+.|+|++|+|+ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4677899999999999999 4565 55554 999999999999965 78999999999999999999655555689999
Q ss_pred hhhhhhcCCCcccCCC--CCCCCCccccccccCCCCCCC
Q 007200 167 LQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 167 L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|+.|+|++|+|+..+. ....+++|+.|++++|++...
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~ 128 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCc
Confidence 9999999999987665 457889999999999988654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.6e-13 Score=145.61 Aligned_cols=118 Identities=26% Similarity=0.292 Sum_probs=86.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4578888888888886 555 554 88888888888886 665 57888888888888885 555 567888888
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCcc-------ccccccCCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF-------TPISFANNQLNNPP 204 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l-------~~l~l~~N~i~~~~ 204 (613)
|++|+|++ +|. |. ++|+.|+|++|.|+..+. ... +| +.|++++|.+...|
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp 223 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITHIP 223 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCCCC
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcceecC
Confidence 88888885 565 54 788888888888886555 322 56 77888888777543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.35 E-value=5.6e-15 Score=139.04 Aligned_cols=128 Identities=21% Similarity=0.254 Sum_probs=109.5
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|.+++ +| .+.++++|+.|+|++|.|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|++|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4589999999999997 56 8999999999999999999 688888889999999999999996 45 689999999999
Q ss_pred ccCccccCccc-cccccccchhhhhhcCCCcccCCCC-----------CCCCCccccccccCCCCCC
Q 007200 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPT-----------NGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~-----------~~~~~~l~~l~l~~N~i~~ 202 (613)
|++|++++..+ ..+..+++|+.|++++|++++.++. ...+++|+.|+ +|+++.
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 99999995433 4788999999999999999887654 35567777775 666543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.4e-13 Score=145.66 Aligned_cols=107 Identities=26% Similarity=0.348 Sum_probs=97.7
Q ss_pred CCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhc
Q 007200 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (613)
Q Consensus 94 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (613)
.|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57789999999995 676 999999999999999999 889999999999999999999995 67 89999999999999
Q ss_pred CCCcccC--CCCCCCCCccccccccCCCCCCCCC
Q 007200 174 NNKLTGD--IPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 174 ~N~l~~~--~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+|+|++. +...+.+++|+.|++++|++.+.++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999998 4556889999999999999987654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.2e-13 Score=135.63 Aligned_cols=127 Identities=25% Similarity=0.432 Sum_probs=89.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|.+++..+ +..+++|++|+|
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEEC
Confidence 467777777777774433 6777777777777777774433 6777777777777777774433 777777777777
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|.+++. ..+..+++|+.|++++|.+++. +....+++|+.|++++|.+...+
T Consensus 251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcC
Confidence 77777743 3567777777777777777765 33456677777777777776543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=6.6e-13 Score=136.37 Aligned_cols=107 Identities=20% Similarity=0.116 Sum_probs=96.4
Q ss_pred CEEEcccc-cCCCCCccccccCCcCCeEeccC-ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhc
Q 007200 96 QYLELYSN-NISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (613)
Q Consensus 96 ~~L~L~~N-~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (613)
..++++++ +|+ .+|. |..+++|++|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 898 5888 99999999999996 99998888899999999999999999999889999999999999999
Q ss_pred CCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 174 NNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 174 ~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|+|++.++.......|+.|++.+|++.|..
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 9999999887654445999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.5e-12 Score=133.81 Aligned_cols=129 Identities=18% Similarity=0.186 Sum_probs=80.5
Q ss_pred eeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccc
Q 007200 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140 (613)
Q Consensus 61 ~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 140 (613)
.++......+++.|+|++|.+++. + +.++++|+.|+|++|+|++. + +..+++|++|+|++|+..+.+ .+..+
T Consensus 98 ~~~~~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 98 TNLDVTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp SCCCCTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred ceeecCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccC
Confidence 333334456788889988888864 3 78888888888888888863 3 666666666666666444344 35556
Q ss_pred cccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
++|++|+|++|++++ +| +..+++|+.|++++|.|++. ....+++|+.|++++|.+..
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc
Confidence 666666666666664 33 45555555555555555554 23445555555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-13 Score=143.92 Aligned_cols=134 Identities=16% Similarity=0.241 Sum_probs=85.3
Q ss_pred CCeEEEEcCCCCccc----ccchhhhCC---------CCCCEEEcccccCC-CCCc---cccccCCcCCeEeccCccCC-
Q 007200 69 NSVTRVDLGNANLSG----QLVSQLGQL---------TNLQYLELYSNNIS-GKVP---EELGNLTNLVSLDLYLNNLN- 130 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~----~~~~~~~~l---------~~L~~L~L~~N~i~-~~~p---~~~~~l~~L~~L~Ls~N~l~- 130 (613)
++++.|+|++|.++. .++..+..+ ++|+.|+|++|+|+ +.+| ..|..+++|++|+|++|+|+
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 467777777777752 244555555 67777777777776 3333 35566777777777777776
Q ss_pred -C---CCCcccccccccccccccCcccc----CccccccccccchhhhhhcCCCcccC-----CCCC--CCCCccccccc
Q 007200 131 -G---PIPTTLGKLSKLRFLRLNNNSLM----GEIPRSLTNVNSLQVLDLSNNKLTGD-----IPTN--GSFSLFTPISF 195 (613)
Q Consensus 131 -~---~~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~-----~~~~--~~~~~l~~l~l 195 (613)
| ..|..+.++++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|.|++. +... +.+++|+.|++
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L 281 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence 2 23336667777777777777774 35566666777777777777777654 1111 33666777777
Q ss_pred cCCCCCC
Q 007200 196 ANNQLNN 202 (613)
Q Consensus 196 ~~N~i~~ 202 (613)
++|.+..
T Consensus 282 ~~n~i~~ 288 (386)
T 2ca6_A 282 QYNEIEL 288 (386)
T ss_dssp CSSCCBH
T ss_pred cCCcCCH
Confidence 7776655
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.5e-12 Score=133.81 Aligned_cols=117 Identities=26% Similarity=0.274 Sum_probs=65.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++. | .+..+++|++|+|++|+|++. | +..+++|++|+|++|+|++. + ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 3566666666666643 2 455666666666666666642 3 55566666666666666643 2 555666666666
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN 198 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 198 (613)
++|++++ +| +..+++|+.|++++|+|++.+ ...+++|+.|++++|
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLN 158 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCC
Confidence 6666653 22 555566666666666665531 334445555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.29 E-value=8e-13 Score=145.45 Aligned_cols=139 Identities=23% Similarity=0.274 Sum_probs=98.9
Q ss_pred CCCCCCCCCCCCccceeE--------EeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCC
Q 007200 46 VLQSWDATLVNPCTWFHV--------TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117 (613)
Q Consensus 46 ~~~~w~~~~~~~C~~~gv--------~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~ 117 (613)
..++|.. ..+||.|.|. .|. .+.++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~-~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACL-NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHH-HHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHh-cCCcchhccccccCccccccc-CCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 3446644 3678888653 332 235888899988888 5666554 78888888888888 4555 568
Q ss_pred cCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccC
Q 007200 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197 (613)
Q Consensus 118 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 197 (613)
+|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++.+.. +++|+.|++++
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~ 150 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSD 150 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCS
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcC
Confidence 8888888888888 4555 66788888888888884 444 457777888888888775542 46777788888
Q ss_pred CCCCCCC
Q 007200 198 NQLNNPP 204 (613)
Q Consensus 198 N~i~~~~ 204 (613)
|.+...+
T Consensus 151 N~l~~l~ 157 (622)
T 3g06_A 151 NQLASLP 157 (622)
T ss_dssp SCCSCCC
T ss_pred CcCCCcC
Confidence 8776543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.9e-11 Score=120.10 Aligned_cols=145 Identities=12% Similarity=0.011 Sum_probs=112.7
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 364 (613)
..+.|.....++.|+.+.||++... ++.+++|+....... ....+.+|+.+++.+. +..+.++++++......++||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3456877788888899999999865 789999998753211 2235788999998885 677889999998888899999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------------------------------------ 408 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 408 (613)
||++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 90 e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999998876321 122346788999999999981
Q ss_pred --------------------CCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 409 --------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 409 --------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
..+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013689999999999998766667999998753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.4e-13 Score=138.59 Aligned_cols=135 Identities=23% Similarity=0.256 Sum_probs=93.4
Q ss_pred CCeEEEEcCCCCcccccc----hhhhCCC-CCCEEEcccccCCCCCccccccC-----CcCCeEeccCccCCCCCCcccc
Q 007200 69 NSVTRVDLGNANLSGQLV----SQLGQLT-NLQYLELYSNNISGKVPEELGNL-----TNLVSLDLYLNNLNGPIPTTLG 138 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~i~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~ 138 (613)
.+++.|+|++|.|++..+ ..+.+++ +|+.|+|++|.|++..+..|..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 458888888888876665 6677777 78888888888887666666665 7888888888888766655444
Q ss_pred c----c-cccccccccCccccCccccccc----c-ccchhhhhhcCCCcccCCCC-----CCCC-CccccccccCCCCCC
Q 007200 139 K----L-SKLRFLRLNNNSLMGEIPRSLT----N-VNSLQVLDLSNNKLTGDIPT-----NGSF-SLFTPISFANNQLNN 202 (613)
Q Consensus 139 ~----l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~l~~N~l~~~~~~-----~~~~-~~l~~l~l~~N~i~~ 202 (613)
. + ++|++|+|++|+|++..+..+. . .++|+.|+|++|.|+..... ...+ ++|+.|++++|.+..
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 4 3 7888888888888765554433 3 25788888888888743221 1223 377888888887654
Q ss_pred C
Q 007200 203 P 203 (613)
Q Consensus 203 ~ 203 (613)
.
T Consensus 182 ~ 182 (362)
T 3goz_A 182 K 182 (362)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=131.33 Aligned_cols=117 Identities=28% Similarity=0.332 Sum_probs=65.5
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|++++|.+++. +. ..++|++|+|++|++++ +| .|.++++|++|+|++|++++ +|..+ ++|++|+|+
T Consensus 112 ~L~~L~l~~n~l~~l-~~---~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~ 181 (454)
T 1jl5_A 112 SLKSLLVDNNNLKAL-SD---LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAG 181 (454)
T ss_dssp TCCEEECCSSCCSCC-CS---CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECC
T ss_pred CCcEEECCCCccCcc-cC---CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECc
Confidence 455555555555532 11 01466666666666664 55 36666666666666666664 44332 366666666
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~ 201 (613)
+|++++ +| .+..+++|+.|++++|.+++.+.. .++|+.|++++|.+.
T Consensus 182 ~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 182 NNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNILE 228 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCS
T ss_pred CCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC---cCcccEEECcCCcCC
Confidence 666664 34 456666666666666666653321 135555555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-13 Score=139.83 Aligned_cols=131 Identities=22% Similarity=0.248 Sum_probs=71.5
Q ss_pred CCeEEEEcCCCCcccc-cchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCc-cCCCC-CCccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQ-LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGP-IPTTLGKLSKLRF 145 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~ 145 (613)
.+++.|+|++|.+++. ++..+.++++|+.|+|++|.+++..+..+..+++|++|+|++| .+++. ++..+.++++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 3556666666665543 5555556666666666666665555555556666666666666 45432 3444555666666
Q ss_pred ccccCc-cccCc-ccccccccc-chhhhhhcCCC--cc--cCCCCCCCCCccccccccCCC
Q 007200 146 LRLNNN-SLMGE-IPRSLTNVN-SLQVLDLSNNK--LT--GDIPTNGSFSLFTPISFANNQ 199 (613)
Q Consensus 146 L~L~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N~--l~--~~~~~~~~~~~l~~l~l~~N~ 199 (613)
|+|++| .+++. ++..+..++ +|+.|++++|. ++ +.+.....+++|+.|++++|.
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 666666 55532 344455555 66666666663 32 111222345556666666665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.24 E-value=4.6e-13 Score=139.74 Aligned_cols=133 Identities=22% Similarity=0.264 Sum_probs=64.3
Q ss_pred CCeEEEEcCCCCccc----ccchhhhCCCCCCEEEcccccCCCCCccc----cccC---------CcCCeEeccCccCC-
Q 007200 69 NSVTRVDLGNANLSG----QLVSQLGQLTNLQYLELYSNNISGKVPEE----LGNL---------TNLVSLDLYLNNLN- 130 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~p~~----~~~l---------~~L~~L~Ls~N~l~- 130 (613)
++++.|+|++|.+++ .++..+.++++|+.|+|++|.|+...+.. +..+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 345555555555554 24445555555555555555554222222 2222 55555555555554
Q ss_pred CCCC---cccccccccccccccCccccC-----ccccccccccchhhhhhcCCCcc----c-CCCCCCCCCccccccccC
Q 007200 131 GPIP---TTLGKLSKLRFLRLNNNSLMG-----EIPRSLTNVNSLQVLDLSNNKLT----G-DIPTNGSFSLFTPISFAN 197 (613)
Q Consensus 131 ~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~-~~~~~~~~~~l~~l~l~~ 197 (613)
+.++ ..+..+++|++|+|++|+|+. ..+..+..+++|+.|+|++|.|+ + .+.....+++|+.|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 2222 244455555555555555541 22334555555555555555553 1 122223445555555555
Q ss_pred CCCC
Q 007200 198 NQLN 201 (613)
Q Consensus 198 N~i~ 201 (613)
|.+.
T Consensus 254 n~i~ 257 (386)
T 2ca6_A 254 CLLS 257 (386)
T ss_dssp CCCC
T ss_pred CCCc
Confidence 5543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.22 E-value=7.6e-13 Score=135.16 Aligned_cols=132 Identities=19% Similarity=0.249 Sum_probs=113.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccc-cCCC-CCccccccCCcCCeEeccCc-cCCCC-CCccccccc-c
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN-NISG-KVPEELGNLTNLVSLDLYLN-NLNGP-IPTTLGKLS-K 142 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~ 142 (613)
.++++.|+|++|.+++..+..+..+++|+.|+|++| .+++ .++..+.++++|++|+|++| .+++. ++..+..++ +
T Consensus 117 ~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~ 196 (336)
T 2ast_B 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 196 (336)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC
Confidence 468999999999999888899999999999999999 6875 36777899999999999999 99854 577788999 9
Q ss_pred cccccccCc--ccc-CccccccccccchhhhhhcCCC-ccc-CCCCCCCCCccccccccCCC
Q 007200 143 LRFLRLNNN--SLM-GEIPRSLTNVNSLQVLDLSNNK-LTG-DIPTNGSFSLFTPISFANNQ 199 (613)
Q Consensus 143 L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~~~l~~l~l~~N~ 199 (613)
|++|+|++| .++ +.++..+..+++|+.|++++|. +++ .++....+++|+.|++++|.
T Consensus 197 L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 197 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 999999999 455 4567778889999999999999 664 34455778999999999996
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.7e-12 Score=134.22 Aligned_cols=130 Identities=20% Similarity=0.196 Sum_probs=110.8
Q ss_pred EEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCc----cccccCC-cCCeEeccCccCCCCCCcccccc-----cc
Q 007200 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP----EELGNLT-NLVSLDLYLNNLNGPIPTTLGKL-----SK 142 (613)
Q Consensus 73 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 142 (613)
.+.|++|++++.+|..+...++|+.|+|++|.|++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999997766 7788998 99999999999998878888876 99
Q ss_pred cccccccCccccCcccccccc----c-cchhhhhhcCCCcccCCCCC-----CC-CCccccccccCCCCCC
Q 007200 143 LRFLRLNNNSLMGEIPRSLTN----V-NSLQVLDLSNNKLTGDIPTN-----GS-FSLFTPISFANNQLNN 202 (613)
Q Consensus 143 L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~-----~~-~~~l~~l~l~~N~i~~ 202 (613)
|++|+|++|++++..+..+.. + ++|+.|+|++|.|++..... .. .++|+.|++++|.+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 999999999999776665444 4 89999999999998765532 22 3689999999998764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.7e-11 Score=134.77 Aligned_cols=56 Identities=30% Similarity=0.247 Sum_probs=39.5
Q ss_pred cccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
++|+.|+|++|+|++ +| ..+++|+.|+|++|.|+..+. .+++|+.|++++|.+...
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~l 276 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTRL 276 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCSC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCcC
Confidence 567777777777774 44 345777788888888876554 556777888888877743
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.4e-11 Score=126.52 Aligned_cols=134 Identities=15% Similarity=0.139 Sum_probs=108.1
Q ss_pred EEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCC-ccccccc
Q 007200 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP-TTLGKLS 141 (613)
Q Consensus 63 v~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~ 141 (613)
++|+. +.++.++++|+ .+|..+ .++|++|+|++|+|+...+++|.++++|++|+|++|++.+.+| ..|.+++
T Consensus 7 C~C~~----~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN----RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET----TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC----CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 67864 46889999999 566655 4689999999999996666789999999999999999977665 4688999
Q ss_pred cccc-ccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccC-CCCCCC
Q 007200 142 KLRF-LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFAN-NQLNNP 203 (613)
Q Consensus 142 ~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~-N~i~~~ 203 (613)
+|++ +.++.|+|+...|..|..+++|+.|++++|+|+..++.. .....+..+++.+ |.+...
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l 144 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEE
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccc
Confidence 8775 677889999777889999999999999999999877654 4455667777765 444443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-10 Score=114.14 Aligned_cols=129 Identities=14% Similarity=0.038 Sum_probs=97.1
Q ss_pred ccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc--cceeeEEEEcCCceEEEEecccCCcchh
Q 007200 297 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGSVAS 374 (613)
Q Consensus 297 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 374 (613)
+.|..+.||++...+|+.+++|...... ...+..|+.+++.+.+.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 4556699999987778889999876531 134678999998886544 556888888777889999999998884
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 007200 375 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------------- 409 (613)
Q Consensus 375 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------- 409 (613)
... .+ ...++.++++.|+.||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356777788888888641
Q ss_pred ----------CCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 410 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 410 ----------~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999999853
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.16 E-value=6.3e-11 Score=126.07 Aligned_cols=121 Identities=25% Similarity=0.289 Sum_probs=99.6
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.+++ +|.. +++|+.|+|++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|+|
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 578999999999987 5543 4789999999999985 4431 2689999999999996 67 5999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|++++ +|..+ ++|+.|++++|.+++.+ ....+++|+.|++++|.+...+
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~l~ 211 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLP 211 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSSCC
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCcCC
Confidence 9999985 56543 58999999999999854 6788999999999999988643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=4.5e-10 Score=115.71 Aligned_cols=143 Identities=14% Similarity=0.164 Sum_probs=106.7
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEec--cccCcccHHHHHHHHHHHhhcc--cCccceeeEEEEcC---CceEEEEe
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP---TERLLVYP 365 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 365 (613)
.+.++.|.++.||+.... +..+++|+.. ..........+.+|+.+++.+. +..+.+++.++.+. ...++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999999876 4678898776 3322223446788999999887 45688889888766 34799999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 409 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 409 (613)
|++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988754221 12678888999999999999999731
Q ss_pred -------------------CCCeEecCCCCCceeecCCCc--EEEeccccceec
Q 007200 410 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLM 442 (613)
Q Consensus 410 -------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~~~ 442 (613)
.+.++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999998753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.07 E-value=3.6e-12 Score=136.15 Aligned_cols=133 Identities=21% Similarity=0.198 Sum_probs=84.6
Q ss_pred CCeEEEEcCCCCccccc-----chhhhCCCCCCEEEcccccCCCC----CccccccCCcCCeEeccCccCCCCCCccccc
Q 007200 69 NSVTRVDLGNANLSGQL-----VSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 139 (613)
.+++.|+|++|.++... +..+..+++|+.|+|++|.|+.. ++..+..+++|++|+|++|.++...+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 46778888888776432 22223577788888888877743 5666777777888888888776443333333
Q ss_pred c-----cccccccccCccccCc----cccccccccchhhhhhcCCCcccCCCCC------CCCCccccccccCCCCC
Q 007200 140 L-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIPTN------GSFSLFTPISFANNQLN 201 (613)
Q Consensus 140 l-----~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~------~~~~~l~~l~l~~N~i~ 201 (613)
. ++|++|+|++|.+++. ++..+..+++|+.|+|++|.|++..... ...+.|+.|++++|.+.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 2 5777777777777654 3455566677777777777776432211 11456777777777665
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5.8e-10 Score=112.04 Aligned_cols=187 Identities=19% Similarity=0.181 Sum_probs=122.6
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCc--cceeeEEEEcCC---ceEEEEec
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPF 366 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 366 (613)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.+++..+. +.. +.+++....... ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999863 45889986533 23457889999998773 333 344444433332 34789999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------------- 408 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 408 (613)
++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999988754321 266777888888888888888861
Q ss_pred -----------------CCCCeEecCCCCCceeecC--CCcEEEeccccceecCCCCCceeec-------------cccc
Q 007200 409 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVTTA-------------VRGT 456 (613)
Q Consensus 409 -----------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~-------------~~gt 456 (613)
..+.++|+|++|.||++++ +..+.|+||+.+...+......... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1236899999999999998 5567899999987644321000000 0000
Q ss_pred ccccc-ccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 457 IGHIA-PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 457 ~~y~a-PE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
.++.. |+.... .....+.|++|.++|++.+|..+|-
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 222111 1122588999999999999998874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.95 E-value=3.6e-11 Score=128.32 Aligned_cols=135 Identities=18% Similarity=0.161 Sum_probs=96.0
Q ss_pred CCCeEEEEcCCCCcccccchhhh-----CCCCCCEEEcccccCCCC----CccccccCCcCCeEeccCccCCCCCCcccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLG-----QLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 138 (613)
.++++.|+|++|.++...+..+. ..++|+.|+|++|++++. ++..+..+++|++|+|++|.++...+..+.
T Consensus 112 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 191 (461)
T 1z7x_W 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC 191 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH
Confidence 45788999999988754444333 256788888888888853 355667778888888888888754344443
Q ss_pred c-----ccccccccccCccccCc----cccccccccchhhhhhcCCCcccCC-----CC-CCCCCccccccccCCCCCC
Q 007200 139 K-----LSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDI-----PT-NGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 139 ~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~-~~~~~~l~~l~l~~N~i~~ 202 (613)
. +++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.. +. ...+++|+.|++++|.+..
T Consensus 192 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~ 270 (461)
T 1z7x_W 192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA 270 (461)
T ss_dssp HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCH
Confidence 2 56888888888888753 4666777888888888888887531 11 1246778888888887765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=2e-11 Score=126.07 Aligned_cols=134 Identities=18% Similarity=0.213 Sum_probs=88.1
Q ss_pred CCeEEEEcCCCCcccccchh-hhCCCCCCEEEcccccCCCCCcccc-----ccCCcCCeEeccCccCCCC----CCcccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEEL-----GNLTNLVSLDLYLNNLNGP----IPTTLG 138 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~ 138 (613)
.+++.|+|++|.|+...... ...+++|+.|+|++|.|+......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 47888888888876433322 2345677888888888764333333 2457788888888887632 344456
Q ss_pred cccccccccccCccccCc----cccccccccchhhhhhcCCCcccCCCC-----CCCCCccccccccCCCCCC
Q 007200 139 KLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIPT-----NGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 139 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~~~l~~l~l~~N~i~~ 202 (613)
.+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+..... ...++.|+.|++++|.+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 678888888888887642 245566677888888888888743211 1234678888888887643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=5.7e-11 Score=122.71 Aligned_cols=133 Identities=19% Similarity=0.197 Sum_probs=100.4
Q ss_pred CCeEEEEcCCCCcccccchhhhCC-----CCCCEEEcccccCCCCCccc-cccCCcCCeEeccCccCCCCCCccc-----
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTL----- 137 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~----- 137 (613)
..++.|+|++|.|+......+..+ ++|+.|+|++|.|+...... ...+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 479999999999986544444433 79999999999997433323 3456789999999999985433444
Q ss_pred ccccccccccccCccccCc----cccccccccchhhhhhcCCCcccCC-----CCCCCCCccccccccCCCCC
Q 007200 138 GKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLN 201 (613)
Q Consensus 138 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~i~ 201 (613)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+... ......++|+.|++++|.+.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 2468899999999999752 4455677899999999999998532 12244578999999999764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.6e-09 Score=107.53 Aligned_cols=135 Identities=19% Similarity=0.186 Sum_probs=99.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccc---------------------------------
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG--------------------------------- 114 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~--------------------------------- 114 (613)
..+++.|+|.+ +++.+...+|.++++|+.|+|++|.++...+.+|.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 35789999998 88877778899999999999999976422222221
Q ss_pred ---------------------------------------------cCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 115 ---------------------------------------------NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 115 ---------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.+++|+.|+|++|+++...+..|.+|++|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 26678888888888886556678888888888888
Q ss_pred CccccCccccccccccchh-hhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQ-VLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
+| ++...+..|.++++|+ .|++.+ .++.+.+.. ..+++|+.+++++|.+...+.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 87 6655566788888888 888877 666655444 667788888888887766543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.5e-10 Score=112.57 Aligned_cols=79 Identities=28% Similarity=0.412 Sum_probs=58.5
Q ss_pred ccCCcCCeEeccCccCCC--CCCcccccccccccccccCccccCcccccccccc--chhhhhhcCCCcccCCCC------
Q 007200 114 GNLTNLVSLDLYLNNLNG--PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPT------ 183 (613)
Q Consensus 114 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~------ 183 (613)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++..+.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 567899999999999987 4457778899999999999999854 3344444 889999999999875542
Q ss_pred --CCCCCcccccc
Q 007200 184 --NGSFSLFTPIS 194 (613)
Q Consensus 184 --~~~~~~l~~l~ 194 (613)
...+++|+.|+
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 13455665554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.65 E-value=4.9e-09 Score=101.97 Aligned_cols=80 Identities=28% Similarity=0.294 Sum_probs=66.3
Q ss_pred hCCCCCCEEEcccccCCC--CCccccccCCcCCeEeccCccCCCCCCccccccc--ccccccccCccccCcccc------
Q 007200 90 GQLTNLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS--KLRFLRLNNNSLMGEIPR------ 159 (613)
Q Consensus 90 ~~l~~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~------ 159 (613)
.++++|+.|+|++|+|++ .+|+.+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 578999999999999997 4557778999999999999999965 4455555 999999999999976652
Q ss_pred -ccccccchhhhh
Q 007200 160 -SLTNVNSLQVLD 171 (613)
Q Consensus 160 -~~~~l~~L~~L~ 171 (613)
.+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 366788888776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.3e-09 Score=120.11 Aligned_cols=135 Identities=14% Similarity=0.166 Sum_probs=83.3
Q ss_pred CCeEEEEcCCCCcccccchhhhC-CCCCCEEEcc----cccCCCC-----CccccccCCcCCeEeccCc--cCCCCCCcc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQ-LTNLQYLELY----SNNISGK-----VPEELGNLTNLVSLDLYLN--NLNGPIPTT 136 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~i~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~ 136 (613)
++++.|+|+.|++++.....+.. +++|+.|+|+ .|.+++. ++..+.++++|++|+|++| .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 35666666666666555555544 6677777775 5566643 2233556777777777643 255443333
Q ss_pred cc-cccccccccccCccccC-ccccccccccchhhhhhcCCCcccC-CCC-CCCCCccccccccCCCCCCC
Q 007200 137 LG-KLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGD-IPT-NGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 137 ~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~-~~~-~~~~~~l~~l~l~~N~i~~~ 203 (613)
+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|++++. ++. ...+++|+.|++++|.++..
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 33 36778888888888765 2344556778888888888887643 121 24567788888888876543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=4.7e-09 Score=97.08 Aligned_cols=111 Identities=19% Similarity=0.214 Sum_probs=78.9
Q ss_pred CCCeEEEEcCCC-Cccc----ccchhhhCCCCCCEEEcccccCCC----CCccccccCCcCCeEeccCccCCCC----CC
Q 007200 68 ENSVTRVDLGNA-NLSG----QLVSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IP 134 (613)
Q Consensus 68 ~~~l~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 134 (613)
..+++.|+|++| .|.. .+...+...++|++|+|++|.|+. .+...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 457888888888 8763 234556677888888888888873 2344566667888888888888743 34
Q ss_pred cccccccccccccc--cCccccCc----cccccccccchhhhhhcCCCcc
Q 007200 135 TTLGKLSKLRFLRL--NNNSLMGE----IPRSLTNVNSLQVLDLSNNKLT 178 (613)
Q Consensus 135 ~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 178 (613)
..+...++|++|+| ++|.|... +...+...++|+.|+|++|.|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56677778888888 77888743 2334455577777888777765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.58 E-value=3.1e-08 Score=100.54 Aligned_cols=124 Identities=14% Similarity=0.057 Sum_probs=88.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccc-ccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR-FLR 147 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~ 147 (613)
.+++.+.+.++-...........+++|+.|+|++|+++.+.+.+|.++++|+.|+|++| ++...+..|.+|++|+ .|+
T Consensus 202 ~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 202 RDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp GGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 45666666554222111112234788888888888888666677888888888888887 7655667788888888 888
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCcccccc
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPIS 194 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~ 194 (613)
|.+ .++...+..|.++++|+.|++++|.++.+.+.. ..+++|+.++
T Consensus 281 l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 281 LPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred Ecc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 888 666556678888888888888888888776654 5566776654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.6e-08 Score=111.36 Aligned_cols=104 Identities=13% Similarity=0.203 Sum_probs=74.0
Q ss_pred CeEEEEcCCCC-ccc-ccchhhhCCCCCCEEEcccccCCCC----CccccccCCcCCeEeccCccCCC----CCCccccc
Q 007200 70 SVTRVDLGNAN-LSG-QLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNG----PIPTTLGK 139 (613)
Q Consensus 70 ~l~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~ 139 (613)
+++.|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48888888876 221 1233345788888888888888755 44455678888888888888873 23445567
Q ss_pred ccccccccccCccccCccccccccccchhhhhhcC
Q 007200 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174 (613)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 174 (613)
+++|+.|+|++|.+.+ ++..+..+++|+.|+++.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 8888888888888874 566677777777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=3.4e-09 Score=98.03 Aligned_cols=119 Identities=18% Similarity=0.190 Sum_probs=92.5
Q ss_pred ccccchhhhCCCCCCEEEcccc-cCCC----CCccccccCCcCCeEeccCccCCCC----CCcccccccccccccccCcc
Q 007200 82 SGQLVSQLGQLTNLQYLELYSN-NISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNS 152 (613)
Q Consensus 82 ~~~~~~~~~~l~~L~~L~L~~N-~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~ 152 (613)
...+...+...+.|+.|+|++| .|+. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.
T Consensus 25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 3345567788999999999999 8873 2455677789999999999999742 34556677899999999999
Q ss_pred ccCc----cccccccccchhhhhh--cCCCcccCC-----CCCCCCCccccccccCCCC
Q 007200 153 LMGE----IPRSLTNVNSLQVLDL--SNNKLTGDI-----PTNGSFSLFTPISFANNQL 200 (613)
Q Consensus 153 l~~~----~~~~~~~l~~L~~L~l--~~N~l~~~~-----~~~~~~~~l~~l~l~~N~i 200 (613)
|... +...+...++|+.|+| ++|.|.... ......+.|+.|++++|.+
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 9853 4567778889999999 889998532 1123457899999998855
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-06 Score=84.65 Aligned_cols=135 Identities=19% Similarity=0.154 Sum_probs=95.2
Q ss_pred ccccCcCc-EEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCceEEEEecccCCc
Q 007200 295 ILGRGGFG-KVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 295 ~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+++..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45566666 68988765 4667999986532 2446788999888774 3347788888888889999999999988
Q ss_pred chhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 007200 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------------------------------------------- 408 (613)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 408 (613)
+.+...... .....+..++++.|+.||..
T Consensus 107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 776543211 12234455555555555532
Q ss_pred ------------CCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 409 ------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 409 ------------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
..+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112488999999999999887778999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.7e-08 Score=111.06 Aligned_cols=60 Identities=8% Similarity=0.107 Sum_probs=25.8
Q ss_pred ccccccccccCccccCcccccc-ccccchhhhhhcCCCcccCCC--CCCCCCccccccccCCC
Q 007200 140 LSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQ 199 (613)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~ 199 (613)
+++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++... ....+++|+.|++++|+
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 4445555555555443322222 334555555555555432211 11234445555555543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.2e-06 Score=84.59 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=93.6
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccC---ccceeeEEEE-cCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 369 (613)
+.++.|....||+. |..+++|+... ......+.+|.+++..+.+. .+.+++.+.. ..+..+++|||++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899988 56788888532 22345788999999988742 3566677664 34567899999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH----------------------------------------- 408 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 408 (613)
..+.+..-. .++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888763211 133444455555555555555532
Q ss_pred ----------------CCCCeEecCCCCCceeecC---CCc-EEEeccccceec
Q 007200 409 ----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKLM 442 (613)
Q Consensus 409 ----------------~~~~ivH~Dlk~~NIll~~---~~~-~kl~DfGla~~~ 442 (613)
..+.++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2336799999999999998 455 489999988643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.2e-08 Score=108.00 Aligned_cols=130 Identities=15% Similarity=0.140 Sum_probs=72.5
Q ss_pred CCeEEEEcCCCCcccccchhhh-CCCCCCEEEcccc-cCCCC-CccccccCCcCCeEeccCccCCCCCCcccc----ccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSN-NISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLG----KLS 141 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N-~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 141 (613)
++++.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3667777777776655555554 5677777777776 44421 334344677777777777776654443333 455
Q ss_pred ccccccccCcc--ccCc-cccccccccchhhhhhcCC-CcccCCCCCCCCCccccccccCC
Q 007200 142 KLRFLRLNNNS--LMGE-IPRSLTNVNSLQVLDLSNN-KLTGDIPTNGSFSLFTPISFANN 198 (613)
Q Consensus 142 ~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~l~~l~l~~N 198 (613)
+|+.|+|++|. +... ++..+..+++|+.|+|++| .+.+.+.....+++|+.|+++.+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence 77777777765 2211 1112234567777777766 33332222244555666655443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.9e-07 Score=95.54 Aligned_cols=60 Identities=22% Similarity=0.219 Sum_probs=26.7
Q ss_pred hhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccc--ccccccccccc
Q 007200 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG--KLSKLRFLRLN 149 (613)
Q Consensus 87 ~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~ 149 (613)
..+..+|+|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+. .+++|+.|+|+
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 44455555555555555211 1222 22 45555555555554422222222 45555555553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.9e-06 Score=85.89 Aligned_cols=81 Identities=7% Similarity=-0.008 Sum_probs=55.3
Q ss_pred Ccc-ccCcCcEEEEEEeC-------CCCEEEEEEeccccC--cccHHHHHHHHHHHhhccc---CccceeeEEEEcC---
Q 007200 294 NIL-GRGGFGKVYKGRLT-------DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 357 (613)
Q Consensus 294 ~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 357 (613)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988754 266789998654320 0011346788888887752 3467788877654
Q ss_pred CceEEEEecccCCcchh
Q 007200 358 TERLLVYPFMVNGSVAS 374 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~ 374 (613)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999887664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.09 E-value=5.9e-06 Score=85.90 Aligned_cols=127 Identities=14% Similarity=0.075 Sum_probs=72.1
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccc---------------------cCCCCCccccccCCcCCeEeccCcc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN---------------------NISGKVPEELGNLTNLVSLDLYLNN 128 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N---------------------~i~~~~p~~~~~l~~L~~L~Ls~N~ 128 (613)
+++.+.|.+ +++.+....|.++++|+.|+|..| +++..-..+|.++++|+.++|.+|.
T Consensus 204 ~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 204 GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGST 282 (401)
T ss_dssp CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESSC
T ss_pred ccCEEEeCC-chheehhhHhhCCCCCCEEecCCCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCcc
Confidence 456666653 355444455666666666666543 3333334556666666666666665
Q ss_pred CC-----CCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCC
Q 007200 129 LN-----GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQL 200 (613)
Q Consensus 129 l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i 200 (613)
+. ...+..|.+|++|+.++|. |.++......|.++++|+.|.|.+| ++.+.... ..+ +|+.+.+.+|.+
T Consensus 283 ~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 283 FNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 54 2334556666667777666 3355444556666677777776444 54444333 334 667777766644
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=6.7e-07 Score=91.45 Aligned_cols=131 Identities=20% Similarity=0.297 Sum_probs=91.7
Q ss_pred CCCeEEEEcCCCC-cccccchhhhCCCCCCEEEcccccCCCCCccccc--cCCcCCeEeccC--ccCCCC-----CCccc
Q 007200 68 ENSVTRVDLGNAN-LSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG--NLTNLVSLDLYL--NNLNGP-----IPTTL 137 (613)
Q Consensus 68 ~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~ 137 (613)
.++++.|+|++|. +. ++. + .+++|+.|+|..|.++......+. .+++|++|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp CTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 4689999998873 32 333 3 388999999999988743333444 789999999864 222211 11223
Q ss_pred --ccccccccccccCccccCccccccc---cccchhhhhhcCCCcccC-----CCCCCCCCccccccccCCCCCC
Q 007200 138 --GKLSKLRFLRLNNNSLMGEIPRSLT---NVNSLQVLDLSNNKLTGD-----IPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 138 --~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
..+++|++|+|++|.+.+..+..+. .+++|+.|+|+.|.|.+. ......+++|+.|++++|.++.
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 2478999999999998754433332 578999999999999863 2222457889999999997754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.04 E-value=3.9e-06 Score=87.26 Aligned_cols=111 Identities=13% Similarity=0.113 Sum_probs=90.8
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCC-----CCCccccccCCcCCeEeccCccCCCCCCccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS-----GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (613)
.+++.+.| .++++......|.++++|+.++|.+|.+. ...+.+|.++++|+.++|. |.++..-...|.+|++|
T Consensus 248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSC
T ss_pred CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCc
Confidence 35677777 45676566788999999999999998875 3556789999999999999 55876667889999999
Q ss_pred ccccccCccccCccccccccccchhhhhhcCCCcccCCCC
Q 007200 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183 (613)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 183 (613)
+.|.|..| ++......|.++ +|+.|++++|.+......
T Consensus 326 ~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~ 363 (401)
T 4fdw_A 326 TQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEK 363 (401)
T ss_dssp CEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred cEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccc
Confidence 99999766 665667789999 999999999988765543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.8e-05 Score=77.87 Aligned_cols=141 Identities=16% Similarity=0.187 Sum_probs=79.7
Q ss_pred CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--CccceeeE------EEEcCCceEEEEe
Q 007200 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRG------FCMTPTERLLVYP 365 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e 365 (613)
+.|+.|..+.||+....+| .+++|+.... ...+..|..++..+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987654 5899988652 1233445555554431 12333332 1223566789999
Q ss_pred cccCCcch--------------hhhhccCCC---C-------CCCCHHHH------------------------------
Q 007200 366 FMVNGSVA--------------SCLRERGQS---Q-------PPLNWSVR------------------------------ 391 (613)
Q Consensus 366 ~~~~gsL~--------------~~l~~~~~~---~-------~~l~~~~~------------------------------ 391 (613)
|++|..+. ..+|..... . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987653 112211100 0 01123211
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 392 -KQIALGAARGLAYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 392 -~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
..+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666763 124489999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=4.2e-05 Score=79.47 Aligned_cols=76 Identities=9% Similarity=-0.044 Sum_probs=49.1
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccC------cccHHHHHHHHHHHhhccc--Cc-cceeeEEEEcCCceEE
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT------QGGELQFQTEVEMISMAVH--RN-LLRLRGFCMTPTERLL 362 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 362 (613)
.+.||.|.++.||++... +++.++||....... .....++..|.+++..+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 356899999999999754 468899998653221 1122356778888877642 33 4455543 3455789
Q ss_pred EEecccCC
Q 007200 363 VYPFMVNG 370 (613)
Q Consensus 363 v~e~~~~g 370 (613)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0002 Score=71.40 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=92.6
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc---cCccceeeEEEEcCCceEEEEecccC
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
.+.|+.|.+..+|+... ++..+++|+.... ....+..|.+.++.+. ...+.+++.+.......++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35689999999999986 4678899987542 2456888999888775 35688888888877889999999998
Q ss_pred Ccchh-----------hhhccCC-C-----------------CCCCCHHHHH---HHHH----------------HHHHH
Q 007200 370 GSVAS-----------CLRERGQ-S-----------------QPPLNWSVRK---QIAL----------------GAARG 401 (613)
Q Consensus 370 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~i~~~ 401 (613)
..+.. .+|.... . ...-+|.... ++.. .+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86632 2233221 0 0012454332 1111 11111
Q ss_pred -HHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 402 -LAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 402 -L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2246899999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.73 E-value=3.5e-06 Score=75.93 Aligned_cols=83 Identities=13% Similarity=0.241 Sum_probs=55.1
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEccccc-CCCCCccccccC----CcCCeEeccCcc-CCCCCCccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNL----TNLVSLDLYLNN-LNGPIPTTLGKLSKL 143 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 143 (613)
.++.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+ ++|++|+|++|. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 68888888888775544566788888888888874 553222234443 368888888774 663323346667777
Q ss_pred ccccccCcc
Q 007200 144 RFLRLNNNS 152 (613)
Q Consensus 144 ~~L~L~~N~ 152 (613)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 778777764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.72 E-value=7.3e-06 Score=73.86 Aligned_cols=86 Identities=13% Similarity=0.112 Sum_probs=67.3
Q ss_pred CCCCEEEcccccCCCCCccccccCCcCCeEeccCcc-CCCCCCcccccc----cccccccccCcc-ccCccccccccccc
Q 007200 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKL----SKLRFLRLNNNS-LMGEIPRSLTNVNS 166 (613)
Q Consensus 93 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~ 166 (613)
.+|+.|||+++.|+..--..+..+++|++|+|++|. |+..--..++.+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999885444567899999999999995 764323345553 479999999985 88655556788999
Q ss_pred hhhhhhcCCC-cc
Q 007200 167 LQVLDLSNNK-LT 178 (613)
Q Consensus 167 L~~L~l~~N~-l~ 178 (613)
|+.|+|++++ ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 44
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.68 E-value=7.3e-06 Score=75.31 Aligned_cols=83 Identities=16% Similarity=0.180 Sum_probs=47.2
Q ss_pred CCeEEEEcCCC-Cccc----ccchhhhCCCCCCEEEcccccCCC----CCccccccCCcCCeEeccCccCCCC----CCc
Q 007200 69 NSVTRVDLGNA-NLSG----QLVSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPT 135 (613)
Q Consensus 69 ~~l~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 135 (613)
..++.|+|++| .|.. .+...+..-+.|+.|+|++|.|.. .+...+..-+.|++|+|++|.|... +.+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 45677777764 5542 233455555667777777777662 2344455556677777777766632 223
Q ss_pred ccccccccccccccCc
Q 007200 136 TLGKLSKLRFLRLNNN 151 (613)
Q Consensus 136 ~~~~l~~L~~L~L~~N 151 (613)
.+..-+.|++|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 3444455666666644
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00046 Score=72.14 Aligned_cols=79 Identities=11% Similarity=0.058 Sum_probs=47.8
Q ss_pred CCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCceeecc-ccccccccccccccC---CCCCcccchhHHHHHHH
Q 007200 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLE 485 (613)
Q Consensus 410 ~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DVwS~G~il~e 485 (613)
.+.++|+|+++.|||++.++ ++++||+.+..-+....- .... .-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999999876 999999998754321100 0000 011346666654311 11223455577777787
Q ss_pred HHhCC
Q 007200 486 LITGQ 490 (613)
Q Consensus 486 lltg~ 490 (613)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00033 Score=69.09 Aligned_cols=79 Identities=16% Similarity=0.207 Sum_probs=55.8
Q ss_pred CCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc---CccceeeEEEEcCCceEEEEe
Q 007200 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 365 (613)
.....+.+|.|..+.||+.+..+|+.|++|+...... .....|..|...|+.+.- --+.+++++. ..+++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3444567899999999999999999999998754432 223357889998887742 2244555542 3478999
Q ss_pred cccCCcc
Q 007200 366 FMVNGSV 372 (613)
Q Consensus 366 ~~~~gsL 372 (613)
|+.++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0007 Score=67.21 Aligned_cols=140 Identities=11% Similarity=0.066 Sum_probs=76.7
Q ss_pred CCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccc-eeeEEEEcCCceEEEEecc-cCC
Q 007200 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFM-VNG 370 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~-~~g 370 (613)
.+.|+.|....+|+. ..+++|+....... ......|..++..+....+. +++++ .+..-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567889999999999 45888887643211 11235677777766533333 44443 444567999999 665
Q ss_pred cchhh------------------hhccCCCC-CCCC-HHHHHHHHHH--------------HHHHHH----HHHh-cCCC
Q 007200 371 SVASC------------------LRERGQSQ-PPLN-WSVRKQIALG--------------AARGLA----YLHD-HCDP 411 (613)
Q Consensus 371 sL~~~------------------l~~~~~~~-~~l~-~~~~~~i~~~--------------i~~~L~----~LH~-~~~~ 411 (613)
++... +|...... ..++ +.....+... +.+.+. .+.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55320 11111100 0011 1111111110 111111 1111 1233
Q ss_pred CeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 412 ~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
.++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 6899999999999 55668899999988643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0002 Score=74.26 Aligned_cols=109 Identities=7% Similarity=0.148 Sum_probs=53.8
Q ss_pred chhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccccccccc
Q 007200 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165 (613)
Q Consensus 86 ~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 165 (613)
..+|.++..|+.+.+.++..+ .-..+|.++++|+.+.+. +.++......|.++.+|+.++|..| ++.....+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 345555666666666544332 334455555566665554 3343233345555556666555543 3323344555555
Q ss_pred chhhhhhcCCCcccCCCCC-CCCCccccccccCC
Q 007200 166 SLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANN 198 (613)
Q Consensus 166 ~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N 198 (613)
+|+.+.|..+ ++.+.... ..+++|+.+.+.+|
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence 5555555433 33332222 34455555555544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0012 Score=65.98 Aligned_cols=159 Identities=11% Similarity=0.079 Sum_probs=87.1
Q ss_pred cCHHHHHHHhhCCCCC-----CccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc--ccee
Q 007200 278 FSLRELQVATDNFSNR-----NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRL 350 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l 350 (613)
++.+++......|... +.|+.|....+|+....+| .+++|+...... ...+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4455555555556542 3466788889999987655 688998865311 123456777776664222 2333
Q ss_pred eEE------EEcCCceEEEEecccCCcchh--------------hhhccCCC--CC---CC---CHHHHHH---------
Q 007200 351 RGF------CMTPTERLLVYPFMVNGSVAS--------------CLRERGQS--QP---PL---NWSVRKQ--------- 393 (613)
Q Consensus 351 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~--~~---~l---~~~~~~~--------- 393 (613)
+.. ....+..+++++|++|..+.. .+|..... .+ .. .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112345689999999876432 12221100 00 01 1222100
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 394 ---IALGAARGLAYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 394 ---i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
+...+.+.+++++.. ...+++|+|+++.||+++.++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134455555532 23479999999999999987666899999875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00022 Score=61.06 Aligned_cols=56 Identities=23% Similarity=0.278 Sum_probs=38.5
Q ss_pred EEEcccccCC-CCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCcccc
Q 007200 97 YLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154 (613)
Q Consensus 97 ~L~L~~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 154 (613)
.++.++++++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777888776 24554333 46777888888877655666777777777777777664
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00041 Score=59.40 Aligned_cols=57 Identities=28% Similarity=0.293 Sum_probs=45.2
Q ss_pred EEEEcCCCCcc-cccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCC
Q 007200 72 TRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130 (613)
Q Consensus 72 ~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~ 130 (613)
+.++.++++|+ ..+|..+ .++|+.|+|++|+|+...++.|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 37888888887 2445433 247999999999999777778899999999999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0014 Score=65.92 Aligned_cols=144 Identities=17% Similarity=0.087 Sum_probs=72.8
Q ss_pred CccccCcCcE-EEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--CccceeeEEEEcCCceEEEEecccCC
Q 007200 294 NILGRGGFGK-VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNG 370 (613)
Q Consensus 294 ~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 370 (613)
+.|+.|.... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+..+ . -+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~-g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA-R-GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT-T-TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC-C-CEEEEeeCCCc
Confidence 3465565554 6677654467787876543221 123456666665542 234556665322 2 37899998776
Q ss_pred cchhhhhc---------------------cCCC-CCCCCHHHHHH--------H------------HHHHHHHHHHHHh-
Q 007200 371 SVASCLRE---------------------RGQS-QPPLNWSVRKQ--------I------------ALGAARGLAYLHD- 407 (613)
Q Consensus 371 sL~~~l~~---------------------~~~~-~~~l~~~~~~~--------i------------~~~i~~~L~~LH~- 407 (613)
.+.+++.. .... .+.++...... + ...+.+.++.+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 55433321 1100 11122211100 0 0011122233311
Q ss_pred --cCCCCeEecCCCCCceeecCC----CcEEEeccccceecC
Q 007200 408 --HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMD 443 (613)
Q Consensus 408 --~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla~~~~ 443 (613)
.....++|||+.+.||+++.+ +.+.|+||+.+..-+
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123479999999999999875 689999999887543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0015 Score=68.24 Aligned_cols=73 Identities=14% Similarity=0.188 Sum_probs=49.6
Q ss_pred CccccCcCcEEEEEEeCC--------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCcc-ceeeEEEEcCCceEEEE
Q 007200 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 364 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 364 (613)
+.|+.|....+|+....+ ++.+++|+..... ....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 467888889999998753 5789999874321 11345578888887764444 566665432 3899
Q ss_pred ecccCCcch
Q 007200 365 PFMVNGSVA 373 (613)
Q Consensus 365 e~~~~gsL~ 373 (613)
||++|.++.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0055 Score=61.32 Aligned_cols=142 Identities=18% Similarity=0.172 Sum_probs=81.6
Q ss_pred ccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc--cceeeEE-----EEcCCceEEEEecc
Q 007200 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF-----CMTPTERLLVYPFM 367 (613)
Q Consensus 295 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 367 (613)
.++ |....||+....+|+.+++|....... ....+..|..++..+.... +.+++.. ....+..+++|+|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 888899998877777899999864322 2345667887777664222 3444432 11234557899999
Q ss_pred cCCcchh----h----------hhccC----C-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 007200 368 VNGSVAS----C----------LRERG----Q-SQPPLNWSVR----KQI---------------ALGAARGLAYLHDH- 408 (613)
Q Consensus 368 ~~gsL~~----~----------l~~~~----~-~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~- 408 (613)
+|..+.. . +|... . ..+..++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 0 11110 0 0111222211 001 01111223333321
Q ss_pred ---CCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 409 ---CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 409 ---~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999998754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00096 Score=68.54 Aligned_cols=111 Identities=16% Similarity=0.138 Sum_probs=66.3
Q ss_pred ccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccccccc
Q 007200 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN 163 (613)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 163 (613)
.....|.++..|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++......|.++.+|+.+.+.+|.++......|.+
T Consensus 231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcC
Confidence 33445666667777776655 44344456667777777777543 44334456777777777777777666444556777
Q ss_pred ccchhhhhhcCCCcccCCCCC-CCCCccccccccC
Q 007200 164 VNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFAN 197 (613)
Q Consensus 164 l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~ 197 (613)
+.+|+.+.|..+ ++.+.... ..+++|+.+.+..
T Consensus 309 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 309 CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 777777777543 44433332 3455666665543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00012 Score=67.06 Aligned_cols=92 Identities=17% Similarity=0.187 Sum_probs=70.1
Q ss_pred cchhhhCCCCCCEEEcccc-cCCC----CCccccccCCcCCeEeccCccCCC----CCCcccccccccccccccCccccC
Q 007200 85 LVSQLGQLTNLQYLELYSN-NISG----KVPEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMG 155 (613)
Q Consensus 85 ~~~~~~~l~~L~~L~L~~N-~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 155 (613)
+...+.+-+.|+.|+|++| .|.. .+.+++..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|.|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3445566788999999986 8763 245667788999999999999983 344556677899999999999985
Q ss_pred c----cccccccccchhhhhhcCCC
Q 007200 156 E----IPRSLTNVNSLQVLDLSNNK 176 (613)
Q Consensus 156 ~----~~~~~~~l~~L~~L~l~~N~ 176 (613)
. +-+.+..-+.|+.|+|++|.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHHHHhhCCceeEEECCCCc
Confidence 3 34456666779999998653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=68.21 Aligned_cols=108 Identities=14% Similarity=0.120 Sum_probs=85.3
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-..+|.++++|+.+.|.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 35777777654 66555678899999999999765 55455668999999999999999998666788999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 180 (613)
..+ ++.....+|.++++|+.+.+..| ++.+
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLI 347 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence 865 66455678999999999988654 4433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0045 Score=63.27 Aligned_cols=142 Identities=13% Similarity=0.103 Sum_probs=84.0
Q ss_pred CccccCcCcEEEEEEeC--------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc-cceeeEEEEcCCceEEEE
Q 007200 294 NILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 364 (613)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+.-.+ ..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45777888899999864 2478999986321 123456678999988775333 3556665533 3999
Q ss_pred ecccCCcchhh-----------------hhccCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 007200 365 PFMVNGSVASC-----------------LRERGQ-SQPPL--NWSVRKQIALGAAR-------------------GLAYL 405 (613)
Q Consensus 365 e~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------~L~~L 405 (613)
||++|.++..- +|.... ...+. -+..+.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998766421 111111 01112 24555555544321 23333
Q ss_pred Hhc-----CCCCeEecCCCCCceeecCC----CcEEEecccccee
Q 007200 406 HDH-----CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 441 (613)
Q Consensus 406 H~~-----~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla~~ 441 (613)
.+. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 321 12368899999999999876 7899999998863
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00074 Score=69.87 Aligned_cols=124 Identities=12% Similarity=0.123 Sum_probs=82.5
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.++.+.+.++-.+ .....|.++++|+.+.+. +.++..-..+|.++.+|+.++|..| ++..-...|.+|.+|+.+.|.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 4566666544332 445678888999999986 4565455678899999999999765 654556789999999999997
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 199 (613)
.+ ++..-..+|.++++|+.+++.+|.... ......+.|+.+.+..|.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC---------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCC
Confidence 55 664556788899999999998876542 223445666766665553
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0081 Score=60.57 Aligned_cols=32 Identities=25% Similarity=0.336 Sum_probs=28.2
Q ss_pred CCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 411 ~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
..++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0046 Score=63.16 Aligned_cols=73 Identities=8% Similarity=0.040 Sum_probs=44.2
Q ss_pred CccccCcCcEEEEEEeCC---------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc-cceeeEEEEcCCceEEE
Q 007200 294 NILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLV 363 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 363 (613)
+.++.|....+|+....+ +..+++|+....... ......|..++..+...+ +.++++.. + -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 457788889999998753 268888876543211 112457888887775434 34666543 2 3789
Q ss_pred EecccCCcc
Q 007200 364 YPFMVNGSV 372 (613)
Q Consensus 364 ~e~~~~gsL 372 (613)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.002 Score=66.52 Aligned_cols=55 Identities=13% Similarity=0.077 Sum_probs=29.9
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
+|+.+.|.+ +++.+-..+|.++++|+.++|.+| ++..-..+|.++.+|+.+.+..
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~ 126 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPL 126 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccC
Confidence 566666653 355444455666666666666544 3323344566666666555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0023 Score=66.16 Aligned_cols=55 Identities=13% Similarity=0.044 Sum_probs=25.6
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
.++.+.+.++ ++......+.++..|+.+.+..|... .....|..+..|+.+.+..
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~ 285 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGS 285 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECS
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCc
Confidence 4555555432 23233345556666666666555433 3333344444444444433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0092 Score=62.68 Aligned_cols=74 Identities=11% Similarity=0.109 Sum_probs=47.6
Q ss_pred CccccCcCcEEEEEEeCC-CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCcc-ceeeEEEEcCCceEEEEecccCCc
Q 007200 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGS 371 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 371 (613)
+.|+.|-...+|+....+ +..+++|+..... . ......+|..++..+...++ .++++++. + .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 467888889999998764 4788898774322 1 11123578888888865444 46666652 2 35999998866
Q ss_pred ch
Q 007200 372 VA 373 (613)
Q Consensus 372 L~ 373 (613)
+.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.012 Score=54.30 Aligned_cols=102 Identities=16% Similarity=0.090 Sum_probs=64.7
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
-+|.+.|...+. |+++.+++.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 478888887654 5999999999999999887662211 111233456889999999988763 1110
Q ss_pred eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCC
Q 007200 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491 (613)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~ 491 (613)
.....+.|||... ...+.+.=|||+|+++|..+-=..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0223456888753 344567789999999998875333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.039 Score=57.19 Aligned_cols=141 Identities=9% Similarity=0.076 Sum_probs=84.6
Q ss_pred CccccCcCcEEEEEEeCC--------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCc-cceeeEEEEcCCceEEEE
Q 007200 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 364 (613)
+.+..|-...+|+....+ ++.+++|+..... . ......+|..+++.+...+ ..++++.+ .-++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 457778889999998763 5789999864322 1 1123457888887775333 34555433 237899
Q ss_pred ecccCCcchhh-----------------hhcc-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 007200 365 PFMVNGSVASC-----------------LRER-------GQ--SQPPLNWSVRKQIALGA-------------------A 399 (613)
Q Consensus 365 e~~~~gsL~~~-----------------l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~ 399 (613)
+|++|.+|..- +|.. .. ...+.-+..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1111 00 11222345444444332 1
Q ss_pred HHHHHHHhc---------------------CCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 400 RGLAYLHDH---------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 400 ~~L~~LH~~---------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
..+++|.+. .+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236889999999999 7788999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.05 E-value=0.66 Score=47.58 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.2
Q ss_pred CeEecCCCCCceee------cCCCcEEEecccccee
Q 007200 412 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 441 (613)
Q Consensus 412 ~ivH~Dlk~~NIll------~~~~~~kl~DfGla~~ 441 (613)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.41 E-value=0.58 Score=43.00 Aligned_cols=117 Identities=8% Similarity=0.063 Sum_probs=79.5
Q ss_pred cccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007200 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (613)
Q Consensus 342 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 421 (613)
..||+++.. .+-.+++...+.++.-..+.=...++. ++...+++++.+|+....+++.. +|--|+|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 358888866 455666666666665443322223332 77899999999998877666654 78999999
Q ss_pred ceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 422 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 422 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
||+++.++.+++.-.|+...+.+.. +.+|. =.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~~-------------~~ee~----------fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPLP-------------VSEAE----------FLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCCC-------------CCHHH----------HHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCCCC-------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998777653322110 01121 13345678889999999985
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.18 E-value=0.2 Score=32.97 Aligned_cols=33 Identities=21% Similarity=0.218 Sum_probs=22.3
Q ss_pred CCcccccccchhhHHHhhhhhhHHHHhhccCCC
Q 007200 224 ATGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 256 (613)
Q Consensus 224 ~~~~~~~~v~~~~~~l~~~~~~~~~~~r~rk~~ 256 (613)
....+++++.++.+.++++....++++|+|+.+
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 345577777777777766666667777776654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.83 Score=42.11 Aligned_cols=115 Identities=16% Similarity=0.148 Sum_probs=78.1
Q ss_pred ccCccceeeEEEEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 007200 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA-YLHDHCDPKIIHRDVKAA 421 (613)
Q Consensus 343 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlk~~ 421 (613)
.||++ -..+-.+++...+.++.-+++.-...++. ++...+++++.+|+.... +++.. +|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 57777 44555677777777776544443444432 778999999999887666 55544 88899999
Q ss_pred ceeecCCCcEEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 007200 422 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (613)
Q Consensus 422 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~ 494 (613)
||+++.++.+++.-.|+-..+++.. +.+|.+ .-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 9999999999998777653322111 112221 2345678888999988885
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.39 E-value=0.23 Score=32.66 Aligned_cols=34 Identities=26% Similarity=0.322 Sum_probs=23.0
Q ss_pred CCcccccccchhhHHHhhhhhhHHHHhhccCCCC
Q 007200 224 ATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 257 (613)
Q Consensus 224 ~~~~~~~~v~~~~~~l~~~~~~~~~~~r~rk~~~ 257 (613)
....+++++.++.+.++++....++++|+|+...
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 3456777777777777766666677777766543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 613 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 2e-66
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 346
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+L G+ T + +V + S+ L + IA A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 465
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 466 STGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522
S ++DV+ +G++L EL+TGQ + N+ D ++ +G L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSK-- 233
Query: 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ + ++ C + ERP +++ +E
Sbjct: 234 --------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+RL T ++ +M NGS+ L+ L + +A A G+A++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
G + K+DV+ +G++L E++T R + ++ Q ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY-----------------PGMTNPEVIQNLERGY 227
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ E+L Q+ LC + P +RP + +LE
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-65
Identities = 69/290 (23%), Positives = 130/290 (44%), Gaps = 30/290 (10%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
++ + + ++G G FG+VYKG L S VA+K LK T+ + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ H N++RL G +++ +M NG++ LRE+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 456
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516
I APE +S K + +DV+ +G+++ E++T L
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSN 219
Query: 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566
++ + ++ + + Q+ + C Q RPK +++V +L+
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (539), Expect = 2e-64
Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 47/314 (14%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQF 332
L L+ +N +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ--------- 383
Q E +++ + N+++L G C L++ +M G + LR
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 384 -----------PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
PPL+ + + IA A G+AYL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 433 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
+ DFGL++ + D I + PE + + + ++DV+ YGV+L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 551
G+ E+ + + D ++ E +L + LC P
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLP 283
Query: 552 MERPKMSEVVRMLE 565
+RP + R+L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 2e-64
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 278 FSLRELQVATDNFSNR---------NILGRGGFGKVYKGRLT----DGSLVAVKRLKEER 324
F+ + A F+ ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 325 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384
T+ F +E ++ H N++ L G T +++ FM NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DG 123
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 445 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 499
+ T + I APE + K + +DV+ YG+++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 559
+ + + ++ D + L Q+ L C Q RPK +
Sbjct: 236 -------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 560 VVRMLE 565
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-63
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 25/278 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 62
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L G C+ LV+ FM +G ++ LR + + L G+AYL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE 119
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ S K+DV+ +GV++ E+ + + N + +++ + +L +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDI------STGFRLYKPRL 226
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ Q+ C + P +RP S ++R L
Sbjct: 227 AS-------THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 33/285 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
+F+ ++GRG FG VY G L D AVK L G QF TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 345 RNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N+L L G C+ + L+V P+M +G + + +R L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGM- 143
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHI 460
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
A E L T K + K+DV+ +GV+L EL+T DV D LL+ ++L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQGRRLL 254
Query: 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
Q E + L +V L C RP SE+V +
Sbjct: 255 Q----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-62
Identities = 66/292 (22%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 281 RELQVATDNFSNRNI-LGRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQTEV 336
++L + DN +I LG G FG V +G VA+K LK+ + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+++ + ++RL G C +LV G + L + + + S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 454
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 513
+ APE ++ K S ++DV+ YGV + E ++ GQ+ + ++ +++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIE-- 226
Query: 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ K++E E +L + C +RP V + +
Sbjct: 227 -QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 4e-62
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 25/291 (8%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT 334
+ + ++ + + ++ LG G +G+VY+G VAVK LKE+ + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 335 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
E ++ H NL++L G C ++ FM G++ LRE + ++ V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 514
I APE L+ K S K+DV+ +GV+L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGI 220
Query: 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ +L++ D E E++ ++ C Q +P +RP +E+ + E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-61
Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 27/279 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 61
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L G C ++ +M NG + + LRE + ++ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K S K+D++ +GV++ E+ + G+ ++ + + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE------------------RFTNSETAEHIAQG 217
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ E++ + C ERP ++ +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 62/307 (20%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
+++ D+F + LG G G V+K G ++A K + E Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++ G + E + M GS+ L++ G + + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
PE L S ++D++ G+ L+E+ G+ A + ++M V+G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRP 230
Query: 522 LVDSDMEGNYIEEEVEQLIQVALL--------------------------CTQGSPMERP 555
+Y + + LL C +P ER
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 556 KMSEVVR 562
+ +++
Sbjct: 291 DLKQLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-61
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 25/278 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
++ LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L + +V +M GS+ +G++ L +A A G+AY+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
G+ + K+DV+ +G++L EL T R +++ V+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQVERGY 231
Query: 528 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
E E L + C + P ERP + LE
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 7e-61
Identities = 63/294 (21%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ +G+G FG+V++G+ G VAVK + + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64
Query: 353 FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T T+ LV + +GS+ L + ++AL A GLA+LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119
Query: 409 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 460
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 461 APEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLDWVKG 512
APE L +S ++ D++ G++ E+ + D++ D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 513 LLKEKKLEQLVDSDMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+++ EQ + ++ + E + + ++ C + R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMIS- 340
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS--------------QPPL 386
+ H N++ L G C L++ + G + + LR + S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 387 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ + A+G+A+L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 447 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
+ V R + +APE + + ++DV+ YG+ L EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
G+ + K +++ E ++ + C P++RP ++V+++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 566 GD 567
Sbjct: 304 KQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-60
Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 48/306 (15%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISM 341
+N +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 342 AV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---------------- 384
H N++ L G C L++ + G + + LR + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 385 ---PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 442 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 499
+ +V R + +APE L G + K+DV+ YG++L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 500 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 559
G+ + +L+ + + + E++ + C +RP
Sbjct: 269 ------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 560 VVRMLE 565
+ L
Sbjct: 317 LTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 70/317 (22%), Positives = 138/317 (43%), Gaps = 41/317 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMIS-MAV 343
++ ++++G G FG+V K R+ L A+KR+KE ++ F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------GQSQPPLNWSVR 391
H N++ L G C L + +G++ LR+ + L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
R + +A E L+ + +DV+ YGV+L E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELYE 237
Query: 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 571
L + +LE+ ++ D +++ + C + P ERP ++++ L + E
Sbjct: 238 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN--RMLE 285
Query: 572 RWEEWQKEEMFRQDFNH 588
+ + ++ + F +
Sbjct: 286 ERKTYVNTTLY-EKFTY 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-59
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 348 LRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++L G + L +V +M GS+ LR RG+S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K S K+DV+ +G++L E+ + R + L D V + K K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ +V C RP ++ LE
Sbjct: 227 ----------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-58
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 25/281 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHR 345
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 346 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++R + T L V + G +AS + + + + L+ ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 404 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521
PE ++ +EK+D++ G +L EL F L + +E K +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKI----REGKFRR 233
Query: 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ +E+ ++I RP + E++
Sbjct: 234 IPYR------YSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-58
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 33/279 (11%)
Query: 294 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 349
LG G FG V KG VAVK LK E + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ G C + +LV G + L++ + ++ + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K S K+DV+ +GV++ E + GQ+ + +K ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKG 226
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
++ + LC RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-58
Identities = 57/278 (20%), Positives = 108/278 (38%), Gaps = 26/278 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+++ LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G + L + G + + + ++ G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 465
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ +E DV+ G++L ++ G+ +D +D DW + ++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKK--- 231
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
I+ L+ +P R + ++ +
Sbjct: 232 -------IDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-57
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
+GRG F VYKG T+ VA L++ + E Q F+ E EM+ H N++R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 352 GFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+ + +LV M +G++ + L+ + V + +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 408 HCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526
K E DV+ +G+ +LE+ T + + + + V +K +++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAI-- 239
Query: 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
++ ++ C + + ER + +++
Sbjct: 240 ----------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-56
Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQF 332
++++L ++F LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK 392
+ EVE+ S H N+LRL G+ T L+ + G+V L++ +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTA 109
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
A L+Y H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 512
+ GT+ ++ PE + EK D++ GV+ E + G+ F+ AN +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV 219
Query: 513 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
++ E LI + +P +RP + EV+
Sbjct: 220 EFTFPD------------FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (477), Expect = 3e-55
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 35/282 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV 343
FS+ +G G FG VY R + + +VA+K++ Q E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N ++ RG + LV + + + + PL + GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 464 YLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
+ G+ K DV+ G+ +EL + N + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSAL---------YHIA 227
Query: 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
Q ++ + E + C Q P +RP +++
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-55
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 32/285 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
F +LG G FG VYKG VA+K L+E + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
+ ++ RL G C+T T +L+ M G + +RE + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIA 461
YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + + I +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
E + + ++DV+ YGV + EL+T G + +D + ++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GIPASEIS 223
Query: 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+++ + + + C RPK E++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ------PPLNWS 389
++ +++RL G L++ M G + S LR + P + S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 448
Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 508
+ ++PE L G + +DV+ +GV+L E+ T ++ +L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF 247
Query: 509 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567
++G L +K + + L ++ +C Q +P RP E++ ++ +
Sbjct: 248 VMEGGLLDK--------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 3e-53
Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 288 DNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
D LGRG FG+V + VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 342 AVHR-NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP------------LN 387
H N++ L G C P L ++ F G++++ LR + P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 388 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 448 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+V R + +APE + + ++DV+ +GV+L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242
Query: 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ LKE + D ++ Q L C G P +RP SE+V L
Sbjct: 243 DEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 76/287 (26%), Positives = 110/287 (38%), Gaps = 33/287 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 341
+ LG G FG V +G VAVK LK + E F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
HRNL+RL G +TP ++ V GS+ LR+ Q + A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 123
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGH 459
+ YL IHRD+ A N+LL +GDFGL + + D H + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518
APE L T S +D + +GV L E+ T GQ + GL +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----------------GLNGSQI 223
Query: 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
L ++ E+ + + V + C P +RP + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 30/282 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
D + LG G FGKVYK + + L A K + + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L ++ F G+V + + E + PL S + + L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 466 STGKS-----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520
S K DV+ G+ L+E+ + + + +L K +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVL--------LKIAK 229
Query: 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ + + + ++ C + + R S++++
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-52
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMI 339
D LG G FG+V + VAVK LK + T+ +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 340 SMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPL 386
M H+N++ L G C ++ + G++ L+ R + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 387 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 447 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
+ T R + +APE L + ++DV+ +GV+L E+ T +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 240
Query: 506 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ ++L +L+ + +L + C P +RP ++V L+
Sbjct: 241 --------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-52
Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 28/282 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAV 343
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H ++++L G T ++ G + S L+ R + L+ + A + LA
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 122
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
++ + + +DV+ +GV + E++ V D + + ++L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNNDVIGRIENGERLPMPP 232
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ L + C P RP+ +E+ L
Sbjct: 233 NCP----------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 6e-51
Identities = 50/277 (18%), Positives = 106/277 (38%), Gaps = 27/277 (9%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++ +G+G G VY + G VA++++ ++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ + E +V ++ GS+ + E + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFL 132
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525
+ K D++ G+M +E+I G+ + N++ + L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL--------YLIATNGTPE 235
Query: 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ + C +R E+++
Sbjct: 236 LQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 8e-47
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ LG G FG V++ G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L E +++Y FM G + + + ++ + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 407 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
TD++ GV+ L++G F +DD L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNMD------- 245
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
D + I E+ + I+ P R + +
Sbjct: 246 -DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 344
++F ILG G F V R L A+K L++ + E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++L + + NG L + + + + + L Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 463
LH IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
L+ + + +D++ G ++ +L+ G F A ++ ++ +K +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYDFPE----- 231
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
+ L++ +R E+
Sbjct: 232 -------KFFPKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 21/291 (7%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
A + +G G +GKV+K R G VA+KR++ + +G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 343 V---HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALG 397
H N++RL C +V V L +P + K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 509
+ APE L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ + ++ + ++ + E + L C +P +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 8e-46
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 40/289 (13%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--------EERTQGGELQFQTEVE- 337
+N+ + ILGRG V + AVK + E Q EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
+ ++ H N+++L+ T T LV+ M G + L E+ L+ ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 458 GHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
++APE + ++ D++ GV++ L+ G F + +++L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIM 228
Query: 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ + D + V+ L+ P +R E
Sbjct: 229 SGNYQFGSPEWDD-------YSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 2e-45
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 27/278 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D + LG G FG V++ G + K + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L E +L+ F+ G + + ++ + A GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ TD++ GV+ L++G F +DD+ L VK E +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAF-- 252
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ + E + I+ Q P +R + + +
Sbjct: 253 -----SSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 2e-45
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 30/313 (9%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 339
++ + D + R++LG G F +V LVA+K + ++ +G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H N++ L + L+ + G + + E+G ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+ YLHD I+HRD+K N+L DE+ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGT 172
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516
G++APE L+ S+ D + GV+ L+ G F +++D L + + E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYE 227
Query: 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM--LEGDGLAERWE 574
D I + + I+ + P +R + ++ + GD ++
Sbjct: 228 FDSPYWDD-------ISDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277
Query: 575 EWQKEEMFRQDFN 587
E +++F
Sbjct: 278 HQSVSEQIKKNFA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 3e-44
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAV- 343
++FS I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 344 --HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++ + TP + + M G + L + G + + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 462 PEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 494
PE L G + D F G ML +L+ G F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-44
Identities = 50/278 (17%), Positives = 100/278 (35%), Gaps = 28/278 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ + LGRG FG V++ + K +K + T ++ + E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+L L + E ++++ F+ + + LN L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH 119
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
H I H D++ NI+ + + +FG A+ + D + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
S TD++ G ++ L++G F A + ++ + + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNA--------EYTF 222
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ I E + R SE ++
Sbjct: 223 DEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 6e-44
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 18/286 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRN 346
+ + +G G +G VYK + G A+K+++ E+ +G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++L T +LV+ + G L K L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWVKGLLKE 516
+ K S D++ G + E++ G F + R+ + V L K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ + ++++ E I + + P +R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 6e-44
Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 31/294 (10%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340
EL+V + + +G G FG +Y G + G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYK 57
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
M + +C + ++ ++ S+ + + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 401 GLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 451
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511
+ GT + + + S + D+ G +L+ G + + A
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-- 229
Query: 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
EKK+ ++ +G E + C ++P S + ++
Sbjct: 230 ----EKKMSTPIEVLCKG--YPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 3e-43
Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 32/289 (11%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE--RTQGGELQFQTEVEMISMAV 343
+D + ILG GG +V+ R L VAVK L+ + R L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 344 HRNLLRLRGFCMTPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H ++ + T +V ++ ++ + G P+ ++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 457
+ L + H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517
+++PE ++DV+ G +L E++TG+ F D + + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPV------SVAYQH 226
Query: 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLE 565
E + + +++ ++ +P R + +E+ L
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 52/292 (17%), Positives = 117/292 (40%), Gaps = 20/292 (6%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++N + +G G +G V + VA+K++ Q + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ + PT + ++V + + L + ++Q L+ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 463
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 464 YLSTG-KSSEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVMLLDWVKGLLK 515
+ ++ D++ G +L E+++ + F L + + + ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 516 EKKLEQLVDSDMEGNYIEEEV-----EQLIQVALLCTQGSPMERPKMSEVVR 562
K L+ + + + + + +P +R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV- 343
++F +LG+G FGKV+ A+K LK++ + E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H L + T V ++ G + ++ + S A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
L K + D + +GV+L E++ GQ F D+ L ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRM----------- 217
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
D+ ++E+E + L+ P +R + +R
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 24/288 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
+NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L T + LV+ F+ + + + K +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFD-----------LARLANDDDVMLLDWVKGLL 514
S D++ G + E++T + F L D+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 515 KEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
+ + D ++E+ L+ P +R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (376), Expect = 3e-41
Identities = 38/282 (13%), Positives = 84/282 (29%), Gaps = 32/282 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
++ ++ S+ L G + A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 415 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 463
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523
+ S + D+ G + + + G + L + + + + L +L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565
EE + + + P + +
Sbjct: 242 AG------FPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 8e-41
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 344
+F LG G FG+V+ R +G A+K LK+E + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++R+ G + ++ ++ G + S LR+ + P+ ++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------A 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
L II+RD+K NILLD+ + DFG AK + + GT +IAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEV 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ST ++ D + +G+++ E++ G F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-41
Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 33/277 (11%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRG 352
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 353 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L+V + G + S +++RG +I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 409 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 525
K + D++ GV++ L+ G F ++ + + +K ++ + E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEF---P 237
Query: 526 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ E + + EEV+ LI+ + P +R ++E +
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 26/290 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 347 LLRLRGFCMTPTE-RLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++RLR F + E + VY +V +V R +++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
LAY+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRA 190
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWV 510
+ DV+ G +L EL+ GQ F + ++ + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 511 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 560
E K Q+ + + I + + +P R E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 44/320 (13%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L + LV+ FM + L S K L +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 469 KS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 527
+ D++ G +L EL+ D D+ L + L EQ D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 528 EGNYIEEEV--------------EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 573
+Y+ + + L+ + +P R ++ ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 574 EEWQKEEMFRQDFNHTPHPN 593
++ P PN
Sbjct: 281 -KYFSNRPGPTPGCQLPRPN 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-----QFQTEVEMISM 341
D + LG G F V K R + G A K +K+ RT+ + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H N++ L T+ +L+ + G L + + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517
+APE ++ + D++ GV+ L++G F D L V + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEF 235
Query: 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ E + + I+ P +R + + ++
Sbjct: 236 EDEYF-------SNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 44/278 (15%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE-----LQFQTEVEMISM--AVHRN 346
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++RL + P +L+ L + + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 407 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 225
Query: 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
+ E + LI+ C P +RP E+
Sbjct: 226 ------RVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-37
Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 20/288 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
+ +G G +G V+K + +VA+KR++ ++ +G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++RL + + LV+ F G P + S Q+ G L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG-------L 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF-----------DLARLANDDDVMLLDWVKGLL 514
S D++ G + EL R + RL + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 515 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562
K + N + + + + +P++R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 341
V ++F +LG+G FGKV R G A+K L++E + TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H L L+ T V + G + L +I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 118 ---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE L D +G GV++ E++ G+ F
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 5e-36
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 344
D F LG G FG+V + G+ A+K L +++ + E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
L++L + +V ++ G + S LR G + + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEY 156
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH +I+RD+K N+L+D++ V DFG AK + + + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEI 209
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 510
+ + ++ D + GV++ E+ G F D + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKI 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 34/300 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 345
+ +G+G FG+V+K R G VA+K++ E +G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 346 NLLRLRGFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
N++ L C T LV+ F + + V + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 454
L L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 455 GTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVML 506
T+ + PE L + D++G G ++ E+ T LA ++ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 507 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL------CTQGSPMERPKMSEV 560
+ + + E+L + +++ ++ ++ P +R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 12/222 (5%)
Query: 278 FSLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQ 331
F +E+ +G G +G V G+ VA+K+L + +++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 391
E+ ++ H N++ L F + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER---TQGGELQFQTEV 336
+V +NF +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 337 EMISMAVHR-NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
+++ L+ L T T+ L+ ++ G + + L +R + +I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 456 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFD 494
TI ++AP+ + G S + D + GV++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 8e-31
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHR 345
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90
Query: 346 NLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++ L P R LV+ + N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 463 E-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 6e-30
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 8/210 (3%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVH 344
+ + N + +G G +G V G VAVK+L + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L + + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 10/209 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 345
+ N +G G G V VA+K+L + + Q + E+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 346 NLLRLRGFCMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L T ++V + + L + Q + + G+ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKH 134
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH IIHRD+K +NI++ + + DFGLA+ + + T T + APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEV 189
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ E D++ G ++ E++ + F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 7e-27
Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 19/214 (8%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 355 MTPTERLLVYP------------FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
+LL + + + KQI+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHI 460
Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+PE L D++ ++ ELITG F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.5 bits (242), Expect = 5e-24
Identities = 24/162 (14%), Positives = 48/162 (29%), Gaps = 20/162 (12%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMAVH 344
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
R L +L+G + + G+ + + ++ +A
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 2e-18
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 12/187 (6%)
Query: 29 EGDALNALKTNLADPNNVLQSWDATLVNPC--TWFHVTCNSENSVTRV---DLGNANLSG 83
+ AL +K +L +P L SW T + C TW V C+++ RV DL NL
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 84 --QLVSQLGQLTNLQYLELYSN-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140
+ S L L L +L + N+ G +P + LT L L + N++G IP L ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF--SLFTPISFANN 198
L L + N+L G +P S++++ +L + N+++G IP + LFT ++ + N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 199 QLNNPPP 205
+L P
Sbjct: 185 RLTGKIP 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 5e-14
Identities = 22/61 (36%), Positives = 33/61 (54%)
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
L NN + G +P+ LT + L L++S N L G+IP G+ F ++ANN+ P P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
Query: 208 P 208
Sbjct: 311 A 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 8e-13
Identities = 24/66 (36%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
NL L+L +N I G +P+ L L L SL++ NNL G IP G L + NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 153 LMGEIP 158
+ P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 4e-12
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
DL N + G +P L +L L L ++ N+L GEIP N+ V +NNK P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 5e-11
Identities = 21/81 (25%), Positives = 32/81 (39%), Gaps = 3/81 (3%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
N + ++ +DL N + G L L QL L L + NN+ G++P + GN
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 116 LTNLVSLDLYLNNL--NGPIP 134
L N P+P
Sbjct: 290 LQRFDVSAYANNKCLCGSPLP 310
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 4e-15
Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
++ ++T + L N+S +S + LT LQ L +N +S L NLT
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLT 351
Query: 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
N+ L N ++ P L L+++ L LN+
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.7 bits (182), Expect = 5e-15
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L NL YL LY NNIS P + +LT L L N ++ ++L L+ + +L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N + P L N+ + L L++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 4e-13
Identities = 35/160 (21%), Positives = 54/160 (33%), Gaps = 48/160 (30%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNL---- 119
++ + L L + L LTNL L+L +N IS P L LT L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272
Query: 120 -------------------------------------VSLDLYLNNLNGPIPTTLGKLSK 142
L LY NN++ P + L+K
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L+ L NN + SL N+ ++ L +N+++ P
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 9e-12
Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 27/168 (16%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
++ + N +S ++ LG LTNL L L N + L +LT
Sbjct: 186 KVSDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLT 241
Query: 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP------------------- 158
NL LDL N ++ P L L+KL L+L N + P
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299
Query: 159 -RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
++N+ +L L L N ++ P S + + FANN++++
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISPV-SSLTKLQRLFFANNKVSDVSS 346
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 9e-08
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 6/81 (7%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ LG N++ L + L+ I K + + L NL ++ N L
Sbjct: 24 KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 79
Query: 131 GPIPTTLGKLSKLRFLRLNNN 151
P L L+KL + +NNN
Sbjct: 80 DITP--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 9e-07
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 10/78 (12%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV---NSLQVLD 171
L + L N+ + + L ++ L+ + + +S+ V N+L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI-----KSIDGVEYLNNLTQIN 72
Query: 172 LSNNKLTGDIPTNGSFSL 189
SNN+LT P L
Sbjct: 73 FSNNQLTDITPLKNLTKL 90
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (170), Expect = 9e-14
Identities = 31/165 (18%), Positives = 47/165 (28%), Gaps = 10/165 (6%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ +DL N ++ L NL L L +N IS
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
P L L L L N L L +LR + + L + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + I A+ + P PP L
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 174
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.3 bits (142), Expect = 3e-10
Identities = 43/224 (19%), Positives = 71/224 (31%), Gaps = 18/224 (8%)
Query: 3 KLERVVWAFLVSILFFDLLLRVASNAEGDALNALK--TNLADPNNVLQSWDATLVNPCTW 60
+++ + L ++ L+ S A L L N L+ +
Sbjct: 45 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQE 104
Query: 61 FHVTCNSENSVTRVDLG-------------NANLSGQLVSQLGQLTNLQYLELYSNNISG 107
V N V + SG + L Y+ + NI+
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
+P+ G +L L L N + +L L+ L L L+ NS+ SL N L
Sbjct: 164 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
+ L L+NNKL + NN ++ + P
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 24/148 (16%), Positives = 46/148 (31%), Gaps = 32/148 (21%)
Query: 60 WFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL 119
+ ++ + + + N++ G +L L L N I+ L L NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 120 VSLDLYLNNLNGPI-----------------------PTTLGKLSKLRFLRLNNNSLMG- 155
L L N+++ P L ++ + L+NN++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 156 -----EIPRSLTNVNSLQVLDLSNNKLT 178
P T S + L +N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.0 bits (142), Expect = 3e-11
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L + +L+ + L QL + +L+L N + P L L L L N L
Sbjct: 4 HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 135 TTLGKLSKLRFLRLNNNSL-MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
L +L+ L L NN L + L + L +L+L N L +
Sbjct: 61 VA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 3e-07
Identities = 28/115 (24%), Positives = 39/115 (33%), Gaps = 7/115 (6%)
Query: 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG 155
+ L L +++ V L L + LDL N L P L L L L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNAL 55
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTG--DIPTNGSFSLFTPISFANNQLNNPPPSPP 208
E + N+ LQ L L NN+L I S ++ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 12/95 (12%), Positives = 30/95 (31%), Gaps = 7/95 (7%)
Query: 34 NALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANL-SGQLVSQLGQL 92
N L+ + + + + + L N L + L
Sbjct: 30 NRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 89
Query: 93 TNLQYLELYSNNISG------KVPEELGNLTNLVS 121
L L L N++ ++ E L +++++++
Sbjct: 90 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 8e-10
Identities = 20/92 (21%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 94 NLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRL 148
++Q L++ +S E L L + L L I + L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 149 NNNSLMGEIPRSL-----TNVNSLQVLDLSNN 175
+N L + T +Q L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (140), Expect = 1e-09
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 5/80 (6%)
Query: 118 NLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDL 172
++ SLD+ L+ L L + + +RL++ L +I +L +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 173 SNNKLTGDIPTNGSFSLFTP 192
+N+L L TP
Sbjct: 63 RSNELGDVGVHCVLQGLQTP 82
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 6e-09
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 93 TNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGPIPTTLGK-----LSKL 143
+ L+ L L ++S + L +L LDL N L L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 144 RFLRLNNNSLMGEIPRSLTNV----NSLQVL 170
L L + E+ L + SL+V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 2e-08
Identities = 18/106 (16%), Positives = 34/106 (32%), Gaps = 15/106 (14%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEE 112
+ + + L + ++S L + L +L+ L+L +N + +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 113 LG-----NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
L L L LY + + L L K + SL
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK------DKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 5e-08
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 70 SVTRVDLGNANLSGQLVSQL-GQLTNLQYLELYSNNISGKVPEELG----NLTNLVSLDL 124
+ +D+ LS ++L L Q + L ++ +++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 125 YLNNLNGPIPTTLGKL-----SKLRFLRLNNN 151
N L + + K++ L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 5e-07
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 115 NLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-----TNVN 165
+ L L L +++ + TL LR L L+NN L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 166 SLQVLDLSNNKLTGDIP 182
L+ L L + + ++
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 10/71 (14%)
Query: 141 SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---- 192
S LR L L + + + +L +SL+ LDLSNN L S+ P
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 193 --ISFANNQLN 201
+ + +
Sbjct: 429 EQLVLYDIYWS 439
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 7e-04
Identities = 12/68 (17%), Positives = 18/68 (26%), Gaps = 9/68 (13%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELG-----NLTNLV 120
V L + L+ + S L L L L SN + + +
Sbjct: 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
Query: 121 SLDLYLNN 128
L L
Sbjct: 88 KLSLQNCC 95
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 35/166 (21%), Positives = 56/166 (33%), Gaps = 3/166 (1%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
L + ++ + L + L L NL +L L+ N IS
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
L +L L L+ N + P L +L L L N+L +L + +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
LQ L L++N D + L+ + + P S P L
Sbjct: 227 LQYLRLNDNPWVCDCR---ARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 6e-07
Identities = 27/137 (19%), Positives = 40/137 (29%), Gaps = 1/137 (0%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNI 105
L + ++DL + + L L L L +
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 106 SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
P L L L L N L T L L L L+ N + R+ ++
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 166 SLQVLDLSNNKLTGDIP 182
SL L L N++ P
Sbjct: 178 SLDRLLLHQNRVAHVHP 194
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 25/157 (15%), Positives = 44/157 (28%), Gaps = 28/157 (17%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
LQ T ++T + L +S L +L L L+ N ++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 107 GKVPEELGNLT------------------------NLVSLDLYLNNLNGPIPTTLGKLSK 142
P +L L L L N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249
Query: 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
L+ R +++ + +P+ L + L+ N L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 33/194 (17%), Positives = 52/194 (26%), Gaps = 55/194 (28%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C +E VT L + + Q + L+ N IS NL L
Sbjct: 7 VCYNEPKVT-TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 124 LYLNNLNGPI-------------------------PTTLGKLSKLRFLRLNN-------- 150
L+ N L P T L +L L L+
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 151 ----------------NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTP 192
N+L + ++ +L L L N+++ G SL
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 193 ISFANNQLNNPPPS 206
+ N + P +
Sbjct: 183 LLHQNRVAHVHPHA 196
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 3/101 (2%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+DL NL + +L + + + + E + + +DL + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 132 -PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
+ L + SKL+ L L L I +L ++L L+
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYL 126
V + + L +Q+++L ++ I + L + L +L L
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 127 NNLNGPIPTTLGKLSKLRFL 146
L+ PI TL K S L L
Sbjct: 81 LRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 16/88 (18%), Positives = 38/88 (43%), Gaps = 3/88 (3%)
Query: 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG 155
Q L+L N+ V L + +++ + ++ P+ +++ + L+N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 156 E-IPRSLTNVNSLQVLDLSNNKLTGDIP 182
+ L+ + LQ L L +L+ I
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 18/60 (30%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 65 CNSENSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
S V +DL N+ + L L Q + LQ L L +S + L +NLV L+
Sbjct: 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 4/115 (3%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLEL-YSNNISGKVPEELG 114
+ N V + L + QL LQ+L L +I + ELG
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
+ L +L ++ +G + L L++N + ++ N + ++
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 16/103 (15%)
Query: 100 LYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR 159
Y N S ++ +L L++ N L +P +L +L + N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHL-AEVPE 321
Query: 160 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
N L+ L + N L P P S + ++N+
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPD-------IPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 9e-08
Identities = 19/121 (15%), Positives = 41/121 (33%), Gaps = 16/121 (13%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
+ + + S ++ S +L+ L + +N + ++P
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR 305
Query: 116 LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLS 173
L L N+L +P L+ L + N L +IP S+ + L ++
Sbjct: 306 LER---LIASFNHLAE-VPELPQ---NLKQLHVEYNPLREFPDIPESVED------LRMN 352
Query: 174 N 174
+
Sbjct: 353 S 353
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 2e-07
Identities = 22/101 (21%), Positives = 32/101 (31%), Gaps = 4/101 (3%)
Query: 50 WDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV 109
L L N ++ L L+ L L+ N IS
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-- 187
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +L NL+ + L N ++ P L S L + L N
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 4e-07
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
L NL+ L +L N ++ P L L L + L NN + P L N ++L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 170 LDLSN 174
+ L+N
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 11/61 (18%), Positives = 25/61 (40%), Gaps = 4/61 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ G +N++ L + L + ++ E + L NL+ L+L N +
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 130 N 130
Sbjct: 76 T 76
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 8e-05
Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L N + + +N+ + T L + L + I + +N+L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 175 NKL 177
N++
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 11/64 (17%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L N + +N++ V + +L + +L + + + L+ L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 151 NSLM 154
N +
Sbjct: 73 NQIT 76
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
+ +L ++ + T +L+ + + NN+ + + + ++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 175 NKLTG 179
NKLT
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 9/65 (13%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +++ V + L ++ + +++ + L + L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 151 NSLMG 155
N L
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 16/37 (43%), Positives = 19/37 (51%), Gaps = 2/37 (5%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
L LT LQ L L N+IS L L NL L+L+
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 11/61 (18%), Positives = 26/61 (42%), Gaps = 4/61 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ V+Q +L ++ + +++I + L N+ L L N L
Sbjct: 26 TIKDNLKKKSVTD-AVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 131 G 131
Sbjct: 82 D 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 2/38 (5%)
Query: 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L L+KL+ L L+ N + R+L + +L VL+L +
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 2e-06
Identities = 14/61 (22%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+ S V+ NL+ L L + L L N + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 124 L 124
L
Sbjct: 62 L 62
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 22/80 (27%), Positives = 26/80 (32%), Gaps = 1/80 (1%)
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS 160
N + P L L L L NNL L L L L L NSL IP+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 161 LTNVNSLQVLDLSNNKLTGD 180
+ L L N +
Sbjct: 191 FFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
++ + + N++ +P +L + L L N L TL ++L L L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 150 NNSLM 154
L
Sbjct: 64 RAELT 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 5e-05
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 112 ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
E+ + + + ++ NL +P L K L L+ N L +L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 172 LSNNK 176
L +
Sbjct: 62 LDRAE 66
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 3e-06
Identities = 25/137 (18%), Positives = 46/137 (33%), Gaps = 9/137 (6%)
Query: 81 LSGQLVSQLGQLTN---LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL 137
L+ +L+ Q Q TN + L+L I + L ++D N +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-- 59
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
L +L+ L +NNN + + L L L+NN L ++ +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKS--LTY 116
Query: 198 NQLNNPPPSPPPPLQPT 214
+ P + +
Sbjct: 117 LCILRNPVTNKKHYRLY 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 4/123 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG--PIPTTLGKLSKLRFL 146
L L ++++ + N+ L+SL+L N L + + + K L+ L
Sbjct: 38 LVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN-NQLNNPPP 205
L+ N L E L+ L L N L+ ++ F +L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHEL 156
Query: 206 SPP 208
PP
Sbjct: 157 PPP 159
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 2e-05
Identities = 10/48 (20%), Positives = 17/48 (35%), Gaps = 3/48 (6%)
Query: 111 EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+ + V LD+ ++ L L KLR N ++P
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 5e-05
Identities = 8/41 (19%), Positives = 12/41 (29%), Gaps = 2/41 (4%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ L++ I L NL L + NL
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 6e-05
Identities = 7/44 (15%), Positives = 12/44 (27%)
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
S L ++ + L N+ L+ N K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 11/76 (14%), Positives = 23/76 (30%), Gaps = 14/76 (18%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
C+ C E+ VT + ++L N L +
Sbjct: 8 CSNRVFLC-QESKVTEI---PSDLP----------RNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 118 NLVSLDLYLNNLNGPI 133
+L +++ N++ I
Sbjct: 54 DLEKIEISQNDVLEVI 69
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 6e-05
Identities = 20/110 (18%), Positives = 31/110 (28%), Gaps = 2/110 (1%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNN 151
L + L NL L + + L L +LR L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201
L P + L L+LS N L + + N L+
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 8e-05
Identities = 11/86 (12%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNN 128
++D + + L + +++ + L N I + + E + + +L +
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLM 154
L L L L
Sbjct: 71 TGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 10/109 (9%)
Query: 48 QSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
S A + ++ ++ G A + + LQ L L N I
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLS--ARGAAAVVDAF--SKLENIGLQTLRLQYNEIEL 287
Query: 108 KVPEEL-----GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L + +L+ L+L N + ++ ++ R
Sbjct: 288 DAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 16/79 (20%), Positives = 26/79 (32%), Gaps = 12/79 (15%)
Query: 100 LYSNNISGKVPEELGN------LTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLRL 148
L +S + + + L +L L N + TL K+ L FL L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 149 NNNSLMGEIPRSLTNVNSL 167
N N E + + +
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 13/68 (19%), Positives = 26/68 (38%), Gaps = 11/68 (16%)
Query: 124 LYLNNLNGPIPTTLG------KLSKLRFLRLNNNSLMGEIPRSL-----TNVNSLQVLDL 172
L L+ + + L+ LRL N + + R+L + L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 173 SNNKLTGD 180
+ N+ + +
Sbjct: 310 NGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 8/68 (11%), Positives = 28/68 (41%), Gaps = 8/68 (11%)
Query: 118 NLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQV 169
++ L L+ + + L + ++ + L+ N++ E + ++ + L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 170 LDLSNNKL 177
+ S+
Sbjct: 64 AEFSDIFT 71
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 18/101 (17%), Positives = 34/101 (33%), Gaps = 26/101 (25%)
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL----------------- 143
N I + L L +L+LY N ++ +P + L+ L
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145
Query: 144 ------RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
R LN + P + + +Q+ DL +++
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 4e-04
Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L + L N+ + + L ++ L+ + + I + +N+L ++ SN
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 175 NKLTG 179
N+LT
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 4e-04
Identities = 17/70 (24%), Positives = 25/70 (35%), Gaps = 2/70 (2%)
Query: 53 TLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE 112
L + L ++ + L LT L+ L++ SN +S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 113 LGNLTNLVSL 122
L LTNL SL
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 4/62 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ LG N++ L + L+ I + + L NL ++ N L
Sbjct: 19 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 74
Query: 130 NG 131
Sbjct: 75 TD 76
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.1 bits (87), Expect = 0.001
Identities = 15/61 (24%), Positives = 22/61 (36%), Gaps = 8/61 (13%)
Query: 68 ENSVTRVDLGNANLSGQ------LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVS 121
SV + L G + + L L ++L L +NNI L + NL
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRI 74
Query: 122 L 122
L
Sbjct: 75 L 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.57 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.57 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.4 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.26 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.18 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.17 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.06 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.98 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.39 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.48 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-53 Score=421.84 Aligned_cols=263 Identities=29% Similarity=0.401 Sum_probs=216.8
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
++++..++|++.+.||+|+||+||+|++. +|+.||||+++.... ..++|.+|+.++++++||||++++|++.+++..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34455678999999999999999999986 588999999875433 456799999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++|||||++|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999976433 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
..............|++.|+|||.+.+..++.++|||||||++|||++|..||.... . ... +...+...
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~---~~~-~~~~i~~~--- 232 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----D---LSQ-VYELLEKD--- 232 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----C---HHH-HHHHHHTT---
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----h---HHH-HHHHHhcC---
Confidence 776555444555568999999999999999999999999999999999777763211 1 111 11111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 568 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 568 (613)
.....+...+..+.+++..||+.||++|||++||++.|+.+.
T Consensus 233 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111112233467899999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=412.47 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=202.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|+||+||+|++. +|+.||||++...........+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999986 79999999997655444455789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997543 499999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-ceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 447 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .......||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ....... ........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~----~~~~~~~~----- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYS----DWKEKKTY----- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS---TTSHHHH----HHHTTCTT-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC---hHHHHHH----HHhcCCCC-----
Confidence 2 22345679999999999988776 678999999999999999999996332 1111111 11111100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..........+.+++.+||+.||++|||++|+++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122356789999999999999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=413.63 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=199.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
++|+..+.||+|+||+||+|++.+++.||||+++.... ...+|.+|++++++++||||++++|++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 56888899999999999999998888999999976433 3567999999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 2489999999999999999999999 999999999999999999999999999987755444
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhC-CCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......||+.|+|||.+.+..++.++|||||||++|||+|+ ++||... . ..+.+.........
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~---~~~~~~~i~~~~~~------- 221 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----S---NSEVVEDISTGFRL------- 221 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----C---HHHHHHHHHHTCCC-------
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----C---HHHHHHHHHhcCCC-------
Confidence 444455689999999999999999999999999999999995 5555311 1 11222222111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+..+...+.+++..||+.||++||||+||++.|+++
T Consensus 222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 01112335789999999999999999999999999853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=416.18 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=209.1
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|++.+.||+|+||+||+|.+++++.||||+++.... ....|.+|++++++++||||++++|++.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 44567888999999999999999998888999999975433 35679999999999999999999998754 5679999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++..... .++++..+..|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 87 Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999998765432 2489999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
..........||+.|+|||.+.++.++.++|||||||++|||+||..|+.... . ..+.+........
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~---~~~~~~~i~~~~~------ 228 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----T---NPEVIQNLERGYR------ 228 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----C---HHHHHHHHHTTCC------
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----C---HHHHHHHHHhcCC------
Confidence 54444455668999999999999999999999999999999999665553111 1 1111222111111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. .+...+..+.+++.+||+.||++||||+||++.|++
T Consensus 229 ~~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11 112234578999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=403.86 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=213.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
++|+..++||+|+||+||+|++++++.||||+++.... ...+|.+|+.++++++||||++++|++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 67899999999999999999998888999999976543 3567999999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.+++..... .+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999765432 389999999999999999999999 999999999999999999999999999987765544
Q ss_pred ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+...........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~~------- 220 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRL------- 220 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC-------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCCCC-------
Confidence 44445668999999999999999999999999999999998 899996322 11111112111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
..+......+.+++.+||+.||++|||++|+++.|.++
T Consensus 221 ---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11122336789999999999999999999999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=406.48 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=202.5
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
+..++|++.+.||+|+||+||+|+++ ..||||+++.... ......|.+|++++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44578999999999999999999875 3599999975432 3345679999999999999999999998754 568999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||++|+|.++++.... ++++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999976432 499999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 444 YKDT-HVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 444 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
.... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.... . ...+.........
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-----~---~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-----N---RDQIIFMVGRGYL 227 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHHTSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcCCC
Confidence 4322 23345679999999999864 357899999999999999999999996221 1 1111111211111
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. +.. .......+..+.+++.+||+.||++||||+||++.|+.
T Consensus 228 ~----p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 228 S----PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp C----CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 000 01112234678999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=401.99 Aligned_cols=249 Identities=19% Similarity=0.307 Sum_probs=207.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|+..+.||+|+||+||+|.+. +|+.||||+++..... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999975 7999999998755433 456789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|++|+|.+++... ++++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988653 389999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+..........
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~------ 235 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE------ 235 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC------
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC------
Confidence 2 3344569999999999999999999999999999999999999995221 111222222211110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223467889999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-51 Score=413.07 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=198.6
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCC---EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
++|++.+.||+|+||+||+|.++ +++ .||||.+...........|.+|++++++++||||++++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777789999999999999975 332 58999987766665667899999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998876432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce----eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 444 YKDTHV----TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 444 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
...... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.... ..+.+........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 432211 122447899999999999999999999999999999998 899995221 1122222211111
Q ss_pred ccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 519 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. ..+...+..+.+++.+||+.||++||||.||++.|+.
T Consensus 252 ~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 L----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1122344678999999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=409.78 Aligned_cols=256 Identities=21% Similarity=0.348 Sum_probs=195.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc--CCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 363 (613)
++|++.+.||+|+||+||+|+.. +|+.||||.+..... +.....+.+|++++++++||||+++++++.+ +...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999976 789999999976543 3334568999999999999999999999865 4567999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
||||++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998764333445999999999999999999999972 11399999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.... +.......
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~-i~~~~~~~ 233 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IREGKFRR 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHTCCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHH-HHcCCCCC
Confidence 65332 22344669999999999999999999999999999999999999996321 1111111 11121111
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. +...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 -----~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1123357899999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=405.70 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=206.6
Q ss_pred hCCCCCCc-cccCcCcEEEEEEeC---CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNI-LGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~-ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
++|.+.+. ||+|+||+||+|.+. ++..||||+++..........|.+|++++++++||||++++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3557999999876655566789999999999999999999999865 568999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986543 2489999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 444 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 444 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.... .. +...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~---~~~~~i~~~~~~- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKRM- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----TH---HHHHHHHTTCCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HH---HHHHHHHcCCCC-
Confidence 543322 233458999999999999999999999999999999998 999996221 11 111111111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 232 ---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122334678999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=397.49 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=206.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|+++ +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57889999999999999999986 689999999865432 223567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||++|+|.+++.... ++++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......+.. .
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~-~----- 221 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE-F----- 221 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC-C-----
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-C-----
Confidence 2 2344569999999999999999999999999999999999999996321 111122211111 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .+......+.+++.+||+.||++|||++|+++
T Consensus 222 -~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -C----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 11123357889999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=404.08 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=201.5
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCC-----CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDG-----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
+.|+..++||+|+||+||+|.++.+ ..||||+++..........|.+|+.++++++||||++++|++.++...++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999987632 36999999876666556679999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
||||+.+|++.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876533 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
..... .......||+.|+|||.+.++.++.++|||||||++|||++|..|+.... ...+.........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~--- 230 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGF--- 230 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTC---
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhccC---
Confidence 54322 12233458999999999999999999999999999999999766653111 1112222211111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+...+..+.+++.+||+.||++||||.||++.|+.
T Consensus 231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111122334678999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=414.89 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCC-C-----CEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcC
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 357 (613)
+..++|++.+.||+|+||+||+|++.. + ..||+|.+...........+.+|+.++.++ +|||||++++++.++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445789999999999999999998652 2 269999987665554556789999999988 899999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQ-------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (613)
+..++|||||++|+|.++++.... ....+++..++.++.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999976432 123589999999999999999999999 9999999
Q ss_pred CCCceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccc
Q 007200 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (613)
Q Consensus 419 k~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~ 496 (613)
||+||+++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2334568999999999999999999999999999999998 89999522
Q ss_pred cccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 007200 497 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 565 (613)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 565 (613)
. ....+.. ...... ....+...+..+.+++.+||+.||++|||++||++.|.
T Consensus 271 ~----~~~~~~~----~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 P----VDANFYK----LIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp C----CSHHHHH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C----HHHHHHH----HHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1111111 121111 11112233467899999999999999999999999984
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=414.17 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=179.4
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
..++|++.+.||+|+||+||+|++. +|+.||+|+++..........+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999976 789999999987655555668999999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
|||++|+|.+++.+.+ .+++..+..++.|++.||+|||+ + +|+||||||+|||+++++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998654 38999999999999999999997 5 89999999999999999999999999998654
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~ 495 (613)
.. ......||+.|+|||++.+..|++++||||+||++|||++|+.||..
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 22345799999999999999999999999999999999999999963
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=399.90 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=197.2
Q ss_pred CccccCcCcEEEEEEeC---CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecccC
Q 007200 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (613)
++||+|+||+||+|.++ .++.||||+++..... .....|.+|++++++++||||++++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 3468999999754332 234579999999999999999999999865 467899999999
Q ss_pred CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCCce
Q 007200 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (613)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 449 (613)
|+|.++++... ++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997654 399999999999999999999999 99999999999999999999999999998775443322
Q ss_pred --eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccccCc
Q 007200 450 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 526 (613)
Q Consensus 450 --~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (613)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.. ..+..+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~-~~i~~~~-------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVT-AMLEKGE-------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHH-HHHHcCC--------
Confidence 233568999999999999999999999999999999998 899996221 11111 1221111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 527 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 527 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+...+..+.+++.+||+.||++|||+++|++.|+.
T Consensus 228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 011122334678899999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=399.49 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=203.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
+.|++.+.||+|+||+||+|++. +|+.||||+++.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888999999999999999976 689999999875432 3445788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
|++|+|.+++..... ++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999876432 499999999999999999999999 99999999999999999999999999997654221
Q ss_pred Cceeeccccccccccccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 447 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||.... .... +........ .
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-----~~~~---~~~i~~~~~-~- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-----PMRV---LLKIAKSEP-P- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----GGGH---HHHHHHSCC-C-
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-----HHHH---HHHHHcCCC-C-
Confidence 1223456999999999984 4568899999999999999999999996321 1111 111111111 0
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....+......+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112233467899999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=404.54 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=202.9
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+..++|++.+.||+|+||+||+|++++++.||||+++.... ....|.+|+.++++++|||||+++|++. ++..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 44578999999999999999999998888999999975433 3567999999999999999999999985 46689999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|..++..... ..++|..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999998875432 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
..........||+.|+|||.+.++.++.++|||||||++|||+||..|+.... . ..+.+........
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~---~~~~~~~i~~~~~------ 232 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----V---NREVLDQVERGYR------ 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----C---HHHHHHHHHTTCC------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----C---HHHHHHHHHhcCC------
Confidence 44444445668999999999999999999999999999999999766653211 1 1122222111111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..........+.+++.+||+.||++|||+++|++.|+.
T Consensus 233 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 233 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 11122334678999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-50 Score=401.54 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.+.|++.+.||+|+||+||+|++. +|+.||||++...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999986 6899999999766554445678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEEEeccccceec
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 442 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~~ 442 (613)
||+||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 499999999999999999999999 999999999999995 5789999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccc
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 522 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (613)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .+..........
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~---~~~~~~i~~~~~---- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----D---AKLFEQILKAEY---- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHHHHHTTCC----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----H---HHHHHHHhccCC----
Confidence 4322 2334569999999999999999999999999999999999999995221 1 111111111111
Q ss_pred ccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 523 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 523 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
..........+..+.+++.+||+.||++|||++|+++.
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111112234578999999999999999999999983
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=394.00 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=195.5
Q ss_pred CCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc-CcccHHHHHHHHHHHhhcccCccceeeEEEEc----CCceEEEE
Q 007200 291 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 364 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 364 (613)
+..+.||+|+||+||+|.+. +++.||+|.+.... .......+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999976 68899999987654 33345578999999999999999999999865 34578999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeec-CCCcEEEecccccee
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 441 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfGla~~ 441 (613)
||+++|+|.+++.... .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997654 389999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
.... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.... ................
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~~~- 232 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVKPA- 232 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCCCG-
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCCCc-
Confidence 4332 2345679999999999865 69999999999999999999999995211 1111111111111100
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. ........+.+++.+||+.||++|||++|+++
T Consensus 233 ----~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----c----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 11112346889999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=398.57 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=204.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999986 78999999997543 2234567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988764 389999999999999999999999 999999999999999999999999999997754
Q ss_pred CCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......+.. .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~-~---- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLE-Y---- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC-C----
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCC-C----
Confidence 332 23345679999999999999999999999999999999999999996321 111111221111 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. +......+.+++.+||+.||++|||++|+++
T Consensus 228 --~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 --DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 1123356889999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=398.34 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=198.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCC----CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 361 (613)
..++|++.+.||+|+||+||+|++.. +..||||.++..........+.+|+.++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 45789999999999999999998752 34689999876665555678999999999999999999999985 56789
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
+||||+++|+|.+++..... ++++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999998765432 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
.............||+.|+|||.+.+..++.++|||||||++|||+| |++||.... .......+ ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~i---~~~~~~- 228 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGERL- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCCC-
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHHH---HcCCCC-
Confidence 76544444455668999999999999999999999999999999998 899996322 11122221 111111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 229 ---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122334678999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-50 Score=401.64 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=201.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--cHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
+.|+..+.||+|+||+||+|++. +|+.||||+++...... ....+.+|+.++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999976 68899999997654332 2346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||.+|++..++.... ++++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987665433 499999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccccccccc---CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 521 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (613)
. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.... ..+.+.........
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~~-- 232 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESP-- 232 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC--
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCC--
Confidence 2 23569999999999864 458999999999999999999999995221 11222222211110
Q ss_pred cccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... .......+.+++.+||+.||++|||++|+++
T Consensus 233 ----~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ----ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011 1122357889999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-50 Score=401.37 Aligned_cols=267 Identities=26% Similarity=0.431 Sum_probs=215.2
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++.........+|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4456667789999999999999999999864 3578999999876655556789999999999999999999999
Q ss_pred EEcCCceEEEEecccCCcchhhhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007200 354 CMTPTERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413 (613)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 413 (613)
+.+....+++|||+.+|+|.++++.... ....+++..+..|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999865321 123589999999999999999999999 99
Q ss_pred EecCCCCCceeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCC-C
Q 007200 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-R 491 (613)
Q Consensus 414 vH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~-~ 491 (613)
|||||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986644322 2233456889999999999999999999999999999999986 5
Q ss_pred CcccccccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 492 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 492 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
||.... ..+.+.. +..+... . .+...+..+.+++..||+.||++||||.||+++|+.+
T Consensus 242 p~~~~~--------~~e~~~~-v~~~~~~-----~----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMA--------HEEVIYY-VRDGNIL-----A----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSC--------HHHHHHH-HHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCC--------HHHHHHH-HHcCCCC-----C----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 664211 1122222 1222111 1 1122335789999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=400.71 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=201.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCC----EEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 362 (613)
++|+..+.||+|+||+||+|.+. +|+ +||+|.++........+.+.+|++++++++||||++++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999875 444 68999987665555677899999999999999999999999864 5678
Q ss_pred EEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceec
Q 007200 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~ 442 (613)
++||+.+|+|.+++..... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876533 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhccccc
Q 007200 443 DYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 520 (613)
Q Consensus 443 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (613)
....... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||+... .......+.. ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~---~~~-- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GER-- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH---TCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCC--
Confidence 5433322 233458999999999999999999999999999999998 788886321 1112221111 111
Q ss_pred ccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 521 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
...+......+.+++.+||+.||++|||+.||++.|+.
T Consensus 232 --------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 232 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11122334678999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-48 Score=394.81 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=207.4
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 368999999999999999999976 789999999975532 345678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~ 443 (613)
||++|+|.+++.... .++++..+..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 104 ~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999986543 2499999999999999999999999 9999999999999964 5789999999998775
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+.+.........
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~---- 243 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWN---- 243 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCC----
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC----
Confidence 433 2344569999999999999999999999999999999999999995221 11222222211110
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
............+.+++.+||+.||++|||++|+++.
T Consensus 244 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ---MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111223578899999999999999999999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=385.19 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=206.2
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-----ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.++++++||||+++++++.++...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999986 7999999998654322 2356799999999999999999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEecc
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 436 (613)
++|||||++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997754 399999999999999999999999 999999999999998776 4999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765432 2334568999999999999999999999999999999999999996221 11111111111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ..........+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NY-------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 0000001122356889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.9e-48 Score=396.14 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=207.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....+.+|+.++++++||||+++++++.++...++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999975 799999999876532 2345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCcEEEeccccceecCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~ 444 (613)
|++|+|.+++.... .++++..+..++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876543 2499999999999999999999999 999999999999998 678999999999998764
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+.+........
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~------ 245 (352)
T d1koba_ 182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDW------ 245 (352)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCC------
T ss_pred CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC------
Confidence 33 2344569999999999999999999999999999999999999995221 1111212211110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 563 (613)
.............+.+++.+||+.||++|||+.|+++.
T Consensus 246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111112234578899999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=389.31 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=197.5
Q ss_pred HhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc-CCceEEEE
Q 007200 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVY 364 (613)
Q Consensus 286 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 364 (613)
..++|+..+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|++.+ ++..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467888899999999999999985 7899999997543 34678999999999999999999999865 45689999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+++|+|.+++..... .++++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999976432 2389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
. .....++..|+|||.+.+..+++++|||||||++|||+| |++||.... ......++.. ..
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i~~----~~----- 217 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEK----GY----- 217 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHHTT----TC-----
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc----CC-----
Confidence 2 223457899999999999999999999999999999998 788875321 1122222211 11
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.+ ..+......+.+++.+||+.||++||||.++++.|+.
T Consensus 218 ~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 KM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11 1122233578899999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=389.48 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=206.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 363 (613)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999976 79999999997543 223456788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||++|+|.+++...+. +++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987553 89999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... ......+||+.|+|||++.+..++.++||||+||++|||++|++||.... ..+....... ...
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~-~~~---- 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-EEI---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCC----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhc-CCC----
Confidence 332 23345679999999999999999999999999999999999999996322 1111111111 111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
. .+......+.+++.+||+.||++||+ +.|+++
T Consensus 223 --~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --C----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 11223356789999999999999995 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=393.61 Aligned_cols=267 Identities=27% Similarity=0.381 Sum_probs=201.9
Q ss_pred HHHHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeE
Q 007200 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 352 (613)
Q Consensus 280 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 352 (613)
..++++..++|++.+.||+|+||+||+|.+. +++.||||+++..........+.+|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3455566688999999999999999999864 24689999998766555566788888888776 6899999999
Q ss_pred EEEcC-CceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007200 353 FCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK 419 (613)
Q Consensus 353 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 419 (613)
++.++ ...++|||||++|+|.++++.... ....+++..+..++.||++||+|||++ +|||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98765 468999999999999999975421 123589999999999999999999999 99999999
Q ss_pred CCceeecCCCcEEEeccccceecCCCCCc-eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCC-CCccccc
Q 007200 420 AANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLAR 497 (613)
Q Consensus 420 ~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~-~p~~~~~ 497 (613)
|+|||+++++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. +||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 233456999999999999999999999999999999999974 5674221
Q ss_pred ccCCCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 498 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.. +.+...+..+... . .+......+.+++.+||+.||++|||++||++.|+.
T Consensus 242 ----~~----~~~~~~~~~~~~~-----~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 242 ----ID----EEFCRRLKEGTRM-----R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp ----CS----HHHHHHHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HH----HHHHHHHhcCCCC-----C----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 1111222211111 1 112233578999999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=385.15 Aligned_cols=256 Identities=29% Similarity=0.387 Sum_probs=195.9
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC--CC--CEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|++.+.||+|+||.||+|++. ++ ..||||+++..... .....|.+|+.++++++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888999999999999999864 23 36899998755332 234579999999999999999999999965 467
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++||||+++|++.+++..... ++++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998876432 389999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCce--eeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.+..+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHHHHHHHHhCC
Confidence 875443322 233457889999999999999999999999999999998 899995221 112222222221
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
. ....+...+..+.+++.+||+.||++||||.||++.|++
T Consensus 232 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 E---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 111122233578999999999999999999999998874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=393.56 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=212.5
Q ss_pred HHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEc
Q 007200 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (613)
Q Consensus 284 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 356 (613)
++..++|++.+.||+|+||.||+|++. +++.||||+++..........+.+|+.+++.+ +||||++++|++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345578889999999999999999852 45689999998766665666799999999998 69999999999999
Q ss_pred CCceEEEEecccCCcchhhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007200 357 PTERLLVYPFMVNGSVASCLRERGQ--------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (613)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 422 (613)
+...++|||||++|+|.++++.... ....+++..+..++.||++||+|||++ +||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976431 223589999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccC
Q 007200 423 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 500 (613)
Q Consensus 423 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~ 500 (613)
|+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+| |.+||....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--- 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999987764433 33344668999999999999999999999999999999999 555553211
Q ss_pred CCcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 501 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
....+... +.... ....+......+.+++.+||+.||++||||+||+++|+.
T Consensus 253 -~~~~~~~~----i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 253 -VDSKFYKM----IKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp -SSHHHHHH----HHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHH----HhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111121 11111 111112234678999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-47 Score=382.03 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=205.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|+++ +|+.||||+++... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999976 69999999997542 2234567899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
|||.||+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999876543 78899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+..........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~~------ 218 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAEL------ 218 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCC------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCCC------
Confidence 2 234679999999999999999999999999999999999999996321 1122222222110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 563 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 563 (613)
. .+......+.+++.+||..||++|| |++++++.
T Consensus 219 -~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1112235688999999999999996 89998763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=385.88 Aligned_cols=252 Identities=32% Similarity=0.465 Sum_probs=201.7
Q ss_pred CCccccCcCcEEEEEEeCCC----CEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEc-CCceEEEEecc
Q 007200 293 RNILGRGGFGKVYKGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFM 367 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 367 (613)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++||||++++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999997532 25899999765555556789999999999999999999999875 56789999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
++|+|.++++.... .+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876543 378899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 448 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 448 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.... .......+ ....... .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~---i~~g~~~---~- 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY---LLQGRRL---L- 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH---HHTTCCC---C-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHH---HHcCCCC---C-
Confidence 2 2223458999999999999999999999999999999999888875221 11111121 1111111 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
.+......+.+++.+||+.||++||||.||++.|+.+
T Consensus 255 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 255 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112335788999999999999999999999999753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=388.05 Aligned_cols=262 Identities=29% Similarity=0.406 Sum_probs=207.8
Q ss_pred HHhhCCCCCCccccCcCcEEEEEEeCC--------CCEEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEE
Q 007200 285 VATDNFSNRNILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (613)
Q Consensus 285 ~~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 355 (613)
+..++|++.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345788999999999999999998542 2479999998776665667788899988888 7999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 423 (613)
++...++||||+++|+|.++++.... ....+++.+++.++.||+.||+|||+. +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976532 123589999999999999999999999 999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCC-ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHh-CCCCcccccccCC
Q 007200 424 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 501 (613)
Q Consensus 424 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~ellt-g~~p~~~~~~~~~ 501 (613)
|++.++.+||+|||+++....... .......|++.|+|||.+.++.+++++|||||||++|||++ |.+||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---- 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence 999999999999999987654332 22344568999999999999999999999999999999998 688885221
Q ss_pred CcchHHHHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 502 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
. ..+...+..+.. .. .+...+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 243 -~----~~~~~~i~~~~~-----~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 -V----EELFKLLKEGHR-----MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -H----HHHHHHHHTTCC-----CC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H----HHHHHHHHcCCC-----CC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 112122221111 11 1112335789999999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=390.73 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=214.8
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeC------CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEE
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 355 (613)
++++..++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++||||++++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34455678999999999999999999864 257899999986655555567999999999999999999999999
Q ss_pred cCCceEEEEecccCCcchhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 007200 356 TPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (613)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 429 (613)
.+...++||||+.+|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986431 2223479999999999999999999999 999999999999999999
Q ss_pred cEEEeccccceecCCCCCce-eeccccccccccccccccCCCCCcccchhHHHHHHHHHhCC-CCcccccccCCCcchHH
Q 007200 430 EAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLL 507 (613)
Q Consensus 430 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~-~p~~~~~~~~~~~~~~~ 507 (613)
++||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||... ...
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~ 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNE 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHH
Confidence 99999999998765433322 23345899999999999999999999999999999999985 666421 122
Q ss_pred HHHHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 007200 508 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 567 (613)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 567 (613)
+............ .+...+..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 243 ~~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 QVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 3332222222111 1122346799999999999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=389.33 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=202.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCC--EEEEEEeccccCcccHHHHHHHHHHHhhc-ccCccceeeEEEEcCCceEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 362 (613)
.++|++.+.||+|+||+||+|++. +|. .||||+++..........+.+|+++++++ +||||++++|++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 367888999999999999999976 444 47888876555444556799999999998 79999999999999999999
Q ss_pred EEecccCCcchhhhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 007200 363 VYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (613)
Q Consensus 363 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 430 (613)
||||+++|+|.++++... .....+++..+..++.||++||.|||++ +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997541 2334599999999999999999999999 9999999999999999999
Q ss_pred EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCC-CcccccccCCCcchHHHH
Q 007200 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLLDW 509 (613)
Q Consensus 431 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~-p~~~~~~~~~~~~~~~~~ 509 (613)
+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..+.
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~ 235 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 235 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHH
Confidence 9999999997544222 1223458999999999999999999999999999999999765 564211 1121
Q ss_pred HHHHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 510 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......... + ..+......+.+++.+||+.||++||||+||++.|+.
T Consensus 236 ~~~i~~~~~------~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 236 YEKLPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHHGGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcCC------C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111 1 1122334679999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-47 Score=375.13 Aligned_cols=258 Identities=24% Similarity=0.315 Sum_probs=201.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc--ccHHHHHHHHHHHhhcccCccceeeEEEEcCC----c
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----E 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 359 (613)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 7999999999765433 23457899999999999999999999987654 3
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.++||||+++|+|.+++...+ ++++.++..++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987654 389999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCC--CceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 440 KLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 440 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
....... ........||+.|+|||++.+..+++++|||||||++|||+||+.||.... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcC
Confidence 7654322 223344569999999999999999999999999999999999999996321 112222222222
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 566 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 566 (613)
.... .......+..+.+++.+||+.||++|| |++++++.|..
T Consensus 231 ~~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1110 001112235788999999999999999 89999887753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=382.62 Aligned_cols=257 Identities=26% Similarity=0.267 Sum_probs=194.3
Q ss_pred CCccccCcCcEEEEEEeC-CCCEEEEEEeccccCccc----HHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEecc
Q 007200 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (613)
Q Consensus 293 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 367 (613)
.++||+|+||+||+|++. +|+.||||+++....... ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999976 699999999875433221 235889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCCC
Q 007200 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (613)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 447 (613)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988777665432 388899999999999999999999 999999999999999999999999999986654322
Q ss_pred ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccccC-
Q 007200 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS- 525 (613)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 525 (613)
......||+.|+|||++.+. .++.++|||||||++|||+||+.||... ........+.............+.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-----~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC-----CHHHHHHHHHHhcCCCChhhccchh
Confidence 23345699999999998654 5799999999999999999999999522 111122222221111000000000
Q ss_pred --------ccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 526 --------DMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 526 --------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 112357899999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-47 Score=377.39 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=204.1
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc--------cHHHHHHHHHHHhhcc-cCccceeeEEEEcC
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--------GELQFQTEVEMISMAV-HRNLLRLRGFCMTP 357 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 357 (613)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67899999999999999999975 78999999987543221 1235889999999997 99999999999999
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
+..++|||||++|+|.++++..+ ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998654 399999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCceeecccccccccccccccc------CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 511 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 511 (613)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... . .....
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~---~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----Q---MLMLR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----H---HHHHH
Confidence 998775432 2344569999999999863 346889999999999999999999996321 1 11111
Q ss_pred HHhhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
..... ... .........+..+.+++.+||++||++|||+.|+++
T Consensus 226 ~i~~~-~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSG-NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHT-CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhC-CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 111 111112233467899999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-46 Score=382.24 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=205.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 364 (613)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 79999999986532 2233557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCC
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 444 (613)
||+.+|+|..++...+ .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997764 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccccccc
Q 007200 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 524 (613)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (613)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||.... ............ .
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~-~----- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcCC-C-----
Confidence 2 234569999999999999999999999999999999999999996221 112122221111 1
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 007200 525 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 562 (613)
Q Consensus 525 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 562 (613)
. .+......+.+++.+||+.||++|+ |++++++
T Consensus 256 -~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -C----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 1112335788999999999999994 8999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=379.82 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=200.3
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC----ceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 363 (613)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.... ....++.|+..+..++||||+++++++.+++ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4567788999999999999997 489999999864321 1222344555566789999999999998653 57899
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
||||++|+|.++++.. +++|..+.+++.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999864 3899999999999999999999731 23999999999999999999999999999
Q ss_pred ceecCCCCCc---eeeccccccccccccccccCC------CCCcccchhHHHHHHHHHhCCCCcccccccCC------Cc
Q 007200 439 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLAND------DD 503 (613)
Q Consensus 439 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwS~G~il~elltg~~p~~~~~~~~~------~~ 503 (613)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877544322 233466999999999987643 57789999999999999999998853321111 01
Q ss_pred chHHHHHHHHhhcccccccccCccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 504 VMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
......+......... ++..+.. ...+....+.+++.+||+.||++|||+.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1122222222222221 2222111 123456779999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=383.73 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=204.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
-++|++.+.||+|+||+||+|.+. +|+.||||.++.... ....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999986 688999999976432 24568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CcEEEeccccceecC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 443 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfGla~~~~ 443 (613)
||+||+|.+++...+. ++++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999976532 489999999999999999999999 99999999999999854 589999999998764
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.... ..+.+......... .
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~---~ 222 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---C
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC---C
Confidence 332 2344568999999999999999999999999999999999999996321 11222222211110 0
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ........+.+++..||..||++|||+.|+++
T Consensus 223 ~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chh----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00112356889999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-46 Score=383.45 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=198.5
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC--cccHHHHHH---HHHHHhhcccCccceeeEEEEcCCce
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 360 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 360 (613)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+ ++.+++.++||||+++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999976 699999999864321 112233334 46667778899999999999999999
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
++|||||++|+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999998754 388999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccc
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 519 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (613)
...... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ........ ....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~-~~~~-- 224 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRM-TLTM-- 224 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHH-SSSC--
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-cccC--
Confidence 765432 334569999999999975 56899999999999999999999999632211 11111111 1000
Q ss_pred cccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 520 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
.... +......+.+++.+||+.||++||| ++|+++
T Consensus 225 ----~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ----AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011 1122356899999999999999999 677775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=379.75 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=201.9
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEecccc--CcccHHHHHHHHHHHh-hcccCccceeeEEEEcCCceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 363 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999986 68999999997542 2223445666776655 68999999999999999999999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecC
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 443 (613)
||||++|+|.++++.... +++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987543 89999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcccccccc
Q 007200 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 523 (613)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (613)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... . .+..... ....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~---~~~~~~i-~~~~----- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----E---EELFHSI-RMDN----- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHH-HHCC-----
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----H---HHHHHHH-HcCC-----
Confidence 3332 2344569999999999999999999999999999999999999996321 1 1111111 1111
Q ss_pred cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 007200 524 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVR 562 (613)
Q Consensus 524 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 562 (613)
+.. +......+.+++.+||..||++|||+. |+++
T Consensus 220 -~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 112235688999999999999999995 6654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=380.58 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=197.7
Q ss_pred hhCCCCCC-ccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhh-cccCccceeeEEEEc----CCc
Q 007200 287 TDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTE 359 (613)
Q Consensus 287 ~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~ 359 (613)
.++|.+.+ .||+|+||+||+|++. +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35788764 5999999999999975 7899999998542 356789988665 479999999999865 456
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEecc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 436 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Df 436 (613)
.++|||||+||+|.+++...+. .++++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 7999999999999999976532 3499999999999999999999999 9999999999999985 467999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 437 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
|+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+..
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~---- 227 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKT---- 227 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHHH----
Confidence 99987654332 334569999999999999999999999999999999999999996332110 0111100
Q ss_pred ccccccccCc--cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSD--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.+.... .+..........+.+++.+||+.||++|||+.|+++
T Consensus 228 ----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 ----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011111 111112334567899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=372.02 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=197.2
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|++++++++||||+++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 67999999999999999999975 7999999999754322 234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
|+.++.+. ++..... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~-~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHH-HHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhh-hhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765444 4433222 2399999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHH-HHHHhhcc--cccc
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW-VKGLLKEK--KLEQ 521 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~ 521 (613)
. .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.... ....... ........ ....
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-----EIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTT
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC-----HHHHHHHHHHhcCCCchhhccc
Confidence 2 2233346999999999887765 5789999999999999999999996321 1111111 11100000 0000
Q ss_pred cc---c--CccC--CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 522 LV---D--SDME--GNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 522 ~~---~--~~~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. + .... ... .......+.+++.+||..||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0 0000 000 0112357889999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=368.95 Aligned_cols=240 Identities=23% Similarity=0.392 Sum_probs=196.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcc-----cHHHHHHHHHHHhhcc--cCccceeeEEEEcCCc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 359 (613)
++|.+.+.||+|+||+||+|++. +|+.||||+++...... ...++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999976 78999999987543211 1123668999999987 8999999999999999
Q ss_pred eEEEEecccC-CcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEeccc
Q 007200 360 RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 437 (613)
Q Consensus 360 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 437 (613)
.++||||+.+ +++.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57777776643 389999999999999999999999 99999999999999854 799999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCC-CCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 438 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ...+.
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~ 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhc
Confidence 99865432 2344669999999999987765 677999999999999999999996321 11111
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. ..+.. .+..+.+++.+||+.||++|||++|+++
T Consensus 220 ~~-------~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QV-------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC-------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-------CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 01111 2356889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-45 Score=367.88 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=200.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEec
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 366 (613)
++|++.+.||+|+||+||+|++++|+.||||+++.... .....++.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999999999999999976532 23356789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCCC
Q 007200 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (613)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 446 (613)
+.++.+..+....+ .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98887777765433 399999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc---cc--
Q 007200 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LE-- 520 (613)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 520 (613)
. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.... .......+........ ..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhhccch
Confidence 2 23344589999999998765 56899999999999999999999996321 1111111111111000 00
Q ss_pred -cc------c---cCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 -QL------V---DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 -~~------~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.. . .+.............+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000000111123457889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=365.98 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=195.7
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-C-CCEEEEEEeccccCcc-cHHHHHHHHHHHhhc---ccCccceeeEEEEc----
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 356 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 356 (613)
.++|++.+.||+|+||+||+|++. + ++.||||+++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 5679999987543221 223456777776655 79999999999853
Q ss_pred -CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEec
Q 007200 357 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (613)
Q Consensus 357 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 435 (613)
....+++|||+.++++........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346789999999887765544332 2489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh
Q 007200 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 515 (613)
Q Consensus 436 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 515 (613)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhC
Confidence 9999765432 22344569999999999999999999999999999999999999996321 1111111111111
Q ss_pred cccccc----------cccC---ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 EKKLEQ----------LVDS---DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ~~~~~~----------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...... .... .............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 0000111223356788999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=361.01 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=195.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEc--------C
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 357 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 357 (613)
++|++.+.||+|+||+||+|++. +|+.||||++..... .....++.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999975 799999999865433 2345678899999999999999999999865 3
Q ss_pred CceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccc
Q 007200 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (613)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 437 (613)
...++||||+.++.+....... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4579999999888776554432 2489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC---ceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 438 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 438 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+++....... .......||+.|+|||.+.+. .+++++||||+||++|||++|+.||... ........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-----~~~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-----CHHHHHHHHHHh
Confidence 9987653221 122335699999999998765 6899999999999999999999999621 111222222221
Q ss_pred hhcc---cccccccCcc---------CCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 514 LKEK---KLEQLVDSDM---------EGNYIEE------EVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 514 ~~~~---~~~~~~~~~~---------~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.... .......... ......+ ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1110 0000000000 0000111 1245678999999999999999999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=362.97 Aligned_cols=263 Identities=20% Similarity=0.305 Sum_probs=196.6
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcCC----ceE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 361 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 361 (613)
+++|++.+.||+|+||+||+|++. +|+.||||++...........+.+|++++++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999975 799999999976555445567899999999999999999999987653 335
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677899999999754 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 442 MDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 442 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
....... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||..... ...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCC
Confidence 6443221 2234568999999999854 5678999999999999999999999963221 111111111000000
Q ss_pred ccc-------------cccCccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 LEQ-------------LVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~~~-------------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ...+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000 0011246889999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=351.15 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=204.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999976 7899999999765433 335678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccceecCCC
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 445 (613)
++.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876543 388999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccccc----
Q 007200 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---- 520 (613)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 520 (613)
.. ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||.... ........+..........
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC----CHHHHHHHHHhhcCCCChhhhhh
Confidence 32 233344788999999987665 6899999999999999999999974221 1111111111111110000
Q ss_pred --cccc---------CccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 521 --QLVD---------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 521 --~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
...+ ..............+.+++.+|++.||++||||+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001111223456889999999999999999999977
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=360.55 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=191.8
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccC-cccHHHHHHHHHHHhhcccCccceeeEEEEcCC------
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 358 (613)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+++++.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367999999999999999999976 699999999975433 233457889999999999999999999997654
Q ss_pred ceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEecccc
Q 007200 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (613)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl 438 (613)
..++||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 66777776543 399999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccC-CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
++..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.... ...............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTP 238 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-----hHHHHHHHHhccCCC
Confidence 9876432 2345699999999998764 56899999999999999999999996321 111111000000000
Q ss_pred ------------------cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 518 ------------------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 518 ------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
.......... ..........+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 0011122346789999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-43 Score=350.13 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=194.7
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccc-eeeEEEEcCCceEEEEe
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYP 365 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 365 (613)
++|++.+.||+|+||+||+|++. +|+.||||++...... ..+..|+++++.++|+|++ .+.+++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999975 6889999988754332 2467899999999877655 45555677788899999
Q ss_pred cccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEeccccceec
Q 007200 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 442 (613)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGla~~~ 442 (613)
|+ ++++...+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 556666655433 2499999999999999999999999 9999999999999864 457999999999977
Q ss_pred CCCCCc------eeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhc
Q 007200 443 DYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 516 (613)
Q Consensus 443 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 516 (613)
...... ......||+.|+|||.+.+..+++++|||||||++|||+||+.||.......... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC-
Confidence 543221 2334569999999999999999999999999999999999999996432111110 01111111000
Q ss_pred ccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 517 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
..... .. ...+..+.+++..||+.+|++||+++++.+.|+.
T Consensus 235 ~~~~~-----~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCHHH-----HT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CChhH-----hc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000 00 1123568999999999999999999999988864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=362.34 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=191.0
Q ss_pred CCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCccceeeEEEEcC------CceE
Q 007200 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 361 (613)
Q Consensus 289 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 361 (613)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999986 6999999999765432 24799999999999999999998643 3468
Q ss_pred EEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccce
Q 007200 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 440 (613)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~ 440 (613)
+|||||.++.+..+.+. ......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999987654443322 12233599999999999999999999999 999999999999999775 89999999998
Q ss_pred ecCCCCCceeecccccccccccccccc-CCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHH---------
Q 007200 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--------- 510 (613)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--------- 510 (613)
....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.... .......+
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~-----~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-----GVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHCCCCH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC-----HHHHHHHHHHHhCCChH
Confidence 7654332 234569999999998875 468999999999999999999999995322 11111111
Q ss_pred ---HHHhhcc---cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 511 ---KGLLKEK---KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 511 ---~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
....... .....................+.+++.+||..||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100000 000000000000011123456889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=359.99 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=203.0
Q ss_pred hCCCCCCccccCcCcEEEEEEeC----CCCEEEEEEeccccC---cccHHHHHHHHHHHhhccc-CccceeeEEEEcCCc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 359 (613)
++|++.+.||+|+||+||+|+.. +|+.||||.++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 488999999875432 1223457889999999987 899999999999999
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++|||+.+|+|.+++..... +.+..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987653 77899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccC--CCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhcc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 517 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (613)
+.+............|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccCC
Confidence 87765544445556799999999999765 46889999999999999999999996432211 1111111111111
Q ss_pred cccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 007200 518 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 562 (613)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 562 (613)
. ..+......+.+++.+||++||++||| ++|+++
T Consensus 253 -------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 111223467899999999999999994 788765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.1e-43 Score=348.45 Aligned_cols=259 Identities=15% Similarity=0.197 Sum_probs=203.0
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhccc-CccceeeEEEEcCCceEEEE
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 364 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 364 (613)
.++|.+.+.||+|+||+||+|++. +|+.||||++...... ..+.+|++.++.+.| +|++.+++++.++...++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999976 6889999988654332 246788888888875 89999999999999999999
Q ss_pred ecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCcEEEeccccc
Q 007200 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 439 (613)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfGla 439 (613)
||+ +++|.++++..+. .+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899998876543 489999999999999999999999 9999999999999974 568999999999
Q ss_pred eecCCCCC------ceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHH
Q 007200 440 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 513 (613)
Q Consensus 440 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 513 (613)
+....... .......||+.|||||.+.+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhc
Confidence 87653321 1233456999999999999999999999999999999999999999632211 111111111111
Q ss_pred hhcccccccccCccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 007200 514 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 566 (613)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 566 (613)
.......++ .. ..+.++.+++..|+..+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~l-----~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh-----cC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 11 123568899999999999999999999887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-42 Score=352.26 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=195.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcC--CceEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLV 363 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 363 (613)
++|++.++||+|+||+||+|++. +|+.||||+++.. ...++.+|+++++.+. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999985 7899999998643 2457889999999995 99999999999753 568999
Q ss_pred EecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEeccccceec
Q 007200 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (613)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~ 442 (613)
|||+.+++|..+.+ .+++..++.++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999987643 389999999999999999999999 999999999999998654 6999999999876
Q ss_pred CCCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhh------
Q 007200 443 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK------ 515 (613)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 515 (613)
.... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||..... .......+.....
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~----~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD----NYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS----HHHHHHHHHHHHCHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch----hHHHHHHHHHHHCCchhhh
Confidence 5432 234456899999999987754 79999999999999999999999963221 1111111111100
Q ss_pred ------ccc---ccccccC--------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 516 ------EKK---LEQLVDS--------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 516 ------~~~---~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
... ....... .............+.+++.+||..||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 0001111223456889999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=354.87 Aligned_cols=258 Identities=19% Similarity=0.208 Sum_probs=189.4
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEc------CCc
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 359 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999987 6999999999765432 334568899999999999999999999864 367
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.|+||||+.++.+.. +.. .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHH-HTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHh-hhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 899999997765543 322 289999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHH--------
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-------- 511 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 511 (613)
+..... .......||+.|+|||++.+..+++++||||+||++|||++|+.||.... .......+.
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-----~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-----HHHHHHHHHHhccCCCH
Confidence 765432 22344568999999999999999999999999999999999999995221 111111110
Q ss_pred -----------HHhhcccc------ccccc-CccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 512 -----------GLLKEKKL------EQLVD-SDME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 512 -----------~~~~~~~~------~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
........ ..... .... ..........+.+++.+|+..||++||||+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00000 0000 1112344677899999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=351.90 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=194.1
Q ss_pred hhCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCc-ccHHHHHHHHHHHhhcccCccceeeEEEEcC-----Cc
Q 007200 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (613)
Q Consensus 287 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 359 (613)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 7999999999765432 2345688999999999999999999998643 34
Q ss_pred eEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEeccccc
Q 007200 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (613)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla 439 (613)
.+++++|+.+|+|.++++.. ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 57778888999999998643 399999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCC-CCCcccchhHHHHHHHHHhCCCCcccccccCCCcchHHHHHHHHhhccc
Q 007200 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 518 (613)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (613)
..... ......|++.|+|||.+.+.. ++.++||||+||++|+|++|+.||.... .......+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 75432 223456899999999877654 6899999999999999999999995221 1111111111110000
Q ss_pred c--cc---------ccc--CccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 007200 519 L--EQ---------LVD--SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 562 (613)
Q Consensus 519 ~--~~---------~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 562 (613)
. .. ... ....... .......+.+++.+||..||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00 000 0000000 0012356789999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-38 Score=323.81 Aligned_cols=281 Identities=20% Similarity=0.247 Sum_probs=197.8
Q ss_pred hCCCCCCccccCcCcEEEEEEeC-CCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-----------cCccceeeEEEE
Q 007200 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 355 (613)
Q Consensus 288 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 355 (613)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ....+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 45899999999999999999975 799999999975432 2345778888887765 578999998875
Q ss_pred c--CCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCc--
Q 007200 356 T--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFE-- 430 (613)
Q Consensus 356 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~-- 430 (613)
. ....+++++++..+.......... ....+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 456667777766555443333222 22348999999999999999999998 6 8999999999999987653
Q ss_pred ----EEEeccccceecCCCCCceeeccccccccccccccccCCCCCcccchhHHHHHHHHHhCCCCcccccccCCC-cc-
Q 007200 431 ----AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DV- 504 (613)
Q Consensus 431 ----~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwS~G~il~elltg~~p~~~~~~~~~~-~~- 504 (613)
++++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||......... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865432 23456999999999999999999999999999999999999999743321111 00
Q ss_pred hHHHHHHHHhh--------ccccccccc---------Cc----------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 007200 505 MLLDWVKGLLK--------EKKLEQLVD---------SD----------MEGNYIEEEVEQLIQVALLCTQGSPMERPKM 557 (613)
Q Consensus 505 ~~~~~~~~~~~--------~~~~~~~~~---------~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 557 (613)
.+...+...-. ........+ .. ............+.+++.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111110000 000000000 00 0112345667889999999999999999999
Q ss_pred HHHHHHhhcCCcchhhHHHhhhhhhcccccCC
Q 007200 558 SEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT 589 (613)
Q Consensus 558 ~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (613)
+|+++ ++|+.+.....+..-|
T Consensus 323 ~e~L~-----------Hp~f~~~~~~~~~~~p 343 (362)
T d1q8ya_ 323 GGLVN-----------HPWLKDTLGMEEIRVP 343 (362)
T ss_dssp HHHHT-----------CGGGTTCTTCTTCCCT
T ss_pred HHHhc-----------CcccCCCCCcccCCCC
Confidence 99976 4555555544444444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=2.1e-26 Score=231.71 Aligned_cols=179 Identities=31% Similarity=0.595 Sum_probs=160.6
Q ss_pred cCchHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--cceeEEeCCCC---CeEEEEcCCCCccc--ccchhhhCCCCCCE
Q 007200 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPC--TWFHVTCNSEN---SVTRVDLGNANLSG--QLVSQLGQLTNLQY 97 (613)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~C--~~~gv~c~~~~---~l~~L~l~~n~l~~--~~~~~~~~l~~L~~ 97 (613)
|.++|++||++||+.+.||. .+++|+. ++||| .|.||+|+..+ +|+.|+|++|+++| .+|..+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67899999999999999985 6899975 47999 59999997644 69999999999987 47899999999999
Q ss_pred EEccc-ccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCC
Q 007200 98 LELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176 (613)
Q Consensus 98 L~L~~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 176 (613)
|+|++ |+++|.+|..|.+|++|++|+|++|+|.+..+..+..+.+|+.|++++|.+.+.+|..+..+++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCCCcc-ccccccCCCCCCCCC
Q 007200 177 LTGDIPTN-GSFSLF-TPISFANNQLNNPPP 205 (613)
Q Consensus 177 l~~~~~~~-~~~~~l-~~l~l~~N~i~~~~~ 205 (613)
+++.+|.. ..+..+ ..+.+++|.+.+..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~ 191 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECC
T ss_pred ccccccccccccccccccccccccccccccc
Confidence 99877654 555554 788899998876544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.3e-23 Score=195.07 Aligned_cols=162 Identities=12% Similarity=0.067 Sum_probs=120.1
Q ss_pred CCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCc-----------------ccHHHHHHHHHHHhhcccCccceeeEE
Q 007200 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVHRNLLRLRGF 353 (613)
Q Consensus 291 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 353 (613)
.+.++||+|+||+||+|++.+|+.||||+++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999999988999999987632110 011234568888999999999988876
Q ss_pred EEcCCceEEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 007200 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (613)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 433 (613)
. ..+++|||+++..+.+ ++......++.|++++|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999998866543 23344568899999999999999 99999999999999976 5899
Q ss_pred eccccceecCCCCCceeecccccccccc------ccccccCCCCCcccchhHHH
Q 007200 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIA------PEYLSTGKSSEKTDVFGYGV 481 (613)
Q Consensus 434 ~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DVwS~G~ 481 (613)
+|||.|+........ .|.. .+. ..+.|..++|+||..-
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 999999865432211 1111 111 2456788999999753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.4e-19 Score=164.91 Aligned_cols=146 Identities=22% Similarity=0.277 Sum_probs=91.7
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCccccc-chhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccC
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~ 126 (613)
|.|..|.|++. .+++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..++.|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45666777532 25667777777776433 44566777777777777777766666677777777777777
Q ss_pred ccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
|+|+...|..|.++++|++|+|++|+|++..++.|..+++|++|+|++|++.+..........+..+.+..|.+.|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeC
Confidence 77776666667777777777777777776556666677777777777777665433221112334444444544443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=7.4e-18 Score=155.75 Aligned_cols=137 Identities=23% Similarity=0.335 Sum_probs=121.3
Q ss_pred eeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCC-ccccccCCcCCeEeccCccCCCCCCccccc
Q 007200 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139 (613)
Q Consensus 61 ~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 139 (613)
.|.+|.. +.++.++++|+ .+|..+ .+++++|+|++|+|++.+ +..|.++++|++|+|++|.+....+..|..
T Consensus 4 ~~C~C~~----~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG----TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET----TEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC----CEEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 4678853 47999999999 566655 368999999999998644 667899999999999999999999999999
Q ss_pred ccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCC
Q 007200 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
+++|++|+|++|+|+...+..|.++++|+.|+|++|+|+++++.. ..+++|+.|++++|++.|..
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 999999999999999888889999999999999999999998875 67899999999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=5.9e-16 Score=150.63 Aligned_cols=135 Identities=28% Similarity=0.301 Sum_probs=96.9
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
..++++.|+|++|+|+. ++ .++.+++|+.|+|++|+++ ..+..+..+++|++|++++|.+....+..+..+.+|++|
T Consensus 53 ~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L 129 (266)
T d1p9ag_ 53 PYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (266)
T ss_dssp TCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred ccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccc
Confidence 34578888888888874 33 3567888888888888887 455667778888888888888776666667777777777
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~ 204 (613)
++++|.++...+..+..+++|+.|++++|+|++.++.. ..+++|+.|++++|.+...|
T Consensus 130 ~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred cccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccC
Confidence 77777777555566666777777777777777666553 55677777777777776443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6.3e-16 Score=151.97 Aligned_cols=135 Identities=20% Similarity=0.214 Sum_probs=101.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
++++.|+|++|++....+..+..+++|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|++|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 46777778777777666667777777778888888877666667777777888888888777666777777778888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~ 203 (613)
++|++++..|..|..+++|+.|++++|.+.+.++.. ..+++|+.|++++|++.|.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 888777777777777778888888888877766543 5677777788888877764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=1.3e-15 Score=129.38 Aligned_cols=105 Identities=28% Similarity=0.351 Sum_probs=88.9
Q ss_pred EEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
+.|+|++|+|+ .++ .+.++++|++|+|++|.|+ .+|+.|..+++|+.|++++|.|+. +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 36899999998 444 4889999999999999998 677789999999999999999995 44 5899999999999999
Q ss_pred cccCcc-ccccccccchhhhhhcCCCcccCC
Q 007200 152 SLMGEI-PRSLTNVNSLQVLDLSNNKLTGDI 181 (613)
Q Consensus 152 ~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~ 181 (613)
+|+... ...+..+++|+.|++++|+++...
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 998543 256888999999999999998654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=4e-15 Score=144.61 Aligned_cols=136 Identities=27% Similarity=0.268 Sum_probs=121.3
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|+|++|.|++..+..|.++++|++|+|++|+|+ .+|. +..+++|++|+|++|+++ ..+..+.++++|+.|+|
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 47999999999999877788999999999999999998 4553 688999999999999999 56778999999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSP 207 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~~~ 207 (613)
++|.+.+..+..+..+.+|+.|++++|.++..++.. ..++.++.+++++|.+...++..
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccc
Confidence 999999877888899999999999999999888766 56889999999999998876543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.57 E-value=5.3e-15 Score=146.78 Aligned_cols=73 Identities=29% Similarity=0.372 Sum_probs=64.9
Q ss_pred ccceeEEeCC----------CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCc
Q 007200 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (613)
Q Consensus 58 C~~~gv~c~~----------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N 127 (613)
|.|.+|.|+. .+.++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 6889999965 246899999999999766678999999999999999999888889999999999999998
Q ss_pred cCC
Q 007200 128 NLN 130 (613)
Q Consensus 128 ~l~ 130 (613)
+|+
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.54 E-value=1.5e-15 Score=151.55 Aligned_cols=133 Identities=27% Similarity=0.436 Sum_probs=102.6
Q ss_pred EEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCc
Q 007200 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (613)
Q Consensus 72 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 151 (613)
+.+++++|++++..+..+.++..+ .+++++|.+.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|
T Consensus 177 ~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N 254 (313)
T d1ogqa_ 177 TSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254 (313)
T ss_dssp CEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccC
Confidence 334444444444333333333322 34555555555566667778899999999999987654 6888999999999999
Q ss_pred cccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCCCC
Q 007200 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206 (613)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~~ 206 (613)
+|+|.+|..|+++++|++|+|++|+|+|.+|..+.+++|+.+++++|+..|+.|.
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred eecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence 9999999999999999999999999999888888899999999999998887653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2.9e-15 Score=133.61 Aligned_cols=125 Identities=19% Similarity=0.127 Sum_probs=100.3
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
+...++.|+|++|+|+. ++..+..+++|+.|+|++|.|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34578999999999984 4666788999999999999998 454 48899999999999999996656667789999999
Q ss_pred cccCccccCccc-cccccccchhhhhhcCCCcccCCC----CCCCCCcccccc
Q 007200 147 RLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPIS 194 (613)
Q Consensus 147 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~ 194 (613)
+|++|+|+.... ..+..+++|+.|++++|+++..+. ....+++|+.|+
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999984322 467889999999999999987653 124567777765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=9.2e-15 Score=123.94 Aligned_cols=104 Identities=26% Similarity=0.341 Sum_probs=91.3
Q ss_pred CEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhhcCC
Q 007200 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (613)
Q Consensus 96 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (613)
+.|+|++|+|+ .++. +..+++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999999 5664 899999999999999999 678889999999999999999994 44 5899999999999999
Q ss_pred CcccCCC--CCCCCCccccccccCCCCCCCC
Q 007200 176 KLTGDIP--TNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 176 ~l~~~~~--~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
+|+..+. ....+++|+.|++++|+++..+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 9997654 3477889999999999987653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.2e-13 Score=135.23 Aligned_cols=136 Identities=24% Similarity=0.239 Sum_probs=105.0
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEecc-CccCCCCCCcccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY-LNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.++.|+|++|+|+...+..|.++++|++|++++|+|....+..+..+..++.|+++ .|.++...+..|.++++|++|+|
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 57999999999997777889999999999999999987777777777777777654 55566556777777788888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-CCCCccccccccCCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|.+....+..+..+++|+.+++++|.|++.++.. ..+++|+.|++++|.+...++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 888777666666777777778888888887766554 456677777888877765543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=9.6e-15 Score=130.15 Aligned_cols=113 Identities=20% Similarity=0.167 Sum_probs=97.0
Q ss_pred hhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccch
Q 007200 88 QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167 (613)
Q Consensus 88 ~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 167 (613)
.+.++.+|++|+|++|+|+ .+++.+..+++|+.|||++|+|+. + +.|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4668889999999999999 567777889999999999999994 4 468999999999999999996555566789999
Q ss_pred hhhhhcCCCcccCCC--CCCCCCccccccccCCCCCCC
Q 007200 168 QVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 168 ~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+.|++++|+|+.... ....+++|+.|++++|+++..
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccc
Confidence 999999999986543 346789999999999988654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.4e-13 Score=121.65 Aligned_cols=104 Identities=22% Similarity=0.156 Sum_probs=85.5
Q ss_pred EEcCCCCcccccchhhhCCCCCCEEEcccc-cCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCcc
Q 007200 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSN-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152 (613)
Q Consensus 74 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 152 (613)
++++++++. ..|..+..+++|+.|+|++| .|+...++.|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444556666 45667888999999999866 5887667889999999999999999998778899999999999999999
Q ss_pred ccCccccccccccchhhhhhcCCCccc
Q 007200 153 LMGEIPRSLTNVNSLQVLDLSNNKLTG 179 (613)
Q Consensus 153 l~~~~~~~~~~l~~L~~L~l~~N~l~~ 179 (613)
|+...+..+. ..+|+.|+|++|++..
T Consensus 92 l~~l~~~~~~-~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 92 LESLSWKTVQ-GLSLQELVLSGNPLHC 117 (156)
T ss_dssp CSCCCSTTTC-SCCCCEEECCSSCCCC
T ss_pred CcccChhhhc-cccccccccCCCcccC
Confidence 9944444444 4479999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=3.8e-13 Score=124.22 Aligned_cols=125 Identities=28% Similarity=0.460 Sum_probs=90.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
++++.|+|++|.+++..+ +.++++|+.|++++|.+. .++ .+.++++|+.|++++|.+... ..+.++++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhh
Confidence 567788888887775432 777778888888887776 344 377778888888887777643 34677788888888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
++|++. .++ .+..+++|+.|++++|++++.+ ....+++|+.|++++|+++.
T Consensus 136 ~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 136 SSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhc-ccc-cccccccccccccccccccCCc-cccCCCCCCEEECCCCCCCC
Confidence 888876 333 4677788888888888887654 35677788888888887754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.39 E-value=2.3e-13 Score=134.68 Aligned_cols=130 Identities=24% Similarity=0.348 Sum_probs=91.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
..++.+++++|+++. ++.. .+++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..|.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 356777777777763 3332 2567777777777777777777777777777777777777666777777777777888
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCC-------CCCCccccccccCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-------GSFSLFTPISFANNQLNN 202 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~~~l~~l~l~~N~i~~ 202 (613)
++|+|+ .+|..|..+++|+.|+|++|+|+.+.... ..+..|+.|++++|++..
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 777777 55667777777777777777777654322 234566777777777754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.2e-13 Score=120.35 Aligned_cols=111 Identities=19% Similarity=0.082 Sum_probs=98.0
Q ss_pred CCCCCEEEcccccCCCCCccccccCCcCCeEeccCc-cCCCCCCcccccccccccccccCccccCccccccccccchhhh
Q 007200 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVL 170 (613)
Q Consensus 92 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 170 (613)
......++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...+..|..+++|+.|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567999999998 57778999999999999876 4886667889999999999999999997778899999999999
Q ss_pred hhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 171 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 171 ~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+|++|+|+..++.......|..|++++|++.|.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred eccCCCCcccChhhhccccccccccCCCcccCC
Confidence 999999998888776666899999999999875
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=1.6e-12 Score=121.06 Aligned_cols=127 Identities=24% Similarity=0.352 Sum_probs=94.7
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
.++++.|+|++|.|++.. .+.++++|+.|++++|+|++ +| .+..+++|+.|++++|.+.. ...+.++++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccccccccc--cccccccccccccc
Confidence 347888888888887543 36778888888888888873 44 37778888888888888763 24577788888888
Q ss_pred ccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+++|.+++ +..+..+++|+.+++++|++++.. ....+++|+.|++++|.+...
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~~l 193 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL 193 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCBC
T ss_pred cccccccc--cccccccccccccccccccccccc-cccCCCCCCEEECCCCCCCCC
Confidence 88888773 234667888888888888888654 356788888888888887643
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=1.8e-12 Score=119.57 Aligned_cols=127 Identities=24% Similarity=0.378 Sum_probs=108.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++++|+++. + ..+..+++|++|+|++|+|++. +. +.++++|++|++++|.+.. ++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCccccccccccccccc-cc-ccccccccccccc
Confidence 578999999999984 3 3588999999999999999964 43 8999999999999999984 33 4889999999999
Q ss_pred cCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
++|.+... ..+..+++|+.|++++|++... +....+++++.|++.+|.+...+
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCCG
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccCCc
Confidence 99998843 3478899999999999999864 45678899999999999887653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=3.8e-14 Score=130.71 Aligned_cols=115 Identities=26% Similarity=0.304 Sum_probs=89.7
Q ss_pred ccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccccccc
Q 007200 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN 163 (613)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 163 (613)
.++..+..|++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 45677888888999999999888 454 4888888999999999887 566666667788889999998884 3 34778
Q ss_pred ccchhhhhhcCCCcccCC--CCCCCCCccccccccCCCCCCC
Q 007200 164 VNSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 164 l~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
+++|+.|++++|+|+... .....+++|+.|++++|++...
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 888888999998887653 2346788888899988876543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.26 E-value=3.1e-12 Score=130.46 Aligned_cols=129 Identities=26% Similarity=0.355 Sum_probs=92.7
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCC---------------
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI--------------- 133 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------- 133 (613)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++..+ +..+++|++|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 4567777777777642 356667777777777777764332 666677777777776665321
Q ss_pred -----CcccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCCC
Q 007200 134 -----PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (613)
Q Consensus 134 -----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~ 204 (613)
...+..+++++.|+|++|++++.. .+..+++|+.|++++|+|++.+ ....+++|+.|++++|+++..+
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred cccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcCCCCh
Confidence 134667788899999999998653 3778899999999999988654 5677888999999999887654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.25 E-value=6.1e-12 Score=117.02 Aligned_cols=122 Identities=26% Similarity=0.299 Sum_probs=104.7
Q ss_pred CCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccc
Q 007200 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (613)
Q Consensus 67 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (613)
...+++.|++++|.|++ ++ .+.++++|+.|++++|.+. .++ .+..+++|+.+++++|.++. +..+..+++|+++
T Consensus 88 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred cCccccccccccccccc-cc-ccccccccccccccccccc-ccc-cccccccccccccccccccc--ccccccccccccc
Confidence 35689999999999985 44 5899999999999999997 444 58999999999999999984 3567889999999
Q ss_pred cccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccC
Q 007200 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197 (613)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 197 (613)
++++|++++. + .+.++++|+.|+|++|+|+.. +....+++|+.|++++
T Consensus 162 ~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 162 SLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred cccccccccc-c-cccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEccC
Confidence 9999999854 3 388999999999999999875 4567889999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=9.7e-14 Score=127.95 Aligned_cols=112 Identities=25% Similarity=0.288 Sum_probs=95.2
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (613)
..+++.|+|++|+|+. ++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+|+.. +.+.++++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccccccc
Confidence 4689999999999994 44 5899999999999999998 6777667778999999999999953 4588999999999
Q ss_pred ccCccccCccc-cccccccchhhhhhcCCCcccCCCCC
Q 007200 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTN 184 (613)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~ 184 (613)
|++|+|+.... ..+..+++|+.|+|++|++....+..
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 159 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTT
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccc
Confidence 99999984322 46889999999999999998765543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.18 E-value=2.1e-11 Score=114.79 Aligned_cols=129 Identities=23% Similarity=0.387 Sum_probs=89.5
Q ss_pred CCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCC-------------
Q 007200 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP------------- 134 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------- 134 (613)
.++++.|+|++|.+++..+ +.++++|+.|++++|.++ .++ .+..+++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 4577888888888775433 777788888888888776 344 36777788888877777653211
Q ss_pred -------cccccccccccccccCccccCccccccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCCC
Q 007200 135 -------TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 135 -------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~ 203 (613)
..+.++++|++|++++|.+.+.. .+.++++|+.|+|++|++++.+ ....+++|+.|++++|+++..
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTSCCCBC
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCCh-hhcCCCCCCEEECcCCcCCCC
Confidence 23455667777777777776332 3677788888888888887643 356677888888888877654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=3.3e-11 Score=114.55 Aligned_cols=97 Identities=18% Similarity=0.295 Sum_probs=77.6
Q ss_pred ccceeEEeCCC----------CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCC-ccccccCCcCCeEeccC
Q 007200 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYL 126 (613)
Q Consensus 58 C~~~gv~c~~~----------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L~Ls~ 126 (613)
|....|.|... .++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++.+++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45556888531 36999999999999776778999999999999999988644 45688888888888764
Q ss_pred -ccCCCCCCcccccccccccccccCcccc
Q 007200 127 -NNLNGPIPTTLGKLSKLRFLRLNNNSLM 154 (613)
Q Consensus 127 -N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 154 (613)
|.+....+..|.++++|+.|++++|++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 6777667777888888888888888776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=2.9e-11 Score=123.07 Aligned_cols=126 Identities=31% Similarity=0.423 Sum_probs=62.8
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
.+..+++++|.+++..+ +..+++|+.|++++|.++. ++ .+..+++|+.|++++|.+++.. .+..+++|++|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--cccccccCCEeecc
Confidence 45555555555554332 3344555555555555552 22 3555555555555555555432 24455555555555
Q ss_pred CccccCccc--------------------cccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 150 NNSLMGEIP--------------------RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 150 ~N~l~~~~~--------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
+|++++..+ ..+..+++++.|++++|+|++.++ ...+++|+.|++++|.++.
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC
Confidence 555543211 113334455555555555554432 3445555555555555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.06 E-value=1.7e-10 Score=108.41 Aligned_cols=127 Identities=24% Similarity=0.406 Sum_probs=95.0
Q ss_pred CCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccc
Q 007200 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 148 (613)
.+++.|++.+|+|+. + ..+.++++|+.|+|++|.|++..| +..+++|++|++++|.++. + ..+.++++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccccccc
Confidence 579999999999985 4 358999999999999999996443 8999999999999999984 3 46889999999999
Q ss_pred cCccccCccc--------------------cccccccchhhhhhcCCCcccCCCCCCCCCccccccccCCCCCC
Q 007200 149 NNNSLMGEIP--------------------RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 149 ~~N~l~~~~~--------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~ 202 (613)
++|...+..+ ..+..+++|+.|++++|.++...+ ...+++|+.|++++|.+..
T Consensus 115 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD 187 (227)
T ss_dssp TTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred ccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh-hcccccceecccCCCccCC
Confidence 9998764322 123444556666666666654332 3456666666666666544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=2.6e-10 Score=108.17 Aligned_cols=139 Identities=17% Similarity=0.202 Sum_probs=108.3
Q ss_pred ccceeEEeCCCCCeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCC-Ccc
Q 007200 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI-PTT 136 (613)
Q Consensus 58 C~~~gv~c~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~ 136 (613)
|.-.-+.|.. +.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..
T Consensus 1 ~~~~~C~C~~----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~ 73 (242)
T d1xwdc1 1 CHHRICHCSN----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73 (242)
T ss_dssp CCCSSEEECS----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSS
T ss_pred CcCCcCCCcC----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccc
Confidence 5555678863 47888999998 5665542 58999999999999666668999999999999999998655 457
Q ss_pred cccccccccccccC-ccccCccccccccccchhhhhhcCCCcccCCCCC--CCCCccccccccCCCCCCC
Q 007200 137 LGKLSKLRFLRLNN-NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNP 203 (613)
Q Consensus 137 ~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~l~l~~N~i~~~ 203 (613)
|.+++++++|.+.. |++....+..|.++++|+.|++++|.+...++.. ..+..+..+...++.+...
T Consensus 74 f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp EESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 89999999999864 7788777888999999999999999998654422 3445555556666665543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.75 E-value=1.1e-08 Score=101.96 Aligned_cols=101 Identities=29% Similarity=0.374 Sum_probs=80.6
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCccccccccccccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 149 (613)
+++.|||++|+|+ .+|+ .+++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++... ++|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCC---CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence 6789999999998 4664 3578999999999998 67764 468899999999998 444321 469999999
Q ss_pred CccccCccccccccccchhhhhhcCCCcccCCCCC
Q 007200 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184 (613)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 184 (613)
+|.+. .+|. +..+++|+.|++++|.+...+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccccc
Confidence 99998 5564 578999999999999998766543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=6.6e-10 Score=98.21 Aligned_cols=86 Identities=24% Similarity=0.168 Sum_probs=42.0
Q ss_pred CCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCC--CcccccccccccccccCccccCccccccccccchhhhh
Q 007200 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI--PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171 (613)
Q Consensus 94 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 171 (613)
.+..|++.+|.+. .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+|+.|+
T Consensus 43 ~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~ 121 (162)
T d1koha1 43 IDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121 (162)
T ss_dssp CCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCC
T ss_pred chhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceee
Confidence 3333444444333 33334445556666666666665331 23345556666666666666532221222333456666
Q ss_pred hcCCCcccC
Q 007200 172 LSNNKLTGD 180 (613)
Q Consensus 172 l~~N~l~~~ 180 (613)
+++|+++..
T Consensus 122 L~~Npl~~~ 130 (162)
T d1koha1 122 LDGNSLSDT 130 (162)
T ss_dssp CTTSTTSSS
T ss_pred cCCCCcCcC
Confidence 666666543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.54 E-value=6.9e-08 Score=95.92 Aligned_cols=100 Identities=29% Similarity=0.308 Sum_probs=81.6
Q ss_pred CCCCEEEcccccCCCCCccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCccccccccccchhhhhh
Q 007200 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDL 172 (613)
Q Consensus 93 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 172 (613)
.+|+.|||++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47889999999998 67863 578999999999999 678654 57899999999998 44431 246999999
Q ss_pred cCCCcccCCCCCCCCCccccccccCCCCCCCCC
Q 007200 173 SNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (613)
Q Consensus 173 ~~N~l~~~~~~~~~~~~l~~l~l~~N~i~~~~~ 205 (613)
++|.|+..+ ..+.++.|+.|++++|.+...+.
T Consensus 106 ~~n~l~~lp-~~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 106 SNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CSSCCSSCC-CCTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccccccc-chhhhccceeecccccccccccc
Confidence 999999765 45788999999999998876543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=1.1e-08 Score=99.08 Aligned_cols=129 Identities=19% Similarity=0.246 Sum_probs=64.2
Q ss_pred CeEEEEcCCCCcccccchhhhCCCCCCEEEcccc-cCCCC-CccccccCCcCCeEeccCc-cCCCC-CCccccc-ccccc
Q 007200 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN-NISGK-VPEELGNLTNLVSLDLYLN-NLNGP-IPTTLGK-LSKLR 144 (613)
Q Consensus 70 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~ 144 (613)
+++.|+|+++.++......+..+++|+.|+|+++ .++.. +...+.++++|++|+|+++ .++.. +...+.. .++|+
T Consensus 72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~ 151 (284)
T d2astb2 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151 (284)
T ss_dssp CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccc
Confidence 4555555555554444444555555555555552 33311 1111234455555555553 22211 1111222 24455
Q ss_pred cccccCc--cccCc-cccccccccchhhhhhcCCC-cccCC-CCCCCCCccccccccCC
Q 007200 145 FLRLNNN--SLMGE-IPRSLTNVNSLQVLDLSNNK-LTGDI-PTNGSFSLFTPISFANN 198 (613)
Q Consensus 145 ~L~L~~N--~l~~~-~~~~~~~l~~L~~L~l~~N~-l~~~~-~~~~~~~~l~~l~l~~N 198 (613)
.|+|+++ .++.. +...+.++++|+.|++++|. +++.. .....+++|+.|+++++
T Consensus 152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred hhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 5555542 22211 12223457889999998864 66433 34467788999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=8e-09 Score=91.03 Aligned_cols=88 Identities=25% Similarity=0.132 Sum_probs=67.9
Q ss_pred ccchhhhCCCCCCEEEcccccCCCCC--ccccccCCcCCeEeccCccCCCCCCcccccccccccccccCccccCcccc--
Q 007200 84 QLVSQLGQLTNLQYLELYSNNISGKV--PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-- 159 (613)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~i~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-- 159 (613)
.++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+...+-.+....+|+.|+|++|.+......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~ 135 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccch
Confidence 44555678999999999999999542 45678899999999999999954443455567899999999999865432
Q ss_pred -----ccccccchhhhh
Q 007200 160 -----SLTNVNSLQVLD 171 (613)
Q Consensus 160 -----~~~~l~~L~~L~ 171 (613)
.+..+|+|+.||
T Consensus 136 ~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 136 TYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHHTTSTTCCEET
T ss_pred hHHHHHHHHCCCCCEEC
Confidence 245677777765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=7.9e-07 Score=84.43 Aligned_cols=149 Identities=13% Similarity=0.044 Sum_probs=95.5
Q ss_pred HHHHHhhCCCCCCccccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcc-cCccceeeEEEEcCCce
Q 007200 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (613)
Q Consensus 282 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 360 (613)
++....+.|...+..+-++.+.||+... +++.+++|+....... ....+.+|..++..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3444445665555433344568998865 4667888887654322 2234667888877664 33366778888888889
Q ss_pred EEEEecccCCcchhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 007200 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------- 408 (613)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------- 408 (613)
++||++++|.++.+..... .....++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998776543211 01122334444444444431
Q ss_pred ---------------------C---CCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 409 ---------------------C---DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 409 ---------------------~---~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
. .+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 22488999999999999876677999998863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.40 E-value=9.2e-09 Score=102.69 Aligned_cols=132 Identities=20% Similarity=0.219 Sum_probs=63.7
Q ss_pred CeEEEEcCCCCccc----ccchhhhCCCCCCEEEcccccCCCC-----CccccccCCcCCeEeccCccCCCC----CCcc
Q 007200 70 SVTRVDLGNANLSG----QLVSQLGQLTNLQYLELYSNNISGK-----VPEELGNLTNLVSLDLYLNNLNGP----IPTT 136 (613)
Q Consensus 70 ~l~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 136 (613)
.++.|++++|.++. .+...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 34455555555431 1223344555666666666665421 223345556666666666665421 2234
Q ss_pred cccccccccccccCccccCccc----ccccc--ccchhhhhhcCCCcccCC-----CCC-CCCCccccccccCCCCC
Q 007200 137 LGKLSKLRFLRLNNNSLMGEIP----RSLTN--VNSLQVLDLSNNKLTGDI-----PTN-GSFSLFTPISFANNQLN 201 (613)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~----~~~~~--l~~L~~L~l~~N~l~~~~-----~~~-~~~~~l~~l~l~~N~i~ 201 (613)
+..+++|++|+|++|.|++... ..+.. .+.|+.|++++|.|+... ... ...+.|+.|++++|.+.
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 4555666666666666653211 12211 244566666666654211 000 12345566666666553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=9.8e-09 Score=106.13 Aligned_cols=111 Identities=25% Similarity=0.302 Sum_probs=87.0
Q ss_pred CCeEEEEcCCCCccccc-chhhhCCCCCCEEEcccccCCC----CCccccccCCcCCeEeccCccCCCC----CCcccc-
Q 007200 69 NSVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPTTLG- 138 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 138 (613)
.+|+.||++.|+++... ...+..+++|+.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998532 4557788999999999999873 3456678899999999999998621 122222
Q ss_pred cccccccccccCccccCc----cccccccccchhhhhhcCCCccc
Q 007200 139 KLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTG 179 (613)
Q Consensus 139 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~ 179 (613)
...+|++|+|++|+++.. ++..+..+++|+.|+|++|.|+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235799999999999753 45677888999999999999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=1.5e-08 Score=98.14 Aligned_cols=133 Identities=22% Similarity=0.256 Sum_probs=97.4
Q ss_pred CCCeEEEEcCCCCcccc-cchhhhCCCCCCEEEcccccCCCCCccccccCCcCCeEeccCc-cCCCC-CCcccccccccc
Q 007200 68 ENSVTRVDLGNANLSGQ-LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGP-IPTTLGKLSKLR 144 (613)
Q Consensus 68 ~~~l~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~ 144 (613)
..+++.|||+++.++.. +...+.++++|++|+|++|.++...+..+..+++|++|+|+++ .++.. +...+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 35799999999998744 4556889999999999999998777788999999999999995 56522 223345789999
Q ss_pred cccccCc-cccCc-cccccc-cccchhhhhhcCC--CcccC-CCC-CCCCCccccccccCCCC
Q 007200 145 FLRLNNN-SLMGE-IPRSLT-NVNSLQVLDLSNN--KLTGD-IPT-NGSFSLFTPISFANNQL 200 (613)
Q Consensus 145 ~L~L~~N-~l~~~-~~~~~~-~l~~L~~L~l~~N--~l~~~-~~~-~~~~~~l~~l~l~~N~i 200 (613)
+|+|+++ .++.. +...+. ..++|+.|+++++ .++.. +.. ...+++|+.|++++|..
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~ 187 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 187 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccC
Confidence 9999995 45422 222333 3478999999875 34321 111 14578899999998754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.26 E-value=3.4e-08 Score=98.43 Aligned_cols=132 Identities=21% Similarity=0.226 Sum_probs=72.4
Q ss_pred CCeEEEEcCCCCcccc----cchhhhCCCCCCEEEcccccCCCCCc----cc---------cccCCcCCeEeccCccCCC
Q 007200 69 NSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVP----EE---------LGNLTNLVSLDLYLNNLNG 131 (613)
Q Consensus 69 ~~l~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~p----~~---------~~~l~~L~~L~Ls~N~l~~ 131 (613)
++++.|+|++|.++.. +...+...++|+.|+|++|.++..-. .. ....+.|+.|++++|.++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 3566677776666542 23344456667777776666541100 00 1234566666666666652
Q ss_pred C----CCcccccccccccccccCccccCc-----cccccccccchhhhhhcCCCcccC-----CCCCCCCCccccccccC
Q 007200 132 P----IPTTLGKLSKLRFLRLNNNSLMGE-----IPRSLTNVNSLQVLDLSNNKLTGD-----IPTNGSFSLFTPISFAN 197 (613)
Q Consensus 132 ~----~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~ 197 (613)
. +...+..++.|+.|+|++|+|... +...+..+++|+.|+|++|.++.. ......+++|+.|++++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 222344566677777777776531 233455666777777777776532 11223456667777776
Q ss_pred CCC
Q 007200 198 NQL 200 (613)
Q Consensus 198 N~i 200 (613)
|.+
T Consensus 253 n~i 255 (344)
T d2ca6a1 253 CLL 255 (344)
T ss_dssp CCC
T ss_pred Ccc
Confidence 654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=1.1e-05 Score=75.75 Aligned_cols=142 Identities=15% Similarity=0.079 Sum_probs=85.4
Q ss_pred cccCcC-cEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhccc--CccceeeEEEEcCCceEEEEecccCCcc
Q 007200 296 LGRGGF-GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (613)
Q Consensus 296 ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (613)
+..|.. +.||+....++..+++|........ .+..|...++.+.. -.+.+++.+..+++..+++|+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 445554 5789998887888999986544322 35677777776643 3356778888888888999999988776
Q ss_pred hhhh-----------------hccCCCCCCC--CHHHHHHHHH--------------------HHHHHHHHHHhcC----
Q 007200 373 ASCL-----------------RERGQSQPPL--NWSVRKQIAL--------------------GAARGLAYLHDHC---- 409 (613)
Q Consensus 373 ~~~l-----------------~~~~~~~~~l--~~~~~~~i~~--------------------~i~~~L~~LH~~~---- 409 (613)
.+.. |.......++ .......-.. .....+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 4421 1000000000 0000000000 0111223333221
Q ss_pred CCCeEecCCCCCceeecCCCcEEEecccccee
Q 007200 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 410 ~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
.+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22489999999999999886678999998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=5.7e-08 Score=100.20 Aligned_cols=110 Identities=24% Similarity=0.237 Sum_probs=84.4
Q ss_pred CCCCEEEcccccCCCCC-ccccccCCcCCeEeccCccCCC----CCCcccccccccccccccCccccCc----cccccc-
Q 007200 93 TNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLT- 162 (613)
Q Consensus 93 ~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~- 162 (613)
.+|+.|||++|+|++.. ...+..+++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998532 4457788999999999999873 2455678899999999999999632 233333
Q ss_pred cccchhhhhhcCCCcccCC-----CCCCCCCccccccccCCCCCC
Q 007200 163 NVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLNN 202 (613)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~i~~ 202 (613)
...+|+.|+|++|+|+... .....+++|+.|++++|.+..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 2357999999999998542 223567899999999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.97 E-value=8.4e-07 Score=78.05 Aligned_cols=86 Identities=15% Similarity=0.167 Sum_probs=57.0
Q ss_pred CCeEEEEcCCC-Ccccc----cchhhhCCCCCCEEEcccccCCC----CCccccccCCcCCeEeccCccCCCC----CCc
Q 007200 69 NSVTRVDLGNA-NLSGQ----LVSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPT 135 (613)
Q Consensus 69 ~~l~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 135 (613)
++++.|+|+++ .++.. +...+...+.|+.|+|++|.++. .+...+...+.|++|+|++|.|+.. +..
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56888888764 46422 33456667778888888888762 3334556667888888888887732 223
Q ss_pred ccccccccccccccCcccc
Q 007200 136 TLGKLSKLRFLRLNNNSLM 154 (613)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~ 154 (613)
.+...++|++|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 4556677888888777654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=6e-05 Score=75.53 Aligned_cols=77 Identities=10% Similarity=-0.022 Sum_probs=48.5
Q ss_pred CccccCcCcEEEEEEeC-CCCEEEEEEeccc------cCcccHHHHHHHHHHHhhcc-c--CccceeeEEEEcCCceEEE
Q 007200 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEE------RTQGGELQFQTEVEMISMAV-H--RNLLRLRGFCMTPTERLLV 363 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 363 (613)
+.||.|....||+.... +++.++||.-... .......+...|.+.+..+. + ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999876 4678999975421 11112234556777776553 2 345555544 45567899
Q ss_pred EecccCCcc
Q 007200 364 YPFMVNGSV 372 (613)
Q Consensus 364 ~e~~~~gsL 372 (613)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.48 E-value=8.4e-06 Score=71.32 Aligned_cols=110 Identities=18% Similarity=0.190 Sum_probs=69.4
Q ss_pred CCCeEEEEcCC-CCccc----ccchhhhCCCCCCEEEcccccCCCC----CccccccCCcCCeEeccCccCCCC----CC
Q 007200 68 ENSVTRVDLGN-ANLSG----QLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGP----IP 134 (613)
Q Consensus 68 ~~~l~~L~l~~-n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 134 (613)
.+.++.|+|++ +.++. .+...+...++|+.|+|++|.++.. +...+...++|+.|++++|.++.. +.
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35788888887 45652 2334566778888888888887632 334466678888888888887632 23
Q ss_pred ccccccccccc--ccccCccccC----ccccccccccchhhhhhcCCCc
Q 007200 135 TTLGKLSKLRF--LRLNNNSLMG----EIPRSLTNVNSLQVLDLSNNKL 177 (613)
Q Consensus 135 ~~~~~l~~L~~--L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l 177 (613)
..+...++|+. |++++|.+.. .+...+...++|+.|+++.|..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 45566777775 4445666653 2333445566666666655543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.46 E-value=1.2e-05 Score=70.41 Aligned_cols=91 Identities=18% Similarity=0.185 Sum_probs=68.3
Q ss_pred hhCCCCCCEEEcccc-cCCCC----CccccccCCcCCeEeccCccCCC----CCCcccccccccccccccCccccCc---
Q 007200 89 LGQLTNLQYLELYSN-NISGK----VPEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE--- 156 (613)
Q Consensus 89 ~~~l~~L~~L~L~~N-~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~--- 156 (613)
..+.+.|+.|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|++|+|++|.|+..
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 346789999999974 56532 33457778899999999999973 2345566788999999999999853
Q ss_pred -cccccccccchhhhhhcCCCccc
Q 007200 157 -IPRSLTNVNSLQVLDLSNNKLTG 179 (613)
Q Consensus 157 -~~~~~~~l~~L~~L~l~~N~l~~ 179 (613)
+-..+...++|+.|+|++|.+..
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHHhCCcCCEEECCCCcCCC
Confidence 23456667889999998887653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.0012 Score=63.77 Aligned_cols=136 Identities=16% Similarity=0.149 Sum_probs=78.1
Q ss_pred cEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCcc--ceeeE-----EEEcCCceEEEEecccCCcchh
Q 007200 302 GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRLRG-----FCMTPTERLLVYPFMVNGSVAS 374 (613)
Q Consensus 302 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 374 (613)
-.||++...+|+.|++|+.+.... ...++..|...+..+....+ +..+. .+......+.+++++.|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 589999999999999999875533 34567788888777653222 11111 1233456788999987754421
Q ss_pred h--------------hhc----cC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 007200 375 C--------------LRE----RG-QSQPPLNWS-------------------VRKQIALGAARGLAYLHD----HCDPK 412 (613)
Q Consensus 375 ~--------------l~~----~~-~~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~----~~~~~ 412 (613)
. ++. .. ......+.. ....+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 111 00 001111111 111112222223333332 23457
Q ss_pred eEecCCCCCceeecCCCcEEEecccccee
Q 007200 413 IIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (613)
Q Consensus 413 ivH~Dlk~~NIll~~~~~~kl~DfGla~~ 441 (613)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.00 E-value=1.3e-05 Score=70.03 Aligned_cols=114 Identities=18% Similarity=0.193 Sum_probs=79.7
Q ss_pred cchhhhCCCCCCEEEccc-ccCCC----CCccccccCCcCCeEeccCccCCCC----CCcccccccccccccccCccccC
Q 007200 85 LVSQLGQLTNLQYLELYS-NNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMG 155 (613)
Q Consensus 85 ~~~~~~~l~~L~~L~L~~-N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 155 (613)
+.....+.+.|+.|+|++ |.|+. .+-.++...++|++|+|++|.++.. +...+...++|+.|++++|.+..
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 444556789999999998 56762 1344567889999999999998743 33456678999999999999874
Q ss_pred c----cccccccccchhh--hhhcCCCcccCC-----CCCCCCCccccccccCC
Q 007200 156 E----IPRSLTNVNSLQV--LDLSNNKLTGDI-----PTNGSFSLFTPISFANN 198 (613)
Q Consensus 156 ~----~~~~~~~l~~L~~--L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N 198 (613)
. +...+...++|+. |++++|.+.... ......+.|+.|+++.+
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 3 3356677788886 455677775321 11134567777777655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.49 E-value=0.0047 Score=61.26 Aligned_cols=73 Identities=14% Similarity=0.185 Sum_probs=49.3
Q ss_pred CccccCcCcEEEEEEeCC--------CCEEEEEEeccccCcccHHHHHHHHHHHhhcccCcc-ceeeEEEEcCCceEEEE
Q 007200 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 364 (613)
Q Consensus 294 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 364 (613)
+.|+.|-.-.+|++...+ .+.|.+++.-. . .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 467888889999998653 34566666542 1 233456788888887764444 467776642 6899
Q ss_pred ecccCCcch
Q 007200 365 PFMVNGSVA 373 (613)
Q Consensus 365 e~~~~gsL~ 373 (613)
||++|..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.017 Score=54.93 Aligned_cols=159 Identities=10% Similarity=-0.000 Sum_probs=82.2
Q ss_pred cCHHHHHHHhhCCCCCCcc-----ccCcCcEEEEEEeCCCCEEEEEEeccccCcccHHHHHHHHHHHhhcccCcc--cee
Q 007200 278 FSLRELQVATDNFSNRNIL-----GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRL 350 (613)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~i-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l 350 (613)
.+.++++.....|.+.+.. ..|---+.|+.+..+|+ +++|+....... ..+..|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 4567777778888775543 35556788999877554 899988653222 234456666666543222 111
Q ss_pred eE------EEEcCCceEEEEecccCCcchhhh--------------hcc----CCC-CCCCCH-----------------
Q 007200 351 RG------FCMTPTERLLVYPFMVNGSVASCL--------------RER----GQS-QPPLNW----------------- 388 (613)
Q Consensus 351 ~~------~~~~~~~~~lv~e~~~~gsL~~~l--------------~~~----~~~-~~~l~~----------------- 388 (613)
+- +..-......++.+..+......- +.. ... ......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 011233445666666554332110 000 000 000000
Q ss_pred -HHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEeccccce
Q 007200 389 -SVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (613)
Q Consensus 389 -~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~ 440 (613)
......+..+...+...+. ..+.+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111112222222222221 234489999999999999998777899999885
|